Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,collagen fibril organization (GO:0030199),0.7685273901408279,2.1918606474271374,0.0,0.0,0.0,29/88,5.17%,COL15A1;COL4A1;CYP1B1;COL24A1;COL18A1;COL1A2;COL4A2;COL27A1;COL7A1;COL1A1;COL3A1;LUM;COL8A1;TLL2;COL6A3;COL23A1;COL5A2;COL11A2;COL5A3;COL5A1;PLOD2;ADAMTS2;COL13A1;DPT;COL11A1;SERPINH1;DDR2;NF1;BMP1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.8405631298230518,-2.1690162237200803,0.0,0.012107521128714245,0.012,5/13,4.05%,ATP1A2;ATP1B3;SLC12A2;ATP1B1;KCNJ2
prerank,external encapsulating structure organization (GO:0045229),0.6970724028909507,2.1080341492231227,0.0,0.000510930405144149,0.001,65/205,8.72%,MMP3;MMP13;COL15A1;COL4A1;MMP27;COL24A1;COL18A1;COL1A2;COL4A2;IBSP;COL27A1;COL7A1;COL1A1;DCN;COL3A1;MMP2;LAMA2;SPP1;POSTN;LUM;COL8A1;COL6A3;ITGB8;COL23A1;COL5A2;MMP14;HSPG2;LAMB1;FBN2;SPARC;ADAM19;BGN;COL11A2;LAMA1;COL5A3;NID1;COL5A1;ADAMTS2;COL13A1;ADAM12;ITGB5;ST7;LAMC1;ITGA8;VCAN;MMP11;COL11A1;LAMA4;FBN1;DDR2;NF1;ADAMTS15;ADAMTS5;ADAMTS4;ICAM1;ADAMTS14;LOXL1;ADAMTS12;ADAMTS1;ITGA11;ADAMTS9;ADAMTS18;ITGA3;MMP16;PXDN
prerank,extracellular structure organization (GO:0043062),0.6946256602106157,2.0999870917161467,0.0,0.0006812405401921986,0.002,66/204,9.03%,MMP3;MMP13;COL15A1;COL4A1;MMP27;COL24A1;COL18A1;COL1A2;COL4A2;IBSP;COL27A1;COL7A1;COL1A1;DCN;COL3A1;MMP2;LAMA2;SPP1;POSTN;LUM;COL8A1;COL6A3;ITGB8;COL23A1;COL5A2;MMP14;HSPG2;LAMB1;FBN2;SPARC;ADAM19;BGN;COL11A2;LAMA1;COL5A3;NID1;COL5A1;ADAMTS2;COL13A1;ADAM12;ITGB5;ST7;LAMC1;ITGA8;VCAN;MMP11;COL11A1;LAMA4;FBN1;DDR2;NF1;ADAMTS15;ADAMTS5;ADAMTS4;ICAM1;ADAMTS14;LOXL1;ADAMTS12;ADAMTS1;ITGA11;ADAMTS9;ADAMTS18;ITGA3;MMP16;PXDN;TGFBR1
prerank,extracellular matrix organization (GO:0030198),0.6862135603192083,2.091928201081607,0.0,0.001021860810288298,0.004,83/276,8.76%,MMP3;MMP13;COL15A1;COL4A1;MMP27;SCUBE1;CYP1B1;COL24A1;COL18A1;COL1A2;COL4A2;IBSP;COL27A1;COL7A1;COL1A1;DCN;COL3A1;MMP2;LAMA2;CREB3L1;GPM6B;SPP1;POSTN;LUM;COL8A1;TLL2;COL6A3;ITGB8;COL23A1;COL5A2;MMP14;SH3PXD2B;HSPG2;LAMB1;FBN2;SPARC;ADAM19;BGN;COL11A2;LAMA1;COL5A3;NID1;COL5A1;PLOD2;ADAMTS2;COL13A1;ADAM12;ITGB5;FLRT2;ST7;LAMC1;DPT;TIMP1;ITGA8;VCAN;MMP11;COL11A1;LAMA4;FBN1;KLK2;SERPINH1;CTSS;DDR2;NF1;BMP1;ADAMTS15;ADAMTS5;ADAMTS4;CTSK;ICAM1;ADAMTS14;CTSL;LOXL1;ADAMTS12;CAPN2;ADAMTS1;ITGA11;ADAMTS9;ADAMTS18;ITGA3;MMP16;PXDN;LCP1
prerank,extracellular matrix disassembly (GO:0022617),0.769837872880671,2.0857790997998067,0.0,0.001021860810288298,0.004,21/53,8.76%,MMP3;MMP13;SCUBE1;MMP2;TLL2;MMP14;SH3PXD2B;LAMC1;TIMP1;MMP11;KLK2;CTSS;BMP1;ADAMTS15;ADAMTS5;ADAMTS4;CTSK;CTSL;CAPN2;MMP16;LCP1
prerank,cellular component disassembly (GO:0022411),0.7701127766019965,2.083925052948558,0.0,0.001021860810288298,0.005,21/53,8.76%,MMP3;MMP13;SCUBE1;MMP2;TLL2;MMP14;SH3PXD2B;LAMC1;TIMP1;MMP11;KLK2;CTSS;BMP1;ADAMTS15;ADAMTS5;ADAMTS4;CTSK;CTSL;CAPN2;MMP16;LCP1
prerank,regulation of humoral immune response (GO:0002920),0.7628860055434665,2.036658338168803,0.0,0.0017517613890656537,0.009,8/44,6.33%,C6;CFH;C3;SERPING1;GATA6;PROS1;C1QB;C7
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7588490107771436,2.0157450295023964,0.0,0.003321047633436969,0.021,9/42,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCR1;CCL5;CXCL10
prerank,regulation of complement activation (GO:0030449),0.7575911794526635,2.004388941326953,0.0,0.004314523421217258,0.031,7/40,6.33%,C6;CFH;C3;SERPING1;PROS1;C1QB;C7
prerank,regulation of immune effector process (GO:0002697),0.7561424648036705,1.9964735811063794,0.0,0.00531367621349915,0.042,7/41,6.33%,C6;CFH;C3;SERPING1;PROS1;C1QB;C7
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7826289816791451,-1.9801106633875805,0.0,0.17183366524982907,0.279,8/12,18.73%,DMD;ATP1B3;ATP1B1;WNK4;WNK3;ANK3;WNK2;FXYD1
prerank,response to interferon-gamma (GO:0034341),0.7027859747920194,1.976978751139317,0.0,0.008639368668801065,0.073,20/67,10.36%,CCL11;CCL7;IL23R;STAT1;SYNCRIP;TLR2;CD40;XCL1;CASP1;AIF1;LGALS9;CYP27B1;TRIM21;SHFL;CCL5;SP100;WNT5A;GBP7;GAPDH;CCL2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5788124897884613,-1.968456525061976,0.0,0.14063351464891163,0.333,17/30,9.23%,TJP1;DMD;SLC12A2;TJP2;OCLN;JAM2;PECAM1;CLDN5;ESAM;ACTB;CDH5;GJB6;SLC1A1;WNK3;LSR;CLDN12;VCL
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.8080149909836071,1.9590531337168784,0.0,0.01217717465593555,0.116,5/24,0.97%,RORA;CYP1B1;C3;SULF1;CCBE1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.7427438017472364,1.9582354118281902,0.0,0.011319073590885761,0.117,8/38,3.66%,RORA;NR1H4;ADIPOQ;TNIP1;STAT1;TNFAIP3;TLE1;TREM2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6794376875599185,-1.9558232857068774,0.0,0.12596478712758474,0.384,5/18,5.17%,UNC13C;UNC13B;GRID2;GRIK4;GRIA2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.7536393289863343,1.9535534384959112,0.0012755102040816326,0.012408309839215046,0.135,7/33,4.31%,RUNX1;IL34;IL23R;ZFP36L1;TNFSF11;PRKCA;CCR1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7947260167126382,1.9522359037720893,0.0,0.011921709453363476,0.139,5/26,0.97%,RORA;CYP1B1;C3;SULF1;CCBE1
prerank,membrane repolarization (GO:0086009),-0.7028397689446699,-1.9495862262617445,0.003236245954692557,0.10915395971425458,0.411,5/15,4.05%,ATP1A2;ATP1B3;KCND3;ATP1B1;KCNJ2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.762818761358874,1.941914114517999,0.0,0.01398671984082108,0.17,15/34,14.12%,RORA;ENPP1;ADIPOQ;YAP1;ASXL1;ZFP36L2;ZFPM2;E2F1;RUNX1T1;TRIO;WNT5A;WWTR1;TNF;SMAD3;TRIB3
prerank,potassium ion homeostasis (GO:0055075),-0.6197477763845626,-1.935996946227826,0.0,0.10974381330770476,0.469,7/23,4.05%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B1;SLC12A6;KCNJ2
prerank,response to peptide (GO:1901652),0.759963747716089,1.9331921290639713,0.0,0.016289663505184043,0.202,11/33,11.01%,MMP3;MMP13;MMP2;CACNA1A;STAT1;IRS1;STAT3;STAT5A;ANXA1;GNAI1;ERBIN
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.737264042101501,-1.9301692898878837,0.0,0.1021821563390389,0.493,5/13,5.26%,DDO;GLUL;MTHFS;ASPA;GLUD1
prerank,response to UV-A (GO:0070141),0.872731642623099,1.9298636696932574,0.0,0.016633623189692852,0.215,5/14,5.20%,MMP3;MMP2;TIMP1;EGFR;PPID
prerank,establishment of endothelial barrier (GO:0061028),-0.5772480608972407,-1.9298473528526983,0.00425531914893617,0.08964222374144201,0.493,13/29,12.63%,TJP1;TJP2;PECAM1;PPP1R16B;RAPGEF3;EZR;RAPGEF2;RAPGEF6;PDE4D;PDE2A;RAP1A;ROBO4;RDX
prerank,chondrocyte differentiation (GO:0002062),0.7566671586752172,1.9022682650023268,0.0,0.030440695717009296,0.372,6/32,1.86%,RUNX1;SLC39A14;RUNX2;RUNX3;SULF1;SOX5
prerank,endoderm formation (GO:0001706),0.7539435635736682,1.8999863026730748,0.0,0.030093800862990374,0.384,10/35,3.96%,COL4A2;COL7A1;MMP2;COL8A1;MMP14;LAMB1;ITGB5;DUSP2;DUSP5;COL11A1
prerank,muscle cell development (GO:0055001),-0.5889756766881813,-1.8994983586359977,0.0,0.11507319226607043,0.618,9/30,9.42%,NEBL;DMD;SGCZ;ANK2;MYOF;CXADR;RAMP2;DYSF;IGF1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5456740138429806,-1.898306390609506,0.0,0.10514916426398756,0.622,15/37,16.29%,GRM7;GRM1;GRID2;GRIK4;GRM8;PLCB1;GRIN3A;GRIA2;GRM3;HOMER2;CLN3;APP;GRIN2B;GRIK2;GRM5
prerank,acute inflammatory response (GO:0002526),0.7919246146227522,1.8971139520064007,0.0013175230566534915,0.030217883961382527,0.398,4/23,2.18%,HP;HPR;LBP;CRP
prerank,regulation of protein processing (GO:0070613),0.8098384677932389,1.8960039902829686,0.0,0.02916948131186596,0.399,5/21,2.43%,RUNX1;CCBE1;NKD2;SERPINE2;LRRK2
prerank,cellular response to chemokine (GO:1990869),0.7061681602680508,1.8941666876801602,0.0012106537530266344,0.028789817611600745,0.408,9/46,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCR1;CCL5;CXCL10
prerank,cartilage development (GO:0051216),0.7017318193011728,1.8934772126575572,0.0,0.02818632735045222,0.414,8/49,1.86%,RUNX1;SLC39A14;RUNX2;RUNX3;SULF1;ITGB8;COL11A2;SOX5
prerank,regulation of acute inflammatory response (GO:0002673),0.8360427554345214,1.8917727344978608,0.0,0.027958111769487832,0.423,3/18,2.01%,OSMR;PTGES;CREB3L3
prerank,regulation of T cell proliferation (GO:0042129),0.6795646691300484,1.890689239419399,0.0,0.027629544216641284,0.428,12/61,8.96%,GLMN;IL23R;VSIG4;TNFRSF21;SPN;CD276;NCK1;AIF1;NCK2;CCL5;GPNMB;ANXA1
prerank,regulation of sodium ion transport (GO:0002028),-0.5552481309445276,-1.8906402520460064,0.004739336492890996,0.10532696702182183,0.66,14/34,8.96%,FGF12;NKAIN2;SLMAP;SNTA1;WNK4;WNK3;PER1;NKAIN3;ATP2B4;NKAIN4;GPD1L;SIK1;NKAIN1;ANK3
prerank,regulation of defense response (GO:0031347),0.6656279435149641,1.8900603028353207,0.0,0.02679546124755981,0.429,24/76,9.14%,CASP4;ZBP1;IL1RL2;SBNO2;PTGES;BCL6;LACC1;IL1R1;JAK2;XCL1;BIRC3;CASP1;TREM2;APOE;CASP12;PIK3AP1;IRF1;ADAMTS12;TIRAP;CELF1;AREL1;PSMA6;ANXA1;WNT5A
prerank,cellular response to UV-A (GO:0071492),0.8971730202635833,1.883076571558267,0.0,0.02996241875881045,0.477,4/11,5.20%,MMP3;MMP2;TIMP1;PPID
prerank,response to amyloid-beta (GO:1904645),0.7121698947369026,1.8785916591680085,0.0,0.03167768511893724,0.504,11/44,6.91%,MMP3;MMP13;CASP4;MMP2;CACNA1A;LRP1;CACNA2D1;TREM2;CACNB1;CD36;ICAM1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.5259969756764672,-1.874770648178143,0.0,0.11649608470641079,0.725,11/41,7.29%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B1;SLC12A6;KCNJ2;KCNJ3;KCNJ13;ABCC9;KCNJ10
prerank,cellular response to interferon-gamma (GO:0071346),0.6389373832884667,1.873523782883154,0.0,0.03358515863147539,0.529,25/88,10.36%,CCL11;CCL7;MID1;JAK1;STAT1;SYNCRIP;TLR2;IRF7;JAK2;XCL1;CASP1;CAMK2D;AIF1;LGALS9;TRIM21;CCL5;ICAM1;IRF1;TRIM8;SP100;WNT5A;OASL;GBP7;GAPDH;CCL2
prerank,signal release from synapse (GO:0099643),-0.5149358539432379,-1.8641251915729795,0.0,0.12336775966654395,0.769,17/43,17.24%,SNAP25;SYN3;NRXN1;LIN7A;PCLO;NRXN2;CPLX1;RIMS1;SNAPIN;DNAJC5;GAD1;SYN2;PTPRN2;LIN7C;NAAA;SNPH;PIP5K1C
prerank,lipid catabolic process (GO:0016042),0.7997339650407441,1.8639193593604229,0.0027662517289073307,0.03975368184540926,0.587,5/18,8.79%,CEL;PLA1A;LIPC;LPL;HSD11B1
prerank,negative regulation of axon extension (GO:0030517),-0.5688952503812112,-1.8639055347909108,0.004878048780487805,0.11482187619868564,0.771,22/30,30.08%,MAP2;SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;DIP2B;SEMA4D;CDKL3;SEMA5A;MAG;SEMA5B;SEMA3G;TRIM46;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F;RTN4R
prerank,regulation of fibrinolysis (GO:0051917),0.8351446532284978,1.8621233429658504,0.0030581039755351682,0.03991643790188664,0.595,3/13,5.63%,FAP;USF1;APOH
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8539530963336501,1.8619499669605286,0.002962962962962963,0.03886167627005497,0.596,4/13,4.42%,RUNX1;RUNX3;GLI3;SHH
prerank,camera-type eye development (GO:0043010),0.764261264677183,1.86114792677113,0.0,0.038199561466953726,0.603,7/25,5.10%,CYP1B1;FBN2;LAMA1;CACNA1C;TENM3;FBN1;NF1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.7332795741971694,1.8592203673881844,0.00517464424320828,0.03833437839738672,0.617,7/31,8.49%,GLMN;VSIG4;TNFRSF21;SPN;BLK;ATM;GPNMB
prerank,positive regulation of lipid transport (GO:0032370),0.8732847635420479,1.8582560644480182,0.0,0.03831978038581117,0.624,4/12,3.78%,ADIPOQ;SPP1;LRP1;APOE
prerank,regulation of steroid metabolic process (GO:0019218),0.7773462124036548,1.856699322318267,0.0,0.03849929647410506,0.637,6/23,4.96%,RORA;NR1H4;APOE;ABCA2;ABCG1;EPHX2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6873328174478209,-1.856023710732797,0.0,0.11734982017061497,0.797,5/15,5.52%,GRM7;GRM1;GRM8;GRM3;HOMER2
prerank,positive regulation of leukocyte migration (GO:0002687),0.7427133901844102,1.8501799169474549,0.0026246719160104987,0.042568570070694096,0.681,8/27,7.08%,EDN3;PTN;PLVAP;XCL1;MDK;AIF1;ICAM1;MIA3
prerank,negative regulation of nervous system development (GO:0051961),0.8092896033933981,1.8501672521114658,0.001488095238095238,0.04150326983324779,0.681,5/17,6.36%,CCL11;ROBO2;TLR2;SLIT1;PCM1
prerank,triglyceride homeostasis (GO:0070328),0.7510975788036047,1.8471919567627433,0.0,0.04312252619416618,0.703,5/26,5.58%,RORA;NR1H4;LIPC;APOE;ANGPTL4
prerank,regulation of fat cell differentiation (GO:0045598),0.6481549082255261,1.846743459886443,0.0,0.042419685344163,0.704,26/74,14.55%,RORA;ENPP1;ADIPOQ;YAP1;ZFP36L1;ASXL1;CMKLR1;ZFP36L2;ZFPM2;FRZB;E2F1;ASXL2;SFRP1;PPARG;RUNX1T1;CARM1;LPL;TRIO;FTO;WNT5A;WWTR1;TNF;WDFY2;SMAD3;TRIB3;TRPM4
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6397200875332302,-1.8426075183314214,0.003134796238244514,0.1280021103944357,0.842,5/16,15.01%,CLDN5;CLDN12;CLDN11;CLDN14;CLDN1
prerank,negative regulation of T cell activation (GO:0050868),0.713765029062994,1.8315426421152754,0.0,0.05466955335042394,0.788,4/35,1.37%,GLMN;VSIG4;TNFRSF21;SPN
prerank,regulation of small molecule metabolic process (GO:0062012),0.7303545747797028,1.8262772455235958,0.0012953367875647669,0.05829359459621383,0.827,7/28,5.70%,RORA;NR1H4;ADIPOQ;NCOR2;APOE;EPHX2;FOXK2
prerank,regulation of B cell activation (GO:0050864),0.7429019419962981,1.8238095525098097,0.0,0.05987175383916437,0.844,5/25,6.40%,ZFP36L1;SH3KBP1;ZFP36L2;TNFAIP3;AHR
prerank,regulation of inflammatory response (GO:0050727),0.5948342952581832,1.816485100275417,0.0,0.06680698897484827,0.879,38/190,9.14%,RORA;MMP3;NR1H4;CASP4;ZBP1;ADIPOQ;IL1RL2;SBNO2;PTGES;TNIP1;IL16;BCL6;TLR2;LACC1;IL1R1;TNFAIP3;JAK2;CCN4;XCL1;BIRC3;CASP1;TSLP;APOE;MDK;CASP12;MVK;CCL5;PPARG;PIK3AP1;TLR7;ADAMTS12;CELF1;AREL1;PLA2G7;LPL;PSMA6;ANXA1;WNT5A
prerank,endodermal cell differentiation (GO:0035987),0.7262780231971357,1.8129448997430937,0.00258732212160414,0.06959760692680951,0.889,8/31,3.96%,COL4A2;COL7A1;MMP2;COL8A1;MMP14;LAMB1;ITGB5;COL11A1
prerank,skin development (GO:0043588),0.6415020937245421,1.8116686051791413,0.0011235955056179776,0.06948653509960427,0.892,13/65,9.14%,COL1A2;COL1A1;COL3A1;COL5A2;COL5A3;COL5A1;GATA6;UGCG;JAG1;ERRFI1;ITGA3;ANXA1;WNT5A
prerank,positive regulation of interleukin-17 production (GO:0032740),0.7480261948811815,1.8110097552136826,0.0027247956403269754,0.06880529455941206,0.895,3/22,0.90%,NR1H4;IL23R;RFTN1
prerank,regulation of lipid storage (GO:0010883),0.7611940644602652,1.81044819628101,0.0,0.06796417103529721,0.896,10/22,12.29%,C3;CRP;IKBKE;VSTM2A;FBXW7;LPL;FTO;MEST;PTPN2;TNF
prerank,positive regulation of interleukin-12 production (GO:0032735),0.7065849633310817,1.8094524487349324,0.0038560411311053984,0.06779024615452568,0.897,8/31,7.99%,IL23R;IL16;TLR2;CD40;MDK;LGALS9;TIRAP;MAPK11
prerank,positive regulation of lipid localization (GO:1905954),0.8551627953277154,1.807620612006545,0.0,0.06898562293769823,0.905,5/11,8.76%,C3;LRP1;IKBKE;VSTM2A;LPL
prerank,neurotransmitter secretion (GO:0007269),-0.5005827756947865,-1.806738359938519,0.0,0.1778874258141862,0.931,17/44,17.24%,SNAP25;SYN3;NRXN1;LIN7A;PCLO;NRXN2;CPLX1;RIMS1;SNAPIN;DNAJC5;GAD1;SYN2;PTPRN2;LIN7C;NAAA;SNPH;PIP5K1C
prerank,pyroptosis (GO:0070269),0.8134898836093818,1.8043111357689638,0.005961251862891207,0.07190362893932466,0.909,4/15,3.66%,CASP4;ZBP1;CASP1;TREM2
prerank,positive regulation of glial cell differentiation (GO:0045687),0.7812275731233619,1.7968315940209554,0.0,0.08022571380395488,0.932,8/17,9.55%,IL34;SERPINE2;PTN;MDK;PTPRZ1;TENM4;CXCR4;DICER1
prerank,response to fatty acid (GO:0070542),0.7874306231559363,1.7910629194070444,0.0014577259475218659,0.08594984815424905,0.95,7/17,9.23%,NR1H4;IRS1;CD36;GLDC;PID1;LPL;FOXO3
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6697859535208162,-1.784828343079789,0.0,0.210743305800227,0.956,4/14,1.87%,ATP1B3;ATP1B1;ACTN2;ANK2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7694782244242074,1.782941454209122,0.0014326647564469914,0.09659371550343385,0.964,7/19,8.14%,NR1H4;LBP;LGALS9;LY96;PIK3AP1;TIRAP;CD14
prerank,regulation of spindle organization (GO:0090224),0.782222516165096,1.7826136156571333,0.0013812154696132596,0.09532501558832265,0.964,9/18,10.99%,CLTC;PARP3;DYNC1H1;RAE1;GPSM2;BORA;TPX2;SENP6;GNAI1
prerank,negative regulation of blood coagulation (GO:0030195),0.6804035098300476,1.7782872521406234,0.002442002442002442,0.10010650464297992,0.968,7/38,6.23%,KNG1;PDGFRA;SERPING1;SERPINE2;APOE;APOH;PLAT
prerank,tight junction assembly (GO:0120192),-0.47513484853671567,-1.7769642289749261,0.006134969325153374,0.2168079593210652,0.967,18/49,21.14%,OCLN;PECAM1;CLDN5;ESAM;CDH5;RAMP2;APC;LSR;CLDN12;PARD3;PATJ;CLDN11;CLDN14;CLDN1;PARD6G;AFDN;RAB13;MPP7
prerank,response to cytokine (GO:0034097),0.5938532413109597,1.7728103851086654,0.0,0.1071192021819457,0.976,42/141,11.96%,COL3A1;IL23R;ADIPOQ;IL1RL2;OSMR;PTPN7;STAT1;CD40;TIMP1;IL1R1;JAK2;PRKCA;DPYSL3;CASP1;REL;IRAK3;STAT3;IKBKE;PTPN13;ALDH1A2;BCL2;LGALS9;CYP27B1;TRIM21;SHFL;DDOST;EIF2AK2;PTPN6;IRAK2;PTPN18;IFNAR2;PID1;SP100;ANXA1;CXCR4;SETD2;LIFR;PTPN23;PTPN9;PTPN2;CASP8;RHOA
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8452176776454399,1.7720341958733523,0.006329113924050633,0.10665455711449727,0.978,3/10,5.17%,ABCA1;APOE;BMP1
prerank,intestinal lipid absorption (GO:0098856),0.8565382672430806,1.769924818738916,0.0030120481927710845,0.1080447496744827,0.979,4/11,5.55%,CEL;UGCG;LIMA1;CD36
prerank,regulation of execution phase of apoptosis (GO:1900117),0.8425731888067981,1.768501530855424,0.0015408320493066256,0.10831724589055959,0.98,2/11,0.26%,FAP;DLC1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.8420960041535703,1.7656988323420537,0.004594180704441042,0.11105319580197665,0.983,5/11,7.58%,JAK1;STAT1;JAK2;STAT3;CANX
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8450794049584013,1.7631733719982428,0.001584786053882726,0.1134427699548628,0.984,4/11,5.04%,RUNX1;RUNX3;XCL1;LGALS9
prerank,sodium ion homeostasis (GO:0055078),-0.5833905239115016,-1.7626036650191081,0.003472222222222222,0.23879757056941017,0.983,4/21,1.45%,ATP1A2;ATP1B3;SLC12A2;ATP1B1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6622425363045299,-1.761146875757309,0.00949367088607595,0.23088554943621373,0.983,8/13,24.47%,GLUL;NOS3;ALDH4A1;GLUD1;PRODH;GAD1;GLS;GLS2
prerank,negative regulation of T cell proliferation (GO:0042130),0.7127848252708916,1.7598449499199493,0.0025974025974025974,0.11684339702640258,0.986,6/28,8.49%,GLMN;VSIG4;TNFRSF21;SPN;LGALS9;GPNMB
prerank,epithelial cell morphogenesis (GO:0003382),0.7762074431052106,1.7597865756490558,0.005847953216374269,0.11512441098063395,0.986,3/17,3.31%,COL15A1;COL18A1;SIPA1L3
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.6295491237905471,1.758840408218554,0.001122334455667789,0.11500578937608298,0.988,25/72,13.07%,RUNX1;ZBP1;JAK1;STAT1;TNFAIP3;JAK2;BIRC3;CFLAR;TSLP;IRAK3;PTPN6;IRAK2;IFNAR2;PTPN1;ABCE1;CDC37;IL7;LIFR;TNFRSF1A;CBFB;TRIM44;PTPN2;CASP8;TNF;TRAF2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7594710523819697,1.7571461313874024,0.010101010101010102,0.11582105960193037,0.989,4/19,6.74%,RUNX1;CREB3L1;TGFB3;EMILIN1
prerank,acylglycerol homeostasis (GO:0055090),0.7460320453906311,1.756099049342432,0.00546448087431694,0.11592109250829309,0.992,5/20,8.76%,RORA;LIPC;APOE;ANGPTL4;LPL
prerank,lymphocyte chemotaxis (GO:0048247),0.6831776145641667,1.7542757786042282,0.0012755102040816326,0.11715856333609746,0.993,6/34,6.32%,CCL11;CYP7B1;CCL7;XCL1;CCL5;CXCL10
prerank,regulation of plasminogen activation (GO:0010755),0.8211275211146557,1.7524110828889747,0.0061633281972265025,0.11853585399344257,0.995,3/12,6.24%,RUNX1;SERPINE2;ENO1
prerank,T cell differentiation in thymus (GO:0033077),0.8108939843853286,1.7522457312998738,0.0014814814814814814,0.11696708176356334,0.995,4/14,4.42%,ZFP36L1;GLI3;ZFP36L2;SHH
prerank,activin receptor signaling pathway (GO:0032924),0.7774402213788923,1.7514107891197923,0.004310344827586207,0.11671921255293004,0.995,9/15,18.07%,SMAD2;ACVR1;INHBB;TGFBR1;ACVR1B;ACVR2A;ACVR1C;SMAD3;INHBA
prerank,neutrophil migration (GO:1990266),0.6350902539555917,1.7505312672401576,0.0034602076124567475,0.11659011902590731,0.995,14/58,11.44%,CCL11;CXCL5;CCL7;CXCL1;EDN3;JAML;PRTN3;XCL1;CCL5;CXCL10;GBF1;IRAK4;CCL2;TGFB2
prerank,protein autoprocessing (GO:0016540),0.7698051965873531,1.7459674734623247,0.0045662100456621,0.12292709369170848,0.996,5/17,7.12%,CASP4;CASP1;FXN;OMA1;CTSL
prerank,regulation of interleukin-12 production (GO:0032655),0.642855865854124,1.7442673768611696,0.003592814371257485,0.1243127737742724,0.996,11/47,8.33%,IL23R;IL16;CMKLR1;TLR2;CD40;IRAK3;MDK;LGALS9;TIRAP;MAPK11;MAST2
prerank,negative regulation of B cell activation (GO:0050869),0.7407778829164711,1.7441424564598835,0.001392757660167131,0.12291909904810026,0.996,6/21,5.95%,PARP3;TNFRSF21;TNFAIP3;BLK;ATM;SFRP1
prerank,neutrophil chemotaxis (GO:0030593),0.6406190514617343,1.7437092201950126,0.00351288056206089,0.12193320941466079,0.996,12/53,11.44%,CCL11;CXCL5;CCL7;CXCL1;EDN3;JAML;XCL1;CCL5;CXCL10;GBF1;CCL2;TGFB2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6371984052934003,1.7414932747345806,0.0024067388688327317,0.12437880170355257,0.996,20/51,17.64%,IL34;EDN3;CXCL12;PTN;CMKLR1;XCL1;MDK;CCR1;AIF1;LGALS9;CCL5;CXCL10;PLA2G7;PTK2;CALR;VEGFC;IL6R;CREB3;MAPK1;ANO6
prerank,toll-like receptor signaling pathway (GO:0002224),0.6154778821857547,1.7408366978092689,0.0,0.12426603549923644,0.996,21/84,9.80%,NR1H4;LBP;RFTN1;COLEC12;TNIP1;TLR2;BIRC3;IRAK3;CTSS;LGALS9;CD36;LY96;PIK3AP1;CTSK;TLR7;IRAK2;CTSL;TIRAP;CD14;IRAK4;CTSB
prerank,regulation of extracellular matrix organization (GO:1903053),0.7850477104106945,1.7393862254653827,0.0014925373134328358,0.12511408295967347,0.998,4/15,5.07%,RUNX1;FAP;LRP1;DDR2
prerank,cellular response to cytokine stimulus (GO:0071345),0.5580277601850402,1.7386519310595685,0.0,0.12502025469082756,0.998,103/416,13.89%,RORA;MMP3;CCL11;COL1A2;MMP2;CCL7;IL34;IL23R;IL1RL2;CXCL1;LBP;OSMR;ZEB1;SBNO2;TNFRSF21;CXCL12;ZFP36L1;TEC;GHR;PTPN7;TNFSF11;JAK1;IL16;BCL6;NUMBL;STAT1;SYNCRIP;GAB2;TLR2;ZFP36L2;CD40;TIMP1;IL1R1;PRTN3;JAK2;XCL1;DPYSL3;BATF;CASP1;IRAK3;STAT3;FSCN1;CCR1;PTPN13;BCL2;CEBPD;AIF1;LGALS9;CD36;CCL5;PTPRZ1;SFRP1;STAT5A;NPR2;PTPN6;CXCL10;IL3RA;ICAM1;IRAK2;PTPN18;IRF1;ADAMTS12;IFNAR2;PID1;MAPK11;SDC1;CBL;GRB2;POU2F1;ANXA1;CXCR4;WNT5A;FOXO3;IL7;IRAK4;JUNB;GREM2;GBP7;LIFR;TCF7;GAPDH;CCL2;TNFRSF1A;PTPRJ;PTPN23;PTPN9;PTPN2;ERBIN;SOCS5;YWHAZ;NFE2L2;RHOA;VAV1;TNF;GSK3B;FGF2;ADAMTS7;UBE2K;TANK;PIK3R1;YBX3;SMAD3;IL20RB
prerank,skeletal system development (GO:0001501),0.5835367085520828,1.738469963118817,0.00102880658436214,0.12384454552006226,0.998,35/148,10.51%,COL1A2;COL1A1;TRPS1;SULF1;ITGB8;PAX1;MMP14;SH3PXD2B;GLI2;CDH11;COL11A2;DEAF1;COL13A1;PAPSS2;SOX5;CHD7;CMKLR1;ANKRD11;VCAN;EXT1;SUFU;FRZB;FBN1;BMP1;ADAMTS4;PRELP;SPEF2;CREB3L2;MMP16;TGFBR1;TRIP11;WNT5A;BMP5;TBX3;FGFR1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.8363732676629277,1.7384427404676674,0.004918032786885246,0.12238937729007193,0.998,5/10,11.00%,ADIPOQ;APOD;LRP1;PTPRJ;PTPN2
prerank,granulocyte chemotaxis (GO:0071621),0.6350119170620019,1.7381062944938677,0.00234192037470726,0.12157710640501489,0.998,13/55,11.44%,CCL11;CXCL5;CCL7;CXCL1;EDN3;JAML;XCL1;CCL5;CXCL10;GBF1;ANXA1;CCL2;TGFB2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.7524528628207612,1.7374253017856565,0.0056657223796034,0.12139706426224979,0.998,10/18,12.92%,IL34;TNFRSF21;PTN;MDK;NF1;PTPRZ1;TENM4;CXCR4;DRD3;OPALIN
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5239258470297264,-1.7372745513369752,0.008438818565400843,0.27864232192026983,0.996,9/29,6.42%,KCNIP4;FGF12;DPP10;DPP6;SLMAP;SNTA1;WNK3;ATP2B4;SLC30A5
prerank,lymphocyte migration (GO:0072676),0.6743225242092709,1.7369276966405869,0.00628140703517588,0.12094792078982076,0.998,6/32,10.36%,CCL11;CCL7;XCL1;CCL5;MSN;CCL2
prerank,response to sterol (GO:0036314),0.8254108071453027,1.735861663852102,0.001557632398753894,0.12139001694631678,0.998,4/11,9.03%,RORA;SMAD2;ABCA2;TGFBR1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.6330716969298487,-1.7351850282563193,0.010344827586206896,0.2710222037273727,0.996,12/17,32.21%,ANK2;SNTA1;GPD1L;KCNQ1;NEDD4L;KCNE4;SCN3B;RYR2;KCNJ8;PKP2;KCNH2;SCN5A
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.8337520933327295,1.7322238155998315,0.0030959752321981426,0.12590950870404563,0.998,4/10,10.71%,RUNX1;RUNX3;SH3RF1;CBFB
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.546629855536068,-1.730544175774599,0.00851063829787234,0.27082817294005357,0.997,6/26,1.88%,ATP1B3;ATP1B1;FHL1;ACTN2;ANK2;WWP2
prerank,supramolecular fiber organization (GO:0097435),0.5654610046137204,1.7302439118254183,0.0,0.12810001191445552,0.999,58/333,7.53%,COL15A1;COL4A1;LTBP3;LTBP2;CYP1B1;COL24A1;COL18A1;COL1A2;COL4A2;COL27A1;COL7A1;COL1A1;COL3A1;LUM;COL8A1;TLL2;COL6A3;COL23A1;COL5A2;HSPG2;IAPP;COL11A2;MYO1B;PPP1R9B;COL5A3;COL5A1;PLOD2;ADAMTS2;COL13A1;RND3;DPT;USP9X;COL11A1;DYNC1H1;SERF1A;NCKAP5;KIF2A;HOOK2;SERPINH1;DDR2;NF1;BMP1;RHOD;CD36;CARMIL1;MYO5A;PCM1;CDC42;FAT1;SIAH2;MYO1D;EMILIN1;CGNL1;MYO1H;ADAMTS14;LOXL1;TMOD1;MYO7A
prerank,organic anion transport (GO:0015711),-0.4175316445454076,-1.72731333055695,0.0,0.2681163986564813,0.997,18/76,10.82%,ABCC4;SLC4A10;ABCG2;SLC26A7;LRRC8D;SLCO1C1;SLC22A6;SLCO3A1;SLC39A8;CA2;SLC52A1;SLC25A42;SLC25A4;SLCO2A1;ABCC6;CA4;SLC4A8;SLC4A3
prerank,reverse cholesterol transport (GO:0043691),0.7997398696939548,1.7256125029522316,0.009104704097116844,0.13532843330918026,0.999,4/13,4.34%,ABCA1;LIPC;APOE;ABCG1
prerank,regulation of interleukin-17 production (GO:0032660),0.6810906881243369,1.7217756444441943,0.005235602094240838,0.14048901755513074,0.999,3/31,0.90%,NR1H4;IL23R;RFTN1
prerank,regulation of chemotaxis (GO:0050920),0.6748193977087384,1.7204979928328235,0.00641025641025641,0.14129447138779824,0.999,10/30,13.33%,PDGFRA;MYCBP2;PDGFRB;ZSWIM6;TREM2;AIF1;CXCR4;PTPN2;ZSWIM8;ZSWIM4
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.796415855943777,1.7189929798755186,0.012903225806451613,0.1427528564222104,0.999,3/12,2.90%,IL23R;IL1R1;XCL1
prerank,response to nitric oxide (GO:0071731),0.7952076179752399,1.7175003488428444,0.010494752623688156,0.14415847026843745,0.999,1/13,0.03%,MMP3
prerank,embryonic digestive tract development (GO:0048566),0.7530779180598146,1.7172705750346815,0.00741839762611276,0.1430712698699437,0.999,8/18,14.64%,PDGFRA;GLI2;GLI3;RARB;SALL1;TGFB2;TNF;NIPBL
prerank,positive regulation of cytokine production (GO:0001819),0.5560434389745783,1.7167756849096654,0.0,0.14227282906576447,0.999,48/292,9.53%,RORA;RUNX1;GLMN;NR1H4;CYP1B1;C3;ZBP1;IL23R;ADIPOQ;SULF1;LBP;RFTN1;CCBE1;IL16;CD276;TLR2;IRF7;LACC1;CD40;IL1R1;STOML2;XCL1;BATF;TSLP;STAT3;MDK;AIF1;PRKD2;LGALS9;PLA2R1;NOD1;PAEP;CREBBP;EIF2AK2;HPSE;TLR7;ARNT;IRF1;RAB7B;TIRAP;TMEM106A;MAPK11;CD14;LPL;ANXA1;WNT5A;CRCP;IL7
prerank,regulation of immune response (GO:0050776),0.5828308901048393,1.7165899158442404,0.0,0.1411537422376588,0.999,19/135,7.77%,COL1A2;C3;COL1A1;COL3A1;SPN;ULBP1;COLEC12;JAML;BCL6;CD276;IRF7;CD40;BIRC3;ADCY7;TREM2;AHR;ICAM1;IRF1;TIRAP
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7987569418347988,1.7162501685027176,0.0091324200913242,0.14032859984550936,0.999,5/12,10.88%,ADIPOQ;CBLB;APOD;CBL;PTPRJ
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.7660584972860917,1.715654614454957,0.0074962518740629685,0.13993300005129752,0.999,3/16,6.17%,RUNX1;CREB3L1;TGFB3
prerank,phosphate ion homeostasis (GO:0055062),0.8232970452952907,1.711774011068132,0.011128775834658187,0.14638156107379868,0.999,2/10,1.64%,ENPP1;SFRP4
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.6449628328216417,1.7114941757732494,0.0036540803897685747,0.14548869754401705,0.999,19/43,13.23%,CBLB;SH3KBP1;EGFR;ERRFI1;PTPN3;EGF;CDC42;RAB7A;EPS15L1;CBL;GRB2;MVP;PTPRJ;PTPN2;SOCS5;ZGPAT;SPRY2;EPS15;BTC
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.8478230463475674,1.7111716440207498,0.006230529595015576,0.14467345060169912,0.999,4/10,9.14%,WNT2;FZD1;LRP6;WNT5A
prerank,cellular response to tumor necrosis factor (GO:0071356),0.5692191823633742,1.7110945872368426,0.0,0.14347719454746957,0.999,48/175,17.14%,PSMA7;CCL11;CCL7;MAP3K14;TNFRSF21;ZFP36L1;TNFSF11;STAT1;ZFP36L2;CD40;PLVAP;JAK2;XCL1;BIRC3;LIMS1;CCL5;TNFRSF12A;SFRP1;ADAMTS12;PID1;PYDC1;PSMB8;PSMA6;FOXO3;EDA2R;CCL2;TNFRSF1A;ERBIN;EDA;NFE2L2;TNFRSF4;TNF;PSMF1;ADAMTS7;COMMD7;TANK;TRAF2;YBX3;CX3CL1;RIPK1;PSMA8;PSMD2;PSMD12;PSMD11;TRAF5;BAG4;PSMD14;AKT1
prerank,regulation of response to external stimulus (GO:0032101),0.5785833430592922,1.710920764622889,0.0,0.14247097835750308,0.999,27/121,9.14%,CASP4;ZBP1;IL1RL2;PDGFRA;SBNO2;PTGES;BCL6;LACC1;IL1R1;GATA6;JAK2;XCL1;BIRC3;CASP1;TREM2;CASP12;CD36;PIK3AP1;IRF1;ADAMTS12;TIRAP;CELF1;AREL1;PSMA6;ANXA1;CXCR4;WNT5A
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5382465263759225,-1.7108119744294856,0.007380073800738007,0.3001089112910294,0.999,8/25,4.33%,DMD;ATP1B3;ATP1B1;ACTN2;ANK2;SLC6A9;WNK4;WNK3
prerank,cellular response to organic substance (GO:0071310),0.5802298295695306,1.7107082850783486,0.0,0.1415715162596559,0.999,33/116,12.75%,NR1H4;CYP1B1;IBSP;IL1RL2;ROBO2;GHR;PTPN7;LRRK2;SLIT3;DPYSL3;CASP1;STAT3;IGFBP5;PTPN13;ACVR1;CCL5;SFRP1;PTPN6;PTPN18;PID1;CXCR4;TGFBR1;CYP1A1;RPS6KB1;ACVR1B;CCL2;PTPN23;PTPN9;PTPN2;ACVR2A;RHOA;TNF;ACVR1C
prerank,bicellular tight junction assembly (GO:0070830),-0.45871786446938784,-1.7071676869061643,0.005847953216374269,0.29813477240876707,0.999,16/46,21.14%,OCLN;PECAM1;CLDN5;ESAM;CDH5;RAMP2;APC;PARD3;PATJ;CLDN11;CLDN14;CLDN1;PARD6G;AFDN;RAB13;MPP7
prerank,eosinophil chemotaxis (GO:0048245),0.7709647047866856,1.706016949528173,0.016442451420029897,0.14752041062171345,1.0,3/14,5.67%,CCL11;CCL7;CCL5
prerank,eosinophil migration (GO:0072677),0.7709647047866856,1.706016949528173,0.016442451420029897,0.14752041062171345,1.0,3/14,5.67%,CCL11;CCL7;CCL5
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5841324369538032,-1.7059637218699535,0.0,0.29114596824075767,0.999,16/20,29.80%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;SEMA4D;SEMA5A;SEMA5B;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7685515196848668,1.7056184002158494,0.0029850746268656717,0.14690195315311216,1.0,3/14,4.31%,IL23R;TNFSF11;CCR1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7689707754202681,1.7050186957078481,0.007288629737609329,0.14680108649820606,1.0,3/16,3.05%,SLC39A14;C3;PRKCA
prerank,toxin transport (GO:1901998),0.8184478019475885,1.7047337377359713,0.009202453987730062,0.14594030299662872,1.0,2/10,0.71%,ANTXR1;ANTXR2
prerank,muscle cell differentiation (GO:0042692),0.6692250531160996,1.7040258897649605,0.003896103896103896,0.14572103392840963,1.0,6/32,2.70%,RORA;GLMN;TBX18;MRTFA;FBXO40;GATA6
prerank,cellular lipid catabolic process (GO:0044242),0.6948396074039696,1.7038972678512285,0.007936507936507936,0.1446206759274983,1.0,2/27,0.18%,CEL;CYP1B1
prerank,action potential (GO:0001508),-0.4696501698835652,-1.7036122314915587,0.00625,0.28695146229459356,0.999,25/44,32.21%,DMD;AKAP6;KCND2;SCN2A;KCNJ2;GNA11;GNA14;SCN8A;ANK3;CLN3;SCN9A;SLC4A3;KCNQ1;GPER1;MYH14;CACNA1I;KCNE4;SCN3B;SCN3A;YWHAH;KCNMB2;CHRNA4;KCNH2;KCNB1;SCN5A
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6665725202283992,-1.7034790134640818,0.016713091922005572,0.27772790773712214,0.999,4/11,7.90%,TJP1;TJP2;RAPGEF2;RAPGEF6
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.8229039370582721,1.700255542374288,0.0031746031746031746,0.14986086148759004,1.0,5/12,5.97%,ABCA1;ADIPOQ;CRP;ABCG1;PPARG
prerank,carnitine shuttle (GO:0006853),-0.6898272758216513,-1.6998742415597698,0.010554089709762533,0.2784729859604277,0.999,2/11,0.67%,PRKAG2;PRKAA2
prerank,eye morphogenesis (GO:0048592),0.7397163926129647,1.6985530828235638,0.00424929178470255,0.15197938630208854,1.0,7/19,5.10%,COL5A2;FBN2;COL5A1;TENM3;STAT3;FBN1;NF1
prerank,cellular response to fatty acid (GO:0071398),0.790928200721685,1.69665481153133,0.013719512195121951,0.15408772444529892,1.0,4/12,8.76%,NR1H4;IRS1;PID1;LPL
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.7192811307740778,1.6962689395665853,0.009749303621169917,0.15354339589073304,1.0,5/22,7.77%,LBP;TNFAIP3;TREM2;RAB7B;TIRAP
prerank,regulation of striated muscle contraction (GO:0006942),-0.5151373254933793,-1.694801625830009,0.00411522633744856,0.2821692724588572,0.999,5/27,5.11%,DMD;ATP1A2;ANK2;CALM1;SLC8A3
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.788634473723184,1.689654036372188,0.004559270516717325,0.16577726529984774,1.0,5/13,10.77%,MDFIC;APOD;SUFU;SP100;NUP153
prerank,presynaptic endocytosis (GO:0140238),0.693723720109178,1.6890872124458798,0.012534818941504178,0.16535959468182246,1.0,5/24,8.40%,CEL;STON2;OPHN1;CANX;SYT2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.8053545141512186,1.686313905674299,0.006230529595015576,0.1696460686391228,1.0,1/11,0.03%,MMP3
prerank,inflammatory response (GO:0006954),0.5532644724524972,1.683859730202839,0.0,0.17302658170206603,1.0,37/195,12.69%,CCL11;SCUBE1;HP;HPR;CXCL5;CCL7;OLR1;CXCL1;HSPG2;CRP;CMKLR1;TLR2;CD40;XCL1;REL;STAT3;CCR1;AIF1;PTGDR;LGALS9;ADM;NOD1;HRH4;CCL5;CXCL10;PXK;CD14;ANXA1;CXCR4;HRH1;LOXL3;CCL2;TNFRSF1A;TNFRSF4;PJA2;TNF;TPST1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.7318774234937193,1.6828273548752495,0.008982035928143712,0.17391902088493563,1.0,2/16,1.15%,IL23R;TNFRSF21
prerank,positive regulation of T cell differentiation (GO:0045582),0.6429581238466349,1.68085892838658,0.005050505050505051,0.1765641465645682,1.0,7/36,4.42%,IL23R;GLI2;GLI3;BCL6;ZMIZ1;MDK;SHH
prerank,alcohol catabolic process (GO:0046164),0.8267021209032995,1.6804963157461343,0.0032414910858995136,0.17587636873010787,1.0,3/10,8.44%,CEL;APOE;SRD5A3
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7410225020675221,1.6801827064044845,0.016105417276720352,0.17509255351770536,1.0,3/16,1.92%,LTBP3;SOX5;PTN
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5354455334725794,-1.6778690277904351,0.012396694214876033,0.3190289483426243,1.0,13/25,22.90%,MINK1;SHANK3;SHISA6;CACNG2;SHANK1;CACNG7;SHISA7;RELN;NLGN1;ADRB2;MEF2C;SHISA9;CACNG8
prerank,cytokine-mediated signaling pathway (GO:0019221),0.538650101669489,1.6764261253181234,0.0,0.18146613013423712,1.0,134/532,16.78%,PSMA7;RORA;MMP3;CCL11;COL1A2;MMP2;CXCL5;CCL7;IL34;IL23R;MAP3K14;IL1RL2;CXCL1;LBP;OSMR;ZEB1;MID1;YAP1;CXCL12;TEC;GHR;TNFSF11;JAK1;IL16;BCL6;NUMBL;STAT1;GAB2;IRF7;CD40;PLVAP;TIMP1;IL1R1;IRS1;PRTN3;JAK2;XCL1;UGCG;BIRC3;BATF;CASP1;TSLP;IRAK3;STAT3;FSCN1;CCR1;CUL1;CAMK2D;BCL2;CEBPD;NOD1;LIMS1;TRIM21;CD36;CCL5;RALA;TNFRSF12A;PTPRZ1;STAT5A;PTPN6;CXCL10;CDC42;IL3RA;ICAM1;IRAK2;IRF1;SKP1;IFNAR2;PYDC1;CANX;SDC1;MSN;TRIM8;CBL;GRB2;LMNB1;POU2F1;PSMB8;LCP1;PSMA6;SP100;ANXA1;FOXO3;IP6K2;IL7;IRAK4;PELI3;OASL;JUNB;EDA2R;GREM2;LIFR;BRWD1;CCL2;TNFRSF1A;PTPRJ;SOCS5;YWHAZ;EDA;TNFRSF4;VAV1;FBXW11;TNF;FGF2;PSMF1;COMMD7;TRAF2;SPI1;TALDO1;PIK3R1;ARF1;IL20RB;IRF9;SRC;CDKN1B;SMAD4;CX3CL1;IL22;RIPK1;IL6R;PSMA8;FCGR1A;HIF1A;PSMD2;STAT5B;PSMD12;SQSTM1;PSMD11;PELI2;TRAF3IP2;SMARCA4;TRAF5;BAG4;PSMD14
prerank,transition metal ion homeostasis (GO:0055076),0.6673552179622884,1.6758714063095306,0.007874015748031496,0.18117754366540142,1.0,3/28,2.41%,SLC39A14;HEPH;CP
prerank,positive regulation of collagen metabolic process (GO:0010714),0.7417984127132088,1.6748678189476929,0.01195814648729447,0.18186708578697952,1.0,3/17,6.17%,RUNX1;CREB3L1;TGFB3
prerank,cholesterol transport (GO:0030301),0.6317131151031014,1.6740894832553894,0.0035502958579881655,0.1820189568326031,1.0,14/45,13.62%,CEL;ABCA1;LIPC;APOE;ABCG1;LIMA1;CD36;VPS4A;SOAT1;NPC2;OSBPL5;RELCH;ABCG4;MSR1
prerank,zymogen activation (GO:0031638),0.6500230234681025,1.6729553660583187,0.006180469715698393,0.1828338710253039,1.0,8/39,7.12%,HP;HPR;MMP14;KLK2;APOH;OMA1;PLAT;CTSL
prerank,ATP transport (GO:0015867),-0.6975703421405703,-1.672771398907927,0.017543859649122806,0.32375292357527974,1.0,7/10,30.04%,CD47;SLC25A42;SLC25A4;ABCC6;SLC17A9;SLC25A17;SLC25A24
prerank,adenine nucleotide transport (GO:0051503),-0.5924978646605039,-1.6722885313336446,0.015873015873015872,0.3159663865546219,1.0,5/17,8.93%,ABCC4;LRRC8D;SLC25A42;SLC25A4;ABCC6
prerank,purine ribonucleotide transport (GO:0015868),-0.5933998523850749,-1.6721395726883852,0.015015015015015015,0.30744825020008565,1.0,5/16,8.93%,ABCC4;LRRC8D;SLC25A42;SLC25A4;ABCC6
prerank,aorta development (GO:0035904),0.741539705777048,1.6718927095253988,0.016442451420029897,0.18361266667326426,1.0,7/14,8.15%,LRP1;ROBO2;PDGFRB;TBX2;JAG1;PKD2;ADAMTS9
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.6345998138100961,1.669461529067937,0.0073439412484700125,0.18717213849517333,1.0,15/40,14.44%,COL1A1;TCF7L2;SNAI1;SMAD2;JAG1;MDK;TGFB3;TGFBR1;TGFB1I1;WWTR1;PDPN;TGFB2;GCNT2;SMAD3;SMAD4
prerank,negative regulation of intracellular protein transport (GO:0090317),0.7024118690068653,1.6689147617387838,0.009510869565217392,0.18672183897086175,1.0,7/22,10.58%,ADIPOQ;MDFIC;APOD;LRRK2;SUFU;SP100;LMAN1
prerank,regulation of blood coagulation (GO:0030193),0.6829066948682885,1.6688273709186427,0.015873015873015872,0.18546389548533251,1.0,6/27,6.67%,FAP;KNG1;SERPINE2;APOE;APOH;HPSE
prerank,cholesterol homeostasis (GO:0042632),0.6018327827649499,1.6664479467666942,0.004530011325028313,0.1891967664421841,1.0,12/64,9.98%,RORA;CYP7B1;ABCA1;LIPC;APOE;ABCA2;ABCG1;LIMA1;EPHX2;SOAT1;LPL;NPC2
prerank,sterol homeostasis (GO:0055092),0.6002160954284718,1.6662799774729262,0.004524886877828055,0.18809051314706604,1.0,12/65,9.98%,RORA;CYP7B1;ABCA1;LIPC;APOE;ABCA2;ABCG1;LIMA1;EPHX2;SOAT1;LPL;NPC2
prerank,response to interleukin-1 (GO:0070555),0.5852329315309602,1.665601376257803,0.0033407572383073497,0.1879923343633325,1.0,21/73,15.89%,CCL11;CCL7;CD40;IL1R1;XCL1;PRKCA;IRAK3;LGALS9;CCL5;SFRP1;IRAK2;ADAMTS12;MAPK11;ANXA1;CCL2;ADAMTS7;TANK;SRC;CX3CL1;HIF1A;RBMX
prerank,positive regulation of T cell migration (GO:2000406),0.7131662444716452,1.6650888074428813,0.008333333333333333,0.18759723532526265,1.0,8/20,11.96%,CXCL12;SPN;XCL1;AIF1;CCL5;CXCL10;WNT5A;RHOA
prerank,regulation of interleukin-2 production (GO:0032663),0.6341629837669928,1.6640198647365492,0.007352941176470588,0.18820010401657522,1.0,8/43,5.00%,RUNX1;GLMN;VSIG4;TNFAIP3;STOML2;XCL1;NAV3;PRKD2
prerank,blood vessel morphogenesis (GO:0048514),0.613594888904296,1.6632881601245486,0.007067137809187279,0.18845612857367278,1.0,11/54,5.41%,COL4A1;GLMN;CYP1B1;ITGB8;CCBE1;LAMA1;NRP1;SHH;ADM;NF1;CCM2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6367994865137648,1.660926233194871,0.018957345971563982,0.19174488204481135,1.0,8/43,6.27%,NR1H4;ADIPOQ;LBP;TNFAIP3;IRAK3;LGALS9;ILRUN;PTPN6
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.6434164775172853,1.6608161989012191,0.018094089264173704,0.19054442853971582,1.0,8/41,6.27%,NR1H4;ADIPOQ;LBP;TNFAIP3;IRAK3;LGALS9;ILRUN;PTPN6
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4653076447472366,-1.6595289235744541,0.0048543689320388345,0.3321890984108979,1.0,15/40,21.36%,UNC13C;SNAP25;UNC13B;PCLO;SYT7;CPLX1;RIMS1;SNAPIN;DNAJC5;STX3;STX2;SNPH;PIP5K1C;RIMS2;BLOC1S6
prerank,positive regulation of protein maturation (GO:1903319),0.7819325386922447,1.657164219812752,0.02118003025718608,0.19734147183476053,1.0,2/11,1.01%,CCBE1;NKD2
prerank,regulation of T cell differentiation (GO:0045580),0.6454494355423035,1.6568045931727988,0.007537688442211055,0.19671892480018568,1.0,7/33,10.71%,RUNX1;ZMIZ1;MDK;IL7;PRDM1;TCF7;CBFB
prerank,response to tumor necrosis factor (GO:0034612),0.5747595885710434,1.6516443644366776,0.003257328990228013,0.2074235519772705,1.0,25/91,17.14%,CCL11;CCL7;ADIPOQ;TNFRSF21;ZFP36L1;ZFP36L2;CD40;JAK2;XCL1;CCL5;SFRP1;ADAMTS12;PID1;CCL2;ERBIN;NFE2L2;CASP8;ADAMTS7;TANK;YBX3;CX3CL1;RIPK1;GGT7;BAG4;AKT1
prerank,vasoconstriction (GO:0042310),0.7857308066306141,1.6504080461588675,0.015698587127158554,0.2088613023069951,1.0,3/11,2.89%,EDN3;CRP;EDNRA
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7182382456201888,1.6421691197182111,0.019801980198019802,0.22690209321052282,1.0,3/16,5.70%,RORA;ADIPOQ;FOXK2
prerank,regulation of epidermal cell differentiation (GO:0045604),0.7073774575872822,1.6416657451199843,0.015193370165745856,0.2265611396524912,1.0,6/21,7.12%,RUNX1;ZFP36L1;SFRP4;ERRFI1;CTSK;CTSL
prerank,skeletal system morphogenesis (GO:0048705),0.6301226474533685,1.6414166030791657,0.007194244604316547,0.2256448185204856,1.0,10/42,10.51%,MMP13;PDGFRA;FBN2;SFRP4;ANKRD11;HOXB3;LRP6;SPEF2;TGFBR1;FGFR1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6268994683716278,-1.6391742241264633,0.01791044776119403,0.38011243964621294,1.0,9/13,22.15%,SLC4A10;SHISA6;CLN3;GRIK2;SHISA7;SYP;SYNGR1;SLC8A2;SHISA9
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.5567473087693603,1.6387863928666428,0.0,0.23047419054059426,1.0,33/112,15.51%,LTBP2;COL1A2;COL3A1;PDE3A;WNT2;ZFP36L1;ITGB5;SOX5;ZMIZ1;ZFP36L2;XCL1;SMAD2;USP9X;ACVR1;LIMS1;SFRP1;TGFB3;CBL;TGFBR1;WNT5A;SMAD5;PTK2;TGFB2;GCNT2;TGFBRAP1;RHOA;SMAD3;SRC;ARHGEF18;SMAD4;LRRC32;SMAD1;SMURF1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7214320165728001,1.638612553866178,0.0228310502283105,0.22927150380168446,1.0,3/16,3.66%,APOD;ADCY7;TREM2
prerank,phospholipid homeostasis (GO:0055091),0.7943889554777902,1.6376417651560506,0.013493253373313344,0.23006756269782294,1.0,4/11,11.52%,ABCA1;ABCG1;TLCD2;RCN3
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.791639536485933,1.6371231259436427,0.009216589861751152,0.2298380090930022,1.0,4/11,9.14%,WNT2;FZD1;LRP6;WNT5A
prerank,negative regulation of cell development (GO:0010721),0.6678086476483499,1.6370063991127912,0.013623978201634877,0.22859627420743514,1.0,6/25,12.44%,CCL11;FBN1;PCM1;FBXW7;TNF;GSK3B
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5576175900530604,1.6368884011835758,0.002173913043478261,0.2274038430479887,1.0,28/108,10.71%,RUNX1;SULF1;MDFIC;LRP1;NKD2;SFRP4;KREMEN1;TLR2;LRRK2;TNFAIP3;TLE1;TAX1BP3;FRZB;ATP6AP2;SFRP1;CDK14;FAM53B;NXN;MDFI;GSKIP;TERT;ITGA3;CSNK2A1;SALL1;SFRP5;WLS;DISC1;CBFB
prerank,cellular sodium ion homeostasis (GO:0006883),-0.6173412868838127,-1.6367748038154704,0.015105740181268883,0.3781749597521081,1.0,4/15,1.45%,ATP1A2;ATP1B3;SLC12A2;ATP1B1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.5789741272737307,1.6367182287127726,0.008168028004667444,0.22632568785288562,1.0,12/63,5.70%,HP;DAP;EIF4G2;TIMP1;EIF4G3;NELL1;KLHL22;TREM2;STAT3;PTPN3;BCL2;FOXK2
prerank,regulation of establishment of planar polarity (GO:0090175),0.5717441688229143,1.6340514469985918,0.001092896174863388,0.23116980676848925,1.0,24/88,16.78%,PSMA7;ROR2;CLTC;PRICKLE2;SMURF2;FZD1;CDC42;PRICKLE1;ARHGEF19;PSMB8;PSMA6;WNT5A;NPHP3;RHOA;PSMF1;DACT1;RAC1;AP2A2;PSMA8;SMURF1;PSMD2;PSMD12;PSMD11;PSMD14
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.6664150802524623,1.6327527210797383,0.025537634408602152,0.23295172140782464,1.0,8/26,7.18%,TLR2;IRF7;BIRC3;FLOT2;IRAK3;TREM2;CD36;IRF1
prerank,regulation of mitotic spindle organization (GO:0060236),0.636850217333357,1.6323521944158939,0.004932182490752158,0.23240219213227656,1.0,11/35,10.99%,CLTC;PARP3;CHMP4B;DYNC1H1;RAE1;PLK1;GPSM2;BORA;EML3;TPX2;GNAI1
prerank,response to organic cyclic compound (GO:0014070),0.596217653945473,1.6322042937835173,0.0035335689045936395,0.23122332221731062,1.0,18/52,15.91%,CYP1B1;SPP1;LRRK2;STAT3;IGFBP5;ABCA2;CYP27B1;CCL5;SFRP1;GLDC;ANXA1;CYP1A1;DRD3;CCL2;TNF;STAT5B;GGT7;BGLAP
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7358583199132736,1.6321364688065267,0.014992503748125937,0.22993145557499564,1.0,4/15,4.34%,LIPC;APOE;PLTP;ABCG1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7555439271469082,1.6320047446198231,0.01597444089456869,0.2288143110043691,1.0,2/13,2.90%,IL23R;XCL1
prerank,positive regulation of reproductive process (GO:2000243),0.6429535266716057,1.6316442502965922,0.008,0.22817142648492963,1.0,6/31,10.18%,PDE3A;SYDE1;LHFPL2;SMURF2;INHBB;ACVR1B
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5994277918374268,1.6291501698930126,0.0057670126874279125,0.2326457341705444,1.0,15/56,9.80%,LBP;TLR2;LACC1;ALPK1;CTSS;NOD1;CD36;LY96;CTSK;TLR7;IRAK2;CTSL;CD14;IRAK4;CTSB
prerank,epithelial cell migration (GO:0010631),0.6302757657017274,1.6281270422644714,0.011042944785276074,0.23380050722224271,1.0,6/37,3.21%,FAP;CYP1B1;ZEB2;STAT1;NRP1;FSTL1
prerank,regulation of osteoclast differentiation (GO:0045670),0.6340364210611396,1.6271619183477033,0.011335012594458438,0.234724524671132,1.0,6/33,4.45%,IL23R;TNFSF11;LRRC17;MAFB;CCR1;FBN1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6826880007751781,1.625834569988814,0.019021739130434784,0.23656077758174096,1.0,5/22,5.67%,CYP1B1;MGAT5;GHR;TSLP;CCL5
prerank,eye development (GO:0001654),0.5966889710675617,1.6255432748476446,0.009269988412514484,0.23583568473132682,1.0,11/54,5.29%,COL5A2;SH3PXD2B;FBN2;LAMA1;COL5A1;MEIS2;CACNA1C;SIPA1L3;MEIS1;FBN1;PBX3
prerank,embryonic digit morphogenesis (GO:0042733),0.7050746383917571,1.6249064540443385,0.01729106628242075,0.23594644459460337,1.0,8/18,10.21%,GLI3;TBX2;SHH;CREBBP;HDAC1;SALL1;WDPCP;TBX3
prerank,dorsal/ventral pattern formation (GO:0009953),0.696480196109651,1.6244076595194592,0.02097902097902098,0.23571728892472785,1.0,6/20,6.54%,GLI2;SHH;AIDA;ACVR1;SFRP1;MDFI
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.7102018520013237,1.6236459259701472,0.014104372355430184,0.23626624123054024,1.0,10/18,15.25%,YAP1;JAK1;STAT1;JAK2;STAT3;CBL;SPI1;SRC;SMAD4;IL6R
prerank,regulation of chromatin organization (GO:1902275),-0.6036751990555471,-1.6227285108438985,0.029585798816568046,0.41272676832228594,1.0,7/14,19.59%,MLLT3;HNRNPU;TLK1;IGF2;SSRP1;METTL4;SETD1A
prerank,synaptic vesicle cycle (GO:0099504),-0.48601273768621017,-1.621268901113814,0.00904977375565611,0.40722613747553515,1.0,10/30,19.82%,SNAP25;PCLO;SYNDIG1;SYT7;CPLX1;RIMS1;SNAPIN;DNAJC5;PIP5K1C;NLGN1
prerank,positive regulation of bone resorption (GO:0045780),0.7678918612416842,1.6208135002876793,0.019969278033794162,0.24167306953028858,1.0,3/11,3.05%,SPP1;TNFSF11;PRKCA
prerank,negative regulation of proteolysis (GO:0045861),0.6351367770812912,1.6204972068331138,0.006443298969072165,0.2409749786401375,1.0,10/34,8.36%,KNG1;SERPINE2;LRRK2;TIMP1;DNAJC1;PTPN3;TRIM21;PLAT;BAG6;GAS1
prerank,regulation of chemokine production (GO:0032642),0.624087137716859,1.6203715225378574,0.015384615384615385,0.239936462281624,1.0,14/36,15.67%,TLR2;SNAI2;TSLP;TREM2;AIF1;LGALS9;EIF2AK2;TLR7;LPL;WNT5A;IL7;TNF;IL6R;HIF1A
prerank,regulation of acrosome reaction (GO:0060046),-0.6765800338496541,-1.619542299531959,0.026385224274406333,0.4026970397389207,1.0,2/10,7.24%,PLCB1;GLRA1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.6164479192643779,1.61851290886839,0.0037174721189591076,0.24302081718701185,1.0,16/39,13.23%,SH3KBP1;EGFR;ERRFI1;PTPN3;EGF;CDC42;PTPN18;EPS15L1;CBL;GRB2;MVP;PTPRJ;PTPN2;SPRY2;EPS15;BTC
prerank,bicarbonate transport (GO:0015701),-0.5118909082722878,-1.6175160535010555,0.012345679012345678,0.39982976750637744,1.0,12/25,24.46%,SLC4A10;SLC26A7;SLC39A8;CA2;CA4;SLC4A8;SLC4A3;CYB5R1;SLC26A6;CYB5R4;CYB5RL;CFTR
prerank,artery morphogenesis (GO:0048844),0.6391136145107414,1.6168134501917217,0.005270092226613966,0.2457429268627601,1.0,11/30,11.44%,LRP1;PDGFRB;NRP1;TBX2;JAG1;PKD2;NF1;ADAMTS9;HOXA1;TGFBR1;TGFB2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.5658001909773324,1.6168107773813407,0.0021810250817884407,0.24436407831485163,1.0,22/85,16.78%,PSMA7;ROR2;CLTC;PRICKLE2;SMURF2;FZD1;CDC42;PRICKLE1;ARHGEF19;PSMB8;PSMA6;WNT5A;RHOA;PSMF1;RAC1;AP2A2;PSMA8;SMURF1;PSMD2;PSMD12;PSMD11;PSMD14
prerank,negative regulation of peptidase activity (GO:0010466),0.6014882334341858,1.616309634489587,0.014457831325301205,0.24417277463465126,1.0,11/47,11.22%,KNG1;LRP1;SERPING1;FETUB;SERPINE2;TIMP1;SERPINH1;SERPINF1;SERPINA2;GAPDH;VTN
prerank,embryonic skeletal system development (GO:0048706),0.6330560226085521,1.615996484974265,0.006402048655569782,0.24350139398420476,1.0,6/35,4.05%,COL1A1;SULF1;PDGFRA;DEAF1;WNT9A;HOXB3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5898214328462001,1.6156611488745647,0.00922722029988466,0.24292885430730857,1.0,13/55,8.32%,DCN;CEMIP;LUM;HSPG2;BGN;SLC9A1;GPC6;VCAN;CEMIP2;PRELP;HPSE;SDC1;SDC2
prerank,negative regulation of lipid storage (GO:0010888),0.6897819606888534,1.615586145714323,0.02710413694721826,0.24176091370520808,1.0,7/19,12.29%,ABCA1;CRP;TREM2;ABCG1;PPARG;PTPN2;TNF
prerank,regulation of cytokine production (GO:0001817),0.542001661764389,1.6152434963901923,0.0010504201680672268,0.24127206402475526,1.0,25/126,12.29%,GLMN;IGF2BP1;ZBP1;DTX4;IGF2BP2;BCL6;CD276;CRP;IRF7;SNAI2;CCN4;BATF;TREM2;LGALS9;PLA2R1;TRIM21;EIF2AK2;MAST2;GPNMB;ANXA1;GAPDH;PLD4;CASP8;ATP2B1;TNF
prerank,negative regulation of immune effector process (GO:0002698),-0.6230574891876254,-1.6143391768681081,0.014367816091954023,0.40111455487611003,1.0,7/13,19.06%,CD47;CD55;GRN;RPS19;HAVCR2;RC3H1;FER
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.6322038579851821,1.6128985283003276,0.016352201257861635,0.2457406810148254,1.0,8/33,6.17%,ADIPOQ;APOD;TNFAIP3;IGFBP5;PTEN;AIF1;PPARG;TGFB3
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6643792950457756,1.6126810430464273,0.024623803009575923,0.24487805450482522,1.0,4/25,5.00%,RUNX1;GLMN;STOML2;PRKD2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7272306895147844,1.6108514411415809,0.035398230088495575,0.2480456045147638,1.0,4/14,9.14%,CCL7;XCL1;CCL5;WNT5A
prerank,regulation of muscle contraction (GO:0006937),-0.5065129148115195,-1.6104244492783901,0.027559055118110236,0.40414284629128727,1.0,5/26,1.98%,PLCE1;ATP1A2;CHRM2;CAV1;KCNB2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.7023127527990016,1.6104045766732233,0.024355300859598854,0.247759819705306,1.0,6/17,8.59%,CXCL12;CCR1;AIF1;CCL5;CXCL10;PLA2G7
prerank,bone morphogenesis (GO:0060349),0.7431681809741713,1.6098549060566767,0.013024602026049204,0.2477408138663468,1.0,3/14,6.00%,MMP13;SFRP4;LRP6
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5941406023325103,1.6085988676903955,0.013349514563106795,0.24945425662920218,1.0,10/49,8.14%,ADIPOQ;LBP;TLR2;STAT3;PRKD2;LGALS9;NOD1;TLR7;TIRAP;CD14
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7662822888599905,1.608398018277795,0.0282574568288854,0.24859481925183832,1.0,5/11,6.26%,NOS1AP;CACNA2D1;CACNB1;CAMK2D;SESTD1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.7281959150559358,1.608353408201318,0.033873343151693665,0.2473876361669384,1.0,4/15,5.07%,FAP;LRP1;FSCN1;DDR2
prerank,regulation of monocyte differentiation (GO:0045655),0.7245797919944539,1.6073042166245501,0.03139013452914798,0.24867251729105277,1.0,4/14,5.86%,IL34;ZFP36L1;IRF7;CDK6
prerank,positive regulation of cell development (GO:0010720),0.6446917172303948,1.6072898079853288,0.01877346683354193,0.24741336739153055,1.0,5/31,7.23%,PDE3A;ADIPOQ;NUMBL;NKX6-1;SERPINF1
prerank,melanocyte differentiation (GO:0030318),0.7695528069567308,1.6071060721354384,0.02674591381872214,0.24665165308333792,1.0,4/11,5.49%,ENPP1;LRMDA;MITF;SLC24A5
prerank,nerve growth factor signaling pathway (GO:0038180),-0.6668708861287901,-1.6060952528273982,0.024324324324324326,0.4083352610767707,1.0,6/10,27.28%,KIDINS220;RAPGEF2;RAP1A;BDNF;MAGI2;NTF3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7396427981617948,1.6057196395216717,0.029850746268656716,0.24889458461576475,1.0,3/13,4.42%,COL4A1;NRP1;SHH
prerank,positive regulation of lipid storage (GO:0010884),0.6674813369216475,1.605603641822642,0.01912568306010929,0.24784865240879156,1.0,6/21,8.76%,C3;PLIN2;IKBKE;OSBPL11;VSTM2A;LPL
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6837691094002111,1.6055055948076826,0.0163265306122449,0.24682916864717647,1.0,1/22,0.01%,PSMA7
prerank,lipoprotein transport (GO:0042953),0.7969575055475628,1.6047098416038672,0.017684887459807074,0.24727988893864272,1.0,5/10,7.08%,LRP1;VMP1;CD36;PPARG;MIA3
prerank,regulation of T cell migration (GO:2000404),0.7153418216181336,1.6040513503510825,0.016736401673640166,0.24744074230041968,1.0,6/18,6.32%,APOD;CXCL12;SPN;AIF1;CCL5;CXCL10
prerank,regulation of stem cell differentiation (GO:2000736),0.5575468800019142,1.6034949387326902,0.0032967032967032967,0.24754320083574857,1.0,10/89,6.20%,PSMA7;RUNX1;KMT2A;PDGFRA;YAP1;PTN;ZFP36L2;JAG1;TCF12;EIF2AK2
prerank,cellular response to mechanical stimulus (GO:0071260),0.6047645335183639,1.600992039588771,0.016587677725118485,0.252142871193901,1.0,12/46,12.25%,MAP3K14;SLC9A1;CASP8AP2;CD40;CASP1;MAP2K4;PIEZO2;TLR7;IRF1;TNFRSF1A;CASP8;MAP3K2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5346147928616898,1.6007069342462152,0.0,0.2514850547160015,1.0,31/151,12.55%,ROR2;CCL11;ROR1;CCL7;PDGFRA;TNFSF11;PDGFRB;XCL1;PRKCA;NRP1;EGFR;TREM2;APOE;CCR1;PRKD2;LGALS9;CD36;CCL5;ICAM1;TIRAP;ANGPT1;FBXW7;GPNMB;MAP2K1;CCL2;BMPER;GCNT2;SPRY2;TNF;FGF2;NTRK3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.5276697289460346,1.5987271864187873,0.0,0.2549568141092445,1.0,57/208,17.47%,RORA;NR1H4;ROR1;ADIPOQ;MAP3K14;TRIML2;NEK6;TNIP1;STAT1;ALPK1;CD40;TNFAIP3;BIRC3;CFLAR;CASP1;REL;TLE1;TREM2;LITAF;IKBKE;SLC20A1;UNC5CL;LGALS9;NOD1;TRIM21;VAPA;TIRAP;TRIM13;TMEM106A;TRIM8;WNT5A;IRAK4;WLS;EDA2R;CXXC5;GAPDH;TNFRSF1A;CASP8;ANKRD17;RHOA;TNF;AKAP13;TANK;TRAF2;SPHK2;CX3CL1;TIFA;RIPK1;SQSTM1;PELI2;RBCK1;TRAF3IP2;LAMTOR5;TRAF5;BRD4;MAP3K3;DDX1
prerank,embryonic eye morphogenesis (GO:0048048),0.7672580994264359,1.5984327505867433,0.023112480739599383,0.2544838114968471,1.0,4/11,6.00%,FBN2;TBX2;FBN1;LRP6
prerank,mesonephros development (GO:0001823),-0.6427915790543927,-1.5978248432692088,0.032171581769437,0.4254079600511251,1.0,4/11,4.85%,ZBTB16;BMP4;FGF1;OSR1
prerank,positive regulation of synapse assembly (GO:0051965),-0.48134926495554403,-1.5976794734597763,0.02702702702702703,0.4169527588700968,1.0,19/27,29.69%,NRXN1;GRID2;IL1RAPL1;AGRN;CLSTN3;SYNDIG1;CUX2;LRRC4B;CLSTN1;SEMA4D;PTPRD;BDNF;EPHB1;NLGN1;VSTM5;SEMA4A;SLITRK2;CLSTN2;NLGN2
prerank,dopaminergic neuron differentiation (GO:0071542),0.687138924944049,1.59752643414922,0.029914529914529916,0.2554450673836944,1.0,3/19,6.00%,WNT2;SHH;LRP6
prerank,negative regulation of cell junction assembly (GO:1901889),0.6603242054858951,1.5969457936150007,0.020718232044198894,0.2557256768962657,1.0,14/25,19.84%,DLC1;APOD;ROBO2;TLR2;SLIT1;PTEN;TNF;ARHGAP6;SRC;PHLDB2;ITGB1BP1;ACVRL1;BCAS3;CORO1C
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6810821304401156,1.595925940214713,0.019417475728155338,0.25703039425222335,1.0,6/21,5.97%,ADIPOQ;LRP1;TREM2;APOE;PLTP;PPARG
prerank,negative regulation of defense response (GO:0031348),0.5521521366517845,1.5948542211205792,0.004449388209121246,0.25822819515134915,1.0,10/77,5.97%,RORA;NR1H4;ADIPOQ;TNFAIP3;IRAK3;APOE;ILRUN;MVK;TRIM21;PPARG
prerank,regulation of protein autophosphorylation (GO:0031952),0.6154008493447134,1.5923672916096303,0.02360248447204969,0.26340807234866326,1.0,11/36,10.65%,ENPP1;EPHA7;ADIPOQ;TNKS1BP1;ERRFI1;RAP2A;TOM1L1;RASSF2;GPNMB;PPP2R5A;MVP
prerank,basement membrane organization (GO:0071711),0.7235723458151324,1.591536275066266,0.023006134969325152,0.26433279277673977,1.0,6/14,8.72%,COL4A1;LAMB1;NID1;FLRT2;CTSS;PXDN
prerank,positive regulation of chemokine production (GO:0032722),0.592458523951223,1.5914031463152545,0.016786570743405275,0.2634445176074357,1.0,14/44,15.67%,ADIPOQ;TLR2;TSLP;AIF1;LGALS9;EIF2AK2;TLR7;TIRAP;LPL;WNT5A;IL7;TNF;IL6R;HIF1A
prerank,regulation of hemopoiesis (GO:1903706),0.7688572406326849,1.5913833742449834,0.0296875,0.262292205985572,1.0,4/10,5.85%,RUNX1;PTN;MAFB;CREBBP
prerank,regulation of mononuclear cell migration (GO:0071675),0.6640690582493658,1.5912309186286135,0.023415977961432508,0.2613832779757347,1.0,9/23,12.29%,IL34;CMKLR1;MDK;AIF1;CCL5;MSN;BMP5;PTK2;TNF
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.5445721094510887,1.5903164853356733,0.0021164021164021165,0.2624109640231379,1.0,30/114,16.78%,PSMA7;MAP3K14;TNFSF11;STAT1;CD40;PLVAP;JAK2;BIRC3;LIMS1;TNFRSF12A;PYDC1;PSMB8;PSMA6;FOXO3;EDA2R;TNFRSF1A;EDA;TNFRSF4;TNF;PSMF1;COMMD7;TRAF2;RIPK1;PSMA8;PSMD2;PSMD12;PSMD11;TRAF5;BAG4;PSMD14
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.5498056397793588,-1.5898914247631457,0.02040816326530612,0.4320503340295188,1.0,10/17,31.17%,CAV1;OSR1;KLF7;AJAP1;APOLD1;PRKX;DSPP;CEACAM1;DLL1;SOX9
prerank,establishment of protein localization to extracellular region (GO:0035592),0.6053991643917239,1.5897642303131216,0.018564356435643563,0.26258464596394226,1.0,11/39,13.50%,LTBP2;ABCA1;ARFGAP3;STEAP3;RAB8B;MIA3;CANX;COPG1;TMEM167A;RCN3;RAB10
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.7317613999502683,1.58949463380445,0.032448377581120944,0.2621311730915253,1.0,6/13,9.83%,JAK1;STAT1;JAK2;STAT3;CANX;OASL
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7743173383575703,1.5875853297719242,0.025974025974025976,0.26573133908473834,1.0,5/10,7.37%,GHR;JAK2;STAT3;STAT5A;PTPN1
prerank,cellular response to sterol (GO:0036315),0.7413896878996244,1.5869407120836165,0.027149321266968326,0.2661379710350856,1.0,5/13,11.03%,RORA;INSIG2;LRP6;GRAMD1A;GRAMD1C
prerank,negative regulation of hemostasis (GO:1900047),0.7506896013218043,1.586843760969862,0.026771653543307086,0.26517523478780936,1.0,5/12,11.22%,KNG1;SERPINE2;APOE;APOH;VTN
prerank,negative regulation of B cell proliferation (GO:0030889),0.7571590587844481,1.5867523095725808,0.026234567901234566,0.2642682053322645,1.0,3/11,5.91%,TNFRSF21;BLK;ATM
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7068575587701627,1.5863025751096878,0.021374045801526718,0.26408336200861554,1.0,3/15,4.42%,IL23R;GLI3;SHH
prerank,regulation of transmembrane transport (GO:0034762),-0.47204247782871617,-1.5854791917737,0.02109704641350211,0.43827363790387297,1.0,9/31,7.29%,OCLN;SLC2A1;WWP2;ACTB;KCNJ2;KCNJ3;PRKCB;KCNJ13;KCNJ10
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6901936830620063,1.5853211794781763,0.02086230876216968,0.2652193284884628,1.0,10/18,22.34%,MDFIC;APOD;SUFU;ILRUN;GSK3B;CTNNA1;LATS2;MFHAS1;LATS1;POLR1A
prerank,regulation of interleukin-8 production (GO:0032677),0.5655699288296533,1.5851726164336875,0.005649717514124294,0.26440764061323996,1.0,13/69,8.96%,ADIPOQ;LBP;BCL3;CRP;TLR2;STAT3;PRKD2;LGALS9;NOD1;TLR7;TIRAP;CD14;ANXA1
prerank,cholesterol efflux (GO:0033344),0.6762662597935648,1.5850939581374297,0.02197802197802198,0.263455969989464,1.0,6/20,13.37%,ABCA1;APOE;ABCG1;SOAT1;NPC2;ABCG4
prerank,cell proliferation in forebrain (GO:0021846),0.772648756378405,1.5850720464774544,0.027777777777777776,0.2623387057802917,1.0,4/10,12.59%,NUMBL;PCM1;CEP120;NUMB
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.5686206512911055,-1.5843433873231396,0.03134796238244514,0.43347847516182514,1.0,7/16,12.49%,ST6GALNAC3;ST8SIA4;ST3GAL5;ST8SIA6;B4GALT6;ST8SIA2;ST6GALNAC5
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.7014971500246481,1.5830591913633478,0.022026431718061675,0.26616736980839745,1.0,2/16,2.90%,IL23R;XCL1
prerank,monocyte chemotaxis (GO:0002548),0.6141845630798702,1.5811723059628284,0.022900763358778626,0.2696213809972684,1.0,7/32,10.36%,CCL11;CCL7;TNFSF11;XCL1;CCL5;ANXA1;CCL2
prerank,positive regulation of calcium ion import (GO:0090280),0.7446923553986666,1.578750542897203,0.030721966205837174,0.2746002244709244,1.0,4/12,13.14%,CXCL12;PDGFRB;CCL2;SPHK2
prerank,negative regulation of reproductive process (GO:2000242),0.6860899337358161,1.5786558631934406,0.033093525179856115,0.2736156113257415,1.0,5/17,12.75%,SULF1;TIMP1;PAEP;CALR;ACVR1C
prerank,heart process (GO:0003015),-0.57551026947789,-1.5786405763121487,0.026239067055393587,0.44282004790877366,1.0,5/14,19.70%,SGCD;SGCZ;ACE;SOD1;PPCS
prerank,secretion (GO:0046903),-0.5920056278270062,-1.5784802601963637,0.038356164383561646,0.4348866950557622,1.0,6/14,11.13%,FBLN5;SLC22A6;NPR1;SLC22A4;TPD52;RIMS1
prerank,odontogenesis (GO:0042476),0.6112225650087515,1.5774072485591792,0.020330368487928845,0.2756603991122459,1.0,9/35,11.51%,COL1A2;GLI2;LAMB1;ANKRD11;LRP6;TGFB3;HDAC1;TGFB2;EDA
prerank,respiratory chain complex IV assembly (GO:0008535),-0.5157544554675222,-1.5756320257268401,0.02214022140221402,0.4363191873421837,1.0,11/21,26.57%,COX16;PET100;COX18;COX10;COX14;COX17;TIMM21;BCS1L;SCO1;COA3;COA6
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5616704577836785,1.575531998853674,0.0055248618784530384,0.2793205208768834,1.0,18/70,16.78%,PSMA7;RUNX1;KMT2A;YAP1;TCF12;EIF2AK2;PSMB8;PSMA6;CBFB;PSMF1;PSMA8;ITCH;PSMD2;PRKDC;PSMD12;PSMD11;TCF3;PSMD14
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6454985724060003,1.5752993918399805,0.023715415019762844,0.2787147574426774,1.0,9/27,8.81%,SNAI1;SNAI2;SPRED1;KMT5A;SPRED2;PLA2R1;ATM;EEF1E1;ATR
prerank,regulation of keratinocyte differentiation (GO:0045616),0.6536764136894397,1.5735157424216493,0.025806451612903226,0.28221052923442536,1.0,6/24,7.12%,RUNX1;ZFP36L1;ERRFI1;CYP27B1;CTSK;CTSL
prerank,intracellular lipid transport (GO:0032365),-0.5300039259783696,-1.573047937390804,0.029801324503311258,0.43619249895741297,1.0,3/21,1.29%,PRKAG2;PRKAA2;CERT1
prerank,response to lipid (GO:0033993),0.5441957571469271,1.5720671218710913,0.0021344717182497333,0.28477763228099096,1.0,22/105,11.09%,IL23R;SPP1;LBP;ASXL1;GATA6;JAK2;RXRG;IRAK3;STAT3;ABCA2;ABCG1;LGALS9;CYP27B1;CD36;PPARG;LY96;TIRAP;ANXA1;FOXO3;HMGB2;ERBIN;TMEM161A
prerank,osteoclast differentiation (GO:0030316),0.6614617403078429,1.5720450371706427,0.025991792065663474,0.2835948817016416,1.0,5/22,3.66%,SBNO2;TNFSF11;FARP2;GAB2;TREM2
prerank,negative regulation of cell differentiation (GO:0045596),0.5225258523551696,1.5716891713669676,0.0,0.2833654962341768,1.0,44/181,12.65%,RORA;ABCA1;ENPP1;ADIPOQ;COL5A2;YAP1;COL5A1;ASXL1;TNN;MEIS2;CRP;ZFP36L2;SNAI2;ZFPM2;SPRED1;WNT9A;SUFU;EGFR;MEIS1;JAG1;ABCG1;SHH;E2F1;SPRED2;PTEN;CDK6;SFRP1;PPARG;RUNX1T1;ADAMTS12;TRIO;TGFBR1;WNT5A;BMP5;TBX3;WWTR1;NEPRO;NPHP3;LDLRAD4;NBR1;CALR;SPRY2;TNF;ADAMTS7
prerank,regulation of cation channel activity (GO:2001257),-0.3687656590186273,-1.5711177924148663,0.0,0.4343905829133068,1.0,23/89,11.80%,DMD;FGF12;CACNB2;CACNB4;FGF14;LRRC7;ACTN2;DLG2;ANK2;MINK1;CALM1;SLMAP;SHISA6;GRIA2;GRIA1;CACNG2;AHNAK;ANK3;SHANK1;PDE4D;APP;GRIN2B;CAMK2B
prerank,synaptic vesicle recycling (GO:0036465),0.6230844710426204,1.5709107974116054,0.030585106382978722,0.2840120801020433,1.0,5/31,8.40%,CEL;STON2;OPHN1;CANX;SYT2
prerank,fatty acid transmembrane transport (GO:1902001),-0.5452213069350956,-1.5708178034444829,0.027586206896551724,0.42763568553402054,1.0,5/19,10.23%,PRKAG2;PRKAA2;SLC2A1;ABCD3;SLC27A1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5722771457768052,1.5698892284816397,0.014319809069212411,0.28546287924019875,1.0,16/50,15.58%,RORA;GLI3;KCTD21;SUFU;STK36;SHH;CREBBP;SFRP1;GAS1;ZIC1;IFT81;HERC4;RAB34;DLG5;SMO;MOSMO
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.684797131529285,1.5694458843916324,0.028901734104046242,0.28539666985064566,1.0,4/18,4.23%,EDN3;PTN;XCL1;MDK
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.7787955765251481,1.5686560200893978,0.03,0.2863099423246423,1.0,2/10,3.66%,C3;TREM2
prerank,endothelial cell migration (GO:0043542),0.6128371156880449,1.5684762520662492,0.01838235294117647,0.28563361210092064,1.0,8/37,6.84%,FAP;CYP1B1;STAT1;EGR3;NRP1;FSTL1;MYH9;PLXND1
prerank,cellular response to lipid (GO:0071396),0.5199268833978506,1.568463906889067,0.0,0.28446476081738115,1.0,34/191,11.96%,RORA;NR1H4;CXCL5;WNT2;SPP1;CXCL1;LBP;SBNO2;NRIP1;IRS1;TNFAIP3;WNT9A;CASP1;EGFR;MGST1;ADCY2;NUGGC;ATM;SFRP1;LY96;CD68;CXCL10;AHR;PID1;CD14;MSN;LPL;WNT5A;UBE2L3;HMGB2;CCL2;GNAI1;LCOR;RHOA
prerank,cellular response to leucine starvation (GO:1990253),-0.6373660297253663,-1.5681714251915997,0.0316622691292876,0.4279703622314218,1.0,6/10,17.67%,SESN2;GCN1;SESN3;RRAGB;IMPACT;RRAGD
prerank,dopamine metabolic process (GO:0042417),-0.5538180356055201,-1.5679987933322812,0.04126984126984127,0.421190193945702,1.0,5/18,4.47%,SNCAIP;MOXD1;PRKN;MAOA;MAOB
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.547962610870523,1.5673969081441002,0.005537098560354375,0.2858878221314875,1.0,21/74,14.44%,COL1A1;SNAI1;SPRED1;SMAD2;MDK;SPRED2;PTEN;SFRP1;TGFB3;TGFBR1;BMP5;TGFB1I1;WWTR1;PDPN;TGFB2;GCNT2;LDLRAD4;SPRY2;SMAD3;PHLDB2;SMAD4
prerank,regulation of adaptive immune response (GO:0002819),0.6924198406189381,1.5672405833391478,0.039160839160839164,0.28514139172375286,1.0,5/18,7.18%,IRF7;ADCY7;AHR;SASH3;IRF1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7263107177456032,1.5666589933645851,0.02857142857142857,0.28549445379128735,1.0,3/13,2.84%,DCN;BGN;VCAN
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6929012437338761,1.5666266550995942,0.03566121842496285,0.28438721386654575,1.0,5/17,8.66%,SULF1;SFRP4;FSTL1;CASK;ITGA3
prerank,regulation of platelet activation (GO:0010543),0.6527071822761545,1.56606481974696,0.0371900826446281,0.2845402707701142,1.0,5/21,3.81%,PDGFRA;TEC;PRKCA;APOE;BLK
prerank,growth hormone receptor signaling pathway (GO:0060396),0.7058552721347763,1.5648428252403208,0.04229607250755287,0.28655303307694285,1.0,8/14,15.86%,GHR;JAK2;STAT3;STAT5A;PTPN1;PTK2;PIK3R1;STAT5B
prerank,membrane assembly (GO:0071709),0.6197417241360559,1.5644435731369184,0.023376623376623377,0.28632788129576153,1.0,8/34,6.56%,CEL;RFTN1;UGCG;FLOT2;CHMP4B;TLCD2;PTEN;VPS4A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.5572947158177315,1.564022973137306,0.008869179600886918,0.28621167582357154,1.0,19/73,16.78%,PSMA7;RUNX1;KMT2A;YAP1;TCF12;EIF2AK2;PSMB8;PSMA6;CBFB;PSMF1;SPI1;PSMA8;ITCH;PSMD2;PRKDC;PSMD12;PSMD11;TCF3;PSMD14
prerank,regulation of cellular biosynthetic process (GO:0031326),0.6254895457463265,1.5631634878333955,0.027989821882951654,0.287249588016584,1.0,7/28,5.67%,NR1H4;C3;ADIPOQ;NOS1AP;JAK2;MITF;CCL5
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.5815154594647793,1.5629540078914572,0.022277227722772276,0.2866564819453145,1.0,12/45,9.83%,MID1;JAK1;STAT1;IRF7;JAK2;CAMK2D;TRIM21;ICAM1;IRF1;TRIM8;SP100;OASL
prerank,plasma membrane invagination (GO:0099024),0.6178517196419617,1.5629163303308926,0.02631578947368421,0.2856324878479162,1.0,12/29,15.63%,DOCK1;MYH9;AIF1;CD36;CDC42;SPIRE1;SNX18;SNX33;SNX9;RHOA;MSR1;FCGR1A
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.7296520349695145,1.561703068194462,0.0397456279809221,0.28773086315724905,1.0,1/12,0.45%,IL23R
prerank,negative regulation of coagulation (GO:0050819),0.7086617051695637,1.561694788039515,0.04142011834319527,0.28660974292042657,1.0,5/14,11.22%,KNG1;SERPINE2;APOE;APOH;VTN
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5577521830271444,1.5614062337710954,0.011286681715575621,0.2863020652132548,1.0,23/73,17.60%,CASP4;DLC1;DAP;CASP8AP2;JAK2;CFLAR;CASP1;BBC3;CASP12;IFT57;NOD1;PPARG;HSPE1;CASP8;TNF;TRAF2;SMAD3;BCL2L13;RIPK1;CYCS;AIFM1;HSPD1;EIF2AK3
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.5366743447493048,-1.561017091200403,0.027491408934707903,0.4350791150214507,1.0,9/18,24.07%,COX16;PET100;COX18;COX14;COX17;TIMM21;BCS1L;SCO1;COA3
prerank,epithelial tube morphogenesis (GO:0060562),0.6127170720116206,1.5580200763050243,0.027096774193548386,0.29367478228226634,1.0,7/32,5.41%,COL4A1;GLI2;SHH;PRKD2;PKD2;ACVR1;CCM2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.7089069283313901,1.5563118130332045,0.04505813953488372,0.29705813086584043,1.0,5/13,10.04%,FBN2;FSTL1;FBN1;LTBP1;GREM2
prerank,lipoprotein localization (GO:0044872),0.7606457419544119,1.5556241980569596,0.03333333333333333,0.2977630831162259,1.0,5/11,7.08%,LRP1;VMP1;CD36;PPARG;MIA3
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.5164263781194652,1.5554890881874661,0.0031088082901554403,0.29702087552379863,1.0,44/152,17.00%,PSMA7;COL1A1;ZEB2;SULF1;SFRP4;LYPD6;TLR2;LRRK2;TNFAIP3;EGFR;SMURF2;UBR5;EGF;ATP6AP2;SFRP1;FAM53B;GSKIP;CCAR2;TERT;DKK2;LRRK1;PSMB8;PSMA6;CSNK2A1;SALL1;TBL1X;WLS;DISC1;CSNK1G2;RUVBL1;ZBED3;PSMF1;DACT1;TRPM4;PTK7;PSMA8;DEPDC1B;PSMD2;PSMD12;PSMD11;TNKS2;SMARCA4;PSMD14;CSNK1D
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.6524337865479793,1.5552781371470203,0.035479632063074903,0.2963909252945475,1.0,5/22,10.71%,RUNX1;BCL6;MDK;IRF1;CBFB
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.647783884058329,1.5548930192435422,0.038926174496644296,0.2962649605397777,1.0,5/21,2.84%,DCN;CHSY3;BGN;CHST13;VCAN
prerank,sulfur compound transport (GO:0072348),-0.4893325642845533,-1.5542738949965804,0.024896265560165973,0.4483752496682865,1.0,8/27,10.23%,SLC13A4;ABCG2;SLC6A6;SLC26A7;LRRC8D;SLC5A6;SLC25A26;SLC27A1
prerank,regulation of neurogenesis (GO:0050767),0.5658630667363046,1.5534709813624672,0.023310023310023312,0.29907634267093025,1.0,10/55,12.59%,CCL11;YAP1;NUMBL;PCM1;SERPINF1;BHLHE40;HEYL;HMGB2;TNF;NUMB
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5331298170276643,1.553108459597636,0.005302226935312832,0.29899959327603626,1.0,26/112,15.12%,NR1H4;ADIPOQ;LBP;SPN;TLR2;TNFAIP3;JAK2;IRAK3;STAT3;ARFGEF2;LGALS9;ILRUN;LY96;PTPN6;TIRAP;TMEM106A;CD14;LPL;WNT5A;DICER1;PTPRJ;MC1R;SPHK2;PSEN1;CX3CL1;RIPK1
prerank,epidermis development (GO:0008544),0.5660261824400923,1.5529515228349646,0.01611047180667434,0.2982667945345684,1.0,10/56,10.00%,COL7A1;EMP1;GATA6;FGF7;UGCG;FLOT2;SVEP1;HDAC1;ATP2A2;EDA2R
prerank,negative regulation of complement activation (GO:0045916),0.7668467473287077,1.5518477385325753,0.03064516129032258,0.3000516217906764,1.0,2/10,1.02%,VSIG4;SERPING1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.5119190830244409,1.5514198956102097,0.0,0.30005689468593816,1.0,44/214,12.57%,ROR2;CCL11;ROR1;EPHA7;CCL7;ADIPOQ;PDGFRA;FBLN1;TNIP1;PDGFRB;XCL1;PRKCA;SPRED1;NRP1;EGFR;TREM2;APOE;CCR1;SPRED2;PTEN;PRKD2;LGALS9;CD36;CCL5;PTPN6;EMILIN1;ICAM1;PTPN1;TIRAP;ANGPT1;FBXW7;GPNMB;MAP2K1;CNKSR3;CCL2;PTPN2;YWHAZ;BMPER;GCNT2;SPRY2;TNF;FGF2;NTRK3;DUSP26
prerank,positive regulation of transporter activity (GO:0032411),0.7369354331346091,1.5511541042018457,0.030441400304414,0.2996357123340852,1.0,3/13,5.13%,KMT2A;ADIPOQ;TRPC6
prerank,regulation of macrophage differentiation (GO:0045649),0.7010929841583695,1.55059997614356,0.0409711684370258,0.2999295429987765,1.0,6/15,15.12%,IL34;ADIPOQ;PRKCA;PTPN2;CASP8;RIPK1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.6035293930183747,-1.5504376176578611,0.03804347826086957,0.4533410423616218,1.0,4/12,3.53%,PCGF5;HNRNPU;YTHDC1;SMCHD1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7038582796834347,1.549817392972164,0.048458149779735685,0.30072067256204393,1.0,2/14,0.60%,CREB3L1;SULF1
prerank,macrophage activation involved in immune response (GO:0002281),0.7171506994367941,1.5496398999707102,0.03363914373088685,0.30001681440501565,1.0,3/13,3.66%,LBP;SBNO2;TREM2
prerank,dendritic cell differentiation (GO:0097028),0.6400293911133208,1.5495108726033733,0.024291497975708502,0.2992841079851038,1.0,5/22,5.04%,PRTN3;BATF;TREM2;BLK;LGALS9
prerank,lipid homeostasis (GO:0055088),0.5641194275733015,1.5480864068615843,0.013937282229965157,0.30204848098647163,1.0,16/57,14.14%,ABCA1;TREM2;APOE;USF1;ABCA2;ABCG1;TLCD2;PPARG;ADCK1;ACOX1;FBXW7;RCN3;ZBTB20;ORMDL3;ACOX3;ABHD8
prerank,regulation of trophoblast cell migration (GO:1901163),0.7018240431162611,1.5474640403261268,0.03582554517133956,0.302493340892622,1.0,7/14,14.20%,SYDE1;TIMP1;SMURF2;ACVR1B;CALR;ACVR1C;YTHDF3
prerank,myeloid leukocyte differentiation (GO:0002573),0.5542954087806607,1.5462351523851372,0.01557285873192436,0.3045744107441714,1.0,13/65,6.39%,RUNX1;SBNO2;TNFSF11;FARP2;GAB2;PRTN3;BATF;TREM2;MYH9;E2F1;LGALS9;PPARG;CDC42
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6437106899530883,-1.5454485954251447,0.05585106382978723,0.4610910671606805,1.0,3/10,11.35%,BMP6;NEXMIF;NOTCH4
prerank,hyaluronan catabolic process (GO:0030214),0.6773776268015608,1.5447056094872273,0.0364963503649635,0.3074570330692612,1.0,3/18,5.03%,CEMIP;SLC9A1;CEMIP2
prerank,postreplication repair (GO:0006301),-0.41760156323168995,-1.5423305890821724,0.01775147928994083,0.4636947755352773,1.0,32/45,35.18%,WDR33;UBE2A;MSH2;UBE2V2;UBC;UBE2B;UBE2N;POLD3;PCNA;NSMCE1;FAAP20;RFC3;UBA52;POLH;PARP10;USP10;POLD2;RPA2;UBE2V1;PRIMPOL;BRCA1;PCLAF;RFC4;ZBTB1;POLD4;RFC2;DTL;RPA3;POLK;USP43;SPRTN;RFC5
prerank,positive regulation of acute inflammatory response (GO:0002675),0.7005721149391266,1.541822835831945,0.04790419161676647,0.3137187004734914,1.0,2/14,2.01%,OSMR;CREB3L3
prerank,endocrine system development (GO:0035270),0.6316744281964748,1.5415446122047216,0.05449591280653951,0.3133817556711319,1.0,6/21,9.20%,GLI2;MDK;NF1;FOXE1;TGFBR1;SALL1
prerank,regulation of cell size (GO:0008361),0.6427524012314317,1.540730648749518,0.04161073825503356,0.3145413001026045,1.0,11/23,16.76%,PRR16;VAV2;VAV3;PTEN;RPTOR;MSN;RHOA;VAV1;RAC1;LAMTOR5;PLEK
prerank,neurotrophin signaling pathway (GO:0038179),-0.5085222687842408,-1.54061837432679,0.04946996466431095,0.46153297405563853,1.0,9/21,14.90%,SORT1;KIDINS220;NTRK2;RAPGEF2;ZFYVE27;CASP3;DDIT4;RAP1A;BDNF
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.43756965564205386,-1.5405975862172765,0.025510204081632654,0.45454005020631066,1.0,12/39,9.96%,DMD;FGF12;FGF14;SLMAP;FXYD5;WNK4;WNK3;OSR1;GPD1L;HECW1;ANK3;FXYD6
prerank,negative regulation of angiogenesis (GO:0016525),0.5381023930469063,1.5403451007431883,0.013348164627363738,0.31444642042058535,1.0,22/84,12.29%,COL4A2;DCN;CREB3L1;SULF1;HSPG2;SPARC;THBS4;STAT1;THBS2;SPRED1;APOH;PPARG;CXCL10;EMILIN1;SERPINF1;ADAMTS1;ADAMTS9;SEMA3E;TGFB2;PTPRM;SPRY2;TNF
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6793123393745316,1.5401644777601478,0.04131054131054131,0.3138174836814407,1.0,6/18,13.74%,RUNX1;FSCN1;DDR2;EMILIN1;PDPN;SMAD3
prerank,bone development (GO:0060348),0.5988737091939893,1.5398434519017261,0.024330900243309004,0.31358718566011534,1.0,5/39,1.94%,MMP13;SULF1;SH3PXD2B;SFRP4;LRRC17
prerank,regulation of neuroinflammatory response (GO:0150077),0.6588029699077168,1.5396675786291854,0.0423728813559322,0.3128639606844962,1.0,2/19,3.66%,MMP3;TREM2
prerank,positive regulation of cholesterol transport (GO:0032376),0.6282595665738452,1.5396434544953654,0.02929427430093209,0.31181973917350575,1.0,6/27,5.97%,ADIPOQ;LRP1;TREM2;APOE;PLTP;PPARG
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.7042242210463874,1.539588195518819,0.049926578560939794,0.310858724447102,1.0,4/14,4.99%,ADIPOQ;LRP1;IGFBP5;AIF1
prerank,positive regulation of cell death (GO:0010942),0.555309734266346,1.5374243116591826,0.028901734104046242,0.31550672137940133,1.0,9/59,9.14%,MMP3;HP;HPR;LRP1;LRRK2;CD36;TRIM13;CELF1;WNT5A
prerank,anion transport (GO:0006820),-0.4575625815830401,-1.537015219334366,0.022935779816513763,0.45857062516091185,1.0,7/33,7.65%,SLC13A4;ABCG2;SLC13A3;SLC26A7;LRRC8D;SLC22A6;VDAC1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6844499534545619,1.5368185710574738,0.04776119402985075,0.3159772899237784,1.0,5/15,8.76%,PLIN2;TREM2;OSBPL11;PPARG;LPL
prerank,synaptic vesicle endocytosis (GO:0048488),0.5996956450221724,1.535565751449042,0.03717948717948718,0.31823461066698644,1.0,8/33,10.49%,CEL;STON2;ITSN1;OPHN1;DNAJC6;CANX;SYT2;GAK
prerank,negative regulation of protein polymerization (GO:0032272),-0.47432900750243123,-1.5351700138519844,0.03524229074889868,0.4573602410080936,1.0,14/27,23.29%,MAP2;EML2;KANK3;CDH5;HIP1R;TWF2;KANK4;STMN2;PFN1;SLIT2;TWF1;TUBB4A;STMN1;SSH3
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6189195690607796,-1.5350831245114316,0.04451038575667656,0.4509612942144291,1.0,5/11,12.33%,KCND3;ATP1B1;KCNJ2;KCNJ3;KCNQ1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6145775552349615,1.534630132817942,0.03483870967741935,0.3197142559576227,1.0,5/27,2.84%,DCN;CHSY3;BGN;CHST13;VCAN
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7477519720618535,1.5345950888886224,0.043343653250773995,0.31872122523117097,1.0,5/11,5.67%,TNFSF11;JAK1;PRKCA;BLK;CCL5
prerank,regulation of focal adhesion assembly (GO:0051893),0.5591942195794728,1.5342629522396505,0.034924330616996506,0.31842809339838496,1.0,23/54,18.77%,DLC1;GPM6B;APOD;MAP4K4;SLC9A1;PEAK1;NRP1;PTEN;LIMS1;SFRP1;EFNA5;PTPRJ;PTK2;RHOA;ARHGAP6;SRC;PHLDB2;RAC1;ITGB1BP1;ACVRL1;PTPRA;BCAS3;COL16A1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.5279448045502478,1.5340258528316981,0.013157894736842105,0.31797489489798625,1.0,16/88,7.60%,IGF2BP1;KNG1;IGF2BP2;SERPINE2;SYNCRIP;DNAJC1;NELL1;APOE;ILF3;IGFBP5;EIF2AK2;PLAT;BAG6;CAPRIN1;GIGYF2;SAMD4A
prerank,regulation of cholesterol efflux (GO:0010874),0.622748471518831,1.5340044087172247,0.02225130890052356,0.3169454055498323,1.0,8/30,5.97%,ADIPOQ;LRP1;TREM2;APOE;ABCA2;PLTP;SHH;PPARG
prerank,hyaluronan metabolic process (GO:0030212),0.6351264480394571,1.533538526032599,0.04269972451790634,0.3170743106718193,1.0,3/23,5.03%,CEMIP;SLC9A1;CEMIP2
prerank,protein secretion (GO:0009306),0.5526812408891576,1.5329260179978692,0.020761245674740483,0.3176103827035666,1.0,12/56,11.52%,LTBP2;ABCA1;ARFGAP3;STEAP3;RAB8B;MIA3;CANX;COPG1;ANXA1;WLS;TMEM167A;RCN3
prerank,lamellipodium assembly (GO:0030032),-0.4772015686015375,-1.5316884243169306,0.01968503937007874,0.45468398577217656,1.0,11/26,14.21%,ABLIM1;KIT;CDH13;ABLIM3;S1PR1;CCDC88A;PTPRO;ARHGEF6;VCL;PARVB;DMTN
prerank,regulation of cellular metabolic process (GO:0031323),0.5705957205702081,1.5315711270062697,0.021505376344086023,0.3201587238710408,1.0,13/45,13.96%,CYP1B1;NCOR2;ABCA2;ABCG1;TBC1D16;PID1;PANK2;SSH1;NPC2;ARF4;KIF16B;ARF1;MKLN1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6809906731955399,1.531059384850427,0.04552129221732746,0.3193073375878228,1.0,9/17,16.59%,JAK1;IRS1;TSLP;STAT3;STAT5A;IL7;BRWD1;STAT5B;SMARCA4
prerank,cellular response to interleukin-7 (GO:0098761),0.6809906731955399,1.531059384850427,0.04552129221732746,0.3193073375878228,1.0,9/17,16.59%,JAK1;IRS1;TSLP;STAT3;STAT5A;IL7;BRWD1;STAT5B;SMARCA4
prerank,regulation of necroptotic process (GO:0060544),0.6484651379029835,1.5302755330256188,0.0444743935309973,0.32018305389033336,1.0,10/23,15.12%,ZBP1;BIRC3;FLOT2;CFLAR;OGT;CDC37;MLKL;CASP8;YBX3;RIPK1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.5163842587766175,1.5298446252431015,0.005230125523012552,0.3201681946168057,1.0,30/124,16.12%,PSMA7;ROR2;CLTC;TCF7L2;SFRP4;PRICKLE2;FRZB;SMURF2;FZD1;SFRP1;CDC42;PRICKLE1;TNRC6B;ARHGEF19;PSMB8;PSMA6;WNT5A;SFRP5;PPP3CA;PLCB3;MOV10;RHOA;PSMF1;RAC1;AP2A2;PSMA8;SMURF1;PSMD2;PSMD12;PSMD11
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7417537340898986,1.5294226408445721,0.038109756097560975,0.3202422921981762,1.0,2/12,3.81%,RUNX1;BLK
prerank,cardiac muscle cell action potential (GO:0086001),-0.46343994913817443,-1.52919761578939,0.046610169491525424,0.4559275318209328,1.0,7/30,4.05%,DMD;ATP1A2;FGF12;KCND3;ATP1B1;ANK2;KCNJ2
prerank,connective tissue development (GO:0061448),0.5896659122085048,1.5286786868233453,0.0324254215304799,0.3211095410249947,1.0,8/35,9.08%,SULF1;ITGB8;SH3PXD2B;COL11A2;SOX5;ARID5B;CREB3L2;TRIP11
prerank,lipoprotein biosynthetic process (GO:0042158),0.7222321732048493,1.5283069035315067,0.06289308176100629,0.32100008988704226,1.0,6/11,16.47%,WIPI1;UGCG;APOE;ATG7;WDR45;PIK3C3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.6207396831497619,1.5274531871103119,0.04868421052631579,0.3222955762939426,1.0,15/25,19.61%,STAT1;STAT3;ARNT;MAPK11;FOXO3;HMGB2;ACVR1B;ACVR2A;BRD1;HIF1A;STAT5B;PRKDC;ETS1;INHBA;MED1
prerank,regulation of tissue remodeling (GO:0034103),0.6723259836817568,1.5271469696610263,0.03857142857142857,0.3220176818797619,1.0,5/18,8.49%,RUNX1;THBS4;MDK;DDR2;GPNMB
prerank,sodium ion transport (GO:0006814),-0.36602087877761585,-1.525688824026001,0.0,0.4594519689858988,1.0,17/85,11.47%,ATP1A2;ATP1B3;SLC12A2;SLC6A6;SLC24A2;ATP1B1;SLC6A9;SCN2A;SLC6A1;SLC6A12;SLC8A3;SLC9B2;SLC5A6;SCN8A;SLC4A8;SCN9A;SLC5A5
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5888734115465244,1.5256576762008152,0.03638644918444166,0.32490803967650195,1.0,15/36,20.64%,CASP4;ZBP1;CASP1;TSLP;CXCR4;WNT5A;IL7;TRIM44;UBE2K;RIPK1;HIF1A;CD300LF;IRGM;TRIM6;PARP14
prerank,cellular defense response (GO:0006968),0.5842534814150814,1.5250513740830434,0.02631578947368421,0.32554475197797716,1.0,4/40,5.98%,IL1RL2;LBP;SPN;LY96
prerank,regulation of stem cell proliferation (GO:0072091),0.6758303258946443,1.5248824042806532,0.04892086330935252,0.3248983070410755,1.0,6/17,10.06%,FBLN1;YAP1;ZFP36L1;EIF2AK2;TERT;HMGB2
prerank,iron ion transport (GO:0006826),0.567561604277408,1.5228247963371824,0.03125,0.32958173241796873,1.0,14/47,18.00%,SLC39A14;HEPH;CLTC;CP;SLC11A2;STEAP3;ATP6V1F;ATP6V1H;IREB2;ATP6V1G2;TTYH1;ATP6V1G1;ATP6V1D;REP15
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.625762065621824,1.5213020425547201,0.049723756906077346,0.33251947958163847,1.0,8/24,18.91%,EPHA7;NF1;FBXW7;FOXO3;TGFB2;TNF;ATF4;PRNP
prerank,iron ion transmembrane transport (GO:0034755),0.7401896245399284,1.5209822801081418,0.03915171288743882,0.3323031829185101,1.0,2/10,2.99%,SLC39A14;SLC11A2
prerank,negative regulation of cell population proliferation (GO:0008285),0.4940022399705935,1.5200609721773788,0.0,0.33362766558354584,1.0,61/351,11.44%,ROR2;GLMN;FAP;CYP1B1;COL18A1;DLC1;RUNX3;CXCL1;IGFBP7;APOD;FBLN1;TNN;SFRP4;TNFAIP3;GATA6;JAK2;NELL1;WNT9A;CDKN2B;TREM2;FRZB;IGFBP5;E2F1;ALDH1A2;PTEN;AIF1;PKD2;NF1;MORC3;CYP27B1;NCK2;NF2;STRN;CDK6;SFRP1;PPARG;TGFB3;EIF2AK2;PTPN6;PDS5B;PINX1;IRF1;ADAMTS1;CDK10;EEF1E1;FRK;CELF1;BTG1;GPNMB;MAP2K1;WNT5A;SFRP5;BMP5;TGFB1I1;TBX3;RERG;PTPRJ;KLF10;PTPN2;PDPN;TGFB2
prerank,manganese ion transport (GO:0006828),0.7039207463049785,1.5199823905194292,0.04011887072808321,0.33272576557245725,1.0,3/14,5.13%,SLC39A14;SLC11A2;TRPC6
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.7311356240333861,1.5199139935821615,0.044233807266982623,0.3318361973615057,1.0,2/11,2.01%,CREB3L1;CREB3L3
prerank,xenobiotic transport (GO:0042908),-0.5493752543455367,-1.5191601073719654,0.0472972972972973,0.4732905282528054,1.0,5/16,9.83%,ABCG2;SLC47A1;SLC7A5;SLC22A4;ABCA3
prerank,regulation of response to interferon-gamma (GO:0060330),0.686413317675485,1.5188801548556135,0.04277286135693215,0.3335347155318958,1.0,5/14,11.00%,JAK1;STAT1;JAK2;CDC37;PTPN2
prerank,positive regulation of chemotaxis (GO:0050921),0.5723266432210732,1.5181678449702711,0.029556650246305417,0.33434374499171704,1.0,12/43,12.55%,EDN3;PTN;PDGFRB;XCL1;NRP1;TREM2;MDK;AIF1;PRKD2;DSCAM;FGF2;NTRK3
prerank,negative regulation of protein processing (GO:0010955),0.7107395539745962,1.5180414088415357,0.048286604361370715,0.33360024852954734,1.0,3/12,8.36%,SERPINE2;LRRK2;GAS1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5409665090486963,1.5179451075522918,0.015909090909090907,0.33279354926961896,1.0,19/75,11.91%,COL4A2;DCN;SULF1;HSPG2;SPARC;THBS4;STAT1;THBS2;SPRED1;APOH;PPARG;CXCL10;EMILIN1;SERPINF1;ADAMTS1;SEMA3E;TGFB2;PTPRM;SPRY2
prerank,regulation of cardiac conduction (GO:1903779),-0.3978125814277609,-1.5165074617437924,0.012903225806451613,0.4750251246996484,1.0,20/54,20.53%,ATP1A2;ATP1B3;ATP1B1;ANK2;ITPR2;ATP2B4;ATP2B2;SLC8A3;ABCC9;NPR1;ITPR3;DMPK;FXYD6;ATP2A3;STIM1;FXYD1;TRPC1;SLC8A2;ACE2;TMEM65
prerank,vasculogenesis (GO:0001570),0.602633348016195,1.5157623708880152,0.03875968992248062,0.33780397442442145,1.0,7/32,5.41%,GLMN;ITGB8;PDGFRB;SPRED1;SHH;ADM;CCM2
prerank,vasodilation (GO:0042311),-0.5821862547148597,-1.5155133621986154,0.039634146341463415,0.47173385911548377,1.0,6/13,21.73%,NOS3;KLF2;SOD1;GPER1;SOD2;ADRB2
prerank,positive regulation of T cell activation (GO:0050870),0.5488640964549991,1.5151348754154814,0.022300469483568074,0.3383869579478277,1.0,14/62,10.36%,IL23R;TNFSF11;CD276;ZMIZ1;FLOT2;MDK;NCK1;AIF1;LGALS9;NCK2;CCL5;ANXA1;IL7;CCL2
prerank,regulation of cellular senescence (GO:2000772),0.6063660751129669,1.5148227896728403,0.042767295597484274,0.3381718616969446,1.0,14/28,21.87%,NEK6;NUAK1;AKT3;CDK6;EEF1E1;NEK4;TERT;YPEL3;CGAS;MAP3K3;FBXO5;HMGA2;YBX1;RSL1D1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.5411245284606084,1.514619347145489,0.022296544035674472,0.337651551554543,1.0,22/72,17.74%,PSMA7;MAP3K14;BIRC3;REL;CUL1;SKP1;TIRAP;PSMB8;PSMA6;DICER1;FBXW11;PSMF1;NFKB2;TRAF2;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14;AKT1;PSMB1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5362843481857715,1.5146158072104325,0.021541950113378686,0.3366028609291715,1.0,15/68,13.14%,LBP;IL16;TLR2;TSLP;STAT3;AIF1;LGALS9;TLR7;RAB7B;TIRAP;TMEM106A;LPL;WNT5A;TNF;SPHK2
prerank,actin filament depolymerization (GO:0030042),-0.6094013339873291,-1.513941884135698,0.06353591160220995,0.47009779151680886,1.0,7/11,25.67%,GSN;MICAL3;TWF2;MICAL1;CFL1;TWF1;WDR1
prerank,negative regulation of inflammatory response (GO:0050728),0.5019368844277725,1.513375949044247,0.0010162601626016261,0.3388293691107804,1.0,21/182,6.53%,RORA;MC5R;NR1H4;ADIPOQ;IAPP;GPR176;GPR39;TNFAIP3;ADCY7;TREM2;APOE;RXFP2;MDK;MYH9;ADCY2;PTGDR;ADM;MVK;ADCYAP1R1;PPARG;GLP2R
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6195661462263318,1.513274673886225,0.044654939106901215,0.3379796720889147,1.0,7/27,8.76%,ABCA1;ADIPOQ;CRP;ABCG1;CD36;PPARG;LPL
prerank,B cell proliferation (GO:0042100),0.6550702174359093,1.5126213874423806,0.06743185078909612,0.338686934674165,1.0,6/17,17.09%,CD40;BCL2;MS4A1;CTPS1;PTPRC;HSPD1
prerank,apical junction assembly (GO:0043297),-0.39931554618030113,-1.5124428939663674,0.014285714285714285,0.4685767917346551,1.0,16/53,19.16%,OCLN;PECAM1;CLDN5;ESAM;CDH5;RAMP2;APC;PARD3;VCL;PATJ;CLDN11;CLDN14;CLDN1;PARD6G;AFDN;RAB13
prerank,negative regulation of interferon-gamma production (GO:0032689),0.6352419607974797,1.5121352379768167,0.045584045584045586,0.33903140754389716,1.0,3/23,5.04%,NR1H4;XCL1;LGALS9
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5774281293159818,1.5120717307046072,0.028985507246376812,0.338166968273444,1.0,8/40,10.15%,LBP;CRP;TLR2;RNASE7;MPEG1;TIRAP;HMGB2;GBP7
prerank,negative regulation of wound healing (GO:0061045),0.5910434949677006,1.511445020020492,0.05290322580645161,0.3388765443097358,1.0,10/28,14.32%,KNG1;SERPINE2;APOE;CASK;PTEN;APOH;VTN;TNF;FGF2;PHLDB2
prerank,relaxation of muscle (GO:0090075),-0.5630739895033405,-1.5113143107550107,0.038348082595870206,0.4658052334835024,1.0,4/13,4.05%,ATP1A2;ATP1B1;GSN;KCNJ2
prerank,steroid catabolic process (GO:0006706),0.7373845704531221,1.511203708869402,0.05457463884430177,0.3385194322716957,1.0,3/10,8.79%,SPP1;CYP27B1;HSD11B1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.7116732871038666,1.5106774963255356,0.059654631083202514,0.33904968970176563,1.0,5/12,12.29%,POU5F1;NCOR2;PPARG;TERT;TNF
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.5507014910518792,1.510204566757091,0.028669724770642203,0.33928256139899465,1.0,19/54,16.30%,CASP4;ADIPOQ;TNFAIP3;BIRC3;CFLAR;CASP1;PYDC1;PELI3;TNFRSF1A;PTPN2;CASP8;TNF;NLRP2B;UBE2K;TRAF2;RIPK1;CCDC3;RBCK1;TRAIP
prerank,negative regulation of bone remodeling (GO:0046851),0.7244113564021584,1.5101706288864873,0.060653188180404355,0.33834706714551843,1.0,6/11,17.17%,TNFAIP3;SFRP1;TMEM119;UBASH3B;P2RX7;GPR137
prerank,digestive tract development (GO:0048565),0.5985698295561923,1.509714528940023,0.034031413612565446,0.3384698481499504,1.0,12/32,15.46%,GLI2;CLMP;GLI3;RARB;GATA6;EPHB3;SALL1;TGFB2;TNF;NPY;NIPBL;SMO
prerank,cellular response to inorganic substance (GO:0071241),0.6418356964981462,1.5093961401503504,0.059782608695652176,0.33830343852922945,1.0,5/21,14.28%,MMP3;DDX11;TIMELESS;ATRX;FMR1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6007344882010408,1.5090606302659593,0.04247104247104247,0.3381655605448379,1.0,7/29,13.32%,RUNX1;YAP1;DNAAF4;CARM1;CBFB;UBA5;DDRGK1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.7563541164220238,1.5081776969904583,0.03987240829346093,0.3394316578700028,1.0,2/10,7.77%,LBP;TIRAP
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.5056020164238709,1.50787721487975,0.0030959752321981426,0.3391939227150719,1.0,46/158,17.47%,ROR1;ADIPOQ;MAP3K14;TRIML2;NEK6;ALPK1;CD40;BIRC3;CFLAR;CASP1;REL;LITAF;IKBKE;SLC20A1;UNC5CL;LGALS9;NOD1;TRIM21;VAPA;TIRAP;TRIM13;TMEM106A;TRIM8;IRAK4;WLS;EDA2R;CXXC5;GAPDH;TNFRSF1A;CASP8;ANKRD17;RHOA;TNF;AKAP13;TRAF2;CX3CL1;TIFA;RIPK1;PELI2;RBCK1;TRAF3IP2;LAMTOR5;TRAF5;BRD4;MAP3K3;DDX1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5045175869567636,1.5072459863364078,0.006329113924050633,0.33998249148948023,1.0,35/128,15.51%,RUNX2;LTBP2;COL1A2;COL3A1;ITGB5;ZMIZ1;SMAD2;USP9X;SMURF2;ACVR1;HIVEP1;TGFB3;INHBB;RNF111;CBL;TGFBR1;SMAD5;BMP5;TGFB1I1;ACVR1B;PTK2;TGFB2;GCNT2;TGFBRAP1;ACVR2A;RHOA;ACVR1C;SMAD3;BMP7;SRC;ARHGEF18;SMAD4;LRRC32;SMAD1;SMURF1
prerank,negative regulation of cell migration (GO:0030336),0.5000264487972501,1.506416271871844,0.005246589716684155,0.3412440687564232,1.0,35/137,14.97%,CYP1B1;DLC1;COL3A1;ADIPOQ;SULF1;LRP1;TNN;TIMP1;DPYSL3;MITF;NAV3;IGFBP5;JAG1;SHH;PTEN;NF1;NF2;SFRP1;RAP2A;SRGAP1;EPHA1;MIA3;FOXO3;PTPRJ;PTPN23;LDLRAD4;CALR;FGF2;ACVR1C;DLG5;STK24;PHLDB2;RAC1;CX3CL1;TRIB1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6458600266353168,1.5062835834176562,0.04492753623188406,0.34056902633865127,1.0,2/18,1.07%,LBP;SBNO2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6627558532023442,1.5050967149542853,0.05916305916305916,0.34168508302255807,1.0,10/16,19.84%,DLC1;APOD;PTEN;ARHGAP6;SRC;PHLDB2;ITGB1BP1;ACVRL1;BCAS3;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6627558532023442,1.5050967149542853,0.05916305916305916,0.34168508302255807,1.0,10/16,19.84%,DLC1;APOD;PTEN;ARHGAP6;SRC;PHLDB2;ITGB1BP1;ACVRL1;BCAS3;CORO1C
prerank,hematopoietic stem cell proliferation (GO:0071425),0.7203461349086209,1.5049378776176987,0.056402439024390245,0.3411192489128191,1.0,2/11,1.08%,RUNX1;ETV6
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6839938352860091,1.5041966192083305,0.06006006006006006,0.34207014063353464,1.0,4/13,5.75%,MGAT5;JAK2;TSLP;EGF
prerank,regulation of B cell differentiation (GO:0045577),0.6649957234474135,1.5036722905362745,0.05091937765205092,0.3424095166893076,1.0,4/17,5.95%,MMP14;ZFP36L1;ZFP36L2;SFRP1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6744087453399978,1.5034539705786933,0.05187319884726225,0.34202717990736586,1.0,9/17,11.22%,PDGFRB;CCN4;NRP1;IGFBP5;MDK;AIF1;CCL5;ADAMTS1;VTN
prerank,positive regulation of protein processing (GO:0010954),0.6435791033058622,1.5022015208399748,0.04951856946354883,0.34428144577380854,1.0,4/19,6.24%,CCBE1;NKD2;MYH9;ENO1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6635073560536157,1.5019739702152057,0.05500705218617771,0.34389297320993334,1.0,9/16,14.77%,SEC16B;LRRK2;MIA3;VAPA;GBF1;SEC16A;TAPT1;DDRGK1;HSPA5
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.7284380759673905,1.5017397137901793,0.05828220858895705,0.3436329976574665,1.0,2/10,2.74%,CYP1B1;SNAI2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.5208163612246374,1.5017072028449232,0.009836065573770493,0.3427479267975592,1.0,16/95,10.36%,CXCL5;CXCL1;LBP;SBNO2;TLR2;TNFAIP3;CASP1;NUGGC;LY96;CD68;CXCL10;TIRAP;CD14;WNT5A;HMGB2;CCL2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6380030672767951,1.4987430121158933,0.052039381153305204,0.3496895280876009,1.0,5/20,12.48%,CREB3L1;SULF1;PRKD2;SPRY2;FGF2
prerank,positive regulation of inflammatory response (GO:0050729),0.5183990126818928,1.498309764917819,0.020719738276990186,0.3497937271138156,1.0,25/86,19.00%,ZBP1;LBP;OSMR;TNIP1;IL16;CREB3L3;TLR2;CCN4;TSLP;MDK;TLR7;PLA2G7;LPL;WNT5A;TNFRSF1A;NFKBIZ;TNF;ABCC1;CX3CL1;RIPK1;SNX4;ETS1;AGT;NFKBIA;IL17RA
prerank,regulation of steroid biosynthetic process (GO:0050810),0.7197408993701492,1.4974904170267314,0.04838709677419355,0.3509714491563777,1.0,1/11,0.10%,NR1H4
prerank,negative regulation of endopeptidase activity (GO:0010951),0.5560646754529155,1.4972198800635497,0.03341288782816229,0.3507790525424782,1.0,10/47,11.22%,KNG1;SERPING1;FETUB;SERPINE2;TIMP1;SERPINH1;SERPINF1;SERPINA2;GAPDH;VTN
prerank,regulation of angiogenesis (GO:0045765),0.49206416273536174,1.4971020740645462,0.002044989775051125,0.350111451859455,1.0,45/192,12.48%,RUNX1;CYP1B1;COL4A2;DCN;SULF1;ITGB8;HSPG2;SPARC;THBS4;ADAM12;STAT1;RHOJ;THBS2;CD40;TNFAIP3;GATA6;PRKCA;SPRED1;HK2;PRKD2;CEMIP2;NF1;ANGPTL4;APOH;SFRP1;PPARG;CXCL10;EPHA1;EMILIN1;PLXND1;SERPINF1;SASH1;ADAMTS1;BTG1;GPNMB;SP100;WNT5A;RNH1;SEMA3E;BMPER;TGFB2;PTPRM;SPRY2;VEGFC;FGF2
prerank,retinoid metabolic process (GO:0001523),0.5319144695663668,1.4965145899740442,0.02040816326530612,0.35082352629948504,1.0,12/71,9.08%,CYP1B1;LRP1;HSPG2;GPC6;APOE;ALDH1A2;RDH12;SDC1;RDH10;SDC2;LPL;CYP1A1
prerank,positive regulation of viral life cycle (GO:1903902),0.6309505619996207,1.4948900129204397,0.04748603351955307,0.3540776411604298,1.0,14/22,25.84%,LGALS9;VPS4A;FMR1;CHMP2B;DDB1;TYRO3;TMPRSS2;LGALS1;KPNA2;TRIM11;TSG101;P4HB;AXL;CHMP3
prerank,heart contraction (GO:0060047),-0.41870241288441645,-1.49460697735855,0.010256410256410256,0.5116636071152161,1.0,5/41,1.45%,DMD;ATP1A2;SGCD;SGCZ;ATP1B1
prerank,cellular protein catabolic process (GO:0044257),0.5412722726399198,1.4941740926112748,0.028735632183908046,0.3550780262663127,1.0,18/59,15.12%,FAP;CLTC;MYLIP;CTSS;SIAH2;CTSK;CTSL;ADAMTS12;RAB7A;CAPN2;PSMA6;CTSB;CASP8;CTSC;ADAMTS7;CTSW;AP2A2;RIPK1
prerank,cellular response to interleukin-1 (GO:0071347),0.5003621114394358,1.4940154193974866,0.0072992700729927005,0.35453432269354446,1.0,36/143,17.74%,PSMA7;CCL11;CCL7;CD40;IL1R1;XCL1;IRAK3;CUL1;NOD1;CCL5;SFRP1;IRAK2;ADAMTS12;SKP1;MAPK11;PSMB8;PSMA6;IRAK4;PELI3;CCL2;FBXW11;PSMF1;ADAMTS7;TANK;CX3CL1;PSMA8;HIF1A;PSMD2;RBMX;PSMD12;SQSTM1;PSMD11;PELI2;PSMD14;MAP3K3;PSMB1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.6207468939862711,1.4933101114556504,0.059639389736477116,0.3554680879421546,1.0,1/21,0.03%,MMP3
prerank,regulation of axon guidance (GO:1902667),0.7370701081025314,1.4931785475101578,0.05448717948717949,0.3548326508658591,1.0,5/10,13.33%,MYCBP2;NRP1;ZSWIM6;ZSWIM8;ZSWIM4
prerank,defense response to tumor cell (GO:0002357),0.7321551758861139,1.492911053194264,0.05823627287853577,0.3545489028583116,1.0,2/10,1.46%,RBMS3;DLEC1
prerank,retinol metabolic process (GO:0042572),0.6867462993115456,1.4915539500505812,0.060514372163388806,0.35747909158591096,1.0,4/14,9.08%,CYP1B1;RDH12;RDH10;CYP1A1
prerank,lymphocyte proliferation (GO:0046651),0.6150436018539551,1.491385512449718,0.0504774897680764,0.356947522712276,1.0,9/22,17.09%,CD40;ELF4;BCL2;MSN;MS4A1;CTPS1;TNFRSF4;PTPRC;HSPD1
prerank,relaxation of cardiac muscle (GO:0055119),-0.5478072556186196,-1.4911371879615947,0.05309734513274336,0.5165254783065324,1.0,4/13,4.05%,ATP1A2;ATP1B1;GSN;KCNJ2
prerank,protein processing (GO:0016485),0.5106956217580035,1.4898699775949487,0.012903225806451613,0.36013575287866567,1.0,15/102,9.03%,CASP4;HP;HPR;MMP14;ADAM19;STOML2;CASP1;FXN;KLK2;CTSS;CPXM1;OMA1;CTSL;MMP16;OGT
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5402785753370809,1.4896998358226898,0.03229527104959631,0.35961941551770615,1.0,19/59,18.36%,MAP3K14;BCL3;TLR2;BIRC3;REL;LY96;TLR7;IRAK2;CD14;TNFRSF1A;TNF;TANK;TRAF2;TIFA;RIPK1;RELB;RBCK1;AKT1;NFKBIA
prerank,glycine metabolic process (GO:0006544),0.6948103592216794,1.4894639453714413,0.07550077041602465,0.3592734178380012,1.0,4/12,10.40%,SDSL;AMT;GLDC;GCAT
prerank,response to axon injury (GO:0048678),0.6373673169051455,1.4893929196836102,0.05570652173913043,0.3585088670602198,1.0,4/18,4.38%,APOD;DPYSL3;TREM2;NREP
prerank,response to molecule of bacterial origin (GO:0002237),0.5314386932972056,1.4890081186411226,0.024149286498353458,0.3586203852932701,1.0,15/69,15.89%,IL23R;LBP;TNFAIP3;JAK2;IRAK3;LGALS9;CYP27B1;LY96;TIRAP;CD14;HMGB2;ERBIN;C4B;TRIB1;GGT7
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6630002734553022,1.488773774956718,0.05393586005830904,0.35835190903451664,1.0,5/15,12.29%,XCL1;IRAK3;TGFB3;TGFB2;TNF
prerank,negative regulation of platelet activation (GO:0010544),0.6656764600794902,1.4885696039763068,0.06598240469208211,0.35791365326841074,1.0,4/16,8.25%,PDGFRA;SERPINE2;APOE;ADAMTS18
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5824268354780928,1.4885614113768342,0.04859335038363171,0.3569654524910343,1.0,7/35,5.75%,CYP1B1;BCL3;GHR;JAK2;NF2;CCL5;EGF
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6998408249506404,1.4866991759437271,0.06534954407294832,0.3610931964914721,1.0,9/12,22.60%,NCOR2;SFRP1;PIAS2;HEYL;HDAC1;SMARCA4;ZBTB7A;FOXP1;NCOR1
prerank,negative regulation of neurogenesis (GO:0050768),0.5839999894966792,1.4862234649111972,0.042606516290726815,0.36141819677555953,1.0,7/34,12.29%,CCL11;PTN;PTEN;NF1;PCM1;RHOA;TNF
prerank,positive regulation of response to external stimulus (GO:0032103),0.4973285978705159,1.485251057240624,0.012605042016806723,0.3631294411533857,1.0,28/128,12.43%,ZBP1;TNIP1;PTN;IL16;TLR2;PDGFRB;CCN4;PRKCA;TSLP;TREM2;USF1;MDK;PUM1;AIF1;APOH;CCL5;LY96;TLR7;SASH1;PLA2G7;LPL;WNT5A;OASL;TNFRSF1A;ANKRD17;NFKBIZ;TNF;POLR3D
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6276772492075255,1.4840046989005402,0.04551724137931035,0.36548554981311454,1.0,4/20,4.96%,NR1H4;APOE;ABCA2;EPHX2
prerank,epithelial structure maintenance (GO:0010669),-0.5972991890555474,-1.4831342424592961,0.06486486486486487,0.5369852343335353,1.0,2/11,3.81%,RBP4;CXADR
prerank,neuromuscular synaptic transmission (GO:0007274),-0.5057801682428423,-1.482376338919493,0.066006600660066,0.5328445086608818,1.0,6/18,19.27%,FCHSD2;KIF1B;DTNA;TBC1D24;CHRNB1;ERC1
prerank,regulation of endopeptidase activity (GO:0052548),0.5306792431840575,1.4822544698359124,0.03236994219653179,0.36934017547603726,1.0,19/59,18.42%,KNG1;SERPING1;FETUB;SERPINE2;TIMP1;BIRC3;SERPINH1;SERPINF1;PSMB8;SERPINA2;HDAC1;GAPDH;VTN;SERPINB8;PSENEN;AKT1;PICALM;AGT;TIMP2
prerank,positive regulation of macrophage migration (GO:1905523),0.6436993233260375,1.4822419480061728,0.055232558139534885,0.3684038614110201,1.0,8/19,17.06%,IL34;CMKLR1;TREM2;MDK;CCL5;PTK2;CX3CL1;MAPK1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7242063089119122,1.4819037316854524,0.06774193548387097,0.3684375921539474,1.0,3/10,4.98%,DCN;LRRK2;BCL2
prerank,cellular response to nitrogen compound (GO:1901699),0.6374403722354429,1.4818085227611506,0.07213578500707214,0.3677404739758352,1.0,5/20,14.28%,NR1H4;DDX11;TIMELESS;ATRX;FMR1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5488361802317592,-1.4810661951741366,0.07213114754098361,0.5305428234353459,1.0,4/14,8.04%,KIT;SEMA7A;MAVS;CAMK4
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6139234296040128,1.4810410792622923,0.056910569105691054,0.36890519805105304,1.0,8/25,14.06%,GLMN;NRP1;EGFR;CCL5;EGF;DSCAM;PSEN1;SRC
prerank,regulation of endothelial cell proliferation (GO:0001936),0.51311645535172,1.4807801632712052,0.01646542261251372,0.3685994091326545,1.0,25/88,12.48%,CCL11;SULF1;SPARC;THBS4;STAT1;EGR3;PRKCA;NRP1;APOE;NR2F2;AKT3;PRKD2;NF1;APOH;EGF;STAT5A;ARNT;AIMP1;ANGPT1;TGFBR1;WNT5A;HMGB2;PTPRM;VEGFC;FGF2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.5063912878654452,-1.4805420983784934,0.0436241610738255,0.5258123461613042,1.0,10/18,24.83%,DDX19B;NUP133;ZC3H11A;HHEX;POLDIP3;NUP93;SARNP;MCM3AP;ENY2;DDX25
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5013637998149916,1.480440264164915,0.010570824524312896,0.36854934889178,1.0,35/129,17.00%,PSMA7;COL1A1;ZEB2;SFRP4;LYPD6;LRRK2;EGFR;SMURF2;UBR5;EGF;ATP6AP2;SFRP1;FAM53B;GSKIP;CCAR2;DKK2;LRRK1;PSMB8;PSMA6;TBL1X;WLS;CSNK1G2;RUVBL1;ZBED3;PSMF1;DACT1;TRPM4;PTK7;PSMA8;PSMD2;PSMD12;PSMD11;TNKS2;PSMD14;CSNK1D
prerank,cellular response to interleukin-6 (GO:0071354),0.6023770424928309,1.4801178903873198,0.050734312416555405,0.36854223876434244,1.0,12/26,15.25%,SBNO2;YAP1;JAK1;STAT1;JAK2;STAT3;PID1;CBL;SPI1;SRC;SMAD4;IL6R
prerank,negative regulation of cell motility (GO:2000146),0.49976179064228665,1.480090271104003,0.019230769230769232,0.3676330541722361,1.0,19/108,7.08%,CYP1B1;DLC1;ADIPOQ;SULF1;FBLN1;DPYSL3;MITF;NAV3;IGFBP5;JAG1;SHH;PTEN;NF1;NF2;SFRP1;RAP2A;SRGAP1;EPHA1;MIA3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6257541532905591,1.4799123439234714,0.05006765899864682,0.3671665329642382,1.0,6/20,5.67%,LRP1;PDGFRB;CCN4;NRP1;IGFBP5;CCL5
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5831935144855188,1.4798256804869085,0.05269922879177378,0.3664747604938859,1.0,10/29,14.20%,ZBP1;PTPN6;IFNAR2;PTPN1;ABCE1;WNT5A;CDC37;PTPN2;UBE2K;YTHDF3
prerank,hexose metabolic process (GO:0019318),0.5631698773017869,1.4793796260106171,0.05115712545676005,0.3667978620165081,1.0,14/39,19.71%,ADIPOQ;APOD;AKR1A1;OMA1;GALK2;ADPGK;GALK1;KHK;CHST1;GAA;PMM2;SORD;CHST15;DCXR
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7039352666614158,1.4789038677891109,0.06354009077155824,0.367216743557005,1.0,3/12,2.84%,DCN;BGN;VCAN
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6692503409539233,1.4785156465890517,0.0654490106544901,0.36731299069663786,1.0,6/16,11.09%,CXCL12;SNAI1;SNAI2;CCAR2;FBH1;TMEM161A
prerank,Notch signaling pathway (GO:0007219),0.5341836574276013,1.4785054006491243,0.03424657534246575,0.36639212376275493,1.0,20/59,15.59%,DTX4;SNAI1;STAT1;SNAI2;MAML3;JAG1;MDK;CREBBP;GMDS;MIB1;PLXND1;HEYL;MAML2;DTX2;GALNT11;MAML1;PSEN1;DTX3L;PSENEN;ITCH
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6917227038932228,1.4784145578365009,0.05997001499250375,0.3657373126214465,1.0,6/13,8.81%,SPRED1;SPRED2;PLA2R1;ATM;EEF1E1;ATR
prerank,cellular response to organic cyclic compound (GO:0071407),0.5019001032895873,1.4781451810275639,0.01040582726326743,0.365588952395108,1.0,26/141,12.90%,RORA;NR1H4;CYP1B1;PDE3A;SPP1;PDXP;ZFP36L1;NRIP1;LRRK2;EGFR;IGFBP5;ADCY2;PKD2;CCL5;SFRP1;AHR;MSN;CYP1A1;UBE2L3;HRH1;SSH1;CCL2;GNAI1;LCOR;TNF;P2RX7
prerank,camera-type eye morphogenesis (GO:0048593),0.7287337520690312,1.4777936609589162,0.07026143790849673,0.3655245521341179,1.0,4/10,6.00%,TENM3;TBX2;NF1;LRP6
prerank,proteolysis (GO:0006508),0.48161106010912835,1.4766574788585736,0.0020181634712411706,0.36754310372892346,1.0,55/252,15.14%,MMP3;FAP;CASP4;MMP2;OLR1;MMP14;ADAM19;PRTN3;CASP1;ANPEP;SUFU;CPQ;XPNPEP1;CTSD;CTSS;BMP1;CPXM1;HTRA3;CAPN5;PLAT;CTSK;LACTB;CTSL;ADAMTS12;CAPN2;NPEPPS;CPA6;CAPN15;ADAMTS9;MMP16;HTRA4;PSMA6;OGT;ENPEP;TBL1X;NLN;PGPEP1L;CTSB;PAPPA2;SENP6;CASP8;CTSC;MMP15;ADAMTS7;SPG7;SPPL3;DPP7;CTSW;LVRN;FBXO2;PSEN1;HTRA1;XPNPEP3;DPP8;PSENEN
prerank,acute-phase response (GO:0006953),0.706410498990523,1.4766178616303562,0.06501547987616099,0.36673679034959417,1.0,4/12,15.25%,LBP;CRP;IL22;IL6R
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.520233187449808,1.4763329641153078,0.030201342281879196,0.36663127253980143,1.0,17/69,15.12%,LBP;SPN;TLR2;JAK2;STAT3;ARFGEF2;LGALS9;LY96;TIRAP;TMEM106A;CD14;LPL;WNT5A;PTPRJ;SPHK2;PSEN1;RIPK1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6251216006226014,1.4762535117277455,0.0636237897648686,0.3659548679182596,1.0,6/24,11.09%,CXCL12;SNAI1;SNAI2;BCL2;CCAR2;TMEM161A
prerank,cytoskeleton organization (GO:0007010),0.5083524872238636,1.4760458254553974,0.010649627263045794,0.36553861126222503,1.0,29/114,14.73%,CCL11;CCL7;KRT25;PALLD;RND3;SH3KBP1;FMNL2;MAST4;TNFAIP3;SIPA1L3;MARK1;APOE;FMNL3;MDK;RHOD;FGD4;ABI2;MAST2;WDPCP;BRWD1;CCL2;PDZD8;ZMYM4;FGD6;RHOA;CFAP410;WTIP;RANBP9;RAC1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5263510620774271,1.47538698261903,0.035227272727272725,0.3664536284754929,1.0,15/66,8.40%,RUNX3;SULF1;SPARC;STAT1;SNAI2;CDKN2B;APOE;NR2F2;CASK;NF1;APOH;CDK6;SFRP1;AIMP1;FBXW7
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.583039404877514,1.4750779252940975,0.04755784061696658,0.36642140400520357,1.0,14/32,16.80%,DLC1;APOD;MAP4K4;JAG1;CASK;PTEN;NF2;SEMA3E;ARHGAP6;SRC;PHLDB2;ITGB1BP1;RASA1;ACVRL1
prerank,negative regulation of signal transduction (GO:0009968),0.47799896988237683,1.4724573949172703,0.0020161290322580645,0.3727447538735666,1.0,64/249,15.60%,ENPP1;DCN;CREB3L1;ADIPOQ;SULF1;APOD;LRP1;MMP14;NKD2;ASXL1;SFRP4;GLI3;KCTD21;LRRK2;IRS1;TNFAIP3;SNAI2;SUFU;EGFR;TLE1;IRAK3;TAX1BP3;FRZB;IGFBP5;NCK1;PTEN;BCL2;ACVR1;PIP4K2A;CCL5;EGF;SFRP1;SIAH2;NXN;MDFI;EMILIN1;PTPN18;ADAMTS12;PTPN1;PID1;FBXW7;BRAP;CSNK2A1;CSNK2A2;SFRP5;BMP5;RPS6KB1;PTPRJ;PTPN2;SOCS5;CALR;SPRY2;TNF;NLRP2B;FGF2;UBASH3B;HERC4;DACT1;CX3CL1;TRIB1;SMPDL3B;EGFL7;MOSMO;NEDD4
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3514468225877049,-1.4711184841842964,0.011904761904761904,0.5504046234015408,1.0,48/87,29.53%,IMMP2L;COX16;NDUFS1;NDUFAF5;NDUFAF4;ECSIT;NDUFV2;NDUFA13;NDUFAF2;NDUFA6;DMAC2;PET100;COX18;NDUFA12;UQCC2;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;COX14;NDUFB7;NDUFS3;NDUFA1;COX17;NDUFC2;FOXRED1;TIMM21;SAMM50;BCS1L;SDHAF4;NDUFA10;SCO1;NDUFS2;UQCRFS1;LYRM7;TMEM126B;NDUFB11;SLC25A33;COA3;NUBPL;UQCC3;CHCHD4;SDHAF2;NDUFS5;NDUFAF8;TIMMDC1;NDUFV1;NDUFAF6
prerank,endoderm development (GO:0007492),0.6908342824826129,1.4709117534387735,0.08132530120481928,0.376118494513204,1.0,3/13,3.00%,LAMC1;DUSP2;DUSP5
prerank,dermatan sulfate metabolic process (GO:0030205),0.6915513375212212,1.4702918550378214,0.07088989441930618,0.3768790020237732,1.0,3/13,2.84%,DCN;BGN;VCAN
prerank,regulation of B cell proliferation (GO:0030888),0.5515258711078385,1.4701970937244715,0.05875299760191847,0.3761990690510134,1.0,11/44,11.94%,TNFRSF21;CD40;VAV3;BLK;BCL2;ATM;AHR;SASH3;TIRAP;IL7;TNFRSF4
prerank,Notch signaling involved in heart development (GO:0061314),0.7016888614710057,1.4695063888935356,0.05669291338582677,0.37706159277015827,1.0,5/11,11.10%,SNAI1;SNAI2;JAG1;HEYL;GALNT11
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5662557793297743,1.4690054937647787,0.06351183063511831,0.37741397099593804,1.0,19/35,19.61%,ZFP36L1;STAT1;MAFB;STAT3;CDK6;ARNT;MAPK11;FOXO3;HMGB2;ACVR1B;ACVR2A;SPI1;BRD1;HIF1A;STAT5B;PRKDC;ETS1;INHBA;MED1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6044467053435814,1.468971508612956,0.055858310626702996,0.37657956037919293,1.0,6/24,8.59%,CXCL12;CCR1;AIF1;CCL5;CXCL10;PLA2G7
prerank,copper ion transport (GO:0006825),0.702386175086663,1.4688904409551933,0.07062600321027288,0.3758919999767123,1.0,4/11,5.77%,STEAP4;SLC11A2;STEAP2;STEAP3
prerank,cellular response to amyloid-beta (GO:1904646),0.5718879333450129,1.4687833961771728,0.046894803548795945,0.3752627673459464,1.0,8/35,6.91%,CASP4;CACNA1A;LRP1;CACNA2D1;TREM2;CACNB1;CD36;ICAM1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.45771331697003326,-1.4686229608416554,0.03070175438596491,0.5519968331410499,1.0,10/29,15.71%,SORBS1;LDLR;SCARB1;LPGAT1;ELOVL5;CREBL2;SLC27A1;GPLD1;SLC45A3;MFSD2A
prerank,positive regulation of secretion (GO:0051047),-0.5933966408314777,-1.4684406256303995,0.06363636363636363,0.5461980044467358,1.0,3/11,11.60%,NPR1;GPLD1;ACSL3
prerank,positive regulation of hormone secretion (GO:0046887),0.6474357503895929,1.4684004829384991,0.06930693069306931,0.3753543990532891,1.0,2/17,1.15%,SPP1;EDN3
prerank,regulation of calcium ion import (GO:0090279),0.6204881233983339,1.468274400727915,0.06329113924050633,0.37472207757520953,1.0,9/21,21.38%,CXCL12;PDGFRB;PKD2;EGF;CCL2;SPHK2;PRNP;PSEN2;TRIM27
prerank,positive regulation of MAPK cascade (GO:0043410),0.48099381254353313,1.4675537517198365,0.0,0.3756801822173743,1.0,46/245,12.55%,ROR2;CCL11;ROR1;CCL7;IL34;PDGFRA;EDN3;MID1;IAPP;TAOK1;TNFSF11;LRRK2;CD40;PDGFRB;XCL1;PRKCA;NRP1;EGFR;TREM2;APOE;CCR1;PRKD2;LGALS9;CD36;CCL5;EGF;EIF2AK2;ICAM1;TAOK3;PIK3R5;TIRAP;ANGPT1;TMEM106A;FBXW7;GPNMB;MAP2K1;CCL2;FGFR1;PTPRJ;BMPER;TGFB2;GCNT2;SPRY2;TNF;FGF2;NTRK3
prerank,positive regulation of growth (GO:0045927),0.5309693068526141,1.4667365758720887,0.02991944764096663,0.3769849891011289,1.0,15/64,9.19%,RFTN1;MMP14;EIF4G2;KLHL22;EGFR;FXN;BCL2;PABIR1;INO80;SFRP1;CDC42;RPTOR;EXOSC4;TGFBR1;CSNK2A1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.48937407565034957,1.4658473957451832,0.008221993833504625,0.3784587392306878,1.0,32/161,12.58%,PSMA7;RBMS3;BICC1;NKD2;TCF7L2;TNN;SFRP4;KREMEN1;TBX18;GLI3;IGFBP4;SNAI2;TLE1;APOE;FRZB;MDK;SFRP1;LRP6;PRICKLE1;SIAH2;DKK2;PSMB8;PSMA6;WNT5A;HDAC1;SFRP5;WWTR1;NPHP3;DRAXIN;GSK3B;CSNK1A1;PSMF1
prerank,regulation of oxidoreductase activity (GO:0051341),0.6763398196011302,1.4653264414834493,0.08074534161490683,0.37898724485668284,1.0,1/13,0.26%,HP
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.5039520711017248,1.4651499001289072,0.02430939226519337,0.3785969738156358,1.0,24/87,15.51%,LTBP2;COL1A2;COL3A1;ITGB5;ZMIZ1;SMAD2;USP9X;ACVR1;TGFB3;CBL;TGFBR1;SMAD5;PTK2;TGFB2;GCNT2;TGFBRAP1;RHOA;SMAD3;SRC;ARHGEF18;SMAD4;LRRC32;SMAD1;SMURF1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5901819116863583,1.464844678766652,0.07588075880758807,0.37855654636485986,1.0,10/28,17.65%,CASP4;ERN2;BBC3;ITPR1;BCL2;BAG6;TRAF2;TRIB3;AIFM1;ATF4
prerank,response to cholesterol (GO:0070723),0.6454047211108485,1.4646981721190244,0.08286516853932584,0.3780860551635834,1.0,7/17,15.46%,SMAD2;ABCA2;LRP6;GRAMD1A;TGFBR1;GRAMD1C;SMO
prerank,L-amino acid transport (GO:0015807),0.5808924203467025,1.4641826656360633,0.07047872340425532,0.378686007917698,1.0,3/28,1.80%,SLC7A2;SLC1A3;SLC38A3
prerank,regulation of cholesterol storage (GO:0010885),0.6551345481266289,1.4635817096408215,0.08787878787878788,0.37945827989284237,1.0,5/15,8.76%,ABCA1;TREM2;ABCG1;PPARG;LPL
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6716204721455692,1.4628917654603533,0.07298136645962733,0.3804841687372036,1.0,5/14,11.01%,IL34;CMKLR1;MDK;CCL5;PTK2
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.7251987285023413,1.4620928763428132,0.06366459627329192,0.3818054579673161,1.0,3/10,4.35%,ENPP1;ADIPOQ;ERRFI1
prerank,generation of neurons (GO:0048699),0.4850233360837792,1.4619867414354435,0.007142857142857143,0.3812072286626565,1.0,34/190,12.48%,RUNX1;RUNX2;WNT2;RUNX3;YAP1;DNAAF4;LRP12;MDGA1;AUTS2;NRP1;NAV1;WNT9A;ADGRL3;MARK1;BHLHE22;USP9X;SHH;ACSL4;ASTN2;OPHN1;FZD1;CDK6;BHLHE40;HEYL;SH3RF1;MAP2K1;WNT5A;HMGB2;DISC1;FGFR1;NEUROD6;TGFB2;NIF3L1;FGF13
prerank,positive regulation of macrophage differentiation (GO:0045651),0.7018625925778549,1.4616090680235512,0.07,0.38132278567319594,1.0,4/11,15.12%,IL34;PRKCA;CASP8;RIPK1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4959586510911189,1.4615209346339144,0.01583949313621964,0.38069003721074546,1.0,24/113,10.06%,CCL11;LAMB1;YAP1;TCF7L2;THBS4;PTN;JAML;LAMC1;EGR3;FGF7;PRKCA;NRP1;EGFR;MDK;AKT3;PRKD2;EGF;SFRP1;STAT5A;ARNT;TGFBR1;WNT5A;BMP5;HMGB2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6057011661709397,1.46146182074357,0.0560625814863103,0.3799643100264952,1.0,7/27,9.14%,WNT2;PDGFRA;E2F1;DDR2;CDK6;S100A6;WNT5A
prerank,protein localization to kinetochore (GO:0034501),-0.5499476409934032,-1.4613556008101765,0.06168831168831169,0.5627774790379195,1.0,10/14,34.13%,RCC2;ZWILCH;IK;BUB3;CENPT;KNL1;TTK;ZW10;MTBP;SPDL1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6057025413052378,1.4609529876153737,0.07104557640750671,0.38048640269170275,1.0,5/22,14.04%,ADIPOQ;FLOT2;GCNT2;TNF;BMP7
prerank,chloride transport (GO:0006821),-0.3589392674802345,-1.459850674088944,0.00909090909090909,0.5614457420896947,1.0,18/74,9.76%,SLC12A2;SLC4A10;SLC12A7;SLC26A7;GABRA2;GABRB1;GLRA3;GABRG3;SLC1A1;SLC12A6;SLC6A1;GABRA5;CLCN2;GLRA1;CLCN3;GABRB2;ANO3;SLC4A8
prerank,positive regulation of histone methylation (GO:0031062),0.6045116358819435,1.4588931263852671,0.05518169582772544,0.3852630132060075,1.0,8/24,15.02%,KMT2A;AUTS2;PHF1;OGT;DNMT3B;RIF1;SMAD4;PAXIP1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6364493913173976,1.458651217008312,0.0676056338028169,0.38497712792637595,1.0,5/19,10.71%,RUNX1;IRAK2;WNT5A;LIFR;CBFB
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5527814100161321,1.4576485089269493,0.0524390243902439,0.3868123394219455,1.0,17/43,20.71%,RUNX2;FBN2;YAP1;CCN4;NELL1;DDR2;ACVR1;TMEM119;WWTR1;ACVR2A;BMP7;IL6R;FBXO5;LRP5;CTNNBIP1;BMPR1A;IL6ST
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.6600255530351372,1.4572088908629783,0.07814761215629522,0.38711928362659626,1.0,4/15,5.97%,ADIPOQ;IRS1;ADM;PPARG
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.6828399823893502,1.456830778807096,0.08689024390243902,0.38728051626218024,1.0,8/13,21.11%,PIK3AP1;TLR7;IRAK2;IRAK4;PIK3R4;PIK3C3;UNC93B1;TNIP2
prerank,sodium ion transmembrane transport (GO:0035725),-0.3496675449606385,-1.4567388664303023,0.020202020202020204,0.5648624280434761,1.0,17/84,10.98%,ATP1A2;ATP1B3;SLC12A2;SLC6A6;SLC24A2;ATP1B1;SLC9A2;SLC6A9;SCN2A;SLC6A1;SLC6A12;SLC8A3;SCN8A;SLC4A8;SCN9A;SLC9A6;SLC9A7
prerank,regulation of sensory perception of pain (GO:0051930),-0.5789826994794028,-1.4565292817478757,0.09703504043126684,0.5593101624371131,1.0,8/11,33.84%,MGLL;ZFHX2;CCN3;TMEM100;ATPSCKMT;ACP3;SPX;F2R
prerank,regulation of establishment of cell polarity (GO:2000114),-0.5127410862400376,-1.45627138697713,0.05572755417956656,0.5541114352017582,1.0,6/16,14.77%,KRIT1;CDH5;GSN;SHTN1;RACK1;RIPOR2
prerank,estrogen metabolic process (GO:0008210),0.64839435922369,1.4558077695643798,0.07894736842105263,0.3892062510243796,1.0,3/15,9.08%,CYP1B1;HSD17B8;CYP1A1
prerank,actin filament bundle assembly (GO:0051017),0.5732980894343349,1.4555070253660423,0.05235602094240838,0.3891217711361886,1.0,11/33,8.76%,PDXP;MYO1B;DPYSL3;CALD1;FSCN1;LIMA1;BAIAP2;AIF1;RHOD;ADD2;LCP1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5793843958620192,1.4549133836062127,0.05641025641025641,0.38983402636170816,1.0,5/32,10.28%,CXCL5;CXCL1;RNASE7;CXCL10;GAPDH
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5882359053335703,1.4544400874143812,0.05519053876478318,0.39017505072102066,1.0,7/27,8.43%,ADIPOQ;PDGFRB;PRKD2;ATM;TOM1L1;PINX1;SMG6
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.6238109350321855,1.454240462438383,0.08563134978229318,0.38984808336488497,1.0,5/19,11.01%,IL34;CMKLR1;MDK;CCL5;PTK2
prerank,cellular response to peptide (GO:1901653),0.5323129458372259,1.4540082367316924,0.02910360884749709,0.38956460329025044,1.0,16/56,14.06%,CASP4;CACNA1A;LRP1;ZFP36L1;CACNA2D1;TREM2;CACNB1;NOD1;CD36;DDX11;ICAM1;TIMELESS;GSK3B;ABCC1;PSEN1;SRC
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.7183253484591976,1.4530245014874374,0.07165109034267912,0.39038798810504943,1.0,2/10,2.06%,CLTC;MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.7183253484591976,1.4530245014874374,0.07165109034267912,0.39038798810504943,1.0,2/10,2.06%,CLTC;MYLIP
prerank,mitochondrial fission (GO:0000266),-0.5274350311081359,-1.452740864206268,0.08,0.5603408847931746,1.0,10/16,31.77%,DNM3;PRKN;GDAP1;DNM1L;DNM2;MTFR1L;MFF;MTFR2;OPA1;MTFP1
prerank,regulation of signal transduction (GO:0009966),0.47689132745278073,1.4516368540287805,0.009211873080859774,0.3931661603339853,1.0,37/190,11.29%,RORA;RUNX1;ADIPOQ;SULF1;MDFIC;IGFBP7;RGS16;LRRK2;TIMP1;IGFBP4;UGCG;TREM2;IGFBP5;NCK1;ACVR1;CD36;NCK2;CREBBP;DTNBP1;IRAK2;LLGL1;PTPN1;GSKIP;GAS1;ITGA3;BRAP;SP100;OGT;ZIC1;LIFR;TSPEAR;WWTR1;CBFB;PTPN2;SOCS5;GALNT11;IFT81
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5857258884814753,1.4508160674282564,0.07953063885267275,0.3945561797878547,1.0,5/26,5.86%,ADIPOQ;LRRC17;MAFB;FBN1;CDK6
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5160952359569195,-1.4504864429970026,0.07142857142857142,0.5624250710895778,1.0,8/16,23.69%,RANBP3L;PLCB1;AKIRIN1;IGFBP3;RIPOR2;BOC;MEF2C;MAPK14
prerank,glucose metabolic process (GO:0006006),0.5281428984288656,1.4500763082255483,0.041273584905660375,0.3957277088727529,1.0,8/58,10.28%,SLC39A14;ADIPOQ;APOD;AKR1A1;OMA1;ENO1;ADPGK;GAPDH
prerank,regulation of keratinocyte proliferation (GO:0010837),0.6040571044712034,1.4497808284832727,0.07651715039577836,0.39569028241271736,1.0,5/22,4.28%,ZFP36L1;FGF7;SNAI2;MDK;CASK
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5550333680665678,-1.4497581633692056,0.0821917808219178,0.5588772931049498,1.0,3/13,1.45%,ATP1A2;ATP1B3;ATP1B1
prerank,cilium movement (GO:0003341),0.5322061424440663,1.4497327468183538,0.054388133498145856,0.39494805501821334,1.0,9/47,13.37%,TEKT4;CFAP251;DNAAF4;SPEF2;DNAH9;DNAH11;TTC29;ODAD1;DNAAF5
prerank,regulation of catabolic process (GO:0009894),0.6261709583332896,1.4486574450838134,0.09040333796940195,0.39698605129379555,1.0,1/18,0.09%,FAP
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5586251534107359,1.448484098034947,0.06683804627249357,0.39663744525338,1.0,9/39,12.48%,COL4A1;GLI2;NRP1;SHH;PKD2;LRP6;SALL1;SEMA3E;FGF2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5072190955949394,1.4479149213679559,0.03436807095343681,0.39731909911814484,1.0,17/73,15.12%,LBP;SPN;TLR2;JAK2;STAT3;ARFGEF2;LGALS9;LY96;TIRAP;TMEM106A;CD14;LPL;WNT5A;PTPRJ;SPHK2;PSEN1;RIPK1
prerank,neuromuscular process controlling balance (GO:0050885),-0.5766686288967433,-1.44682599011302,0.08333333333333333,0.5628542093947231,1.0,4/12,9.93%,PCDH15;NRXN1;SHANK1;CLN3
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7013067324645818,1.446083078905915,0.08417508417508418,0.4015184709467995,1.0,2/10,4.89%,GFPT2;HK2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.4894320000201669,1.4459737033713211,0.02332979851537646,0.4009100579031089,1.0,25/107,14.77%,CASP4;CREB3L1;THBS4;GORASP2;CREB3L3;ERN2;PDIA3;BBC3;NCK1;ITPR1;BCL2;BAG6;ERLEC1;CREB3L2;NIBAN1;ATP2A2;SEC16A;UBA5;RCN3;GSK3B;TRAF2;PIK3R1;DDRGK1;TRIB3;HSPA5
prerank,body fluid secretion (GO:0007589),-0.5362567796715068,-1.4455335507699538,0.08868501529051988,0.5616603199574918,1.0,6/15,21.75%,NPR1;ERBB4;SLC22A4;GPAT4;SLC22A2;PRLR
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6919436098966761,1.4450733207563284,0.08374384236453201,0.4025678439183216,1.0,3/11,6.77%,PARP8;PARP3;PARP11
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6325460929079694,1.444943431113041,0.08567208271787297,0.4020411884903086,1.0,6/17,14.53%,MID1;TAOK1;EIF2AK2;TAOK3;TGFB2;PDCD10
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4728663298234323,1.4440724639741889,0.003033367037411527,0.40367111227792757,1.0,49/248,12.58%,PSMA7;RBMS3;COL1A1;ZEB2;BICC1;NKD2;TCF7L2;SFRP4;KREMEN1;GLI3;LYPD6;LRRK2;IGFBP4;SNAI2;EGFR;TLE1;APOE;FRZB;MDK;SMURF2;UBR5;EGF;ATP6AP2;SFRP1;LRP6;CDK14;PRICKLE1;SIAH2;FAM53B;GSKIP;CCAR2;DKK2;LRRK1;PSMB8;PSMA6;WNT5A;HDAC1;SFRP5;TBL1X;WLS;WWTR1;NPHP3;DRAXIN;CSNK1G2;RUVBL1;ZBED3;GSK3B;CSNK1A1;PSMF1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5326077126102824,1.4432452175875523,0.043683589138134596,0.4050755286951211,1.0,25/51,22.89%,GAS7;MAP4K4;TAOK1;LRRK2;MAP1S;DTNBP1;TAOK3;DCLK1;TRIO;DICER1;DBN1;NRK;DBNL;SNX2;ANKRD27;BMP7;ALS2;CTTN;ATP7A;EPB41L3;NYAP1;PAK1;CNTNAP1;SNX1;PLXNB1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.692096239874857,1.4432333929140786,0.07938931297709924,0.4042211863748343,1.0,6/12,11.96%,CXCL12;SPN;AIF1;CCL5;CXCL10;RHOA
prerank,mesoderm formation (GO:0001707),0.6336558242233964,1.442798449562574,0.09129213483146068,0.40455155750117583,1.0,4/17,8.66%,SNAI1;ITGA8;SMAD2;ITGA3
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5150389656652694,1.4427370338289398,0.04195011337868481,0.4038407338375025,1.0,22/72,14.06%,ROR2;ROR1;DCN;PDGFRA;PDGFRB;JAK2;TREM2;CCL5;EGF;PTPN6;PIK3AP1;PIK3R5;CBL;FGFR1;PTK2;TGFB2;UNC5B;TNF;FGF2;NTRK3;PIK3R1;SRC
prerank,Golgi localization (GO:0051645),0.6848864045202967,1.4427211165842238,0.09461663947797716,0.40299691484173256,1.0,5/11,14.53%,ARCN1;CDC42;COPG1;YWHAZ;PDCD10
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5432546695281124,1.4424337827802967,0.04609929078014184,0.4029404218660347,1.0,12/49,12.81%,RUNX1;KMT2A;RBBP5;CNOT4;RAB7B;TNRC6B;HDAC1;HMGB2;CBFB;KMT2E;MOV10;KMT2B
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5292875248536303,1.4420193372106909,0.049653579676674366,0.40312853253182174,1.0,15/53,18.32%,MC5R;HTR1D;CCR1;HRH4;ANXA1;HRH1;CCL2;LPAR3;CALCRL;MC1R;HRH3;NPY;MC2R;AGT;HTR1B
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6074133970768653,1.441953728283722,0.0712401055408971,0.40242474673976186,1.0,7/24,9.03%,TRPS1;SOX5;SNAI2;WNT9A;MDK;ADAMTS12;TGFBR1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7007051712089158,1.4416518397658276,0.0851063829787234,0.4015626068870727,1.0,1/10,0.48%,ADIPOQ
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7007051712089158,1.4416518397658276,0.0851063829787234,0.4015626068870727,1.0,1/10,0.48%,ADIPOQ
prerank,sulfate transport (GO:0008272),-0.5543770610343552,-1.4409623851402786,0.1,0.5707451247300335,1.0,3/14,1.78%,SLC13A4;SLC26A7;SLC26A2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4710196588751611,1.4407247886755297,0.0010070493454179255,0.40339717315113816,1.0,41/291,10.36%,RORA;MMP3;NR1H4;PDE3A;CXCL5;WNT2;CXCL1;LBP;PDGFRA;SBNO2;PDXP;ZFP36L1;NRIP1;TLR2;IRS1;TNFAIP3;WNT9A;CASP1;EGFR;IGFBP5;PKD2;NUGGC;CPEB1;ATM;SFRP1;LY96;CD68;CXCL10;AHR;PID1;CAPN2;RPTOR;TIRAP;CD14;RRAGC;LPL;WNT5A;IP6K2;SSH1;HMGB2;CCL2
prerank,regulation of autophagosome assembly (GO:2000785),0.5649786101118304,1.440585146417132,0.07054455445544554,0.4029098285210925,1.0,20/33,25.28%,LRRK2;CHMP4A;CHMP4B;TMEM39A;PIP4K2A;NPRL2;IFT88;RAB3GAP2;SMCR8;ADPRH;RAB3GAP1;SH3GLB1;MTMR3;SCFD1;MTM1;IFT20;RAB5A;TBC1D12;RALB;FEZ2
prerank,regulation of cell differentiation (GO:0045595),0.48149235697201126,1.4405618718470405,0.013471502590673576,0.40210222884844526,1.0,25/148,11.01%,RUNX1;RUNX2;TRPS1;RUNX3;EDN3;ZFP36L1;BCL6;ST7;MAFB;SNAI2;FLOT2;MDK;NREP;SHH;CEBPD;NF1;CREBBP;CDK6;EIF2AK2;DDX17;FADS1;TGFBR1;FGFR1;CBFB;PTK2
prerank,regulation of interleukin-10 production (GO:0032653),0.5389691270942385,1.440411576609365,0.06071871127633209,0.4016481900515827,1.0,6/44,5.04%,IL23R;TNFRSF21;XCL1;TSLP;STAT3;LGALS9
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5626174576621226,1.4401234523061588,0.07151979565772669,0.4015847480534916,1.0,9/33,13.40%,RUNX1;DNAAF4;KLK2;CARM1;CBFB;UBA5;CALR;DDRGK1;SAFB2
prerank,inorganic anion transmembrane transport (GO:0098661),-0.36684030762221154,-1.4400226494307127,0.02962962962962963,0.5678399186707007,1.0,19/63,9.76%,SLC12A2;SLC12A7;SLC20A2;SLC26A2;GABRA2;GABRB1;GLRA3;GABRG3;SLC1A1;SLC12A6;SLC6A1;GABRA5;SLC5A6;GLRA1;CLCN3;XPR1;GABRB2;ANO3;SLC4A8
prerank,regulation of T cell chemotaxis (GO:0010819),0.6816808668452403,1.4388072274320052,0.10426540284360189,0.40433441733488523,1.0,4/11,9.14%,XCL1;CCL5;CXCL10;WNT5A
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.6028733281994467,1.4378844788854035,0.09490084985835694,0.40599617078722466,1.0,3/21,4.80%,CREB3L1;LRRK2;NCK1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.48089442087365386,-1.4377502979353967,0.057926829268292686,0.5695191669391354,1.0,5/20,4.05%,ATP1A2;ATP1B3;SLC12A2;ATP1B1;KCNJ2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6816407234727042,1.4371478764978804,0.08422664624808576,0.4071952612309331,1.0,3/11,7.94%,JAK2;TAF7;TMEM106A
prerank,integrin-mediated signaling pathway (GO:0007229),0.5049304100510181,1.4371327847028323,0.030439684329199548,0.4063715286744803,1.0,28/73,21.28%,COL3A1;ITGB8;FBLN1;TEC;ITGB5;PTN;NRP1;DOCK1;MYH9;CCM2;CDC42;ADAMTS1;ITGA11;ITGBL1;PTK2;ERBIN;ITGA5;ADAM11;SRC;ITGB1BP1;PLEK;PTPRA;FERMT3;COL16A1;DST;ISG15;ADAM9;NME2
prerank,negative regulation of ossification (GO:0030279),0.600744474763348,1.43674996549541,0.06456043956043957,0.40653425306050966,1.0,5/23,9.33%,ENPP1;MDK;CCR1;SFRP1;CHSY1
prerank,defense response to virus (GO:0051607),0.4967258779204442,1.4366210258379957,0.030818278427205102,0.40606679009342456,1.0,25/100,16.09%,ZBP1;MAP3K14;STAT1;TLR2;IRF7;CD40;BCL2;SHFL;EIF2AK2;CXCL10;TLR7;IRF1;IFNAR2;ABCE1;EXOSC4;MLKL;OASL;SETD2;MOV10;ATG7;AKAP1;RNASE1;TRIM56;RTP4;CGAS
prerank,oligosaccharide metabolic process (GO:0009311),-0.3992272499123728,-1.4363962304875169,0.0457516339869281,0.5685463234668738,1.0,8/46,3.39%,ST3GAL6;ST6GALNAC3;AMY1B;AMY1C;AMY1A;ST8SIA4;FUT9;ST3GAL4
prerank,positive regulation of vasoconstriction (GO:0045907),-0.5438446231461187,-1.4360713947052675,0.07878787878787878,0.5638489025191267,1.0,4/13,16.39%,CAV1;ADRA1B;ADRA1A;TBXA2R
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5770691316191573,1.4359839901300802,0.07969151670951156,0.40700393380895444,1.0,12/30,15.84%,MGAT5;B4GALNT2;ST6GAL1;DDOST;ALG5;UGGT2;STT3A;LMAN1;UBE2J1;NUDT14;TUSC3;RPN1
prerank,regulation of B cell apoptotic process (GO:0002902),0.6873515199116229,1.435883332273393,0.09494640122511486,0.4063893213655581,1.0,5/12,13.03%,BCL6;BLK;NOC2L;FNIP1;ORMDL3
prerank,ceramide biosynthetic process (GO:0046513),-0.4041554358887576,-1.4354668103396604,0.05128205128205128,0.5605176454427687,1.0,15/40,15.70%,ST6GALNAC3;ST8SIA4;ST3GAL5;CERS4;SGMS1;SPTLC2;SPTLC1;SGMS2;ST8SIA6;DEGS2;B4GALT6;ST8SIA2;ST6GALNAC5;ASAH2;SMPD2
prerank,sterol metabolic process (GO:0016125),0.5166167088804549,1.435434471105668,0.05517241379310345,0.40676487047023235,1.0,6/60,4.34%,CYP1B1;CYP7B1;ABCA1;INSIG2;APOE;ABCG1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6066090573370033,-1.4350213824131017,0.08753315649867374,0.5565250743668245,1.0,6/10,22.19%,GABRA2;GABRG3;GABRA5;GABRB2;GABRG1;GABRE
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6508336076836404,1.4340139254735025,0.1038961038961039,0.40977473606209525,1.0,3/15,2.84%,DCN;BGN;VCAN
prerank,defense response to symbiont (GO:0140546),0.49804294138228306,1.4333996155740194,0.03636363636363636,0.41070057957050576,1.0,24/92,17.01%,ZBP1;MAP3K14;STAT1;TLR2;IRF7;CD40;BCL2;SHFL;EIF2AK2;TLR7;IRF1;IFNAR2;ABCE1;EXOSC4;MLKL;OASL;SETD2;MOV10;ATG7;RNASE1;TRIM56;RTP4;CGAS;PTPRC
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5154122114457866,-1.433369311887291,0.06769230769230769,0.5565645628303537,1.0,10/16,34.01%,PRKAG2;PPARGC1A;ACADL;ACADVL;TYSND1;MLYCD;NR4A3;SIRT4;SOX9;FABP3
prerank,regulation of cell killing (GO:0031341),0.6369412211112696,1.4330535342204462,0.09601181683899557,0.41076462809232667,1.0,5/16,14.73%,CFH;ICAM1;WNT5A;TGFB2;RAC1
prerank,diacylglycerol metabolic process (GO:0046339),-0.453724446137338,-1.432943912525169,0.0763888888888889,0.5526231124177149,1.0,9/23,19.59%,PLCE1;DGKB;DGKI;DGKA;LIPE;DGAT1;DGKG;DGKQ;PNPLA2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7087212044874361,1.432474269514281,0.0752,0.41062056232508093,1.0,6/10,12.96%,MPG;ASCC3;FTO;ALKBH5;ALKBH1;MGMT
prerank,DNA dealkylation (GO:0035510),0.7087212044874361,1.432474269514281,0.0752,0.41062056232508093,1.0,6/10,12.96%,MPG;ASCC3;FTO;ALKBH5;ALKBH1;MGMT
prerank,intracellular sterol transport (GO:0032366),0.6729771735211147,1.4322301483471405,0.09417040358744394,0.41046858200431496,1.0,5/13,11.20%,ABCA1;ABCG1;VPS4A;NPC2;RELCH
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.627797646247271,1.4318341353526784,0.10147058823529412,0.410693038015931,1.0,7/17,12.42%,STAT1;MAML3;CREBBP;PLXND1;HEYL;MAML2;MAML1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.6080921239398334,1.431719355308835,0.08613138686131387,0.4101412183776308,1.0,6/19,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,negative regulation of phagocytosis (GO:0050765),0.6290358888001063,1.4308191830118695,0.08345534407027819,0.41172370018153015,1.0,3/17,2.72%,ADIPOQ;TLR2;PRTN3
prerank,extracellular matrix assembly (GO:0085029),0.5911578948551566,1.4306871103364853,0.07650273224043716,0.41124337180536713,1.0,5/23,8.72%,LTBP3;GPM6B;LAMB1;EMILIN1;PXDN
prerank,macrophage activation (GO:0042116),0.5564991850848015,1.430538919342769,0.053482587064676616,0.41083201925437135,1.0,9/34,14.73%,LBP;SBNO2;JAK2;TREM2;AIF1;TMEM106A;CRTC3;TNF;CX3CL1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.7040626645911673,1.4304532774039795,0.0748829953198128,0.410263532313846,1.0,1/10,0.26%,HP
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6401625517187828,1.4303229965936342,0.08651026392961877,0.40976618492560757,1.0,6/16,10.88%,PDGFRA;PDGFRB;NRP1;PLAT;PTPN1;PTPRJ
prerank,regulation of fibroblast proliferation (GO:0048145),0.539374853315311,1.4301244176864838,0.06880189798339265,0.40948106286652497,1.0,10/45,9.14%,WNT2;PDGFRA;E2F1;DDR2;NF1;MORC3;CDK6;SFRP1;S100A6;WNT5A
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5894022979857356,1.4297489136935209,0.08356164383561644,0.4096831068109499,1.0,6/23,11.00%,JAK1;STAT1;JAK2;PPARG;CDC37;PTPN2
prerank,lamellipodium organization (GO:0097581),-0.4360949902782537,-1.4295547795326151,0.05150214592274678,0.55860847122753,1.0,12/29,14.21%,ABLIM1;KIT;CDH13;ABLIM3;S1PR1;CCDC88A;PTPRO;ARHGEF6;WASF1;VCL;PARVB;DMTN
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5658489668546894,1.4292034260231095,0.08184143222506395,0.410417025279422,1.0,10/30,15.22%,DCN;CHSY3;BGN;CHST13;VCAN;CHSY1;CHST11;UGDH;IDS;CHPF2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6510272029870978,1.4286736599719645,0.08157099697885196,0.4109287067381217,1.0,6/14,15.02%,KMT2A;AUTS2;KMT2E;DNMT3B;SMAD4;PAXIP1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6463183745880273,1.428599539398065,0.10588235294117647,0.41027195441756836,1.0,5/15,11.51%,GLI2;ANKRD11;LRP6;HDAC1;EDA
prerank,negative regulation of immune response (GO:0050777),0.4852280493814988,1.4285857254496777,0.01652892561983471,0.40948805748732336,1.0,18/154,6.53%,MC5R;COL3A1;IAPP;GPR176;GPR39;TNFAIP3;ADCY7;IRAK3;TREM2;RXFP2;MYH9;ADCY2;PTGDR;ADM;ILRUN;ADCYAP1R1;TRIM21;GLP2R
prerank,negative regulation of cell adhesion (GO:0007162),0.5070182642623482,1.4285252627547558,0.04591265397536394,0.40879983768046557,1.0,26/72,17.01%,CYP1B1;KNG1;FBLN1;SPN;B4GALNT2;SNAI2;PLXNC1;JAG1;MDK;NF2;PLXND1;MIA3;ARHGDIG;ANGPT1;PLXNA3;PTK2;DSCAM;GCNT2;RHOA;TGFBI;CX3CL1;ITGB1BP1;RASA1;ARHGDIA;ACVRL1;PTPRC
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6894859365895196,1.4280849081757914,0.09076433121019108,0.4091649696295945,1.0,6/11,21.11%,RFTN1;COLEC12;CASP8;RIPK1;UNC93B1;TNIP2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.6173017034722698,1.4280786601547164,0.08875739644970414,0.40835933447136286,1.0,6/17,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.4772777118055456,-1.4278669401069783,0.06785714285714285,0.558808667479119,1.0,4/20,1.98%,PLCE1;CHRM2;CAV1;KCNB2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.524647699300318,1.4276094362957403,0.06197854588796186,0.4088240292585217,1.0,17/48,20.64%,ADIPOQ;SLIT3;IRAK3;TREM2;PADI2;PPARG;PYDC1;PELI3;PTPN2;NLRP2B;YTHDF3;CCDC3;TRAIP;PTPRC;STAT2;ISG15;PARP14
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5224110240222476,-1.4275913501351112,0.07371794871794872,0.5543313625592557,1.0,6/15,17.80%,PIK3CB;HIP1R;BMP2K;WASL;DAB2;SNAP91
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5914604179567928,1.427577725625918,0.08746736292428199,0.40810999534885284,1.0,12/25,22.90%,ADIPOQ;ATXN2;ABCA2;DLG4;PSEN1;ANKRD13B;NEU3;RAC1;PICALM;MTMR2;SDCBP;ITGB3
prerank,regulation of ossification (GO:0030278),0.557222774242383,1.4273204825822816,0.07425742574257425,0.4079830174558614,1.0,12/36,11.67%,ENPP1;PTN;MDK;DDR2;ACVR1;CYP27B1;SFRP1;LRP6;WNT5A;CHSY1;TGFB2;NBR1
prerank,regulation of cell aging (GO:0090342),0.6772812346471817,1.4271440031989202,0.09567901234567901,0.4077082425780487,1.0,3/11,7.81%,NEK6;NUAK1;NEK4
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5816194100301392,1.4258197555411618,0.08781127129750983,0.410558938054224,1.0,9/27,9.78%,TNIP1;TLR2;IRAK3;CD36;LY96;IRAK2;TIRAP;CD14;IRAK4
prerank,peptidyl-asparagine modification (GO:0018196),0.5727240567072613,1.4257651538075533,0.08056265984654731,0.40989366459104937,1.0,12/31,15.84%,MGAT5;B4GALNT2;ST6GAL1;DDOST;ALG5;UGGT2;STT3A;LMAN1;UBE2J1;NUDT14;TUSC3;RPN1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6001221358786556,1.4253568821835707,0.07630522088353414,0.4093469599777969,1.0,7/23,14.44%,ZEB2;CDKN2B;CREBBP;RNF111;TGFB1I1;GIPC1;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6001221358786556,1.4253568821835707,0.07630522088353414,0.4093469599777969,1.0,7/23,14.44%,ZEB2;CDKN2B;CREBBP;RNF111;TGFB1I1;GIPC1;SMAD4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5752753071092763,1.4252094873223518,0.07722513089005235,0.40890927015162554,1.0,4/26,3.52%,ZFP36L1;ZFP36L2;SNAI2;EGFR
prerank,secretory granule organization (GO:0033363),0.7004572265267037,1.4251184687675251,0.0949367088607595,0.40839701189492655,1.0,2/10,5.87%,ABCA1;DTNBP1
prerank,regulation of bone mineralization (GO:0030500),0.5210150846847944,1.4249091362125343,0.05620608899297424,0.40817528789939395,1.0,17/55,14.55%,ENPP1;GPM6B;FBN2;PTN;NELL1;CCR1;DDR2;ACVR1;CYP27B1;TGFB3;TMEM119;NBR1;ATP2B1;ACVR2A;P2RX7;BMP7;TRPM4
prerank,positive regulation of biosynthetic process (GO:0009891),0.5435200531361476,1.424667738148252,0.07064555420219244,0.40800842435370255,1.0,6/40,6.17%,RUNX1;CREB3L1;APOE;CD36;CCL5;TGFB3
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5192041528664039,1.4242626851098812,0.05148741418764302,0.40820944384743396,1.0,3/61,1.11%,PSMA7;NR1H4;NCOR2
prerank,positive regulation of immune effector process (GO:0002699),0.5743144272528388,1.42394664456674,0.06357615894039735,0.4082423574014934,1.0,5/27,11.83%,IL23R;LBP;LGALS9;PTPRJ;ANKRD17
prerank,regulation of glucose metabolic process (GO:0010906),0.5608213944508603,1.4234603503890244,0.07760814249363868,0.4087741449560863,1.0,4/34,5.70%,RORA;ADIPOQ;IRS1;FOXK2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5176901467779296,1.4233459117712277,0.046620046620046623,0.4082859748975005,1.0,13/63,9.53%,IL23R;CD276;CD40;VAV3;NCK1;BCL2;AIF1;NCK2;CCL5;SASH3;TIRAP;ANXA1;IL7
prerank,placenta development (GO:0001890),0.6699167734522251,1.423121212826201,0.11198738170347003,0.4080393193702366,1.0,4/12,11.01%,ADAM19;PPARG;E2F8;PTK2
prerank,response to lipopolysaccharide (GO:0032496),0.4812727162353886,1.4225278919659636,0.01865284974093264,0.4088530327121584,1.0,22/138,11.96%,CXCL5;IL23R;CXCL1;LBP;SBNO2;TNFAIP3;JAK2;CASP1;IRAK3;LGALS9;NUGGC;CYP27B1;LY96;CD68;CXCL10;TIRAP;CD14;WNT5A;HMGB2;CCL2;ERBIN;RHOA
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6984530360166898,1.4224255964203092,0.10260336906584992,0.40837740112166354,1.0,4/10,7.08%,TREM2;CD36;CD68;MIA3
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5031206516759952,1.4219367638268472,0.04858757062146893,0.40898846812394296,1.0,28/71,21.55%,FAP;TNFAIP3;USP9X;CHMP4B;CTSS;OMA1;VPS4A;CTSK;BAG6;CTSL;ADAMTS12;CAPN2;PSMA6;CTSB;CASP8;CTSC;ADAMTS7;CTSW;UBE2W;PSMA8;ZYG11B;DDB1;MDM2;RHBDD1;ISG15;NR1D1;HM13;RPS27A
prerank,histone H3 deacetylation (GO:0070932),-0.5193766088487874,-1.4219165392330775,0.07006369426751592,0.5673347330571716,1.0,8/15,17.77%,SFPQ;HDAC4;HDAC9;PER1;SMARCAD1;PER2;SIRT7;HDAC3
prerank,tube closure (GO:0060606),0.5666276604575478,1.421361330650632,0.05977584059775841,0.40973081282063595,1.0,6/31,6.41%,DLC1;DEAF1;MTHFR;MTHFD1L;LRP6;PRICKLE1
prerank,neural tube closure (GO:0001843),0.5589157689865538,1.4213160109644416,0.0594059405940594,0.40907579144149714,1.0,6/34,6.41%,DLC1;DEAF1;MTHFR;MTHFD1L;LRP6;PRICKLE1
prerank,aorta morphogenesis (GO:0035909),0.6222513202432315,1.4206805365294226,0.10795454545454546,0.4100187137465408,1.0,6/17,9.18%,LRP1;PDGFRB;TBX2;JAG1;ADAMTS9;MYLK
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6537249836159185,1.4205967980850565,0.09049773755656108,0.4094555236085217,1.0,5/13,11.57%,CBLB;ERRFI1;CBL;SOCS5;ZGPAT
prerank,negative regulation of innate immune response (GO:0045824),0.5491161842489539,1.419847785733716,0.0722291407222914,0.4107061408617887,1.0,5/34,5.54%,VSIG4;SERPING1;TNFAIP3;IRAK3;TRIM21
prerank,primary neural tube formation (GO:0014020),0.5695340112993503,1.4192610497276736,0.06826801517067003,0.41151989271621653,1.0,6/30,6.41%,DLC1;DEAF1;MTHFR;MTHFD1L;LRP6;PRICKLE1
prerank,regulation of vasculature development (GO:1901342),0.5806861367407492,1.4191664152934225,0.07702349869451697,0.4109842585530804,1.0,8/26,12.48%,NF1;SFRP1;PLXND1;GPNMB;SP100;RNH1;BMPER;FGF2
prerank,endothelial cell differentiation (GO:0045446),0.6730767465679446,1.4190570154850561,0.1083969465648855,0.4105301567647984,1.0,3/12,4.21%,SCUBE1;FSTL1;JAG1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6702440204803959,1.419007321802001,0.09104704097116843,0.4099035942391122,1.0,3/11,7.98%,CXCL12;IRF7;MERTK
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.6005989577764528,1.418909871299251,0.09366391184573003,0.4094204134983076,1.0,9/20,18.23%,RUNX2;SMAD5;NFE2L2;SMAD4;SMAD1;CREB3;HIF1A;ATF4;RBPJ
prerank,Golgi organization (GO:0007030),0.4766464542198086,1.4187897115688466,0.026399155227032733,0.4089332719632593,1.0,36/112,19.07%,SEC16B;VMP1;GORASP2;LRRK2;ATP8B1;STX6;RAB2A;PI4K2B;STX17;ATL2;CDC42;COG4;LMAN2L;GBF1;GOLGA8B;GOLGA5;TRIP11;SEC16A;GAK;LMAN1;SEC23IP;YWHAZ;CSNK1A1;TMED1;RAB1A;DYNC2H1;VCPIP1;PDCD10;LYSMD3;COG7;OBSL1;TBC1D20;CSNK1D;TMED5;BCAS3;TJAP1
prerank,cobalamin metabolic process (GO:0009235),0.6196695401092644,1.4187452318168092,0.0935672514619883,0.40828631493857975,1.0,3/17,7.43%,TCN1;MMAB;TCN2
prerank,regulation of actin filament-based process (GO:0032970),0.5017309534971074,1.4187399232764086,0.05649717514124294,0.40753806736933973,1.0,13/70,8.60%,DLC1;GPM6B;LRP1;RND3;TAOK1;PDGFRB;RICTOR;FSCN1;BAIAP2;RHOD;CDK10;ARHGEF19;EFNA5
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5669704881488828,1.4186810391324975,0.07327001356852103,0.4068999899699208,1.0,11/29,17.64%,CXCL12;CCR1;AIF1;LGALS9;CCL5;CXCL10;PLA2G7;CALR;TNF;CREB3;ANO6
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.6887363084604609,1.4185236464545967,0.09270516717325228,0.406603009046569,1.0,5/11,18.40%,TNFAIP3;TREM2;TIRAP;PJA2;MFHAS1
prerank,positive regulation of signal transduction (GO:0009967),0.46320967669017826,1.4185074302183152,0.005055611729019211,0.4058659236646566,1.0,73/238,17.73%,SLC39A14;C3;ADIPOQ;SULF1;MGAT5;CCBE1;YAP1;ASXL1;TNFSF11;ZMIZ1;TLR2;LRRK2;IRS1;TNFAIP3;JAK2;PRKCA;NRP1;TSLP;MAML3;TREM2;STAT3;STK36;JAG1;SHH;PTEN;PRKD2;PKD2;ASXL2;LIMS1;CYP27B1;CREBBP;ATP6AP2;SFRP1;LY96;DLG4;ARNT;SASH1;MAML2;TERT;TGFBR1;CSNK2A1;SALL1;IL7;DRD3;WLS;DISC1;LOXL3;TRIM44;NEPRO;PDE6H;VTN;TGFB2;MAML1;NTRK3;SNX5;PIK3R1;ITGA5;DACT1;RAB34;DLG5;SRC;PDCD10;CD63;SMO;HIF1A;DEPDC1B;ITGB1BP1;TSPAN14;SMARCA4;PTPRC;ING5;STX1B;GLI1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6590826490751123,1.4176118353844789,0.10097719869706841,0.4075337240882052,1.0,2/12,5.36%,IL23R;PAEP
prerank,nuclear membrane disassembly (GO:0051081),0.6432194898072565,1.416456658104163,0.09104046242774566,0.4096824570379861,1.0,5/14,11.30%,NEK6;PRKCA;PLK1;NEK9;CCNB2
prerank,positive regulation of cell adhesion (GO:0045785),0.49546228054411545,1.416053791174662,0.03070175438596491,0.41003019729109086,1.0,17/74,12.57%,IBSP;FBLN2;CXCL12;JAK2;PRKCA;MDK;PRKD2;RHOD;LIMS1;CCL5;ATM;RSU1;PPP3CA;PTPRJ;TGFB2;TNF;DUSP26
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5778449444749943,1.4160124248188075,0.09249329758713137,0.40938701579377507,1.0,9/26,13.23%,CBLB;ERRFI1;NCK2;EGF;CBL;FBXW7;SOCS5;ZGPAT;BTC
prerank,visual system development (GO:0150063),0.5443396423934893,1.4159044075368588,0.07616707616707617,0.40890706491103174,1.0,7/37,8.25%,C3;SH3PXD2B;MEIS2;SIPA1L3;MEIS1;PBX3;ADAMTS18
prerank,renal system development (GO:0072001),0.5177100031435098,1.4152551035264103,0.06954436450839328,0.4099154030476274,1.0,12/52,11.44%,SULF1;GLI2;TBX18;STAT1;ITGA8;IFT88;BAG6;TGFBR1;GREB1L;SALL1;NPHP3;TGFB2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6360718096010296,1.4151866388639207,0.0951683748169839,0.40938534381180997,1.0,7/14,16.30%,ADIPOQ;PYDC1;PELI3;PTPN2;NLRP2B;CCDC3;TRAIP
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6847822618861281,1.4149848960907878,0.0967238689547582,0.40916774710300774,1.0,6/10,24.23%,CCL2;NFE2L2;HSPA5;EIF2AK3;ATF4;EIF2S1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5355552906628916,1.4140289915255617,0.06675062972292191,0.4109364409638605,1.0,15/40,22.19%,GLMN;PTEN;FBXW7;RAD23A;CSNK2A1;CSNK2A2;RAD23B;PTK2;RPL11;SMURF1;GNA12;XPO1;AXIN1;CLU;LATS1
prerank,renal absorption (GO:0070293),-0.5877710713420928,-1.413867782653492,0.09455587392550144,0.5878398685223285,1.0,4/10,12.33%,KLHL3;GSN;WNK4;KCNQ1
prerank,kinetochore organization (GO:0051383),-0.5298096093841667,-1.4136579482991336,0.09659090909090909,0.5832149686554764,1.0,10/13,41.57%,CENPC;POGZ;CENPT;CENPE;CENPH;NDC80;CENPF;DLGAP5;NUF2;CENPW
prerank,regulation of amyloid-beta clearance (GO:1900221),0.6130576260093829,1.4135175941281584,0.1027190332326284,0.41155678506106674,1.0,5/16,12.29%,LRP1;TREM2;APOE;HDAC1;TNF
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.456147492471639,1.4126944234297978,0.0,0.4131237275879833,1.0,126/476,18.64%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;KMT2A;RUNX3;CXXC1;SPP1;MDFIC;BCL3;GLI2;YAP1;DEAF1;TCF4;SNAI1;GLI3;STAT1;ZMIZ1;IRF7;GATA6;FGF7;MAFB;MITF;ZNF496;SMAD2;EGFR;APOE;STAT3;ELF4;ILF3;NR2F2;SHH;E2F1;MYBL1;SMARCC1;ACVR1;FOXK2;EGF;CREBBP;FZD1;SFRP1;PPARG;LRP6;YAF2;ZBTB48;TGFB3;AHR;FOXE1;GTF2H1;RNF111;IRF1;NEK4;CREB3L2;SP100;TGFBR1;MAP2K1;WNT5A;HDAC1;SALL1;FOXO3;TBL1X;ARID1B;SMAD5;TGFB1I1;HMGB2;ZIC1;TRIM44;TEAD1;KMT2E;RSF1;SP3;MED13;NIF3L1;MAP3K2;FBXW11;TNF;KLF6;FGF2;KMT2B;ELK1;NSD3;SNX5;BRPF1;CTCF;SMAD3;PSEN1;BMP7;EGR2;USP22;SMAD4;DTX3L;MMS19;NAA15;HIF1A;TRIM56;NPAS2;NSD1;POU3F3;ATF7IP;CLOCK;TCF3;SMARCA4;ACVRL1;ZFHX3;AKT1;ING5;CALCOCO1;THRAP3;PCBD2;BRD4;ATF4;PICALM;GLI1;ETS1;MAP3K12;RLF;RAI1;INHBA;BICRA;PAX8;AGT;SOX2;SETD3;HINFP;KAT6B
prerank,lipoprotein catabolic process (GO:0042159),0.6913720433501471,1.412450720723025,0.09775641025641026,0.41302044732327153,1.0,6/11,16.48%,APOE;ABHD17C;CTSD;LYPLAL1;ABHD17B;LYPLA2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3964046277564751,-1.4124292269414156,0.06622516556291391,0.5819027955952915,1.0,15/44,16.50%,ATP1B3;ATP1B1;ACTN2;AKAP6;ANK2;WNK4;KCNJ2;WNK3;KCNJ3;KCNJ10;KCNQ1;KCNJ12;KCNN2;KCNN3;WNK2
prerank,cellular response to UV (GO:0034644),0.5029636711844031,1.4121478008681863,0.04824561403508772,0.41302942656430186,1.0,20/76,21.00%,MMP3;MMP2;TIMP1;PPID;INO80;CREBBP;NOC2L;ATR;TMEM161A;MC1R;MFAP4;FMR1;NEDD4;USP28;DDB1;ATF4;RHBDD1;KDM1A;PRKCD;YY1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.588168124871559,1.4119981828022823,0.08666666666666667,0.412667971816754,1.0,5/25,4.84%,CMKLR1;LRRK2;P2RX5;TREM2;ITPR1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4253921954576665,-1.4119653709811963,0.08888888888888889,0.5783996497103313,1.0,8/29,9.15%,TJP1;PRKN;KANK3;SHANK3;HIP1R;TWF2;KANK4;SHANK1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5474573185882209,-1.41196151030659,0.0935672514619883,0.5733862848916177,1.0,3/13,3.36%,NR3C2;BMP4;ESR1
prerank,triglyceride catabolic process (GO:0019433),0.6100457831675046,1.411626924989192,0.08579465541490858,0.412954390653707,1.0,3/19,12.66%,LIPC;LPL;FABP5
prerank,response to insulin (GO:0032868),0.4976111036390465,1.4113464783995548,0.051535087719298246,0.41290594962945154,1.0,21/80,14.12%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;IRS1;INSIG2;USF1;CPEB1;PPARG;MYO5A;INHBB;RAB8B;DENND4C;OGT;RPS6KB1;GCK;KHK;ZBED3;PIK3R1;RAB10;TRIB3
prerank,presynapse assembly (GO:0099054),0.6312494118816675,1.4113089740526201,0.08356940509915015,0.41227640822044614,1.0,4/16,9.14%,CEL;PTEN;FZD1;WNT5A
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5213834135545005,-1.411232731130316,0.0970873786407767,0.5707395536842047,1.0,5/14,8.96%,DMD;ATP1B1;WNK4;WNK3;ANK3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5560165295220719,-1.4106475522812914,0.10584958217270195,0.5675012467510163,1.0,5/11,15.71%,LDLR;SCARB1;SLC27A1;GPLD1;MFSD2A
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4955821009718677,1.4105268878677528,0.050505050505050504,0.41354873298828404,1.0,14/72,14.73%,ABCA1;DLC1;COL3A1;P2RY10;NRP1;APOE;OPHN1;ITGA3;KCTD10;AKAP13;ARHGEF18;ARHGAP35;PDCD10;RAC1
prerank,regulation of cell adhesion (GO:0030155),0.47467705673393834,1.4098401997316639,0.027455121436114043,0.4147685071593654,1.0,39/129,17.09%,IBSP;EPHA7;KNG1;FBLN1;CXCL12;SPN;PRKCA;PLXNC1;EPHB3;NUAK1;MDK;PRKD2;RHOD;CCL5;ATM;PLXND1;RSU1;MIA3;ARHGDIG;ANGPT1;PLXNA3;EFNA5;CXCR4;PPP3CA;PTPRJ;PTK2;DSCAM;PPP1CB;TNF;DUSP26;TGFBI;SRC;FES;ITGB1BP1;RASA1;ARHGDIA;CHRD;ACVRL1;ZFHX3
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6509865553813393,1.4097385914324752,0.080370942812983,0.41427894320671854,1.0,8/14,16.92%,SEC31A;SEC24D;SEC23A;SEC24A;MIA3;RAB1A;SEC13;TBC1D20
prerank,regulation of interleukin-6 production (GO:0032675),0.484897746766179,1.4093163309009833,0.043149946062567425,0.41462737529109767,1.0,17/96,9.14%,LBP;IL16;TLR2;TNFAIP3;TSLP;IRAK3;TREM2;STAT3;AIF1;LGALS9;PTPN6;TLR7;RAB7B;TIRAP;TMEM106A;LPL;WNT5A
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.48713642332814605,1.408631000190629,0.03470715835140998,0.4157377413663407,1.0,26/100,13.29%,ROR2;ROR1;DCN;PDGFRA;PDGFRB;JAK2;EGFR;PIP5K1B;TREM2;PTPN13;PTEN;PIP4K2A;CCL5;EGF;PTPN6;PIK3AP1;PIK3R5;CBL;FGFR1;PTK2;TGFB2;UNC5B;TNF;FGF2;NTRK3;PIK3R1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6248608696786863,1.4085358960151266,0.09728183118741059,0.4152399160402163,1.0,4/17,6.17%,ADIPOQ;PTEN;PPARG;TGFB3
prerank,intracellular cholesterol transport (GO:0032367),0.6448267622158216,1.4080785845246548,0.08345534407027819,0.41573648440038674,1.0,6/15,11.20%,ABCA1;ABCG1;LRP6;VPS4A;NPC2;RELCH
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5425117195555053,-1.407898991254888,0.09146341463414634,0.5709793308301472,1.0,7/13,20.10%,SHANK3;ADCY1;APP;ZDHHC2;SHISA7;RELN;LGMN
prerank,positive regulation of vasculogenesis (GO:2001214),-0.565754820692915,-1.407317743330514,0.10410958904109589,0.5679030046165242,1.0,5/10,14.13%,CD34;RAPGEF2;KDR;RAP1A;TMEM100
prerank,neuron differentiation (GO:0030182),0.46795437886466495,1.4072682455623,0.020682523267838676,0.4171491292799404,1.0,24/165,12.12%,RUNX1;RUNX2;WNT2;RUNX3;GLI2;UGCG;WNT9A;TENM3;BHLHE22;SHH;ACSL4;PBX3;OPHN1;FZD1;LRP6;TENM4;MYO7A;TGFBR1;MAP2K1;WNT5A;NEUROD6;TGFB2;TDP2;NIF3L1
prerank,receptor signaling pathway via STAT (GO:0097696),0.5685294510553534,1.4069346601193782,0.09530386740331492,0.41726347386526275,1.0,8/25,10.36%,GHR;STAT1;JAK2;STAT3;PKD2;STAT5A;IFNAR2;CCL2
prerank,regulation of mast cell degranulation (GO:0043304),0.6372097676104815,1.4065339959477223,0.11043872919818457,0.41751559911323866,1.0,6/14,14.81%,GAB2;BLK;LGALS9;UNC13D;SPHK2;FES
prerank,defense response to Gram-negative bacterium (GO:0050829),0.5344672903649293,1.4064773900946934,0.07493857493857493,0.4169500660750232,1.0,6/42,10.06%,IL23R;LBP;TREM2;RNASE7;MPEG1;HMGB2
prerank,central nervous system myelination (GO:0022010),0.6772013120887,1.4060018303613104,0.09969788519637462,0.4174627535818215,1.0,4/11,7.14%,B4GALT5;ABCA2;PTEN;TENM4
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5526660797038717,-1.405987767949375,0.09294871794871795,0.5670122891669721,1.0,4/12,11.13%,MAP2;EML2;CDH5;STMN2
prerank,metanephric mesenchyme development (GO:0072075),0.6666593646217825,1.4050826988828455,0.1136,0.4191980506347287,1.0,3/10,5.01%,STAT1;SHH;PKD2
prerank,tetrapyrrole metabolic process (GO:0033013),0.6093801667391775,1.4049901330768817,0.10044313146233383,0.41869212104939785,1.0,3/18,7.43%,TCN1;MMAB;TCN2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.683246526777707,1.4043482122138828,0.10252365930599369,0.41968562390237424,1.0,3/11,8.59%,LIPC;ABCG1;PLA2G7
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5700555771791134,1.403969969398595,0.07760814249363868,0.419929022456098,1.0,9/29,15.12%,IRF7;CD40;BIRC3;IKBKE;LY96;CD14;CASP8;TANK;RIPK1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.34359508033725866,-1.403823646121552,0.009259259259259259,0.5689457338023971,1.0,17/75,5.75%,ATP1A2;ATP1B3;SLC12A2;SLC24A2;SLC12A7;ATP1B1;SLC9A2;SLC39A10;SLC12A6;KCNJ2;KCNJ3;SLC6A1;ATP2B4;SLC8A3;KCNJ13;SLC39A8;ABCC9
prerank,chordate embryonic development (GO:0043009),0.5073403192333048,1.4022897330321782,0.06936416184971098,0.42378309814933357,1.0,11/55,10.51%,COL1A1;SULF1;DEAF1;CHD7;ALDH1A2;PKD2;TGFB3;TGFBR1;WNT5A;BMP5;FGFR1
prerank,regulation of osteoblast proliferation (GO:0033688),0.624047070751412,1.4022012147214753,0.10465116279069768,0.42322964928572177,1.0,7/17,11.96%,TNN;NELL1;SFRP1;EIF2AK2;HPSE;TMEM119;RHOA
prerank,negative regulation of bone mineralization (GO:0030502),0.6426919742002102,1.4020017466764547,0.1080669710806697,0.42306827144552506,1.0,2/13,4.31%,ENPP1;CCR1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.5072931661390425,1.401344600203623,0.07246376811594203,0.42400970982146163,1.0,13/53,17.05%,GLMN;DNAAF4;TREM2;APOE;OPHN1;FBXW7;RAD23A;RAD23B;PSMF1;DDRGK1;FMR1;PSMD14;GNA12
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.3463093365698411,-1.4012500344051966,0.04878048780487805,0.571404764491968,1.0,35/69,28.94%,COX5A;COX8A;NDUFS1;COX4I1;UQCRC2;NDUFV2;COX6C;COX6B1;NDUFA13;NDUFA6;COX6A1;NDUFA12;COX10;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;COX5B;UQCRB;NDUFA1;NDUFC2;NDUFA10;UQCRH;NDUFS2;UQCRFS1;NDUFB11;UQCC3;COA6;UQCR10;SDHAF2;UQCR11;NDUFS5;NDUFV1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.48451879196960496,1.4011523458195403,0.048025613660619,0.423795816678728,1.0,28/95,15.52%,DCN;CEMIP;LUM;CHSY3;HSPG2;BGN;B4GALT5;CHST13;GPC6;VCAN;EXT1;ST3GAL3;EXT2;PRELP;ANGPT1;SDC1;HS2ST1;SDC2;CHSY1;CHST11;ST3GAL1;GCNT2;CHST1;UGDH;SLC35D2;CHPF2;B4GALT2;B4GALT7
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.535097822054314,1.4011245969759187,0.07352941176470588,0.4231269260078613,1.0,7/37,7.61%,MMP2;ADIPOQ;IGFBP5;PTEN;PPARG;TGFB3;ADAMTS1
prerank,positive regulation of DNA replication (GO:0045740),0.6282261211288188,1.4005184918432723,0.08,0.42407045912040836,1.0,5/16,5.80%,GLI2;DNA2;EGFR;EGF;BRPF3
prerank,positive regulation of neutrophil migration (GO:1902624),0.5985746755434495,1.4003403734945692,0.09461426491994178,0.42377951572502986,1.0,6/18,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,androgen metabolic process (GO:0008209),0.6139101449483303,1.4002256976949352,0.1092436974789916,0.4233797794640584,1.0,3/18,8.44%,SPP1;SHH;SRD5A3
prerank,cellular response to superoxide (GO:0071451),-0.5753944098522074,-1.4001067768646533,0.09610389610389611,0.5701968549572843,1.0,6/10,22.69%,NOS3;SOD1;PRDX2;SOD3;SOD2;ADPRS
prerank,cellular response to lipopolysaccharide (GO:0071222),0.48300879457075985,1.3999251195924736,0.04202586206896552,0.42343578316981006,1.0,17/101,12.29%,CXCL5;CXCL1;LBP;SBNO2;TNFAIP3;CASP1;NUGGC;CCL5;LY96;CD68;CXCL10;CD14;WNT5A;HMGB2;CCL2;RHOA;TNF
prerank,embryonic limb morphogenesis (GO:0030326),0.554706475924129,1.3998262122034781,0.07721518987341772,0.4229921346877845,1.0,11/34,11.44%,GLI3;CACNA1C;TBX2;SHH;CREBBP;LRP6;HDAC1;SALL1;WDPCP;TBX3;TGFB2
prerank,ethanol metabolic process (GO:0006067),-0.5401498878579503,-1.3997854017503573,0.08587257617728532,0.5665824170871955,1.0,5/12,20.01%,ALDH1A1;SULT1A1;ALDH2;ACSS1;ACSS2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5312717126186617,1.3991829536145957,0.0692588092345079,0.42397533567556456,1.0,17/46,17.21%,ADIPOQ;FBLN1;TNIP1;SPRED1;SPRED2;PTEN;EMILIN1;PTPN1;CNKSR3;PTPN2;SPRY2;DUSP26;RANBP9;SMAD4;ITGB1BP1;PTPRC;DUSP6
prerank,carbohydrate derivative transport (GO:1901264),0.6055087659643498,1.3990165291588745,0.1,0.4236624366675831,1.0,9/18,21.66%,LBP;SLC15A3;PLTP;ABCG1;NPC2;SLC29A1;CPTP;SLC15A2;SLC25A19
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5877227881024175,1.3987850016096928,0.0993006993006993,0.4235103884014439,1.0,3/19,3.88%,RUNX1;ZFPM2;TBX2
prerank,negative regulation of autophagosome assembly (GO:1902902),0.6465662913597295,1.3987778507746862,0.09882005899705015,0.42280498864384874,1.0,4/13,4.23%,LRRK2;CHMP4A;CHMP4B;TMEM39A
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.5015483340687474,-1.3986960456781172,0.09003215434083602,0.5652833972396437,1.0,8/17,20.66%,ALK;SORL1;GPLD1;BSCL2;PDE3B;MFSD2A;ADRA2A;PRKAA1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5830069110042365,1.3985035329146702,0.10402219140083217,0.42279316049512183,1.0,2/21,2.96%,EPHA7;BIRC3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5811772639587011,1.398241636821457,0.09659863945578231,0.4228250420499072,1.0,5/23,8.09%,ENPP1;GLI3;KCTD21;SUFU;GPR161
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5914604280786085,1.3978695616584482,0.09863013698630137,0.42302421861267564,1.0,4/23,5.67%,CYP1B1;GHR;JAK2;CCL5
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5649204311788716,1.3976133034766607,0.07496823379923762,0.42301381825830586,1.0,9/30,15.12%,IRF7;CD40;BIRC3;IKBKE;LY96;CD14;CASP8;TANK;RIPK1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.6350314765193279,1.3971926817805251,0.10658307210031348,0.4234274907583903,1.0,2/14,5.36%,IL23R;PAEP
prerank,B cell receptor signaling pathway (GO:0050853),0.5534571082445723,1.3966335769113087,0.1010230179028133,0.4241242835095565,1.0,8/32,9.76%,RFTN1;TEC;VAV3;BLK;BCL2;SH2B2;LAT2;MS4A1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.37256079209003456,-1.3962121519568906,0.05755395683453238,0.5684178112320668,1.0,23/57,22.90%,DLGAP1;LRRC7;ACTN2;DLG2;MINK1;SHISA6;DLGAP2;GRIA2;GRIA1;CACNG2;SHANK1;APP;GRIN2B;CAMK2B;LYNX1;CACNG7;SHISA7;RELN;NLGN1;NPTXR;MEF2C;SHISA9;CACNG8
prerank,chloride transmembrane transport (GO:1902476),-0.3754067802377571,-1.3953833316008066,0.04878048780487805,0.566222782476775,1.0,15/48,9.76%,SLC12A2;SLC12A7;GABRA2;GABRB1;GLRA3;GABRG3;SLC1A1;SLC12A6;SLC6A1;GABRA5;GLRA1;CLCN3;GABRB2;ANO3;SLC4A8
prerank,neuron maturation (GO:0042551),0.6175569346883598,1.3951293298152954,0.11894273127753303,0.42728503593588907,1.0,3/18,2.07%,C3;FARP2;B4GALT5
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.47967801989313663,1.3951106846604202,0.05818965517241379,0.42659835918644773,1.0,15/87,8.60%,DLC1;GPM6B;PDGFRA;LRP1;RND3;TAOK1;PDGFRB;RICTOR;FSCN1;MDK;BAIAP2;RHOD;CDK10;ARHGEF19;EFNA5
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5114188917415886,1.3944884215161595,0.08227114716106605,0.4275279209693011,1.0,13/51,12.90%,IL16;JAK2;CASP1;STAT3;LGALS9;CD36;PYDC1;TMEM106A;LPL;WNT5A;CASP8;TNF;P2RX7
prerank,innate immune response (GO:0045087),0.462248962412187,1.3938286246879508,0.004044489383215369,0.4285267222639021,1.0,41/217,16.15%,C3;IL23R;TRIML2;LBP;COLEC12;MASP1;CRP;TLR2;IRF7;ALPK1;CD40;REL;TREM2;BLK;CYP27B1;TRIM21;SHFL;RNASE7;PPARG;CXCL10;STYK1;PYDC1;TRIM13;FRK;TRIM8;SP100;IRAK4;SETD2;PTK2;POLR3A;ANKRD17;PJA2;MFAP4;COLEC11;SRC;AKAP1;FES;TIFA;TRIM56;RELB;YES1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5507828092355198,1.392749663995639,0.09960681520314547,0.4305698259673859,1.0,2/30,0.65%,COL3A1;P2RY10
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4965243924201026,1.392257042389257,0.04723502304147465,0.43112908680657575,1.0,27/65,22.28%,PMEPA1;FBN2;SPRED1;SMAD2;FBN1;SMURF2;SPRED2;HTRA3;EMILIN1;WFIKKN1;HTRA4;TGFBR1;LTBP1;TGFB1I1;LDLRAD4;SPRY2;SKOR2;SMAD3;SNX25;SMURF1;NRROS;ZBTB7A;PIN1;ASPN;RPS27A;SNX6;IL17RD
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.5490060667605583,1.3922489757236802,0.10387984981226533,0.4304331483605322,1.0,17/33,19.61%,STAT1;STAT3;ARNT;RAB7B;MAPK11;FOXO3;HMGB2;ACVR1B;ACVR2A;BRD1;FES;HIF1A;STAT5B;PRKDC;ETS1;INHBA;MED1
prerank,receptor catabolic process (GO:0032801),0.5820619426879651,1.391806227539333,0.1002710027100271,0.43101815112416614,1.0,9/24,16.91%,CLTC;MYLIP;KIF16B;AP2A2;PIK3R4;SNX25;SMURF1;NEDD4;SH3GLB1
prerank,outflow tract septum morphogenesis (GO:0003148),0.5804663032186005,1.3910758111555719,0.09863013698630137,0.4322044028184096,1.0,7/24,5.19%,ROBO2;GATA6;ZFPM2;NRP1;TBX2;PARVA;ACVR1
prerank,response to glucocorticoid (GO:0051384),0.571952109267171,1.390883871598865,0.08398950131233596,0.43195028839303484,1.0,6/26,12.29%,ZFP36L1;ZFP36L2;SLIT3;ANXA1;UBE2L3;TNF
prerank,renal filtration (GO:0097205),0.6718002256903637,1.3908680550632508,0.15024232633279483,0.43128316738757805,1.0,5/10,14.50%,SULF1;TBC1D8B;ITGA3;MYO1E;XPNPEP3
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.6602750115510589,1.3907852133475036,0.10138248847926268,0.4308222985272885,1.0,5/12,11.30%,NEK6;PRKCA;PLK1;NEK9;CCNB2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6532453601942295,1.3907305759496318,0.12179487179487179,0.4302441397683284,1.0,7/12,19.34%,APOBEC1;SETDB1;SETDB2;PPHLN1;RESF1;ATF7IP;TASOR
prerank,regulation of feeding behavior (GO:0060259),0.6689103825560874,1.3906412376729842,0.10593900481540931,0.4297678816815491,1.0,2/11,3.79%,QRFP;STAT3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6242711029470688,1.390603088557703,0.13412816691505217,0.4291561629830813,1.0,4/14,11.83%,TLR2;PUM1;OASL;ANKRD17
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5952455123498154,1.3900519770064235,0.1070931849791377,0.4297743884936656,1.0,9/18,15.67%,ITGB8;XCL1;LGALS9;LTBP1;TGFB2;SMAD3;SMAD4;LRRC32;HIF1A
prerank,muscle tissue morphogenesis (GO:0060415),-0.4823311665884088,-1.3899134734193552,0.0914826498422713,0.5787162262580626,1.0,6/16,18.68%,TGFBR3;BMP4;PROX1;TBX1;HEY2;ZFPM1
prerank,nitric oxide biosynthetic process (GO:0006809),0.6276345059256225,1.389251410159115,0.1171303074670571,0.4310701279572615,1.0,1/13,0.18%,CYP1B1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6092351520962804,1.3891829980413604,0.12301013024602026,0.4305367264039222,1.0,6/17,11.10%,SNAI1;SNAI2;JAG1;ACVR1;HEYL;GALNT11
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5654242588063199,-1.388926885803449,0.11331444759206799,0.5775078205640145,1.0,2/11,1.56%,CAV1;ACTN2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.6315121810493344,1.3889144311499555,0.12248062015503876,0.43048911879214485,1.0,2/14,2.43%,CREB3L1;LRRK2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6380077569023113,1.3884594209636272,0.1142433234421365,0.4310557907727962,1.0,5/14,12.65%,SNAI2;WNT9A;ADAMTS12;TGFBR1;ADAMTS7
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.32974231209147026,-1.3882893350811014,0.012195121951219513,0.5749854619812709,1.0,38/91,20.27%,ARL6IP1;RPL34;SRP19;RPL36;RPL8;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL32;RPL10;RPL15;RPS27;RPL35;SRP9;RPS16;RPL7A;RPS15;RPS29;RPL27;RPS13;RPS19;RPL41;RPLP1;RPL28
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6808579803669428,1.3880076652263114,0.11442006269592477,0.43157369972615345,1.0,3/10,10.46%,FAP;EMILIN1;TNFRSF1A
prerank,regulation of actomyosin structure organization (GO:0110020),0.6398655471581564,1.386652346728757,0.11746522411128284,0.434422967128685,1.0,6/13,14.73%,SLC9A1;ASAP3;ALMS1;CDC42;AKAP13;RAC1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5129268573841952,1.3864352818277943,0.08194774346793349,0.4343125505662092,1.0,10/46,5.97%,APOD;TCF7L2;STAT1;TNFAIP3;PDGFRB;CCN4;IGFBP5;AIF1;CCL5;PPARG
prerank,regulation of programmed necrotic cell death (GO:0062098),0.6021521897267847,1.3858495632176673,0.11659807956104253,0.4351210020944248,1.0,8/20,15.12%,BIRC3;FLOT2;CFLAR;OGT;CDC37;MLKL;CASP8;RIPK1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.40305586716763364,-1.3857334559727,0.04419889502762431,0.5782745470154781,1.0,12/39,12.72%,TJP1;SNCAIP;EZR;HSP90AA1;TIE1;RAPGEF2;VPS11;RAP1A;ANKRA2;GFAP;RDX;PINK1
prerank,mammary gland development (GO:0030879),0.5926387937678637,1.3856161487131884,0.0994550408719346,0.4350197939407779,1.0,5/21,10.21%,WNT2;GLI2;JAK2;TGFB3;TBX3
prerank,genitalia development (GO:0048806),0.6434549492632646,1.3856016564312044,0.13458528951486698,0.43434733749049376,1.0,4/12,10.21%,CHD7;SHH;WNT5A;TBX3
prerank,regulation of nervous system development (GO:0051960),0.5377653998918716,1.3853589435122593,0.08646616541353383,0.4342460550188289,1.0,8/37,11.11%,YAP1;PTN;PTPRZ1;TENM4;BHLHE40;HEYL;HMGB2;NPHP3
prerank,membrane repolarization during action potential (GO:0086011),-0.5222002045135125,-1.3849419764681101,0.102803738317757,0.5762714383378414,1.0,4/13,12.33%,KCND3;ATP1B1;KCNJ2;KCNQ1
prerank,diol metabolic process (GO:0034311),-0.48064319567624025,-1.384897765289319,0.09929078014184398,0.5720646174482664,1.0,8/19,16.84%,NOS3;CALM1;HSP90AA1;DEGS2;PTS;SGPP1;ASAH2;NAAA
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5443153383314737,1.384826620472226,0.09566326530612244,0.43494006550321224,1.0,7/29,11.91%,SPRED1;SPRED2;PTEN;SFRP1;BMP5;LDLRAD4;SPRY2
prerank,nitric oxide metabolic process (GO:0046209),0.6238854625652167,1.38472216224902,0.11259259259259259,0.43453556184812964,1.0,1/14,0.18%,CYP1B1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4591801814428984,-1.384547564757942,0.08243727598566308,0.5688797341355524,1.0,5/20,10.35%,CHRM2;PLCB1;AGRN;GNA11;GRK2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4641711116832258,1.384224747133192,0.02349336057201226,0.43513441605921055,1.0,56/170,21.38%,IGF2BP1;TRIML2;POU5F1;C1D;EDN3;AFF1;ZFP36L1;IGF2BP2;AFF2;NELL1;TREM2;APOE;CGGBP1;SHH;PRDM5;PRDM2;AIF1;TBC1D16;TRIM21;CDK6;AHR;HMG20B;FUBP1;PRDM1;TRIM44;MARF1;NFKBIZ;PRDM10;CTCF;YBX3;KIF16B;ARF1;PSEN1;MKLN1;MTMR9;TCF19;HIF1A;ADNP2;RASA1;PTPRC;ZNF445;MTMR3;STX1B;PRDM4;SOX2;HINFP;MTMR2;MTMR1;PIN1;HNRNPDL;GDNF;TRIM6;FOXP1;ZC3H12A;SIRPA;TRIM27
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6758508829201278,1.3827912058156497,0.1185064935064935,0.43818545258980285,1.0,3/10,5.97%,RARB;RXRG;PPARG
prerank,positive regulation of rRNA processing (GO:2000234),-0.5655694290058109,-1.3826141625027069,0.12396694214876033,0.5699710430838253,1.0,6/10,27.82%,RIOK1;WDR43;DIMT1;SIRT7;UTP15;TRMT112
prerank,regulation of MAP kinase activity (GO:0043405),0.47405585154404045,1.381496118913234,0.04833512352309345,0.4409551540048416,1.0,24/92,15.69%,IL34;ADIPOQ;EDN3;TNFSF11;LRRK2;CD40;PDGFRB;EGFR;IRAK3;APOE;NF1;EGF;PTPN1;PIK3R5;FGFR1;PTPRJ;SPRY2;TNF;FGF2;BMP7;TRIB3;PDCD10;TRIB1;FGF18
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4955323026574292,1.3810733393139103,0.06818181818181818,0.4413699412077875,1.0,16/62,13.10%,RUNX1;KMT2A;MEIS2;MAFB;MEIS1;RBBP5;CNOT4;CREBBP;CDK6;TNRC6B;HDAC1;CBFB;KMT2E;MOV10;KMT2B;SPI1
prerank,negative regulation of cytokine production (GO:0001818),0.45845387930356873,1.3809157941439265,0.028747433264887063,0.44110434325846176,1.0,18/163,6.47%,NR1H4;IL23R;VSIG4;APOD;BCL3;TNFRSF21;CMKLR1;TNFAIP3;XCL1;ADCY7;NAV3;IRAK3;TREM2;IKBKE;LGALS9;ILRUN;PTPN6;INHBB
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5871274347295129,1.38049877136697,0.130374479889043,0.4414684340063305,1.0,1/18,0.16%,RAD51B
prerank,bile acid and bile salt transport (GO:0015721),0.5792568733942536,1.3803606703324411,0.0922266139657444,0.4411168745852525,1.0,3/24,2.99%,NR1H4;ATP8B1;SLC10A6
prerank,secondary alcohol metabolic process (GO:1902652),0.5146178185521503,1.3796239290725614,0.0996309963099631,0.44244451010318164,1.0,8/42,13.25%,ABCA1;APOE;ABCG1;SOAT1;IDH2;OSBPL5;CLN6;IDH3B
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.3661776176455474,-1.3791781774786114,0.04666666666666667,0.5720922701099486,1.0,31/56,29.53%,NDUFS1;NDUFAF5;NDUFAF4;ECSIT;NDUFV2;NDUFA13;NDUFAF2;NDUFA6;DMAC2;NDUFA12;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;FOXRED1;TIMM21;BCS1L;NDUFA10;NDUFS2;TMEM126B;NDUFB11;NUBPL;NDUFS5;NDUFAF8;TIMMDC1;NDUFV1;NDUFAF6
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3661776176455474,-1.3791781774786114,0.04666666666666667,0.5720922701099486,1.0,31/56,29.53%,NDUFS1;NDUFAF5;NDUFAF4;ECSIT;NDUFV2;NDUFA13;NDUFAF2;NDUFA6;DMAC2;NDUFA12;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;FOXRED1;TIMM21;BCS1L;NDUFA10;NDUFS2;TMEM126B;NDUFB11;NUBPL;NDUFS5;NDUFAF8;TIMMDC1;NDUFV1;NDUFAF6
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5000371291132306,1.379054223008745,0.07328605200945626,0.44325290592878713,1.0,8/52,7.13%,CXXC1;SEC31A;ERN2;WIPI1;KDELR3;ARFGAP1;DDX11;YIF1A
prerank,sterol biosynthetic process (GO:0016126),-0.408069742356922,-1.3787351092581064,0.0684931506849315,0.5691479776068726,1.0,17/33,26.49%,PRKAG2;LBR;MSMO1;INSIG1;ACAT2;SQLE;CYP51A1;DHCR24;IDI1;ACLY;LSS;HSD17B7;FDPS;EBP;FDFT1;NSDHL;TM7SF2
prerank,cholesterol metabolic process (GO:0008203),0.490218721520628,1.378394137374673,0.061714285714285715,0.44434999011966403,1.0,7/68,7.56%,CEL;ABCA1;INSIG2;APOE;ABCG1;MVK;SOAT1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.533819997466694,1.3783021643715727,0.11038107752956636,0.4438742417014466,1.0,15/33,18.89%,STAT3;PPARG;TERT;FOXO3;TEAD1;TGFB2;TNF;FGF2;GNL3;SPI1;SMAD3;HIF1A;SMARCA4;ETS1;NR3C1
prerank,regulation of mRNA stability (GO:0043488),0.4646066152317259,1.3779261026508836,0.024896265560165973,0.4441850522181752,1.0,52/145,22.93%,PSMA7;IGF2BP1;ZFP36L1;IGF2BP2;ZFP36L2;PRKCA;E2F1;PUM1;TENT5A;METTL16;CARHSP1;GIGYF2;SAMD4A;CELF1;PSMB8;EXOSC4;PSMA6;DCP2;FTO;XRN1;YWHAZ;TNPO1;PSMF1;ANP32A;YTHDF3;FMR1;DCP1A;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;AKT1;RC3H2;THRAP3;PSMB1;AXIN2;PARN;NUP214;PSMC6;GDNF;EIF4G1;PRKCD;XPO1;RPS27A;YBX1;EXOSC5;ROCK2;PSMB4;YTHDF2;PSMB5;ROCK1
prerank,negative regulation of cellular protein localization (GO:1903828),0.5337766365117897,1.3769304231844417,0.09577114427860696,0.44618232445168193,1.0,13/34,18.70%,ADIPOQ;GPM6B;TAX1BP3;ILRUN;SNX33;GSK3B;SPI1;CTNNA1;LATS2;LEPROT;PICALM;MFHAS1;LEPROTL1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5518343607934107,1.3756542450518,0.10526315789473684,0.4488216404200914,1.0,7/29,8.67%,COPA;COPZ2;COPZ1;COPB2;GOSR1;GOLGA5;COPG1
prerank,phasic smooth muscle contraction (GO:0014821),0.6745993935173494,1.375469947014501,0.11774193548387096,0.4486388678825462,1.0,2/10,3.32%,EDN3;HTR1D
prerank,regulation of establishment of protein localization (GO:0070201),0.640469019573194,1.3753852920447964,0.14580265095729014,0.44814237718580363,1.0,5/13,18.88%,TREM2;CTSD;CEP120;SCFD1;GAPVD1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.473809292638653,1.375194399152009,0.041884816753926704,0.44794193926020476,1.0,13/116,6.53%,MC5R;IAPP;GPR176;GPR39;ADCY7;TREM2;RXFP2;MYH9;ADCY2;PTGDR;ADM;ADCYAP1R1;GLP2R
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5296065862195384,-1.3751851526637073,0.11021505376344086,0.5752446106604893,1.0,4/12,11.13%,UNC13C;UNC13B;SYT7;RIMS1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4989472541325894,1.375150693463915,0.062076749435665914,0.4473565237896091,1.0,18/67,20.27%,PSMA7;ITGB5;PDIA3;CD36;PSMB8;PSMA6;CALR;PSMF1;PSMA8;FCGR1A;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;CYBB;PSMC6;TAP1
prerank,negative regulation of cell communication (GO:0010648),0.5780658859073187,1.374747272220568,0.138268156424581,0.44772582755331863,1.0,6/21,12.88%,ADIPOQ;ACVR1;PTPN1;BRAP;SOCS5;UBASH3B
prerank,cytoplasmic translation (GO:0002181),-0.32624606106683324,-1.3739982979441008,0.011904761904761904,0.574461962652671,1.0,41/91,21.75%,RPL34;RPL36;RPL8;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL22L1;EIF4A2;RPL32;RPL10;RPL15;RPS27;RPL35;DRG2;RPS16;RPL7A;RPS15;RPS29;RPL27;RPS13;EIF3M;RPS19;RPL41;RPLP1;RPL28;GSPT2;RPS17
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.46802132184654327,-1.373944903437919,0.09554140127388536,0.570493449190355,1.0,3/19,3.02%,TJP1;BMP6;NEXMIF
prerank,glucose import (GO:0046323),-0.5193034567455282,-1.3729983082100548,0.1,0.5691846687931092,1.0,3/13,10.23%,SLC2A1;SORT1;SLC27A1
prerank,membrane raft organization (GO:0031579),0.6398857955661549,1.37286730950057,0.11904761904761904,0.4521557902627393,1.0,2/15,3.15%,RFTN1;FLOT2
prerank,cell-cell junction organization (GO:0045216),-0.33385956465426364,-1.3726747880419998,0.03125,0.5661878075753176,1.0,15/79,4.71%,TJP1;PKP4;TJP2;OCLN;CADM2;CDH13;LIMS2;CADM1;CLDN5;CDH5;CXADR;CTNND1;CDH10;CDH1;ARVCF
prerank,adherens junction organization (GO:0034332),-0.37852116808981034,-1.3723431239846542,0.06918238993710692,0.5632066986583528,1.0,13/48,10.31%,TJP1;CADM2;CDH13;CADM1;ACTB;CDH5;CTNND1;CDH10;RAMP2;CDH1;CDH4;VCL;CDH12
prerank,retinal metabolic process (GO:0042574),0.6556216365994718,1.3709373121376476,0.1148036253776435,0.45676538557407864,1.0,2/12,8.12%,CYP1B1;RDH10
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.3262981222697055,-1.3705037823589519,0.0,0.56442886959457,1.0,37/87,20.27%,RPL34;SRP19;RPL36;RPL8;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL32;RPL10;RPL15;RPS27;RPL35;SRP9;RPS16;RPL7A;RPS15;RPS29;RPL27;RPS13;RPS19;RPL41;RPLP1;RPL28
prerank,regulation of macrophage chemotaxis (GO:0010758),0.573943679149185,1.3704768350361174,0.12326869806094183,0.45728430926152946,1.0,4/21,5.67%,IL34;CMKLR1;MDK;CCL5
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6465011672129208,1.37000411934805,0.13249211356466878,0.45785900384101685,1.0,3/12,6.77%,PARP8;PARP3;PARP11
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5162089509636592,-1.3694223136982517,0.10364145658263306,0.5635228182241768,1.0,7/13,26.51%,NAMPT;PARP16;NUDT12;NNMT;PARP10;NAXE;NAPRT
prerank,negative regulation of response to external stimulus (GO:0032102),0.46222742886936335,1.3693540103291746,0.05223880597014925,0.45894920523387606,1.0,12/105,5.97%,RORA;NR1H4;ADIPOQ;TNFAIP3;IRAK3;APOE;CASK;PTEN;ILRUN;MVK;TRIM21;PPARG
prerank,regulation of interferon-gamma production (GO:0032649),0.48221522634842806,1.3692562428716049,0.08409090909090909,0.458508786655549,1.0,8/71,8.14%,NR1H4;IL23R;CD276;IL1R1;XCL1;LGALS9;TLR7;CD14
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5963487693366494,1.3691868247282875,0.1235632183908046,0.4580062662212361,1.0,4/18,8.40%,LRRC17;MAFB;FBN1;FBXW7
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5443460145575594,-1.3686388498135427,0.1105121293800539,0.5618244602877365,1.0,5/11,11.11%,ADIPOR2;CD34;NDNF;KDR;GATA2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4775405977923473,1.3686289769431517,0.05159165751920966,0.45871886271955803,1.0,17/86,11.22%,EPHA7;IL23R;THBS4;TEC;GHR;FGF7;JAK2;NRP1;EGFR;TREM2;ACVR1;SFRP1;PTPN6;ANGPT1;EFNA5;PTPRJ;VTN
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5098626400739381,1.3683813021001434,0.08382526564344746,0.45863201178540025,1.0,14/55,17.74%,PSMA7;FBXL7;CUL1;PINX1;SKP1;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1
prerank,membrane lipid catabolic process (GO:0046466),0.6687337178148908,1.3679067878293751,0.1342062193126023,0.4592293021692071,1.0,1/10,0.18%,CYP1B1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5603645551738844,-1.36755757957994,0.1396011396011396,0.561269187625339,1.0,6/11,15.49%,MLLT3;RSPO3;CSNK1E;WNT5B;DAB2;PLEKHA4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4697869634605623,1.3674239588918924,0.06813186813186813,0.4598594418694625,1.0,28/87,18.40%,ZFP36L1;FLRT2;EGR3;ZFP36L2;FGF7;SPRED1;GALNT3;SPRED2;CCL5;SFRP1;CBL;GRB2;GTF2F2;FRS2;NCBP2;CCL2;FGFR1;FGF2;GTF2F1;KIF16B;SETX;FGF18;ITGB1BP1;MAPK1;RBFOX2;POLR2L;POLR2K;DSTYK
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4804142034092056,1.367201345236258,0.06359649122807018,0.4597617878671858,1.0,14/87,8.91%,PSMA7;ZFP36L1;ZFP36L2;CDKN2B;FBXL7;CUL1;PTEN;PKD2;CDK6;PINX1;SKP1;GPNMB;PSMB8;PSMA6
prerank,T cell activation involved in immune response (GO:0002286),0.6443424012264842,1.3671250357871234,0.1332312404287902,0.45927141095018975,1.0,3/12,8.76%,MDK;ICAM1;LCP1
prerank,wound healing (GO:0042060),0.4916694319032471,1.3669912850718438,0.07865168539325842,0.4589222419686004,1.0,15/62,15.00%,COL3A1;PDGFRA;JAML;CFLAR;MYH9;NF1;HPSE;MIA3;TGFBR1;WNT5A;PPP3CA;TGFB2;FGF2;SMAD3;ANXA6
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5307567460769579,-1.366512256504494,0.13055555555555556,0.5605463499126669,1.0,4/12,7.68%,SORBS1;PRKCZ;GKAP1;SORL1
prerank,replicative senescence (GO:0090399),0.6504317381035314,1.3662420727838405,0.14396284829721362,0.46020097154382444,1.0,4/12,8.81%,PLA2R1;ATM;TERT;ATR
prerank,aerobic electron transport chain (GO:0019646),-0.3420327435652966,-1.365369247268345,0.06557377049180328,0.559951120754854,1.0,35/68,29.96%,COX5A;COX8A;NDUFS1;COX4I1;UQCRC2;NDUFV2;COX6C;COX6B1;NDUFA13;NDUFA6;COX6A1;NDUFA12;COX10;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;COX5B;UQCRB;NDUFA1;NDUFC2;NDUFA10;UQCRH;NDUFS2;UQCRFS1;NDUFB11;UQCC3;UQCR10;SDHAF2;UQCR11;NDUFS5;NDUFV1;SDHA
prerank,regulation of mRNA catabolic process (GO:0061013),0.4621215669475027,1.3653075567639048,0.03882476390346275,0.4620047110650316,1.0,50/121,25.23%,PSMA7;IGF2BP1;ZFP36L1;IGF2BP2;ZFP36L2;PRKCA;PUM1;CARHSP1;SAMD4A;PSMB8;EXOSC4;PSMA6;DCP2;MOV10;XRN1;YWHAZ;TNPO1;PSMF1;ANP32A;YTHDF3;FMR1;DCP1A;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;AKT1;RC3H2;PSMB1;PARN;NUP214;PSMC6;EIF4G1;PRKCD;XPO1;ZC3H12A;RPS27A;EXOSC5;PSMB4;YTHDF2;PSMB5;PCID2;FXR2;PSMD4;ZC3H14;PSMD7;PSMD9;PSMA4;CNOT1
prerank,steroid metabolic process (GO:0008202),0.488756173926775,1.3652577950367604,0.0719910011248594,0.46145296719523576,1.0,8/72,9.08%,CYP1B1;CYP7B1;DHRS4;SHH;CYP27B1;CYP2A6;HSD11B1;CYP1A1
prerank,detection of visible light (GO:0009584),-0.48226494678797366,-1.3652190020476753,0.08940397350993377,0.5566499143486808,1.0,5/16,25.15%,ABCA4;GNA11;RP1;CACNA2D4;TULP1
prerank,negative regulation of macrophage activation (GO:0043031),-0.4891289655573614,-1.364576359170746,0.09937888198757763,0.5548320575537468,1.0,4/16,5.86%,LRFN5;IL31RA;LDLR;CD200
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5176216247168739,1.3641875523240494,0.09159347553324969,0.4636081090243399,1.0,15/39,16.53%,YAP1;ROBO2;ZMIZ1;MAML3;STAT3;JAG1;CREBBP;MAML2;NEPRO;TGFB2;MAML1;SRC;PDCD10;ITGB1BP1;TSPAN14
prerank,negative regulation of cartilage development (GO:0061037),0.6422090406936883,1.363476261563963,0.1141552511415525,0.4647768777843441,1.0,5/13,12.65%,SNAI2;WNT9A;ADAMTS12;TGFBR1;ADAMTS7
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6517022466536087,1.3633621492790473,0.1228878648233487,0.46434786135703404,1.0,6/12,14.79%,CHMP4A;CHMP4B;SEC63;SEC61A1;HSPA5;SEC61A2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.6524003326451394,1.3633141191458436,0.14513556618819776,0.46377261583531243,1.0,5/10,11.96%,OPHN1;RAP2A;CDC42;MSN;RHOA
prerank,thyroid hormone generation (GO:0006590),0.6582020479466832,1.3628918151032265,0.14037854889589904,0.46426904626221355,1.0,3/10,6.69%,CPQ;CTSK;FOXE1
prerank,androgen receptor signaling pathway (GO:0030521),0.6568733209093609,1.362809975296913,0.1402936378466558,0.46378546321493885,1.0,3/11,7.03%,PMEPA1;ZMIZ1;DDX17
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4701160724446149,-1.3627016159699918,0.0989399293286219,0.5564529054495502,1.0,8/17,16.35%,COX5A;COX8A;COX4I1;COX6C;COX6B1;COX6A1;COX10;COX5B
prerank,actin filament bundle organization (GO:0061572),0.5333605559755493,1.3625150851771604,0.11211340206185567,0.4639479968454021,1.0,10/33,8.76%,MYO1B;DPYSL3;CALD1;FSCN1;LIMA1;BAIAP2;AIF1;RHOD;ADD2;LCP1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.49459852935475046,1.362445235239373,0.08946772366930918,0.46342622623686447,1.0,9/65,8.91%,PSMA7;FBXL7;CUL1;PABIR1;VPS4A;PINX1;SKP1;PSMB8;PSMA6
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4924260989353789,1.3622461274008886,0.08705882352941176,0.46328826410821905,1.0,17/62,17.55%,CREB3L1;CXCL12;SNAI1;LRRK2;SNAI2;BCL2;ENO1;BCL2L2;NOC2L;CCAR2;TMEM161A;NFE2L2;YBX3;SRC;CREB3;AKT1;MDM2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4521002091827368,1.362015497406773,0.025510204081632654,0.4632276648783261,1.0,35/186,12.58%,PSMA7;RBMS3;BICC1;LRP1;NKD2;TCF7L2;SFRP4;KREMEN1;GLI3;IGFBP4;SNAI2;TLE1;TAX1BP3;APOE;FRZB;MDK;SFRP1;LRP6;PRICKLE1;SIAH2;NXN;MDFI;DKK2;PSMB8;PSMA6;WNT5A;HDAC1;SFRP5;WWTR1;NPHP3;DRAXIN;RNF213;GSK3B;CSNK1A1;PSMF1
prerank,positive regulation of proteolysis (GO:0045862),0.5029358468531069,1.36123273050252,0.07009345794392523,0.46462243916091867,1.0,15/55,13.06%,CCBE1;NKD2;TNIP1;APOE;PLK1;OGT;SNX33;SNX9;RCN3;CASP8;CLN6;CTSC;FBXW11;TNF;TANK
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4429330928348654,-1.360477341668465,0.10727969348659004,0.559346913922903,1.0,5/21,2.77%,DMD;ATP1A2;AKAP6;ANK2;CALM1
prerank,ketone body metabolic process (GO:1902224),-0.5684340424891862,-1.3601865940431825,0.12137203166226913,0.5566215023719965,1.0,4/10,18.08%,BDH1;HMGCS2;HMGCLL1;HMGCL
prerank,tyrosine metabolic process (GO:0006570),-0.5421884341361762,-1.3599278344167491,0.13812154696132597,0.5537996880772496,1.0,6/11,37.45%,GSTZ1;FAH;THAP4;TYR;HGD;IL4I1
prerank,negative regulation of autophagy (GO:0010507),0.49317435438279555,1.359741424362948,0.08540925266903915,0.46785114693023827,1.0,17/54,18.15%,DAP;EIF4G2;LRRK2;EIF4G3;KLHL22;TREM2;STAT3;BCL2;FOXK2;ATG7;SMCR8;WASHC1;MTMR9;AKT1;CTSA;CPTP;USP36
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.4485266059881285,-1.359665589692917,0.099601593625498,0.5510138204614167,1.0,10/22,19.40%,KANK3;GSN;HIP1R;TWF2;TMSB4X;KANK4;TMSB10;PFN1;SLIT2;TWF1
prerank,endomembrane system organization (GO:0010256),0.44546788895706574,1.3594969570415207,0.02131979695431472,0.4678222799868894,1.0,59/178,20.02%,SEC16B;SEC31A;VMP1;GORASP2;LRRK2;ATP8B1;RAB2A;ARFGEF2;TLCD2;HOOK2;PI4K2B;DNAJC13;STX17;WASHC4;ATL2;CDC42;VPS4A;COG4;MIA3;LMAN2L;VAPA;LEMD2;GBF1;AP3D1;GOLGA8B;GOLGA5;TRIP11;SEC16A;GAK;LMAN1;SNX33;SEC23IP;PLEKHF1;SNX10;CSNK1A1;TMED1;RAB1A;SEC61A1;DYNC2H1;TMCC1;LYSMD3;CHMP2B;SUN1;SQSTM1;ALS2;COG7;TOR1AIP2;OBSL1;TBC1D20;CSNK1D;EIF2AK3;SPTSSB;TMED5;SPTBN1;BCAS3;TJAP1;HOOK1;UBXN2A;WASHC5
prerank,regulation of protein import into nucleus (GO:0042306),0.535548245929928,1.3593336075260467,0.09351620947630923,0.46758392622150047,1.0,9/36,13.92%,MDFIC;APOD;SUFU;UBR5;BAG3;ZIC1;PIK3R1;SMAD3;PSEN1
prerank,cell-matrix adhesion (GO:0007160),0.46678440976198615,1.359006794105088,0.07288317256162916,0.4677418933191839,1.0,29/95,17.86%,DLC1;COL3A1;ITGB8;TNN;COL13A1;ITGB5;PEAK1;ITGA8;RHOD;HPSE;EMILIN1;ADAMTS12;L1CAM;ITGA11;ADAMTS9;TMEM8B;ITGBL1;ITGA3;VTN;NID2;MKLN1;SRC;RAC1;CD63;ITGA1;ITGB1BP1;CTTN;TESK2;FERMT3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.48876873589573033,-1.3580400501974181,0.1196319018404908,0.5521595516888611,1.0,14/16,49.63%,CADM1;AP1G1;LAMP1;PVR;RAET1E;NECTIN2;RASGRP1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,response to growth factor (GO:0070848),0.5136066786751708,1.3576989202332572,0.11481481481481481,0.47057300379931516,1.0,16/41,21.50%,IBSP;GATA6;ACVR1;SFRP1;TGFBR1;RPS6KB1;ACVR1B;ACVR2A;ACVR1C;STAT5B;ACVRL1;AKT1;SOX2;CPNE3;BMPR1A;EPHA2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.514270501784923,-1.3574964792972088,0.13675213675213677,0.5501922361388487,1.0,4/13,7.68%,SORBS1;PRKCZ;GKAP1;SORL1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5479369585835221,1.3574070380918197,0.12618724559023067,0.47068035862265906,1.0,8/27,11.00%,ENPP1;IRS1;NCK1;PIP4K2A;PTPN1;PID1;RPS6KB1;PTPN2
prerank,positive regulation of cell motility (GO:2000147),0.4476009872583887,1.3572772297456372,0.024439918533604887,0.4703570567213627,1.0,28/205,6.60%,ROR2;CCL11;COL1A1;CCL7;CEMIP;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;MAP4K4;SNAI1;CCAR1;PDGFRB;SNAI2;PRKCA;EGFR;STAT3;MDK;CCR1;AIF1;ACVR1;RHOD;CARMIL1;CCL5;EGF;ATM;EPHA1
prerank,defense response to bacterium (GO:0042742),0.46169395149696124,1.3550961592245307,0.048025613660619,0.47556157050097575,1.0,13/105,10.15%,IL23R;LBP;SPN;COLEC12;CRP;TLR2;TREM2;NOD1;RNASE7;MPEG1;TIRAP;HMGB2;GBP7
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5768640651700808,1.3545457887834789,0.13506139154160982,0.47638423240938765,1.0,2/21,7.19%,CEL;ACOX1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.47378850199025363,1.3544926445021515,0.08138238573021182,0.4758147260990418,1.0,26/79,20.69%,CREB3L1;SULF1;CASK;SMURF2;PPARG;HTRA3;EMILIN1;ADAMTS12;PTPN1;LEMD2;SMAD5;BMPER;ACVR2A;SPRY2;FGF2;SKOR2;SMAD4;SMAD1;SMURF1;NEDD4;CHRD;TRIM33;AGT;VWC2;SPRY4;BMPR1A
prerank,response to hexose (GO:0009746),0.5572762487482058,1.3540846208342487,0.11772665764546685,0.47628237018465475,1.0,5/25,11.73%,ADIPOQ;TCF7L2;LPL;KHK;ZBED3
prerank,amino sugar metabolic process (GO:0006040),0.648969942580403,1.352938441621706,0.14174454828660435,0.4786444336049072,1.0,4/10,10.96%,B4GALNT2;ST6GAL1;GFPT2;ST3GAL1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.6501555065194563,1.3528436722796677,0.12599681020733652,0.4782037301668627,1.0,5/10,14.11%,STOML2;INO80;E2F8;DBF4;ATRX
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.6277449402686793,1.3527569437224929,0.14029850746268657,0.47772670108319065,1.0,3/13,12.90%,ENPP1;TPST1;SULT4A1
prerank,calcium ion homeostasis (GO:0055074),0.4665643441426266,1.3527128813889235,0.05646036916395222,0.47716391631006355,1.0,18/95,12.14%,CCL11;CCL7;EDN3;CXCL12;CD40;STOML2;CCR1;FAM20A;CYP27B1;SLC24A5;CCL5;ATP2A2;DRD3;SELENON;TMEM203;ATP2B1;CALR;TPCN2
prerank,positive regulation of bone mineralization (GO:0030501),0.5290173063031637,1.3525678035905704,0.12903225806451613,0.4768938871415506,1.0,11/35,14.04%,GPM6B;FBN2;PTN;NELL1;ACVR1;TGFB3;TMEM119;ATP2B1;ACVR2A;P2RX7;BMP7
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5434240886097257,1.3521738284216027,0.12449255751014884,0.4772075000750013,1.0,8/28,11.00%,ENPP1;IRS1;NCK1;PIP4K2A;PTPN1;PID1;RPS6KB1;PTPN2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5806892150111821,1.3516942267740277,0.1440443213296399,0.47786131365102713,1.0,6/22,8.81%,SPRED1;SPRED2;PLA2R1;ATM;EEF1E1;ATR
prerank,positive regulation of calcium ion transport (GO:0051928),0.5194746467656083,1.351618007621737,0.1285892634207241,0.47736138115704657,1.0,11/36,13.14%,CXCL12;PDGFRB;P2RX5;CCR1;TRPC6;CCL5;MYLK;CCL2;ATP2B1;P2RX7;SPHK2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6285491869538559,1.3510045701178983,0.14714714714714713,0.47837705244033696,1.0,1/14,0.33%,ENPP1
prerank,mRNA 3'-end processing (GO:0031124),-0.331153667855815,-1.3506565353638393,0.028037383177570093,0.5657297456627927,1.0,29/78,25.42%,CDC40;SRSF5;WDR33;CSTF2;PABPC1;RPRD2;U2AF2;RPRD1A;LEO1;APP;TUT1;SRSF7;SRSF9;RBM8A;CHTOP;CPSF2;MAGOH;ZC3H11A;EIF4A3;LSM11;SRSF3;CLP1;POLDIP3;CPSF4;SARNP;PAPOLB;DDX39B;DDX39A;THOC1
prerank,positive regulation of apoptotic process (GO:0043065),0.43884840336409753,1.3498166503486608,0.019076305220883535,0.48095383525166835,1.0,89/293,22.27%,FAP;CYP1B1;DLC1;ZBP1;EPHA7;ADIPOQ;KNG1;IAPP;SFRP4;BCL6;CCAR1;VAV2;VAV3;KALRN;ITSN1;FRZB;E2F1;CTSD;NF1;PPID;FGD4;TNFRSF12A;ATM;OMA1;SFRP1;TGFB3;RASSF2;RRP1B;PHLDA1;AIFM2;EEF1E1;CCAR2;BTG1;ARHGEF19;SAP18;TRIO;TGFBR1;FOXO3;IP6K2;ARHGEF12;PREX1;TGFB2;CASP8;ATG7;VAV1;TNF;NLRP2B;AKAP13;ACVR1C;CALHM2;SPHK2;PSEN1;ARHGEF18;DAPK2;RIPK1;PSENEN;PAWR;SQSTM1;STK4;OLFM1;AIFM1;HSPD1;PTPA;DUSP6;LATS2;ING5;ANO6;ATF4;CLIP3;DDX20;PLEKHG2;PRNP;TLE5;GADD45A;HMGA2;NCSTN;UTP11;ARHGEF26;TIAM2;UBE2Z;MAP3K20;ZC3H12A;PSEN2;RPS27A;RARG;ARHGEF17;CLU;LATS1;ARHGEF1
prerank,gland development (GO:0048732),0.4842349308820243,1.349478210229873,0.0936768149882904,0.48108522732983355,1.0,16/59,10.21%,GLI2;PRKCSH;ARID5B;EPHB3;MDK;SHH;PHF2;PKD2;NF1;TGFB3;FOXE1;MSN;ANXA1;TGFBR1;SALL1;TBX3
prerank,neuron migration (GO:0001764),0.5046512836594306,1.3486699303940908,0.09904534606205251,0.4826391192220974,1.0,14/48,12.48%,DNAAF4;LRP12;MDGA1;AUTS2;NRP1;NAV1;ADGRL3;MARK1;USP9X;ASTN2;SH3RF1;DISC1;FGFR1;FGF13
prerank,positive regulation of multicellular organismal process (GO:0051240),0.43840738495711856,1.3484773403250854,0.009018036072144289,0.4824947922041526,1.0,58/308,12.66%,GLMN;ABCA1;COL1A1;ADIPOQ;LBP;LRP1;PLAC8;SNAI1;GHR;SYDE1;SOX5;PTN;B4GALT5;CMKLR1;JAK2;BATF;NKX6-1;SMAD2;TREM2;APOE;DYNC1H1;MDK;SHH;SMURF2;PLA2R1;BMP1;ACVR1;CYP27B1;CD36;EGF;ALMS1;OMA1;TGFB3;EIF2AK2;ENO1;EHMT1;INHBB;TMEM119;SHLD3;TERT;CXCR4;TGFBR1;OGT;WNT5A;HCRT;TGFB1I1;ACVR1B;GAPDH;WWTR1;PDPN;TGFB2;GCNT2;ZBED3;TNF;FGF2;TAPT1;ELOVL6;FABP5
prerank,regulation of lymphocyte activation (GO:0051249),0.6431467746415768,1.3483099066692357,0.1452599388379205,0.48222796403661644,1.0,2/12,5.67%,DCAF15;CCL5
prerank,regulation of innate immune response (GO:0045088),0.4907341252454428,1.3481369540744255,0.0958904109589041,0.4820151454863094,1.0,15/57,12.43%,TNFAIP3;BIRC3;IRAK3;TREM2;TRIM21;CCL5;PTPN6;IRF1;IFNAR2;PTPN1;ABCE1;TIRAP;CDC37;CASP8;POLR3D
prerank,protein targeting to ER (GO:0045047),-0.3108294014610261,-1.3478685019323329,0.0,0.5699617017534434,1.0,48/99,24.63%,RPL34;SRP19;SPCS2;RPL36;RPL8;SRPRB;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;SPCS3;RPL32;RPL10;RPL15;RPS27;RPL35;SRP9;RPS16;RPL7A;RPS15;RPS29;RPL27;SEC61G;RPS13;RPS19;RPL41;RPLP1;RPL28;SGTA;RPS17;SPCS1;RPL23A;ZFAND2A;UBA52;ZFAND2B
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5508890594109974,-1.3475135678862777,0.12078651685393259,0.5674610033284614,1.0,7/11,29.64%,P3H2;P4HTM;EGLN2;EGLN3;CRTAP;P4HA3;P4HA1
prerank,regulation of keratinocyte migration (GO:0051547),0.6320637120086288,1.3471965806424675,0.1633587786259542,0.48386733712369573,1.0,4/12,10.79%,MAP4K4;FGF7;PTEN;MAPRE2
prerank,artery development (GO:0060840),0.5526084028450835,1.3469211765882863,0.13288590604026845,0.48393293100912954,1.0,6/23,9.03%,ROBO2;NRP1;PKD2;NF1;HOXA1;TGFBR1
prerank,zinc ion transport (GO:0006829),0.56759830704856,1.3463401967979305,0.11576011157601115,0.4847978609640385,1.0,1/21,0.13%,SLC39A14
prerank,Wnt signaling pathway (GO:0016055),0.4688224974811004,1.346334274389164,0.05399568034557235,0.4841076616015743,1.0,21/92,12.56%,WNT2;TCF7L2;SFRP4;LRRK2;WNT9A;FRZB;CUL1;PTEN;STRN;FZD1;SFRP1;LRP6;NXN;SKP1;WNT5A;SFRP5;WLS;TCF7;CSNK1G2;GSK3B;CSNK1A1
prerank,negative regulation of cell activation (GO:0050866),0.6162677209988223,1.3456082789359738,0.12130177514792899,0.48554244949543457,1.0,4/14,6.74%,PDGFRA;TREM2;APOE;EMILIN1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.46431955000912856,1.3454643780239899,0.06295907660020986,0.48525780163057886,1.0,13/117,6.53%,MC5R;IAPP;GPR176;GPR39;ADCY7;TREM2;RXFP2;MYH9;ADCY2;PTGDR;ADM;ADCYAP1R1;GLP2R
prerank,membrane lipid biosynthetic process (GO:0046467),-0.34818826940754033,-1.344808652170932,0.043478260869565216,0.5715047089836036,1.0,18/58,10.49%,CERT1;PPM1L;ACER2;ST3GAL4;CERS4;SGMS1;SPTLC2;SPTLC1;ELOVL7;SGMS2;ST8SIA6;ELOVL5;DEGS2;SPNS2;GBGT1;HACD1;HACD3;HACD4
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5733622523909847,1.3447292630955894,0.14825581395348839,0.4866019195490617,1.0,8/18,20.32%,EDN3;FXN;POR;TNF;SIRT3;ATP7A;AGT;GDNF
prerank,regulation of translational initiation (GO:0006446),0.48467257812335157,1.3441874031781318,0.09090909090909091,0.48729165077739395,1.0,30/63,23.21%,EIF4G2;CTIF;EIF4G3;KHDRBS1;NCK1;NCK2;CCL5;EIF3H;EIF5B;EIF5;RPS6KB1;NCBP2;ALKBH1;EIF4EBP1;MTIF2;YTHDF3;FMR1;EIF1;KLHL25;DNAJC3;DDX1;EIF2AK3;ATF4;AGO2;EIF4G1;CSDE1;HABP4;EIF3E;YTHDF2;POLR2D
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.42929635947554634,-1.3440400612434786,0.09282700421940929,0.570365330470176,1.0,10/24,13.41%,TEK;KRIT1;CDH5;GAS6;NDNF;RAMP2;KDR;SCG2;GATA2;SEMA5A
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5858661415056878,1.3439949172027075,0.1546242774566474,0.48710061104822583,1.0,5/18,11.83%,BIRC3;PUM1;SEC14L1;OASL;ANKRD17
prerank,regulation of cellular amine metabolic process (GO:0033238),0.5007476651707905,1.3439794479133338,0.10235294117647059,0.48644510410219105,1.0,11/50,17.74%,PSMA7;OAZ3;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.4792442846521676,-1.3438990491277838,0.11551155115511551,0.56720773108729,1.0,8/16,29.16%,LDLR;SCARB1;SLC27A1;GPLD1;MFSD2A;PNPLA2;ABHD5;NR1H2
prerank,potassium ion transmembrane transport (GO:0071805),-0.2989016039466623,-1.3429735073345899,0.0,0.5663211655288634,1.0,25/135,7.29%,ATP1A2;ATP1B3;SLC12A2;KCNC2;SLC24A2;SLC12A7;KCND3;ATP1B1;SLC9A2;KCNB2;KCNK5;KCND2;KCNQ5;KCNH5;TMEM175;KCNH7;SLC12A6;KCNJ2;KCNJ3;KCNK10;KCNJ13;ABCC9;KCNQ3;KCNQ4;KCNJ10
prerank,regulation of RNA export from nucleus (GO:0046831),0.636376177607834,1.3428921025649896,0.15477996965098634,0.4886576241495318,1.0,5/11,18.74%,KHDRBS1;SETD2;NCBP2;NUP153;IWS1
prerank,regulation of lipase activity (GO:0060191),0.6171778941636294,1.3421551007518662,0.16079632465543645,0.4898928638819832,1.0,3/13,11.96%,LIPC;LPL;RHOA
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5579442529880344,1.341912791066369,0.14475431606905712,0.4898400108636249,1.0,1/21,0.16%,RAD51B
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.44327188960351843,1.3417581001292949,0.036885245901639344,0.48958148617289177,1.0,42/173,13.45%,COL7A1;SEC16B;SEC31A;DYNLL1;SEC24D;SEC23A;COPA;PROS1;COPZ2;ARCN1;RAB2A;KDELR3;DYNC1H1;SEC24A;ARFGAP3;COPZ1;STX17;ARFGAP1;ATL2;COPB2;DCTN4;COG4;MIA3;YIF1A;LMAN2L;VAPA;DCTN3;GOSR1;GBF1;ERGIC1;COPG1;TRIP11;TRAPPC4;SEC16A;LMAN1;ARF4;ERGIC2;CTSC;KDELR2;TMED1;ACTR1A;RAB1A
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4697225012789355,1.3416673503551202,0.07464324917672886,0.4891586908263635,1.0,15/85,11.96%,ROR1;COL1A1;CEMIP;COL11A2;SNAI2;CRYM;COL11A1;PIEZO2;MYO7A;HOXA1;TPRN;TBL1X;TSPEAR;ALDH7A1;MYO3A
prerank,regulation of epithelial cell proliferation (GO:0050678),0.46724506705776053,1.341607689917688,0.08207343412526998,0.4886474799500688,1.0,13/85,5.95%,RUNX3;LAMB1;YAP1;DEAF1;ZFP36L1;TCF7L2;LAMC1;FGF7;CDKN2B;EGFR;LIMS1;CDK6;SFRP1
prerank,homologous chromosome segregation (GO:0045143),-0.44707719043871885,-1.341565473895814,0.12162162162162163,0.5669677201789388,1.0,15/20,51.41%,CENPC;SIRT7;PTTG1;FMN2;PRDM9;MEI4;SGO1;MEIOB;ZCWPW1;IHO1;FANCD2;RNF212B;MEIKIN;ANKRD31;TERB2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5849080968821695,1.341497626106957,0.14522821576763487,0.48825173436440317,1.0,4/18,7.78%,CMKLR1;BLK;BAG6;SH2B2
prerank,vasculature development (GO:0001944),0.6005308127021302,1.341321092446826,0.1259150805270864,0.4881136512828316,1.0,4/16,8.40%,PDGFRA;PDGFRB;ERRFI1;FBXW7
prerank,regulation of proteolysis (GO:0030162),0.5084356936433977,1.3408163603176317,0.12189349112426036,0.48881791290574134,1.0,13/48,12.26%,KNG1;SERPINE2;DNAJC1;GSAP;SHH;PLK1;PLAT;BAG6;SPOP;OGT;CASP8;CLN6;FBXW11
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4816560773950131,1.33996729465978,0.08958566629339305,0.490493188938383,1.0,18/70,20.27%,PSMA7;ITGB5;PDIA3;CD36;PSMB8;PSMA6;CALR;PSMF1;PSMA8;FCGR1A;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;CYBB;PSMC6;TAP1
prerank,neuron remodeling (GO:0016322),0.6549944150963061,1.3393677920667644,0.1527331189710611,0.4915322721218785,1.0,2/10,1.83%,C3;FARP2
prerank,negative regulation of receptor binding (GO:1900121),0.6350138766581438,1.3387485010587816,0.153125,0.49252114552542076,1.0,2/10,9.67%,ADIPOQ;ATP2A2
prerank,T cell receptor signaling pathway (GO:0050852),0.4535598642118285,1.3385187379716934,0.051470588235294115,0.49246392050108184,1.0,30/138,17.74%,PSMA7;RFTN1;TNFRSF21;TEC;CD276;STOML2;CUL1;LCP2;KHDRBS1;NCK1;PRKD2;SKP1;PSMB8;PSMA6;PTPRJ;NFKBIZ;FBXW11;PSMF1;SPPL3;PIK3R1;PSMA8;PSMD2;PSMD12;PSMD11;RBCK1;EIF2B3;PSMD14;PTPRC;RC3H2;PSMB1
prerank,potassium ion transport (GO:0006813),-0.3061284560421141,-1.3384444304753973,0.0,0.5720581983846259,1.0,32/120,15.85%,ATP1A2;ATP1B3;KCNC2;SLC24A2;KCND3;SLC9A2;KCNB2;KCNK5;KCND2;KCNQ5;KCNH5;TMEM175;KCNH7;KCNJ2;KCNJ3;KCNK10;KCNJ13;ABCC9;KCNQ3;KCNQ4;KCNJ10;SLC9A6;KCNK2;SLC9A7;KCNQ1;LRRC38;KCNJ12;CCDC51;KCNN2;NALCN;KCNN3;KCNC1
prerank,regulation of vasculogenesis (GO:2001212),-0.4856725893574648,-1.3382199268593868,0.12074303405572756,0.5692904631945557,1.0,6/14,14.26%,CD34;RAPGEF2;KDR;RAP1A;TMEM100;HEY2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.6312035035383626,1.3368917388635038,0.154434250764526,0.49623561793941573,1.0,5/12,11.46%,SDK2;STAT3;MYO7A;DSCAM;AGTPBP1
prerank,organophosphate catabolic process (GO:0046434),0.6459230442561549,1.336757653203386,0.14553990610328638,0.4959107638487942,1.0,1/11,1.24%,PDXP
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.49534731315833563,1.3365283366220595,0.11695906432748537,0.49586330265270145,1.0,12/53,17.74%,PSMA7;OAZ3;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PPM1K;PSMB1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4125622861188974,-1.3362837273441746,0.12550607287449392,0.5714037765627905,1.0,9/26,10.79%,PRKAG2;PRKAA2;ADIPOR2;ERLIN1;LPGAT1;ELOVL5;ADIPOR1;ACADL;ERLIN2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4593243535504827,1.3362639507170702,0.06808510638297872,0.4959469084718437,1.0,26/108,17.60%,CASP4;DLC1;DAP;CASP8AP2;JAK2;CFLAR;CASP1;BBC3;CTSD;CASP12;IFT57;LGALS9;NOD1;PPARG;HSPE1;CASP8;TNF;ACVR1C;TRAF2;SMAD3;BCL2L13;RIPK1;CYCS;AIFM1;HSPD1;EIF2AK3
prerank,actin cytoskeleton reorganization (GO:0031532),0.4864102307107076,1.3361803227770896,0.0860091743119266,0.4954902162109472,1.0,23/63,14.61%,ANTXR1;SYDE1;FARP2;FGF7;AUTS2;NRP1;RICTOR;MYH9;PARVA;RALA;DTNBP1;RAP2A;PTPN1;PDLIM4;GRB2;S1PR2;ANXA1;CDC42BPA;NRK;RHOA;MICALL2;MKLN1;PTK7
prerank,endothelial cell development (GO:0001885),0.5485990731029579,1.33584461798125,0.1509433962264151,0.4957302255911105,1.0,2/25,0.19%,COL15A1;COL18A1
prerank,response to hydrogen peroxide (GO:0042542),0.5045410429007438,1.3358276681714965,0.10687960687960688,0.49508660209531,1.0,10/45,15.17%,CYP1B1;HP;TNFAIP3;FXN;ANXA1;NFE2L2;STK24;PDCD10;RIPK1;SETX
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.572522081928017,1.3354082240585123,0.146374829001368,0.4956152308669611,1.0,5/19,14.90%,ENPP1;PAPSS2;TPST1;SULT4A1;SLC35B3
prerank,regulation of viral life cycle (GO:1903900),0.5710729850791976,1.3348130710795756,0.14145658263305322,0.4965692326775662,1.0,11/21,25.13%,TRIML2;TRIM21;VPS4A;TYRO3;KPNA2;TRIM6;TRIM27;TRIM62;HS3ST5;TSG101;AXL
prerank,regulation of myelination (GO:0031641),0.5450291767163766,1.3347939699480469,0.14555256064690028,0.4959341743301805,1.0,9/25,17.61%,TNFRSF21;PTN;PTPRZ1;TENM4;DICER1;EGR2;TPPP;EIF2AK3;NCMAP
prerank,negative regulation of potassium ion transport (GO:0043267),-0.5141521773947317,-1.3339951258247804,0.15548780487804878,0.574391041725296,1.0,2/13,1.56%,CAV1;ACTN2
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.582424913562016,1.333932542152437,0.1632047477744807,0.49752218184997987,1.0,5/16,15.02%,KMT2A;AUTS2;DNMT3B;SMAD4;PAXIP1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.3786969828069956,-1.33340053628742,0.06951871657754011,0.5727518101027501,1.0,25/39,33.61%,ERCC5;ERCC3;UBC;POLD3;CHD1L;PCNA;DDB2;GTF2H2;ERCC1;OGG1;GTF2H4;RFC3;UBA52;GTF2H3;FAN1;POLD2;RBX1;RPA2;PARP1;RFC4;NTHL1;POLD4;RFC2;RPA3;POLK
prerank,negative regulation of interleukin-12 production (GO:0032695),0.598079585496631,1.3330194487701952,0.16448326055312956,0.4993056827857867,1.0,2/14,3.64%,CMKLR1;IRAK3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5467980372537784,1.3328678305831971,0.11684782608695653,0.4990630450048586,1.0,11/24,22.90%,PRKD2;EMILIN1;ARNT;PTPN1;VTN;ITGA5;NEDD4;HIF1A;GRB10;TMEM204;ITGB3
prerank,organelle organization (GO:0006996),0.43216255032941614,1.3318316735759292,0.006,0.5012718553699818,1.0,107/388,19.44%,CCL11;CCL7;KRT25;SEC16B;PALLD;SEC31A;VMP1;SH3KBP1;FMNL2;GORASP2;MAST4;PEX10;LRRK2;ATP8B1;TNFAIP3;STOML2;SIPA1L3;MARK1;RAB2A;APOE;CHMP4A;CHMP4B;FMNL3;MDK;PPRC1;IQCG;PKD2;PPID;VPS13C;FGD4;PI4K2B;STX17;ATL2;CDC42;VPS4A;ADCK1;COG4;MIA3;LMAN2L;RAB7A;VAPA;ABI2;TTC17;GBF1;MTX2;GOLGA8B;GOLGA5;MAST2;TERT;TRIP11;FAM161A;WDPCP;RAB32;SEC16A;BRWD1;CCL2;GAK;LMAN1;TTC29;PDZD8;ZMYM4;SEC23IP;FGD6;AGTPBP1;PEX19;PLEKHF1;EPS15;CSNK1A1;CFAP410;TMED1;CHMP7;RAB1A;RAB3GAP1;SEC61A1;DYNC2H1;RAB34;TMCC1;YTHDF3;WTIP;RANBP9;GABPB1;MTX1;SIRT3;PEX11A;LYSMD3;CYCS;CHMP2B;COG7;TOR1AIP2;OBSL1;TBC1D20;POLRMT;CSNK1D;PEX6;PITPNB;KIF9;EIF2AK3;ZFYVE16;SPTSSB;ATP7A;TMED5;BCAS3;TJAP1;CAMSAP1;GABPA;PEX12;TPM1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.646392141534476,1.3315740385253259,0.16510903426791276,0.5012907113274787,1.0,2/11,1.41%,IGF2BP1;IGF2BP2
prerank,protein localization to cell periphery (GO:1990778),-0.29672952041745654,-1.330553012103128,0.0,0.5774679241408014,1.0,34/133,9.26%,KCNIP4;ATP1B3;TSPAN5;CACNB2;CAV1;BSG;ATP1B1;ACTN2;ANK2;KCNB2;CD81;LIN7A;EFR3B;TTC7B;DPP10;DPP6;C2CD5;EZR;GAS6;EHD4;SLMAP;RAMP1;RAPGEF2;WNK3;RAMP2;CDH1;RAB3C;ARL3;ZFYVE27;PACSIN1;MAP7;RAPGEF6;ANK3;INPP5K
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4687809123337443,-1.3304675262869248,0.1388888888888889,0.5744328293600726,1.0,15/17,51.66%,CADM1;AP1G1;LAMP1;PVR;RAET1E;NECTIN2;RASGRP1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.6342758093530632,1.3303440738245003,0.14860681114551083,0.5038585684132224,1.0,4/11,9.46%,ZMIZ1;SERTAD2;PADI2;ARID1B
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5952896658203367,1.3299065062992577,0.1437308868501529,0.5043826677496341,1.0,4/15,9.03%,PDGFRA;MTHFD1L;HOXA1;TGFBR1
prerank,midbody abscission (GO:0061952),0.5801088890778192,1.3297921452719397,0.15450643776824036,0.5039979450568651,1.0,6/17,17.50%,CHMP4A;CHMP4B;VPS4A;CHMP7;CHMP2B;KIF20A
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.655163683233453,1.3297336636630963,0.1684867394695788,0.5034678936605566,1.0,3/10,5.04%,CXCL12;BLK;LGALS9
prerank,lipid oxidation (GO:0034440),0.6222355656377692,1.3295609200814984,0.16203703703703703,0.5032441741719396,1.0,3/12,8.59%,ADIPOQ;ACOX1;PLA2G7
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6128056884788794,1.3283541080586632,0.13663663663663664,0.5059392754721286,1.0,5/13,13.10%,ZMIZ1;SERTAD2;PADI2;ARID1B;SPI1
prerank,endoplasmic reticulum organization (GO:0007029),0.4638259911157677,1.3280913608421767,0.08951965065502183,0.5059099585544716,1.0,23/72,18.91%,SEC16B;SEC31A;LRRK2;TRAM2;ATL2;WDR83OS;MIA3;LMAN2L;VAPA;SEC16A;GAK;LMAN1;ZBED3;RAB10;SEC61A1;TMCC1;VCPIP1;ALDH3A2;TOR1AIP2;LPCAT3;EIF2AK3;SPTSSB;PRNP
prerank,regulation of interleukin-4 production (GO:0032673),-0.4516490121831562,-1.3277887740400105,0.10135135135135136,0.5786703241175196,1.0,8/21,20.15%,PRKCZ;LEF1;SLC7A5;PRKCQ;SYK;ZFPM1;HAVCR2;FCER1G
prerank,regulation of receptor binding (GO:1900120),0.6391816309576832,1.327541132373948,0.17601246105919002,0.506779182259477,1.0,3/10,10.04%,ADIPOQ;ATP2A2;GREM2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6630577306387535,1.3274542342965734,0.18003273322422259,0.5063181851454087,1.0,2/10,7.40%,ENPP1;PID1
prerank,negative regulation of viral life cycle (GO:1903901),-0.4894536044473053,-1.32680238086184,0.14803625377643503,0.5779065887000673,1.0,5/15,20.07%,GSN;LY6E;PPIA;BST2;MID2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.44910344026528803,1.3264864537987264,0.05452674897119342,0.50837644449922,1.0,35/145,17.74%,PSMA7;RAD51B;DYNLL1;FBXL7;DYNC1H1;CUL1;TUBG1;ALMS1;PLK1;PCM1;HAUS3;PINX1;SKP1;CEP41;CNTRL;DCTN3;PSMB8;PSMA6;TPX2;PCNT;CEP72;PSMF1;ACTR1A;AKAP9;PSMA8;PSMD2;PSMD12;CEP192;PSMD11;PSMD14;CSNK1D;YWHAE;BRD4;CKAP5;PSMB1
prerank,establishment of epithelial cell polarity (GO:0090162),0.5724671085050794,1.326366288324716,0.15226939970717424,0.5080457196945649,1.0,7/19,11.96%,CYTH3;SIPA1L3;OPHN1;RAP2A;CDC42;MSN;RHOA
prerank,positive regulation of endocytosis (GO:0045807),0.48905302736103495,1.3262319175914055,0.125,0.5077324358876597,1.0,9/45,11.22%,C3;LRP1;TREM2;APOE;RAB21;CDC42;CBL;ANKFY1;VTN
prerank,negative regulation of cellular process (GO:0048523),0.42845293496203296,1.3257386278666732,0.003,0.5083991650237852,1.0,81/521,11.44%,ROR2;GLMN;CYP1B1;COL18A1;DLC1;ENPP1;ADIPOQ;RUNX3;KNG1;CXCL1;IGFBP7;FBLN1;TNFRSF21;PPP1R9B;SPN;SFRP4;BCL6;TLR2;SLIT3;PRTN3;JAK2;CCN4;WNT9A;PLXNC1;CDKN2B;TREM2;SERTAD2;CHMP4B;FRZB;MDK;CASK;MYH9;SHH;MYBL1;NCK1;ALDH1A2;PTEN;BCL2;PKD2;VPS13C;CYP27B1;NCK2;NF2;STRN;CDK6;SFRP1;TGFB3;EIF2AK2;ENO1;PTPN6;PDS5B;EMILIN1;PLXND1;PINX1;MIA3;IRF1;ARHGDIG;ADAMTS1;CDK10;EEF1E1;ANGPT1;CCAR2;FRK;CELF1;BTG1;GPNMB;PLXNA3;SP100;MAP2K1;SFRP5;IP6K2;BMP5;TGFB1I1;ACVR1B;RERG;PTPRJ;KLF10;PTPN2;DSCAM;PDPN;TGFB2
prerank,positive regulation of cell communication (GO:0010647),0.5316652785429763,1.3256940199695475,0.13730569948186527,0.5078345657310144,1.0,7/28,12.29%,ADIPOQ;EDN3;DLG4;HCRT;WLS;PTPN23;TNF
prerank,negative regulation of signaling (GO:0023057),0.5443127273996661,1.3242213331867794,0.1519674355495251,0.5113575539506001,1.0,6/25,12.88%,ADIPOQ;ACVR1;PTPN1;BRAP;SOCS5;UBASH3B
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.45826577029943155,1.324079450756031,0.09041394335511982,0.5110730541700147,1.0,13/94,7.46%,CYP1B1;CASP4;ERN2;BBC3;IKBKE;CUL1;E2F1;ITPR1;BCL2;ATM;BAG6;BCL2L2;GSKIP
prerank,regulation of myoblast fusion (GO:1901739),0.6347082570638584,1.3237619757311414,0.15207373271889402,0.5111879250266345,1.0,3/11,7.85%,CFLAR;CD53;EHD2
prerank,histone lysine methylation (GO:0034968),0.52730535188417,1.323104177171577,0.13527180783817952,0.5124748239591631,1.0,10/33,15.80%,KMT2A;CXXC1;RBBP5;PRDM5;SETMAR;SETDB1;SETDB2;KMT2B;PAXIP1;WDR5B
prerank,cellular response to growth factor stimulus (GO:0071363),0.44555902051772706,1.3226363038380209,0.044605809128630707,0.5130998101798947,1.0,36/151,14.44%,RUNX2;IBSP;PDE3A;WNT2;ZFP36L1;SOX5;EGR3;ZFP36L2;SNAI2;XCL1;NRP1;EGFR;PRKD2;ACVR1;LIMS1;CCL5;SFRP1;VSTM2A;ADAMTS12;GAS1;ANXA1;TGFBR1;WNT5A;RPS6KB1;ACVR1B;CCL2;ACVR2A;SPRY2;NTRK3;ADAMTS7;ACVR1C;GAREM1;SMAD3;ACAP2;BMP7;SMAD4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6227954236324258,1.3214439359023957,0.15870570107858242,0.5157736706668773,1.0,7/12,22.60%,NCOR2;STAT3;TERT;TNF;BCDIN3D;ZC3H12A;NCOR1
prerank,RNA 3'-end processing (GO:0031123),-0.3334723844982981,-1.3214404081408277,0.04918032786885246,0.5900430201171232,1.0,26/69,25.42%,CDC40;SRSF5;WDR33;CSTF2;RPRD2;U2AF2;RPRD1A;TUT1;SRSF7;SRSF9;RBM8A;CHTOP;CPSF2;MAGOH;ZC3H11A;SUPV3L1;EIF4A3;SRSF3;CLP1;POLDIP3;TUT4;CPSF4;SARNP;DDX39B;DDX39A;THOC1
prerank,thymus development (GO:0048538),0.6038676182298183,1.3208981057369713,0.17620481927710843,0.516587426589905,1.0,4/13,9.03%,EPHB3;SHH;FOXE1;TGFBR1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.49418720791105897,1.320471514183546,0.12278630460448642,0.5170996686779002,1.0,14/44,20.54%,ADIPOQ;IRAK3;APOE;AIDA;NF1;PTPN1;HIPK3;PTPRJ;SPRY2;BMP7;MAPK8IP1;AGT;SPRY4;PRKCD
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.455666383726251,1.3203921544316872,0.07601713062098502,0.5166131470439171,1.0,36/95,22.30%,ZEB2;PMEPA1;SPRED1;SMAD2;CDKN2B;NREP;SMURF2;SPRED2;CREBBP;HTRA3;EMILIN1;RNF111;WFIKKN1;ITGA3;HTRA4;TGFBR1;TGFB1I1;LDLRAD4;SPRY2;SKOR2;GIPC1;SMAD3;SMAD4;SNX25;SMURF1;LATS2;TRIM33;ZBTB7A;PIN1;DKK3;ASPN;RPS27A;LATS1;SNX6;IL17RD;SDCBP
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5835579847416549,1.3201983151828132,0.1422475106685633,0.5164848225365927,1.0,4/18,15.88%,ZFP36L1;ZFP36L2;PRDM1;PRKDC
prerank,histone ubiquitination (GO:0016574),-0.43362918094240743,-1.3201083126502655,0.12109375,0.5906733190235743,1.0,7/21,15.86%,HUWE1;CTR9;UBE2A;LEO1;UBE2B;UBE2N;PHC1
prerank,regulation of platelet aggregation (GO:0090330),0.5826172261230526,1.3200431229323273,0.15450643776824036,0.5162402866490687,1.0,5/17,11.38%,SERPINE2;PRKCA;BLK;ADAMTS18;PDPN
prerank,positive regulation of cell migration (GO:0030335),0.43276762913926564,1.3200339701625081,0.024217961654894045,0.515579533466454,1.0,49/253,12.59%,ROR2;CCL11;COL1A1;CCL7;CEMIP;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;MAP4K4;SNAI1;SYDE1;CCAR1;PDGFRB;SNAI2;CCN4;PRKCA;NRP1;EGFR;STAT3;DOCK1;MDK;CCR1;SMURF2;AIF1;DDR2;ACVR1;RHOD;CARMIL1;CCL5;EGF;ATM;EPHA1;MIA3;GPNMB;TGFBR1;MYLK;PPP3CA;ACVR1B;SEMA3E;PTK2;VTN;PDPN;TGFB2;GCNT2;SPRY2;NTRK3;NUMB
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4714302094103665,1.3196644641564317,0.103954802259887,0.5159491474571125,1.0,18/64,12.44%,GPM6B;MAP4K4;SLC9A1;PEAK1;JAG1;CASK;NF1;CD36;NF2;CDK6;SFRP1;EPHA1;EFNA5;SEMA3E;PTK2;UTRN;RHOA;GSK3B
prerank,synaptic membrane adhesion (GO:0099560),-0.48884303371522364,-1.3194677376178963,0.15476190476190477,0.5893506309623818,1.0,6/14,13.91%,LRRC4C;LRFN5;NTNG1;SLITRK1;LRRC4B;PTPRD
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6338356303922,1.3194339160775668,0.18298555377207062,0.5159249692102873,1.0,3/10,9.14%,XCL1;CCL5;WNT5A
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5297785025402153,-1.3193265533723488,0.1632047477744807,0.5863765617414222,1.0,5/11,16.83%,NOS3;CALM1;HSP90AA1;PTS;DHFR
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6303732257187433,1.318646015588346,0.15883306320907617,0.5174592598990648,1.0,1/11,0.45%,IL23R
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5483291812882766,1.3185439399696044,0.16256830601092895,0.5170884965094437,1.0,6/24,7.58%,SEC31A;SEC24D;SEC23A;PDIA3;SEC24A;CANX
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5150959051562436,1.3183698230729615,0.1370223978919631,0.5169150136528242,1.0,9/33,11.84%,DCN;APOE;NR2F2;PTEN;APOH;ADAMTS9;SP100;PTPN23;PTPRM
prerank,arachidonic acid metabolic process (GO:0019369),0.5113405854508292,1.3182037614617361,0.14720812182741116,0.5167124454189209,1.0,6/35,9.08%,CYP1B1;PTGES;EPHX2;CYP2A6;PTGES2;CYP1A1
prerank,regulation of cell-cell adhesion (GO:0022407),0.5119579055540993,1.3178979132410813,0.13016270337922403,0.5168537111796391,1.0,10/39,11.01%,EPHA7;B4GALNT2;MDGA1;FLOT2;TENM3;EPHB3;JAG1;NF2;EFNA5;PTK2
prerank,negative regulation of synaptic transmission (GO:0050805),0.5564614390846594,1.3177492370188595,0.17001338688085676,0.516594165782038,1.0,5/23,9.77%,ADIPOQ;LRRK2;PTEN;STXBP1;DRD3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.5402728228267917,-1.317444972910952,0.15649867374005305,0.5882516066625032,1.0,4/10,20.66%,PRKAA2;DIP2B;MYOCD;PRKAA1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4386618401847087,1.317241576614117,0.040774719673802244,0.5172956349820573,1.0,43/184,17.74%,PSMA7;NEK6;PPP1R9B;ZFP36L1;DYNLL1;ZFP36L2;DYNC1H1;MAD2L1;CUL1;E2F1;TUBG1;INO80;ALMS1;PLK1;PTPN6;ANAPC11;PCM1;CDC27;HAUS3;SKP1;CEP41;CNTRL;DCTN3;PSMB8;PSMA6;TPX2;PCNT;CEP72;PSMF1;ACTR1A;AKAP9;CDC14A;PSMA8;PSMD2;PSMD12;CEP192;PSMD11;PSMD14;CSNK1D;YWHAE;DDB1;CKAP5;PSMB1
prerank,zinc ion transmembrane transport (GO:0071577),0.5505671484537098,1.3168279862892875,0.1388888888888889,0.5177481536091313,1.0,1/22,0.13%,SLC39A14
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5567890185978729,1.3166884718914096,0.14583333333333334,0.5174297600628495,1.0,5/21,9.11%,ZFP36L1;ZFP36L2;LGALS9;EGF;MAP2K1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6103023884387964,1.3161944533724788,0.17925925925925926,0.5180594497280507,1.0,5/13,17.56%,B4GALNT2;GFPT2;UAP1L1;AMDHD2;GNPDA2
prerank,cellular iron ion homeostasis (GO:0006879),0.4806727107959125,1.3161895168086404,0.11764705882352941,0.5173981986321846,1.0,8/55,7.29%,SLC39A14;HEPH;CP;SLC11A2;FXN;CUL1;ACO1;SKP1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4495557538919508,-1.315946335662162,0.11604095563139932,0.5891644643242301,1.0,9/20,21.73%,ADRA1B;ADCY9;RAPGEF2;ADRA1A;PDE4D;ZDHHC21;ADRA2A;DRD2;ADRB2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4658217142237852,1.3159385183870924,0.10798650168728909,0.5167868619698662,1.0,15/78,7.74%,CLTC;SEC31A;DYNLL1;SEC24D;SEC23A;DYNC1H1;CTSD;SEC24A;KIF2A;CTSS;DCTN4;CTSL;RAB7A;CANX;DCTN3
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4658217142237852,1.3159385183870924,0.10798650168728909,0.5167868619698662,1.0,15/78,7.74%,CLTC;SEC31A;DYNLL1;SEC24D;SEC23A;DYNC1H1;CTSD;SEC24A;KIF2A;CTSS;DCTN4;CTSL;RAB7A;CANX;DCTN3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5780385919425091,1.3154524216905834,0.1799163179916318,0.517440626026297,1.0,4/18,3.61%,VSIG4;TNFAIP3;XCL1;NAV3
prerank,regulation of pH (GO:0006885),0.6235112551911913,1.314805489758954,0.16747967479674797,0.5186208342992981,1.0,2/11,2.41%,SLC9A1;LACC1
prerank,regulation of viral release from host cell (GO:1902186),0.5539184983250974,1.3140229821002114,0.16643356643356644,0.5200121435227786,1.0,13/21,28.11%,TRIM21;VPS4A;TRIM13;TRIM8;CHMP2B;DDB1;TRIM62;TRIM35;TRIM11;TSG101;CHMP3;TRIM26;PML
prerank,mammary gland epithelium development (GO:0061180),0.5999113237303068,1.3139291261863575,0.16521739130434782,0.5196030196955492,1.0,2/14,2.75%,WNT2;JAK2
prerank,regulation of type I interferon production (GO:0032479),0.46279430784271236,1.3138683995042972,0.0967391304347826,0.519106610156533,1.0,27/84,20.62%,ZBP1;DTX4;IRF7;TNFAIP3;IKBKE;ILRUN;TRIM21;CREBBP;IRF1;TIRAP;CD14;CRCP;GAPDH;POLR3A;POLR3D;NFKB2;ITCH;TRIM56;PRKDC;CGAS;POLR2L;POLR2K;POLR3GL;PIN1;RNF135;POLR3K;ISG15
prerank,response to organonitrogen compound (GO:0010243),0.5015277675730584,1.3134398603548514,0.1349009900990099,0.5196162220315995,1.0,7/38,11.52%,NR1H4;IRAK3;GLRB;ERLEC1;RRAGC;DRD3;RCN3
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5540285296906959,1.3127654668913018,0.1659919028340081,0.5208202292025376,1.0,5/20,12.29%,LBP;CCL5;CD14;CCL2;TNF
prerank,establishment of apical/basal cell polarity (GO:0035089),0.592790178562423,1.312684866111899,0.17867867867867868,0.5203753936875721,1.0,6/14,11.96%,FSCN1;OPHN1;RAP2A;CDC42;MSN;RHOA
prerank,nucleotide-sugar metabolic process (GO:0009225),0.6128383676032363,1.3121514909376548,0.18037974683544303,0.5211463897276217,1.0,3/12,6.07%,B4GALNT2;GFPT2;GMDS
prerank,muscle cell migration (GO:0014812),0.6294582311099237,1.3118504343612398,0.16826923076923078,0.5213429047853944,1.0,8/10,25.24%,THBS4;PLAT;ITGB1BP1;DDR1;MEGF10;ITGB3;ROCK1;AAMP
prerank,"wound healing, spreading of cells (GO:0044319)",0.539121348192889,1.3115169309236643,0.1677762982689747,0.5215232157972783,1.0,10/24,16.80%,COL5A1;MRTFA;ARHGAP24;LCP1;PDPN;RHOA;ITGA5;ARHGAP35;PDCD10;ACVRL1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5129945700371257,-1.3113587915618057,0.15954415954415954,0.5988718899781684,1.0,5/12,14.26%,ACTB;LAMA3;AHI1;LAMA5;SCRIB
prerank,positive regulation of biomineral tissue development (GO:0070169),0.5012585307814587,1.3110848639521497,0.144853875476493,0.5220689493217672,1.0,16/40,20.69%,GPM6B;FBN2;PTN;NELL1;ACVR1;TGFB3;TMEM119;ATP2B1;ACVR2A;P2RX7;BMP7;ANO6;FBXO5;ADGRV1;ISG15;BMPR1A
prerank,protein localization to condensed chromosome (GO:1903083),-0.519639171516844,-1.3103222497464102,0.15384615384615385,0.5984162564557867,1.0,9/12,39.45%,ZWILCH;IK;BUB3;KNL1;TTK;ZW10;MTBP;SPDL1;CDK1
prerank,digestive tract morphogenesis (GO:0048546),0.6037125541765276,1.310022086632958,0.18153364632237873,0.5243333560019534,1.0,2/14,3.57%,PDGFRA;EPHB3
prerank,negative regulation of DNA metabolic process (GO:0051053),0.548703140352376,1.3098956525240126,0.15582655826558264,0.5239917153225917,1.0,2/24,0.48%,KMT2A;ADIPOQ
prerank,actomyosin structure organization (GO:0031032),-0.31933762822592293,-1.309531058634309,0.038834951456310676,0.5972657792887855,1.0,10/75,3.95%,SORBS1;TJP1;PHACTR1;PGM5;ACTN2;FRMD5;EPB41;CIT;EPB41L5;TMOD3
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6056604374639135,1.3094471761080868,0.19545454545454546,0.5245231065212579,1.0,5/12,14.77%,KDELR3;INSIG2;KDELR2;TAPT1;HSPA5
prerank,respiratory system development (GO:0060541),0.5065949306689567,1.309148718802777,0.16645326504481434,0.5247346266246085,1.0,11/32,12.48%,GLI2;CHD7;FGF7;SHH;SPEF2;BAG6;ITGA3;LOXL3;NPHP3;PDPN;FGF2
prerank,serine family amino acid catabolic process (GO:0009071),0.6314103198202015,1.308838483779579,0.18181818181818182,0.524920939109659,1.0,3/10,11.98%,AMT;GLDC;THNSL2
prerank,ameboidal-type cell migration (GO:0001667),-0.34768340600716485,-1.3085756115346365,0.03333333333333333,0.5969989336696497,1.0,25/51,26.72%,SEMA6A;SEMA3C;SEMA3D;GPC3;SEMA6D;SEMA7A;CCN3;ERBB4;TBX1;CENPV;ITGA4;SEMA4D;SEMA5A;AMOTL2;SEMA5B;SEMA3G;FAT2;RADIL;PKN3;SEMA6C;SEMA4B;SOX8;SEMA3B;SEMA4A;SEMA6B
prerank,response to estradiol (GO:0032355),0.5267338632149633,1.3083994942219612,0.14545454545454545,0.5254530183604162,1.0,8/31,15.89%,NRIP1;EGFR;STAT3;SFRP1;ANXA1;LCOR;STAT5B;GGT7
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.464090585814588,1.3077447351153317,0.1242672919109027,0.5266300207871334,1.0,25/59,23.25%,LRRK2;PRKCA;CAMK2D;PRKD2;ACVR1;CDK10;HIPK4;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;HIPK3;ACVR1B;CDC42BPA;GSK3B;PRKDC;MAPK1;AKT1;MAP3K12;PRKCD;DYRK1A;MARK2;ROCK2;ROCK1;NLK
prerank,glycogen metabolic process (GO:0005977),-0.4120767702932397,-1.3077013808928117,0.12946428571428573,0.5962119927266072,1.0,6/27,6.91%,PRKAG2;CALM1;GBE1;PGM2L1;PYGM;PYGB
prerank,histone H3-K4 methylation (GO:0051568),0.541579913658836,1.30731574902991,0.14285714285714285,0.5270770994414006,1.0,9/26,15.80%,KMT2A;CXXC1;RBBP5;OGT;SETMAR;TET2;KMT2B;PAXIP1;WDR5B
prerank,negative regulation of cholesterol transport (GO:0032375),0.653084337702265,1.3070459684167848,0.16585365853658537,0.5271316142741433,1.0,2/10,4.42%,ABCA2;SHH
prerank,negative regulation of translation (GO:0017148),0.45132887109762876,1.3069266535044421,0.0978021978021978,0.5267847304431674,1.0,20/87,14.51%,IGF2BP1;IGF2BP2;SYNCRIP;ILF3;IGFBP5;PUM1;CPEB1;METTL16;EIF2AK2;CAPRIN1;GIGYF2;SAMD4A;CELF1;FTO;GAPDH;EIF4EBP1;CALR;YTHDF3;FMR1;CPEB4
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4340933104196757,-1.306430295590227,0.11764705882352941,0.5964787127584739,1.0,8/19,15.91%,SYNJ2BP;LRRC7;DLG2;PARD3;PATJ;SCRIB;CLIC4;MTCL1
prerank,myofibril assembly (GO:0030239),0.49698015192761574,1.3057638005819099,0.13316892725030827,0.5293728665777507,1.0,6/42,7.34%,PDGFRA;CSRP1;PDGFRB;CFLAR;FHOD3;TMOD1
prerank,cellular response to BMP stimulus (GO:0071773),0.4758578463888933,1.305729325076319,0.10854503464203233,0.5288065344324417,1.0,21/66,17.84%,RUNX2;SMAD2;USP9X;ACVR1;HIVEP1;SFRP1;TGFB3;VSTM2A;ADAMTS12;SMAD5;BMP5;TGFB2;ACVR2A;ADAMTS7;SMAD3;BMP7;SMAD4;SMAD1;SMURF1;ACVRL1;ZFYVE16
prerank,integrated stress response signaling (GO:0140467),0.5990427676326452,1.30550756099042,0.17888563049853373,0.5287879048137533,1.0,6/14,17.65%,OMA1;CCL2;NFE2L2;HSPA5;EIF2AK3;ATF4
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.43938637324836777,1.3048638438961906,0.06528497409326425,0.5298412488581653,1.0,36/163,17.74%,PSMA7;RFTN1;TNFRSF21;TEC;CD276;STOML2;VAV3;BLK;CUL1;LCP2;KHDRBS1;NCK1;BCL2;PRKD2;SKP1;SH2B2;PSMB8;PSMA6;LAT2;MS4A1;PTPRJ;NFKBIZ;FBXW11;PSMF1;SPPL3;PIK3R1;PSMA8;PSMD2;PSMD12;PSMD11;RBCK1;EIF2B3;PSMD14;PTPRC;RC3H2;PSMB1
prerank,positive regulation of organelle assembly (GO:1902117),0.4978350232468612,1.3044521247728702,0.13975903614457832,0.5303060143851486,1.0,22/44,25.23%,ASAP1;FSCN1;DYNC1H1;PIP4K2A;GPSM2;SDC1;LCP1;RAB3GAP2;ENTR1;CEP120;TNF;TAPT1;RAB3GAP1;ARHGAP35;SH3GLB1;CAPG;CNOT2;SDC4;SDCBP;PDCD6IP;RALB;CNOT1
prerank,autophagosome assembly (GO:0000045),0.47264665780323045,1.3039135699395765,0.1280558789289872,0.5311307237936451,1.0,18/52,21.19%,VMP1;WIPI1;AMBRA1;STX17;ATG3;RAB7A;ATP2A2;ATG7;PACS2;RAB1A;ATG16L1;ATG16L2;SMURF1;WDR45;PIK3C3;IRGM;UBXN2A;BECN1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.46262282454127607,1.3036237410538718,0.12939841089670828,0.5312960015684679,1.0,10/61,12.59%,COL3A1;P2RY10;MAP4K4;JAK2;AUTS2;GRB2;MAPRE2;ERBIN;VAV1;AKAP13
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4487266492941259,1.303540457371437,0.08396124865446716,0.5308490269886936,1.0,23/101,14.53%,CEMIP;IL34;ADIPOQ;EDN3;TNFSF11;LRRK2;CD40;PDGFRB;EGFR;PKD2;EGF;CCND3;PIK3R5;RPTOR;MAP2K1;WNT5A;FGFR1;RHOA;TNF;FGF2;CALM2;SRC;PDCD10
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6033350784568413,1.3034940294475603,0.1902587519025875,0.530308764330515,1.0,2/13,2.74%,SNAI1;SNAI2
prerank,response to exogenous dsRNA (GO:0043330),0.5644427429802787,1.3031618017605535,0.1588235294117647,0.5305088505442612,1.0,3/18,3.64%,RFTN1;COLEC12;IRAK3
prerank,positive regulation of ossification (GO:0045778),0.5036336159479109,1.3030697220670955,0.16153846153846155,0.530117973385154,1.0,13/39,14.04%,GPM6B;FBN2;PTN;NELL1;ACVR1;TGFB3;TMEM119;WNT5A;TGFB2;ATP2B1;ACVR2A;P2RX7;BMP7
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5342529231210472,1.3030594236673232,0.14432989690721648,0.5294802291816586,1.0,9/26,11.83%,EGFR;AIF1;CCND3;ADAMTS1;CDK10;RPTOR;ANXA1;KMT2E;ANKRD17
prerank,sulfur compound catabolic process (GO:0044273),0.49564912053715166,1.3029129934531671,0.13608748481166463,0.5291880747520703,1.0,5/38,6.55%,DCN;LUM;BGN;VCAN;PRELP
prerank,positive regulation of innate immune response (GO:0045089),0.5282075602918679,1.302136132147986,0.13419354838709677,0.5306982137719594,1.0,7/30,13.10%,ZBP1;LBP;CCL5;WNT5A;POLR3D;UBE2K;SPI1
prerank,regulation of macrophage cytokine production (GO:0010935),0.6074692007525873,1.302135166330784,0.1893939393939394,0.5300431276602476,1.0,4/13,11.44%,IRAK3;TGFB3;WNT5A;TGFB2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5818287817353633,1.3009130164957814,0.17979197622585438,0.5327435923419862,1.0,8/15,22.93%,SLC9A1;PRKCA;CAMK2D;AGT;IL6ST;PDE9A;ROCK2;ROCK1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5723919101151522,1.300759792246779,0.17056396148555708,0.5325006363645362,1.0,4/18,9.70%,ZFP36L1;ZFP36L2;ANXA1;UBE2L3
prerank,cellular response to hypoxia (GO:0071456),0.4423996225731462,1.3006598102586753,0.08298319327731092,0.5321157243875705,1.0,13/126,8.91%,PSMA7;RORA;ZFP36L1;BACH1;GATA6;CPEB1;CREBBP;SFRP1;ARNT;NPEPPS;TERT;PSMB8;PSMA6
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5745222360171585,1.3005240953440371,0.1829971181556196,0.5318124017026051,1.0,4/18,6.56%,MMP14;ABCA2;PLK1;VPS4A
prerank,response to peptide hormone (GO:0043434),0.4909266586241595,1.3000202640763256,0.1324582338902148,0.532544271420875,1.0,15/43,17.14%,ZFP36L1;STAT1;IRS1;STAT3;IGFBP5;STAT5A;ANXA1;OGT;GNAI1;KHK;ZBED3;SRC;STAT5B;EIF2B3;AKT1
prerank,response to reactive oxygen species (GO:0000302),0.47486667221816636,1.2999039050077767,0.12811387900355872,0.5321921486457933,1.0,6/54,5.01%,HP;PDGFRA;APOD;EGFR;APOE;PKD2
prerank,regulation of actin filament depolymerization (GO:0030834),0.6238076179259989,1.2995943957057356,0.1691616766467066,0.5324271428780272,1.0,4/12,16.76%,PDXP;LIMA1;PLEKHH2;PLEK
prerank,spinal cord development (GO:0021510),0.6036344813005428,1.2992415648218967,0.18885448916408668,0.5327731501454158,1.0,4/12,10.24%,GLI2;PKD2;NF1;LOXL3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4590032314094687,1.2989956486132426,0.11447811447811448,0.5327751845248708,1.0,15/79,7.74%,CLTC;SEC31A;DYNLL1;SEC24D;SEC23A;DYNC1H1;CTSD;SEC24A;KIF2A;CTSS;DCTN4;CTSL;RAB7A;CANX;DCTN3
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4803405395879176,1.2987058997683343,0.1346389228886169,0.5329260528916766,1.0,7/49,5.67%,IL23R;GHR;CD40;JAK2;TSLP;STAT3;CCL5
prerank,canonical Wnt signaling pathway (GO:0060070),0.46392815675434473,1.298497615543778,0.11963882618510158,0.5328491946029736,1.0,15/68,12.56%,WNT2;TCF7L2;SFRP4;LRRK2;WNT9A;FRZB;PTEN;FZD1;SFRP1;LRP6;WNT5A;SFRP5;TCF7;GSK3B;CSNK1A1
prerank,myelin assembly (GO:0032288),0.642954755800793,1.297926600046193,0.18630573248407642,0.5338031186657669,1.0,8/10,22.05%,ABCA2;PMP22;TENM4;DICER1;TPPP;NCMAP;EPB41L3;CNTNAP1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5604587986972263,-1.297401346774222,0.16711590296495957,0.6189766906706538,1.0,2/10,3.04%,IL15;IL18
prerank,positive regulation of phosphorylation (GO:0042327),0.42350149845756624,1.2972946859150467,0.028225806451612902,0.5348868102868102,1.0,43/240,12.90%,ROR2;GLMN;ROR1;C3;EPHA7;IL34;ADIPOQ;PDGFRA;LRRK2;CD40;PDGFRB;FGF7;NRP1;EGFR;EPHB3;TREM2;DDR2;FAM20A;CCL5;EGF;CCND3;RAP2A;EPHA1;TMEM119;ARNT;PFKFB4;ANGPT1;MERTK;GPNMB;EFNA5;NIBAN1;FBH1;FGFR1;FNIP1;PTK2;DSCAM;ACVR2A;TNF;VEGFC;FGF2;NTRK3;ZBTB20;P2RX7
prerank,COPII vesicle coating (GO:0048208),0.4649448793233695,1.2967463175637262,0.13356562137049943,0.5343624309178558,1.0,17/61,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,vesicle coating (GO:0006901),0.4649448793233695,1.2967463175637262,0.13356562137049943,0.5343624309178558,1.0,17/61,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4649448793233695,1.2967463175637262,0.13356562137049943,0.5343624309178558,1.0,17/61,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5523852101599627,1.2965248305591883,0.16164383561643836,0.5343042310571512,1.0,11/20,23.43%,FMNL2;FMNL3;FHOD3;LLGL1;LCP1;TNF;PLEK;DLG1;ROCK2;ROCK1;STRIP1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.44292668909443567,1.2964814842735983,0.09314775160599571,0.5337631108130636,1.0,16/107,12.14%,CCL11;SLC39A14;CCL7;EDN3;CXCL12;CD40;STOML2;CCR1;SLC24A5;CCL5;ATP2A2;DRD3;TMEM203;ATP2B1;CALR;TPCN2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.48474159077662876,1.2964715751238074,0.15558194774346792,0.5331478364903567,1.0,12/45,12.90%,JAK2;CASP1;STAT3;LGALS9;CD36;PYDC1;TMEM106A;LPL;WNT5A;CASP8;TNF;P2RX7
prerank,vesicle transport along actin filament (GO:0030050),0.5494672363866276,1.2960703749957856,0.18194444444444444,0.5335349053417476,1.0,5/19,7.53%,MYO1B;MYO5A;MYO1D;MYO1H;MYO7A
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6138788994653769,1.2955315155195553,0.19571865443425077,0.5343714972101102,1.0,8/12,22.93%,FLOT2;APOE;ABCA2;RANBP9;PICALM;PRNP;ROCK2;ROCK1
prerank,positive regulation of defense response (GO:0031349),0.4492743281570343,1.2952382747439635,0.11938663745892661,0.5345071623436475,1.0,24/89,19.00%,ZBP1;TNIP1;IL16;TLR2;CCN4;TSLP;MDK;CCL5;TLR7;PLA2G7;LPL;WNT5A;TNFRSF1A;NFKBIZ;TNF;POLR3D;ABCC1;CX3CL1;RIPK1;NPAS2;ETS1;AGT;NFKBIA;IL17RA
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.4706568820492416,1.2951182681407185,0.1263408820023838,0.5342423743523524,1.0,13/49,14.77%,PMEPA1;IAPP;TREM2;AIDA;CDC42;PYDC1;LDLRAD4;GSK3B;NLRP2B;ANKRD27;DACT1;SRC;HSPA5
prerank,protein-containing complex assembly (GO:0065003),0.423022938230872,1.2946625337351327,0.029087261785356068,0.5348808058685595,1.0,70/259,17.95%,COL7A1;KMT2A;SEC16B;SH3PXD2B;SEC31A;YAP1;CXCL12;TCF7L2;FARP2;SEC24D;SLC9A1;LAMC1;SEC23A;SKAP2;LRRK2;CD40;STOML2;MITF;TLE1;FBXL7;RBBP5;WIPF1;CUL1;SEC24A;PPID;CREBBP;LLGL1;DLG4;KPNA3;ADD2;SKP1;TERT;HDAC1;TRAPPC4;SEC16A;TCF7;TNFRSF1A;LMAN1;TEAD1;SEC23IP;SNX9;RUVBL1;CASP8;DBNL;CTSC;TSPAN4;TNF;GSK3B;CSNK1A1;SPG7;P2RX7;TRAF2;RAB1A;RANBP9;CX3CL1;TUBGCP4;RIPK1;PPP6C;ITGB1BP1;TCF7L1;SMARCA4;SEC13;TBC1D20;CSNK1D;MDM2;ANO6;PICALM;FERMT3;SCFD1;CAPZA1
prerank,sensory perception of smell (GO:0007608),-0.5333355427693013,-1.294293574452957,0.1661721068249258,0.6249392616278979,1.0,4/11,19.93%,UBR3;BBS4;MKKS;DRD2
prerank,cardiac muscle cell development (GO:0055013),0.5484691876833208,1.2941406221208496,0.19166666666666668,0.5357007042089259,1.0,3/20,4.03%,PDGFRA;PDGFRB;FHOD3
prerank,T cell activation (GO:0042110),0.46082836460336035,1.294102622477555,0.10674157303370786,0.5351520638466009,1.0,15/69,11.94%,JAML;CD276;CHD7;MDK;KIF13B;NCK1;NCK2;DDOST;MSN;LCP1;PPP3CA;CTPS1;PTPN2;CASP8;TNFRSF4
prerank,positive regulation of cell cycle (GO:0045787),0.46110056375234926,1.2938181183123545,0.11136363636363636,0.5353251877974343,1.0,17/62,14.31%,MEIS2;PRKCA;EGFR;PKD2;TRIM21;CCND3;LRP6;ASNS;RAD23A;RPS6KB1;TBX3;EIF4EBP1;TGFB2;CALR;ANKRD17;CDKN1B;USP22
prerank,cell cycle G1/S phase transition (GO:0044843),0.47101036827276727,1.293629444282898,0.1346153846153846,0.5352017410129488,1.0,30/61,25.10%,CCNE2;CUL1;E2F1;KHDRBS1;ACVR1;CACUL1;CDK6;DBF4;RPS6KB1;ACVR1B;EIF4EBP1;CDK7;E2F3;CDKN1B;GSPT1;PPP6C;MAX;RCC1;LATS2;INHBA;HINFP;PLK2;CDC7;LATS1;CCNH;MNAT1;CDKN1A;NASP;CDC25A;BCAT1
prerank,diterpenoid metabolic process (GO:0016101),0.4698493887720221,1.293344564629779,0.13348946135831383,0.5353450556521615,1.0,10/55,11.18%,LRP1;HSPG2;GPC6;APOE;RDH12;SDC1;RDH10;SDC2;LPL;OPN1MW
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5387865741962189,1.2929503502617612,0.18646408839779005,0.5357199914678096,1.0,6/21,11.96%,GPM6B;SLC9A1;PEAK1;EFNA5;PTK2;RHOA
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5981385206294133,1.2927005101790956,0.1898355754857997,0.5357599156681232,1.0,5/13,9.91%,SUFU;NFKBIE;PKD2;MDFI;DBN1
prerank,negative regulation of protein metabolic process (GO:0051248),0.48698441540923154,1.2926863596447749,0.1281094527363184,0.5351566666190531,1.0,8/48,6.47%,IAPP;FLOT2;EGFR;IRAK3;TREM2;APOE;MAD2L1;INHBB
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.4565786841424288,1.2924669564336129,0.10989010989010989,0.535101062810361,1.0,24/80,17.88%,COPA;COPZ2;ARCN1;KDELR3;KIF1C;ARFGAP3;KIF2A;COPZ1;ARFGAP1;COPB2;COG4;GBF1;ERGIC1;COPG1;ARF4;ERGIC2;KDELR2;RINT1;RAB1A;ERGIC3;COG7;KIF5A;PITPNB;SCFD1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.431170739316127,1.2922959461248653,0.0823045267489712,0.5349605374212852,1.0,21/140,13.03%,P2RY10;KNG1;PDGFRA;CACNA1A;IAPP;CMKLR1;CACNA2D1;EDNRA;CACNA1C;P2RX5;CCR1;PTGDR;CD36;S1PR3;DLG4;CXCR4;DRD3;LPAR3;LPAR2;P2RX7;SPPL3
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.441913418917518,1.2913379508929244,0.10138740661686232,0.5369235344015774,1.0,25/109,17.06%,PSMA7;TEC;VAV2;GAB2;VAV3;MAP2K4;CUL1;LCP2;SKP1;GRB2;PSMB8;PSMA6;LAT2;PPP3CA;VAV1;FBXW11;PSMF1;PIK3R1;RAC1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;MAPK1
prerank,lung development (GO:0030324),0.5023033591267505,1.2912956019258506,0.16861219195849547,0.5363860125178788,1.0,11/33,12.48%,GLI2;FGF7;ERRFI1;SHH;BAG6;ITGA3;LOXL3;NPHP3;PDPN;RCN3;FGF2
prerank,peptidyl-threonine modification (GO:0018210),0.4551410214044627,1.2902809219556615,0.13176470588235295,0.5384625317151868,1.0,28/66,23.25%,LRRK2;PRKCA;GALNT3;CAMK2D;PRKD2;ACVR1;CDK10;HIPK4;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;HIPK3;ACVR1B;CDC42BPA;GALNTL6;GALNT11;GSK3B;PRKDC;MAPK1;AKT1;MAP3K12;PRKCD;DYRK1A;MARK2;ROCK2;ROCK1;NLK
prerank,polarized epithelial cell differentiation (GO:0030859),0.5902097744978988,1.289544146299036,0.20783132530120482,0.5398412056075363,1.0,6/13,13.50%,OPHN1;RAP2A;CDC42;MSN;RHOA;RAB10
prerank,limb morphogenesis (GO:0035108),0.558064728237473,1.2894508611499054,0.17606602475928473,0.5394603724479429,1.0,8/20,17.74%,GLI3;SHH;LRP6;TBX3;TGFB2;IQCE;NIPBL;FBXW4
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4496377564740353,1.2894386872679813,0.11650485436893204,0.5388500071178111,1.0,23/88,20.15%,PSMA7;FBXL7;CUL1;SKP1;FBXL18;FBXW7;PSMB8;PSMA6;FBXW11;PSMF1;FBXO2;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;FBXW4;FBXO31;AMN1;FBXO38;FBXL22;PSMC6
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4537526225021291,1.2892065939917219,0.11437908496732026,0.5388845644331443,1.0,19/86,14.44%,ZEB2;SULF1;JAK2;SMAD2;CDKN2B;ACVR1;CREBBP;TGFB3;INHBB;RNF111;TGFBR1;BMP5;TGFB1I1;ACVR1B;TGFB2;ACVR2A;GIPC1;BMP7;SMAD4
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.41623319057138963,1.2889142229489783,0.004004004004004004,0.5390478260972055,1.0,129/497,18.97%,RUNX2;IGF2BP1;ENPP1;CREB3L1;ADIPOQ;MDFIC;BCL3;ZEB1;SBNO2;NCOR2;DAP;DEAF1;IGF2BP2;TCF7L2;ATXN1;GLI3;BCL6;ERN2;SYNCRIP;ATP8B1;GATA6;ZFPM2;XCL1;RCOR1;PHC2;ARID5B;SMAD2;TLE1;TBX2;ILF3;IGFBP5;NR2F2;ARID5A;KMT5A;SMURF2;MBD2;E2F1;PRDM5;KHDRBS1;LIMS1;TAF7;SCMH1;FOXK2;SFRP1;PPARG;RUNX1T1;YAF2;EIF2AK2;ENO1;ZHX2;SFMBT1;MBD1;EHMT1;AHR;PRICKLE1;TSHZ3;FOXE1;IRF1;CAPRIN1;GIGYF2;BHLHE40;SAMD4A;HEYL;CCAR2;PDS5A;ZMYND15;POU2F1;SAP18;ATR;BAHD1;WNT5A;HDAC1;SALL1;NONO;ZBTB38;HMGB2;TBX3;LOXL3;GAPDH;EID1;KLF10;RSF1;ZGPAT;CALR;TIMELESS;SP3;TNFRSF4;SETDB2;FBXW11;TNF;GSK3B;COMMD7;SPI1;GATAD2A;CTCF;BMP7;TRIB3;CDKN1B;FMR1;SMAD4;NIPBL;TSC22D4;PHC3;PATZ1;PHF12;L3MBTL3;POU3F3;ATF7IP;CLOCK;SMARCA4;ACVRL1;MTA3;TRIM33;RBFOX2;MDM2;EIF2AK3;RCOR2;RBPJ;HDAC5;RBM15;SPEN;HINFP;SPINDOC;KAT6B;ZBTB7A;ARID4A;NR3C1;TLE5;WAPL
prerank,defense response to protozoan (GO:0042832),0.6122245073638634,1.2888291290297151,0.1951219512195122,0.5386601009678077,1.0,3/12,10.15%,CD40;BATF;GBP7
prerank,regulation of cell migration (GO:0030334),0.4161908439896971,1.288178394889696,0.016016016016016016,0.5398366980772514,1.0,59/382,9.23%,ROR2;CCL11;CYP1B1;DLC1;COL1A1;CCL7;CEMIP;ADIPOQ;SULF1;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;SERPINE2;MAP4K4;SNAI1;CCAR1;PDGFRB;FGF7;SNAI2;PRKCA;DPYSL3;MITF;PLXNC1;AMOTL1;EGFR;NAV3;STAT3;IGFBP5;JAG1;MDK;CCR1;SHH;KIF2A;PTEN;AIF1;NF1;ACVR1;RHOD;CARMIL1;NF2;CCL5;EGF;ATM;SFRP1;RAP2A;SRGAP1;EPHA1;PLXND1;MIA3;SASH1;IGSF10;GPNMB;PLXNA3;ANXA1;TGFBR1;MYLK;FOXO3
prerank,regulation of mitotic cell cycle (GO:0007346),0.4271320964740634,1.2881757837547194,0.06776180698151951,0.5392114824993111,1.0,47/171,20.35%,PSMA7;NEK6;PDXP;MEIS2;PRKCA;MAD2L1;CUL1;PTPN3;PLK1;CKS1B;ANAPC11;CDC27;ASNS;SKP1;CDK10;GBF1;BORA;TMEM8B;BTG1;GAS1;PSMB8;TTC28;PSMA6;RPS6KB1;EIF4EBP1;PSMF1;MAEA;SMAD3;CDKN1B;USP22;PSMA8;PSMD2;PSMD12;PSMD11;RCC1;OBSL1;PSMD14;DDB1;MDM2;PSMB1;CDK9;FBXO5;PIN1;CDK13;PSMC6;ERCC2;UBE2E1
prerank,cation transport (GO:0006812),-0.28176972528729993,-1.2881234895627178,0.0,0.639406821621897,1.0,28/166,11.47%,TRPM3;ATP1A2;SLC12A2;SLC47A1;SLC6A6;KCND3;ATP1B1;TRPM6;KCNB2;SLC6A9;KCNK5;SCN2A;SLC1A1;KCNJ2;KCNJ3;SLC8A3;KCNJ13;ABCC9;SLC9B2;SLC5A6;KCNQ4;KCNJ10;SCN8A;SLC22A4;CLN3;SCN9A;SLC38A5;SLC5A5
prerank,female gamete generation (GO:0007292),0.5165153004356604,1.2881033842132117,0.17139001349527666,0.5387722188509606,1.0,10/29,23.15%,PTN;USP9X;MDK;DIAPH2;MCM9;MARF1;PARN;GDF9;KMT2D;DMC1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.414052889107843,1.2880703198363068,0.001,0.5382478317236359,1.0,160/807,14.46%,RUNX1;NR1H4;RUNX2;CREB3L1;ADIPOQ;TRPS1;RUNX3;ZEB2;POU5F1;MDFIC;BCL3;GLI2;ZEB1;SBNO2;ETV6;NCOR2;DAP;YAP1;DEAF1;TCF7L2;NRIP1;SNAI1;ATXN1;GLI3;BCL6;MEIS2;STAT1;ERN2;RARB;IRF7;ATP8B1;BACH1;GATA6;SNAI2;ZFPM2;XCL1;RCOR1;FHL2;DNAJB1;NKX6-1;PHC2;MITF;CRYM;ARID5B;SMAD2;NFIX;MIER2;SUFU;TLE1;MLIP;GLIS1;STAT3;CGGBP1;TBX2;USP9X;ILF3;NR2F2;ARID5A;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;KHDRBS1;PRDM2;PPID;LIMS1;TAF7;SCMH1;HIVEP1;RNF2;FOXK2;CREBBP;CBX8;SFRP1;PPARG;RUNX1T1;YAF2;PLK1;ETV5;ENO1;ZHX2;SFMBT1;MBD1;EHMT1;AHR;PRICKLE1;MDFI;TSHZ3;FOXE1;E2F8;NOC2L;IRF1;BHLHE40;HEYL;CCAR2;FRK;ZMYND15;POU2F1;SAP18;SP100;BAHD1;WNT5A;HDAC1;ZBTB5;SALL1;NONO;FOXO3;TBL1X;ZBTB38;DICER1;FOXP4;PRDM1;NR2F1;MTA2;HMGB2;CXXC5;TGIF2;TBX3;LOXL3;EID1;FNIP1;CBFB;GATAD2B;KLF10;ELK4;RSF1;ZGPAT;PHF21A;DNMT3B;CALR;TIMELESS;SP3;LCOR;TNFRSF4;SETDB2;FBXW11;TNF;KDM2A;NAB2;DUSP26;SKOR2;COMMD7;GLIS3;SPI1;RIF1;GATAD2A;CTCF;SMAD3;DACT1;PSEN1;KCNIP3;BMP7;TRIB3;DRAP1;CDKN1B;TFAP2C;SMAD4;MAFK
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4909016548024814,-1.2878914943378483,0.17365269461077845,0.6367605362845828,1.0,3/14,20.33%,MOXD1;ALDH9A1;SLC22A2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4208424474663507,-1.2876888302673017,0.13438735177865613,0.6340403352338639,1.0,8/22,14.90%,KIDINS220;NTRK2;RAPGEF2;SH3GL2;WASF1;STMN2;RAP1A;BDNF
prerank,protein localization to synapse (GO:0035418),-0.5105877495485021,-1.2871748800569587,0.17886178861788618,0.6322315176545971,1.0,7/12,19.82%,NRXN1;PCLO;NRXN2;BSN;SHANK1;ZDHHC15;NLGN1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.41656744902836335,1.2866808006678447,0.01,0.5414452007093897,1.0,116/417,19.44%,RUNX2;CREB3L1;ADIPOQ;MDFIC;BCL3;ZEB1;SBNO2;NCOR2;DAP;DEAF1;TCF7L2;ATXN1;GLI3;BCL6;ERN2;ATP8B1;GATA6;ZFPM2;XCL1;RCOR1;PHC2;ARID5B;SMAD2;TLE1;TBX2;ILF3;NR2F2;ARID5A;KMT5A;SMURF2;MBD2;E2F1;PRDM5;KHDRBS1;LIMS1;TAF7;SCMH1;FOXK2;SFRP1;PPARG;RUNX1T1;YAF2;ENO1;ZHX2;SFMBT1;MBD1;EHMT1;AHR;PRICKLE1;TSHZ3;FOXE1;IRF1;BHLHE40;HEYL;CCAR2;ZMYND15;POU2F1;SAP18;BAHD1;WNT5A;HDAC1;SALL1;NONO;ZBTB38;HMGB2;TBX3;LOXL3;EID1;KLF10;RSF1;ZGPAT;CALR;TIMELESS;SP3;TNFRSF4;NIF3L1;SETDB2;FBXW11;TNF;COMMD7;SPI1;GATAD2A;CTCF;BMP7;TRIB3;CDKN1B;SMAD4;NIPBL;TSC22D4;PHC3;PATZ1;PHF12;L3MBTL3;POU3F3;ATF7IP;CLOCK;SMARCA4;MTA3;TRIM33;RBFOX2;MDM2;RCOR2;RBPJ;HDAC5;RBM15;SPEN;HINFP;SPINDOC;KAT6B;ZBTB7A;ARID4A;NR3C1;TLE5;THAP7;KDM1A;KAT7
prerank,dendritic cell chemotaxis (GO:0002407),0.5826068870119718,1.2866410898162506,0.17820324005891017,0.5409141410927603,1.0,4/14,14.55%,CCR1;CCL5;CXCR4;TRPM4
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5707088887841779,1.2861849592880301,0.2,0.5415659591683465,1.0,6/18,14.92%,KMT2A;EHMT1;SETMAR;SETD2;KMT2B;ASH1L
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5358000883006949,1.286079747707545,0.16059379217273953,0.5411932060642255,1.0,7/25,12.29%,CBLB;ERRFI1;PPARG;CBL;SOCS5;ZGPAT;TNF
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4538385107534181,1.285968703963752,0.11817168338907469,0.540880800511586,1.0,21/76,18.77%,CCL11;PDXP;SYNPO;NRP1;DYNC1H1;NCK1;BAIAP2;NCK2;CARMIL1;CDC42;GPSM2;SNX9;NTRK3;P2RX7;CX3CL1;FES;CDC42EP1;PLEK;CTTN;CDC42EP4;BCAS3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5045583961874897,1.285882803488541,0.17564102564102563,0.5405097109712617,1.0,15/31,22.46%,ARRDC4;PTEN;PLK1;SKP1;ARRDC3;DCUN1D1;FBXW7;UBE2L3;RAB1A;TRIB3;DCUN1D5;PIN1;CDC14B;AXIN1;FZR1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.39550379572006994,-1.2857782947456924,0.12,0.6333212659521252,1.0,11/25,22.56%,HNRNPU;LDB1;NELFB;WDR43;LEO1;EAF2;LARP7;NELFA;SUPT4H1;NELFE;ZMYND11
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.26942061784804405,-1.2857138961790235,0.0,0.6302706024299563,1.0,48/224,9.63%,UNC13C;SNAP25;SLC12A7;CACNB2;DLGAP1;CHRM2;UNC13B;CACNB4;SYNJ2BP;NRXN1;GRM7;GRM1;HTR2C;RIT2;DLG2;GRIK4;GABRA2;MINK1;GABRB1;KCND2;GLRA3;GABRG3;CALM1;DTNA;SLC1A2;SLC1A1;ATXN3;PTCHD1;SLC12A6;SLC6A1;GRIA2;PRKAR1A;GRM3;NOVA1;GABRA5;NRXN2;KCNQ3;GRIA1;HTR1F;CAMKK2;GLRA1;PRKAR2A;CAMK4;GABRB2;BSN;CACNA1E;CACNA1B;CPLX1
prerank,brain development (GO:0007420),0.43325949447335793,1.2854955987502208,0.07564766839378238,0.5409702645741225,1.0,17/136,7.04%,COL4A1;EPHA7;APOD;HSPG2;ROBO2;ATXN1;MEIS2;MDGA1;AFF2;ADGRL3;MEIS1;MAP1S;PTEN;NF1;PBX3;SPEF2;BAG6
prerank,negative regulation of T cell differentiation (GO:0045581),0.6269456386451111,1.2850871807218518,0.18985270049099837,0.5414226368868816,1.0,3/10,7.18%,GLI3;MDK;IRF1
prerank,monosaccharide transmembrane transport (GO:0015749),-0.4629554645715284,-1.2848393223775862,0.16507936507936508,0.6296951070745666,1.0,5/16,20.89%,SLC5A3;SLC2A12;SLC45A3;SLC2A8;SLC2A9
prerank,positive regulation of synaptic transmission (GO:0050806),-0.32555897105117626,-1.2846996448898207,0.053763440860215055,0.6268487968990302,1.0,26/72,20.84%,SLC24A2;NRXN1;PRKCZ;SHANK3;ADCY1;SLC8A3;CACNG2;CLSTN3;ADRA1A;KCTD13;GRIN2D;APP;GRIN2B;RIMS1;CACNG7;CLSTN1;GRIK2;ZDHHC2;LGI1;SHISA7;GPER1;RELN;SLC8A2;NLGN1;LGMN;RIMS2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5106501184052321,1.2843508196472733,0.15155615696887687,0.5427418912730081,1.0,8/29,10.36%,GHR;STAT1;JAK2;STAT3;PKD2;STAT5A;IFNAR2;CCL2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.579861918817653,1.2842392347817897,0.1878698224852071,0.5424377801280381,1.0,3/14,13.11%,EHHADH;ACOX1;ACOX3
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4131358023266202,1.2835413401104168,0.0,0.5437917949242526,1.0,204/834,18.64%,RORA;RUNX1;NR1H4;RUNX2;DCN;KMT2A;WNT2;ZEB2;POU5F1;PLAC8;GLI2;SBNO2;YAP1;TCF7L2;TCF4;NRIP1;ASXL1;TNFSF11;TNIP1;MRTFA;GLI3;CREB3L3;SATB2;MEIS2;SLC9A1;STAT1;ZMIZ1;RARB;TLR2;IRF7;CD40;GATA6;ZFPM2;AUTS2;NPAS4;NKX6-1;RXRG;MITF;SMAD2;NFIX;CDKN2B;EGFR;REL;MAML3;MLIP;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;HOXB3;ELF4;NR2F2;JAG1;PPRC1;SHH;E2F1;MYBL1;NCK1;PRDM2;PRKD2;PKD2;ACVR1;ASXL2;TAF7;TCF12;NCK2;HIVEP1;INO80;FOXK2;CREBBP;ATM;MACC1;PPARG;LRP6;TGFB3;EAPP;ETV5;CXCL10;AHR;MLXIP;E2F8;PLXND1;BCL11B;SUB1;DDX17;ARNT;RNF111;IRF1;PID1;RRP1B;HEYL;ACTR2;CRTC1;MAML2;TERT;HOXA1;POU2F1;OGT;WNT5A;HDAC1;SALL1;FOXO3;TBL1X;ZBTB38;SMAD5;BMP5;NR2F1;JUNB;HMGB2;PPP3CA;PELP1;TBX3;TNFRSF1A;WWTR1;TEAD1;KLF10;ARF4;ELK4;CRTC3;RSF1;TGFB2;NFE2L2;ZBED3;SP3;CDK7;ACVR2A;TET2;E2F3;MED13;TNF;ZSCAN21;HOXB2;KLF6;MAML1;GLYR1;FGF2;GNL3;MC1R;NKX2-8;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;PIK3R1;DDRGK1;GTF2F1;PRDM10;SMAD3;ATRX;EGR2;DRAP1;MYSM1;TFAP2C;SMAD4;GABPB1;CX3CL1;PAXIP1;RIPK1;SETX;SMAD1;RTRAF;CREB3L4;CREB3;CCNT1;HIF1A;STAT5B;PRKDC;RBMX;PTOV1;SQSTM1;SLC30A9;NPAS2;MAX;ITGB1BP1;CLOCK;TCF3;SMARCA4;SREBF1;ACVRL1;ZFHX3;TCERG1;CALCOCO1;THRAP3;BRD4;MZF1;ATF4;GLI1;ETS1;RLF;PRDM4;INHBA;PAX8;RBPJ;HDAC5;NR2C2;NFKBIA;SOX2;CDK9;SETD3;HINFP;KAT6B
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6163754385242177,1.2829187108305415,0.1996879875195008,0.5448394283603786,1.0,7/10,22.90%,PRKD2;ARNT;VTN;ITGA5;HIF1A;GRB10;ITGB3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4784516954922935,-1.2828140204687684,0.16286644951140064,0.6293945328302084,1.0,6/14,17.08%,CHKA;PCYT2;LPIN1;SLC27A1;SELENOI;CHKB
prerank,response to interferon-beta (GO:0035456),0.5353399413257968,1.2826028768295339,0.17524339360222532,0.5450784711839216,1.0,9/22,20.38%,STAT1;IKBKE;SHFL;IRF1;IFNAR2;UBE2K;IRGM;PLSCR1;TRIM6
prerank,negative regulation of anoikis (GO:2000811),0.5752012623819388,1.2823702752102442,0.19326500732064422,0.5450932840079233,1.0,6/14,14.06%,SNAI2;TLE1;BCL2;PTK2;ITGA5;SRC
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4769114536227451,1.2822889174137202,0.14512195121951219,0.5446988480544471,1.0,7/44,11.14%,CCL11;NCK1;BAIAP2;NCK2;CARMIL1;SPIRE1;SNX9
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4459458874850568,1.2821594100747005,0.1146288209606987,0.5444157267999066,1.0,23/94,18.36%,PSMA7;IL1R1;IRAK3;CUL1;NOD1;IRAK2;SKP1;PSMB8;PSMA6;IRAK4;PELI3;FBXW11;PSMF1;PSMA8;PSMD2;PSMD12;SQSTM1;PSMD11;PELI2;PSMD14;MAP3K3;PSMB1;NFKBIA
prerank,mitotic cytokinetic process (GO:1902410),0.5453773942239318,1.2817173348982747,0.18207282913165265,0.5450225443934804,1.0,7/20,17.50%,CHMP4A;CHMP4B;VPS4A;RHOA;CHMP7;CHMP2B;KIF20A
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.4650946205637563,-1.2814802594660952,0.15757575757575756,0.6301499073606198,1.0,6/15,14.90%,SORT1;NTRK2;ZFYVE27;CASP3;DDIT4;BDNF
prerank,lipid phosphorylation (GO:0046834),-0.525165415152066,-1.2807215782171195,0.163727959697733,0.6291926115836614,1.0,5/10,16.74%,DGKB;DGKI;DGKA;DGKG;DGKQ
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5957564056003795,1.2805829131381647,0.2170418006430868,0.547542787364146,1.0,1/12,0.41%,IL34
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.550625377572601,1.280535248198213,0.1910569105691057,0.5470490294546484,1.0,3/19,2.74%,RUNX1;SNAI1;SNAI2
prerank,secondary palate development (GO:0062009),0.5877868875204522,1.2801124883265034,0.1985185185185185,0.5475899540075237,1.0,7/14,14.65%,CHD7;SMAD2;TGFB3;WNT5A;TGFB2;SMAD4;LRRC32
prerank,regulation of protein kinase A signaling (GO:0010738),0.5581522178036145,1.279574087104153,0.18662952646239556,0.5484543019388612,1.0,6/20,12.75%,ADIPOQ;IAPP;LRRK2;PRKAR1B;PJA2;MC1R
prerank,cellular response to ATP (GO:0071318),0.5842331064344984,1.2792525106227717,0.18195488721804512,0.5487182579848785,1.0,5/14,21.68%,PDXP;SSH1;P2RX7;HSP90B1;P2RY12
prerank,fatty acid catabolic process (GO:0009062),0.45331294169620884,1.2791607633775206,0.13641488162344984,0.5483279474098425,1.0,6/67,7.19%,CEL;ADIPOQ;EHHADH;AIG1;SLC27A2;ACOX1
prerank,ERBB2 signaling pathway (GO:0038128),0.513793144289699,1.279090616430361,0.17794486215538846,0.5478442540278778,1.0,10/31,14.06%,PRKCA;EGFR;EGF;PTPN18;GRB2;CDC37;ERBIN;BTC;PIK3R1;SRC
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5274640884964743,1.2784452491435838,0.19781718963165076,0.5489357221065438,1.0,5/23,6.94%,NOS1AP;CACNA2D1;CACNB1;CAMK2D;CBARP
prerank,protein localization to phagophore assembly site (GO:0034497),0.6023416265870544,1.2774676582169735,0.19938650306748465,0.5510187014550386,1.0,4/11,15.93%,WIPI1;STX17;PACS2;WDR45
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.43242825654338746,-1.2771407121749263,0.14429530201342283,0.6363917817338314,1.0,11/19,21.07%,IL1RAPL1;CDKL5;CUX1;CUX2;CAMK2B;LRP8;CDKL3;PTPRD;RELN;DHX36;CUL7
prerank,regulation of actin filament-based movement (GO:1903115),-0.5304778626955544,-1.2771028167820118,0.19008264462809918,0.6333394294101394,1.0,3/10,10.43%,PDE4B;ANK2;PDE4D
prerank,negative regulation of catalytic activity (GO:0043086),0.5258051658767264,1.2766162065290727,0.18331053351573187,0.552729267823331,1.0,3/24,7.96%,HP;TIMP1;CCAR2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5588032669087114,1.2763550006080835,0.20193637621023514,0.5528359669447473,1.0,6/17,20.05%,LTBP3;TERT;PTPRC;KDM1A;KAT7;HMGA2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.42429747081915664,1.2762062968921362,0.09381443298969072,0.5526264923408505,1.0,46/150,17.28%,ENPP1;ADIPOQ;FBLN1;PMEPA1;LRRK2;SPRED1;ERRFI1;SPRED2;PTPN13;NCK1;PTEN;NF1;TAF7;NCK2;DTNBP1;SFRP1;LRP6;PTPN6;EPHA1;EMILIN1;PID1;RASSF2;GSKIP;PYDC1;NIBAN1;CNKSR3;MVP;WWTR1;IBTK;LDLRAD4;ZBED3;SPRY2;NLRP2B;NTRK3;UBASH3B;SMCR8;CALM2;TRIB3;TRIB1;RTRAF;SNX25;PRKDC;ITGB1BP1;PTPRC;AKT1;DNAJC3
prerank,chemical synaptic transmission (GO:0007268),-0.2703359842931967,-1.2758855109180762,0.0,0.6337410748266255,1.0,62/284,11.28%,UNC13C;FCHSD2;SNAP25;SYN3;SLC12A7;CACNB2;DLGAP1;CHRM2;UNC13B;CACNB4;KIF1B;SYNJ2BP;NRXN1;GRM7;GRM1;GRID2;HTR2C;RIT2;DLG2;GRIK4;GABRA2;MINK1;GABRB1;LIN7A;KCND2;GLRA3;GABRG3;CALM1;DTNA;SLC1A2;SLC1A1;ATXN3;PTCHD1;SLC12A6;SHISA6;SLC6A1;DLGAP2;GRIA2;PRKAR1A;GRM3;NOVA1;GABRA5;NRXN2;KCNQ3;GRIA1;HTR1F;CAMKK2;GLRA1;PRKAR2A;CAMK4;GABRB2;BSN;CACNA1E;CACNA1B;CPLX1;TBC1D24;GRIN2D;RPS6KA2;HTR7;GRIN2B;RIMS1;SNAPIN
prerank,glucose transmembrane transport (GO:1904659),-0.44246307333429735,-1.2757374818760565,0.14788732394366197,0.6310994277793445,1.0,8/18,32.75%,SLC2A1;SORT1;SLC5A3;SLC2A8;SLC2A9;SLC45A1;SLC2A4;RAB4B
prerank,protein N-linked glycosylation (GO:0006487),0.45584405046346993,1.2752423482155038,0.14689265536723164,0.5545166989368305,1.0,19/66,15.84%,MGAT5;B4GALNT2;ST6GAL1;GFPT2;DDOST;ALG5;SRD5A3;MAN1C1;MGAT4A;UGGT2;STT3A;LMAN1;ST3GAL1;UBE2J1;NUDT14;TUSC3;PMM2;B4GALT7;RPN1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5837307914917564,1.2750810578339709,0.18181818181818182,0.5543150357495417,1.0,4/15,9.70%,ZFP36L1;ZFP36L2;ANXA1;UBE2L3
prerank,regulation of neuroblast proliferation (GO:1902692),0.5695328282333982,1.275014391491955,0.20508982035928144,0.5538670126446148,1.0,9/15,25.00%,PTN;LRRK2;NF1;DISC1;CX3CL1;KDM1A;SMARCD3;FZD3;VEGFA
prerank,protein localization to cell-cell junction (GO:0150105),-0.45642536728478295,-1.2749143253653166,0.15141955835962145,0.6303009122917995,1.0,5/15,6.66%,TJP1;TJP2;ACTB;CDH5;LSR
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5036338949789694,1.2742151990711594,0.18055555555555555,0.5554568091099243,1.0,12/32,24.24%,NR1H4;ATXN2;FOXO3;NOLC1;PICALM;RBM4B;PRKCD;SAMD8;ROCK1;PCIF1;METAP1;EIF2A
prerank,COPII-coated vesicle budding (GO:0090114),0.45052115435770135,1.274031268046179,0.14709236031927023,0.5553226624397477,1.0,19/68,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;MIA3;VAPA;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,RNA destabilization (GO:0050779),0.5624509077042616,1.2738787654166253,0.19772403982930298,0.5551336439747977,1.0,10/18,22.93%,PUM1;METTL16;GIGYF2;CELF1;FTO;YTHDF3;DXO;ROCK2;YTHDF2;ROCK1
prerank,positive regulation of leukocyte activation (GO:0002696),0.5562319118841151,1.2736228989164318,0.20857988165680474,0.5551597558564252,1.0,7/18,22.65%,LBP;TSLP;WNT5A;HSPD1;TNIP2;CRLF2;IL33
prerank,maturation of 5.8S rRNA (GO:0000460),0.5555823044158749,1.273137488846116,0.183206106870229,0.5558119999250943,1.0,8/17,17.10%,C1D;MAK16;PES1;EXOSC4;MPHOSPH6;PRKDC;RPF1;MTREX
prerank,cellular zinc ion homeostasis (GO:0006882),0.5163714413750966,1.2730523560047446,0.18265440210249673,0.555411135572259,1.0,1/26,0.13%,SLC39A14
prerank,negative regulation of glycolytic process (GO:0045820),-0.5201056012809029,-1.2727362219057454,0.20572916666666666,0.6304105056334347,1.0,3/10,11.09%,HDAC4;CBFA2T3;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.5201056012809029,-1.2727362219057454,0.20572916666666666,0.6304105056334347,1.0,3/10,11.09%,HDAC4;CBFA2T3;GIT1
prerank,pinocytosis (GO:0006907),0.6250271481823819,1.2724401572824955,0.21428571428571427,0.5564049276535074,1.0,5/10,16.49%,CARMIL1;SNX33;SNX5;RAB34;DOCK2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3847576166350621,-1.272035126307961,0.12987012987012986,0.6293549195912556,1.0,9/32,11.80%,LRRC7;ACTN2;DLG2;SLC6A9;GRIA2;GRIA1;APP;GRIN2B;CAMK2B
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5947127943391491,1.2719221011119568,0.2121684867394696,0.5571633201939712,1.0,6/11,18.70%,GPM6B;TAX1BP3;SNX33;LEPROT;PICALM;LEPROTL1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5790532195200608,1.2718849976466255,0.21198830409356725,0.5566435482975823,1.0,4/14,6.54%,SUFU;NFKBIE;PKD2;MDFI
prerank,post-translational protein modification (GO:0043687),0.41424740799270915,1.2715508814436913,0.02902902902902903,0.5569312486519374,1.0,84/332,20.15%,PSMA7;C3;ENAM;KNG1;SPP1;IGFBP7;LAMB1;LAMC1;FBXO40;CP;TIMP1;IGFBP4;VCAN;SPSB1;FSTL1;PRKCSH;KLHL22;RAB2A;APOE;FBXL7;RBBP5;CALU;IGFBP5;WSB2;DCAF10;CUL1;FBN1;FN3KRP;MIA3;KLHL13;SKP1;CKAP4;DCUN1D1;SDC2;FBXL18;FBXW7;FBXO30;CHML;PSMB8;UBE2F;PSMA6;MGAT4A;TNC;LTBP1;STT3A;SOCS5;DCAF11;NEURL2;FBXO7;FBXW11;PSMF1;KCTD7;RAB1A;FBXO2;COPS6;RABGGTB;PSMA8;HIF1A;FBXL19;PSMD2;PSMD12;KLHL25;PSMD11;OBSL1;PSMD14;DNAJC3;DDB1;PSMB1;FBXW4;ASB3;RHBDD1;FBXO31;HSP90B1;DCAF8;EVA1A;FAM20C;PDIA6;FBXO32;FBXL22;LGALS1;ASB6;SHISA5;RAB8A;PSMC6
prerank,positive regulation of type I interferon production (GO:0032481),0.45372406315972874,1.271465652987415,0.12806236080178174,0.5565507373724713,1.0,24/73,20.62%,ZBP1;STAT1;TLR2;IRF7;CREBBP;TLR7;IRF1;CD14;CRCP;SETD2;GAPDH;POLR3A;POLR3D;NFKB2;TRIM56;PRKDC;CGAS;HSPD1;POLR2L;POLR2K;POLR3GL;RNF135;POLR3K;ISG15
prerank,regulation of defense response to virus by host (GO:0050691),0.49513615438199166,1.2708099708907994,0.18051948051948052,0.557758485394688,1.0,7/30,16.40%,IL23R;STAT1;TNFAIP3;TRIM44;DTX3L;CGAS;TRAF3IP2
prerank,regulation of mast cell activation (GO:0033003),0.6199979597891525,1.2698897580751747,0.2159090909090909,0.5595693883844677,1.0,6/10,25.10%,MILR1;TSLP;CD300LF;PLSCR1;CRLF2;CD84
prerank,regulation of protein polymerization (GO:0032271),-0.3626055995389013,-1.269239670572466,0.1326530612244898,0.6341192228954913,1.0,9/35,12.55%,FCHSD2;MAP2;ARHGAP18;ESAM;HSP90AA1;ARHGAP28;TTBK1;PRUNE1;PAK3
prerank,positive regulation of neuron projection development (GO:0010976),0.44114665045699697,1.2688602827548745,0.14798694232861806,0.5618429169154129,1.0,20/85,15.17%,ROR2;ROR1;PTN;DPYSL3;TENM3;APOE;MDK;FZD1;CAPRIN1;WNT5A;BMP5;DBN1;DBNL;NTRK3;BMP7;ARHGAP35;PTK7;CX3CL1;FES;SETX
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5880706312385484,1.2685892150009643,0.2177293934681182,0.5619281778360731,1.0,3/12,3.78%,IAPP;TREM2;APOE
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.5555878382138595,1.2682359360543047,0.17768595041322313,0.5622420921512309,1.0,2/21,3.81%,RUNX1;BLK
prerank,positive regulation of vascular permeability (GO:0043117),-0.48879263857328065,-1.2678362211283596,0.16878980891719744,0.6349849706651746,1.0,4/12,0.74%,TJP1;BMP6;TJP2;OCLN
prerank,Fc receptor signaling pathway (GO:0038093),0.43433644444968494,1.2673256040638847,0.12379935965848453,0.5640965896280524,1.0,25/110,17.06%,PSMA7;TEC;VAV2;GAB2;VAV3;MAP2K4;CUL1;LCP2;SKP1;GRB2;PSMB8;PSMA6;LAT2;PPP3CA;VAV1;FBXW11;PSMF1;PIK3R1;RAC1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;MAPK1
prerank,sensory organ development (GO:0007423),0.46901211821256006,1.2661219281777463,0.1696113074204947,0.5667608556761726,1.0,9/51,8.25%,SH3PXD2B;MEIS2;CHD7;MAFB;SIPA1L3;MEIS1;PBX3;MYO7A;ADAMTS18
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.44702068743079515,1.2658511294335826,0.13712374581939799,0.5668515968461801,1.0,17/75,12.48%,CCL11;THBS4;EGR3;PRKCA;NRP1;MDK;AKT3;PRKD2;EGF;STAT5A;ARNT;TGFBR1;WNT5A;HMGB2;FGFR1;VEGFC;FGF2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.40714928808401235,1.2655290730167048,0.0,0.5671203430114257,1.0,259/1082,18.48%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;DCN;KMT2A;WNT2;RUNX3;ZEB2;POU5F1;CXXC1;SPP1;MDFIC;BCL3;PLAC8;GLI2;SBNO2;YAP1;DEAF1;TCF7L2;TCF4;NRIP1;ASXL1;SNAI1;TNFSF11;TNIP1;MRTFA;GLI3;CREB3L3;SATB2;MEIS2;SLC9A1;STAT1;ZMIZ1;RARB;TLR2;IRF7;CD40;GATA6;FGF7;MAFB;ZFPM2;AUTS2;NPAS4;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;CDKN2B;EGFR;REL;MAML3;MLIP;UBP1;GLIS1;APOE;USF1;STAT3;LITAF;MEIS1;SERTAD2;HOXB3;ELF4;ILF3;PADI2;NR2F2;JAG1;PPRC1;SHH;E2F1;MYBL1;NCK1;PRDM2;PRKD2;PKD2;SMARCC1;ACVR1;ASXL2;TAF7;TCF12;NCK2;HIVEP1;INO80;FOXK2;EGF;CREBBP;FZD1;ATM;MACC1;SFRP1;PPARG;LRP6;YAF2;ZBTB48;TGFB3;ETV5;CXCL10;AHR;FOXE1;MLXIP;E2F8;BCL11B;GTF2H1;DDX17;ARNT;RNF111;IRF1;PID1;RRP1B;RPTOR;NEK4;HEYL;CREB3L2;ACTR2;CRTC1;MAML2;HOXA1;POU2F1;SP100;TGFBR1;OGT;MAP2K1;WNT5A;HDAC1;SALL1;FOXO3;TBL1X;ZBTB38;ARID1B;SMAD5;BMP5;NR2F1;TGFB1I1;JUNB;HMGB2;PPP3CA;PELP1;ZIC1;TBX3;TNFRSF1A;WWTR1;TRIM44;TEAD1;KLF10;ARF4;KMT2E;ELK4;CRTC3;RSF1;NFE2L2;ZBED3;SP3;CDK7;ACVR2A;TET2;E2F3;MED13;NIF3L1;MAP3K2;FBXW11;TNF;ZSCAN21;HOXB2;KLF6;MAML1;GLYR1;FGF2;MC1R;NKX2-8;KMT2B;ELK1;NSD3;GLIS3;SNX5;FOXJ3;NFKB2;SPI1;BRPF1;PIK3R1;DDRGK1;GTF2F1;PRDM10;CTCF;SMAD3;PSEN1;BMP7;ATRX;EGR2;DRAP1;MYSM1;USP22;TFAP2C;SMAD4;ASF1A;DTX3L;GABPB1;MMS19;CX3CL1;NAA15;RIPK1;SETX;SMAD1;RTRAF;CREB3L4;CREB3;CCNT1;HIF1A;TRIM56;STAT5B;PRKDC;RBMX;PTOV1;SQSTM1;SLC30A9;NPAS2;NSD1;POU3F3;MAX;ITGB1BP1;ATF7IP;CLOCK;TCF3;SMARCA4;SREBF1;HMGN1;ACVRL1;ZFHX3;AKT1;ING5;TCERG1;CALCOCO1;THRAP3;PCBD2;BRD4;MZF1;EIF2AK3;ATF4;PICALM;ICE1;GLI1;ETS1;MAP3K12;RLF;PRDM4;RAI1;INHBA;BICRA;PAX8;AGT;RBPJ;HDAC5;NR2C2;NFKBIA;SOX2;CDK9;SETD3
prerank,regulation of endothelial cell migration (GO:0010594),0.43992266250377643,1.2647021811898942,0.13333333333333333,0.5687258160669487,1.0,23/85,12.48%,DCN;SPARC;PTN;RHOJ;PRKCA;NRP1;APOE;NR2F2;PRKD2;NF1;APOH;EGF;SASH1;ANGPT1;ADAMTS9;SP100;WNT5A;PTK2;BMPER;CALR;PTPRM;RIN2;FGF2
prerank,fatty acid elongation (GO:0030497),-0.5011946797715745,-1.2646885793147293,0.18618618618618618,0.6406003323464637,1.0,6/13,10.49%,TECR;ELOVL7;ELOVL5;HACD1;HACD3;HACD4
prerank,positive regulation of exosomal secretion (GO:1903543),0.5726861356886994,1.2644884605012103,0.21052631578947367,0.568702679038587,1.0,8/15,24.73%,VPS4A;RAB7A;SDC1;SMPD3;SDC4;SDCBP;PDCD6IP;TSG101
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.547496017542809,1.263335835052552,0.20719424460431654,0.5712572902082977,1.0,4/17,8.76%,LIPC;ANGPTL4;APOH;LPL
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5234711391411895,1.2633252043836467,0.20408163265306123,0.5706643455873205,1.0,6/25,11.60%,HK2;FOXK2;ENO1;ADPGK;GAPDH;GCK
prerank,heart morphogenesis (GO:0003007),0.4667952208249077,1.263301847657588,0.155011655011655,0.5701097185250494,1.0,10/50,11.44%,DLC1;FLRT2;CHD7;TBX2;ACVR1;HEYL;TGFBR1;TBX3;PTK2;TGFB2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.45127041526923184,-1.2628567848430354,0.15454545454545454,0.6430409849307446,1.0,6/16,13.78%,PPP1R16B;AGTR1;GATA2;JCAD;FGFBP1;THBS1
prerank,inner ear morphogenesis (GO:0042472),0.53089089563783,1.2627895592854412,0.20226308345120225,0.5709120660620914,1.0,7/22,18.17%,TBX18;CHD7;HOXA1;ZIC1;MYO3A;TTC39C;PAX8
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4542043101342414,-1.2626654361707024,0.20447284345047922,0.6406367092699476,1.0,6/15,14.55%,KCND3;ATP1B1;KCNJ2;KCNJ3;KCNQ1;KCNN2
prerank,chromatin assembly (GO:0031497),0.48537570921808226,1.262563672835511,0.17587939698492464,0.5708765880565709,1.0,15/38,20.05%,POLE3;NOC2L;BAHD1;GRWD1;HMGB2;LIN54;RSF1;SPTY2D1;NAP1L3;CTCF;ATRX;ASF1A;KAT6B;NAP1L1;HMGA2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.46791003769376427,1.2617190313959328,0.17427884615384615,0.5726355931544682,1.0,16/43,20.69%,MMP2;STAT1;PDGFRB;CCN4;IGFBP5;AIF1;CCL5;ADAMTS1;TNF;FGF2;CX3CL1;IL6R;AKT1;HTR1B;FOXP1;BMPR1A
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6023939061075546,1.2611931597736317,0.2188976377952756,0.5734604692193972,1.0,4/11,5.86%,GATA6;XCL1;LGALS9;ATP6AP2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.421001711563285,1.2611056562220535,0.1130524152106886,0.5730363385834176,1.0,23/138,11.01%,ROR2;ROR1;EPHA7;PDGFRA;PTN;PDGFRB;JAK2;EGFR;EPHB3;BLK;LCP2;DDR2;NPR2;EPHA1;STYK1;MERTK;FRK;TRIO;FRS2;ACVR1B;LIFR;FGFR1;PTK2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.462731186837786,1.2610510238492365,0.16508313539192399,0.5725719019619324,1.0,14/46,14.73%,ANTXR1;LAMB1;LAMC1;PEAK1;ITGA8;NRP1;EPHB3;PARVA;EPHA1;LAMC3;RHOA;MICALL2;PIK3R1;RAC1
prerank,cell-cell junction assembly (GO:0007043),-0.3294941150809332,-1.260904446474525,0.11016949152542373,0.6426516268516643,1.0,17/63,10.53%,TJP1;PKP4;CLDN5;ACTB;CDH5;GJB6;CTNND1;CDH10;RAMP2;ARVCF;GJB2;CLDN12;CD9;VCL;PATJ;CDH12;CLDN11
prerank,negative regulation of chemokine production (GO:0032682),0.5800081379624952,1.260878050548929,0.19879518072289157,0.5724468711787596,1.0,2/14,5.04%,APOD;LGALS9
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6149944717654464,1.2604292670640427,0.21148036253776434,0.5730882301233939,1.0,3/10,7.08%,APOD;PADI2;MIA3
prerank,sensory perception of sound (GO:0007605),0.43971033765052114,1.2604028229962752,0.1318082788671024,0.5725375048218129,1.0,14/88,11.96%,ROR1;COL1A1;CEMIP;COL11A2;SNAI2;CRYM;COL11A1;MYO7A;HOXA1;TPRN;TBL1X;TSPEAR;ALDH7A1;MYO3A
prerank,negative regulation of endothelial cell migration (GO:0010596),0.49308866373840465,1.2603235149238325,0.18693982074263765,0.5721233359474394,1.0,10/36,12.48%,DCN;APOE;NR2F2;APOH;PPARG;ADAMTS9;SP100;PTPRM;TNF;FGF2
prerank,negative regulation of blood pressure (GO:0045776),0.5832712498237776,1.260317288001627,0.2183734939759036,0.5715227612821875,1.0,3/13,13.62%,ADIPOQ;DRD3;SCPEP1
prerank,glucan biosynthetic process (GO:0009250),-0.5029326775710321,-1.2602640407120762,0.20221606648199447,0.6384453404827677,1.0,5/12,17.59%,GBE1;PGM2L1;PER2;PPP1R3C;UGP2
prerank,glycogen biosynthetic process (GO:0005978),-0.5029326775710321,-1.2602640407120762,0.20221606648199447,0.6384453404827677,1.0,5/12,17.59%,GBE1;PGM2L1;PER2;PPP1R3C;UGP2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4299001796698402,-1.2601908857988557,0.1715210355987055,0.6357388484829148,1.0,6/18,14.77%,TEK;KRIT1;CDH5;SHTN1;RACK1;RIPOR2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3639668450429363,-1.2599109505305839,0.09278350515463918,0.6337162463906654,1.0,24/37,35.18%,ERCC5;ERCC3;UBC;POLD3;CHD1L;PCNA;DDB2;GTF2H2;ERCC1;GTF2H4;RFC3;UBA52;GTF2H3;POLD2;RBX1;RPA2;PARP1;RFC4;NTHL1;POLD4;RFC2;RPA3;POLK;RFC5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5373717755891791,1.2598203324150448,0.21954674220963172,0.5722675172485938,1.0,2/19,0.97%,DCN;CCBE1
prerank,negative regulation of immune system process (GO:0002683),0.5689813394731356,1.2597342918647174,0.21335268505079827,0.5718693621022832,1.0,1/16,0.36%,COL3A1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5888847196627168,1.259493371120643,0.22727272727272727,0.5718852310136381,1.0,3/12,7.61%,ADIPOQ;IGFBP5;ADAMTS1
prerank,protein localization to mitochondrion (GO:0070585),0.6037139368074851,1.259384342666676,0.2260061919504644,0.5715777338826201,1.0,6/11,20.62%,LRRK2;HK2;RALA;AKT1;MAIP1;ISG15
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.45097036159970466,1.2592630168117938,0.15168539325842698,0.5712841281474872,1.0,18/67,14.73%,FBLN2;JAK2;NRP1;DOCK1;MDK;LIMS1;CD36;CARMIL1;CDK6;SFRP1;CDC42;EPHA1;RSU1;CALR;UTRN;GSK3B;RAC1;CX3CL1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4366090083881666,1.2590089945753535,0.12861736334405144,0.5713743529871934,1.0,22/102,14.12%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;IRS1;ADCY7;INSIG2;USF1;ADCY2;CPEB1;PPARG;MYO5A;INHBB;RAB8B;DENND4C;PRKAR1B;RPS6KB1;GCK;PIK3R1;RAB10;SRC;TRIB3
prerank,pre-replicative complex assembly (GO:0036388),0.45075702234348297,1.2587675739559263,0.16459977452085683,0.5714280849782247,1.0,12/64,17.74%,PSMA7;MCM2;MCM7;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1
prerank,neuron projection regeneration (GO:0031102),0.6220085717402862,1.258519921387123,0.23076923076923078,0.5714849977417816,1.0,3/10,13.48%,PTN;NREP;RTN4RL1
prerank,ESCRT III complex disassembly (GO:1904903),0.6136055810131622,1.258415271176676,0.222397476340694,0.5705535713066786,1.0,3/10,15.31%,VPS4A;CHMP7;CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.6136055810131622,1.258415271176676,0.222397476340694,0.5705535713066786,1.0,3/10,15.31%,VPS4A;CHMP7;CHMP2B
prerank,hemopoiesis (GO:0030097),0.4403828273535812,1.2582816770408223,0.14585635359116023,0.5702596656943281,1.0,9/87,5.95%,RUNX1;RUNX2;KMT2A;RUNX3;ETV6;ZFP36L2;MEIS1;JAG1;SFRP1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4140689413053412,1.258131466091069,0.09785932721712538,0.5700396920793158,1.0,54/182,21.08%,RUNX1;RBMS3;CREB3L1;ITGB8;YAP1;APOBEC1;ATXN2;FLOT2;REL;APOE;CCR1;LGALS9;SFRP1;EMILIN1;SUB1;DLG4;CELF1;TERT;TNRC6B;FBXW7;MAP2K1;HDAC1;DICER1;SETDB1;MOV10;TGFB2;SETDB2;TNF;FGF2;SMCR8;SPI1;DDRGK1;MSR1;PSEN1;ANKRD13B;PDCD10;CCDC3;SMO;HIF1A;OLFM1;ACVRL1;PICALM;XDH;HINFP;TLE5;MTMR2;AGO2;TRIM6;FOXP1;PARP14;BMPR1A;YY1;VHL;ZC3H12A
prerank,negative regulation of developmental growth (GO:0048640),-0.3809986366435417,-1.2577827141078257,0.12093023255813953,0.6368386777743851,1.0,9/30,15.97%,MAP2;DCC;DIP2B;WWC2;ULK2;DUSP10;CDKL3;MAG;WWC1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5619889941014388,1.2570137851592507,0.21875,0.5724792129013748,1.0,7/16,16.85%,PARP3;SHLD3;SETMAR;RIF1;DTX3L;PRKDC;PNKP
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.2896969851938104,-1.256885710327867,0.0625,0.6363760304777666,1.0,46/110,21.75%,RPL34;PPP2R1A;RPL36;RPL8;PABPC1;RPS4X;RPL18A;PYM1;RPL19;RPL38;RPS21;RPL5;UPF2;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;UPF1;RPL13A;RPL35A;RPL29;RPL32;PNRC2;RPL10;RPL15;RPS27;RPL35;RPS16;RBM8A;RPL7A;RPS15;RPS29;MAGOH;RPL27;RPS13;RPS19;RPL41;RPLP1;RPL28;EIF4A3;GSPT2;RPS17
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6149382077145871,1.256764065465166,0.21543408360128619,0.5725411882294159,1.0,3/10,4.80%,DNAJB1;BAG3;NCK1
prerank,proton transmembrane transport (GO:1902600),0.4788696384467193,1.2565465944262282,0.1937984496124031,0.5725157859528902,1.0,7/36,12.91%,HVCN1;SLC9A1;ATP5PO;DMAC2L;SLC36A2;ATP6V1F;ATP6V1H
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5346613666287766,1.2563600515603077,0.21828103683492497,0.5724032855310872,1.0,6/21,17.16%,PLA1A;PLA2G12A;OSBPL5;PLA2G4A;PLA2G4E;LPCAT3
prerank,positive regulation of MAP kinase activity (GO:0043406),0.44545118092702785,1.2563211136912935,0.15753424657534246,0.5719057864660485,1.0,15/66,13.07%,IL34;EDN3;TNFSF11;LRRK2;CD40;PDGFRB;EGFR;EGF;SASH1;TAOK3;PIK3R5;FGFR1;TNF;FGF2;TRAF2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4054858426437252,1.2560675730361195,0.026052104208416832,0.5720061561063058,1.0,83/390,15.17%,ROR2;ROR1;SLC39A14;COL4A2;COL1A1;EPHA7;MMP2;SULF1;PDGFRA;GHR;FLRT2;VAV2;EFNA4;IRS1;PDGFRB;FGF7;JAK2;VAV3;SPRED1;NRP1;EGFR;KALRN;EPHB3;STAT3;BLK;ITSN1;GALNT3;DOCK1;LCP2;SPRED2;NCK1;ANKS1B;BAIAP2;PRKD2;DDR2;AP3S1;NCK2;PLAT;CDC42;EPHA1;STYK1;GIGYF2;SH2B2;ANGPT1;MERTK;ACTR2;MAPK11;FRK;SDC2;CBL;GRB2;EFNA5;GTF2F2;FRS2;NCBP2;BRK1;FGFR1;MVP;PTPRJ;PTPN2;PTK2;ATP6V1F;RHOA;SHB;VAV1;GSK3B;VEGFC;FGF2;NTRK3;UBASH3B;ATP6V1H;ABI1;PIK3R1;ATP6V1G2;GTF2F1;KIF16B;PSEN1;SRC;RAC1;AP2A2;FES;PSENEN;SETX
prerank,regulation of cell cycle phase transition (GO:1901987),0.4361960227005612,1.2554757828440504,0.14935064935064934,0.5730163223669044,1.0,34/91,25.19%,PSMA7;MAD2L1;CUL1;PLK1;ANAPC11;CDC27;SKP1;FBXW7;PSMB8;PSMA6;DBF4;PSMF1;CDKN1B;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;DDB1;PSMB1;FBXO5;PSMC6;ERCC2;UBE2E1;FZR1;PSMB4;PSMB5;ANAPC2;CDKN1A;PSMD4;PSMD7;PSMD9;PSMA4;CDC16
prerank,positive regulation of macrophage activation (GO:0043032),0.5555642508377924,1.2551726378615817,0.20294117647058824,0.5732671689055259,1.0,3/17,9.14%,LBP;TREM2;WNT5A
prerank,ephrin receptor signaling pathway (GO:0048013),0.4368349725481607,1.2545145863922438,0.15092290988056462,0.5744190615746697,1.0,24/82,16.40%,EPHA7;MMP2;VAV2;EFNA4;VAV3;KALRN;EPHB3;ITSN1;ANKS1B;NCK2;CDC42;EPHA1;ACTR2;SDC2;EFNA5;PTK2;RHOA;PSEN1;SRC;RAC1;AP2A2;PSENEN;YES1;RASA1
prerank,apoptotic process (GO:0006915),0.41420657670101213,1.2540189827544033,0.08841463414634146,0.5751809860706977,1.0,29/203,9.31%,FAP;CASP4;DLC1;TNFRSF21;IAPP;DAP;KREMEN1;TLR2;JAK2;CFLAR;CASP1;BBC3;CASP12;IFT57;HK2;BCL2;MCM2;PAEP;AHR;YARS1;BAG6;IRF1;AIFM2;CD14;RRAGC;EFNA5;CXCR4;OGT;SFRP5
prerank,dendritic cell migration (GO:0036336),0.5554047149508426,1.2539778753830304,0.2,0.5746631610146061,1.0,6/16,22.13%,CCR1;CCL5;CXCR4;TRPM4;EPS8;TRPM2
prerank,oogenesis (GO:0048477),0.568775277230193,1.2539557925066163,0.2222222222222222,0.5740967419340315,1.0,3/15,12.09%,PTN;MDK;MARF1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4459981888931017,-1.253267050774013,0.17491749174917492,0.6433347713257354,1.0,7/18,9.85%,PPP1R16B;YWHAB;ARPP19;PPP1R8;SH3RF2;INPP5K;URI1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4931347176287676,1.252643468844127,0.19472361809045227,0.5770211683641574,1.0,7/35,11.45%,CDH11;PCDHB6;PCDHB16;DCHS1;CDH6;CDH18;CDH24
prerank,cellular response to estradiol stimulus (GO:0071392),0.55925421894632,1.2521489372179202,0.21813031161473087,0.5777911460097213,1.0,4/18,11.90%,NRIP1;EGFR;SFRP1;LCOR
prerank,response to glucose (GO:0009749),0.47352496485097084,1.2520971777349075,0.18705035971223022,0.5773201312970839,1.0,9/46,12.61%,SLC39A14;ADIPOQ;TCF7L2;NKX6-1;LPL;GCK;KHK;ZBED3;ZBTB20
prerank,positive regulation of cell cycle process (GO:0090068),0.43232065045580176,1.2518281860711524,0.15177610333692143,0.5774761323960393,1.0,22/91,14.53%,SVIL;EDN3;PDGFRB;DYNC1H1;MAD2L1;INO80;EGF;XRCC3;DDX11;CDC42;E2F8;GPSM2;DRD3;DBF4;OPN1MW;CSPP1;RHOA;CEP120;BTC;GIPC1;ATRX;CDC14A
prerank,primary alcohol metabolic process (GO:0034308),0.5149765609270709,1.251803373198978,0.20974289580514208,0.5769473413411025,1.0,9/25,19.58%,CYP1B1;RDH12;RDH10;CYP1A1;ALDH3A2;PECR;ADH1A;DHRS3;GDPD3
prerank,positive regulation of B cell activation (GO:0050871),0.46575666401970955,1.2517840227787322,0.17417061611374407,0.5763896064620287,1.0,12/50,15.02%,MMP14;SH3KBP1;CD40;VAV3;BCL2;SASH3;TIRAP;SHLD3;IL7;TNFRSF4;RIF1;PAXIP1
prerank,lytic vacuole organization (GO:0080171),0.4942438533754716,1.2517500370480559,0.18853503184713377,0.5758855826526952,1.0,7/32,14.50%,ABCA1;LRRK2;HOOK2;MYO7A;CLN6;TPCN2;GAA
prerank,regulation of cell population proliferation (GO:0042127),0.40276269102967716,1.251736038017473,0.012,0.5753194186544849,1.0,103/691,11.96%,ROR2;RUNX1;GLMN;CYP1B1;COL18A1;DLC1;CXCL5;IL34;WNT2;CXCL1;OSMR;IGFBP7;PDGFRA;EDN3;YAP1;PPP1R9B;ZFP36L1;TCF7L2;SFRP4;PTN;BCL6;MEIS2;STAT1;CCAR1;GAB2;TIMP1;IRS1;PDGFRB;PRTN3;FGF7;JAK2;WNT9A;TSLP;CDKN2B;EGFR;NUAK1;STAT3;MEIS1;TBX2;FRZB;FXN;JAG1;SHH;ALDH1A2;PTEN;BCL2;AIF1;PKD2;LIMS1;CYP27B1;NCK2;NF2;CACUL1;EGF;STRN;CDK6;SFRP1;STAT5A;TGFB3;EAPP;EIF2AK2;PTPN6;CXCL10;PDS5B;GLP2R;S1PR3;EPHA1;PINX1;IRF1;ADAMTS1;CDK10;EEF1E1;FRK;CELF1;BTG1;GPNMB;S1PR2;TGFBR1;MAP2K1;HDAC1;CSNK2A1;SFRP5;IL7;BMP5;TGFB1I1;JUNB;NOP2;HMGB2;LIFR;TBX3;RERG;FGFR1;WWTR1;PTPRJ;KLF10;PTPN2;PTK2;PDPN;TGFB2;GCNT2;CALR;TIMELESS;RHOA
prerank,inhibitory synapse assembly (GO:1904862),0.5990836449464119,1.2514305655434088,0.21621621621621623,0.5755194984336071,1.0,4/11,12.48%,LGI2;NPAS4;WNT5A;FGF13
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.44141811632388894,1.2512829940746153,0.15148188803512624,0.5752937405955192,1.0,40/83,26.65%,BACH1;CCNE2;CUL1;E2F1;KHDRBS1;ACVR1;CACUL1;CDK6;CDK14;DBF4;RPS6KB1;ACVR1B;EIF4EBP1;CDK7;E2F3;CDKN1B;GSPT1;PPP6C;MAX;RCC1;LATS2;BRD4;INHBA;CDK16;FBXO5;HINFP;PLK2;CDC7;LATS1;CCNH;MNAT1;CDC6;CDKN1A;TYMS;NASP;CDC25A;BCAT1;TFDP1;CDK18;CDC34
prerank,regulation of ion transmembrane transport (GO:0034765),-0.36977011489752853,-1.2503739594656484,0.12254901960784313,0.6489280503405871,1.0,9/33,13.73%,AKAP6;WWP2;KCNJ2;WNK3;KCNJ3;KCNJ13;KCNJ10;KCNQ1;KCNJ12
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5973370487342242,1.2503503058445418,0.2448,0.5772008015179556,1.0,4/11,14.28%,STAT3;PUM1;WTIP;FMR1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4866725907395525,1.2503231836066087,0.189873417721519,0.5766953615724633,1.0,11/34,12.88%,DUSP2;DUSP5;PTPN13;PTPRZ1;PTPN6;PTPN18;PTPN1;PTPRJ;PTPN9;PTPN2;UBASH3B
prerank,catecholamine metabolic process (GO:0006584),-0.46898438083620153,-1.2493086702748477,0.17796610169491525,0.6489997211618351,1.0,5/14,19.93%,SNCAIP;PRKN;DDC;RNF180;DRD2
prerank,lipid droplet formation (GO:0140042),-0.5192889401313233,-1.2491190367643097,0.2032967032967033,0.6466906439180018,1.0,5/10,25.62%,CDS2;BSCL2;SQLE;PLA2G4C;FITM2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4999133794671189,1.2488352840453738,0.21532364597093792,0.5800099007969023,1.0,4/32,6.32%,CEMIP;XCL1;P2RX5;CXCL10
prerank,regulation of cellular component organization (GO:0051128),-0.28430529027187956,-1.248563508507913,0.045454545454545456,0.6453828008596597,1.0,41/135,18.86%,TJP1;SNCAIP;MLLT3;PLCE1;LTBP4;RIT2;CHPT1;CDH13;NRG3;HNRNPU;SPOCK1;HSP90AA1;PAK5;TFRC;HIP1R;RAPGEF2;RASGRP2;LAMTOR1;AGTR1;PACSIN1;URI1;FAM107A;RAP1A;ANKRA2;GFAP;HIP1;PINK1;SEMA4D;SSRP1;PACSIN3;ARHGEF11;TSC2;METTL4;WFDC1;STON1;EGLN2;PRKCQ;TAOK2;LAMTOR2;SOCS2;OGFR
prerank,mRNA processing (GO:0006397),-0.25068507461068823,-1.2480817741487213,0.0,0.6438895436723238,1.0,100/287,25.11%,ELAVL2;U2SURP;SRRM2;PSPC1;SFPQ;SNRNP70;DDX5;HNRNPU;RNGTT;YTHDC1;NOVA2;PRPF6;CDC40;SRSF5;SNRNP48;FRG1;WDR33;CSTF2;PPARGC1A;CWC22;SNRPN;PABPC1;NOVA1;RPRD2;AQR;HNRNPH3;ZCRB1;U2AF2;ISY1;PRPF38A;PRPF4;GEMIN2;USP49;RPRD1A;ERCC3;RALY;RBM5;CWF19L1;GCFC2;LSM6;SNRPC;PPIH;HNRNPA1;SNRPG;POLR2A;POLR2H;SRSF7;RBM19;POLR2G;PRPF40B;SRSF9;PPIL3;SNRNP27;POLR2F;ERN1;RBM17;IK;PRPF19;CWC25;RBM8A;SART1;CHTOP;SRRM4;CPSF2;LSM5;HNRNPR;MAGOH;GTF2H2;ZC3H11A;SNRPD3;HNRNPA3;SUPT4H1;CMTR1;POLR2E;HNRNPM;HNRNPA0;PRPF8;EIF4A3;SRSF3;CLP1;HNRNPL;CACTIN;POLDIP3;GTF2H4;DNAJC8;RAVER2;CPSF4;SARNP;SF3B6;SF3B5;DDX39B;TXNL4A;PDCD7;DDX46;TBRG4;DDX39A;GTF2H3;SF3A1;SF3A3;HNRNPD
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.403331552889346,-1.2480523841652886,0.17669172932330826,0.6412002670628458,1.0,7/23,12.82%,HDAC7;CCN3;NMI;TMSB4X;ADIPOR1;C1QTNF3;CYLD
prerank,regulation of cell junction assembly (GO:1901888),0.5095532279077003,1.2480048441761522,0.20026881720430106,0.5816676552980122,1.0,3/27,2.74%,RUNX1;SNAI1;SNAI2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.45199386117622453,1.2480012984665259,0.1746031746031746,0.5810730152905251,1.0,12/56,13.21%,RAD51B;EGFR;AIF1;CCND3;ANAPC11;CDC27;ADAMTS1;RPTOR;ANXA1;KMT2E;ANKRD17;NSMCE2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4387780546017572,-1.2478750632306839,0.19407894736842105,0.6389411796722855,1.0,4/16,2.77%,DMD;ATP1A2;ANK2;CALM1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.49320674630521816,-1.2474677380666388,0.19373219373219372,0.6373050879072547,1.0,4/12,14.43%,MAOA;HNMT;DDC;SMS
prerank,membrane fusion (GO:0061025),-0.3681665631416027,-1.2474279878159293,0.14056224899598393,0.6346429548284318,1.0,11/33,16.82%,DNM3;MYOF;HUWE1;NSF;DYSF;GCA;HACE1;RIMS1;DNM1L;NAPA;DNM2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5188076465109284,1.2472975670495414,0.2041958041958042,0.5823491282000053,1.0,2/22,2.90%,IL23R;XCL1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.32361174120440117,-1.2471911453923452,0.10071942446043165,0.6326019212549894,1.0,9/54,4.59%,KCNIP4;CAV1;FHL1;AKAP6;WWP2;DPP10;DPP6;KCNJ2;KCNJ3
prerank,embryonic organ morphogenesis (GO:0048562),0.4751619232894281,1.2470918984711974,0.19327731092436976,0.5823152881041953,1.0,6/42,6.69%,PDGFRA;FBN2;HOXB3;FBN1;ACVR1;FOXE1
prerank,cellular glucan metabolic process (GO:0006073),-0.5081118227400118,-1.246876153018136,0.21492537313432836,0.6307942561245514,1.0,3/11,5.04%,PRKAG2;GBE1;PYGM
prerank,MAPK cascade (GO:0000165),0.40704587970568995,1.2466623830217998,0.05321285140562249,0.5828549898948561,1.0,72/295,17.44%,PSMA7;PDGFRA;ZFP36L1;MAP4K4;TAOK1;PTPN7;RASA3;JAK1;LRRK2;ZFP36L2;PLVAP;IRS1;PDGFRB;FGF7;JAK2;DUSP5;SPRED1;EGFR;CUL1;ABHD17C;PTPN3;LGALS9;NF1;CCM2;CCL5;EGF;IL3RA;DLG4;SKP1;TAOK3;ANGPT1;MAPK11;GRB2;PSMB8;BRAP;PSMA6;MAP2K1;FRS2;CCL2;RALGDS;FGFR1;PTK2;NRK;PDE6D;PPP1CB;FBXW11;TNF;FGF13;FGF2;PSMF1;BTC;PIK3R1;RANBP9;RASAL1;ABHD17B;ZDHHC9;SETX;PSMA8;FNTB;FGF18;PSMD2;PSMD12;PSMD11;RGL1;SYNGAP1;RASA1;PSMD14;MAPK1;PTPRA;DUSP6;YWHAE;MAP3K3
prerank,regulation of DNA binding (GO:0051101),0.47027058469218813,1.2464853381005674,0.19285714285714287,0.5827169212592415,1.0,15/44,20.05%,BCL3;JAK2;E2F1;ILRUN;EGF;PPARG;MDFI;SP100;HMGB2;RSF1;SMO;NFKBIA;ZBTB7A;KDM1A;HMGA2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4160429334113884,1.246217244920099,0.11954261954261955,0.5828361904229762,1.0,35/138,18.89%,RORA;NR1H4;NCOR2;YAP1;RARB;RXRG;MAML3;TEAD3;TAF7;CREBBP;PPARG;GTF2H1;MAML2;HDAC1;TBL1X;GTF2F2;NR2F1;WWTR1;TEAD1;CDK7;E2F3;MAML1;GTF2F1;TAF4;NR6A1;MED26;NRBF2;TAF2;POLR2L;POLR2K;RBPJ;HDAC5;NR2C2;CDK9;NR3C1
prerank,regulation of phospholipase activity (GO:0010517),0.606468363873591,1.2460621531386962,0.21809369951534732,0.582677292129179,1.0,2/10,10.51%,LRP1;FGFR1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4820163945359685,1.2460140270580864,0.2,0.5821978071724272,1.0,11/35,11.84%,SULF1;SPARC;STAT1;APOE;NR2F2;NF1;APOH;PPARG;AIMP1;CCL2;PTPRM
prerank,transition metal ion transport (GO:0000041),0.49034353708887757,1.2457388751933254,0.1828358208955224,0.5823362247377932,1.0,9/35,18.03%,HEPH;CP;SLC11A2;TRPC6;SLC31A1;IREB2;SLC30A9;TTYH1;ATP7A
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4774583929742917,1.245589445550407,0.19634146341463415,0.5821814937048181,1.0,13/42,14.73%,MAP4K4;NRP1;LIMS1;CD36;CDK6;SFRP1;EPHA1;PTPRJ;UTRN;RIN2;GSK3B;RAC1;CX3CL1
prerank,cellular response to ketone (GO:1901655),0.4831399424511338,1.245510771086323,0.1901840490797546,0.5817713530788109,1.0,14/35,22.98%,SPP1;ADCY2;SFRP1;AHR;MSN;GNAI1;SPHK2;SRC;GNB1;NR3C1;PTGFR;ROCK2;NDOR1;KLF9
prerank,amino acid transport (GO:0006865),0.45989232669584984,1.2445295911743937,0.17995169082125603,0.5837895014365566,1.0,8/49,11.38%,SLC7A2;SLC38A3;SLC25A47;SLC7A7;SLC38A4;SLC36A2;SLC7A8;PDPN
prerank,heart development (GO:0007507),0.412505916014722,1.2432411789575817,0.10799584631360332,0.5865628081387246,1.0,26/150,12.59%,SCUBE1;DLC1;COL3A1;SH3PXD2B;GLI2;FLRT2;DNAAF4;CHD7;ZFPM2;CACNA1C;TBX2;SHH;FBN1;PTEN;PKD2;NF1;ACVR1;PDLIM4;TGFBR1;SALL1;BMP5;PTK2;TGFB2;CASP8;NTRK3;AKAP13
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.40987857152221224,1.2429331327273863,0.11076923076923077,0.5867547853720403,1.0,56/166,23.36%,RORA;NR1H4;NCOR2;YAP1;RARB;RXRG;TAF1D;MAML3;TEAD3;TAF7;POLR1E;CREBBP;PPARG;GTF2H1;MAML2;HDAC1;TBL1X;GTF2F2;CRCP;NR2F1;WWTR1;TEAD1;RSF1;CDK7;E2F3;MAML1;GTF2F1;POLR1B;BRF1;TAF1A;TAF4;NR6A1;MED26;NRBF2;POLRMT;TAF2;POLR2L;POLR2K;RBPJ;HDAC5;NR2C2;CDK9;NR3C1;MED1;POLR1G;ERCC2;THRA;NR1D1;NR1D2;RARG;POLR1A;NCOR1;CCNH;THRB;POLR2D;MNAT1
prerank,protein localization to plasma membrane (GO:0072659),-0.27695689263784773,-1.2427468886499153,0.05263157894736842,0.6394100515611677,1.0,32/129,9.26%,KCNIP4;ATP1B3;TSPAN5;CACNB2;BSG;ATP1B1;ACTN2;ANK2;KCNB2;CD81;EFR3B;TTC7B;DPP10;DPP6;C2CD5;EZR;GAS6;EHD4;SLMAP;RAMP1;RAPGEF2;WNK3;RAMP2;CDH1;CCDC88A;RAB3C;ZFYVE27;PACSIN1;MAP7;RAPGEF6;ANK3;INPP5K
prerank,protein localization to membrane (GO:0072657),-0.26601659131958955,-1.2424073038882322,0.0,0.6376958059626073,1.0,44/187,9.26%,KCNIP4;ATP1B3;TSPAN5;CACNB2;CAV1;SYNJ2BP;NRXN1;BSG;ATP1B1;LRRC7;ACTN2;DLG2;ANK2;KCNB2;CD81;LIN7A;EFR3B;TTC7B;DPP10;DPP6;C2CD5;SHANK3;EZR;GAS6;EHD4;SLMAP;RAMP1;CPE;AGRN;RAPGEF2;WNK3;RAMP2;CDH1;RAB3C;NRXN2;ARL3;ZFYVE27;PACSIN1;MAP7;RAPGEF6;FRMPD1;TM9SF1;ANK3;INPP5K
prerank,postsynaptic membrane organization (GO:0001941),0.5502630324179844,1.2421456929720678,0.23348017621145375,0.5882564467678111,1.0,3/17,7.01%,CEL;APOE;DLG4
prerank,positive regulation of actin nucleation (GO:0051127),-0.5025896890868671,-1.241744979338928,0.22388059701492538,0.6368642934259374,1.0,4/11,8.61%,FCHSD2;GSN;NCKAP1;WASF1
prerank,T cell differentiation (GO:0030217),0.46621825369698044,1.2415575839996065,0.1960542540073983,0.5892336306980952,1.0,9/40,13.10%,ZFP36L1;GLI3;CHD7;ZFP36L2;SHH;ANXA1;TCF7;PTPN2;SPI1
prerank,macrophage differentiation (GO:0030225),-0.46442723865265845,-1.2412218162203166,0.20923076923076922,0.6356153862265126,1.0,3/13,2.29%,IL15;BMP4;IL31RA
prerank,regulation of translation (GO:0006417),0.4138002397488651,1.2411029331569645,0.11752577319587629,0.58990445243426,1.0,37/173,16.04%,IGF2BP1;PRR16;BCL3;IGF2BP2;EIF4G2;SYNCRIP;CTIF;ATXN2;EIF4G3;PLD1;ILF3;IGFBP5;SHFL;EIF2AK2;EIF3H;CAPRIN1;GIGYF2;SAMD4A;EIF5B;NIBAN1;EIF5;FOXO3;RPS6KB1;NCBP2;GAPDH;ALKBH1;NAT10;MTIF2;TRAP1;CALR;YTHDF3;FMR1;NOLC1;GSPT1;EIF1;PRKDC;KLHL25
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4819150655424781,-1.2410469542159883,0.22189349112426035,0.6335121511078051,1.0,6/13,10.49%,TECR;ELOVL7;ELOVL5;HACD1;HACD3;HACD4
prerank,regulation of cartilage development (GO:0061035),0.5432276391696161,1.2410032842315402,0.2409972299168975,0.5895896560448994,1.0,4/18,5.17%,TRPS1;SOX5;MDK;BMP1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4377701142631313,1.2406251252122287,0.18693693693693694,0.5900729508218707,1.0,21/67,14.73%,SULF1;VAV2;VAV3;NRP1;DOCK1;NCK1;BAIAP2;PRKD2;NCK2;CDC42;MAPK11;BRK1;PTK2;RHOA;SHB;VAV1;VEGFC;ABI1;PIK3R1;SRC;RAC1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5613715736827974,1.2405824791036013,0.22418879056047197,0.5895824060829717,1.0,3/15,6.55%,NEK6;PLK1;CDC27
prerank,fatty acid metabolic process (GO:0006631),0.42339660209799523,1.2405195002955873,0.12937433722163308,0.5891574438718155,1.0,13/115,10.01%,CEL;ADIPOQ;LIPC;ACSL4;ACADSB;CD36;PPARG;SLC27A2;ACOX1;HSD17B8;LPL;CYP1A1;ACSF2
prerank,peptide catabolic process (GO:0043171),0.5211415904666298,1.239733232839887,0.22359396433470508,0.5906719690476139,1.0,7/23,15.89%,ANPEP;CPQ;XPNPEP1;NPEPPS;ENPEP;LVRN;GGT7
prerank,granulocyte differentiation (GO:0030851),-0.42338240470287347,-1.2394637713038623,0.18596491228070175,0.6352337413047847,1.0,8/18,18.96%,LEF1;LBR;CBFA2T3;EP300;CDK4;TAL1;RXRA;DEK
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.49140800222875186,1.2391614070109305,0.21530479896238652,0.5916438952296267,1.0,14/30,22.60%,NCOR2;KLK2;SFRP1;PIAS2;HEYL;HDAC1;SAFB2;SMARCA4;ZBTB7A;KDM1A;FOXP1;RNF14;PKN1;NCOR1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.39929853381271635,1.238940857647991,0.007,0.5915525230371693,1.0,112/572,14.46%,RUNX1;NR1H4;TRPS1;RUNX3;ZEB2;POU5F1;GLI2;ZEB1;ETV6;NCOR2;YAP1;DEAF1;TCF7L2;NRIP1;SNAI1;ATXN1;GLI3;BCL6;MEIS2;STAT1;RARB;IRF7;BACH1;GATA6;SNAI2;ZFPM2;FHL2;DNAJB1;NKX6-1;MITF;CRYM;ARID5B;SMAD2;NFIX;MIER2;SUFU;MLIP;GLIS1;STAT3;CGGBP1;TBX2;USP9X;NR2F2;ARID5A;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;BAG3;PRDM2;PPID;TAF7;HIVEP1;RNF2;CREBBP;CBX8;PPARG;PLK1;ETV5;ENO1;ZHX2;MDFI;FOXE1;E2F8;NOC2L;BHLHE40;FRK;SP100;HDAC1;ZBTB5;SALL1;FOXO3;TBL1X;DICER1;FOXP4;PRDM1;NR2F1;MTA2;CXXC5;TGIF2;TBX3;EID1;FNIP1;CBFB;GATAD2B;KLF10;ELK4;ZGPAT;PHF21A;DNMT3B;CALR;LCOR;TNF;DUSP26;SKOR2;GLIS3;SPI1;RIF1;GATAD2A;CTCF;SMAD3;DACT1;PSEN1;KCNIP3;ATRX;TRIB3;DRAP1;TFAP2C;SMAD4;MAFK
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4766582072822401,1.2388529721483583,0.19974226804123713,0.5911947188814032,1.0,11/37,13.72%,DYNLL1;IFT57;IFT88;PCM1;DYNC2LI1;TRIP11;WDR35;TNPO1;IFT172;IFT81;DYNC2H1
prerank,regulation of potassium ion transport (GO:0043266),-0.3711278676556739,-1.238825625014016,0.14746543778801843,0.634298285593503,1.0,6/31,2.68%,KCNIP4;FHL1;ACTN2;ANK2;DPP10;DPP6
prerank,transcription preinitiation complex assembly (GO:0070897),0.5719931125938916,1.2381655054747467,0.23270440251572327,0.5924419412394684,1.0,3/12,7.00%,TAF7;POLR1E;BDP1
prerank,synaptic vesicle localization (GO:0097479),-0.4646174788226284,-1.2372712614808299,0.21367521367521367,0.6358941203851077,1.0,7/13,19.82%,RAB27A;SYNDIG1;SNAPIN;TOR1A;SYNJ1;DNM2;NLGN1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.4010604878188066,1.2371767963622045,0.026,0.5943979011172418,1.0,96/509,13.29%,ROR2;ROR1;DCN;ADIPOQ;MAP3K14;TRIML2;PDGFRA;NEK6;IAPP;TCF7L2;TNFSF11;NOS1AP;GAB2;TLR2;ALPK1;CD40;IRS1;PDGFRB;FGF7;JAK2;BIRC3;CFLAR;CASP1;EGFR;P2RX5;REL;TREM2;RICTOR;LITAF;BBC3;IKBKE;MIOS;SLC20A1;PUM1;UNC5CL;BCL2;PRKD2;LGALS9;NOD1;LIMS1;TRIM21;CCL5;EGF;STRN;EIF2AK2;PTPN6;PIK3AP1;HPSE;TLR7;SASH1;VAPA;PIK3R5;RPTOR;TIRAP;TRIM13;ANGPT1;TMEM106A;CD14;TRIM8;CBL;GRB2;RRAGC;TGFBR1;WNT5A;FRS2;IRAK4;OASL;WLS;EDA2R;CXXC5;GAPDH;TNFRSF1A;FGFR1;FNIP1;TRIM44;PTPRJ;PTK2;TGFB2;CASP8;GCNT2;ANKRD17;UNC5B;SPRY2;RHOA;VAV1;TNF;FGF2;NTRK3;AKAP13;MC1R;RASD2;TRAF2;SMCR8;SPHK2;BTC;PIK3R1
prerank,fat cell differentiation (GO:0045444),0.45220425451951685,1.2369882129003107,0.17249417249417248,0.5943330710154426,1.0,10/57,8.71%,ADIPOQ;STEAP4;TCF7L2;MAFB;TMEM120B;OSBPL11;PPARG;INHBB;PID1;PSMB8
prerank,sulfur compound biosynthetic process (GO:0044272),0.4297747832919032,1.2368942841230086,0.15352260778128285,0.5939976667254816,1.0,27/104,16.06%,DCN;LUM;CHSY3;BGN;PAPSS2;B4GALT5;CHST13;VCAN;MGST1;AKR1A1;ST3GAL3;METTL16;PRELP;ANGPT1;CHSY1;CHST11;GSTK1;ST3GAL1;CHST1;GGCT;UGDH;SLC35D2;SLC35B3;CHPF2;B4GALT2;GGT7;CNDP2
prerank,visual perception (GO:0007601),0.43407323723931757,1.2368612839871032,0.16100766703176342,0.5934761149627105,1.0,8/84,9.31%,COL18A1;COL1A1;RGS16;COL11A1;RDH12;MYO7A;RDH10;SFRP5
prerank,positive regulation of transferase activity (GO:0051347),0.41260032204206715,1.2366501473857638,0.1336116910229645,0.593429940673459,1.0,18/142,8.40%,ROR2;ROR1;EPHA7;ADIPOQ;PDGFRA;PARM1;PDGFRB;ARRDC4;EGFR;EPHB3;TREM2;DDR2;PLK1;EPHA1;ARRDC3;MERTK;DCUN1D1;FBXW7
prerank,amino acid import across plasma membrane (GO:0089718),0.5078068756836904,1.2359946580833103,0.21174863387978143,0.5945921686816336,1.0,2/24,0.63%,SLC7A2;SLC1A3
prerank,ncRNA transcription (GO:0098781),0.561983146949502,1.2349327732076298,0.2569230769230769,0.5968346314495332,1.0,6/13,20.16%,SNAPC3;USPL1;GTF3A;BRF1;RPAP2;POLR1G
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.44423119089127716,1.2345001277581313,0.1983568075117371,0.5973588579032614,1.0,11/57,12.29%,IL23R;GHR;CD40;JAK2;TSLP;STAT3;NF2;CCL5;TNFRSF1A;PTPN2;TNF
prerank,regulation of cholesterol esterification (GO:0010872),0.5973723946383704,1.2342238058292172,0.24394184168012925,0.5974948532229333,1.0,3/10,4.34%,APOE;ABCA2;ABCG1
prerank,organic hydroxy compound transport (GO:0015850),0.48284585523961,1.2341301972965366,0.1962962962962963,0.5971545278532345,1.0,6/36,11.69%,NR1H4;ATP8B1;SLC10A6;NPC2;SLC10A1;SLCO1B1
prerank,epithelial to mesenchymal transition (GO:0001837),0.46625516481147167,1.2337268747552765,0.1941747572815534,0.5976297089979977,1.0,19/47,20.05%,SNAI1;SNAI2;LIMS1;DDX17;HEYL;TGFBR1;WNT5A;TBX3;LOXL3;FGFR1;TGFB2;GSK3B;DLG5;BMP7;HIF1A;OLFM1;RBPJ;TASOR;HMGA2
prerank,early endosome to late endosome transport (GO:0045022),0.5335336599378719,1.2334078811117901,0.2453900709219858,0.5978192912774807,1.0,10/20,21.89%,HOOK2;RAB7A;PTPN23;EEA1;ANKRD27;KIF16B;PIK3C3;HOOK1;BECN1;RAB5A
prerank,kidney development (GO:0001822),0.44058423136450997,1.2333111184443029,0.19279907084785133,0.597460228352886,1.0,13/65,11.44%,SULF1;GLI2;ROBO2;ITGA8;SHH;NF1;IFT88;BAG6;TGFBR1;GREB1L;SALL1;NPHP3;TGFB2
prerank,cellular response to nutrient levels (GO:0031669),0.43890377152901144,1.2330049417221038,0.17194570135746606,0.5977241967876061,1.0,25/62,24.69%,LRRK2;WIPI1;CDKN2B;SFRP1;CD68;INHBB;LAMP2;RPTOR;RRAGC;FADS1;LPL;FNIP1;KLF10;ATG7;STK24;WDR45;SREBF1;EIF4G1;ZFYVE1;PDK4;CLEC16A;VPS41;BMPR2;RALB;XBP1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5713836395326332,1.232466046952831,0.251088534107402,0.5986828298326529,1.0,2/12,5.41%,CLTC;TAF7
prerank,P-body assembly (GO:0033962),0.5775579998500577,1.2323439743755666,0.2336874051593323,0.5984351406391362,1.0,2/12,4.11%,ATXN2;DYNC1H1
prerank,embryonic organ development (GO:0048568),0.45039482481071313,1.232339992729628,0.19332566168009205,0.5978507210868772,1.0,13/61,12.29%,KMT2A;GLI2;COL13A1;GLI3;RARB;TBX2;TEAD3;PBX3;FOXE1;SALL1;TEAD1;TGFB2;TNF
prerank,regulation of Golgi organization (GO:1903358),0.5330165796520593,1.2319428022680636,0.2503617945007236,0.5983381804305623,1.0,8/17,17.54%,MYO5A;MAP2K1;CAMSAP2;AKAP9;PDCD10;ARMH3;MAPK1;RAB33B
prerank,smooth muscle cell differentiation (GO:0051145),0.5707096451904544,1.2317948196214867,0.23159509202453987,0.598130211065676,1.0,3/12,2.70%,TBX18;MRTFA;GATA6
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.5000607167348856,1.2317233242671386,0.21138211382113822,0.5977479433701339,1.0,2/27,0.63%,SLC7A2;SLC1A3
prerank,negative regulation of centrosome duplication (GO:0010826),-0.49406327386145715,-1.2316868427490273,0.23415977961432508,0.6486183029081322,1.0,8/11,30.67%,TRIM37;MDM1;CDK5RAP2;KAT2A;CCNF;BRCA1;TMEM67;NPM1
prerank,regulation of heart contraction (GO:0008016),-0.29221900358322545,-1.2315683191670337,0.0625,0.6463476933036942,1.0,20/90,14.38%,ATP1A2;ATP1B3;ATP1B1;ANK2;CELF2;CALM1;ITPR2;ATP2B4;ATP2B2;SLC8A3;ABCC9;NPR1;ITPR3;DMPK;FXYD6;PDE4D;KCNQ1;KCNJ12;ATP2A3;STIM1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5987927936659657,1.2315374158467645,0.2626728110599078,0.5976282423324323,1.0,7/10,25.76%,ST6GAL1;ST3GAL1;AMDHD2;GNPDA2;NPL;GNE;GNPDA1
prerank,synapse assembly (GO:0007416),0.44624173808546735,1.2312755187677829,0.1871476888387824,0.5977277489704229,1.0,16/67,12.66%,LGI2;SLITRK6;PCDHB6;PCDHB16;FARP1;SDK2;NPAS4;ADGRL3;PTEN;FZD1;PLXND1;WNT5A;DSCAM;DBNL;FGF13;SDK1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5510385372360255,1.2311397296958373,0.23706896551724138,0.596894192873808,1.0,4/15,8.24%,AP3B1;AP3S1;DTNBP1;AP3D1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5510385372360255,1.2311397296958373,0.23706896551724138,0.596894192873808,1.0,4/15,8.24%,AP3B1;AP3S1;DTNBP1;AP3D1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4582892976087567,1.2305800956394748,0.2158273381294964,0.5978229392684563,1.0,11/47,11.67%,MID1;MAP4K4;TAOK1;EGFR;LGALS9;RAP2A;EIF2AK2;TAOK3;MAP2K1;TGFB2;NBR1
prerank,negative regulation of cellular component organization (GO:0051129),0.43286437924811516,1.2303167062954858,0.16704035874439463,0.5979804253565543,1.0,13/74,12.44%,FAP;NR1H4;IAPP;DNAJB1;IRAK3;AIDA;CARMIL1;CDC42;SNX33;DNAJB6;SPRY2;TNF;GSK3B
prerank,respiratory tube development (GO:0030323),0.48971624850548456,1.2300728626384083,0.23404255319148937,0.5980074721389235,1.0,9/28,12.48%,GLI2;FGF7;SHH;BAG6;ITGA3;LOXL3;NPHP3;PDPN;FGF2
prerank,cellular response to interleukin-15 (GO:0071350),0.5607023281246996,1.2293692106003804,0.23413897280966767,0.598655393878416,1.0,4/13,8.42%,JAK1;STAT3;STAT5A;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5607023281246996,1.2293692106003804,0.23413897280966767,0.598655393878416,1.0,4/13,8.42%,JAK1;STAT3;STAT5A;GRB2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.48135854867643135,1.2291435630922611,0.2103960396039604,0.5986666099314315,1.0,11/34,19.09%,TNFAIP3;IRAK3;TREM2;LY96;RAB7B;CD14;NLRP2B;SMPDL3B;MFHAS1;CD300LF;TYRO3
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.45491686188950237,1.2291232398690122,0.20278099652375434,0.598126179950077,1.0,20/56,20.69%,PMEPA1;ACVR1;TGFB3;INHBB;EMILIN1;TGFBR1;BMP5;BMPER;TGFB2;LDLRAD4;ACVR2A;BMP7;SMAD4;SNX25;ACVRL1;INHBA;PIN1;GDF9;GDF11;BMPR1A
prerank,regulation of ion transport (GO:0043269),-0.2971789003066801,-1.2282664356645085,0.09259259259259259,0.6532603100800123,1.0,16/76,10.54%,WWP2;PRKN;NKAIN2;KCNJ2;KCNJ3;PER1;NKAIN3;NKAIN4;KCNJ13;CA2;SIK1;KCNJ10;NKAIN1;SYT7;ANK3;RAB11B
prerank,regulation of receptor internalization (GO:0002090),0.4769175168125253,1.228139610669486,0.20149253731343283,0.600149494083289,1.0,10/35,14.82%,SFRP4;ATXN2;EGF;DLG4;ANGPT1;ARF1;ANKRD13B;MKLN1;FMR1;CD63
prerank,organic acid transport (GO:0015849),0.4234025831564287,1.2279710637379335,0.15846994535519127,0.5999987616789835,1.0,15/94,11.76%,NR1H4;SLC7A2;SLC38A3;ATP8B1;SLC10A6;SLC25A47;SLC7A7;SLC38A4;SLC13A5;SLC36A2;SLC7A8;SLC10A1;PDPN;SLCO1B1;SFXN5
prerank,positive regulation of cellular process (GO:0048522),0.3946974534032624,1.2277501588217643,0.016,0.6000376696256124,1.0,107/565,14.73%,IBSP;HP;HPR;CXCL5;IL34;WNT2;LBP;OSMR;PDGFRA;LRP1;MMP14;EDN3;CXCL12;ZFP36L1;COLEC12;EIF4G2;PTN;MEIS2;CCAR1;GAB2;TLR2;TIMP1;IRS1;PDGFRB;PRTN3;FGF7;PRKCA;KLHL22;TSLP;EGFR;P2RX5;TREM2;MEIS1;TBX2;DYNC1H1;FXN;MDK;SHH;PTEN;BCL2;AIF1;PRKD2;RHOD;PABIR1;TRIM21;CD36;INO80;CACUL1;CCL5;EGF;ATM;SFRP1;LRP6;TGFB3;EAPP;PTPN6;CDC42;GLP2R;S1PR3;EPHA1;TENM4;RPTOR;TRIM13;MERTK;CELF1;S1PR2;RAD23A;EXOSC4;TGFBR1;FKBP1B;WNT5A;HDAC1;CSNK2A1;IL7;DICER1;BMP5;NOP2;PPP3CA;LIFR;TBX3;FGFR1;WWTR1;PTPRJ;PTK2;CSPP1;PDPN;TGFB2;GCNT2;CALR;ANKRD17;TNF;VEGFC;FGF2;NTRK3;DUSP26;P2RX7;BTC;DDRGK1;POFUT2;GAREM1;EGR2;CDKN1B;FMR1;PDCD10;TRPM4;RAC1;CX3CL1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.43925381456881385,1.227021791112191,0.18807339449541285,0.6014346454504665,1.0,21/66,21.82%,TNFAIP3;JAK2;CASP1;STAT3;LGALS9;CD36;PYDC1;TMEM106A;LPL;WNT5A;CASP8;TNF;NLRP2B;P2RX7;CX3CL1;CPTP;PANX1;FOXP1;ZC3H12A;SIRPA;NLRP12
prerank,actin polymerization or depolymerization (GO:0008154),0.45715916087040476,1.2269435999001566,0.21009389671361503,0.6010581286660542,1.0,13/50,14.73%,GAS7;SVIL;JAK2;AIF1;ABI2;TTC17;SPIRE1;PREX1;VILL;ARHGAP6;MICALL2;ABI1;RAC1
prerank,regulation of centrosome duplication (GO:0010824),0.4961349009358985,1.2267729679350534,0.20561941251596424,0.6009260762719442,1.0,8/29,15.31%,CEP295NL;CHMP4B;ALMS1;XRCC3;NAT10;CEP120;CENATAC;CHMP2B
prerank,regulation of nervous system process (GO:0031644),-0.42490562617135985,-1.2264370403048388,0.18596491228070175,0.6557030492843929,1.0,5/18,5.11%,DLGAP1;HTR2C;NOS3;DLGAP2;SLC8A3
prerank,muscle contraction (GO:0006936),-0.2728968571950174,-1.2261555004564855,0.023255813953488372,0.653836428683224,1.0,23/126,14.49%,SORBS1;DMD;ACTN2;MYOF;CALM1;DTNA;SNTA1;TMOD3;MYL6;SNTB1;SORBS3;GLRA1;BDKRB2;DYSF;ADRA1A;VCL;MYL9;MYOM1;LMOD1;KCNJ12;ACTA2;TPM2;ARHGEF11
prerank,regulation of GTPase activity (GO:0043087),0.40482064389571015,1.2259096888180272,0.13074565883554648,0.6026653648193174,1.0,37/177,12.76%,CCL11;CCL7;RGS16;MAP4K4;VAV2;ARHGAP15;LRRK2;CD40;PRTN3;VAV3;XCL1;PLXNC1;EPHB3;ASAP3;NF1;LIMS1;FGD4;CCL5;SFRP1;EPHA1;PLXND1;RSU1;ZC3H15;RRP1B;PLXNA3;EFNA5;SNX18;RABGAP1;RAB3GAP2;CCL2;MAPRE2;PTK2;SNX9;FGD6;VAV1;GSK3B;RGS10
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.41915203105811777,1.2258688103458737,0.14507772020725387,0.6021940402827166,1.0,30/136,16.25%,CYP1B1;DAP;TCF7L2;SFRP4;CMKLR1;TNFAIP3;XCL1;SUFU;IRAK3;NFKBIE;PKD2;TRIM21;RNF2;MDFI;IRAK2;BHLHE40;PYDC1;HEYL;SP100;SFRP5;ERBIN;TNFRSF4;NLRP2B;COMMD7;SPI1;BMP7;TRIB1;PAXIP1;ITCH;RBCK1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.44833368504030874,1.2258539634515662,0.19366626065773446,0.6016429612855312,1.0,12/50,12.29%,TLR2;EGFR;LGALS9;NOD1;LIMS1;EIF2AK2;TLR7;SASH1;CD14;TRIM44;RHOA;TNF
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.4907641052557684,1.225814115031885,0.22666666666666666,0.6011556402134114,1.0,2/29,2.90%,IL23R;XCL1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.3890939018322654,-1.2254585860090943,0.21223021582733814,0.6530444719166234,1.0,6/23,14.31%,PLCE1;AGMO;LPGAT1;LPIN1;DGAT1;GPAT4
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5174873168132686,1.225337622215125,0.22340425531914893,0.6018461964190402,1.0,11/21,21.39%,ADAM19;PRTN3;MYH9;SPPL3;PSEN1;PSENEN;RBMX;NCSTN;ADAM9;PSEN2;HM13
prerank,regulation of osteoblast differentiation (GO:0045667),0.43079048527963637,1.2252815944003153,0.16501650165016502,0.6014122573002306,1.0,17/82,11.90%,RUNX2;FBN2;YAP1;TNN;SNAI2;CCN4;NELL1;SUFU;DDR2;ACVR1;CDK6;PPARG;TMEM119;WWTR1;PTK2;NBR1;ACVR2A
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4566455837248408,-1.2252369999441215,0.20504731861198738,0.6509820541364275,1.0,4/13,14.26%,TMSB4X;SIN3A;PER2;HEY2
prerank,regulation of mitochondrial fission (GO:0090140),0.5011991565276678,1.2252054197486895,0.23570432357043236,0.6010178525987401,1.0,5/24,8.71%,DCN;LRRK2;RALA;SPIRE1;INF2
prerank,regulation of hormone secretion (GO:0046883),0.5574069816315715,1.2247702470447908,0.23823529411764705,0.6016708521892646,1.0,2/15,8.96%,EDN3;ANXA1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4990885935012107,1.2243816072592728,0.22467532467532467,0.6021304922871759,1.0,10/30,17.22%,SFRP4;FSTL1;SMAD2;NREP;SMURF2;ITGA3;SMAD3;SMAD4;LATS2;TRIM33
prerank,protein polymerization (GO:0051258),0.4464129492210474,1.2243609476292687,0.20501138952164008,0.6015940905115673,1.0,20/55,20.38%,GAS7;JAK2;CHMP4A;CHMP4B;AIF1;TTC17;SPIRE1;PREX1;ARHGAP6;FGF13;MICALL2;UBE2K;RAC1;TPPP;CKAP5;MSRB1;PIN1;RNF135;WASHC5;TRIM6
prerank,BMP signaling pathway (GO:0030509),0.44398207165242354,1.2243179659307266,0.20642201834862386,0.6011259279416172,1.0,21/62,20.88%,RUNX2;SMAD2;USP9X;ACVR1;HIVEP1;TGFB3;SMAD5;BMP5;TGFB2;ACVR2A;SMAD3;BMP7;SMAD4;SMAD1;SMURF1;CHRD;ACVRL1;ZFYVE16;GDF9;BMPR1A;RGMB
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4295935648497237,1.2241451152828393,0.2031425364758698,0.6010022522191261,1.0,17/70,13.29%,ANTXR1;LAMB1;LAMC1;PEAK1;ITGA8;NRP1;SIPA1L3;EPHB3;PARVA;OPHN1;EPHA1;ABI2;LAMC3;RHOA;MICALL2;SPI1;PIK3R1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.5025316533470058,-1.2240345413751317,0.22546419098143236,0.6517900909387135,1.0,3/10,7.68%,RB1;HSP90AA1;SORL1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.30343422751954724,-1.2233798466375494,0.0970873786407767,0.6509673929197753,1.0,22/71,16.43%,CERT1;PPM1L;ACER2;ST3GAL5;CERS4;SGMS1;SPTLC2;SPTLC1;ELOVL7;SGMS2;ELOVL5;DEGS2;SPNS2;B4GALT6;HACD1;HACD3;HACD4;ST6GALNAC5;SGPP1;ASAH2;SMPD2;PRKD1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.48262329868240345,1.2233750851398904,0.2335958005249344,0.6023908930734856,1.0,4/32,6.32%,CEMIP;XCL1;PKD2;CXCL10
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5192304227538281,1.2229593284069071,0.23480662983425415,0.6028505788233322,1.0,9/20,18.23%,SNAI1;SNAI2;HEYL;TGFBR1;TBX3;TGFB2;OLFM1;ACVRL1;RBPJ
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5210994968186331,1.2224114857390211,0.23226703755215578,0.6037720711332326,1.0,9/21,22.46%,MAD2L1;PTEN;PLK1;SKP1;RAB1A;RPL11;FBXO5;CDC14B;FZR1
prerank,positive regulation of cell differentiation (GO:0045597),0.4019708762267976,1.222212486996079,0.08695652173913043,0.6036954999345268,1.0,62/237,19.37%,RUNX2;COL1A1;ZEB1;EDN3;FBN2;YAP1;ZFP36L1;TCF4;SNAI1;SOX5;PTN;CMKLR1;CCN4;NELL1;SMAD2;FRZB;MDK;DDR2;ACVR1;ASXL2;CD36;SFRP1;PPARG;TGFB3;CDC42;TMEM119;CARM1;HEYL;MAPK11;BTG1;LPL;TGFBR1;TGFB1I1;FGFR1;WWTR1;PDPN;TGFB2;GCNT2;ACVR2A;RHOA;RIN2;WDFY2;MSR1;SMAD3;BMP7;SMAD4;TRPM4;FES;IL6R;CTNNA1;TCF3;OLFM1;ACVRL1;AKT1;AAMDC;PAX8;AGT;FBXO5;AXIN2;LRP5;CTNNBIP1;VWC2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.43347043183190515,-1.2221676739949656,0.2236024844720497,0.6516280487340338,1.0,5/15,10.39%,ARL6IP1;REEP1;ZFYVE27;RAB18;TMEM170A
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5848799299818572,1.2217531012685123,0.25199362041467305,0.6043550122832281,1.0,7/11,23.73%,SETDB1;SETDB2;PPHLN1;RESF1;ATF7IP;TASOR;MPHOSPH8
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4489586709633041,1.2214950254373504,0.2009400705052879,0.6044625717603932,1.0,11/47,11.80%,FBLN1;NRP1;DOCK1;MDK;LIMS1;CARMIL1;CDC42;EFNA5;PTK2;PDPN;CALR
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.33263261180103065,-1.2213827785499978,0.15300546448087432,0.6512116721372733,1.0,9/46,6.60%,ATP1A2;NRXN1;GRM7;GRM1;DGKI;SHANK3;GRM8;GRM3;CACNG2
prerank,cellular response to hydroxyurea (GO:0072711),0.600302429507458,1.221079602181172,0.253125,0.6049249282571073,1.0,4/10,14.28%,DDX11;TIMELESS;ATRX;FMR1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.39544799186996527,-1.2209588970495444,0.1821705426356589,0.6497383966978392,1.0,16/24,29.80%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;SEMA4D;SEMA5A;SEMA5B;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5062465280293755,1.2209008899212273,0.22526041666666666,0.604809335827404,1.0,4/26,12.24%,LBP;TLR2;TIRAP;PJA2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.501346632958876,1.2201453240250688,0.2398921832884097,0.6062717805730304,1.0,12/26,22.60%,NCOR2;SFRP1;PIAS2;HEYL;HDAC1;CALR;CLOCK;SMARCA4;ZBTB7A;FOXP1;CNOT2;NCOR1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4089183981123903,1.2197705163388564,0.14736842105263157,0.6067095655710564,1.0,28/122,14.28%,PRR16;BCL3;GLI2;TLR2;IRS1;PDGFRB;JAK2;DNA2;PLD1;EGFR;PRKD2;EGF;BRPF3;SAMD4A;NMD3;TMEM106A;NIBAN1;RPS6KB1;CCL2;SLC25A37;NAT10;TGFB2;GCK;FGF2;HSPH1;CTC1;YTHDF3;FMR1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3730436972718229,-1.219659704200699,0.18614718614718614,0.6510524315721123,1.0,15/29,22.15%,SLC4A10;MCTP1;SHISA6;CLN3;APP;CAMK2B;GRIK2;ZDHHC2;SHISA7;SYP;NCDN;SYNGR1;SLC8A2;DRD2;SHISA9
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.44592560614197374,1.2194228378234098,0.21444954128440366,0.6070820366269455,1.0,22/54,21.92%,CD40;PRKCA;APOE;AKT3;PRKD2;NF1;PPARG;STAT5A;ANGPT1;FGFR1;TNF;FGF2;HIF1A;FGF18;ACVRL1;AKT1;ANGPT2;ETS1;GADD45A;ATP5F1A;EPHA2;RGCC
prerank,cellular response to hydrogen peroxide (GO:0070301),0.48303766898759803,1.2193327195559869,0.21492921492921493,0.6067569398121014,1.0,7/33,15.17%,CYP1B1;TNFAIP3;FXN;ANXA1;NFE2L2;RIPK1;SETX
prerank,mitotic sister chromatid segregation (GO:0000070),0.4213333001262345,1.2189456273616766,0.15952890792291222,0.6072671130804983,1.0,18/98,9.35%,KIFC1;EML4;SMC1A;KLHL22;CHMP4A;CHMP4B;NAA50;KMT5A;TUBG1;INO80;PLK1;PDS5B;VPS4A;PINX1;PDS5A;CSNK2A1;CSNK2A2;EML3
prerank,negative regulation of viral process (GO:0048525),0.449015260243582,1.2187681905508918,0.2143698468786808,0.6071801470138778,1.0,12/57,12.29%,TNIP1;STAT1;UBP1;ILF3;TRIM21;SHFL;CCL5;EIF2AK2;TRIM13;TRIM8;OASL;TNF
prerank,detection of mechanical stimulus (GO:0050982),0.5255242967683478,1.2186822053091324,0.24133148404993066,0.6068432339985803,1.0,6/19,18.83%,PIEZO2;PKD2;PTK2;PKD1L3;LHFPL5;PIEZO1
prerank,regulation of vacuole organization (GO:0044088),0.5226556354745693,1.2177913005638359,0.23226703755215578,0.6086401330135427,1.0,13/20,27.83%,NPRL2;IFT88;ENO1;ADPRH;MTMR3;MTM1;IFT20;RAB5A;TBC1D12;ENO3;ANXA2;SCARB2;ENO2
prerank,cochlea morphogenesis (GO:0090103),0.5945773434518026,1.2176898174501847,0.2519201228878648,0.6083345272670384,1.0,3/10,11.96%,TBX18;HOXA1;MYO3A
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.462597123260624,1.217591045119542,0.2326478149100257,0.6080100934058971,1.0,10/37,21.21%,APOD;ADCY7;TREM2;STAT3;PLD4;TNF;HIF1A;IL17RA;ZC3H12A;SIRPA
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.4951368210648886,1.2171275253606855,0.2472972972972973,0.6086480265196403,1.0,7/24,18.23%,CREB3L1;CREB3L3;NFE2L2;HSPA5;HIF1A;ATF4;RBPJ
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.43496285510988825,1.2169620073425456,0.18715995647442873,0.6085215025862416,1.0,15/76,16.25%,CYP1B1;DAP;CMKLR1;TNFAIP3;IRAK3;TRIM21;IRAK2;PYDC1;ERBIN;NLRP2B;COMMD7;SPI1;BMP7;ITCH;RBCK1
prerank,aortic valve morphogenesis (GO:0003180),0.49203705384747864,1.216945146216385,0.21875,0.6079975054093187,1.0,7/30,7.87%,SNAI1;ROBO2;SLIT3;SNAI2;JAG1;EMILIN1;HEYL
prerank,positive regulation of kinase activity (GO:0033674),0.4186401009219584,1.216929403267707,0.17219251336898395,0.6074657989107884,1.0,15/107,7.98%,ROR2;ROR1;EPHA7;PDGFRA;JTB;PDGFRB;EGFR;EPHB3;TREM2;LCP2;DDR2;CACUL1;EPHA1;RASSF2;MERTK
prerank,regulation of kinase activity (GO:0043549),0.42511199355585355,1.216820221639265,0.16740088105726872,0.6071726946545343,1.0,11/89,6.60%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;EGFR;EPHB3;TREM2;DDR2;NPRL2;EPHA1
prerank,stem cell development (GO:0048864),0.5419463570858508,1.2167112686008899,0.2576419213973799,0.606905232125929,1.0,5/16,17.01%,SNAI2;SHH;TAPT1;NOLC1;PTPRC
prerank,mitochondrion localization (GO:0051646),0.522183952963888,1.2156728027510457,0.25251076040172166,0.6090859200901341,1.0,4/19,11.73%,LRRK2;MARK1;TRAK1;ZBED3
prerank,neurogenesis (GO:0022008),0.4551783855401063,1.215229468669546,0.22974607013301088,0.6097061099908573,1.0,7/43,11.44%,WNT2;TRAK1;DCHS1;CDK6;ANXA1;CXCR4;TGFB2
prerank,cellular response to virus (GO:0098586),0.49353503651203745,1.2151698342175812,0.23398692810457516,0.60928017821571,1.0,11/30,21.08%,LGALS9;CCL5;CXCL10;RRP1B;MAPK11;GBF1;ARF1;FMR1;HIF1A;IRGM;ZC3H12A
prerank,microtubule anchoring at centrosome (GO:0034454),0.5920828640581938,1.214940065149683,0.2627388535031847,0.6093366586037844,1.0,5/10,22.49%,CEP19;PCM1;NIN;CCDC120;NINL
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.40908951883857037,1.2147608429938686,0.17309697601668406,0.6092451319189637,1.0,21/121,11.22%,IL34;IL23R;THBS4;TEC;GHR;CD40;FGF7;JAK2;NRP1;TSLP;TREM2;STAT3;ACVR1;CCL5;DLG4;PTPN1;ANGPT1;EFNA5;TNFRSF1A;PTPRJ;VTN
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.38841279103776744,1.2143840489760462,0.0,0.6096239290373456,1.0,376/1646,18.67%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;KMT2A;CREB3L1;ADIPOQ;SOHLH2;TRPS1;RUNX3;ZEB2;POU5F1;CXXC1;SPP1;MDFIC;PAX1;BCL3;GLI2;ZEB1;SBNO2;ETV6;NCOR2;DAP;YAP1;MED13L;DEAF1;TCF7L2;TCF4;SNAI1;TBX18;SOX5;ATXN1;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;BAZ1A;STAT1;EGR3;CCAR1;ERN2;CHD7;ZMIZ1;IRF7;ATP8B1;BRIP1;BACH1;GON4L;GATA6;FGF7;MAFB;SNAI2;ZFPM2;XCL1;RCOR1;NPAS4;BATF;NKX6-1;RXRG;PHC2;MITF;ZNF496;ARID5B;SMAD2;NFIX;SUFU;EGFR;ZIC4;REL;TLE1;PRRX2;BHLHE22;UBP1;GLIS1;APOE;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;ZBTB10;SOX21;HOXB3;ELF4;ILF3;NR2F2;ABCA2;ARID5A;TRAK1;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;CAMK2D;PHF1;PHF2;MYBL1;KHDRBS1;VGLL3;SP110;PRDM2;CEBPD;SMARCC1;CCNL1;BAZ2B;ACVR1;HIVEP2;PBX3;LIMS1;TAF7;SCMH1;SP140;TCF12;HIVEP1;FOXK2;EGF;CREBBP;FZD1;SFRP1;PPARG;LRP6;RUNX1T1;YAF2;CDK14;ZNF292;STAT5A;ZBTB48;TGFB3;ETV5;ENO1;ZHX2;SFMBT1;ZNF250;MBD1;EHMT1;AHR;PRICKLE1;PIAS2;TSHZ3;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;SUB1;ZBTB12;GTF2H1;DDX17;ARNT;RNF111;IRF1;NFE2L3;BHLHE40;TADA2B;CARM1;NEK4;HEYL;CREB3L2;CCAR2;EPC2;BTG1;ZMYND15;HOXA1;POU2F1;FADS1;ZFHX4;SAP18;SP100;BAHD1;TGFBR1;OGT;ZNF182;AHRR;MAP2K1;WNT5A;HDAC1;ZBTB5;SALL1;NONO;FOXO3;TBL1X;ZSCAN22;ZBTB38;ARID1B;SMAD5;FOXP4;UBE2L3;PRDM1;NR2F1;TGFB1I1;JUNB;NOP2;HMGB2;TGIF2;ZIC1;ACVR1B;TBX3;LOXL3;TCF7;BRWD1;NEUROD6;EID1;WWTR1;CBFB;TRIM44;TEAD1;FOXN2;KLF10;BBX;LIN54;CHD2;KMT2E;ELK4;RSF1;RUVBL1;NFE2L2;ZGPAT;SAFB;TGFBRAP1;CALR;TIMELESS;SP3;LCOR;TNFRSF4;SPTY2D1;ARID4B;E2F3;MED13;NIF3L1;SETDB2;MAP3K2;FBXW11;TNF;KDM2A;ZSCAN21;HOXB2;KLF6;NAB2;FGF2;ZBTB20;NKX2-8;SKOR2;KMT2B;ELK1;COMMD7;NSD3;GLIS3;SNX5;FOXJ3;NFKB2;SPI1;BRPF1;TFCP2L1;SAFB2;GATAD2A;CTCF;SMAD3;PSEN1;IRF9;BMP7;ATRX;EGR2;TRIB3;DRAP1;WTIP;CDKN1B;USP22;ZFP62;LCORL;HOXB5;TFAP2C;SMAD4;MAFK;DTX3L;NIPBL;MMS19;BAZ2A;NAA15;SMAD1;BNC2;TSC22D4;PHC3;SRCAP;CREB3L4;CREB3;PATZ1;NR6A1;CCNT1;HIF1A;MED26;TRIM56;PHF12;FBXL19;STAT5B;RELB;L3MBTL3;NPAS2;NUP35;NSD1;POU3F3;MAX;LIN9;NFXL1;ZKSCAN8;ATF7IP;CLOCK;TCF7L1;TCF3;SMARCA4;SREBF1;ACVRL1;ZNF18;MTA3;ZFHX3;HSPD1;BACH2;AKT1;HCFC2;TRIM33;NUCKS1;PHF20;ING5;CALCOCO1;THRAP3;RBFOX2;PCBD2;BRD4;ZNF445;MZF1;ZNF25;MDM2;NFE2L1;ATF4;RCOR2;PICALM;GLI1;ETS1;ZNF3;MAP3K12;RLF;RAI1;SALL3;POLR2L;LHX6;INHBA;ZSCAN29;POLR2K;BICRA;PAX8;ZBTB40;AGT;RBPJ;CDK16;ZBTB9;HDAC5;NR2C2;MXD4;SOX2;RBM15;SPEN;RBBP8;SETD3;FBXO5;HINFP;SPINDOC;KAT6B;ZBTB25;ZBTB7A
prerank,regulation of melanin biosynthetic process (GO:0048021),0.5884682455804733,1.2141751824755023,0.2791411042944785,0.6095744827076737,1.0,1/10,0.58%,ZEB2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5949185394614076,1.2140402002932282,0.26424050632911394,0.6093661516527454,1.0,4/10,18.48%,KMT5A;EHMT1;SETD2;SETD3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.49675275200427765,1.213823299631327,0.2371967654986523,0.6093792311870367,1.0,5/24,8.23%,OLR1;TNIP1;CCL5;ICAM1;MSN
prerank,positive regulation of vasculature development (GO:1904018),0.4150246377833944,1.2134845557037481,0.16757940854326397,0.6096991312648584,1.0,14/94,9.14%,RUNX1;CYP1B1;ITGB8;ADAM12;CD40;GATA6;PRKCA;HK2;PRKD2;ANGPTL4;EPHA1;SASH1;BTG1;WNT5A
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3671415230151993,-1.2134706140515439,0.16591928251121077,0.6661510644543563,1.0,18/31,20.52%,EPHA4;TANC2;SRCIN1;SHANK3;ARHGAP44;CUX2;NGEF;PDLIM5;CAMK2B;LRP8;ZDHHC15;ABI3;KIF1A;RELN;DHX36;CFL1;NLGN1;PPFIA2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5947504679627722,1.2134650410828893,0.2575039494470774,0.6091933046695541,1.0,3/10,10.79%,MAP4K4;FGF7;MAPRE2
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4896120407642443,1.2133340258083576,0.2574123989218329,0.6089632087619751,1.0,10/26,20.32%,NOS1AP;APOE;POR;CYP27B1;TERT;TNF;HIF1A;AKT1;ATP7A;GDNF
prerank,cellular protein modification process (GO:0006464),0.3893001524398559,1.2131728675000384,0.005,0.6088469763135745,1.0,269/982,21.18%,PSMA7;CCL11;CEL;C3;COL3A1;ENAM;RUNX3;KNG1;SPP1;PARP8;IGFBP7;NEK6;LAMB1;PARP3;PDXP;PLOD2;MAP4K4;TEC;TAOK1;PTPN7;JAK1;B4GALT5;LAMC1;PEAK1;ERN2;DUSP2;FBXO40;CP;LRRK2;WIPI1;TIMP1;IGFBP4;JAK2;VCAN;SPSB1;UGCG;DUSP5;PRKCA;FSTL1;PRKCSH;KLHL22;MARK1;NUAK1;IRAK3;RAB2A;APOE;FBXL7;STK36;RBBP5;CALU;ILF3;IGFBP5;WSB2;IKBKE;DCAF10;CUL1;AKT3;FBN1;CAMK2D;PTPN3;PTPN13;PTEN;PRKD2;ST3GAL3;ACVR1;MORC3;FAM20A;DDOST;CDK6;ATM;PTPRZ1;CDK14;EIF2AK2;PLK1;PLAT;PTPN6;ALG5;PPP4R1;DAPP1;ATG3;FN3KRP;PTPN18;MIA3;LOXL1;KLHL13;SKP1;TAOK3;PTPN1;DCLK1;CDK10;NEK4;MERTK;PXK;CKAP4;FRK;DCUN1D1;SDC2;MAST2;PRKAR1B;MAN2A1;FBXL18;FBXW7;FBXO30;CHML;PSMB8;UBE2F;PSMA6;ANXA1;TGFBR1;MAP2K1;CSNK2A1;MGAT4A;MAP4K5;TNC;HIPK3;UBE2L3;LTBP1;SSH1;PPP3CA;ACVR1B;CDC42BPA;CCL2;STT3A;PPP2R2A;FGFR1;PPP2R5A;PTPRJ;PTPN9;ST3GAL1;ARF4;SOCS5;DCAF11;YWHAZ;NEURL2;FBXO7;NRK;CSNK1G2;TGFB2;GMFB;GCNT2;PPP4R2;PTPRM;CDK7;ACVR2A;PHKA2;COQ8B;ATG7;PPP1CB;FBXW11;MMP15;MAML1;GSK3B;CSNK1A1;DUSP26;PSMF1;ACVR1C;ILKAP;KCTD7;SSH2;ADPRH;RAB1A;MAP3K6;FBXO2;MKNK1;CTTNBP2NL;STK24;DAPK2;ZDHHC6;SIRT3;COPS6;TRIB1;RABGGTB;PMM2;PIK3R4;PSMA8;TIMM50;B4GALT7;CCNT1;FNTB;HIF1A;PPP6C;PRKAB1;FBXL19;PSMD2;RPN1;PRKDC;GRK4;PSMD12;WDR45;COG7;KLHL25;PSMD11;PIGH;PIGT;YES1;STK4;FAM20B;TNKS2;PIK3C3;B3GNT9;OBSL1;PSMD14;ACVRL1;PTAR1;CSNK1D;PTPRC;PTPN5;MAPK1;PTPRA;AKT1;DUSP6;LATS2;DNAJC3;CDKL1;DDB1;MTMR3;TYK2;EIF2AK3;TESK2;PSMB1;FBXW4;MAP3K12;SIK3;FCGR3A;CDK16;FUT4;ASB3;RHBDD1;CDK9;SETD3;FBXO31;AGA;HSP90B1;DCAF8;PHEX;MTMR2;EVA1A;MTMR6;FAM20C;PDIA6;FBXO32;FBXL22;LGALS1;MAN2A2;MTM1;ASB6;UBL5;SHISA5;CDK13;CDC14B;DUSP11;RAB8A;PSMC6;PLK2;UBE2E1;PRKCD;COPS3;ISG15;PARP14;PARP4;BMPR1A;PDK4;DCAF4;USP25;MAP3K20;VHL;CDK12;DYRK1A;PIGK
prerank,regulation of lipid catabolic process (GO:0050994),-0.41065740463479183,-1.2131275155168835,0.22333333333333333,0.6644511550198655,1.0,6/19,22.92%,ALK;BSCL2;PDE3B;ADRA2A;PRKAA1;TYSND1
prerank,epithelium development (GO:0060429),0.4156251079819005,1.2124230997303578,0.17822838847385272,0.6102851793798874,1.0,18/107,11.80%,WNT2;STAT1;GATA6;SNAI2;JAK2;TBX2;ERRFI1;SHH;ALDH1A2;PKD2;PPARG;SALL1;CTSB;LOXL3;CNN3;GSTK1;RCN3;TIMELESS
prerank,protein transport (GO:0015031),0.39362673062000325,1.212300386905549,0.08425275827482448,0.6100261659571349,1.0,83/332,18.76%,LTBP2;ABCA1;CLTC;LRP1;SEC31A;VMP1;COPA;AP4M1;COPZ2;STX6;AP3B1;ARRDC4;ARCN1;APOE;MYH9;ABCG1;ARFGAP3;TBC1D16;CD36;STEAP3;COPZ1;PPARG;STX17;RAB21;SNX8;STXBP1;LAMP2;TBC1D2B;COPB2;RABGAP1L;RAB8B;MIA3;LMAN2L;RAB7A;CANX;ARRDC3;AP3D1;TBC1D8B;COPG1;RABGAP1;RAB3GAP2;STXBP3;RAB32;WLS;TMEM167A;SNX33;ARF4;SEC23IP;SNX9;ATP6V1F;RCN3;CALCRL;ATP6V1H;TMED1;TBC1D1;ATP6V1G2;ADPRH;RAB1A;RAB10;ARF1;RAB34;TBC1D10B;NDC1;SNX15;STX11;CHMP2B;COG7;SNX4;ATP6V1G1;SEC13;CTSA;ATP6V1D;CTTN;RUFY1;STX1B;SCFD2;SCFD1;REP15;TVP23B;ARL5A;TMED5;SPTBN1;HSP90B1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.4813556453036508,-1.2114245053877373,0.2188449848024316,0.6665732157594468,1.0,8/12,35.85%,PSAT1;CBS;SEPHS1;PHGDH;SEPHS2;CTH;GGT1;SERINC3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5708553247131111,1.2107429020496692,0.26515151515151514,0.613605078225526,1.0,6/13,25.50%,CBLB;KPNA3;NUP35;KPNA2;KPNB1;RGPD1
prerank,sister chromatid segregation (GO:0000819),0.4812213235636814,1.2104404332497902,0.23076923076923078,0.613767969923776,1.0,6/31,6.21%,KIFC1;SMC1A;KLHL22;TUBG1;INO80;PLK1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5880709246029846,1.2104304476187564,0.2566929133858268,0.6132255985157673,1.0,2/11,3.66%,P2RX5;TREM2
prerank,neuron development (GO:0048666),0.40886911527188097,1.2103825155489758,0.15511892450879008,0.6127941924109214,1.0,19/141,7.73%,RUNX1;RUNX3;GPM6B;GLI2;LAMB1;PPP1R9B;LRP12;B4GALT5;ATXN10;UGCG;TENM3;APOE;BLK;PBX3;OPHN1;DTNBP1;TENM4;VAPA;L1CAM
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.4236517258727596,1.2103315242527755,0.20293122886133033,0.6123976795418307,1.0,20/80,15.88%,PRR16;BCL3;SLC2A13;PLD1;GSAP;ABCA2;ABCG1;SAMD4A;NIBAN1;RPS6KB1;NSMAF;TNFRSF1A;NAT10;TNF;SPHK2;SMPD3;YTHDF3;FMR1;SIRT3;PRKDC
prerank,negative regulation of MAPK cascade (GO:0043409),0.4255870153890534,1.2095260195254542,0.19094922737306844,0.614010614381981,1.0,29/87,21.21%,ADIPOQ;FBLN1;TNIP1;SPRED1;IRAK3;APOE;SPRED2;PTEN;NF1;EMILIN1;PTPN1;CNKSR3;PTPRJ;PTPN2;SPRY2;DUSP26;P2RX7;BMP7;RANBP9;SMAD4;ITGB1BP1;PTPRC;DUSP6;AGT;PIN1;SPRY4;DLG1;PRKCD;SIRPA
prerank,positive regulation of defense response to virus by host (GO:0002230),0.49063159617486296,1.2095030068814365,0.24279835390946503,0.6135106729980391,1.0,8/24,21.08%,IL23R;STAT1;TRIM44;DTX3L;CGAS;TRAF3IP2;TRIM6;ZC3H12A
prerank,actin crosslink formation (GO:0051764),0.5658807560066,1.209499733586921,0.2605421686746988,0.612952157355058,1.0,4/12,8.76%,DPYSL3;BAIAP2;AIF1;LCP1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5482416733298563,1.2085921042683603,0.25898203592814373,0.6147912811298225,1.0,1/13,0.45%,IL23R
prerank,polyol metabolic process (GO:0019751),-0.33499078134944893,-1.208223100940371,0.15625,0.6732019999322573,1.0,23/46,25.34%,PLCE1;INPP4B;CALM1;PLCB4;ITPK1;INPP5D;PLCB1;IPPK;NUDT3;ISYNA1;SLC5A3;PPIP5K1;IP6K1;SYNJ1;INPP5A;IMPA2;ITPKB;NUDT11;OCRL;PLCD4;PLCH1;INPPL1;PPIP5K2
prerank,negative regulation of protein catabolic process (GO:0042177),0.46360124847479783,1.2081036671186558,0.2222222222222222,0.6155014565143343,1.0,6/40,4.72%,TIMP1;NELL1;EGFR;IRAK3;MAD2L1;PTPN3
prerank,neural crest cell migration (GO:0001755),-0.3446951029376778,-1.20772614501257,0.165,0.6719404531133568,1.0,19/36,26.72%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;FN1;ERBB4;TBX1;SEMA4D;SEMA5A;SEMA5B;SEMA3G;RADIL;SEMA6C;SEMA4B;SOX8;SEMA3B;SEMA4A;SEMA6B
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5694389920401081,1.2076773954855462,0.2684458398744113,0.6155168240431863,1.0,6/12,23.22%,FBLN1;EFNA5;ITGB1BP1;CORO1C;SPRY4;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5694389920401081,1.2076773954855462,0.2684458398744113,0.6155168240431863,1.0,6/12,23.22%,FBLN1;EFNA5;ITGB1BP1;CORO1C;SPRY4;AP1AR
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5826346672263609,1.2075976092007212,0.26365054602184085,0.6140351287196016,1.0,5/11,15.35%,DCAKD;SLC25A16;PANK2;COASY;PANK1
prerank,coenzyme A biosynthetic process (GO:0015937),0.5826346672263609,1.2075976092007212,0.26365054602184085,0.6140351287196016,1.0,5/11,15.35%,DCAKD;SLC25A16;PANK2;COASY;PANK1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5826346672263609,1.2075976092007212,0.26365054602184085,0.6140351287196016,1.0,5/11,15.35%,DCAKD;SLC25A16;PANK2;COASY;PANK1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.44617344628480965,1.2071581409207752,0.23985239852398524,0.6146877143546697,1.0,16/43,18.89%,POU5F1;STAT3;PPARG;TERT;FOXO3;TEAD1;TGFB2;TNF;FGF2;GNL3;SPI1;SMAD3;HIF1A;SMARCA4;ETS1;NR3C1
prerank,cellular response to interleukin-2 (GO:0071352),0.5733274854866595,1.206462403704794,0.26833073322932915,0.6154109941462635,1.0,2/11,6.10%,JAK1;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5733274854866595,1.206462403704794,0.26833073322932915,0.6154109941462635,1.0,2/11,6.10%,JAK1;STAT5A
prerank,negative regulation of protein transport (GO:0051224),0.4957109542474782,1.2051923059057943,0.2480106100795756,0.6181126656516436,1.0,4/25,12.15%,ADIPOQ;APOE;DRD3;DPH3
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.36698478234947235,-1.2050581485001837,0.17307692307692307,0.6767316247445844,1.0,15/31,30.82%,GPHN;MOCS2;CYP51A1;DHRS11;LIAS;NFS1;LSS;PRLR;NOXRED1;FDFT1;PYCR2;STAR;MOCS3;PYCR3;GCH1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5053969271009273,1.2047792214634963,0.2496513249651325,0.6186479850016143,1.0,4/22,4.56%,SLC9A1;PRKCA;MLIP;CAMK2D
prerank,autophagosome organization (GO:1905037),0.43958938182987356,1.2045208656837978,0.20759193357058126,0.6187801147187685,1.0,16/50,21.19%,VMP1;WIPI1;AMBRA1;ATG3;RAB7A;ATP2A2;ATG7;PACS2;RAB1A;ATG16L1;ATG16L2;WDR45;PIK3C3;IRGM;UBXN2A;BECN1
prerank,actin filament polymerization (GO:0030041),0.4878889002247466,1.2044398724247716,0.22739018087855298,0.6184411641725741,1.0,9/29,14.73%,GAS7;JAK2;AIF1;TTC17;SPIRE1;PREX1;ARHGAP6;MICALL2;RAC1
prerank,positive regulation of programmed cell death (GO:0043068),0.3932046968261951,1.2044382834008647,0.1027190332326284,0.617880201928507,1.0,80/272,22.27%,CYP1B1;ZBP1;KNG1;IAPP;SFRP4;BCL6;CCAR1;VAV2;LRRK2;VAV3;KALRN;ITSN1;FRZB;E2F1;CTSD;NF1;PPID;FGD4;TNFRSF12A;ATM;OMA1;SFRP1;TGFB3;RASSF2;RRP1B;PHLDA1;AIFM2;EEF1E1;CCAR2;ARHGEF19;SAP18;TRIO;FOXO3;IP6K2;ARHGEF12;PREX1;CASP8;ATG7;VAV1;TNF;NLRP2B;AKAP13;ACVR1C;CALHM2;SPHK2;PSEN1;ARHGEF18;DAPK2;RIPK1;PSENEN;PAWR;SQSTM1;STK4;OLFM1;AIFM1;HSPD1;PTPA;DUSP6;LATS2;ING5;ANO6;ATF4;CLIP3;DDX20;PLEKHG2;GADD45A;HMGA2;NCSTN;UTP11;ARHGEF26;TIAM2;UBE2Z;MAP3K20;PSEN2;RPS27A;RARG;ARHGEF17;CLU;LATS1;ARHGEF1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5457198440854897,1.204424849474763,0.2551622418879056,0.6173556264196666,1.0,3/14,4.55%,ZEB1;SPRED1;SPRED2
prerank,establishment of spindle orientation (GO:0051294),0.4887669084533665,1.2040423885013936,0.23285899094437257,0.6177766921612999,1.0,8/28,15.92%,MAD2L1;PLK1;GPSM2;LLGL1;INSC;FBXW11;NDEL1;MAP4
prerank,cGMP-mediated signaling (GO:0019934),0.5481838067937281,1.2038521367010158,0.2540381791483113,0.617720433605514,1.0,3/13,5.55%,PDE3A;APOE;CD36
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4317102611051413,1.2033995791767582,0.20045300113250283,0.6183473740265526,1.0,17/66,11.83%,CDKN2B;EGFR;E2F1;PTEN;AIF1;PKD2;INO80;CDK6;CCND3;PTPN6;ADAMTS1;RPTOR;GPNMB;ANXA1;CCL2;KMT2E;ANKRD17
prerank,smoothened signaling pathway (GO:0007224),0.47637257893393914,1.2026837037339744,0.24412532637075718,0.619659362649743,1.0,4/32,4.42%,GLI2;GLI3;STK36;SHH
prerank,prostanoid metabolic process (GO:0006692),0.554411349509295,1.2025009917816596,0.2916666666666667,0.6196145203736697,1.0,2/13,7.19%,PTGES;ACOX1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4248596574996095,1.202432910015149,0.20134228187919462,0.6192420974433483,1.0,23/73,18.08%,MYO10;VAV2;VAV3;BLK;DOCK1;WIPF1;NCK1;BAIAP2;CDC42;ACTR2;GRB2;BRK1;PTK2;VAV1;ABI1;PIK3R1;SRC;RAC1;FCGR1A;WIPF2;YES1;MAPK1;FCGR3A
prerank,regulation of spindle assembly (GO:0090169),0.4876734553501013,1.2023524242492314,0.2529182879377432,0.6188860695172219,1.0,6/25,10.58%,CHMP4B;DYNC1H1;PLK1;GPSM2;EML3;SENP6
prerank,mitotic cell cycle phase transition (GO:0044772),0.3990720714576463,1.2023144385341018,0.1301715438950555,0.6184253579776049,1.0,58/203,18.90%,DYNLL1;CDKN2B;FBXL7;CHMP4B;DYNC1H1;CCNE2;CUL1;E2F1;KHDRBS1;TUBG1;ACVR1;CACUL1;ALMS1;CDK6;CCND3;CDK14;PLK1;PCM1;CDC27;HAUS3;SKP1;CEP41;CNTRL;PHLDA1;DCTN3;BORA;DBF4;RPS6KB1;PCNT;ACVR1B;PPP2R2A;EIF4EBP1;CCNB2;CDK7;CEP72;E2F3;PPP1CB;FBXW11;CCNI;CHMP7;PPME1;ACTR1A;AKAP9;CDKN1B;GSPT1;PPP6C;CEP192;MAX;RCC1;CSNK1D;LATS2;YWHAE;CKAP5;TAF2;INHBA;HINFP;EPS8;HAUS6
prerank,endodermal cell fate commitment (GO:0001711),0.5893961500416656,1.2019909232723125,0.27697262479871176,0.6187076432894343,1.0,1/10,0.60%,POU5F1
prerank,translesion synthesis (GO:0019985),-0.33129710174461724,-1.2019000412177778,0.15730337078651685,0.6831846323896216,1.0,27/42,35.18%,RCHY1;UBC;POLD3;PCNA;UFD1;FAAP20;RFC3;NPLOC4;UBA52;POLH;PARP10;USP10;POLD2;RPA2;PRIMPOL;PCLAF;POLE2;RFC4;ZBTB1;POLD4;RFC2;DTL;RPA3;POLK;USP43;SPRTN;RFC5
prerank,histone mRNA catabolic process (GO:0071044),0.5303858604512743,1.2017577385956204,0.2616279069767442,0.6188068121652881,1.0,5/15,11.16%,ATM;ERI1;EXOSC4;DCP2;XRN1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.409624807350845,1.20169728674052,0.19119226638023631,0.6184211324171895,1.0,27/100,17.55%,GLMN;NKD2;LRRK2;PABIR1;RNF144A;PLK1;PRICKLE1;BAG6;EIF3H;CCAR2;RAD23A;ARIH1;OGT;RAD23B;SOCS5;RNF19B;GSK3B;CSNK1A1;GIPC1;DDRGK1;TRIB3;RPL11;TRIB1;ZYG11B;CSNK1D;GNA12;MDM2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5251710788948861,1.201610615617412,0.268188302425107,0.6181005892602769,1.0,4/19,9.84%,STAT1;IRF7;TLR7;SETD2
prerank,lipid transport (GO:0006869),0.4154764893162097,1.201518365909262,0.18783930510314875,0.6177723452383967,1.0,19/97,13.37%,NR1H4;ABCA1;LBP;ATP8B1;UGCG;SLC10A6;APOE;ABCA2;PLTP;ABCG1;CD36;NPC2;OSBPL5;SLC10A1;PEX19;SLCO1B1;FABP5;ABCA9;ABCG4
prerank,positive regulation of cell projection organization (GO:0031346),0.40856514741102307,1.2011466150917562,0.19831223628691982,0.6182046546141355,1.0,16/115,9.14%,ROR2;ROR1;ROBO2;PTN;DPYSL3;PLXNC1;TENM3;APOE;MDK;CARMIL1;FZD1;PLXND1;DLG4;CAPRIN1;PLXNA3;WNT5A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4186368950521325,1.2006344799649349,0.20260021668472372,0.61896762628436,1.0,19/86,17.45%,CCL11;PDXP;SYNPO;NAV3;APOE;NCK1;BAIAP2;NCK2;CARMIL1;SNX9;PSEN1;AKAP9;RAC1;CX3CL1;FES;CDC42EP1;TOGARAM1;PLEK;CTTN
prerank,cell chemotaxis (GO:0060326),0.43330944382747594,1.2005019023319856,0.21882086167800455,0.618767908481943,1.0,7/60,4.50%,PDGFRA;CXCL12;EGR3;PDGFRB;NRP1;CCR1;PARVA
prerank,regulation of endocytic recycling (GO:2001135),-0.48739957645487947,-1.2000735344716575,0.23163841807909605,0.6860727203062178,1.0,5/11,10.54%,INPP5F;ACTN2;ATP9A;SORL1;RAB11B
prerank,cellular calcium ion homeostasis (GO:0006874),0.40171597670139036,1.1997936469583284,0.17065556711758584,0.6200651396829392,1.0,22/133,12.64%,CCL11;CCL7;EDN3;CXCL12;CD40;STOML2;CCR1;CAMK2D;BCL2;TRPC6;SLC24A5;CCL5;FKBP1B;ATP2A2;DRD3;PDZD8;TMEM203;ATP2B1;CALR;TPCN2;MICU2;PACS2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5026258513144009,1.1994913855161673,0.25371120107962214,0.6203455104536474,1.0,4/20,12.59%,CLTC;PID1;PPP2R5A;NUMB
prerank,positive regulation of potassium ion transport (GO:0043268),-0.3433961667696658,-1.1987062094472454,0.1925133689839572,0.6875931719798358,1.0,12/38,16.48%,FHL1;ACTN2;AKAP6;ANK2;KCNJ2;KCNJ3;KCNJ10;KCNQ1;KCNJ12;KCNN2;KCNN3;ADRA2A
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4656967705093557,1.1983920777853996,0.24615384615384617,0.6226389115752088,1.0,9/35,16.39%,DLC1;ARHGAP24;MAPKAP1;ITGA3;TGFB2;KCTD10;SPRY2;ARHGAP35;SYNGAP1
prerank,epidermal cell differentiation (GO:0009913),0.4531326250387364,1.1974554577507248,0.2391304347826087,0.6245351866228283,1.0,13/41,21.50%,GATA6;UGCG;JAG1;ANXA1;WNT5A;HDAC1;GLI1;PIP5K1A;MED1;ERCC2;ADAM9;WNT16;EPHA2
prerank,cellular response to reactive oxygen species (GO:0034614),0.43346951317272675,1.1974041705835188,0.2315668202764977,0.6241003483947373,1.0,6/59,5.01%,CYP1B1;PDGFRA;TNFAIP3;EGFR;FXN;PKD2
prerank,cardiac myofibril assembly (GO:0055003),0.5427076032919402,1.1972015396686735,0.2673559822747415,0.6240896289991729,1.0,3/15,4.03%,PDGFRA;PDGFRB;FHOD3
prerank,protein-DNA complex assembly (GO:0065004),0.4055632400329001,1.1967163744365363,0.1953781512605042,0.6247735388419946,1.0,42/116,25.08%,PSMA7;TCF4;MCM2;GTF2H1;MCM7;PSMB8;PSMA6;RAD23B;GRWD1;HMGB2;RSF1;CDK7;SPTY2D1;PSMF1;NAP1L3;ATRX;ASF1A;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;DDB1;PSMB1;KAT6B;NAP1L1;PSMC6;ERCC2;RPS27A;RPA1;CCNH;PSMB4;PSMB5;DMC1;RAD51;MNAT1;CDC6;PSMD4;ORC4;PSMD7;PSMD9;PSMA4
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4562917804561874,-1.1959881490111535,0.26461538461538464,0.6928169126992062,1.0,4/12,10.79%,ERLIN1;PIBF1;ACADL;ERLIN2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.25599453196315325,-1.1959760713086538,0.0,0.6902411689741921,1.0,82/241,25.11%,ELAVL2;U2SURP;SRRM2;PSPC1;SFPQ;SNRNP70;DDX5;HNRNPU;YTHDC1;NOVA2;PRPF6;CDC40;SRSF5;SNRNP48;FRG1;WDR33;CSTF2;CWC22;SNRPN;PABPC1;NOVA1;AQR;HNRNPH3;ZCRB1;U2AF2;ISY1;PRPF38A;PRPF4;USP49;RALY;RBM5;CWF19L1;GCFC2;LSM6;SNRPC;PPIH;HNRNPA1;SNRPG;POLR2A;POLR2H;SRSF7;RBM19;POLR2G;PRPF40B;SRSF9;PPIL3;SNRNP27;POLR2F;RBM17;IK;PRPF19;CWC25;RBM8A;SART1;CPSF2;LSM5;HNRNPR;MAGOH;SNRPD3;HNRNPA3;POLR2E;HNRNPM;HNRNPA0;PRPF8;EIF4A3;SRSF3;CLP1;HNRNPL;CACTIN;DNAJC8;RAVER2;CPSF4;SF3B6;SF3B5;DDX39B;TXNL4A;PDCD7;DDX46;DDX39A;SF3A1;SF3A3;HNRNPD
prerank,miRNA metabolic process (GO:0010586),0.5077442027976722,1.195964221843472,0.2541899441340782,0.626254046055696,1.0,7/20,19.61%,DDX17;DICER1;SND1;TUT7;PARN;BCDIN3D;AGO2
prerank,regulation of dendritic spine development (GO:0060998),-0.40927539534001567,-1.1958136436252105,0.22033898305084745,0.6880839407915503,1.0,11/19,22.05%,TANC2;CPEB3;SHANK3;GRIN3A;SHANK1;CAMK2B;LLPH;KIF1A;NLGN1;PPFIA2;MEF2C
prerank,positive regulation of interferon-gamma production (GO:0032729),0.44303931367530613,1.195196548095708,0.24009603841536614,0.6276991587871197,1.0,6/48,8.14%,IL23R;CD276;IL1R1;LGALS9;TLR7;CD14
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5641678497046209,1.1944096380427134,0.28785607196401797,0.6292762512111233,1.0,6/12,22.46%,PTEN;PLK1;SKP1;RAB1A;CDC14B;FZR1
prerank,cellular component assembly (GO:0022607),0.3946299880650386,1.1942957674095018,0.11133400200601805,0.6290384400783509,1.0,52/253,15.18%,KMT2A;GPM6B;YAP1;MYO1B;VMP1;GORASP2;FLNC;LAMC1;SKAP2;RHOJ;CD40;DPYSL3;CALD1;MITF;FSCN1;WIPF1;PARVA;LIMA1;TLCD2;BAIAP2;AIF1;PPID;RHOD;OPHN1;LIMS1;CREBBP;FZD1;CDC42;LLGL1;DLG4;BAG6;KPNA3;NOC2L;ADD2;LCP1;WNT5A;TEAD1;SNX9;YWHAZ;FBLIM1;RHOA;TSPAN4;SPG7;TRAF2;AIF1L;YTHDF3;RANBP9;VCPIP1;PDCD10;RAC1;TUBGCP4;PAWR
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4440208650483628,1.1940221314329165,0.23642943305186973,0.6292339355430677,1.0,7/48,7.06%,BCL3;IKBKE;E2F1;BCL2;ATM;BAG6;BCL2L2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4024113698386081,1.1935706161289346,0.1651186790505676,0.6298153420230937,1.0,34/149,16.63%,ROR1;TRIML2;TNFSF11;TLR2;CD40;FLOT2;CFLAR;IRAK3;STAT3;PRKD2;LGALS9;NOD1;TRIM21;CD36;EIF2AK2;IRAK2;RAB7B;TIRAP;TRIM13;TRIM8;PSMA6;WNT5A;EDA2R;EDA;TNF;NFKB2;TRAF2;DDRGK1;CX3CL1;RIPK1;RBCK1;CLOCK;LAMTOR5;TRAF5
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4208375183046819,1.1933599839627025,0.2061742006615215,0.6298358683668448,1.0,19/86,17.74%,PSMA7;BACH1;DNAJB1;BAG3;INO80;CREBBP;ARNT;PSMB8;PSMA6;NFE2L2;PSMF1;PSMA8;HIF1A;PSMD2;PSMD12;PSMD11;PSMD14;ATF4;PSMB1
prerank,regulation of insulin secretion (GO:0050796),0.41244975448353766,1.193358008119623,0.19189765458422176,0.6292825233143068,1.0,14/101,6.47%,NR1H4;CACNA1A;TCF7L2;IRS1;RAPGEF4;PRKCA;CACNA1C;BLK;ACSL4;ITPR1;KCNA5;CCL5;SFRP1;INHBB
prerank,immunoglobulin mediated immune response (GO:0016064),-0.4833318513953742,-1.1931948032308684,0.2614213197969543,0.6931145983402208,1.0,2/10,20.15%,CD81;FCER1G
prerank,cellular response to decreased oxygen levels (GO:0036294),0.42912376406225905,1.1929598071223182,0.20993227990970656,0.6297863819047084,1.0,7/65,8.34%,RORA;ZFP36L1;GATA6;CPEB1;SFRP1;NPEPPS;TERT
prerank,regulation of cell morphogenesis (GO:0022604),0.4653287645158094,1.1929159703066308,0.24744897959183673,0.6293533213822546,1.0,8/30,14.24%,SPARC;FMNL2;EFNA5;PDZD8;ZMYM4;MOV10;PDPN;WTIP
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4931229980061355,1.192613275978447,0.2479108635097493,0.6296061782414738,1.0,6/23,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4072885426013834,1.1925278722924433,0.20360551431601273,0.6292759567272025,1.0,17/110,12.75%,MC5R;ABCA1;IAPP;ADCY7;ADGRL3;RXFP2;ADCY2;ADM;CXCL10;S1PR3;GPR161;S1PR2;DRD3;LPAR3;LPAR2;CALCRL;MC1R
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3822444495093751,1.192445207725881,0.003,0.6289328009368061,1.0,408/1668,20.08%,RORA;RUNX1;NR1H4;RUNX2;DCN;KMT2A;CREB3L1;SOHLH2;WNT2;TRPS1;RUNX3;ZEB2;POU5F1;PAX1;PLAC8;GLI2;ZEB1;SBNO2;ETV6;NCOR2;YAP1;MED13L;DEAF1;TCF7L2;TCF4;NRIP1;ASXL1;SNAI1;TBX18;TNFSF11;SOX5;TNIP1;ATXN1;PRRX1;MRTFA;GLI3;BCL6;CREB3L3;SATB2;MEIS2;SLC9A1;BAZ1A;STAT1;EGR3;ZMIZ1;RARB;TLR2;IRF7;BRIP1;BACH1;CD40;GATA6;MAFB;SNAI2;ZFPM2;RCOR1;AUTS2;FHL2;NPAS4;BATF;DNAJB1;NKX6-1;RXRG;MITF;CRYM;ZNF496;ARID5B;SMAD2;NFIX;MIER2;SUFU;CDKN2B;EGFR;ZIC4;REL;MAML3;MLIP;PRRX2;BHLHE22;UBP1;GLIS1;APOE;USF1;STAT3;LITAF;CGGBP1;MEIS1;TBX2;PKNOX2;TEAD3;USP9X;ZBTB10;SOX21;HOXB3;ELF4;NR2F2;JAG1;PPRC1;ABCA2;ARID5A;TRAK1;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;CAMK2D;PHF2;MYBL1;VGLL3;NCK1;SP110;PRDM2;PTEN;CEBPD;PRKD2;PKD2;SMARCC1;CCNL1;BAZ2B;ACVR1;PPID;ASXL2;HIVEP2;PBX3;TAF7;SP140;TCF12;NCK2;HIVEP1;INO80;RNF2;FOXK2;CREBBP;ATM;CBX8;MACC1;PPARG;LRP6;ZNF292;STAT5A;ZBTB48;TGFB3;PLK1;ETV5;ENO1;ZHX2;ZNF250;CXCL10;AHR;PIAS2;MDFI;TSHZ3;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;SUB1;ZBTB12;GTF2H1;DDX17;ARNT;NOC2L;RNF111;IRF1;NFE2L3;PID1;BHLHE40;RRP1B;TADA2B;HEYL;CREB3L2;ACTR2;FRK;CRTC1;MAML2;EPC2;TNRC6B;HOXA1;POU2F1;ZFHX4;SAP18;SP100;OGT;ZNF182;AHRR;WNT5A;HDAC1;ZBTB5;SALL1;FOXO3;TBL1X;ZSCAN22;ZBTB38;ARID1B;DICER1;SMAD5;FOXP4;PRDM1;BMP5;NR2F1;MTA2;JUNB;NOP2;HMGB2;PPP3CA;PELP1;CXXC5;TGIF2;ZIC1;TBX3;TCF7;BRWD1;TNFRSF1A;NEUROD6;EID1;FNIP1;WWTR1;CBFB;TEAD1;GATAD2B;KLF10;ARF4;BBX;CHD2;MOV10;ELK4;CRTC3;RSF1;RUVBL1;NFE2L2;ZGPAT;PHF21A;DNMT3B;SAFB;ZBED3;CALR;SP3;CDK7;ACVR2A;LCOR;TET2;ARID4B;E2F3;MED13;TNF;KDM2A;ZSCAN21;HOXB2;KLF6;MAML1;GLYR1;FGF2;DUSP26;ZBTB20;MC1R;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;PIK3R1;TFCP2L1;DDRGK1;RIF1;SAFB2;GATAD2A;GTF2F1;PRDM10;CTCF;SMAD3;DACT1;PSEN1;KCNIP3;MED15;IRF9;ATRX;EGR2;TRIB3;DRAP1;MYSM1;ZFP62;LCORL;HOXB5;TFAP2C;SMAD4;MAFK;GABPB1;NIPBL;CX3CL1;RIPK1;SETX;SMAD1;RTRAF;SRCAP;CREB3L4;CREB3;PATZ1;NR6A1;CCNT1;HIF1A;MED26;PHF12;FBXL19;STAT5B;PRKDC;RBMX;PTOV1;SQSTM1;RELB;SLC30A9;NPAS2;NSD1;POU3F3;MAX;LIN9;ITGB1BP1;ZKSCAN8;CLOCK;TCF7L1;TCF3;SMARCA4;SREBF1;ACVRL1;ZNF18;MTA3;ZFHX3;HSPD1;BACH2;HCFC2;TRIM33;NUCKS1;PHF20;TCERG1;CALCOCO1;THRAP3;BRD4;ZNF445;MZF1;ZNF25;MDM2;NFE2L1;ATF4;RCOR2;GLI1;ETS1;ZNF3;RLF;PRDM4;RAI1;SALL3;LHX6;INHBA;ZSCAN29;PAX8;ZBTB40;RBPJ;DDX20;ZBTB9;HDAC5;NR2C2;NFKBIA;MXD4;SOX2;SPEN;RBBP8;CDK9;SETD3;RPAP2;HINFP;KAT6B;ZBTB25;ZBTB7A;BCAS3;ARID4A;NR3C1;TLE5;DVL2;BRMS1L;LRP5;THAP7;GADD45A;MGA;GABPA;STAT2;KDM1A;KAT7;MED12;MED1;AGO2;CCNL2;PCGF3;ELF2;CC2D1B;TMF1;RBAK;LAGE3;PIN1;CDK13;YEATS2;HMGA2;MXI1;ZNF367
prerank,regulation of hippo signaling (GO:0035330),-0.4116056995256705,-1.1923616411448246,0.23920265780730898,0.6927489887600904,1.0,9/17,23.69%,SCHIP1;CIT;MOB3B;WWC2;MARK3;WWC1;NEK8;MAP2K3;MAPK14
prerank,positive chemotaxis (GO:0050918),0.5212689054177296,1.1916445580232984,0.26795580110497236,0.6305547434720749,1.0,6/17,14.73%,FGF7;NRP1;ANGPT1;GPNMB;PTPRJ;CX3CL1
prerank,zinc ion homeostasis (GO:0055069),0.47635871884662095,1.1915880598174635,0.24444444444444444,0.6301507979374413,1.0,1/28,0.13%,SLC39A14
prerank,DNA replication (GO:0006260),0.40238171222844255,1.191477646100036,0.1955128205128205,0.6299048414378736,1.0,26/105,19.97%,RBMS1;BAZ1A;POLE3;BRIP1;DNA2;MCM2;NT5M;ATM;MCM7;ATR;DBF4;GRWD1;RNASEH2A;MCM9;TIMELESS;POLA2;REV1;RMI1;POLG;ATRIP;PNKP;ING5;RAD9A;RBBP8;KAT7;NAP1L1
prerank,regulation of interleukin-13 production (GO:0032656),0.543065381527201,1.1911876189267505,0.28703703703703703,0.6301747373267985,1.0,3/13,5.04%,TNFRSF21;TSLP;LGALS9
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5796423434572506,1.1904458539032694,0.2727272727272727,0.631562015812599,1.0,4/10,18.30%,KMT2A;SPHK2;SMAD4;HDAC5
prerank,positive regulation of lyase activity (GO:0051349),0.5425370803773255,1.1902826505165929,0.28059701492537314,0.6314122765227985,1.0,3/14,5.10%,CACNA1C;FXN;NF1
prerank,ion homeostasis (GO:0050801),-0.36651682084355836,-1.1902128650206323,0.22413793103448276,0.6965442710085756,1.0,7/30,10.82%,SLC4A10;FHL1;KLHL3;WNK4;WNK3;SLC4A8;SLC4A3
prerank,protein palmitoylation (GO:0018345),-0.35621582854983214,-1.189424238286719,0.1934156378600823,0.6961307233577839,1.0,10/30,16.77%,GLUL;ZDHHC13;ZDHHC21;ZDHHC17;ZDHHC14;SELENOK;ZDHHC5;ZDHHC15;PORCN;ZDHHC2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4920968800221456,1.189122936775067,0.25444596443228457,0.6339065622904482,1.0,8/24,14.73%,MAP4K4;NRP1;LIMS1;SFRP1;MAPRE2;PTPRJ;PIK3R1;RAC1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.43828853849149396,-1.1890736263020454,0.2379421221864952,0.6944898863725729,1.0,4/15,11.90%,ALDH4A1;GGACT;PRODH;CHAC2
prerank,regulation of cellular localization (GO:0060341),0.44224687387841677,1.1888892478587412,0.25178997613365156,0.6339599412647964,1.0,8/46,8.60%,NR1H4;LRRK2;BLK;DYNC1H1;CAMK2D;UNC13D;GOSR1;EFNA5
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4290441302666195,-1.188509501047771,0.2344632768361582,0.6910839328281292,1.0,2/15,0.40%,SORBS1;PHACTR1
prerank,stress fiber assembly (GO:0043149),-0.4290441302666195,-1.188509501047771,0.2344632768361582,0.6910839328281292,1.0,2/15,0.40%,SORBS1;PHACTR1
prerank,response to hydroxyurea (GO:0072710),0.5709662709607103,1.1884947368858403,0.2801857585139319,0.6344343085888358,1.0,5/11,19.44%,DDX11;TIMELESS;ATRX;FMR1;KAT7
prerank,regulation of cellular component size (GO:0032535),0.47312888456953733,1.1884722514042383,0.23591087811271297,0.6339324340077327,1.0,11/30,18.74%,VAV2;VAV3;PTEN;RPTOR;MSN;VAV1;RAC1;PEX11A;LAMTOR5;PICALM;EPS8
prerank,DNA geometric change (GO:0032392),0.4913494031592519,1.1875625097135614,0.26336898395721925,0.6358098282550843,1.0,6/24,10.37%,DNA2;ASCC3;DDX11;ANXA1;HMGB2;MCM9
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5502399851753126,1.1874253135930968,0.27669172932330827,0.6356170408735153,1.0,3/12,4.97%,B4GALT5;MYCBP2;PTEN
prerank,regulation of integrin activation (GO:0033623),0.530788132309354,1.1871831715170396,0.27958579881656803,0.6356695867941193,1.0,6/15,21.93%,FARP2;FBLIM1;SRC;PLEK;PIEZO1;RAP1B
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3605139170098033,-1.187099318355353,0.23949579831932774,0.6924604728640275,1.0,16/30,26.49%,LBR;MSMO1;INSIG1;ACAT2;SQLE;CYP51A1;DHCR24;IDI1;ACLY;LSS;HSD17B7;FDPS;EBP;FDFT1;NSDHL;TM7SF2
prerank,anterior/posterior axis specification (GO:0009948),0.5274857039086281,1.1869803231074891,0.2777777777777778,0.6356383696415454,1.0,3/15,10.21%,SHH;WLS;TBX3
prerank,regulation of cell death (GO:0010941),0.4090104691664175,1.1867438057258943,0.21297297297297296,0.6357246007581301,1.0,11/94,8.29%,HP;HPR;LRP1;LRRK2;CCN4;CHMP4B;NCK1;CD36;CCL5;TRIM13;CELF1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.41148195919759195,1.1867275922187699,0.21397379912663755,0.635216225488353,1.0,21/88,18.04%,MMP3;SYNPO;PRKCA;VPS4A;EMILIN1;RAB7A;TIRAP;SDC1;BRK1;FNIP1;TNF;GSK3B;SMPD3;SMAD3;BMP7;CX3CL1;PLEK;SH3GLB1;TPPP;ICE1;SLF2
prerank,natural killer cell activation (GO:0030101),0.4889526922949181,1.1859774264289795,0.2597054886211513,0.6366281628357633,1.0,7/23,21.97%,ULBP1;ELF4;BAG6;CASP8;PTPRC;KAT7;NFIL3
prerank,cellular response to insulin stimulus (GO:0032869),0.4010889478463383,1.1857363232858171,0.18769883351007424,0.636723954580108,1.0,27/124,14.12%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;IRS1;INSIG2;USF1;BAIAP2;AP3S1;CPEB1;PPARG;MYO5A;INHBB;RAB8B;DENND4C;SH2B2;GRB2;RPS6KB1;PTPN2;ATP6V1F;GCK;GSK3B;ATP6V1H;PIK3R1;ATP6V1G2;RAB10;TRIB3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41163524461532974,1.18518641103759,0.21651785714285715,0.6376039225895145,1.0,20/72,18.12%,FLRT2;FGF7;SPRED1;GALNT3;SPRED2;CBL;GRB2;GTF2F2;FRS2;NCBP2;FGFR1;FGF2;GTF2F1;KIF16B;SETX;FGF18;MAPK1;RBFOX2;POLR2L;POLR2K
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.423401689954065,1.1840503478232114,0.22701475595913734,0.640146209945986,1.0,20/65,18.20%,SH3KBP1;EGFR;ERRFI1;PTPN3;EGF;CDC42;EPS15L1;CBL;GRB2;MVP;PTPRJ;PTPN2;PDE6H;SPRY2;EPS15;BTC;NEU3;ITGA1;AKT1;AGT
prerank,receptor clustering (GO:0043113),-0.3632164205766362,-1.1837114974576628,0.22943722943722944,0.6996961860677937,1.0,6/27,6.07%,SYNJ2BP;NRXN1;LRRC7;DLG2;AGRN;NRXN2
prerank,circulatory system development (GO:0072359),0.3968737644701688,1.1834731895103165,0.20210526315789473,0.6411225501986724,1.0,22/118,12.59%,COL3A1;SH3PXD2B;GLI2;HSPG2;DNAAF4;ZFPM2;CACNA1C;SHH;FBN1;PTEN;PKD2;NF1;ACVR1;NXN;PDLIM4;FBXW7;TGFBR1;SALL1;TGFB2;CASP8;NTRK3;AKAP13
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.41918329678664745,1.183430641854344,0.22595078299776286,0.640667833694662,1.0,22/70,18.08%,MYO10;VAV2;VAV3;DOCK1;WIPF1;NCK1;BAIAP2;CDC42;ACTR2;GRB2;BRK1;PTK2;VAV1;ABI1;PIK3R1;SRC;RAC1;FCGR1A;WIPF2;YES1;MAPK1;FCGR3A
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5826018765226673,1.1831843596893241,0.29449838187702265,0.6407765007422173,1.0,1/10,0.38%,PDE3A
prerank,maintenance of protein localization in organelle (GO:0072595),0.5092232997614872,1.1827383593555845,0.2591549295774648,0.6414488566703245,1.0,7/19,17.14%,BCL3;HK2;MORC3;SKP1;TAPT1;HSPA5;AKT1
prerank,regulation of Notch signaling pathway (GO:0008593),0.4157567761150499,1.1826100413189033,0.22752497225305215,0.641226034364188,1.0,25/76,18.67%,MMP14;YAP1;ZMIZ1;EGFR;MAML3;STAT3;JAG1;EGF;CREBBP;LLGL1;MAML2;FBXW7;TSPEAR;NEPRO;GALNT11;TGFB2;MAML1;SRC;PDCD10;EGFL7;ITGB1BP1;TSPAN14;AKT1;RBPJ;ZBTB7A
prerank,negative regulation of gene expression (GO:0010629),0.38247777278395395,1.1825548110997783,0.12712712712712712,0.6408159614477247,1.0,58/302,15.67%,RUNX1;RBMS3;IGF2BP1;CREB3L1;ITGB8;NCOR2;YAP1;IGF2BP2;SYNCRIP;ZFP36L2;FLOT2;REL;APOE;ILF3;IGFBP5;CCR1;PHF1;LGALS9;METTL16;SFRP1;EIF2AK2;PTBP3;EMILIN1;CAPRIN1;GIGYF2;SAMD4A;CELF1;TERT;TNRC6B;FBXW7;GPNMB;MAP2K1;DCP2;HDAC1;RNH1;DICER1;GAPDH;SETDB1;MOV10;TGFB2;ATP2B1;DNMT3B;CALR;SETDB2;TNF;FGF2;SMCR8;SPI1;DDRGK1;MSR1;PSEN1;FMR1;PPHLN1;PDCD10;DXO;CCDC3;SMO;HIF1A
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4995882859461732,1.1824624971197175,0.2719665271966527,0.6405078128542725,1.0,5/21,8.07%,SULF1;EXT1;EXT2;HPSE;HS2ST1
prerank,regulation of BMP signaling pathway (GO:0030510),0.4190960517601745,1.1821008171122567,0.24382022471910111,0.6409133866483684,1.0,20/73,18.23%,SULF1;SFRP4;FSTL1;SMAD2;SMURF2;PPARG;HTRA3;LEMD2;ITGA3;SMAD5;BMPER;ACVR2A;SKOR2;SMAD4;SMAD1;SMURF1;CHRD;ACVRL1;TRIM33;RBPJ
prerank,epithelial cell differentiation (GO:0030855),0.41315058531031124,1.1813339496942417,0.1978021978021978,0.6423559393499125,1.0,12/88,10.94%,SCUBE1;GATA6;FSTL1;JAG1;PPARG;E2F8;DEUP1;ANXA1;HDAC1;CTSB;CNN3;GSTK1
prerank,cell junction assembly (GO:0034329),0.4064848629886321,1.1811567643284022,0.20626349892008639,0.6422579548993705,1.0,25/100,12.66%,CDH11;VMP1;SLITRK6;PCDHB6;FLNC;PCDHB16;FARP1;SDK2;ADGRL3;FSCN1;PTEN;DCHS1;OPHN1;LIMS1;CDC42;CDH6;PLXND1;GJC1;DSCAM;CDH18;CDH24;DBNL;FBLIM1;RHOA;SDK1
prerank,positive regulation of behavior (GO:0048520),-0.48709434591554535,-1.1809110227622988,0.2779220779220779,0.7053812114442337,1.0,5/10,26.29%,SGIP1;CFAP20;NLGN1;MEF2C;NR4A3
prerank,regulation of cell communication (GO:0010646),0.45583324128932584,1.1807125121210527,0.24246231155778894,0.6428618456566669,1.0,6/35,8.96%,IGFBP7;TBX18;UGCG;CAMK2D;PTPN1;ANXA1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.40703099510853863,1.1802015162605675,0.20434782608695654,0.6435891467514817,1.0,34/93,26.27%,SH3RF3;MID1;TAOK1;UNC5CL;EIF2AK2;SASH1;TAOK3;RASSF2;TIRAP;SH3RF1;EDA2R;TGFB2;PJA2;TRAF2;SPI1;PDCD10;RIPK1;TRAF5;MAPK8IP1;MFHAS1;XDH;GADD45A;DUSP15;ZC3H12A;WNT16;AXIN1;SDCBP;RELL1;TRAF3;SEMA3A;VEGFA;LTBR;MBIP;PYCARD
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3974894702869961,1.1801243234535033,0.2141350210970464,0.6432311708237373,1.0,26/110,18.04%,MMP3;ABCA1;IAPP;FARP2;APOE;AIDA;CD36;EIF2AK2;CDC42;STXBP1;TIRAP;BRK1;FNIP1;FBLIM1;TNF;GSK3B;TRAF2;SRC;HSPA5;ATF7IP;SH3GLB1;KIF9;TPPP;STX1B;ICE1;SLF2
prerank,type I interferon signaling pathway (GO:0060337),0.45429848245179666,1.179191563582011,0.2512690355329949,0.6446106034816846,1.0,9/41,9.83%,JAK1;STAT1;IRF7;IRF1;IFNAR2;PSMB8;SP100;IP6K2;OASL
prerank,cellular response to type I interferon (GO:0071357),0.45429848245179666,1.179191563582011,0.2512690355329949,0.6446106034816846,1.0,9/41,9.83%,JAK1;STAT1;IRF7;IRF1;IFNAR2;PSMB8;SP100;IP6K2;OASL
prerank,positive regulation of double-strand break repair (GO:2000781),0.45269172482775044,1.1788890885443664,0.2674846625766871,0.6448570550340875,1.0,14/39,18.04%,PARP3;DDX11;ACTR2;SHLD3;SPIRE1;SETMAR;TIMELESS;MGMT;RIF1;DTX3L;MMS19;PRKDC;PNKP;SLF2
prerank,I-kappaB phosphorylation (GO:0007252),0.5710188119042617,1.178687309197209,0.30063291139240506,0.6448456570201885,1.0,2/10,6.73%,TLR2;TLR7
prerank,aortic valve development (GO:0003176),0.4671213851999213,1.1784362355235096,0.26403061224489793,0.6449807567982315,1.0,8/34,10.46%,SNAI1;ROBO2;SLIT3;SNAI2;JAG1;EMILIN1;HEYL;TNFRSF1A
prerank,mitotic metaphase plate congression (GO:0007080),0.4328071133568603,1.1780613088811158,0.23453908984830804,0.6454292407980543,1.0,10/51,15.31%,KIFC1;EML4;CHMP4A;CHMP4B;VPS4A;PINX1;EML3;CHMP7;MAD1L1;CHMP2B
prerank,sensory perception of light stimulus (GO:0050953),0.411194523444394,1.177751480156742,0.22900763358778625,0.6456776369839455,1.0,8/87,9.31%,COL18A1;COL1A1;RGS16;COL11A1;RDH12;MYO7A;RDH10;SFRP5
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4137623277327693,1.1771070572975768,0.24179431072210067,0.6468483289377892,1.0,24/88,13.81%,CLTC;MYO1B;AP4M1;STEAP2;ARFGEF2;PUM1;RABIF;VPS13C;DNAJC6;TXNDC5;DTNBP1;MYO5A;LLGL1;EXOC4;GBF1;ACBD3;EXOC1;OSBPL5;CLINT1;EPS15;CCDC93;RAB10;KIF16B;ARF1
prerank,myeloid cell differentiation (GO:0030099),0.43931545468962163,1.1771068510415887,0.2578397212543554,0.6462982878417537,1.0,9/47,13.10%,RUNX1;JAK2;CDKN2B;TIRAP;UBA5;PTPN2;KMT2E;TET2;SPI1
prerank,protein ADP-ribosylation (GO:0006471),0.46968788665737204,1.176839966150334,0.2672998643147897,0.6464706481183108,1.0,8/28,20.64%,PARP8;PARP3;PARP11;ARF4;SIRT3;TNKS2;PARP14;PARP4
prerank,adipose tissue development (GO:0060612),0.5635180743466361,1.1763475895880933,0.31280388978930307,0.6472126330398649,1.0,2/11,3.37%,SH3PXD2B;ARID5B
prerank,platelet aggregation (GO:0070527),0.45531607944644215,1.1762943776098937,0.2780678851174935,0.6468014907462228,1.0,15/33,24.04%,PDGFRA;CSRP1;MYH9;STXBP1;STXBP3;UBASH3B;GNAS;PLEK;FERMT3;TYRO3;ACTN1;FIBP;P2RY12;ITGB3;METAP1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5237449954320538,1.1753941306024234,0.28508124076809455,0.6486287472817097,1.0,5/15,12.46%,TREM2;CD36;EIF2AK2;PYDC1;NLRP2B
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2866513889123097,-1.175309394356715,0.14655172413793102,0.7192324818679952,1.0,33/84,23.77%,KHDRBS2;QKI;DDX5;CELF2;MBNL1;HNRNPU;YTHDC1;WTAP;NOVA2;TIA1;NCL;CWC22;NOVA1;RBFOX3;U2AF2;CIRBP;RBM5;LARP7;HNRNPA1;SRSF7;DAZAP1;SRSF9;RBM8A;SRRM4;MAGOH;NUP98;FXR1;SRSF3;HNRNPL;PCBP4;RBM3;ZC3H10;CELF6
prerank,positive regulation of neuron death (GO:1901216),0.4347364137466665,1.1752244951199011,0.26102502979737785,0.6484861950662599,1.0,10/46,18.91%,EPHA7;NF1;WNT5A;FOXO3;TGFB2;TNF;GSK3B;ATF4;PICALM;PRNP
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.44592850239542836,1.1749038940996404,0.26634382566585957,0.6488012143170313,1.0,9/40,14.82%,C3;SFRP4;EGF;RAB21;ANGPT1;CBL;VTN;FMR1;CD63
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.4000762342001796,1.1748641433546438,0.200836820083682,0.6483512489054133,1.0,34/128,17.67%,DYNLL1;BACH1;CDKN2B;FBXL7;DYNC1H1;CUL1;KHDRBS1;TUBG1;ALMS1;CDK14;PLK1;PCM1;HAUS3;SKP1;CEP41;CNTRL;PHLDA1;DCTN3;BORA;PCNT;PPP2R2A;CCNB2;CDK7;CEP72;PPP1CB;FBXW11;PPME1;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;TAF2
prerank,neurotransmitter transport (GO:0006836),-0.2914622000717633,-1.1748346792661177,0.14545454545454545,0.7179786830702487,1.0,23/73,17.20%,ATP1A2;SNAP25;SYN3;UNC13B;NRXN1;GABRA2;GLUL;LIN7A;SLC1A2;SLC1A1;NRXN2;CPLX1;RIMS1;SNAPIN;DNAJC5;GAD1;SYN2;PTPRN2;LIN7C;SYNJ1;NAAA;SNPH;PPFIA1
prerank,ERBB signaling pathway (GO:0038127),0.4287473696750917,1.1745953181465143,0.2759407069555302,0.6485346651701167,1.0,17/64,14.06%,FAM83A;PRKCA;EGFR;NCK2;EGF;PTPN18;CBL;GRB2;CDC37;MVP;PTK2;ERBIN;BTC;PIK3R1;GAREM1;KIF16B;SRC
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4685034311837375,1.1743217070724725,0.27631578947368424,0.6486936266371681,1.0,11/30,23.74%,CXCL12;SNAI1;SNAI2;CCAR2;TMEM161A;MDM2;FBXO5;KDM1A;DYRK1A;CLU;THOC5
prerank,regulation of response to biotic stimulus (GO:0002831),0.47640072864120186,1.1736599391363123,0.2781456953642384,0.6499086449595984,1.0,8/28,14.73%,GATA6;BIRC3;TREM2;CD36;IRF1;TIRAP;CASP8;CX3CL1
prerank,long-term synaptic potentiation (GO:0060291),-0.3985939841557884,-1.1732082372330557,0.23703703703703705,0.7200853888167456,1.0,5/21,11.06%,SLC24A2;PRKCZ;SLC8A3;GRIN2D;GRIN2B
prerank,mRNA destabilization (GO:0061157),0.4483237780196054,1.1728932403534689,0.25970873786407767,0.6514298099824823,1.0,18/38,25.23%,ZFP36L1;ZFP36L2;PUM1;METTL16;GIGYF2;CELF1;FTO;MOV10;YTHDF3;RC3H2;TUT7;ZC3H12A;ROCK2;YTHDF2;ROCK1;POLR2D;PLEKHN1;CNOT1
prerank,negative regulation of cellular senescence (GO:2000773),0.5502162238540226,1.172502116181123,0.27518796992481204,0.6519489172683285,1.0,7/13,21.73%,AKT3;CDK6;TERT;MAP3K3;FBXO5;HMGA2;YBX1
prerank,cholesterol biosynthetic process (GO:0006695),-0.35135524326401624,-1.172292966472101,0.23605150214592274,0.7202711099599012,1.0,16/31,26.49%,LBR;MSMO1;INSIG1;ACAT2;SQLE;CYP51A1;DHCR24;IDI1;ACLY;LSS;HSD17B7;FDPS;EBP;FDFT1;NSDHL;TM7SF2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5076272864971242,1.1718245120048332,0.3027656477438137,0.6531916498262532,1.0,4/18,14.08%,DLC1;ITGA3;KCTD10;ARHGAP35
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3959436123133184,-1.1717709219448236,0.24175824175824176,0.7192424370480796,1.0,5/20,3.68%,PRKCZ;CD81;MALT1;IL18;CD55
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.340406893563458,-1.1715444088674998,0.23300970873786409,0.71733264638178,1.0,7/33,5.63%,GLUL;MTHFS;GCLC;ALDH4A1;GLUD1;SLC39A8;PRODH
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4132441971261092,-1.1713998046950587,0.22591362126245848,0.7151928198344798,1.0,4/17,1.15%,PRKAG2;PRKAA2;ADIPOR2;CAV1
prerank,positive regulation of B cell proliferation (GO:0030890),0.46932974714966863,1.1711086905450871,0.27190721649484534,0.6545215992406099,1.0,7/29,11.94%,CD40;VAV3;BCL2;SASH3;TIRAP;IL7;TNFRSF4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3879424433935205,1.1709760242479594,0.16547497446373852,0.6543435506525447,1.0,32/190,14.24%,RORA;NR1H4;PDE3A;ADIPOQ;TNIP1;STAT1;TNFAIP3;SPRED1;TLE1;TREM2;ITPR1;PTEN;BCL2;NF1;NPRL2;CGNL1;BCL2L2;NOC2L;SFRP5;OTUD3;DRD3;FNIP1;PTPRJ;CASP8;P2RX7;TANK;SPI1;DLG5;BMP7;SRC;TRIB3;WTIP
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.38677612742954,1.170857581946239,0.1707070707070707,0.6541297956409424,1.0,52/234,16.63%,ROR1;WNT2;TRIML2;TNFSF11;TLR2;CD40;FLOT2;NKX6-1;CFLAR;ARID5B;IRAK3;STAT3;STK36;IKBKE;PPRC1;SHH;PTEN;PRKD2;LGALS9;DDR2;NOD1;TRIM21;CD36;FZD1;PPARG;LRP6;EIF2AK2;IRAK2;RAB7B;TIRAP;TRIM13;CRTC1;TRIM8;PSMA6;WNT5A;EDA2R;CRTC3;EDA;TNF;NFKB2;TRAF2;DDRGK1;SMAD3;CX3CL1;RIPK1;SMO;RBCK1;CLOCK;TCF3;SMARCA4;LAMTOR5;TRAF5
prerank,positive regulation of angiogenesis (GO:0045766),0.39656037099503977,1.1704938393576723,0.20995670995670995,0.6545596659256938,1.0,16/108,9.14%,RUNX1;CYP1B1;ITGB8;ADAM12;JAK1;CD40;GATA6;PRKCA;MDK;HK2;PRKD2;ANGPTL4;EPHA1;SASH1;BTG1;WNT5A
prerank,liver development (GO:0001889),0.45922530046251464,1.1700929706462677,0.27225130890052357,0.6550589942053145,1.0,9/32,12.77%,PRKCSH;ARID5B;PHF2;PKD2;NF1;E2F8;ANXA1;NPHP3;NKX2-8
prerank,microtubule nucleation (GO:0007020),0.505830022820579,1.1693848690024324,0.276797829036635,0.6563664243008127,1.0,9/19,17.48%,TUBG1;TPX2;AKAP9;RANBP9;TUBGCP4;NDEL1;TUBG2;CSNK1D;TPPP
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.35289596085346375,-1.1693364115547158,0.20909090909090908,0.7188463539911406,1.0,5/30,4.39%,FLT1;MLLT3;KIT;BMP4;KDR
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.41338944296893865,1.1691942347963111,0.24608501118568232,0.656319154962467,1.0,22/71,18.08%,MYO10;VAV2;VAV3;DOCK1;WIPF1;NCK1;BAIAP2;CDC42;ACTR2;GRB2;BRK1;PTK2;VAV1;ABI1;PIK3R1;SRC;RAC1;FCGR1A;WIPF2;YES1;MAPK1;FCGR3A
prerank,cellular metal ion homeostasis (GO:0006875),0.39888135517018697,1.168626559429709,0.21114683815648447,0.6572434580057291,1.0,16/102,12.14%,CCL11;CCL7;EDN3;CXCL12;SLC9A1;CD40;STOML2;CCR1;SLC24A5;CCL5;ATP2A2;DRD3;TMEM203;ATP2B1;CALR;TPCN2
prerank,hexose transmembrane transport (GO:0008645),-0.38723345063399345,-1.1679470498118465,0.2196969696969697,0.7204710346147448,1.0,7/21,25.00%,SLC2A1;SLC5A3;SLC2A12;SLC45A3;SLC2A8;SLC2A9;SLC45A1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3912513032601016,-1.167922783384582,0.25390625,0.7180495989460708,1.0,4/21,4.77%,PRKCH;CD81;SLC39A10;PRKCB
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.41807773443181456,1.1678845277778107,0.25510204081632654,0.6587197969920551,1.0,16/74,18.23%,PSMA7;BACH1;CREBBP;ARNT;PSMB8;PSMA6;NFE2L2;PSMF1;PSMA8;HIF1A;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;RBPJ
prerank,positive regulation of protein polymerization (GO:0032273),0.41630192114221454,1.1678565241353005,0.2511261261261261,0.6582479617433012,1.0,15/65,18.41%,CCL11;NAV3;NCK1;BAIAP2;NCK2;CARMIL1;SNX9;AKAP9;RAC1;FES;CDC42EP1;TOGARAM1;CTTN;TPPP;CDC42EP4
prerank,neuromuscular junction development (GO:0007528),-0.37370441687918654,-1.1668682255782954,0.23076923076923078,0.7183806686751162,1.0,6/24,4.28%,UNC13C;GPHN;CACNB2;UNC13B;CACNB4;AGRN
prerank,phosphorylation (GO:0016310),0.37602498629407344,1.166797677087851,0.11823647294589178,0.6605887332162721,1.0,97/384,18.46%,CCL11;EPHA7;RUNX3;NEK6;MAP4K4;TEC;TAOK1;JAK1;PEAK1;ERN2;LRRK2;JAK2;PRKCA;MARK1;NUAK1;IRAK3;STAT3;STK36;ILF3;IKBKE;AKT3;CAMK2D;PRKD2;ACVR1;MORC3;FAM20A;CDK6;ATM;CDK14;EIF2AK2;PLK1;PPP4R1;DGKH;TAOK3;DCLK1;CDK10;NEK4;MERTK;PXK;FRK;MAST2;PRKAR1B;TGFBR1;MAP2K1;CSNK2A1;PANK2;MAP4K5;HIPK3;ACVR1B;CDC42BPA;CCL2;FGFR1;YWHAZ;NRK;CSNK1G2;TGFB2;GMFB;GK;CDK7;ACVR2A;COQ8B;MAML1;GSK3B;CSNK1A1;ACVR1C;PI4KA;SPHK2;MAP3K6;MKNK1;STK24;DAPK2;TRIB1;NADK;PIK3R4;CCNT1;PRKAB1;PRKDC;GRK4;STK4;FAM20B;ACVRL1;PNKP;CSNK1D;GNPTG;MAPK1;AKT1;LATS2;CDKL1;TYK2;EIF2AK3;TESK2;MAP3K12;SIK3;CDK16;GNPTAB;CDK9;POMK
prerank,glycerolipid catabolic process (GO:0046503),-0.3974721136444897,-1.1664356632218575,0.2635135135135135,0.7171830637819105,1.0,6/19,17.00%,GPCPD1;MGLL;ABHD6;GDE1;GDPD1;ENPP6
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4936510622611977,-1.166412338888884,0.2949061662198391,0.7147530239918904,1.0,5/10,29.16%,LPGAT1;ELOVL5;SLC45A3;MLXIPL;NR1H2
prerank,positive regulation of cellular component organization (GO:0051130),0.39290126632419586,1.1662520386628947,0.23150105708245244,0.6614774741796204,1.0,16/107,12.44%,MMP3;RUNX1;LRP1;TREM2;ASAP1;APOE;TGFB3;TIRAP;TGFBR1;BRK1;LMAN1;FNIP1;PTPN23;TGFB2;TNF;GSK3B
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3789092526627236,1.1660637525010848,0.119358074222668,0.6614491422855583,1.0,94/327,21.97%,RORA;RUNX3;POU5F1;CXXC1;SBNO2;ATXN1;CCAR1;CHD7;ZMIZ1;BACH1;GON4L;MAFB;SNAI2;MITF;SUFU;PRRX2;STAT3;SOX21;E2F1;PHF1;MYBL1;PRDM2;FOXK2;CREBBP;YAF2;AHR;BHLHE40;CARM1;CCAR2;BTG1;FADS1;TGFBR1;NONO;ZBTB38;UBE2L3;TGIF2;ACVR1B;TCF7;WWTR1;FOXN2;LIN54;TGFBRAP1;CALR;SP3;SPTY2D1;NIF3L1;ZSCAN21;NAB2;SKOR2;NSD3;NFKB2;SPI1;ATRX;DRAP1;WTIP;BAZ2A;BNC2;PATZ1;HIF1A;PHF12;NUP35;NSD1;NFXL1;CLOCK;TCF7L1;TCF3;ACVRL1;ZFHX3;HCFC2;MZF1;ATF4;NR2C2;SOX2;HINFP;KAT6B;NR3C1;TULP3;DVL2;THAP7;RPL6;KAT7;RBAK;HMGA2;NUP107;VHL;HINT1;MAGED1;NR1D2;RNF14;YBX1;ZNF423;RPS6KA4;CREM;NFIL3
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4841552218157496,1.165399202707848,0.2784636488340192,0.6621496793563557,1.0,5/24,11.60%,HK2;FOXK2;ENO1;GAPDH;GCK
prerank,canonical glycolysis (GO:0061621),0.4841552218157496,1.165399202707848,0.2784636488340192,0.6621496793563557,1.0,5/24,11.60%,HK2;FOXK2;ENO1;GAPDH;GCK
prerank,negative regulation of gluconeogenesis (GO:0045721),0.5717811141077295,1.1652004563231737,0.3001555209953344,0.6621420605832585,1.0,1/11,0.48%,ADIPOQ
prerank,transepithelial transport (GO:0070633),-0.4212860166596367,-1.16514139361459,0.2572347266881029,0.7160362303169077,1.0,5/15,3.81%,SLC12A2;ABCG2;SLC1A2;SLC1A1;CXADR
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2850344273565214,-1.1651367318693202,0.17592592592592593,0.7135852262379403,1.0,12/76,8.49%,PLCE1;CHRM2;GRM1;ACTN2;HTR2C;ADRA1B;ESR1;GPR4;GNA11;GNA14;AGTR1;ADRA1A
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4819978657412413,1.1642601029283097,0.29772079772079774,0.6640603994049636,1.0,6/22,12.29%,TIMP1;APOE;PTPN3;SNX33;SNX9;TNF
prerank,negative regulation of protein depolymerization (GO:1901880),0.4823154462305461,1.1638779224643958,0.2921195652173913,0.6645540978139781,1.0,7/24,13.76%,TAOK1;NAV3;LIMA1;TPX2;CAMSAP2;FGF13;PLEKHH2
prerank,regulation of phosphate metabolic process (GO:0019220),0.5179644411434732,1.163508806798678,0.3042212518195051,0.664996224165513,1.0,4/16,13.92%,SMG7;SMG6;MCM7;PSEN1
prerank,positive regulation of GTPase activity (GO:0043547),0.38587284096685004,1.1634476696977618,0.19734151329243355,0.6646355133279108,1.0,40/188,14.96%,CCL11;CCL7;RGS16;MAP4K4;SYDE1;CD40;PRTN3;ARHGAP24;XCL1;ARHGAP42;SIPA1L3;TAX1BP3;ASAP3;TBC1D16;NF1;LIMS1;CCL5;SFRP1;EPHA1;TBC1D2B;RABGAP1L;RSU1;ZC3H15;ARHGEF19;TBC1D8B;SNX18;RABGAP1;CCL2;MAPRE2;SNX9;GSK3B;NTRK3;RGS10;TBC1D1;ADPRH;RAB3GAP1;ARHGAP22;TBC1D10B;CX3CL1;SIPA1L2
prerank,microglial cell activation (GO:0001774),0.49703596332089783,1.1630887276032191,0.27823691460055094,0.6650185702049607,1.0,5/21,14.73%,JAK2;TREM2;AIF1;TNF;CX3CL1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5669832517548893,1.1629277112097718,0.3234323432343234,0.6643216615782916,1.0,7/10,20.54%,NSMAF;TNFRSF1A;TNF;SPHK2;SMPD3;SIRT3;PRKCD
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5669832517548893,1.1629277112097718,0.3234323432343234,0.6643216615782916,1.0,7/10,20.54%,NSMAF;TNFRSF1A;TNF;SPHK2;SMPD3;SIRT3;PRKCD
prerank,atrioventricular valve development (GO:0003171),0.5347579388912931,1.1627691783667793,0.3028919330289193,0.6642078418385722,1.0,4/14,11.44%,SLIT3;ACVR1;HEYL;TGFB2
prerank,organophosphate ester transport (GO:0015748),-0.37898847478909936,-1.162554120838724,0.24166666666666667,0.7187835962809608,1.0,6/24,9.97%,PITPNC1;LDLR;PITPNA;SCARB1;ABCA3;TNFAIP8L3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.46385046347511444,1.1624573384124663,0.2701005025125628,0.6644847725563923,1.0,2/33,0.87%,CEL;CACNA1A
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.503098656089543,1.1620576216454084,0.32805755395683456,0.6650093535438416,1.0,6/19,21.08%,TNFAIP3;PYDC1;NLRP2B;CX3CL1;CPTP;ZC3H12A
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4837990066269639,1.16184182030589,0.2968960863697706,0.6650002923308816,1.0,15/22,27.15%,SLC2A13;GSAP;ABCA2;ABCG1;TNF;RANBP9;PICALM;IFNGR1;EFNA3;CLU;ROCK2;RELA;CHRNA7;EFNA1;GSK3A
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.44097033220775583,1.1613632916767833,0.27010804321728693,0.6657150290972925,1.0,11/45,14.24%,ZFP36L1;BCL6;ZFP36L2;MAD2L1;PTPN3;TOM1L1;BTG1;GAS1;SMAD3;BMP7;CDKN1B
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.28532846336184264,-1.1610807538275232,0.13392857142857142,0.7206629253822433,1.0,21/75,12.55%,MAP2;DCC;CTNNA2;NTNG1;CNTN4;MINK1;ACTB;RB1;KLF7;SHTN1;DSCAML1;DCDC2;FGFR2;SLITRK1;PARD3;ANK3;MAP1A;APP;ZDHHC17;S100B;PAK3
prerank,cellular response to ionizing radiation (GO:0071479),0.4329978197354623,1.1597378853783353,0.2846975088967972,0.6695369619462859,1.0,16/47,21.02%,YAP1;TNKS1BP1;INO80;ATM;GRB2;ATR;TANK;NIPBL;CLOCK;NUCKS1;MDM2;RAD9A;SWI5;GADD45A;KDM1A;MAP3K20
prerank,lysine catabolic process (GO:0006554),0.554769253179143,1.1592224192691511,0.3160377358490566,0.6698364618706041,1.0,6/12,21.44%,CRYM;DLST;ALDH7A1;HYKK;PIPOX;SLC25A21
prerank,lysine metabolic process (GO:0006553),0.554769253179143,1.1592224192691511,0.3160377358490566,0.6698364618706041,1.0,6/12,21.44%,CRYM;DLST;ALDH7A1;HYKK;PIPOX;SLC25A21
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.561400128487708,1.1592170089221998,0.3076923076923077,0.6693012557371839,1.0,1/10,0.34%,DCN
prerank,long-chain fatty acid metabolic process (GO:0001676),0.4141243050501212,1.1591696953442607,0.2511111111111111,0.6688597459721835,1.0,8/64,9.08%,CYP1B1;ACSL4;EPHX2;AIG1;SLC27A2;ACOX1;FADS1;CYP1A1
prerank,regulation of gene expression (GO:0010468),0.3720555331329073,1.1587415542867447,0.046,0.6694934578110757,1.0,204/903,19.25%,RORA;RUNX1;GLMN;RBMS3;IGF2BP1;CREB3L1;TRIML2;RUNX3;POU5F1;CXXC1;ITGB8;SEC16B;C1D;SBNO2;EDN3;ADAM19;YAP1;AFF1;ZFP36L1;IGF2BP2;SFRP4;ATXN1;BCL6;NOS1AP;CD276;CCAR1;CRP;CHD7;TLR2;BACH1;GON4L;FGF7;MAFB;SNAI2;CCN4;AFF2;NELL1;FLOT2;MITF;SUFU;REL;TLE1;PRRX2;TREM2;APOE;STAT3;CGGBP1;SOX21;CCR1;SHH;E2F1;PRDM5;PHF1;MYBL1;UBR5;PUM1;PRDM2;EPHX2;AIF1;LGALS9;LIMS1;TRIM21;CD36;FOXK2;EGF;METTL16;CREBBP;CDK6;DTNBP1;ATM;SFRP1;YAF2;AHR;PTBP3;HMG20B;VSTM2A;EMILIN1;TMEM119;PID1;FUBP1;BHLHE40;RRP1B;CARM1;ANGPT1;CCAR2;MAPK11;MSN;CELF1;BTG1;TERT;TNRC6B;FBXW7;FADS1;TGFBR1;MAP2K1;WNT5A;HDAC1;NONO;ZBTB38;DICER1;UBE2L3;PRDM1;TGIF2;ACVR1B;TCF7;SETDB1;HNRNPH2;WWTR1;TRIM44;FOXN2;LIN54;MOV10;TGFB2;NFE2L2;CASP8;GCNT2;DNMT3B;TGFBRAP1;CALR;SP3;SPRY2;SPTY2D1;MARF1;SETDB2;NFKBIZ;TNF;ZSCAN21;NAB2;GSK3B;FGF2;NTRK3;SKOR2;NSD3;P2RX7;NFKB2;SMCR8;SPI1;DDRGK1;PRDM10;MSR1;CTCF;YBX3;SMAD3;PSEN1;BMP7;ATRX;DRAP1;WTIP;TFAP2C;RPL11;PDCD10;BAZ2A;SMAD1;BNC2;CCDC3;SMO;TCF19;PATZ1;HIF1A;FGF18;ADNP2;MED26;PRKAB1;PHF12;NUP35;NSD1;POU3F3;NFXL1;CLOCK;TCF7L1;TCF3;LAMTOR5;OLFM1;ACVRL1;PTPRC;MAPK1;ZFHX3;AKT1;HCFC2;CALCOCO1;MZF1;STX1B;EIF2AK3;ATF4;PICALM;ETS1;PRDM4;INHBA;USP36;RBPJ;HDAC5;NR2C2;SOX2;XDH;HINFP;KAT6B;NR3C1;TLE5;TULP3;DVL2;THAP7;MBNL2;SON;RPL6
prerank,positive regulation of hydrolase activity (GO:0051345),0.3900858174147418,1.1583717432135066,0.22536687631027252,0.669856476459281,1.0,34/137,18.77%,CCL11;CCL7;RGS16;MAP4K4;CD40;PRTN3;XCL1;ASAP3;NF1;LIMS1;CCL5;SFRP1;RSU1;ZC3H15;SNX18;HMGB2;CCL2;MAPRE2;SNX9;RCN3;RHOA;GSK3B;RGS10;RAB3GAP1;CALM2;CX3CL1;MTMR9;NDEL1;ALS2;TBC1D20;DOCK10;PICALM;CCL15;BCAS3
prerank,regulation of tube diameter (GO:0035296),-0.44716065779744224,-1.1578284662249207,0.2961876832844575,0.7252894508322766,1.0,7/13,23.37%,NOS3;GCLC;NPR1;AGTR1;ACE;ACE2;GCLM
prerank,vascular process in circulatory system (GO:0003018),-0.44716065779744224,-1.1578284662249207,0.2961876832844575,0.7252894508322766,1.0,7/13,23.37%,NOS3;GCLC;NPR1;AGTR1;ACE;ACE2;GCLM
prerank,DNA methylation or demethylation (GO:0044728),0.4980780188271804,1.1578204559859497,0.2922636103151863,0.670195663995298,1.0,8/19,18.44%,EHMT1;KMT2E;DNMT3B;GATAD2A;ATRX;BAZ2A;ATF7IP;MTRR
prerank,DNA alkylation (GO:0006305),0.4980780188271804,1.1578204559859497,0.2922636103151863,0.670195663995298,1.0,8/19,18.44%,EHMT1;KMT2E;DNMT3B;GATAD2A;ATRX;BAZ2A;ATF7IP;MTRR
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4714529032620658,1.1576327427881232,0.3046875,0.6701274915756648,1.0,8/26,20.99%,TNFAIP3;IRAK3;ILRUN;TRIM21;TRIB1;ITCH;TYRO3;LYAR
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.23787026620127089,-1.1573691697687276,0.0,0.7242644883090147,1.0,86/264,25.11%,ELAVL2;U2SURP;SRRM2;PSPC1;SFPQ;SNRNP70;DDX5;HNRNPU;YTHDC1;NOVA2;PRPF6;CDC40;SRSF5;SNRNP48;FRG1;WDR33;CSTF2;CWC22;SNRPN;PABPC1;NOVA1;AQR;HNRNPH3;ZCRB1;U2AF2;ISY1;PRPF38A;PRPF4;GEMIN2;USP49;RALY;RBM5;CWF19L1;GCFC2;LSM6;SNRPC;PPIH;DCPS;HNRNPA1;SNRPG;POLR2A;POLR2H;SRSF7;RBM19;POLR2G;PRPF40B;SRSF9;PPIL3;SNRNP27;POLR2F;RBM17;IK;SCNM1;PRPF19;CWC25;RBM8A;SART1;CPSF2;LSM5;HNRNPR;MAGOH;SNRPD3;HNRNPA3;POLR2E;HNRNPM;HNRNPA0;PRPF8;EIF4A3;SRSF3;CLP1;HNRNPL;CACTIN;DNAJC8;RAVER2;CPSF4;SNUPN;SF3B6;SF3B5;DDX39B;TXNL4A;PDCD7;DDX46;DDX39A;SF3A1;SF3A3;HNRNPD
prerank,urogenital system development (GO:0001655),0.5493464754936247,1.1573412152403781,0.3137254901960784,0.6703448522201751,1.0,3/11,8.96%,EPHB3;SHH;ANXA1
prerank,negative regulation of macroautophagy (GO:0016242),0.47717715312274783,1.1572625450754987,0.29581151832460734,0.6700363782402825,1.0,10/26,21.25%,LRRK2;CHMP4A;CHMP4B;TMEM39A;SMCR8;AKT1;SCFD1;USP36;MTM1;CLEC16A
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.562460561671531,1.1568203504980537,0.32142857142857145,0.6706339572938648,1.0,6/11,25.13%,BIRC3;CASP8;YBX3;RIPK1;FZD9;ARHGEF2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.46233967018825833,1.1566149200399765,0.2847769028871391,0.6706362093789063,1.0,11/29,18.78%,TCF7L2;TLE1;RBBP5;CREBBP;TERT;HDAC1;TCF7;RUVBL1;TCF7L1;SMARCA4;AXIN2
prerank,positive regulation of signaling (GO:0023056),0.44787098362088223,1.156457614631495,0.2803398058252427,0.6704924776922101,1.0,7/37,12.29%,ADIPOQ;EDN3;DLG4;HCRT;WLS;PTPN23;TNF
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3852827280564241,1.1563782763624386,0.20146137787056367,0.6701658232352785,1.0,34/150,14.73%,PDGFRA;IAPP;TCF7L2;GAB2;IRS1;PDGFRB;FGF7;EGFR;RICTOR;EGF;STRN;PIK3AP1;HPSE;PIK3R5;ANGPT1;GRB2;TGFBR1;FRS2;FGFR1;PTPRJ;PTK2;GCNT2;SPRY2;VAV1;TNF;FGF2;MC1R;RASD2;BTC;PIK3R1;SRC;TRIB3;RAC1;CX3CL1
prerank,DNA modification (GO:0006304),0.49083752135263414,1.1563441156670125,0.2958904109589041,0.6697063760056219,1.0,2/22,1.20%,PARP3;MPG
prerank,regulation of DNA replication (GO:0006275),0.424031624631552,1.1563052510659084,0.2855421686746988,0.6692518099083629,1.0,18/49,21.84%,GLI2;DNA2;EGFR;EGF;BRPF3;PDS5A;ATR;ZBTB38;ANKRD17;CTC1;ACVRL1;NUCKS1;GLI1;FBXO5;WAPL;KAT7;TERF1;RBBP6
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.39261257259552856,1.156257255041127,0.24119530416221985,0.6688318760323143,1.0,35/104,22.28%,PMEPA1;SPRED1;SMAD2;SMURF2;SPRED2;ACVR1;PPARG;HTRA3;EMILIN1;LEMD2;WFIKKN1;HTRA4;TGFBR1;SMAD5;TGFB1I1;BMPER;LDLRAD4;ACVR2A;SPRY2;SKOR2;SMAD3;SMAD4;SMAD1;SNX25;SMURF1;CHRD;TRIM33;ZBTB7A;VWC2;PIN1;BMPR1A;ASPN;RPS27A;SNX6;IL17RD
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5330495063337215,1.1561420119469383,0.32761310452418096,0.6686009673240085,1.0,3/12,14.04%,GCNT2;TNF;BMP7
prerank,regulation of macrophage migration (GO:1905521),-0.4616683415175794,-1.1553316690796995,0.2611111111111111,0.7277934119971592,1.0,3/10,5.86%,CD81;MTUS1;CD200
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.4957307023596988,1.1546226933982493,0.3121468926553672,0.6720971695816707,1.0,4/19,9.53%,MMP14;ZMIZ1;MDK;IL7
prerank,glial cell development (GO:0021782),0.47728117877555326,1.154327438051455,0.3071718538565629,0.6723720419734496,1.0,7/25,17.89%,TLR2;MDK;NF1;CDK6;EIF2B3;TPPP;NRROS
prerank,cardiac muscle contraction (GO:0060048),-0.3411100449602697,-1.154018849903716,0.21739130434782608,0.7292890656539007,1.0,4/34,3.22%,DMD;ATP1A2;ATP1B1;GSN
prerank,nervous system development (GO:0007399),0.3740067076174015,1.1537437396896382,0.12124248496993988,0.6733213936062306,1.0,71/429,12.76%,IGF2BP1;WNT2;ZEB2;GPM6B;CXCL1;YAP1;SLITRK6;IGF2BP2;ROBO2;RBFOX1;PCDHB6;PTN;ATXN1;MYLIP;NUMBL;CHD7;PCDHB16;FARP1;ATXN10;HPCAL4;VCAN;SDK2;NELL1;NAV1;ADGRL3;ZIC4;P2RX5;KALRN;NAV3;STAT3;JAG1;MDK;GLRB;TRAK1;SHH;MAP1S;SERF1A;PMP22;ALDH1A2;PTEN;PKD2;DCHS1;NF1;OPHN1;GDA;PTPRZ1;PLXND1;DLG4;DCLK1;L1CAM;MERTK;SCD5;EFNA5;CXCR4;TGFBR1;WDPCP;ZIC1;ACVR1B;TBX3;WWTR1;TEAD1;DSCAM;ESS2;GMFB;DBNL;NAB2;FGF13;FGF2;SDK1;ACVR1C;SPG7
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.41301301767582377,-1.1536067325170967,0.29180327868852457,0.727918374090651,1.0,7/17,21.73%,ADRA1B;ADCY9;RAPGEF2;ADRA1A;ADRA2A;DRD2;ADRB2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.42802776793597314,1.1534992414695315,0.2804733727810651,0.6734087442317457,1.0,16/51,17.22%,FSTL1;FBN1;SMURF2;PPARG;HTRA3;LEMD2;SMAD5;GREM2;BMPER;ACVR2A;SKOR2;SMAD4;SMAD1;SMURF1;CHRD;TRIM33
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.40392107279511186,1.1534519180523373,0.2644808743169399,0.6730006561221202,1.0,17/80,14.70%,CLTC;HEATR5A;STX6;TMEM87B;SNX8;RAB7A;RAB7B;GOSR1;GBF1;RAB9A;ANKFY1;LMAN1;DENND5A;SNX2;SNX5;TBC1D10B;WASHC1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4893299868604389,1.153426267874578,0.3016759776536313,0.6725258130565621,1.0,4/20,12.59%,CLTC;PID1;PPP2R5A;NUMB
prerank,histone H3 acetylation (GO:0043966),-0.3216624284658686,-1.1533144195149767,0.2019704433497537,0.7263208790337762,1.0,17/40,17.29%,LEF1;PHF14;LDB1;JADE1;PER1;BRCA2;DR1;TADA1;JADE2;WDR5;TAF6L;NAA60;JADE3;MAP3K7;KAT6A;TRIM16;SUPT7L
prerank,negative regulation of TOR signaling (GO:0032007),-0.3353449042327389,-1.1532514449795177,0.21296296296296297,0.7240904093990088,1.0,14/36,20.66%,PRKAA2;RNF152;NPRL3;DEPDC5;SESN2;SESN3;DDIT4;TSC1;SPAAR;TSC2;MINAR1;AKT1S1;TNFAIP8L1;PRKAA1
prerank,response to iron ion (GO:0010039),0.5429280866014932,1.1529890758968144,0.3333333333333333,0.6731146657905572,1.0,4/12,6.95%,SLC11A2;FXN;BCL2;ACO1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.532546987197297,1.152478635885773,0.31981981981981983,0.6739118693688539,1.0,3/13,10.24%,SEC16B;TM9SF4;SEC16A
prerank,second-messenger-mediated signaling (GO:0019932),0.40373525352790496,1.152251745416392,0.2636761487964989,0.6740139777202963,1.0,16/82,14.55%,EDN3;PPP1R9B;TNFSF11;LRRK2;APOE;CCR1;RCAN2;CD36;CXCR4;SAMD14;LAT2;HRH1;RCAN3;TPCN2;NUDT4;TRPM4
prerank,cellular response to pH (GO:0071467),0.5094899785488806,1.1515073269510183,0.31869688385269124,0.6754393426811313,1.0,2/17,2.09%,HVCN1;SLC9A1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.40244361340363544,1.1502780553270946,0.26435536294691225,0.6782191728925481,1.0,28/84,25.19%,PSMA7;MAD2L1;PLK1;ANAPC11;CDC27;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;FBXO5;FBXO31;PSMC6;UBE2E1;RPS27A;FZR1;PSMB4;PSMB5;ANAPC2;PSMD4;PSMD7;PSMD9;PSMA4;CDC16
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4557829530744809,1.1502528198739361,0.29708222811671087,0.6777473416015973,1.0,12/29,21.63%,ARRDC4;PLK1;ARRDC3;DCUN1D1;FBXW7;UBE2L3;TRIB3;DTX3L;FBXO5;DCUN1D5;PIN1;AXIN1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3863079023303204,1.149896439498366,0.25627615062761505,0.6781428032078367,1.0,36/140,16.70%,DLC1;SYDE1;VAV2;ARHGAP15;RHOJ;ARHGAP24;VAV3;ARHGAP32;KALRN;ITSN1;RHOD;OPHN1;FGD4;SRGAP1;CDC42;CGNL1;ARHGDIG;ARHGEF19;TRIO;ARHGEF12;PREX1;FAM13B;RHOA;VAV1;ARHGAP6;AKAP13;ARHGAP22;SRC;ARHGEF18;ARHGAP35;RAC1;RHOF;DEPDC1B;SQSTM1;ARHGAP9;ARHGDIA
prerank,ruffle organization (GO:0031529),0.5168089433966223,1.1497069033947958,0.32215743440233235,0.6780744870341832,1.0,9/16,22.69%,LIMA1;AIF1;CARMIL1;AIF1L;RAC1;PLEK;PIP5K1A;TPM1;ARFIP2
prerank,regulation of nuclear division (GO:0051783),0.48796796099327383,1.1493906541599024,0.3117816091954023,0.6783923344353008,1.0,10/20,26.02%,PDXP;BORA;RCC1;OBSL1;FBXO5;PIN1;CDK13;PRMT5;CUL9;L3MBTL1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4098113708115514,1.1493665247935052,0.27752808988764044,0.6779080071585929,1.0,17/69,13.29%,PDGFRA;ZFP36L1;GAB2;IRS1;PDGFRB;PTEN;NF1;PIK3R5;OGT;PLCL1;EXOC1;RPS6KB1;FGFR1;PLCB3;RHOA;PI4KA;PIK3R1
prerank,nucleosome organization (GO:0034728),0.42121774225942354,1.1490711064856443,0.2687427912341407,0.6781529559735524,1.0,18/55,20.23%,POLE3;SMARCC1;INO80;SETD2;GRWD1;HMGB2;LIN54;RSF1;SPTY2D1;NAP1L3;CTCF;ATRX;ASF1A;SRCAP;SMARCA4;KAT6B;NAP1L1;ARID2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.41893909612090824,1.1490623082493,0.2728337236533958,0.6776280654551635,1.0,14/55,19.71%,CYP1B1;PDGFRB;DHRS4;PID1;GRB2;ARF4;SPHK2;RAC1;RIPK1;AGT;XDH;CCN6;GADD45A;DCXR
prerank,cellular response to interferon-beta (GO:0035458),0.5160718523362657,1.1487763928170756,0.3088023088023088,0.6778118283491852,1.0,5/14,20.38%,STAT1;IRF1;UBE2K;IRGM;TRIM6
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4483684299523151,-1.1485935473341127,0.29754601226993865,0.7351942179011289,1.0,6/12,27.89%,PPP3CB;GPLD1;PLA2G6;ANO1;CFTR;BAIAP3
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5407165032341225,1.1484595602549923,0.3153961136023916,0.6780920382683748,1.0,1/13,0.33%,ENPP1
prerank,regulation of protein localization to cell surface (GO:2000008),0.4437413281064102,1.1484144089865038,0.3053152039555006,0.6776813562093582,1.0,8/33,12.29%,GPM6B;TM9SF4;TAX1BP3;ABCA2;EGF;GBF1;SNX33;TNF
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4971131914270256,1.1482106793888307,0.3064971751412429,0.6776828304608534,1.0,4/20,10.36%,SFRP4;CD40;PLA2R1;CCL2
prerank,receptor-mediated endocytosis (GO:0006898),0.3941243512473143,1.148119662539005,0.24760892667375134,0.6774012631478298,1.0,31/132,15.88%,HP;HPR;CLTC;LRP1;HSPG2;SPARC;COLEC12;MASP1;APOE;ADM;DNAJC6;CD36;DNAJC13;LRP6;CTSL;CANX;GPR107;GRB2;GAK;SNX9;CALR;CALCRL;TPCN2;EPS15;MSR1;HSPH1;COLEC11;AP2A2;NEDD4;FCGR1A;GRK4
prerank,engulfment of apoptotic cell (GO:0043652),-0.4145871701093611,-1.1479840078902646,0.29430379746835444,0.7347196687983159,1.0,5/15,20.76%,RHOBTB1;XKR4;THBS1;RHOG;RHOH
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.45205974723316245,-1.147937104677285,0.34065934065934067,0.7324315008309644,1.0,2/12,5.03%,GSN;LY6E
prerank,inositol phosphate metabolic process (GO:0043647),-0.30940444043426163,-1.1479108807636382,0.24242424242424243,0.7300942116589344,1.0,22/46,25.34%,PLCE1;INPP4B;CALM1;PLCB4;ITPK1;INPP5D;PLCB1;IPPK;NUDT3;ISYNA1;PPIP5K1;IP6K1;SYNJ1;INPP5A;IMPA2;ITPKB;NUDT11;OCRL;PLCD4;PLCH1;INPPL1;PPIP5K2
prerank,B cell differentiation (GO:0030183),-0.30323718336901034,-1.1477381674455909,0.20496894409937888,0.7281922184733888,1.0,13/46,17.12%,KIT;HDAC4;HDAC9;VCAM1;TPD52;MSH2;ITGA4;DNAJB9;BLNK;CEBPG;NHEJ1;GPS2;IRF2BP2
prerank,coenzyme A metabolic process (GO:0015936),0.5288790566285412,1.147681637768195,0.30927835051546393,0.67801720816757,1.0,6/14,17.85%,DCAKD;SLC25A16;PANK2;COASY;PANK1;NUDT7
prerank,phosphatidylserine metabolic process (GO:0006658),0.45604672537156504,1.1476562140591704,0.2988650693568726,0.6775431098593567,1.0,9/32,20.28%,PLA1A;PLA2G12A;OSBPL5;ABHD16A;PLA2G4A;PLA2G4E;LPCAT3;PTDSS2;PLSCR1
prerank,regulation of histone acetylation (GO:0035065),0.45356195573568364,1.1472813770957537,0.31835686777920413,0.6780123338319054,1.0,10/33,19.16%,KMT2A;TAF7;NOC2L;TADA2B;GLYR1;SPI1;PAXIP1;HDAC5;IWS1;THAP7
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.38184201682360747,1.146823555751916,0.25204081632653064,0.678714452841027,1.0,20/142,11.75%,KNG1;PDGFRA;CACNA1A;IAPP;CMKLR1;EDNRA;CACNA1C;CCR1;PTGDR;TRPC6;CD36;S1PR3;DLG4;CXCR4;FKBP1B;WNT5A;DRD3;LPAR3;ATP2B1;LPAR2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3587322327162146,-1.1467065982660614,0.2584745762711864,0.7286719406033906,1.0,5/27,2.77%,DMD;CACNB2;CACNB4;ANK2;CALM1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.47018070203681517,1.146682669562905,0.3095890410958904,0.6785608145574188,1.0,2/24,2.43%,CREB3L1;LRRK2
prerank,nuclear membrane organization (GO:0071763),0.4993823304737688,1.1462384073503509,0.32147742818057456,0.6791758324886302,1.0,6/19,19.93%,CHMP4B;PLK1;VPS4A;CHMP7;TOR1AIP1;UBXN2A
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.3307617408808575,-1.1461142099493575,0.22815533980582525,0.7278845756686615,1.0,16/38,23.60%,NDUFS1;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;NDUFA10;NDUFS2;NDUFB11
prerank,central nervous system development (GO:0007417),0.37324674540887104,1.1456057079225888,0.1846619576185671,0.6803504109780801,1.0,25/250,5.93%,COL4A1;C3;EPHA7;APOD;HSPG2;ROBO2;ATXN1;MEIS2;MDGA1;CHD7;HPCAL4;VCAN;AFF2;ADGRL3;ZIC4;STAT3;MEIS1;SHH;MAP1S;PTEN;PKD2;NF1;PBX3;ATP6AP2;PTPRZ1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4081248744486865,1.145572429924004,0.2777777777777778,0.6798879983468249,1.0,4/75,1.36%,SLC39A14;C3;RGS16;PPP1R9B
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5475636950476607,1.1455297246953593,0.3189522342064715,0.6794641611949599,1.0,4/11,14.53%,CYP1B1;GSKIP;STK24;PDCD10
prerank,positive regulation of filopodium assembly (GO:0051491),0.476346009271683,1.1454838569418313,0.3016759776536313,0.679061911488269,1.0,6/24,6.39%,DPYSL3;NRP1;FSCN1;RALA;TGFB3;CDC42
prerank,"phototransduction, visible light (GO:0007603)",-0.4183449341216281,-1.1454631221223122,0.2894736842105263,0.727418784347778,1.0,5/14,26.73%,ABCA4;GNA11;RP1;SAG;PDE6A
prerank,negative regulation of viral release from host cell (GO:1902187),0.5282052840545519,1.1452606693054823,0.3282674772036474,0.6791105245299456,1.0,8/13,28.11%,TRIM21;TRIM13;TRIM8;TRIM35;TRIM11;CHMP3;TRIM26;PML
prerank,positive regulation of binding (GO:0051099),0.39566530322008264,1.1452579029463628,0.27124183006535946,0.6785822560560006,1.0,21/84,14.58%,LRP1;TCF7L2;LRRK2;APOE;TRIM21;EGF;PPARG;DDX11;ADD2;NMD3;TERT;HMGB2;VTN;DPH3;GSK3B;SPPL3;DACT1;PSEN1;TRIB3;RPL11;DTX3L
prerank,lymphocyte differentiation (GO:0030098),-0.2857628928563855,-1.1451443126504037,0.21487603305785125,0.7259645633995664,1.0,19/68,17.48%,KIT;HDAC4;HDAC9;TOX;GPR89B;GPR89A;VCAM1;TPD52;MSH2;JAG2;ITGA4;DNAJB9;BLNK;CEBPG;PIK3CD;NHEJ1;GPS2;LFNG;IKZF1
prerank,negative regulation of hormone secretion (GO:0046888),-0.4842088461536578,-1.1450566126947936,0.29736842105263156,0.7238938046894831,1.0,3/10,19.05%,RAB11FIP3;RAB11FIP1;GJA1
prerank,regulation of primary metabolic process (GO:0080090),0.3868947929394567,1.1445696091310462,0.23854166666666668,0.6798810024134412,1.0,37/126,22.92%,PSMA7;NCOR2;APOE;MVK;CREBBP;PPARG;OAZ3;LACTB;CARM1;PSMB8;PSMA6;TBL1X;CHD9;PSMF1;ELOVL6;PSMA8;PRKAB1;PSMD2;PSMD12;RUBCNL;PSMD11;TGS1;SREBF1;PSMD14;PSMB1;ACACA;FASN;MED1;PSMC6;CERS2;NR1D1;NR1D2;ROCK2;NCOR1;SMARCD3;PSMB4;PSMB5
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.35348722612121053,-1.1440973892657913,0.24017467248908297,0.724364690486915,1.0,11/27,27.89%,CHKA;PCYT2;LPIN1;SLC27A1;SELENOI;PLA2G6;NAAA;CHKB;PLAAT3;PNPLA8;ETNPPL
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.3404080347680274,-1.1440645145453043,0.2571428571428571,0.7221426684123661,1.0,15/32,23.99%,ADGRB3;IL1RAPL1;CDKL5;CUX1;RAPGEF2;HECW1;CUX2;SEMA4D;CDKL3;PTPRD;CUL7;SARM1;HECW2;LZTS1;NEDD4L
prerank,regulation of dephosphorylation (GO:0035303),0.5131936706883929,1.1440199515511227,0.32132564841498557,0.6808063429248233,1.0,8/15,19.49%,SMG7;SMG6;PPP1R16A;SRC;MTMR9;MTMR3;MTMR2;MTMR1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.46394149979237875,1.1439827563964653,0.31341301460823373,0.6803773683548022,1.0,10/27,20.36%,EGFR;STAT3;PUM1;TNRC6B;MAP2K1;WTIP;FMR1;RIPK1;AGO2;EIF4G1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4892946339986131,1.1439801240916305,0.33194444444444443,0.67985136473328,1.0,6/19,14.73%,MAP4K4;NRP1;LIMS1;SFRP1;PTPRJ;RAC1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5292567219785071,1.1438782790956432,0.3333333333333333,0.6795830504832111,1.0,4/13,8.76%,ABCA1;CD36;PPARG;LPL
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4935180345491874,1.1438764295955743,0.31586402266288954,0.6790552932481314,1.0,13/18,27.15%,SLC2A13;GSAP;ABCA2;ABCG1;TNF;PICALM;IFNGR1;CLU;ROCK2;RELA;CHRNA7;EFNA1;GSK3A
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.45014270465319994,1.1438090786421524,0.30445544554455445,0.6786921466311747,1.0,13/33,21.92%,EGFR;AIF1;CCND3;ADAMTS1;RPTOR;ANXA1;KMT2E;ANKRD17;DDRGK1;AKT1;GLI1;EIF4G1;RGCC
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4552091433071528,1.143724161499258,0.32806324110671936,0.6783934337314501,1.0,13/27,26.27%,TNFSF11;MDK;CCL2;RHOA;TNF;HSPD1;ETS1;SIRPA;CCDC88B;CYRIB;RELA;THY1;PYCARD
prerank,cranial nerve development (GO:0021545),0.5473357164121981,1.143472104628137,0.3213166144200627,0.6785363183757448,1.0,2/11,9.20%,CHD7;SALL1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3923644530229918,-1.1434550634172975,0.26755852842809363,0.7216165642834123,1.0,9/18,20.84%,NRXN1;PRKCZ;SHANK3;CUX2;SHANK1;RIMS1;RELN;NLGN1;RIMS2
prerank,positive regulation of cell growth (GO:0030307),0.39612173238673104,1.1427113880934616,0.2622415669205658,0.6799471396658119,1.0,19/96,11.62%,MMP14;EIF4G2;KLHL22;EGFR;FXN;BCL2;PABIR1;INO80;SFRP1;CDC42;RPTOR;L1CAM;SYT2;EXOSC4;TGFBR1;CSNK2A1;DBN1;TGFB2;DBNL
prerank,spindle assembly (GO:0051225),0.41062493177917225,1.1421640954213175,0.28651685393258425,0.6808539906105463,1.0,17/67,17.00%,NEK6;KIFC1;SMC1A;KIF2A;INO80;HAUS3;STAG2;GOLGA8B;TPX2;STAG1;MAPRE2;RHOA;TUBGCP4;TOGARAM1;CEP192;RCC1;CSNK1D
prerank,protein targeting to lysosome (GO:0006622),0.4889557938348296,1.1420602676789406,0.3146853146853147,0.6805736248035525,1.0,7/20,18.32%,AP4M1;VPS4A;LAMP2;RAB7A;NEDD4;ZFYVE16;GNPTAB
prerank,peptidyl-tyrosine modification (GO:0018212),0.41371505196528313,1.141909328598048,0.2817229336437718,0.6804368353992558,1.0,16/56,14.81%,PDGFRA;TEC;PDGFRB;JAK2;EGFR;BLK;DDR2;PTPN6;EPHA1;ABI2;FGFR1;PTK2;TPST1;ABI1;SRC;FES
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.3193765953911688,-1.1418319182672492,0.20725388601036268,0.7238523639201344,1.0,7/38,4.59%,CACNB2;KCND3;CAV1;CTNNA3;ANK2;KCNJ2;KCNJ3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.4336510922063219,1.141777110907395,0.30656934306569344,0.6802382796151818,1.0,13/45,14.06%,FAM83A;EGFR;NCK2;EGF;CBL;GRB2;PTK2;ERBIN;BTC;PIK3R1;GAREM1;KIF16B;SRC
prerank,axon extension (GO:0048675),0.48249798684648254,1.141274656897414,0.3228454172366621,0.6810015502124809,1.0,5/23,3.93%,SLIT3;SLIT1;AUTS2;NRP1;USP9X
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.40079615001378743,1.1410675289895353,0.27417519908987487,0.6810202477349082,1.0,20/74,15.12%,TCF7L2;TNFAIP3;SNAI2;CFLAR;BCL2;ACVR1;SIAH2;ICAM1;TERT;SH3RF1;TGFBR1;BMP5;PELI3;CASP8;UNC5B;TNF;GSK3B;TRAF2;SRC;RIPK1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3801426085607508,-1.14083646437034,0.2535211267605634,0.7244647854344533,1.0,5/20,2.77%,DMD;ATP1A2;ATP1B1;ANK2;CALM1
prerank,positive regulation of exocytosis (GO:0045921),0.44697964755764646,1.1406254449920294,0.3093994778067885,0.6816104923862518,1.0,17/35,27.57%,RAB2B;VPS4A;UNC13D;RAB7A;SDC1;RAB9A;RAB27B;SMPD3;RAB15;SDC4;RAB5A;SDCBP;PDCD6IP;TSG101;CLASP2;CLASP1;CADPS2
prerank,telomere maintenance (GO:0000723),0.4207878610757756,1.140422759429268,0.3104265402843602,0.6815827447426208,1.0,14/50,17.03%,PARP3;DNA2;XRCC3;ATM;ZBTB48;TERT;ATR;SP100;LTO1;NSMCE2;RIF1;CTC1;PRKDC;TEP1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5477478569748753,1.1400454109025622,0.3380726698262243,0.6820837798383854,1.0,3/11,10.14%,ZFP36L1;ZC3H3;NCBP2
prerank,regulation of protein localization to nucleus (GO:1900180),0.42530501891234646,1.1396356767853322,0.29440993788819875,0.682614094067741,1.0,17/43,19.95%,YAP1;SHH;ILRUN;PLK1;WWTR1;GSK3B;ORMDL3;DTX3L;CTNNA1;BYSL;LAMTOR5;AKT1;LATS2;EIF2AK3;MFHAS1;KAT7;PIN1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.47314407126433006,1.1396274836818923,0.3071718538565629,0.6821098726680821,1.0,7/23,13.45%,CBLB;ERRFI1;CBL;MVP;SOCS5;ZGPAT;SH3BP5L
prerank,regulation of amyloid fibril formation (GO:1905906),0.5121147091208778,1.139410475092538,0.3448275862068966,0.6821394723578695,1.0,3/15,3.78%,IAPP;TREM2;APOE
prerank,positive regulation of type 2 immune response (GO:0002830),-0.43942561685946663,-1.1391509517718998,0.29430379746835444,0.7268743405310407,1.0,3/14,3.04%,PRKCZ;CD81;IL18
prerank,mRNA stabilization (GO:0048255),0.4375455497839687,1.139003163534705,0.3035294117647059,0.6826653587274191,1.0,5/40,7.77%,IGF2BP1;SYNCRIP;E2F1;TENT5A;TIRAP
prerank,nitrogen compound transport (GO:0071705),0.3787476115304235,1.1389244082017405,0.24712041884816754,0.6823365174501467,1.0,21/141,11.87%,SLC7A2;TCN1;SLC15A3;SLC38A3;SLC6A2;ARRDC4;SLC25A47;SLC7A7;MYH9;SLC38A4;SEC14L1;MIA3;LMAN2L;RAB7A;TCN2;ARRDC3;SLC36A2;SLC7A8;PDPN;RCN3;CALCRL
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.31817532552638794,-1.138770860966688,0.2122905027932961,0.7257366486722,1.0,13/39,13.78%,TEK;KRIT1;CDH5;GAS6;NDNF;RAMP2;KDR;SCG2;ITGA4;GATA2;SEMA5A;ECSCR;THBS1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.5047491652595498,1.1382484412018838,0.31681681681681684,0.6835831252417415,1.0,9/15,21.42%,NSMAF;TNFRSF1A;TNF;ORMDL3;SPHK2;SMPD3;SIRT3;PRKCD;SAMD8
prerank,positive regulation of dephosphorylation (GO:0035306),0.4563976383402315,1.1380783187435226,0.3068920676202861,0.6834997080699008,1.0,10/27,20.54%,DLC1;PPP2R5A;SPPL3;CALM2;SRC;MTMR9;PTPA;ANKLE2;PIN1;PRKCD
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.43307452570186294,1.1380427686931456,0.3111668757841907,0.6830702924976109,1.0,10/41,14.73%,ADAM19;TNFSF11;JAK1;MDK;CCL5;PTPN23;GCNT2;TNF;BMP7;CX3CL1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.3229166749230232,-1.1379400797077868,0.20809248554913296,0.7258147980806894,1.0,26/42,35.18%,UBC;POLD3;PCNA;FAAP20;RFC3;UBA52;POLH;PARP10;USP10;POLD2;RPA2;PRIMPOL;PCLAF;POLE;RFC4;ZBTB1;CDKN2D;POLD4;RFC2;WRN;DTL;RPA3;POLK;USP43;SPRTN;RFC5
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.43553445334165614,-1.1377095235864205,0.28450704225352114,0.7241898388966502,1.0,4/12,31.17%,RBP4;TLR4;NOD2;SOX9
prerank,regulation of ATP biosynthetic process (GO:2001169),0.5037869882909138,1.1370483682553965,0.3263785394932936,0.6851057942110121,1.0,5/16,13.14%,TREM2;ANTKMT;ENO1;PID1;SPHK2
prerank,regulation of MAPK cascade (GO:0043408),0.3796648859926617,1.136874934059103,0.2611862643080125,0.6850402496310186,1.0,23/157,12.90%,ROR2;ROR1;EPHA7;IAPP;MAP4K4;TAOK1;SPRED1;EGFR;NF1;EGF;ATP6AP2;PTPN6;TAOK3;TMEM106A;MAP2K1;FGFR1;PTPRJ;YWHAZ;NRK;NBR1;FGF2;NTRK3;P2RX7
prerank,regulation of calcium ion transport (GO:0051924),0.41709222685758407,1.1367248939123398,0.28875739644970416,0.6848978914794056,1.0,11/54,11.67%,IL16;CACNA2D1;CCR1;BCL2;PKD2;TRPC6;CCL5;EGF;EFHB;MYLK;ATP2B1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.4157871046616149,1.1367147297255888,0.3013205282112845,0.6843934343423361,1.0,15/47,19.12%,ZFP36L1;CMKLR1;FRZB;ASXL2;SFRP1;PPARG;VSTM2A;CARM1;LPL;WDFY2;BMP7;TRPM4;AKT1;AAMDC;LRP5
prerank,actin filament network formation (GO:0051639),0.5316353720114427,1.1366446473997511,0.3328173374613003,0.6840527471154001,1.0,4/11,8.76%,FHOD3;CARMIL1;SPIRE1;LCP1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4704004065682354,-1.1366178833768905,0.3079019073569482,0.7249889646677692,1.0,4/10,24.58%,PCGF5;IGF2;KDM1B;ZFP57
prerank,import into cell (GO:0098657),0.4301851422946289,1.1358280963042302,0.31851851851851853,0.6857281143713269,1.0,5/41,3.66%,SLC39A14;SLC1A3;SLC11A2;SLC12A4;TREM2
prerank,cellular response to organonitrogen compound (GO:0071417),0.39272993002416406,1.1357490618829411,0.274364406779661,0.6854041404922094,1.0,14/99,9.92%,NR1H4;PDE3A;PDXP;ZFP36L1;IGFBP5;PKD2;CPEB1;SFRP1;AHR;CAPN2;RPTOR;RRAGC;HRH1;SSH1
prerank,Golgi to endosome transport (GO:0006895),0.4996523507955613,1.1355508342314908,0.33979135618479883,0.6853754148711158,1.0,6/16,13.77%,WIPI1;AP4M1;VPS13C;GBF1;EPS15;KIF16B
prerank,striated muscle tissue development (GO:0014706),-0.3467190711198307,-1.1353999820804674,0.24347826086956523,0.726118643516022,1.0,8/29,7.19%,SGCD;PGM5;CAV1;SGCZ;RBP4;IGSF8;MYL6;NDUFV2
prerank,endosome organization (GO:0007032),0.4293281950622438,1.135245662104839,0.3004866180048662,0.6856850097256315,1.0,16/41,20.02%,ARFGEF2;HOOK2;PI4K2B;DNAJC13;WASHC4;SNX33;EEA1;PLEKHF1;SNX10;TMCC1;CHMP2B;SQSTM1;ALS2;HOOK1;CORO1C;WASHC5
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.39359777384744316,-1.134783188185997,0.2848101265822785,0.7255920056851417,1.0,5/18,4.77%,PRKAG2;OCLN;SLC2A1;C2CD5;PRKCB
prerank,positive regulation of catalytic activity (GO:0043085),-0.32481157123868526,-1.1347536163880891,0.23,0.7234358855614061,1.0,16/37,23.69%,CAV1;XRCC4;YWHAB;APH1A;MSH2;SLC5A3;IGF2;NHEJ1;FGFR4;SOD1;SSBP1;CHTOP;MAPK3;CIB1;MSH3;MAPK14
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.46457086298487116,1.1343707533562302,0.31906614785992216,0.6874164618808624,1.0,10/27,25.48%,DTYMK;GUK1;CTPS1;AK2;AK8;TXNRD1;CTPS2;NME2;TYMS;NUDT13
prerank,positive regulation of T cell proliferation (GO:0042102),0.41345539430427797,1.1337919050352143,0.30257009345794394,0.6883886255702228,1.0,7/55,8.96%,IL23R;CD276;NCK1;AIF1;NCK2;CCL5;ANXA1
prerank,positive regulation of protein binding (GO:0032092),0.4134402161470488,1.1337754545394676,0.309662398137369,0.6879103059844465,1.0,16/56,14.58%,LRP1;TCF7L2;LRRK2;APOE;TRIM21;ADD2;NMD3;TERT;VTN;GSK3B;SPPL3;DACT1;PSEN1;TRIB3;RPL11;DTX3L
prerank,blood circulation (GO:0008015),0.4231481423640386,1.1336906727804126,0.30461165048543687,0.687615747015735,1.0,5/49,2.14%,OLR1;SERPING1;EDN3;CXCL12;STAT1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.46578335082204025,1.133426843724549,0.32301480484522205,0.6878298432085285,1.0,3/26,2.62%,C3;ADIPOQ;IRS1
prerank,ventricular septum morphogenesis (GO:0060412),0.45409533847393957,1.1333760443948737,0.3188976377952756,0.6874245867396968,1.0,8/27,14.44%,ROBO2;SLIT3;ZFPM2;ACVR1;HEYL;TGFBR1;TGFB2;SMAD4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3890502296225382,1.1332264483855778,0.2821888412017167,0.6867657840415462,1.0,15/104,16.78%,PSMA7;CUL1;CREBBP;SKP1;PSMB8;PSMA6;FBXW11;PSMF1;SRC;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14
prerank,cellular response to lectin (GO:1990858),0.3890502296225382,1.1332264483855778,0.2821888412017167,0.6867657840415462,1.0,15/104,16.78%,PSMA7;CUL1;CREBBP;SKP1;PSMB8;PSMA6;FBXW11;PSMF1;SRC;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.40126513570530536,1.1326241343918166,0.2947845804988662,0.6876921519139505,1.0,30/76,24.12%,NKD2;LRRK2;PTEN;PABIR1;RNF144A;PLK1;PRICKLE1;FBXW7;RAD23A;ARIH1;PTK2;SOCS5;RNF19B;GSK3B;CSNK1A1;DDRGK1;TRIB3;TRIB1;SMURF1;ZYG11B;CSNK1D;MDM2;ARIH2;FBXO22;RNF14;AXIN1;CLU;RNF144B;RNF217;PIAS1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.4534675248160209,-1.1321837945812527,0.3137254901960784,0.7284285907000885,1.0,4/11,15.49%,TPK1;DCK;NT5C3A;SLC19A3
prerank,heterocycle biosynthetic process (GO:0018130),-0.42803374298010843,-1.1321790475621447,0.2997032640949555,0.7262055747504457,1.0,9/14,30.82%,GPHN;MOCS2;LIAS;NFS1;NOXRED1;PYCR2;MOCS3;PYCR3;GCH1
prerank,regulation of cell cycle (GO:0051726),0.37048885734502174,1.1320623309515565,0.20925553319919518,0.6886217659389473,1.0,48/271,14.53%,FAP;RUNX3;NEK6;PPP1R9B;TCF7L2;EIF4G2;GATA6;RASSF1;BIRC3;CDKN2B;STAT3;PUM1;PKD2;PES1;TRIM21;NF2;CDK6;ATM;SFRP1;LRP6;PLK1;CKS1B;IRF1;CDK10;GBF1;TMEM8B;RAD23A;TTC28;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;SND1;SETMAR;JUNB;TBX3;LIN54;CCNB2;TGFB2;CALR;ANKRD17;CDK7;NLRP2B;MAEA;SMAD3;BMP7;CDKN1B;CDC14A
prerank,water-soluble vitamin metabolic process (GO:0006767),0.40143253685067615,1.1319888871789616,0.3087248322147651,0.6883003407561767,1.0,5/68,3.92%,ENPP1;TCN1;MMAB;MTHFR;MTHFD1L
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.45455908562535974,1.1318360976440094,0.30978260869565216,0.6881915161130915,1.0,11/28,22.12%,TREM2;PTEN;FBXW7;PTK2;CTSC;DDRGK1;FMR1;SMURF1;PSMC6;AXIN1;CLU
prerank,regulation of interferon-alpha production (GO:0032647),0.4773503281476086,1.1318359779806433,0.33921302578018997,0.6876705535725063,1.0,4/23,9.84%,STAT1;IRF7;TLR7;SETD2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.38820720023389427,1.1317418157723313,0.2802139037433155,0.6873992741680738,1.0,15/105,16.78%,PSMA7;CUL1;CREBBP;SKP1;PSMB8;PSMA6;FBXW11;PSMF1;SRC;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.43020088567693054,1.1315865145379973,0.30390920554854983,0.6872790192661472,1.0,12/39,16.40%,FBLN1;MAP4K4;JAG1;CASK;NF2;EFNA5;SEMA3E;GCNT2;RHOA;CX3CL1;ITGB1BP1;RASA1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.47518893976853577,1.1315770844080524,0.30955585464333785,0.6867846238935361,1.0,13/23,21.63%,CEMIP;TNKS1BP1;EGF;PLK1;RPTOR;S1PR2;UBE2K;CALM2;BMP7;MAPK1;IRGM;TRIM6;AXIN1
prerank,positive regulation of myelination (GO:0031643),0.5346385119184078,1.131512323132975,0.3380503144654088,0.6864321072522672,1.0,5/11,17.61%,TENM4;DICER1;EGR2;TPPP;NCMAP
prerank,stabilization of membrane potential (GO:0030322),-0.3993638983406108,-1.1310535403002036,0.3125,0.7272231186346123,1.0,7/16,25.92%,KCNK5;KCNK10;KCNK2;KCNK13;KCNK6;CHCHD10;KCNK12
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4107701649860021,1.1310041578642458,0.30533484676503975,0.6872052480893566,1.0,7/59,9.82%,CYP7B1;LIPC;ALDH1A2;SLC27A2;HSD17B8;LPL;OSBPL3
prerank,rRNA methylation (GO:0031167),0.47394065845551514,1.130912517796627,0.343878954607978,0.6869330313225085,1.0,6/22,12.24%,METTL15;METTL16;MTERF4;NOP2;MRM1;MRM2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4050560701376279,1.130538225780313,0.3108265424912689,0.6873168159441388,1.0,22/66,21.08%,YAP1;UBR5;BAG3;PLK1;PINX1;NMD3;TERT;CCT8;ZIC1;WWTR1;ORMDL3;PIK3R1;SMAD3;PSEN1;CCT3;DTX3L;LAMTOR5;AKT1;EIF2AK3;KAT7;PRKCD;ZC3H12A
prerank,mesenchyme morphogenesis (GO:0072132),0.5036680773743366,1.1303908196880323,0.33285302593659943,0.6871879392648698,1.0,5/17,11.44%,SMAD2;TBX2;ACVR1;HEYL;TGFB2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.461878526753705,1.130382822264551,0.32170542635658916,0.68668815956454,1.0,6/26,12.02%,KMT2A;ANTKMT;OGT;SETD2;VCPKMT;TET2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4123974368344919,1.1303388009531106,0.3090277777777778,0.6863019885032134,1.0,11/59,15.73%,RUNX2;TCF7L2;MITF;PTEN;TNRC6B;CBFB;MOV10;MED13;MED15;SETX;MED26
prerank,regulation of protein localization (GO:0032880),0.4111548475577698,1.1302192871740362,0.30590961761297797,0.686091310389986,1.0,11/58,10.97%,TRIML2;STX6;CTSD;TRIM21;VPS4A;RABGAP1L;BORA;FBXW7;RAB9A;WDPCP;DNAJB6
prerank,positive regulation of cell population proliferation (GO:0008284),0.36605695486479845,1.1299379320847625,0.16416416416416416,0.6863071708864713,1.0,70/423,12.55%,CXCL5;IL34;WNT2;OSMR;PDGFRA;LAMB1;EDN3;YAP1;TCF7L2;PTN;MEIS2;LAMC1;STAT1;CCAR1;GAB2;TIMP1;IRS1;PDGFRB;PRTN3;FGF7;CCN4;ZFPM2;TSLP;EGFR;MEIS1;TBX2;FXN;MDK;SHH;E2F1;PTEN;BCL2;AIF1;DDR2;CACUL1;CCL5;EGF;CDK6;SFRP1;TGFB3;EAPP;PTPN6;GLP2R;S1PR3;EPHA1;HPSE;TMEM119;PID1;TERT;S1PR2;S100A6;TGFBR1;WNT5A;HDAC1;CSNK2A1;IL7;BMP5;NOP2;LIFR;TBX3;FGFR1;WWTR1;PTK2;TGFB2;GCNT2;CALR;TNF;VEGFC;FGF2;NTRK3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.49689834544414424,1.12989516913373,0.3465491923641703,0.685908365647691,1.0,3/16,4.56%,SLC9A1;PRKCA;CAMK2D
prerank,positive regulation of response to wounding (GO:1903036),0.46274606097848225,1.1297426771023984,0.32219251336898397,0.685799493739822,1.0,6/24,11.22%,PTN;MDK;ANXA1;MYLK;PTK2;VTN
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.5047889319254227,1.1297196632864375,0.3343195266272189,0.6853397113767833,1.0,2/15,5.97%,ADIPOQ;PPARG
prerank,regulation of cellular component movement (GO:0051270),0.42152920953378803,1.129424499612573,0.3022432113341204,0.6855860599730731,1.0,20/49,22.93%,MYCBP2;EGFR;ZSWIM6;EGF;CDK6;SP100;TGFBR1;PDPN;MEMO1;RHOA;ZSWIM8;BTC;ZSWIM4;FES;ETS1;ACTN1;PKN1;RAF1;ROCK2;ROCK1
prerank,dendrite self-avoidance (GO:0070593),0.49941851383522395,1.1291112656694735,0.3150887573964497,0.6858434961739682,1.0,2/16,1.57%,PALLD;TNN
prerank,protein prenylation (GO:0018342),0.5479623433838208,1.1288689623838488,0.33544303797468356,0.6859647067612461,1.0,4/10,16.88%,CHML;RABGGTB;FNTB;PTAR1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.38014690536727785,-1.1287691908008985,0.2922077922077922,0.7313096093389968,1.0,4/20,4.84%,PRKAA2;RPS6KA5;DIP2B;PPARGC1A
prerank,triglyceride biosynthetic process (GO:0019432),-0.38942096670856857,-1.1282739057358848,0.2932098765432099,0.7305220218456255,1.0,5/18,14.31%,AGMO;LPGAT1;LPIN1;DGAT1;GPAT4
prerank,proteoglycan metabolic process (GO:0006029),0.4653212197640682,1.128171977469772,0.33200531208499334,0.6872013949188803,1.0,7/26,16.27%,SULF1;CHST13;HPSE;ADAMTS12;CHST11;B4GALT7;FAM20B
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.42367308772702567,-1.1281047893160363,0.30357142857142855,0.7266032096566103,1.0,4/14,16.98%,ABCG2;BLVRB;BLVRA;HMOX2
prerank,heme catabolic process (GO:0042167),-0.42367308772702567,-1.1281047893160363,0.30357142857142855,0.7266032096566103,1.0,4/14,16.98%,ABCG2;BLVRB;BLVRA;HMOX2
prerank,carboxylic acid transport (GO:0046942),-0.30107537687755376,-1.1279680777828527,0.20512820512820512,0.7247316406487346,1.0,13/55,12.99%,SLC6A6;SLC13A3;SLC6A9;SLC7A5;SLC1A1;SLC6A12;SLC16A11;SLC16A1;CLN3;SLC16A9;SLC38A5;SLC16A4;SLC6A17
prerank,regulation of aerobic respiration (GO:1903715),-0.41755246213586,-1.1278714315885876,0.3106796116504854,0.7228349533732525,1.0,6/15,16.52%,COX7A2;CBFA2T3;PINK1;UQCC2;IDE;NOP53
prerank,positive regulation of protein deacetylation (GO:0090312),-0.42520961281206526,-1.1275544983864352,0.32335329341317365,0.7215379899179734,1.0,6/14,25.18%,SAP30BP;AKAP8;NNMT;CTBP1;APLNR;BRMS1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.43789109341658566,1.126854433934703,0.32213930348258707,0.690107335411076,1.0,12/37,14.04%,CEMIP;SPRED1;TNKS1BP1;SPRED2;EGF;PLK1;RPTOR;S1PR2;SPRY2;UBE2K;CALM2;BMP7
prerank,fatty acid beta-oxidation (GO:0006635),0.4135331779749436,1.1264905089220445,0.30342384887839435,0.6904771365029789,1.0,5/51,7.19%,ADIPOQ;EHHADH;ETFA;SLC27A2;ACOX1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5181824762329266,1.1259485229071715,0.3273001508295626,0.6913249799236141,1.0,4/13,12.48%,MDK;AKT3;FGFR1;FGF2
prerank,mitotic nuclear division (GO:0140014),0.40094920791958766,1.1255835729608965,0.29898074745186864,0.6917381832038434,1.0,18/71,16.65%,KIFC1;SMC1A;KLHL22;CHMP4B;KIF2A;TUBG1;INO80;PLK1;STAG2;TPX2;STAG1;RHOA;CHMP7;NDEL1;TOGARAM1;CEP192;TUBG2;NCAPG2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.42990827494803086,1.1250793859248749,0.3236363636363636,0.6925253277278731,1.0,4/41,8.61%,CYP1B1;ACOX1;SCD5;FADS1
prerank,amyloid-beta metabolic process (GO:0050435),-0.3931149776366054,-1.1248834008283684,0.28253968253968254,0.7267320621279064,1.0,7/16,17.61%,BACE2;APH1A;APH1B;ABCA7;ACE;IDE;APEH
prerank,limb development (GO:0060173),0.45672486831445336,1.1248356638250427,0.3268983268983269,0.6926553682183686,1.0,3/28,2.22%,KREMEN1;GLI3;CHD7
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.3755937728195713,-1.124675326324626,0.2771929824561403,0.7251789801317192,1.0,9/20,28.61%,HSP90AA1;NDUFAF1;MKKS;PSMG3;HSP90AB1;HOPX;TMEM35A;HSPA1A;PTGES3L
prerank,lysosome organization (GO:0007040),0.43519684067558934,1.1246143656340928,0.311495673671199,0.6927290777653285,1.0,7/36,14.50%,ABCA1;LRRK2;HOOK2;MYO7A;CLN6;TPCN2;GAA
prerank,regulation of autophagy (GO:0010506),0.366476347592975,1.1234205753361692,0.25228891149542215,0.6953095723868653,1.0,55/216,18.35%,DCN;TRIML2;DAP;EIF4G2;LRRK2;EIF4G3;KLHL22;DRAM1;TREM2;STAT3;RMC1;ITPR1;BCL2;PIP4K2A;TRIM21;FOXK2;ATM;NPRL2;EXOC4;RPTOR;TRIM8;FBXW7;RRAGC;CSNK2A2;FOXO3;EXOC1;EXOC7;GAPDH;PLEKHF1;TPCN2;GSK3B;DCAF12;ATP6V1H;SNX5;ORMDL3;SMCR8;ATP6V1G2;TRIB3;DAPK2;WASHC1;MTMR9;NEDD4;PRKAB1;LAMTOR5;ATP6V1G1;SREBF1;SH3GLB1;AKT1;CTSA;GPR137;ATP6V1D;MTMR3;CPTP;USP36;LAMTOR3
prerank,inner dynein arm assembly (GO:0036159),0.5454343617057656,1.1229792206088036,0.3687707641196013,0.6958947867567408,1.0,2/10,13.37%,DNAAF4;DNAAF5
prerank,negative regulation of organelle assembly (GO:1902116),0.43545363793032826,1.1228706391557126,0.32147395171537485,0.6956563469565992,1.0,6/35,7.63%,YAP1;LRRK2;CHMP4A;CHMP4B;TMEM39A;CDK10
prerank,base conversion or substitution editing (GO:0016553),0.5439503284662492,1.122373706899527,0.3566009104704097,0.6963690218256896,1.0,1/11,1.47%,APOBEC1
prerank,regulation of intracellular protein transport (GO:0033157),0.4467126521162164,1.1223348461027813,0.3333333333333333,0.6959529676424958,1.0,9/32,18.77%,ADIPOQ;PCM1;PTPN1;LCP1;PCNT;PDCD10;NDEL1;ICE1;BCAS3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.46640238355770613,1.1223026727043468,0.3346883468834688,0.6955171365683107,1.0,4/21,12.48%,MMP2;IGFBP5;ADAMTS1;FGF2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5463264626664357,1.1218145328789497,0.3669291338582677,0.6962819187515161,1.0,3/10,10.36%,TLR2;JAK2;CCL2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4121088953171226,-1.1213281057199507,0.2808988764044944,0.732216227566383,1.0,7/15,30.06%,HNRNPA1;DHX36;MKNK2;PPIF;GSTO2;ATF3;HSF1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.48575704409052783,1.1208182510758047,0.35253772290809327,0.6983185618080796,1.0,7/19,17.56%,GFPT2;UAP1L1;GMPPB;UGDH;AMDHD2;PMM2;GNPDA2
prerank,signal transduction in response to DNA damage (GO:0042770),0.42262220044034376,1.1204616449666382,0.32147093712930014,0.6987146614819958,1.0,15/49,19.28%,BCL3;BRIP1;BATF;E2F1;ATM;GRB2;ATR;ATRX;PAXIP1;USP28;CLOCK;ATRIP;RAD9A;HINFP;GADD45A
prerank,protein polyubiquitination (GO:0000209),0.36503954009638023,1.1202982645447843,0.22590361445783133,0.6986176961822376,1.0,91/297,23.20%,PSMA7;TRIML2;DCAF15;MYLIP;FBXO40;TNFAIP3;SPSB1;HECTD2;FBXL7;CUL1;SMURF2;UBR5;BCL2;TRIM21;RNF144A;ANAPC11;SIAH2;CDC27;SKP1;SASH1;SPOP;NPEPPS;TPP2;FBXL18;FBXW7;FBXO30;AREL1;PSMB8;ARIH1;PSMA6;UBE2L3;PELI3;CBFB;UBE2R2;UBE2J1;FBXO7;RNF213;RNF19B;FBXW11;PSMF1;UBE2K;TRAF2;UBE2W;FBXO2;DTX3L;PSMA8;SMURF1;ITCH;NEDD4;TRIM56;FBXL19;PSMD2;PSMD12;PSMD11;PELI2;RBCK1;TNKS2;TRAF3IP2;TRAF5;PSMD14;RC3H2;MDM2;PSMB1;FBXW4;FBXO31;ARIH2;FBXO32;FBXO38;FBXL22;RNF135;UBE2Q1;PSMC6;UBE2E1;TRIM6;IFI27;TRIM27;FBXO22;TRIM62;RPS27A;RUSC1;RNF14;RBBP6;UBE2L6;ZNRF2;FZR1;CHFR;PSMB4;PSMB5;ANKRD39;UBE3D;RNF144B
prerank,positive regulation of transmembrane transport (GO:0034764),0.5162062974797208,1.1200262425802154,0.34711964549483015,0.698798536898382,1.0,6/13,17.93%,C3;P2RX7;AZIN2;ANO6;ACSL5;CLIP3
prerank,regulation of viral entry into host cell (GO:0046596),0.4505851804927444,1.1180851035371202,0.3403693931398417,0.7032628061316569,1.0,3/30,5.54%,TRIML2;LGALS9;TRIM21
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5457108881259229,1.1172222542525285,0.36153846153846153,0.7049622374435824,1.0,3/10,14.60%,LIPC;PLA2G7;PLA2G4A
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3942542709483662,1.117174338596248,0.319634703196347,0.7045756565503839,1.0,17/70,15.25%,CASP8AP2;JAK2;SIVA1;BAG3;BCL2;BCL2L2;ACVR1B;TNFRSF1A;TGFB2;CASP8;TNF;GSK3B;P2RX7;TRAF2;SMAD3;RIPK1;IL6R
prerank,calcineurin-mediated signaling (GO:0097720),-0.4644393495296478,-1.1169303726735937,0.35260115606936415,0.7401577399060078,1.0,4/10,12.44%,NFATC1;NFATC2;PPP3CB;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4644393495296478,-1.1169303726735937,0.35260115606936415,0.7401577399060078,1.0,4/10,12.44%,NFATC1;NFATC2;PPP3CB;NFATC3
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.39284028608916893,1.116893799655148,0.33108866442199775,0.7048101124060069,1.0,21/78,18.75%,CLTC;LRP1;MMP14;NKD2;EGFR;TREM2;VPS4A;PID1;ITGA3;PPP2R5A;PTPN9;TNF;NUMB;KIF5B;PIK3R1;STAC3;SQSTM1;AKT1;PICALM;CLIP3;SPTBN1
prerank,regulation of cytoskeleton organization (GO:0051493),0.3840037482932304,1.1168037411380773,0.2932330827067669,0.7044999315338378,1.0,22/108,14.73%,DLC1;GPM6B;LRP1;RND3;TAOK1;SYDE1;PDGFRB;RICTOR;FSCN1;BAIAP2;RHOD;CAPN2;CDK10;ARHGEF19;EFNA5;PTK2;RHOA;GSK3B;P2RX7;ARHGAP35;PHLDB2;RAC1
prerank,regulation of microtubule-based movement (GO:0060632),-0.4394452627930067,-1.1167942960670738,0.3155080213903743,0.7383451267140033,1.0,9/11,43.88%,MAP2;TTC21B;LAMP1;CFAP298;DRC1;CCDC65;IGBP1;HDAC6;HAP1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.37620664826995165,1.1165971684553329,0.28914405010438415,0.7044838780805671,1.0,40/132,21.38%,DCN;TRIML2;LRRK2;IRS1;APOE;TRIM21;NPRL2;ARNT;PFKFB4;PTPN1;MSN;TRIM8;FOXO3;SNX33;MOV10;SNX9;PLEKHF1;TNF;GSK3B;ZSWIM8;ZBTB20;P2RX7;ORMDL3;DACT1;PSEN1;DTX3L;DXO;ITCH;HIF1A;SH3GLB1;IRGM;PLK2;TRIM6;PRKCD;PHKG2;ADAM9;TPCN1;ZC3H12A;VPS35;TRIM27
prerank,negative regulation of response to stimulus (GO:0048585),0.40496776482790703,1.1161637796764812,0.3223234624145786,0.7050989314184902,1.0,20/60,22.12%,COL3A1;CASK;AKT3;ACVR1;VPS13C;CDK6;PTPN1;TERT;BRAP;SOCS5;UBASH3B;GGT7;LPCAT3;MAP3K3;FBXO5;TLE5;HMGA2;YBX1;NLRP12;CLU
prerank,positive regulation of cellular respiration (GO:1901857),-0.4508008107262398,-1.1159401474895907,0.3424657534246575,0.7386243382553787,1.0,8/11,47.29%,PINK1;IFNAR1;ISCU;IL10RB;IFNLR1;IL4;PRELID1;VCP
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5238402930903208,1.1158181802800904,0.35202492211838005,0.7054998848752947,1.0,5/12,13.25%,ACO1;ACO2;IDH2;IREB2;IDH3B
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.4340972717508147,1.1147157479225889,0.33969465648854963,0.7077944691926383,1.0,11/32,20.54%,DLC1;PDGFRB;PPP2R5A;DUSP26;SPPL3;CALM2;ITGA1;PTPA;ANKLE2;PIN1;PRKCD
prerank,DNA-dependent DNA replication (GO:0006261),0.37449016383052347,1.1146694529578003,0.2957600827300931,0.7073943505362221,1.0,37/128,25.08%,PSMA7;BAZ1A;POLE3;DNA2;MCM2;MCM7;PSMB8;PSMA6;DBF4;PSMF1;POLA2;LRWD1;PSMA8;POLG;PSMD2;PSMD12;PSMD11;PSMD14;PNKP;PSMB1;PSMC6;RFC1;RPS27A;TWNK;CDC7;RPA1;PSMB4;PSMB5;RAD51;CDC6;DDX21;TEFM;PSMD4;ORC4;PSMD7;PSMD9;PSMA4
prerank,regulation of vasoconstriction (GO:0019229),-0.3444113385082188,-1.1140696780633348,0.3291139240506329,0.7418021666438088,1.0,11/27,20.39%,CAV1;ADRA1B;BDKRB2;AGTR1;ADRA1A;ZDHHC21;PER2;ACE;TBXA2R;CHRM3;ACE2
prerank,positive regulation of developmental growth (GO:0048639),-0.2955655618516338,-1.1140134980925618,0.2346368715083799,0.7397996807905288,1.0,14/49,15.45%,CDKL5;SEMA7A;INSR;PLCB1;AGRN;ITSN2;SHTN1;TWF2;ZFYVE27;RIMS1;SEMA4D;BDNF;RNF157;PPIB
prerank,gluconeogenesis (GO:0006094),0.4206420811817652,1.1139077205180192,0.33618581907090467,0.7088564094533427,1.0,3/39,10.28%,SLC39A14;ENO1;GAPDH
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3653220898463012,1.1138458080815128,0.26171079429735233,0.7085030904524743,1.0,32/199,13.10%,NR1H4;ADIPOQ;PARP3;TBX18;TIMP1;SPRED1;EGFR;MDK;SHH;LAMA4;SPRED2;PTEN;ADM;PAEP;ADAMTS5;SFRP1;SFMBT1;ARRDC3;GPNMB;PLCL1;CHSY1;BMP5;ACOT13;PTPN23;LDLRAD4;ATP2B1;CALR;SPRY2;TNF;GSK3B;ACVR1C;SPI1
prerank,organic cation transport (GO:0015695),-0.3855999067970148,-1.1133352384372672,0.27816901408450706,0.7395307477257211,1.0,7/19,23.16%,SLC47A1;SLC25A42;SLC25A26;SLC22A4;SLC22A2;RALBP1;SLC25A29
prerank,determination of bilateral symmetry (GO:0009855),0.45407588663940873,1.1131112403363297,0.35524475524475524,0.7098779844320944,1.0,5/24,11.11%,DNAAF4;PKD2;DNAH11;GALNT11;NPHP3
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3479907061913216,-1.1129956368095435,0.28793774319066145,0.7382753351796593,1.0,7/27,9.96%,FGF12;SLMAP;FXYD5;SNTA1;ATP2B4;GPD1L;FXYD6
prerank,neuron cell-cell adhesion (GO:0007158),0.5048798641015897,1.11275784245437,0.3583208395802099,0.7102476332955209,1.0,2/14,5.08%,CEL;ASTN2
prerank,sympathetic nervous system development (GO:0048485),0.49812523417904897,1.112342850725519,0.3550834597875569,0.71077824683346,1.0,2/15,5.10%,NRP1;NF1
prerank,cellular senescence (GO:0090398),0.45279059459757687,1.1123219824590416,0.3337628865979381,0.7103137445559469,1.0,10/27,20.54%,CDKN2B;TBX2;MAP2K1;TBX3;CALR;SPI1;NSMCE2;SMC5;HMGA2;PRKCD
prerank,chromatin organization (GO:0006325),0.37473639144686827,1.112026728200911,0.3077720207253886,0.7105930894165017,1.0,36/132,18.67%,SNAI1;SATB2;BAZ1A;PADI2;PHF1;SMARCC1;BAZ2B;INO80;DDX11;EHMT1;PWWP3A;TADA2B;HDAC1;SETD2;MTA2;HMGB2;BRWD1;SETDB1;RSF1;RUVBL1;SAFB;SETDB2;SPI1;LRWD1;ATRX;HMGN3;MYSM1;BAZ2A;TCF7L1;SMARCA4;HMGN1;HCFC2;NUCKS1;HDAC5;SOX2;ZBTB7A
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3714676094595475,-1.1112324419776742,0.3022508038585209,0.7411994020635005,1.0,7/18,23.40%,STT3B;OGA;SAMHD1;DERA;MANBA;FBXO44;FUCA1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4582963239725222,1.1111890325403506,0.34010840108401086,0.7122993658087811,1.0,3/25,6.32%,CEMIP;XCL1;CXCL10
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5349523620059139,1.110968034245012,0.34915773353751917,0.7123431039400586,1.0,4/11,17.56%,GFPT2;UAP1L1;AMDHD2;GNPDA2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.35293275666209567,-1.1109316682494716,0.2918287937743191,0.7399249445275866,1.0,8/23,12.06%,ACSL1;TECR;FAR2;ELOVL7;ELOVL5;HACD1;ACSL3;DGAT1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4119393063859186,-1.110573516463872,0.32840236686390534,0.738850504104228,1.0,6/14,19.38%,SLC24A2;ATP2B4;SLC8A3;TRPV2;TRPV4;SLC8A2
prerank,cell cycle G2/M phase transition (GO:0044839),0.3778284224123555,1.110229973504079,0.29331941544885176,0.7136889466479717,1.0,33/129,17.67%,DYNLL1;CDKN2B;FBXL7;DYNC1H1;CUL1;KHDRBS1;TUBG1;ALMS1;CDK14;PLK1;PCM1;HAUS3;SKP1;CEP41;CNTRL;PHLDA1;DCTN3;BORA;PCNT;PPP2R2A;CCNB2;CDK7;CEP72;PPP1CB;FBXW11;PPME1;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;TAF2
prerank,response to alcohol (GO:0097305),0.451107626860989,1.1096121639370407,0.3507362784471218,0.7147594026086677,1.0,5/27,9.77%,SLIT3;SMAD2;ABCA2;TGFBR1;DRD3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3604041837047916,1.1092953176605378,0.20661985957873621,0.7149804589029134,1.0,101/366,21.97%,RORA;RUNX3;POU5F1;CXXC1;SBNO2;ATXN1;CCAR1;CHD7;BACH1;GON4L;MAFB;SNAI2;ATXN2;MITF;SUFU;PRRX2;STAT3;SOX21;E2F1;PHF1;MYBL1;PRDM2;FOXK2;CREBBP;YAF2;AHR;TOM1L1;BHLHE40;CARM1;CCAR2;BTG1;FADS1;TGFBR1;NONO;FOXO3;ZBTB38;UBE2L3;TGIF2;ACVR1B;TCF7;WWTR1;FOXN2;LIN54;TGFBRAP1;CALR;SP3;ANKRD17;SPTY2D1;ZSCAN21;NAB2;SKOR2;NSD3;NFKB2;SPI1;ATRX;DRAP1;WTIP;BAZ2A;NOLC1;BNC2;PATZ1;HIF1A;PHF12;NUP35;NSD1;NFXL1;CLOCK;TCF7L1;TCF3;ACVRL1;ZFHX3;HCFC2;NUCKS1;MZF1;ATF4;NR2C2;SOX2;FBXO5;HINFP;KAT6B;NR3C1;TULP3;DVL2;THAP7;RPL6;KAT7;RBAK;HMGA2;RBM4B;NUP107;VHL;HINT1;MAGED1;NR1D2;RNF14;YBX1;ZNF423;RBBP6;RPS6KA4;CREM;NFIL3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5149182130302185,1.109138906088725,0.3476923076923077,0.7148682208617367,1.0,3/12,11.91%,DCN;ADAMTS12;SPRY2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.36843435183065454,1.1089298991669312,0.2830957230142566,0.7148788868513779,1.0,32/198,13.52%,ENPP1;EPHA7;LGALS13;PDXP;TAOK1;LRRK2;INPP1;PPA1;DUSP5;STAT3;GFPT2;SLC20A1;HK2;EPHX2;PTEN;PIP4K2A;ITPKC;PFKFB4;LPL;IP6K2;PANK2;PPP3CA;PLD4;PLCB3;GCK;GK;THNSL2;DUSP28;PI4KA;NUDT14;SPHK2;NUDT4
prerank,heart trabecula morphogenesis (GO:0061384),-0.3664256182739837,-1.1088969923258287,0.2905405405405405,0.7415182865222201,1.0,5/18,8.80%,TEK;TGFBR3;RBP4;S1PR1;ADGRG6
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4641166270799209,1.108723396494674,0.3510204081632653,0.7148799320727522,1.0,4/22,12.44%,MGAT5;FKBP1B;TNF;GSK3B
prerank,regulation of membrane depolarization (GO:0003254),0.4797837000014229,1.108714435422833,0.3573487031700288,0.7143885038469409,1.0,3/18,4.72%,LRRK2;CAMK2D;PTPN3
prerank,response to laminar fluid shear stress (GO:0034616),0.548067802406591,1.1087130015896682,0.3412816691505216,0.7138815535407145,1.0,1/10,0.25%,ABCA1
prerank,muscle organ development (GO:0007517),0.4104202280320867,1.1087089795118774,0.3329532497149373,0.7133775465844473,1.0,9/54,11.95%,LAMA2;COL6A3;EGR3;TCF12;CXCL10;FHL3;ITGA11;CHD2;UTRN
prerank,mitochondrion distribution (GO:0048311),0.5280264742804578,1.1084395495421118,0.3573717948717949,0.7135992202707441,1.0,2/12,4.41%,LRRK2;TRAK1
prerank,calcium-mediated signaling (GO:0019722),0.3846990033313292,1.1084139852638548,0.3127001067235859,0.7131535674141778,1.0,26/93,19.17%,PPP1R9B;TNFSF11;SLC9A1;LRRK2;CACNA1C;EGFR;CCR1;RCAN2;STIMATE;CXCR4;FKBP1B;SAMD14;ATP2A2;LAT2;PPP3CA;PTPRJ;RCAN3;TPCN2;P2RX7;NUDT4;TRPM4;MCTP2;PTPRC;EIF2AK3;PRNP;IRGM
prerank,potassium ion export across plasma membrane (GO:0097623),0.5147336839679273,1.108080124411055,0.35661218424962854,0.7134699860078358,1.0,2/13,4.90%,KCNT2;KCNA5
prerank,negative regulation of viral genome replication (GO:0045071),0.42726582268054236,1.107794045992071,0.3267080745341615,0.7137374293132447,1.0,14/40,20.62%,TNIP1;ILF3;SHFL;CCL5;EIF2AK2;OASL;SETDB1;TNF;RESF1;TASOR;HMGA2;PLSCR1;TRIM6;ISG15
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5356549933767498,1.1076845378531384,0.353030303030303,0.713510086700656,1.0,2/11,3.66%,NOS1AP;TREM2
prerank,mitochondrial protein processing (GO:0034982),0.5365843603413769,1.107544956169473,0.34796747967479674,0.713341798362527,1.0,5/11,14.18%,STOML2;OMA1;PMPCB;SPG7;PMPCA
prerank,cell junction organization (GO:0034330),0.39230456631103583,1.106616514837311,0.3295838020247469,0.715138247875531,1.0,20/71,14.48%,VMP1;FLNC;SDK2;PPFIBP2;OPHN1;LIMS1;TGFB3;CDC42;RAB8B;L1CAM;PPFIBP1;SEMA3E;TGFB2;FBLIM1;RHOA;SDK1;ELFN1;SMAD3;PSEN1;PPFIA4
prerank,neuron projection development (GO:0031175),0.3693052501696995,1.1064387730844907,0.28439425051334705,0.715054065900024,1.0,33/168,12.49%,GAS7;GPM6B;LAMB1;PPP1R9B;MAP4K4;TAOK1;LRP12;ATXN10;LRRK2;EPHB3;APOE;BLK;MAP1S;PTEN;OPHN1;DTNBP1;IFT88;CDC42;DLG4;TAOK3;VAPA;DCLK1;L1CAM;TRIO;DICER1;SAMD14;DBN1;NRK;DBNL;PTPRM;CAMSAP2;GSK3B;MICALL2
prerank,positive regulation of gene expression (GO:0010628),0.35494731122491835,1.1063830696179224,0.198,0.7146953108493147,1.0,98/442,18.23%,GLMN;RBMS3;PRR16;ITGB8;SEC16B;BCL3;ADAM19;YAP1;SFRP4;NOS1AP;CRP;TLR2;FGF7;BATF;MITF;PLD1;EGFR;TAF1D;TLE1;TREM2;STAT3;E2F1;PHF2;UBR5;EPHX2;LGALS9;PLA2R1;LIMS1;CD36;POLR1E;EGF;DTNBP1;ATM;EIF2AK2;VSTM2A;EMILIN1;TMEM119;PID1;FUBP1;SAMD4A;ANGPT1;MAPK11;MSN;CELF1;TNRC6B;NIBAN1;TGFBR1;MAP2K1;WNT5A;RPS6KB1;GAPDH;NAT10;MOV10;NFE2L2;DNMT3B;SPRY2;TNF;GSK3B;FGF2;NTRK3;P2RX7;SPHK2;PIK3R1;DDRGK1;CTCF;SMAD3;PSEN1;POLR1B;BMP7;YTHDF3;FMR1;TAF1A;RPL11;PDCD10;RIPK1;SETX;SMAD1;SMO;HIF1A;FGF18;MED26;PRKAB1;PRKDC;POU3F3;LAMTOR5;OLFM1;MAPK1;AKT1;CALCOCO1;EIF2AK3;ATF4;ETS1;POLR2L;INHBA;PLXNB2;POLR2K;AGT;RBPJ
prerank,peptide cross-linking (GO:0018149),0.45357630209941263,1.1057825187660173,0.35356200527704484,0.7157066267772234,1.0,1/25,0.36%,COL3A1
prerank,hepaticobiliary system development (GO:0061008),0.46734918379257645,1.1056763280197393,0.33709449929478136,0.7154583698879871,1.0,5/20,5.10%,PRKCSH;ARID5B;PHF2;PKD2;NF1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.47593012020684733,1.1055450801524935,0.3629842180774749,0.7153032981465942,1.0,5/20,5.86%,ZFP36L1;MEIS2;MAFB;MEIS1;CDK6
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4862544017603114,1.1051018197197116,0.3620689655172414,0.7158912875828609,1.0,8/18,22.84%,ADAM19;APOE;ABCG1;PSEN1;PSENEN;NCSTN;PSEN2;TMCC2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.2762250098207534,-1.1049747013466904,0.2328767123287671,0.7504747184371475,1.0,16/56,14.90%,TEK;CAV1;NRXN1;GRID2;IL1RAPL1;CLDN5;CNTNAP2;KDR;CLSTN3;SYNDIG1;CUX2;LRRC4B;CLSTN1;TSC1;PTPRD;BDNF
prerank,regulation of lymphocyte migration (GO:2000401),0.536641203881361,1.104939049032794,0.3590551181102362,0.7158470730335765,1.0,3/10,8.23%,SPN;MIA3;MSN
prerank,dendritic spine morphogenesis (GO:0060997),0.49986672852481245,1.104935979180186,0.3462109955423477,0.715342683079443,1.0,4/15,7.01%,EPHB3;PTEN;CDC42;DLG4
prerank,DNA integrity checkpoint signaling (GO:0031570),0.42875186750936867,1.104528761617937,0.36239103362391034,0.7158900278388217,1.0,12/36,18.59%,BRIP1;DNA2;E2F1;ATM;ATR;SETMAR;TIMELESS;USP28;CLOCK;ATRIP;RAD9A;HINFP
prerank,plasma membrane organization (GO:0007009),0.39949582448309623,1.104480433537193,0.33256880733944955,0.715495577262198,1.0,17/61,18.75%,PLSCR5;COL5A1;UGCG;CHMP4A;MYH9;TLCD2;EHD2;CXCR4;SNX33;SNX9;BIN3;P2RX7;PLSCR4;ANXA6;ANO6;EPB41L3;SPTBN1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5122974836062253,1.1040383539630871,0.3676923076923077,0.7161111764327418,1.0,2/12,2.50%,GLI2;MYCBP2
prerank,cytosolic transport (GO:0016482),0.37719025455929156,1.1039387408296024,0.30965005302226933,0.7158647724732341,1.0,36/108,22.67%,CLTC;HEATR5A;AP4M1;STX6;TMEM87B;HOOK2;VPS13C;MYO1D;RAB7A;GOSR1;GBF1;RAB9A;ANKFY1;GAK;PTPN23;EEA1;DENND5A;SNX2;EPS15;SNX5;ANKRD27;KIF16B;TBC1D10B;WASHC1;PIK3C3;HOOK1;SYS1;BECN1;VPS35;TRIM27;SPAG9;GOSR2;RAB5A;SNX6;CORO7;SNX1
prerank,calcium ion transmembrane transport (GO:0070588),0.385316066866158,1.1039028700131737,0.3154435925520263,0.7154333886426705,1.0,22/86,18.80%,MCOLN2;CACNA1A;STOML2;CACNA2D1;CACNA1C;PKD2;TRPC6;SLC24A5;PMPCB;ATP2A2;ATP2B1;MICU2;SPG7;P2RX7;PMPCA;TRPM4;MCUR1;ORAI1;MAIP1;ANO6;TRPC4AP;MICU3
prerank,regulation of cholesterol transport (GO:0032374),0.46540796601668954,1.1036950076713714,0.36427566807313644,0.7154478210483314,1.0,2/20,4.25%,LRP1;ABCA2
prerank,O-glycan processing (GO:0016266),0.40397409664401274,1.103691327340429,0.3581395348837209,0.7149483995346064,1.0,7/54,11.10%,B4GALT5;ST6GAL1;GALNT3;ST3GAL3;GXYLT2;ST3GAL1;GALNT11
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.36070595562517616,1.1036574399333396,0.22945891783567135,0.7145243864711915,1.0,76/341,17.74%,PSMA7;RNF150;MYLIP;KCTD21;TNFAIP3;SPSB1;KLHL22;FBXL7;USP9X;MAD2L1;SMURF2;UBR4;CNOT4;APPBP2;RNF144A;PLK1;ANAPC11;SIAH2;MIB1;CDC27;VPS4A;TOM1L1;BAG6;RNF111;SPOP;TRIM13;CBL;FBXW7;AREL1;PSMB8;RAD23A;ARIH1;NTAN1;PSMA6;TBL1X;RAD23B;UBE2L3;TGFB1I1;VPS37C;UBE2R2;PTPN23;DCAF11;FBXO7;NFE2L2;RNF213;KCTD10;RNF19B;FBXW11;ZSWIM8;PSMF1;RNF149;UBE2K;MAEA;UBE2W;RNF11;DTX3L;PSMA8;SMURF1;ITCH;NEDD4;FBXL19;PSMD2;PSMD12;SQSTM1;KLHL25;PSMD11;RBCK1;CLOCK;PCNP;PSMD14;KCTD2;RC3H2;DDB1;MDM2;PSMB1;FBXW4
prerank,regulation of isotype switching (GO:0045191),0.5032723489647999,1.103607228315453,0.36053412462908013,0.7141408346635872,1.0,5/14,18.69%,PARP3;SHLD3;RIF1;PAXIP1;HMCES
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4685034127567588,1.1033559172155538,0.3473541383989145,0.714243047453083,1.0,10/23,22.19%,SMAD2;NREP;SMURF2;ITGA3;SMAD3;SMAD4;LATS2;TRIM33;DKK3;LATS1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3799540178493109,1.1031968650576875,0.31965442764578833,0.7141569541262517,1.0,27/98,21.08%,ADIPOQ;SFRP4;PDGFRB;DHRS4;APOE;CCL5;EGF;PPARG;PID1;ANGPT1;GRB2;RAB1A;FMR1;CD63;RIPK1;AKT1;INHBA;PAX8;AGT;NFKBIA;XDH;ACACA;FASN;GADD45A;DCXR;EIF4G1;ZC3H12A
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5453897995554651,1.1031403493266376,0.3776,0.7137925563229113,1.0,2/10,8.25%,SERPINE2;ADAMTS18
prerank,regulation of intracellular signal transduction (GO:1902531),0.3584613940341106,1.1030342120899723,0.22122122122122123,0.7135269575760107,1.0,104/420,17.67%,DLC1;BCL3;MAP4K4;TAOK1;SYDE1;TNFSF11;VAV2;ARHGAP15;CMKLR1;RHOJ;LRRK2;BRIP1;ARHGAP24;VAV3;BIRC3;DNA2;SPRED1;ARHGAP32;EGFR;KALRN;PIP5K1B;NUAK1;TREM2;RICTOR;ITSN1;KMT5A;PTPN13;PTEN;PRKD2;RHOD;PIP4K2A;OPHN1;TAF7;FGD4;NF2;ATP6AP2;ATM;SRGAP1;CDC42;EHMT1;NOC2L;ARHGDIG;TAOK3;RASSF2;MAPKAP1;MAPK11;PRKAR1B;ARHGEF19;RRAGC;ATR;TRIO;WNT5A;HDAC1;CSNK2A1;CSNK2A2;TPX2;PRDM1;ARHGEF12;MTA2;NOP2;TTI1;PREX1;FAM13B;GNAI1;NRK;RCN3;RHOA;VAV1;PJA2;TNF;ARHGAP6;NTRK3;AKAP13;RASD2;TRAF2;BRPF1;SPHK2;GPAT3;ARHGAP22;RMI1;ARHGEF18;ARHGAP35;DAPK2;TAF4;RPL11;RAC1;BANP;RHOF;PRKAB1;DEPDC1B;SQSTM1;STK4;ARHGAP9;ATRIP;TRAF5;ARHGDIA;GNA12;MAPK1;AKT1;PHF20;ING5;MDM2;RAD9A;TAF2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.416036353744844,-1.103014213057192,0.32098765432098764,0.7537097740904377,1.0,3/14,3.04%,PRKCZ;MALT1;IL18
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.5435461059303233,1.1028843131176678,0.3829457364341085,0.7133830576373236,1.0,2/10,5.59%,PDXP;CARMIL1
prerank,regulation of cell cycle process (GO:0010564),0.37529851594799774,1.10265606428216,0.3304628632938644,0.7134659600251252,1.0,39/104,24.43%,PDXP;CDKN2B;DYNC1H1;NUGGC;SFRP1;PLK1;CDC42;KLHL13;ZFYVE26;BORA;CSNK2A1;CSNK2A2;SND1;DBF4;SETD2;ENTR1;CALM2;MAD1L1;PIK3R4;FSD1;RCC1;PIK3C3;OBSL1;SH3GLB1;KIF20A;FBXO5;PIN1;CDK13;HMGA2;PLK2;MYO19;E4F1;BECN1;KIF11;YTHDF2;PRMT5;CALM3;TTL;CUL9
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5344763809553829,1.1022952965474648,0.38474295190713104,0.7138278280648717,1.0,6/10,25.00%,DISC1;CX3CL1;KDM1A;SMARCD3;FZD3;VEGFA
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3920464901606844,1.101757056097107,0.32036613272311215,0.714705160564482,1.0,19/62,20.96%,POU5F1;STAT3;NUP37;PUM1;RAE1;PPARG;NUP153;WTIP;FMR1;NDC1;NUP35;NUP188;SEC13;POLR2L;POLR2K;NUP214;AGO2;EIF4G1;NUP107
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4265706242110086,1.1015732442098731,0.3524904214559387,0.7146494116310323,1.0,10/38,15.12%,TNFAIP3;CFLAR;SFRP1;ICAM1;SP100;BMP5;CASP8;GSK3B;TRAF2;RIPK1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3643744917742567,1.101407054300805,0.30256410256410254,0.7145815076722953,1.0,40/166,18.10%,PRR16;ZEB2;BCL3;GLI2;NOS1AP;IRS1;PDGFRB;DNA2;PLD1;EGFR;PRKD2;PKD2;CD36;CCL5;EGF;BRPF3;ARNT;SAMD4A;NMD3;NIBAN1;RPS6KB1;SLC25A37;NAT10;PTPN2;GCK;TNF;FGF2;GIPC1;SMAD3;CTC1;YTHDF3;FMR1;HIF1A;PRKDC;SREBF1;AKT1;DDB1;GLI1;ATP7A;PLXNB2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.2995619897190794,-1.1012733708586055,0.2784090909090909,0.7564369619867791,1.0,12/47,10.96%,EXOC6;STXBP6;KIF13A;EXOC6B;GOPC;GGA1;VAMP4;PREPL;ARL3;NSF;ANK3;EXOC2
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.33132671084380066,-1.1009711274800211,0.3218884120171674,0.7552175137168341,1.0,6/30,8.96%,KIF13A;GGA1;VAMP4;PREPL;NSF;ANK3
prerank,cellular response to hormone stimulus (GO:0032870),0.3975884684121404,1.1008694572533322,0.3412698412698413,0.7153924564356481,1.0,13/69,11.60%,ZFP36L1;ROBO2;GHR;SLIT3;STAT3;ARID5A;CTSS;SFRP1;CTSL;UBE2L3;CTSB;PELP1;GCK
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3611360379521721,-1.100415913338099,0.2791519434628975,0.754736352393608,1.0,4/22,1.14%,DMD;PDE4B;CACNB2;CACNB4
prerank,regulation of synapse maturation (GO:0090128),-0.46246864939825916,-1.1004152799212898,0.3413333333333333,0.7526208285590247,1.0,4/10,18.18%,NRXN1;ARHGEF15;CAMK2B;RELN
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3720490817878976,-1.1004084965151417,0.34285714285714286,0.7505355027079332,1.0,5/18,10.35%,CHRM2;PLCB1;AGRN;GNA11;GRK2
prerank,negative regulation of cell aging (GO:0090344),0.49332059624606134,1.100299986889085,0.36324786324786323,0.7163107744569664,1.0,7/16,21.73%,AKT3;CDK6;TERT;MAP3K3;FBXO5;HMGA2;YBX1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5384317559309281,1.1002988987496543,0.36363636363636365,0.7158117023490289,1.0,3/10,15.12%,LRRK2;NFE2L2;RIPK1
prerank,negative regulation of vascular permeability (GO:0043116),0.5174696582822387,1.1002924914875702,0.3763440860215054,0.7153255303660848,1.0,3/12,10.88%,PDE3A;ANGPT1;PTPRJ
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3802578970542922,-1.100252259497944,0.35494880546075086,0.7488375290470298,1.0,3/18,5.98%,ATP1A2;CAV1;SLC43A2
prerank,positive regulation of protein modification process (GO:0031401),0.35968618351805354,1.1002218832106465,0.296220633299285,0.7149870452674038,1.0,46/203,17.93%,DLC1;C3;IL34;ADIPOQ;TAOK1;NOS1AP;LRRK2;CD40;FGF7;EGFR;TREM2;FAM20A;CCND3;RAP2A;TMEM119;ANGPT1;GPNMB;EFNA5;NIBAN1;FAM161A;RAB3GAP2;FBH1;PPP2R5A;FNIP1;PTK2;ACVR2A;ATG7;TNF;VEGFC;FGF2;NTRK3;SPPL3;RAB3GAP1;WDFY2;CALM2;FMR1;RAC1;RIPK1;FGF18;STK4;PELI2;CSNK1D;PTPA;AKT1;ANKLE2;CLIP3
prerank,establishment of spindle localization (GO:0051293),0.5082751017065354,1.0999122115899274,0.37147102526002973,0.7152832192061018,1.0,7/14,27.10%,DYNC1H1;LLGL1;ZBED3;MAP4;KPNB1;CLASP2;CLASP1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.40317737266441034,1.0998769132187722,0.34717416378316035,0.7148721969516451,1.0,12/60,16.43%,RUNX2;TCF7L2;PTEN;SUB1;TNRC6B;CBFB;MOV10;MED13;MED15;PAXIP1;MED26;ATF7IP
prerank,keratan sulfate catabolic process (GO:0042340),0.5272769683061442,1.0996995336365074,0.3723404255319149,0.714823838292787,1.0,4/11,14.06%,LUM;PRELP;GALNS;GNS
prerank,icosanoid metabolic process (GO:0006690),0.42160592356205395,1.0994630976971616,0.337037037037037,0.7149149894837007,1.0,6/40,14.60%,CYP1B1;DPEP2;FADS1;ABCC1;TBXAS1;PLA2G4A
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4873679575418826,1.0989174099267074,0.36603221083455345,0.7157713369161786,1.0,5/16,18.70%,CHMP4A;CHMP4B;CHMP7;LEPROT;LEPROTL1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5314689565077624,1.0984120352199678,0.38772455089820357,0.7166064930156356,1.0,2/11,6.40%,XCL1;AHR
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.39016927089639175,1.0981116932006108,0.34758155230596177,0.7168546253459266,1.0,26/73,23.73%,GLMN;TAF1D;CGGBP1;PHF1;PHF2;POLR1E;DNMT3B;SPI1;SPHK2;CTCF;POLR1B;TAF1A;TFAP2C;PPHLN1;POLR2L;POLR2K;HDAC5;TASOR;POLR1G;TRIM27;SUZ12;POLR1A;PPM1D;DDX21;BAZ1B;MPHOSPH8
prerank,cortical cytoskeleton organization (GO:0030865),0.4211400780637552,1.0976599770422746,0.3506024096385542,0.7175110130702405,1.0,18/41,23.43%,RND3;FMNL2;FMNL3;FHOD3;RHOD;LLGL1;LCP1;RHOA;TNF;RAC1;RHOF;PLEK;EPB41L3;DLG1;RHOC;ROCK2;ROCK1;STRIP1
prerank,L-serine metabolic process (GO:0006563),-0.4535591128916962,-1.0973491750180708,0.37433155080213903,0.7548105474444091,1.0,5/10,36.08%,PSAT1;CBS;PHGDH;SERINC3;SHMT1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.44467434443097,1.0972457605194779,0.35113484646194926,0.7180553205561626,1.0,8/30,15.12%,TNFAIP3;CFLAR;ICAM1;BMP5;CASP8;GSK3B;TRAF2;RIPK1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.46993415873223643,1.0962505023954867,0.3539325842696629,0.72002021728415,1.0,2/20,3.24%,C3;CASP1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.43887965678156343,1.0961075231336974,0.3581699346405229,0.7198781695765674,1.0,4/30,5.04%,XCL1;TSLP;STAT3;LGALS9
prerank,hexose biosynthetic process (GO:0019319),0.41155891315117854,1.0959824207554352,0.3737864077669903,0.7196851198627735,1.0,7/42,18.57%,SLC39A14;ENO1;GAPDH;SLC25A10;ATF4;SORD;CHST15
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.400580877753345,-1.0959428294130602,0.3424657534246575,0.7566305677636374,1.0,8/16,31.17%,ERLIN1;ACADL;ERLIN2;ACADVL;SIRT4;BRCA1;CEACAM1;SOX9
prerank,ganglioside biosynthetic process (GO:0001574),-0.3972598449400539,-1.0956954507994001,0.3522388059701492,0.7551962820948941,1.0,7/15,12.49%,ST6GALNAC3;ST8SIA4;ST3GAL5;ST8SIA6;B4GALT6;ST8SIA2;ST6GALNAC5
prerank,pancreas development (GO:0031016),0.5134986906190564,1.0956296887063242,0.3712948517940718,0.7200665135663237,1.0,3/12,11.11%,TCF7L2;NKX6-1;NPHP3
prerank,establishment of mitotic spindle orientation (GO:0000132),0.46022736284807275,1.0952271589360074,0.35924932975871315,0.7206021830650341,1.0,6/23,15.66%,MAD2L1;PLK1;GPSM2;INSC;FBXW11;NDEL1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.38474594020641806,-1.0951400983566073,0.3284132841328413,0.7547193497614914,1.0,9/17,34.13%,RB1;ZWILCH;IK;BUB3;KNL1;TTK;ZW10;MTBP;SPDL1
prerank,cilium-dependent cell motility (GO:0060285),0.45798000239091374,1.0950583514390737,0.3627450980392157,0.7205729562559829,1.0,1/22,0.46%,TEKT4
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5042083719919394,1.094854106455385,0.3694968553459119,0.7205522796088621,1.0,2/13,5.97%,POU5F1;PPARG
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3745062405695026,1.0944316927603732,0.3265524625267666,0.7211013792757262,1.0,27/118,14.32%,SPARC;FMNL2;BCL6;LRRK2;TNFAIP3;EPHB3;KIF13B;NF1;SFRP1;RAP2A;PLXND1;PID1;ABI2;SDC2;GPNMB;EFNA5;INF2;SP100;RNH1;PDZD8;ZMYM4;BMPER;GSK3B;FGF2;ARHGAP35;WTIP;PHLDB2
prerank,calcium ion import (GO:0070509),0.440394370650594,1.0942147150136103,0.38246505717916135,0.7211731327716561,1.0,8/28,18.80%,CACNA1A;CACNA1C;ATP2A2;MS4A1;MICU2;MCUR1;MAIP1;MICU3
prerank,negative regulation of hippo signaling (GO:0035331),-0.42355448988290667,-1.0941828570627992,0.32335329341317365,0.7553230488759426,1.0,6/12,23.69%,CIT;WWC2;MARK3;WWC1;MAP2K3;MAPK14
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.47901388108722814,1.0939157504917392,0.3889695210449927,0.7214323167438565,1.0,6/18,15.12%,NCOR2;EGFR;TERT;MAP2K1;TNF;RIPK1
prerank,modulation by symbiont of host process (GO:0044003),0.5336681207842269,1.09327154763935,0.36932707355242567,0.7225263098849193,1.0,2/10,6.24%,TLR2;ENO1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3567652293172082,1.093080418640746,0.26104417670682734,0.7225170741258979,1.0,102/348,22.52%,C3;CEMIP;IL34;ADIPOQ;THBS4;TEC;GHR;JTB;LRRK2;CD40;FGF7;JAK2;NRP1;TNKS1BP1;EGFR;TREM2;LCP2;PRKD2;DDR2;ACVR1;FAM20A;CACUL1;EGF;CCND3;RAP2A;TGFB3;PLK1;INHBB;TOM1L1;TMEM119;RASSF2;RPTOR;ANGPT1;GPNMB;S1PR2;EFNA5;NIBAN1;TGFBR1;BMP5;FBH1;FNIP1;PTPRJ;PTK2;SNX9;VTN;TGFB2;ACVR2A;SPRY2;TNF;VEGFC;FGF2;NTRK3;UBE2K;DDRGK1;ITGA5;WDFY2;CALM2;BMP7;SRC;AKAP9;FMR1;SMAD4;PDCD10;RAC1;CX3CL1;RIPK1;IL6R;FGF18;ALS2;STK4;PELI2;ACVRL1;CSNK1D;PTPRC;MAPK1;AKT1;CLIP3;INHBA;AGT;CDK9;AXIN2;PRNP;DVL2;IRGM;PIN1;GDF9;GDF11;EIF4G1;TRIM6;BMPR1A;MMD2;NPTN;AXIN1;VEGFB;PAK1;RPS6KA4;RAF1;LATS1;CSF1;SDCBP;ROCK2;CD80
prerank,regulation of synapse assembly (GO:0051963),0.41023980410175376,1.09246973583141,0.34911242603550297,0.723517000474285,1.0,6/46,3.57%,ROBO2;MDGA1;TLR2;SLIT1;GPC6;EPHB3
prerank,regulation of interferon-beta production (GO:0032648),0.40887828643820656,1.0924026846015593,0.3547619047619048,0.7232085800869327,1.0,20/46,26.98%,TLR2;IRF7;REL;TLR7;IRF1;TIRAP;POLR3A;POLR3D;TRIM56;RELB;RNF135;ISG15;YY1;SIRPA;TRAF3;TLR3;NLRC3;PYCARD;PTPRS;DHX58
prerank,macrophage chemotaxis (GO:0048246),0.5414802188343544,1.092172996058747,0.38576158940397354,0.7232926865810814,1.0,2/10,10.36%,CCL5;CCL2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.42327995907178617,1.0918815482317439,0.3648989898989899,0.7235296038220193,1.0,8/36,15.67%,JAK2;NRP1;EGF;FBXW7;HDAC1;CCL2;BTC;HIF1A
prerank,L-glutamate transmembrane transport (GO:0015813),0.5315910345004463,1.0916484263423336,0.3719806763285024,0.7236161901276895,1.0,1/10,0.63%,SLC1A3
prerank,positive regulation of viral process (GO:0048524),0.395164362296196,1.0913130638431072,0.35518474374255066,0.7239553073274936,1.0,19/60,19.93%,MDFIC;TMEM39A;PPID;CCL5;VPS4A;RAB7A;RAD23A;GTF2F2;RSF1;STAU1;GTF2F1;CCNT1;TBC1D20;DDB1;POLR2L;POLR2K;CDK9;TYRO3;KPNA2
prerank,maintenance of protein location in nucleus (GO:0051457),0.47054690525431964,1.0902719709108697,0.37777777777777777,0.7260859063650229,1.0,4/20,8.93%,BCL3;MORC3;SKP1;SP100
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4379391535854443,1.0896398674192043,0.3592105263157895,0.7271924167124395,1.0,2/26,4.25%,CYP1B1;ABCA2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4666691126085109,1.0896034665179062,0.37390029325513197,0.7267972722753403,1.0,3/18,8.45%,DCN;RALA;SPIRE1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4293533838775323,1.0895267788924345,0.3782051282051282,0.7265114538783982,1.0,16/35,21.63%,PMEPA1;YAP1;ZMIZ1;PADI2;UBR5;DDX17;SAFB;SRC;NEDD4;CALCOCO1;RBFOX2;NR3C1;MED1;TMF1;TADA3;RNF14
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4142181302012049,-1.089386149329463,0.34293948126801155,0.766648032614477,1.0,6/13,20.50%,CPEB3;PABPC1;TOB1;TNRC6C;POLR2G;ZFP36
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3787604329275337,1.0892804501773048,0.35053763440860214,0.7266159760767301,1.0,17/91,16.67%,SLC39A14;HEPH;CP;SLC11A2;FXN;CUL1;ACO1;SKP1;SLC22A17;SLC31A1;IREB2;ARF1;SMAD4;FRRS1;SLC39A6;SLC30A9;ATP6V1G1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.3536133705105686,-1.0870394930306617,0.32677165354330706,0.7712352792012751,1.0,9/25,22.10%,PRPSAP2;PAICS;PRPSAP1;ADK;GMPR;DCK;PRPS1;PRPS1L1;APRT
prerank,multivesicular body assembly (GO:0036258),0.4325227094772453,1.086949484954928,0.3748344370860927,0.7319915587070109,1.0,6/30,15.31%,CHMP4A;CHMP4B;VPS4A;VPS37C;CHMP7;CHMP2B
prerank,protein ubiquitination (GO:0016567),0.351792414356078,1.0868003907957324,0.246,0.7318848677805514,1.0,99/471,17.74%,PSMA7;TRIML2;SH3RF3;DTX4;DCAF15;PDZRN3;MYLIP;PEX10;FBXO40;MYCBP2;SPSB1;ARRDC4;KLHL22;HECTD2;FBXL7;USP9X;CUL1;SMURF2;UBR5;BCL2;TRIM21;CNOT4;RNF144A;PLK1;ANAPC11;SIAH2;MIB1;CDC27;ATG3;RNF111;KLHL13;SKP1;SASH1;SPOP;NPEPPS;TRIM13;TPP2;CBL;FBXL18;FBXW7;FBXO30;AREL1;PSMB8;ARIH1;BRAP;PSMA6;SH3RF1;DTX2;UBE2L3;PELI3;FBH1;CBFB;TRIM44;UBE2R2;EIPR1;UBE2J1;FBXO7;NFE2L2;RNF213;KCTD10;RNF19B;PJA2;FBXW11;RNF181;ZSWIM8;PSMF1;UBE2K;TRAF2;UBE2W;FBXO2;RNF11;USP22;VCPIP1;DTX3L;RNF141;PSMA8;SMURF1;ITCH;NEDD4;HIF1A;FBXL19;PSMD2;PRKDC;PSMD12;KLHL25;PSMD11;PELI2;RBCK1;TRAIP;TNKS2;PCNP;PSMD14;KLHL7;TRIM33;RC3H2;DDB1;MDM2;PSMB1;FBXW4
prerank,regulation of cellular respiration (GO:0043457),-0.3881710826066441,-1.0867805405809177,0.36271186440677966,0.7699107618986736,1.0,5/17,16.83%,PRDM16;CBFA2T3;IDE;NOP53;IFNAR1
prerank,response to retinoic acid (GO:0032526),0.3992353916405855,1.086693605685448,0.3633217993079585,0.7316600391177318,1.0,11/59,15.71%,WNT2;ASXL1;GATA6;WNT9A;RXRG;ATM;WNT5A;TMEM161A;PTK7;SETX;ADNP2
prerank,keratan sulfate metabolic process (GO:0042339),0.44184853679898695,1.0865713979771165,0.38305941845764857,0.7314676918064514,1.0,10/31,15.44%,LUM;B4GALT5;ST3GAL3;PRELP;GALNS;ST3GAL1;CHST1;GNS;SLC35D2;B4GALT2
prerank,histone H3-K4 trimethylation (GO:0080182),0.5217378798362552,1.0864018718479413,0.40654205607476634,0.7313895360182214,1.0,3/11,12.02%,KMT2A;OGT;TET2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3539427901723208,1.0863284354189113,0.2685370741482966,0.7310844845008271,1.0,106/336,24.75%,RAD51B;BCL3;PARP3;YAP1;TAOK1;BCL6;POLE3;SUSD6;IRF7;BACH1;VAV3;SMC1A;BATF;RAD52;BLK;RBBP5;IKBKE;E2F1;PHF1;UBR5;BABAM2;BCL2;GNL1;INO80;XRCC3;ATM;DDX11;PDS5B;PWWP3A;GTF2H1;BCL2L2;LIG1;TAOK3;NEK4;GRB2;PDS5A;MCM7;ATR;RNF169;ZBTB38;FBH1;MCM9;ALKBH1;USP3;TIMELESS;POLI;MGMT;TANK;RIF1;PSEN1;FMR1;VCPIP1;ASF1A;DTX3L;NIPBL;MMS19;SETX;CHCHD6;PRKDC;USP28;CGAS;TRAIP;ATRIP;PNKP;MTREX;DDB1;RAD9A;SLF2;ZBTB40;RBBP8;FBXO31;HINFP;HMCES;EID3;GADD45A;MBD4;DCUN1D5;SMC5;FANCC;FOXP1;PARP4;YY1;ZC3H12A;EPHA2;PAK1;RBBP6;CDKN2AIP;ZRANB3;RPA1;SLX4;ENDOV;CBX5;RAD51;MNAT1;MSH6;DOT1L;BAZ1B;ETAA1;MACROD1;TRRAP;CDKN1A;TNFRSF1B;OARD1;TRIP12;BRAT1;FAM111A
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.43663236005460887,1.0858060370091784,0.36387782204515273,0.7318896575677177,1.0,7/28,13.10%,CASP8AP2;BAG3;BCL2;TNFRSF1A;CASP8;TNF;SPI1
prerank,peroxisome organization (GO:0007031),0.4412723986278831,1.085754027143016,0.3686382393397524,0.7315107444363951,1.0,2/25,2.13%,SEC16B;PEX10
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5011127136523248,1.0851469798885864,0.38073394495412843,0.7325717360796343,1.0,3/13,15.60%,EMILIN1;PTPN1;NEDD4
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4697033208573469,1.0848345108272879,0.38493723849372385,0.732826748705035,1.0,1/20,0.48%,ADIPOQ
prerank,nucleic acid metabolic process (GO:0090304),0.38719431147287864,1.0847307759687033,0.36454849498327757,0.7325558655967715,1.0,23/69,23.26%,ENPP1;ATXN2;DNA2;WDR74;GTF2F2;SETMAR;NCBP2;HNRNPH2;GTF2F1;MMS19;DXO;POLG;RBMX;RBFOX2;DDX1;POLR2L;POLR2K;KPNA2;DUSP11;DDX24;HNRNPC;POLR2D;PCBP1
prerank,heterochromatin organization (GO:0070828),0.5005309957187126,1.0846816188619666,0.37554585152838427,0.7321650096131078,1.0,5/14,12.13%,SNAI1;POLE3;BAHD1;SETDB1;SETDB2
prerank,negative regulation of hydrolase activity (GO:0051346),0.4032518232393172,1.0843926642020547,0.35792019347037485,0.732407961051308,1.0,4/49,7.54%,SLC39A14;LRRK2;PPP1R36;RRP1B
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.4470609561605212,-1.0843519378604691,0.38107416879795397,0.7747541189345516,1.0,8/10,42.16%,WWP2;NDFIP2;CORO2B;NDFIP1;MAPT;SNX12;PPM1F;DNAJA1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5012258747572041,1.0843175821015358,0.36578171091445427,0.7320698373431604,1.0,4/13,8.57%,NRP1;PLXNC1;PLXND1;PLXNA3
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.3809826351765204,-1.0842800636141652,0.35668789808917195,0.7728714682020918,1.0,4/17,4.05%,ATP1A2;CACNB2;ANK2;KCNJ2
prerank,DNA recombination (GO:0006310),0.4223105977416026,1.0838756598037338,0.3502475247524752,0.7326922501486305,1.0,4/37,10.03%,RAD51B;RAD52;XRCC3;FBH1
prerank,regulation of protein neddylation (GO:2000434),-0.4506790075945343,-1.0837864760218687,0.3733681462140992,0.7721202097729484,1.0,4/10,8.10%,EPAS1;DCUN1D4;DCUN1D3;RPL5
prerank,homeostasis of number of cells (GO:0048872),-0.4224991605964625,-1.0835837161775006,0.35919540229885055,0.7706006860225147,1.0,3/12,6.10%,NOS3;CCN3;OCIAD1
prerank,amino sugar biosynthetic process (GO:0046349),0.5086229593376047,1.0828932916902587,0.37648809523809523,0.7346645055691857,1.0,4/12,17.56%,GFPT2;UAP1L1;AMDHD2;GNPDA2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.45995429379005154,1.0825376125911137,0.3869209809264305,0.7350839622905239,1.0,3/21,4.90%,NOS1AP;CACNA2D1;KCNA5
prerank,regulation of cellular response to stress (GO:0080135),0.3665601479227102,1.0823852173486213,0.3433155080213904,0.7349610908307852,1.0,28/115,17.65%,NEK6;DNAJB1;NUAK1;NUP37;CAMK2D;BAG3;RAE1;CREBBP;ATM;RPTOR;AIFM2;NEK4;CCAR2;ATR;NUP153;DNAJB6;DNAJC7;GSK3B;HSPH1;NDC1;NPAS2;NUP35;NUP188;BAG4;SEC13;MAPK1;YWHAE;ATF4
prerank,response to glucagon (GO:0033762),-0.3730136725711895,-1.082311645237574,0.34782608695652173,0.7720847917441562,1.0,6/19,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,activation of protein kinase A activity (GO:0034199),-0.393325625490596,-1.0820662951052533,0.3576158940397351,0.7706940527886766,1.0,6/16,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,negative regulation of biomineral tissue development (GO:0070168),0.45329237475559225,1.0820470619002867,0.38535911602209943,0.7353001617175116,1.0,2/21,4.31%,ENPP1;CCR1
prerank,protein phosphorylation (GO:0006468),0.3494363883019229,1.0818754753026751,0.23623623623623624,0.7352181293446378,1.0,110/478,17.81%,CCL11;RUNX3;PDGFRA;NEK6;MAP4K4;TEC;TAOK1;JAK1;MAST4;PEAK1;ERN2;TLR2;LRRK2;PDGFRB;JAK2;PRKCA;SMAD2;MARK1;EGFR;EPHB3;NUAK1;IRAK3;RICTOR;BLK;STK36;ILF3;IKBKE;AKT3;CAMK2D;PRKD2;DDR2;ACVR1;MORC3;FAM20A;CDK6;ATM;CDK14;EIF2AK2;PLK1;PTPN6;PPP4R1;EPHA1;TLR7;GTF2H1;TAOK3;DCLK1;CDK10;ABI2;HIPK4;NEK4;MERTK;PXK;FRK;MAST2;PRKAR1B;ATR;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;MAP4K5;HIPK3;RPS6KB1;ACVR1B;CDC42BPA;CCL2;FGFR1;PTK2;YWHAZ;NRK;CSNK1G2;TGFB2;GMFB;CDK7;ACVR2A;MYO3A;COQ8B;MAML1;GSK3B;CSNK1A1;ACVR1C;ABI1;MAP3K6;SRC;MKNK1;STK24;DAPK2;FES;TRIB1;VRK3;RIPK1;PIK3R4;CCNT1;PRKAB1;PRKDC;GRK4;STK4;FAM20B;ACVRL1;CSNK1D;MAPK1;AKT1;LATS2;CDKL1;MAP3K3;TYK2;EIF2AK3;TESK2;DCLK3;MAP3K12
prerank,cell-cell junction maintenance (GO:0045217),-0.4288062726247207,-1.081866973685204,0.37941176470588234,0.7692356822324902,1.0,1/11,0.05%,TJP1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5347853551537403,1.0815618713540618,0.408955223880597,0.7355268381236985,1.0,4/10,21.04%,PCBD1;KYAT1;ATP7A;QDPR
prerank,neuropeptide signaling pathway (GO:0007218),-0.27322540281493085,-1.0815268135930642,0.29357798165137616,0.7681371957995475,1.0,9/58,7.68%,SORCS1;GLRA3;SORT1;SORCS3;CPE;RAPGEF2;SORCS2;GLRA1;SORL1
prerank,autophagy of peroxisome (GO:0030242),0.507372269964286,1.0810032955753115,0.3996983408748115,0.736363678141645,1.0,5/12,16.47%,ATM;NBR1;PIK3R4;SQSTM1;PIK3C3
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3815440178964479,-1.0809387890734112,0.33774834437086093,0.7677966345060802,1.0,6/17,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,regulation of cytokinesis (GO:0032465),0.3786438288657599,1.0809100953812112,0.36604189636163176,0.736090530226241,1.0,26/78,20.30%,SVIL;PDXP;PLK1;CDC42;VPS4A;E2F8;KLHL13;ZFYVE26;DRD3;SETD2;OPN1MW;CSPP1;RHOA;ENTR1;GIPC1;CALM2;CDC14A;PIK3R4;FSD1;PIK3C3;SH3GLB1;KIF20A;PIN1;CDC14B;PLK2;MYO19
prerank,regulation of filopodium assembly (GO:0051489),0.4144297257075738,1.080520550379329,0.34827144686299616,0.7365311908008227,1.0,7/38,6.39%,MYO10;DPYSL3;NRP1;FSCN1;RALA;TGFB3;CDC42
prerank,dephosphorylation (GO:0016311),0.3613002896383007,1.0800356110828837,0.33958333333333335,0.7372236190781146,1.0,44/147,20.59%,PDXP;PTPN7;DUSP2;DUSP5;PTPN3;PTPN13;EPHX2;PTEN;PTPRZ1;PTPN6;PPP4R1;DAPP1;PTPN18;PTPN1;SSH1;PPP3CA;PPP2R2A;PPP2R5A;PTPRJ;PTPN9;PPP4R2;PTPRM;THNSL2;PPP1CB;FBXW11;DUSP28;DUSP26;ILKAP;SSH2;CTTNBP2NL;TIMM50;PPP6C;PNKP;PTPRC;PTPN5;PTPRA;DUSP6;MTMR3;MTMR2;MTMR6;MTM1;CDC14B;DUSP11;DUSP15
prerank,negative regulation of interferon-beta production (GO:0032688),0.5285117578031122,1.0799552079412165,0.40348101265822783,0.7369318395112824,1.0,7/10,26.89%,REL;RELB;YY1;SIRPA;NLRC3;PYCARD;PTPRS
prerank,natural killer cell mediated immunity (GO:0002228),0.47621007891346373,1.0793975010516172,0.37388724035608306,0.7378475434751571,1.0,2/15,13.13%,ULBP1;KIF5B
prerank,positive regulation of blood coagulation (GO:0030194),0.4663784878099374,1.0793061284548149,0.3806818181818182,0.7375694991614847,1.0,3/17,6.67%,USF1;APOH;HPSE
prerank,positive regulation of nuclear division (GO:0051785),0.43606519557565326,1.0786565958688168,0.3893333333333333,0.7386719600529777,1.0,5/25,13.23%,EDN3;PDGFRB;EGF;DRD3;BTC
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3782022389783727,1.078502070465494,0.37814207650273224,0.7385861502375773,1.0,22/75,20.54%,ADIPOQ;IRAK3;APOE;NR2F2;PTEN;NF1;LRP6;PLK1;PTPN1;PRKAR1B;PTPRJ;SPRY2;BMP7;CDKN1B;AKT1;LATS2;AGT;LRP5;GADD45A;PKIB;SPRY4;PRKCD
prerank,regulation of protein acetylation (GO:1901983),0.5006014837666837,1.0783995372419304,0.37254901960784315,0.7383363262326418,1.0,3/12,12.44%,TAOK1;FAM161A;GSK3B
prerank,oxoacid metabolic process (GO:0043436),0.43960573142951587,1.0777576227642336,0.3835263835263835,0.7394936978684724,1.0,2/27,2.97%,ENPP1;PPA1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4045178131552551,1.0777569201930526,0.38571428571428573,0.738998079185883,1.0,11/46,17.95%,JAK1;JAK2;RALA;CDC42;MSN;LMNB1;LCP1;TALDO1;ARF1;TYK2;CAPZA1
prerank,ventricular septum development (GO:0003281),0.4098129747843974,1.077147540592284,0.37576499388004897,0.7399862284649497,1.0,8/37,11.44%,ROBO2;SLIT3;ZFPM2;ACVR1;HEYL;TGFBR1;SALL1;TGFB2
prerank,chromosome organization (GO:0051276),0.37136494668717457,1.076852449047139,0.37041036717062636,0.7402196705121963,1.0,35/99,23.70%,TCF7L2;POLE3;MTHFR;PADI2;PHF1;RAE1;EHMT1;PWWP3A;BAHD1;HDAC1;RAD23B;HMGB2;BRWD1;TOP2B;SAFB;LRWD1;HMGN3;COPS6;TCF7L1;SMARCA4;HMGN1;NUCKS1;DDB1;HDAC5;SOX2;ZBTB7A;AXIN2;HMGA2;COPS3;RPS27A;LATS1;ACTL6B;MSH6;DOT1L;HDAC8
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.484418555169673,1.0765176045592673,0.38803894297635605,0.7405602560712453,1.0,6/16,16.13%,PIGW;PIGN;PIGL;PIGC;PIGP;PIGH
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.33425072673793704,-1.0763897077414581,0.36818181818181817,0.7787557589989003,1.0,8/30,10.49%,ACSL1;TECR;ELOVL7;ELOVL5;ABCD3;HACD1;HACD3;HACD4
prerank,protein modification by small protein removal (GO:0070646),0.3521490653627719,1.075773110887131,0.3420787083753784,0.741879155986656,1.0,50/252,16.12%,PSMA7;ASXL1;TNIP1;TNFAIP3;BIRC3;SMAD2;USP9X;SMURF2;BABAM2;OTULINL;PTEN;ASXL2;INO80;FOXK2;SIAH2;TADA2B;USP42;USP24;PSMB8;RAD23A;PSMA6;TGFBR1;OGT;RAD23B;USP12;OTUD3;USPL1;USP40;USP38;SENP6;USP3;RUVBL1;RHOA;PSMF1;TRAF2;SMAD3;MYSM1;USP22;VCPIP1;SMAD4;COPS6;RIPK1;SMAD1;PSMA8;STAMBPL1;HIF1A;PSMD2;PSMD12;USP28;PSMD11
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.45953991766651164,1.0757067466099794,0.38396624472573837,0.7415442262175868,1.0,1/18,0.45%,IL23R
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3436546484938075,-1.0756168523467386,0.3235294117647059,0.7789956305918022,1.0,8/27,9.26%,TJP1;TMEFF2;PRKN;RHPN2;SHANK3;ARHGAP28;SHANK1;INPP5K
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3521052354649932,-1.0753405610695566,0.33941605839416056,0.7756771864510968,1.0,11/21,27.25%,ERCC5;ERCC3;CHD1L;DDB2;GTF2H2;ERCC1;GTF2H4;GTF2H3;RBX1;RPA2;PARP1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3521052354649932,-1.0753405610695566,0.33941605839416056,0.7756771864510968,1.0,11/21,27.25%,ERCC5;ERCC3;CHD1L;DDB2;GTF2H2;ERCC1;GTF2H4;GTF2H3;RBX1;RPA2;PARP1
prerank,regulation of anoikis (GO:2000209),0.4582002704636997,1.075153652942167,0.38935574229691877,0.7424221793347472,1.0,6/19,14.06%,SNAI2;TLE1;BCL2;PTK2;ITGA5;SRC
prerank,regulation of microtubule depolymerization (GO:0031114),0.43768132095471934,1.074981888572138,0.38791946308724834,0.7423549157472564,1.0,6/25,12.48%,TAOK1;NAV3;MAP1S;TPX2;CAMSAP2;FGF13
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3611882229918629,1.074738447319386,0.3436213991769547,0.7424419078809273,1.0,20/152,12.75%,MC5R;ABCA1;IAPP;ADCY7;HTR1D;ADGRL3;RXFP2;ADCY2;ADM;ADCYAP1R1;CXCL10;GLP2R;S1PR3;GPR161;S1PR2;GNAI1;LPAR3;LPAR2;CALCRL;MC1R
prerank,regulation of postsynapse organization (GO:0099175),-0.33922796693556656,-1.0746446805350285,0.32340425531914896,0.7756603423326583,1.0,13/28,20.52%,EPHA4;TANC2;IL1RAPL1;SRCIN1;SHANK3;CDKL5;ARHGAP44;PDLIM5;ZDHHC15;ABI3;KIF1A;CFL1;PPFIA2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.49930534913847485,1.0743984530799027,0.4126506024096386,0.7427857829640387,1.0,3/13,10.36%,TLR2;JAK2;CCL2
prerank,modulation by symbiont of entry into host (GO:0052372),0.4859500126488232,1.0735557120349786,0.41294964028776976,0.7443942632301762,1.0,7/16,21.59%,TRIML2;TRIM21;EXOC7;TRIM6;TRIM27;TRIM62;HS3ST5
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4284630593364976,1.0731017697120127,0.36750998668442075,0.7450100556618688,1.0,5/26,6.39%,SLC9A1;SYNPO;ASAP3;ALMS1;CDC42
prerank,neuron projection morphogenesis (GO:0048812),0.3566579567600212,1.07230910512283,0.3700623700623701,0.7464570759138806,1.0,24/137,11.62%,GAS7;SLITRK6;MAP4K4;TNN;TAOK1;FARP1;LRRK2;EPHB3;MAP1S;BAIAP2;PTEN;DTNBP1;CDC42;LLGL1;DLG4;TAOK3;DCLK1;SDC2;S100A6;TRIO;DICER1;DBN1;NRK;DBNL
prerank,protein deubiquitination (GO:0016579),0.35162580807188143,1.072239858534819,0.3319838056680162,0.7461276818243375,1.0,47/242,16.12%,PSMA7;ASXL1;TNIP1;TNFAIP3;BIRC3;SMAD2;USP9X;SMURF2;BABAM2;OTULINL;PTEN;ASXL2;INO80;FOXK2;SIAH2;TADA2B;USP42;USP24;PSMB8;RAD23A;PSMA6;TGFBR1;OGT;RAD23B;USP12;OTUD3;USP40;USP38;USP3;RUVBL1;RHOA;PSMF1;TRAF2;SMAD3;MYSM1;USP22;VCPIP1;SMAD4;RIPK1;SMAD1;PSMA8;STAMBPL1;HIF1A;PSMD2;PSMD12;USP28;PSMD11
prerank,muscle tissue development (GO:0060537),0.4973931908618432,1.0720568547370188,0.40150375939849625,0.7460779709669807,1.0,3/13,5.10%,CSRP1;SHH;NF1
prerank,Rho protein signal transduction (GO:0007266),0.3935279877388827,1.0719278210519527,0.3817762399077278,0.7458809881002431,1.0,15/53,18.74%,COL1A2;RHOJ;TAX1BP3;RHOD;CDC42;ARHGDIG;PDPN;RHOA;ARHGAP6;RTKN;CDC42EP1;ARHGDIA;GNA12;CDC42EP4;EPS8
prerank,carbohydrate homeostasis (GO:0033500),0.3817609041771082,1.0719141478533623,0.3729003359462486,0.7454196415215009,1.0,7/67,5.97%,ADIPOQ;TCF7L2;IRS1;USF1;STAT3;PYGL;PPARG
prerank,histone H4-K16 acetylation (GO:0043984),0.46143773676811983,1.0714693908086068,0.40710382513661203,0.7460194183670773,1.0,3/19,9.03%,KMT2A;KANSL1;OGT
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4415866264967918,1.0712198114064184,0.39946380697050937,0.746167778108852,1.0,4/26,6.55%,NEK6;PLK1;ANAPC11;CDC27
prerank,phospholipid translocation (GO:0045332),0.43351532612729293,1.0712017396931701,0.40077821011673154,0.7457105445544829,1.0,3/28,2.43%,ABCA1;PLSCR5;ATP8B1
prerank,regulation of RNA metabolic process (GO:0051252),0.38840355274433763,1.070668048370304,0.37257142857142855,0.7464950376181122,1.0,9/59,10.49%,IGF2BP1;IGF2BP2;AFF2;MITF;PTBP3;RRP1B;CELF1;OASL;HNRNPH2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3088086606081628,-1.0703048243740212,0.33663366336633666,0.7858663542010512,1.0,7/34,12.33%,PDE4B;ATP1B1;ANK2;CALM1;ADRA1A;PDE4D;KCNQ1
prerank,microtubule polymerization (GO:0046785),0.43413567491217037,1.0698580213278395,0.3782722513089005,0.7479939977572926,1.0,12/28,19.95%,TUBG1;TPX2;FGF13;AKAP9;RANBP9;TUBGCP4;NDEL1;TUBG2;CSNK1D;TPPP;CKAP5;PIN1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3754596098921975,-1.069720128849648,0.35514018691588783,0.7855661846329488,1.0,5/17,10.98%,SLC12A2;SLC9A2;SLC6A1;SLC9A6;SLC9A7
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4304543214861763,1.0694756962042424,0.3906447534766119,0.7484177509606157,1.0,15/30,25.72%,ADIPOQ;PINX1;DCP2;NAT10;XRN1;CTC1;SRC;ACVRL1;HNRNPC;TERF1;BMPR2;CDKN1A;CERS1;NIBAN2;TERF2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.40987493883552234,1.0694752251324162,0.3879849812265332,0.7479257943791753,1.0,9/40,12.55%,PDGFRA;PDGFRB;EDNRA;EGFR;FGFR1;LPAR2;ARHGAP6;FGF2;NTRK3
prerank,phospholipid catabolic process (GO:0009395),-0.34103206041977174,-1.069462884426566,0.33212996389891697,0.7842240870273276,1.0,7/24,22.76%,GPCPD1;ENPP2;GDE1;GDPD1;ENPP6;SMPDL3A;PLA2G4C
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4666901099688563,1.0694387576367026,0.3937592867756315,0.7475087311942304,1.0,5/15,14.31%,RICTOR;CELF1;FGFR1;TGFB2;USP22
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.3843925503199145,-1.0689113764717761,0.35714285714285715,0.7837692794772076,1.0,6/17,20.15%,PRKCZ;SLC7A5;PRKCQ;SYK;HAVCR2;FCER1G
prerank,rRNA pseudouridine synthesis (GO:0031118),0.518656010032893,1.068230552336894,0.4050632911392405,0.7499446604139585,1.0,1/10,1.03%,RPUSD3
prerank,negative regulation of kinase activity (GO:0033673),0.3832898273546824,1.0680545021359527,0.3699885452462772,0.749868559426343,1.0,20/62,17.14%,SPRED1;NF1;TAF7;DTNBP1;LRP6;NPRL2;EPHA1;GSKIP;PYDC1;PPP2R5A;WWTR1;UBASH3B;SMCR8;TRIB3;CDKN1B;TRIB1;RTRAF;ITGB1BP1;PTPRC;AKT1
prerank,microtubule bundle formation (GO:0001578),0.4097789750387718,1.0679643137772197,0.39928057553956836,0.7495965393261248,1.0,9/42,17.61%,NAV1;MAP1S;NCKAP5;PLK1;NCKAP5L;TOGARAM1;TPPP;KIF20A;CFAP74
prerank,actin filament organization (GO:0007015),0.35957002817729217,1.0678821971311685,0.3699481865284974,0.7493107412042886,1.0,31/151,14.73%,SVIL;MYO1B;PPP1R9B;RND3;DPYSL3;FHOD3;BAIAP2;AIF1;RHOD;CARMIL1;MYO5A;CDC42;FAT1;MYO1D;CGNL1;MYO1H;TMOD1;MYO7A;ABI2;SPIRE1;LCP1;SAMD14;DBN1;VILL;ZBED3;RHOA;BIN3;ABI1;TPM4;MYO1E;RAC1
prerank,negative regulation of transport (GO:0051051),0.4022589136194748,1.0674103485258957,0.38848920863309355,0.7499731810534466,1.0,8/51,10.82%,ADIPOQ;TLR2;PRTN3;PTEN;EGF;RAB7A;PXK;SNX33
prerank,neural crest cell differentiation (GO:0014033),0.4729353121820898,1.0671891986821773,0.4008810572687225,0.7500095318017715,1.0,4/18,14.87%,SNAI2;LRP6;TAPT1;NOLC1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.46909347671558643,1.0667950865752125,0.3952451708766716,0.7504899175889548,1.0,4/17,12.48%,SFRP4;NKX6-1;BTG1;FGF2
prerank,regulation of coagulation (GO:0050818),-0.43139762129677944,-1.0663216193478158,0.378698224852071,0.788887949697312,1.0,1/11,1.15%,CAV1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4811177910643961,1.0660948450701067,0.3925373134328358,0.7516652357203463,1.0,5/14,16.31%,PINX1;TERT;ATR;ATRX;TNKS2
prerank,negative regulation of DNA binding (GO:0043392),0.4286626220356707,1.0659183254692886,0.4053030303030303,0.7515709100121394,1.0,10/28,20.05%,JAK2;E2F1;ILRUN;MDFI;SP100;RSF1;SMO;NFKBIA;KDM1A;HMGA2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.41401044215084293,1.0657548400249657,0.38762626262626265,0.7514659798934681,1.0,8/34,13.23%,EDN3;PDGFRB;EGF;ANAPC11;CDC27;DRD3;NSMCE2;BTC
prerank,neutrophil mediated immunity (GO:0002446),0.3467609089180719,1.0656955130049015,0.308,0.7511293422468476,1.0,103/432,20.67%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;DYNLL1;HVCN1;TLR2;PRTN3;PLD1;ANPEP;MGST1;PADI2;DYNC1H1;CTSD;CD53;CTSS;PYGL;CD36;UBR4;DDOST;TXNDC5;ATP6AP2;DNAJC13;CD68;PTPN6;LAMP2;HPSE;SLC27A2;PDAP1;UNC13D;RAB7A;VAPA;ACTR2;PTGES2;CKAP4;FRK;CD14;CCT8;STXBP3;IRAK4;CTSB;NPC2;GALNS;MVP;PTPRJ;KMT2E;DBNL;RHOA;ATG7;CTSC;RAB37;FABP5;ORMDL3;KCMF1;DPP7;RAB10;PSEN1;GNS;GAA;RAC1;AP2A2;CD63;SLCO4C1;NEU1;RHOF;PSMD2;PSMD12;FGL2;PSMD11;SRP14;GGH;ARHGAP9;DOCK2;TSPAN14;PSMD14;PTPRC;MAPK1;CTSA;DNAJC3;ATP6V1D;ANO6;LAIR1;PSMB1;FCGR3B;LAMTOR3;TIMP2;AGA;IMPDH2;ATP11A;CPNE3;ADGRG3;CYBB;MGAM;HGSNAT;CYB5R3;AMPD3;CDK13;NCSTN;PRKCD;LCN2;TOM1
prerank,polyamine metabolic process (GO:0006595),-0.41326631636639205,-1.0654853170391079,0.39886039886039887,0.7892700706540139,1.0,8/13,35.66%,DHPS;SMS;OAZ2;PAOX;SAT2;HDAC10;SRM;SAT1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.42511041872170324,1.0645192637723655,0.3986842105263158,0.7535868570090187,1.0,7/26,17.55%,MEIS2;PRKCA;ASNS;RPS6KB1;EIF4EBP1;USP22;MDM2
prerank,positive regulation of cellular senescence (GO:2000774),0.5198785966355106,1.0642665996715415,0.39819004524886875,0.7536983012234859,1.0,4/10,20.05%,EEF1E1;YPEL3;CGAS;HMGA2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.30813901136596245,-1.0638532418425124,0.34594594594594597,0.7916721532609725,1.0,18/39,27.43%,FGF12;FHL1;ANK2;WWP2;FXYD5;WNK3;GPD1L;FXYD6;CHRM3;SCN4B;FXYD1;NEDD4L;TCAF2;SCN3B;PPIF;CACNA1D;YWHAH;PHB2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3663542292616668,1.0637367896180954,0.3814207650273224,0.7545358697517911,1.0,22/85,17.55%,NKD2;LRRK2;TREM2;PABIR1;RNF144A;PLK1;PRICKLE1;BAG6;FBXW7;RAD23A;ARIH1;SOCS5;RNF19B;GSK3B;CSNK1A1;DDRGK1;TRIB3;FMR1;TRIB1;ZYG11B;CSNK1D;MDM2
prerank,protein trimerization (GO:0070206),0.4929780825504587,1.063698955129715,0.43026706231454004,0.753645055605626,1.0,2/14,9.63%,STEAP4;MLKL
prerank,protein homotrimerization (GO:0070207),0.4929780825504587,1.063698955129715,0.43026706231454004,0.753645055605626,1.0,2/14,9.63%,STEAP4;MLKL
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4631892053714887,1.0633918435785599,0.4167852062588905,0.7539123531539622,1.0,6/19,16.65%,SLIT3;ACVR1;HEYL;TGFB2;SMAD4;OLFM1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3721547512844796,1.0633852383359106,0.3834080717488789,0.7534342504932977,1.0,16/76,14.04%,BCL3;TLR2;EGFR;LGALS9;NOD1;LIMS1;EIF2AK2;TLR7;SASH1;RASSF2;CD14;TRIM44;RHOA;TNF;SPI1;BMP7
prerank,ureteric bud morphogenesis (GO:0060675),0.4684279619251298,1.0631946717475438,0.40441176470588236,0.7534107097485679,1.0,6/16,20.32%,SHH;PKD2;SALL1;FGF2;PAX8;GDNF
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4329485923456578,-1.0626210101253906,0.375,0.7930510569727132,1.0,8/12,34.10%,WNK3;GPD1L;ANK3;SCN4B;SCN3B;PKP2;SCN5A;AHCYL1
prerank,cellular response to drug (GO:0035690),-0.3299071139819427,-1.0624536057634295,0.35269709543568467,0.791539995503627,1.0,5/25,4.06%,PDE4B;PPM1E;GAS6;ACER2;TFRC
prerank,regulation of protein kinase B signaling (GO:0051896),0.34957661317129807,1.0621876247777986,0.3566362715298885,0.755332332398578,1.0,40/193,14.73%,PDGFRA;IAPP;TCF7L2;GAB2;IRS1;PDGFRB;FGF7;EGFR;RICTOR;PTEN;EGF;STRN;PIK3AP1;HPSE;PIK3R5;ANGPT1;GRB2;TGFBR1;SFRP5;FRS2;OTUD3;DRD3;FGFR1;PTPRJ;PTK2;RCN3;GCNT2;SPRY2;VAV1;TNF;FGF2;NTRK3;MC1R;RASD2;BTC;PIK3R1;SRC;TRIB3;RAC1;CX3CL1
prerank,DNA methylation (GO:0006306),0.4391711034109175,1.062182542765843,0.4095238095238095,0.7548495791210181,1.0,10/23,22.74%,EHMT1;KMT2E;DNMT3B;GATAD2A;ATRX;BAZ2A;ATF7IP;MTRR;N6AMT1;PPM1D
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.32472093645583344,-1.0619284305938794,0.32669322709163345,0.7910470597048026,1.0,4/29,5.90%,TGFBR3;S1PR1;PROX1;FGFR2
prerank,mitotic spindle organization (GO:0007052),0.3571495970045587,1.0612442343801032,0.3772204806687565,0.7566619843338483,1.0,33/153,17.54%,NEK6;KIFC1;DYNLL1;TAOK1;EML4;SMC1A;CENPQ;DYNC1H1;MAD2L1;NUP37;CENPN;KIF2A;TUBG1;PLK1;GPSM2;NEK9;STAG2;TPX2;PCNT;STAG1;SPC25;CENPL;RHOA;MAD1L1;NDEL1;TOGARAM1;MAP4;CEP192;RCC1;TUBG2;SEC13;PTPA;CKAP5
prerank,defense response to fungus (GO:0050832),0.47524962175053753,1.0609396038503993,0.40654843110504774,0.7568770773187625,1.0,2/17,10.28%,RNASE7;GAPDH
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.43672642743820916,1.060887070933163,0.39466666666666667,0.7565185057619024,1.0,1/26,0.10%,NR1H4
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.38789403676339484,-1.0607191840522248,0.37719298245614036,0.7922211374281641,1.0,6/14,16.62%,GAB1;VEGFD;KDR;PIK3CD;FLT4;PGF
prerank,renal water homeostasis (GO:0003091),-0.34443814514331555,-1.0597245334236733,0.34959349593495936,0.7929437824401591,1.0,6/23,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,cation transmembrane transport (GO:0098655),-0.29652054120255444,-1.0595525836258042,0.3687150837988827,0.7914008958813439,1.0,7/44,5.75%,TRPM3;ATP1A2;ATP1B1;TRPM6;SLC6A9;SLC7A5;ABCC9
prerank,protein kinase B signaling (GO:0043491),0.44155176245247296,1.0595318545822432,0.4087301587301587,0.7593581140656414,1.0,10/23,22.05%,ZFP36L1;PTEN;CCL5;CCL2;TNF;SETX;AKT1;TYRO3;EPHA2;THEM4
prerank,axonogenesis (GO:0007409),0.34404929319711675,1.0595316672565764,0.364741641337386,0.7588663514731447,1.0,37/237,11.28%,EPHA7;LAMA2;PALLD;GLI2;CXCL12;LAMA1;SLITRK6;ROBO2;SH3KBP1;B4GALT5;GAB2;SLIT3;SLIT1;EFNA4;AUTS2;PRKCA;NRP1;EPHB3;USP9X;SHH;MAP1S;BAIAP2;PTEN;OPHN1;EPHA1;LLGL1;L1CAM;GRB2;EFNA5;S100A6;CXCR4;WNT5A;FRS2;SEMA3E;PTK2;DSCAM;DRAXIN
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3727554347314932,1.0593314309140887,0.3938053097345133,0.7588672587355595,1.0,28/78,26.05%,CDKN2B;EGFR;NR2F2;CCNE2;PTEN;PKD2;CCND3;PLK1;GTF2H1;CDC37;CCNB2;CDK7;CCNI;CDKN1B;CCNT1;AKT1;LATS2;SERTAD1;GADD45A;RGCC;LATS1;CCNH;MNAT1;CDC6;CDKN1A;CDC25A;BCCIP;CCNY
prerank,neutrophil degranulation (GO:0043312),0.3446976136702494,1.0591684997253386,0.34234234234234234,0.7587495441435216,1.0,101/425,20.67%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;DYNLL1;HVCN1;TLR2;PRTN3;PLD1;ANPEP;MGST1;PADI2;DYNC1H1;CTSD;CD53;CTSS;PYGL;CD36;UBR4;DDOST;TXNDC5;ATP6AP2;DNAJC13;CD68;PTPN6;LAMP2;HPSE;SLC27A2;PDAP1;UNC13D;RAB7A;VAPA;ACTR2;PTGES2;CKAP4;FRK;CD14;CCT8;STXBP3;CTSB;NPC2;GALNS;MVP;PTPRJ;DBNL;RHOA;ATG7;CTSC;RAB37;FABP5;ORMDL3;KCMF1;DPP7;RAB10;PSEN1;GNS;GAA;RAC1;AP2A2;CD63;SLCO4C1;NEU1;RHOF;PSMD2;PSMD12;FGL2;PSMD11;SRP14;GGH;ARHGAP9;DOCK2;TSPAN14;PSMD14;PTPRC;MAPK1;CTSA;DNAJC3;ATP6V1D;ANO6;LAIR1;PSMB1;FCGR3B;LAMTOR3;TIMP2;AGA;IMPDH2;ATP11A;CPNE3;ADGRG3;CYBB;MGAM;HGSNAT;CYB5R3;AMPD3;CDK13;NCSTN;PRKCD;LCN2;TOM1
prerank,muscle filament sliding (GO:0030049),-0.2970295626455227,-1.0588263036243766,0.37089201877934275,0.789355064043865,1.0,3/38,4.34%,DMD;ACTN2;MYL6
prerank,actin-myosin filament sliding (GO:0033275),-0.2970295626455227,-1.0588263036243766,0.37089201877934275,0.789355064043865,1.0,3/38,4.34%,DMD;ACTN2;MYL6
prerank,cardiac conduction system development (GO:0003161),0.4354211740002066,1.0588142023640577,0.40612516644474034,0.7591386078723225,1.0,6/24,15.19%,TBX18;GATA6;SMAD5;MAML1;SMAD4;SMAD1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.41696012722624876,-1.0587304642855713,0.36363636363636365,0.7876254908357059,1.0,5/12,16.23%,SORBS1;INSR;IGF1;IGF2;DYRK2
prerank,positive regulation of developmental process (GO:0051094),0.3456646274188095,1.0585798036083784,0.37923946557040084,0.759207505215873,1.0,34/164,15.02%,DCN;EDN3;SYDE1;SOX5;PTN;B4GALT5;APOE;MDK;SHH;SMURF2;BMP1;ACVR1;RALA;DLG4;TMEM119;SHLD3;SPIRE1;WNT5A;BMP5;ACVR1B;FGFR1;ZBED3;TNF;TAPT1;RIF1;PSEN1;DLG5;BMP7;SRC;FMR1;PHLDB2;TRPM4;ZDHHC6;PAXIP1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4459027286736669,1.058320181921473,0.40620592383638926,0.7593530356075181,1.0,8/21,20.28%,STK36;SHH;SFRP1;RAB34;DLG5;SMO;GLI1;KIF7
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4748839007488342,1.058027209208659,0.3891336270190896,0.7595598480137645,1.0,3/16,10.87%,KLK2;ADM;PLCB3
prerank,transcription by RNA polymerase II (GO:0006366),0.3420342829809516,1.0578481973071294,0.34804413239719156,0.759494909665104,1.0,96/305,24.31%,RORA;NR1H4;PAX1;NCOR2;YAP1;DEAF1;SOX5;PRRX1;RARB;RXRG;NFIX;MAML3;TEAD3;CEBPD;TAF7;CSTF1;CREBBP;PPARG;MBD1;TTF2;GTF2H1;NFE2L3;MAML2;SNAPC3;POU2F1;TRIP11;HDAC1;TBL1X;GTF2F2;NR2F1;SETD2;NCBP2;WWTR1;CBFB;ELL2;TEAD1;INTS1;CDK7;E2F3;MAML1;NKX2-8;GLIS3;GTF2F1;IRF9;DRAP1;TAF1A;TAF4;INTS4;SETX;NR6A1;CCNT1;MED26;RBMX;NRBF2;INTS14;MLLT1;ATF4;TAF2;ICE1;POLR2L;POLR2K;RBPJ;HDAC5;NR2C2;CDK9;RPAP2;IWS1;NR3C1;MED1;SNRPB;PMF1;CDK13;ERCC2;INTS8;THRA;CDK12;NR1D1;SNAPC5;NR1D2;RARG;PCF11;NFIC;NCOR1;CCNH;THRB;TCEA1;POLR2D;MNAT1;DDX21;CDC73;PCID2;TAF5;FIP1L1;CPSF3;TAF3;PPARD
prerank,early endosome to Golgi transport (GO:0034498),0.5010304051737304,1.0576940373171089,0.4129746835443038,0.7593581024846451,1.0,7/11,27.51%,SNX8;LMAN1;SNX2;SNX1;TRAPPC10;RBSN;RAB6A
prerank,positive regulation of lipid metabolic process (GO:0045834),0.44296312772401786,1.0570693036640737,0.40802213001383125,0.7604623500482229,1.0,3/22,5.97%,ADIPOQ;APOE;PPARG
prerank,modified amino acid transport (GO:0072337),0.47277188259863634,1.0568412717852917,0.3918722786647315,0.7605202376895851,1.0,3/15,11.38%,MGST1;SLC16A12;PDPN
prerank,synaptic vesicle membrane organization (GO:0048499),-0.37683615465895975,-1.0568193351942345,0.3402777777777778,0.7907683579145696,1.0,7/17,19.45%,SNAP25;STX3;STX2;TOR1A;SYP;SYNGR1;SYNGR2
prerank,ncRNA catabolic process (GO:0034661),0.423050511297102,1.0567444514756084,0.3841059602649007,0.7602789373340723,1.0,8/28,18.90%,ERN2;POP1;EXOSC4;SND1;XRN1;ZCCHC8;MTREX;PARN
prerank,regulation of hydrolase activity (GO:0051336),0.3731733091173536,1.0566251440914962,0.3793490460157127,0.7600985221559159,1.0,21/71,16.35%,VAV2;ARHGAP15;VAV3;PLXNC1;EPHB3;NF1;FGD4;EPHA1;PLXND1;PLXNA3;EFNA5;RABGAP1;RAB3GAP2;PTK2;FGD6;VAV1;FBXW11;RAB3GAP1;TBC1D10B;ARHGAP9;ITGB1BP1
prerank,negative regulation of histone modification (GO:0031057),0.48444591272918736,1.0566222924689392,0.4069069069069069,0.7596130312626164,1.0,4/14,19.16%,TAF7;NOC2L;SPHK2;THAP7
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.28871904510557317,-1.0563858085707014,0.33146067415730335,0.7900362808351722,1.0,11/41,15.79%,ACTN2;AKAP6;ANK2;KCNJ2;KCNJ3;KCNJ10;ANK3;KCNQ1;KCNJ12;KCNN2;KCNN3
prerank,negative regulation of protein localization to membrane (GO:1905476),0.4357086123572844,1.0557547046086082,0.41356382978723405,0.761223177128239,1.0,6/24,17.71%,CLTC;PID1;PPP2R5A;NUMB;ITGB1BP1;PICALM
prerank,protein dephosphorylation (GO:0006470),0.3517690276590505,1.0557112839688416,0.38534031413612563,0.7608401020633764,1.0,43/135,20.10%,PDXP;PTPN7;DUSP2;DUSP5;PTPN3;PTPN13;NCK1;PTEN;PTPRZ1;PTPN6;PPP4R1;DAPP1;PTPN18;PTPN1;SSH1;PPP3CA;PPP2R2A;PPP2R5A;PTPRJ;PTPN9;PTPN2;PPP4R2;PTPRM;PPP1CB;FBXW11;DUSP26;ILKAP;UBASH3B;SSH2;CTTNBP2NL;TIMM50;PPP6C;PTPRC;PTPN5;PTPRA;DUSP6;MTMR3;RPAP2;MTMR2;MTMR6;MTM1;CDC14B;DUSP11
prerank,neutrophil activation involved in immune response (GO:0002283),0.3433707041702408,1.0552479638809265,0.35535535535535534,0.7614820070847472,1.0,101/428,20.67%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;DYNLL1;HVCN1;TLR2;PRTN3;PLD1;ANPEP;MGST1;PADI2;DYNC1H1;CTSD;CD53;CTSS;PYGL;CD36;UBR4;DDOST;TXNDC5;ATP6AP2;DNAJC13;CD68;PTPN6;LAMP2;HPSE;SLC27A2;PDAP1;UNC13D;RAB7A;VAPA;ACTR2;PTGES2;CKAP4;FRK;CD14;CCT8;STXBP3;CTSB;NPC2;GALNS;MVP;PTPRJ;DBNL;RHOA;ATG7;CTSC;RAB37;FABP5;ORMDL3;KCMF1;DPP7;RAB10;PSEN1;GNS;GAA;RAC1;AP2A2;CD63;SLCO4C1;NEU1;RHOF;PSMD2;PSMD12;FGL2;PSMD11;SRP14;GGH;ARHGAP9;DOCK2;TSPAN14;PSMD14;PTPRC;MAPK1;CTSA;DNAJC3;ATP6V1D;ANO6;LAIR1;PSMB1;FCGR3B;LAMTOR3;TIMP2;AGA;IMPDH2;ATP11A;CPNE3;ADGRG3;CYBB;MGAM;HGSNAT;CYB5R3;AMPD3;CDK13;NCSTN;PRKCD;LCN2;TOM1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.47312037938281726,1.0550612777422774,0.42035398230088494,0.7614713805745452,1.0,2/17,2.74%,SNAI1;SNAI2
prerank,negative regulation of developmental process (GO:0051093),-0.26797286505429563,-1.0550303811437016,0.32456140350877194,0.7919685418940455,1.0,15/69,9.72%,NFIB;DCC;BMP4;RAPGEF3;PRKN;HUWE1;NOS3;GAS6;CST3;TFRC;GRIN3A;KLF7;TBX1;ARHGEF15;IL17D
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.39650326120375323,-1.0550195166010738,0.3855421686746988,0.7900093345849638,1.0,8/13,35.63%,OGA;EXTL2;CHST3;RENBP;CHST7;NAGK;CHST2;CHST5
prerank,cellular response to gamma radiation (GO:0071480),0.4684679523189373,1.0549411593021785,0.420899854862119,0.7612908948237499,1.0,6/17,21.02%,YAP1;ATM;ATR;MDM2;KDM1A;MAP3K20
prerank,proteasomal protein catabolic process (GO:0010498),0.35066959210454496,1.0549405939226633,0.3916581892166836,0.7608051966508297,1.0,43/201,17.74%,PSMA7;SPSB1;KLHL22;SMURF2;APPBP2;SIAH2;BAG6;ERLEC1;SPOP;TRIM13;FBXW7;AREL1;PSMB8;RAD23A;PSMA6;TBL1X;RAD23B;DCAF11;RCN3;NFE2L2;KCTD10;FBXW11;ZSWIM8;PSMF1;UBE2K;MAEA;UBE2W;PSMA8;SMURF1;ITCH;NEDD4;FBXL19;PSMD2;PSMD12;PSMD11;RBCK1;CLOCK;PCNP;PSMD14;KCTD2;DDB1;MDM2;PSMB1
prerank,cellular protein metabolic process (GO:0044267),0.34521419270957215,1.0547963713905966,0.33266533066132264,0.7606790825294376,1.0,99/396,21.71%,C3;MMP2;ENAM;KNG1;SPP1;RPSA;RRBP1;IGFBP7;LAMB1;PLOD2;ASMT;TNIP1;LAMC1;CP;TIMP1;IGFBP4;GATA6;STOML2;VCAN;FSTL1;PRKCSH;RPL3L;APOE;CALU;IGFBP5;FBN1;OMA1;PLAT;SIAH2;ATG3;MIA3;PABPC4;CKAP4;SDC2;MGAT4A;MSRB3;TNC;UBE2L3;LTBP1;PAPPA2;CCDC59;ST3GAL1;GALNT11;RPL12;PPP4R2;MRPS18A;PHKA2;MMP15;SPG7;SPPL3;RPL22;RPL14;ADPRH;FBXO2;PCMT1;PSEN1;MRPS14;RPL11;RABGGTB;RIPK1;PSENEN;GSPT1;B4GALT7;RPN1;PRKDC;PIGH;YES1;SEC11A;MRPL55;L2HGDH;FDXR;DNAJC3;RPL36A;MSRB1;MRPL52;RPS9;HSP90B1;PHEX;EVA1A;RPL6;CSF2RA;FAM20C;PDIA6;RPLP2;AGO2;LGALS1;MRPS33;UBL5;SHISA5;NCSTN;EIF4G1;PARP4;ADORA2B;USP25;PSEN2;HM13;FBXO22;RPS27A;MXRA8
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.4183429335541277,1.0546075483141146,0.40428211586901763,0.7606277565954994,1.0,5/32,7.31%,TAOK1;BABAM2;ATM;PLK1;TAOK3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.43927812876769895,1.0542425578716692,0.4046961325966851,0.7610049975518346,1.0,5/21,12.48%,TAOK1;NAV3;TPX2;CAMSAP2;FGF13
prerank,negative regulation of calcium ion transport (GO:0051926),-0.38569970236905404,-1.0541249927842142,0.4024390243902439,0.790569905577188,1.0,5/15,19.44%,ATP1A2;INPP5K;PACSIN3;ADRA2A;TMBIM6
prerank,RNA biosynthetic process (GO:0032774),0.4159494684060209,1.0537157963287247,0.3893229166666667,0.7618125979400744,1.0,9/31,15.17%,TAF7;TTF2;TERT;RSF1;POLA2;SMN1;BRF1;TAF4;SETX
prerank,regulation of viral transcription (GO:0046782),0.40438837807656813,1.0527834983140052,0.40977443609022557,0.7636161985813344,1.0,15/39,23.95%,MDFIC;UBP1;TRIM21;TRIM13;GTF2F2;RSF1;GTF2F1;CCNT1;POLR2L;POLR2K;CDK9;TRIM27;TRIM62;POLR2D;TRIM11
prerank,positive regulation of neuron migration (GO:2001224),-0.4290923358418391,-1.05233145924577,0.40054495912806537,0.7937359189982913,1.0,3/11,5.43%,SEMA6A;RAPGEF2;SHTN1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3587045697495996,-1.051967677220351,0.35039370078740156,0.7927576693117948,1.0,9/21,21.95%,PPP1R16B;YWHAB;ARPP19;TIPRL;PPP1R8;FKBP1A;CRY2;MASTL;STYXL1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.29449884141692145,-1.0514520028869265,0.38578680203045684,0.7922580369803729,1.0,8/38,5.08%,CAV1;CD47;KLF2;HSP90AA1;INSR;CD34;KLF4;ATP2B4
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4348063983803228,1.0511982802123765,0.41410256410256413,0.7669264529806096,1.0,8/25,14.55%,TBX18;NOS1AP;CACNA1C;CAMK2D;ATP2A2;FGF13;AKAP9;TRPM4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.31605598344438735,-1.0510775991626429,0.3952380952380952,0.7913781955730275,1.0,4/27,1.87%,PDE4B;CAV1;CTNNA3;ANK2
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.4190191705587531,-1.0509496231125497,0.3793103448275862,0.7878697540245211,1.0,4/11,12.54%,CCT4;CCT5;LARP7;DKC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.4190191705587531,-1.0509496231125497,0.3793103448275862,0.7878697540245211,1.0,4/11,12.54%,CCT4;CCT5;LARP7;DKC1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.48836258875104727,1.050903507432009,0.4513677811550152,0.7671401435939623,1.0,4/13,10.83%,TSLP;WNT5A;IL7;TRIM44
prerank,positive regulation of JNK cascade (GO:0046330),0.3710144723588453,1.05088462319334,0.39120631341600903,0.7666968838453575,1.0,19/70,22.30%,SH3RF3;TAOK1;UNC5CL;TAOK3;RASSF2;TIRAP;SH3RF1;EDA2R;PJA2;TRAF2;RIPK1;TRAF5;MAPK8IP1;MFHAS1;GADD45A;DUSP15;WNT16;AXIN1;SDCBP
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3968760946993883,1.05037535582924,0.4132334581772784,0.7674285473745825,1.0,12/39,16.42%,MYO1B;TRAK1;MYO5A;MYO1D;MYO1H;MYO7A;FBXW11;KIF5B;RAB1A;MYO1E;NDEL1;CCDC186
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4784329108573919,1.0502542089654592,0.4270986745213549,0.7672351096821008,1.0,7/14,21.31%,ADAM19;ABCG1;PSEN1;PSENEN;NCSTN;DYRK1A;PSEN2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.414506847183579,1.0500413119775611,0.4131812420785805,0.7672488940361522,1.0,6/34,13.14%,LACC1;XCL1;SASH3;WNT5A;TNFRSF4;SPHK2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.4556488614643377,1.0499432825600317,0.4126984126984127,0.76699012126212,1.0,4/18,12.29%,NCOR2;PTBP3;TERT;TNF
prerank,positive regulation of mitochondrial translation (GO:0070131),0.47750033990181384,1.0498495068143028,0.41916167664670656,0.7667128265937174,1.0,2/14,6.91%,RPUSD3;TRUB2
prerank,regulation of double-strand break repair (GO:2000779),0.4025337184570526,1.049505211166419,0.3978102189781022,0.7670426346501378,1.0,10/39,13.88%,UBR5;DDX11;ACTR2;SPIRE1;RNF169;SETD2;PPP4R2;TIMELESS;MGMT;PPP4C
prerank,positive regulation of locomotion (GO:0040017),0.41755673563285595,1.0491403962639108,0.43333333333333335,0.7674603165655708,1.0,3/27,4.99%,PDGFRB;TREM2;AIF1
prerank,cellular response to estrogen stimulus (GO:0071391),0.4784060580235189,1.049064055086374,0.43026706231454004,0.7671443235099205,1.0,3/14,10.09%,ARID5A;SFRP1;PELP1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.41063249354232534,1.0488447740262081,0.40759493670886077,0.7671821033779491,1.0,7/33,14.24%,E2F1;PTEN;INO80;PTPN6;FBXW7;DDRGK1;CDKN1B
prerank,monocyte differentiation (GO:0030224),-0.4271458191826847,-1.0486641848648315,0.4061624649859944,0.7924259306716283,1.0,3/10,2.29%,PIR;BMP4;IL31RA
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.39211335131810404,1.0477574283517275,0.4028103044496487,0.7693523298958973,1.0,12/46,17.37%,TCF7L2;KHDRBS1;UBR5;BAG3;NCBP2;ZIC1;GSK3B;PIK3R1;SMAD3;PSEN1;NEDD4;YWHAE
prerank,mesenchymal cell differentiation (GO:0048762),0.3869812831557362,1.047698717935275,0.4169611307420495,0.7690104834779117,1.0,15/51,15.67%,SNAI1;SNAI2;LIMS1;LRP6;DDX17;HEYL;TGFBR1;WNT5A;LOXL3;FGFR1;TGFB2;GSK3B;DLG5;BMP7;HIF1A
prerank,regulation of G0 to G1 transition (GO:0070316),0.40105049463651554,1.0475623380382475,0.41457286432160806,0.7688315064432185,1.0,16/38,26.01%,CDKN2B;E2F1;RNF2;YAF2;EHMT1;PHC3;MAX;RBBP8;MGA;SUZ12;CDC7;CBX5;RAD51;RYBP;TFDP1;RBBP7
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5056627080052009,1.0473957501942874,0.40425531914893614,0.768290671533912,1.0,2/11,4.97%,INPP1;PTEN
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5056627080052009,1.0473957501942874,0.40425531914893614,0.768290671533912,1.0,2/11,4.97%,INPP1;PTEN
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.35894268845827115,-1.0472711694442005,0.40441176470588236,0.7943186716967996,1.0,11/20,28.50%,ACTN2;OSR1;GOPC;HECW1;ADRA2A;HECW2;NEDD4L;TCAF2;CASQ2;PLN;PRKCE
prerank,aminoglycan catabolic process (GO:0006026),0.42124507970851854,1.0471373656553904,0.4315514993481095,0.7684173677264652,1.0,7/28,15.15%,HSPG2;GPC6;HPSE;SDC1;SDC2;GNS;IDS
prerank,C4-dicarboxylate transport (GO:0015740),-0.3956698755936917,-1.0469175206385364,0.40700808625336926,0.7933284142395387,1.0,4/14,11.25%,LRRC8D;SLC1A2;SLC1A1;SLC25A12
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4830011718779603,1.046841639000388,0.41517857142857145,0.7686846275730032,1.0,3/13,10.24%,SEC16B;TM9SF4;SEC16A
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3807899273844093,-1.0463634177661527,0.3967741935483871,0.7929267833533789,1.0,4/16,11.13%,SNCAIP;MCTP1;CPLX1;RIMS1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5171034730693507,1.0463403101292752,0.4317817014446228,0.7694257088689533,1.0,2/10,4.42%,STAT1;SHH
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5078836242682766,1.0462183971597627,0.42662116040955633,0.7692465026708574,1.0,4/10,15.46%,DMGDH;ALDH7A1;COMT;SMOX
prerank,response to ATP (GO:0033198),0.44864362953664383,1.0461101141379179,0.4209039548022599,0.7690346631253917,1.0,5/18,21.68%,PDXP;SSH1;P2RX7;HSP90B1;P2RY12
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.4819733528496568,1.0455943866448876,0.44043887147335425,0.7698249906246012,1.0,2/13,4.42%,GLI2;SHH
prerank,regulation of cellular response to heat (GO:1900034),0.3638214339728079,1.0455841220343565,0.41065482796892344,0.7693614493249256,1.0,22/77,17.37%,DNAJB1;NUP37;CAMK2D;BAG3;RAE1;CREBBP;ATM;RPTOR;CCAR2;ATR;NUP153;DNAJB6;DNAJC7;GSK3B;HSPH1;NDC1;NUP35;NUP188;BAG4;SEC13;MAPK1;YWHAE
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.31117317388932675,-1.0454366886632658,0.3568075117370892,0.7934720509724995,1.0,12/34,16.62%,FLT1;GAB1;SEMA6A;VEGFD;RAMP2;KDR;HSPB1;NR4A1;ERN1;FLT4;PRKD1;PGF
prerank,regulation of metal ion transport (GO:0010959),0.46220314982789684,1.0451217390491623,0.4273255813953488,0.7700103840627499,1.0,3/16,4.98%,IL16;CACNA2D1;BCL2
prerank,regulation of chromosome segregation (GO:0051983),0.46273939109493933,1.0450731983156567,0.4312590448625181,0.7696546367533128,1.0,3/16,9.20%,PUM1;CSNK2A1;CSNK2A2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.32061294875361673,-1.0450502676291629,0.38317757009345793,0.7926696427085579,1.0,11/32,20.15%,CHPT1;CHKA;LPIN1;ABHD3;SLC27A1;PCYT1B;GPAT4;MFSD2A;CHKB;PCTP;PCYT1A
prerank,positive regulation of phagocytosis (GO:0050766),0.3891308018600701,1.044992872673429,0.423500611995104,0.7693751251888366,1.0,15/47,21.54%,C3;TREM2;MERTK;CCL2;PTPRJ;CALR;TNF;C4B;DOCK2;PTPRC;ANO6;CD300LF;LYAR;SIRPA;C2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4131162993934396,1.0449775538130917,0.4165554072096128,0.7689277942090548,1.0,11/28,26.27%,SH3KBP1;TNFSF11;CCL2;PRKDC;HSPD1;TNIP2;SIRPA;CCDC88B;CYRIB;THY1;PYCARD
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3949658989092379,1.0448540454040143,0.40762812872467225,0.7687517249517469,1.0,15/42,21.21%,PPA1;YARS1;CARS2;AIMP1;EEF1E1;IARS2;TARS1;RARS2;RARS1;EARS2;GARS1;LARS2;NARS2;FARS2;NARS1
prerank,endothelial cell proliferation (GO:0001935),-0.3694120734091296,-1.044558451781081,0.3927272727272727,0.792166535596176,1.0,3/17,3.63%,TEK;BMP4;CD34
prerank,regulation of urine volume (GO:0035809),-0.425549496840856,-1.0437478304030976,0.41798941798941797,0.7925364666595157,1.0,3/10,9.26%,NPR3;NPR1;INPP5K
prerank,regulation of defense response to virus (GO:0050688),0.4755727229838506,1.0437355305492768,0.41333333333333333,0.7710273168469216,1.0,2/14,5.26%,TNFAIP3;ILRUN
prerank,substrate-dependent cell migration (GO:0006929),0.47352811784960885,1.0429427558495286,0.42835365853658536,0.7724287508199758,1.0,9/14,24.13%,NRP1;OPHN1;ITGA11;VEGFC;ITGB1BP1;PTPRC;P2RY12;SDCBP;ITGA2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.27417909162972587,-1.0428021438023813,0.32515337423312884,0.7934746446476093,1.0,10/52,6.01%,KHDRBS2;DDX5;CELF2;MBNL1;HNRNPU;YTHDC1;WTAP;NOVA2;NOVA1;RBFOX3
prerank,metanephros development (GO:0001656),0.4178833949674562,1.0419820307472374,0.4174496644295302,0.7743047847773082,1.0,4/26,5.10%,ROBO2;SHH;PKD2;NF1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4565700524869385,1.041831055616482,0.4415204678362573,0.7741904157255736,1.0,3/17,5.97%,EGFR;PKD2;CCND3
prerank,magnesium ion transport (GO:0015693),0.48120065937606665,1.041803691814387,0.41641337386018235,0.7737877923012877,1.0,7/12,22.98%,NIPAL2;NIPAL4;TUSC3;NIPA2;CNNM4;NIPA1;SLC41A1
prerank,positive regulation of response to stimulus (GO:0048584),0.39290760990008317,1.0416282841782234,0.3902439024390244,0.7737071208685115,1.0,12/40,22.52%,ADIPOQ;EEF1E1;WNT5A;SELENON;TGFB2;YPEL3;FMR1;CGAS;HMGA2;PRKCD;CDKN2AIP;CD80
prerank,regulation of stem cell population maintenance (GO:2000036),0.4593030120554972,1.041568597496171,0.4153400868306802,0.7733742783874861,1.0,2/18,4.42%,PTN;ZC3H13
prerank,intracellular protein transport (GO:0006886),0.3389196842764934,1.0410134349792166,0.3845381526104418,0.774213066307361,1.0,70/304,18.47%,LTBP2;CLTC;SEC31A;COPA;AP4M1;COPZ2;STX6;AP3B1;ARCN1;STAT3;TRAK1;KIF13B;BAG3;ARFGAP3;TBC1D16;COPZ1;STX17;RAB21;SNX8;PRICKLE1;FAM53B;STXBP1;LAMP2;TBC1D2B;COPB2;RABGAP1L;RAB7A;AP3D1;TBC1D8B;RABGAP1;CDC37;RAB3GAP2;STXBP3;RAB32;WLS;SEC16A;XPO7;LMAN1;NUP153;ARF4;SEC23IP;SNX9;TNPO1;CALR;E2F3;TMED1;TBC1D1;GIPC1;ADPRH;RAB1A;ARF1;EGR2;TBC1D10B;RPL11;SNX15;STX11;SMURF1;COG7;NUP188;SEC13;AKT1;CTSA;CTTN;STX1B;MAIP1;SCFD2;SCFD1;CLIP3;ARL5A;TMED5
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.36089643162553914,1.0403888276677573,0.4244762954796031,0.7751841209772423,1.0,10/84,7.60%,IGF2BP1;IGF2BP2;SYNCRIP;APOE;ILF3;IGFBP5;EIF2AK2;CAPRIN1;GIGYF2;SAMD4A
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.39235158532896885,-1.040228240762274,0.39090909090909093,0.7986486311397882,1.0,4/13,10.21%,NOS3;CALM1;HSP90AA1;PTS
prerank,regulation of cell-substrate adhesion (GO:0010810),0.39457028893184515,1.0401335962818454,0.4411764705882353,0.7753552170041849,1.0,11/42,14.73%,FBLN2;JAK2;NF1;LIMS1;RSU1;PTK2;PDPN;GCNT2;RHOA;RAC1;CX3CL1
prerank,sensory perception of pain (GO:0019233),0.441543338636497,1.0401103964230343,0.40620782726045884,0.7749266165133373,1.0,3/21,12.90%,PTGES;CCL2;P2RX7
prerank,RNA catabolic process (GO:0006401),0.38671812049945103,1.0400831398566752,0.4052443384982122,0.7745055535115208,1.0,12/46,17.10%,ZFP36L2;DNA2;METTL16;PABPC4;DCP2;RNASEH1;RNH1;SND1;RNASEH2A;DXO;SIDT2;MTREX
prerank,heterochromatin assembly (GO:0031507),0.44127145874183527,1.0398436405086013,0.44763271162123386,0.7746239414638252,1.0,7/20,20.05%,POLE3;MBD2;BAHD1;HDAC1;BAZ2A;ZNFX1;HMGA2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.39524859976839244,-1.0398020019108876,0.40988372093023256,0.7980288063934015,1.0,4/13,10.43%,CAV1;CALM1;ANK3;PDE4D
prerank,regulation of cellular catabolic process (GO:0031329),0.37195445687880957,1.0397552049805259,0.4279123414071511,0.7743390335047247,1.0,15/62,17.44%,LRRK2;DRAM1;RMC1;ITPR1;PIP4K2A;ATM;RPTOR;RRAGC;TPCN2;DCAF12;SMCR8;TRIB3;DAPK2;GPR137;MTMR3
prerank,protein localization to cell junction (GO:1902414),-0.3452751552448648,-1.0391424101215876,0.37943262411347517,0.7980001669656357,1.0,5/22,9.15%,TJP1;TJP2;PCLO;BSN;SHANK1
prerank,regulation of stress fiber assembly (GO:0051492),0.3622372853539129,1.0389764081448007,0.4158305462653289,0.7756832294465491,1.0,19/74,14.73%,DLC1;SLC9A1;NRP1;ASAP3;CARMIL1;NF2;ALMS1;SFRP1;TGFB3;CDC42;EPHA1;CGNL1;TGFBR1;RHOA;ARHGAP6;PIK3R1;ARHGEF18;PHLDB2;RAC1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4032117521023545,-1.0386639120722028,0.42134831460674155,0.797467091578425,1.0,3/12,6.19%,PODXL;PTPRO;PROM1
prerank,acylglycerol metabolic process (GO:0006639),-0.28862824113204666,-1.0382849135122054,0.3684210526315789,0.7966992827112317,1.0,8/37,12.43%,DGKB;CAV1;MGLL;DGKI;ABHD6;DGKA;DGAT1;DGKG
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.39685931155651244,-1.0382219480400379,0.39710144927536234,0.794972802427915,1.0,5/13,16.23%,SORBS1;INSR;IGF1;IGF2;DYRK2
prerank,regulation of peptidase activity (GO:0052547),-0.35449901324342753,-1.0381824021907098,0.3920265780730897,0.7931993298841441,1.0,6/19,12.83%,CAV1;CST3;NDUFA13;PSMA3;PINK1;MAPK12
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.35634425099406486,1.038165448008464,0.4343649946638207,0.7770606845261497,1.0,43/104,26.78%,CDKN2B;CCNE2;CCND3;LRP6;GTF2H1;RPTOR;MAP2K1;CDC37;CCNB2;CDK7;RHOA;CCNI;CALM2;SRC;TRIB3;CDKN1B;PDCD10;TRIB1;CCNT1;AKT1;LRP5;IRGM;SERTAD1;GADD45A;TELO2;HMGA2;CDK12;CCNH;MNAT1;CDC6;ETAA1;CALM3;RALB;CDKN1A;TSG101;CDC25A;CAB39;MAP2K2;THY1;BCCIP;PYCARD;PIH1D1;PPP2CA
prerank,regulation of apoptotic process (GO:0042981),0.33495009216575533,1.0378876550120286,0.349,0.7772324098745231,1.0,145/676,18.40%,NR1H4;CYP1B1;ZBP1;KNG1;BCL3;IAPP;MAP4K4;SFRP4;BCL6;STAT1;EGR3;CCAR1;VAV2;GATA6;JAK2;VAV3;BIRC3;FHL2;FSTL1;CFLAR;CASP1;TSLP;EGFR;KALRN;ITSN1;FRZB;FXN;MAD2L1;SHH;E2F1;CTSD;BAG3;IFT57;BABAM2;BCL2;NF1;NUGGC;PPID;FGD4;ANGPTL4;NF2;TXNDC5;STEAP3;TNFRSF12A;CREBBP;ATM;OMA1;SFRP1;TGFB3;PLK1;PTPN6;CXCL10;SIAH2;ASNS;BCL2L2;RASSF2;RRP1B;PHLDA1;AIFM2;EEF1E1;ANGPT1;CCAR2;USP42;GAS1;CBL;ARHGEF19;AREL1;SAP18;TRIO;SH3RF1;ANXA1;WNT5A;HDAC1;FOXO3;IP6K2;IL7;HIPK3;CTSB;RPS6KB1;ARHGEF12;PREX1;TBX3;ARF4;PTK2;YWHAZ;PDPN;CASP8;CALR;SPRY2;ATG7;VAV1;TNF;GSK3B;NLRP2B;AKAP13;ANP32A;ACVR1C;CALHM2;MGMT;TRAF2;SPHK2;PIK3R1;DDRGK1;PSEN1;SRC;ARHGEF18;DAPK2;PDCD10;RTKN;CX3CL1;HSPA5;RABGGTB;NAA15;RIPK1;PSENEN;SETX;PAWR;ITCH;PRKDC;SQSTM1;POU3F3;STK4;RASA1;OLFM1;BAG4;ARHGDIA;AIFM1;HSPD1;PTPA;AKT1;DUSP6;LATS2;DNAJC3;ING5;ANO6;ATF4;ANKLE2;CLIP3;USP36;PAX8;AGT;DDX20;NFKBIA;RHBDD1;DSTYK
prerank,platelet degranulation (GO:0002576),0.35380440960534065,1.0378623534233902,0.43441762854144805,0.7768057750771492,1.0,14/118,6.60%,KNG1;SERPING1;SPARC;LHFPL2;TIMP1;PROS1;BLK;CD36;APOH;EGF;BRPF3;TGFB3;STXBP1;LAMP2
prerank,regulation of mitochondrion organization (GO:0010821),0.3794713919493815,1.037851151533949,0.4150717703349282,0.7763511437122395,1.0,15/47,21.29%,IAPP;LRRK2;TREM2;OMA1;PID1;FBXW7;INF2;CSNK2A2;GSK3B;SQSTM1;SREBF1;USP36;STAT2;MYO19;VPS35
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.352678816496982,1.0375889847189157,0.4312896405919662,0.7765185549496995,1.0,26/125,17.54%,NEK6;DYNLL1;TAOK1;EML4;CENPQ;DYNC1H1;MAD2L1;NUP37;CENPN;KIF2A;TUBG1;PLK1;GPSM2;NEK9;SETD2;PCNT;SPC25;CENPL;MAD1L1;NDEL1;MAP4;RCC1;TUBG2;SEC13;PTPA;CKAP5
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3860959113336669,1.0375551701288814,0.41849148418491483,0.7761210128629636,1.0,10/43,12.95%,ENPP1;IRS1;NCK1;PIP4K2A;PTPN1;PID1;OGT;RPS6KB1;PTPN2;SNX5
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4677524957705904,1.037422662948691,0.43002915451895046,0.7759599718080612,1.0,2/16,2.45%,ZFP36L1;ZFP36L2
prerank,positive regulation of viral transcription (GO:0050434),0.422440262619075,1.0372697175713232,0.4124137931034483,0.775835805758794,1.0,8/25,18.45%,MDFIC;GTF2F2;RSF1;GTF2F1;CCNT1;POLR2L;POLR2K;CDK9
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.35817951142714666,-1.037115499235184,0.37800687285223367,0.7942855318535252,1.0,4/17,8.61%,FCHSD2;CTNNA2;NCKAP1;WASF1
prerank,actin filament-based transport (GO:0099515),0.43962459228840917,1.0369316416439571,0.449438202247191,0.7761724837805217,1.0,5/21,7.53%,MYO1B;MYO5A;MYO1D;MYO1H;MYO7A
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4655611773467,1.0366099559596569,0.4356005788712012,0.7764872726652943,1.0,4/16,8.44%,SMC1A;NAA50;PDS5B;PDS5A
prerank,glycosaminoglycan metabolic process (GO:0030203),0.37207527015560615,1.036579370379524,0.42545871559633025,0.7760644685888649,1.0,15/54,15.52%,HSPG2;GPC6;EXT1;EXT2;HPSE;SDC1;HS2ST1;SDC2;GCNT2;CLN6;UGDH;GNS;SLC35D2;IDS;B4GALT7
prerank,nucleotide biosynthetic process (GO:0009165),-0.3585701556067479,-1.0360112018369287,0.41,0.7952809438056306,1.0,4/18,9.41%,PRPSAP2;ME1;NMNAT3;PRPSAP1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.39760088023018975,1.0359259936265925,0.42066420664206644,0.7771459619074231,1.0,5/39,7.08%,ADIPOQ;B4GALNT2;JAG1;NF2;MIA3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5013068504697903,1.0356458867498968,0.4538341158059468,0.777346728010072,1.0,5/11,19.26%,STAT1;WNT5A;CHRD;LRP5;CTNNBIP1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.29666038978641995,-1.0353162027723466,0.41397849462365593,0.7953293666543692,1.0,8/36,5.32%,CAV1;NPR3;NOS3;CALM1;HSP90AA1;PIK3CB;ATP2B4;SCARB1
prerank,positive regulation of receptor internalization (GO:0002092),0.42904577234149976,1.0351190072555836,0.42105263157894735,0.7781400770290436,1.0,5/22,14.82%,SFRP4;EGF;ANGPT1;FMR1;CD63
prerank,positive regulation of translation (GO:0045727),0.35814858261729504,1.035045121589024,0.44021739130434784,0.7778457375350177,1.0,14/94,14.28%,PRR16;BCL3;RPUSD3;PLD1;KHDRBS1;CCL5;TRUB2;SAMD4A;NIBAN1;RPS6KB1;NAT10;YBX3;YTHDF3;FMR1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3678840964884717,1.035008181217728,0.44431946006749157,0.7774636690788904,1.0,16/67,14.81%,PDGFRA;TEC;GHR;PDGFRB;JAK2;EGFR;BLK;DDR2;PTPN6;EPHA1;ABI2;FGFR1;PTK2;ABI1;SRC;FES
prerank,glutamate metabolic process (GO:0006536),-0.3558806159030152,-1.0349809760041746,0.40293040293040294,0.7944396555994809,1.0,5/19,5.63%,GLUL;MTHFS;GCLC;GLUD1;PRODH
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.47854865943120445,1.0344773403338785,0.46971935007385524,0.7782252972935426,1.0,5/14,16.35%,TIMP1;LIMS1;LOXL3;CD63;ITGB1BP1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5098142628270245,1.0344478409768,0.44849445324881143,0.7778082721164913,1.0,2/10,7.11%,TAF7;NOC2L
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.40394825755055225,1.0342649859828184,0.4355444305381727,0.7777616895132654,1.0,6/33,7.93%,YAP1;TCF7L2;TNFAIP3;MDK;ICAM1;ANGPT1
prerank,B cell mediated immunity (GO:0019724),-0.43041908804898155,-1.0342354808026928,0.42349726775956287,0.7946446829794301,1.0,6/10,49.21%,MSH2;FCER1G;CD27;TLR8;CARD9;SLA2
prerank,heme biosynthetic process (GO:0006783),-0.34587640654986607,-1.0341718317737847,0.4068441064638783,0.7929882327754599,1.0,7/22,14.86%,ABCG2;CPOX;FLVCR1;SLC25A38;UROS;COX10;ABCB10
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5084154409203355,1.0341251428207687,0.45024469820554647,0.7776053203765052,1.0,6/10,27.69%,LRP6;BMP5;BMP7;PHACTR4;ARHGAP12;DLL4
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4284184493309064,1.0340616303501446,0.44502617801047123,0.7772973382392439,1.0,2/26,2.07%,TNIP1;B4GALT5
prerank,glucose homeostasis (GO:0042593),0.35867657961742055,1.0339149113150885,0.42513661202185793,0.7771646414580226,1.0,9/83,5.97%,ADIPOQ;TCF7L2;IRS1;USF1;STAT3;HK2;PYGL;FOXK2;PPARG
prerank,regulation of RNA splicing (GO:0043484),-0.26146451079502636,-1.0338945228469396,0.3858267716535433,0.791860538672654,1.0,24/69,21.42%,KHDRBS2;QKI;SNRNP70;MBNL1;YTHDC1;TIA1;CWC22;HNRNPH3;U2AF2;AHNAK;CLK1;LARP7;POLR2A;METTL4;ERN1;HNRNPLL;SRRM4;PRX;RPS13;FAM50A;TMBIM6;PTBP2;SRSF3;HNRNPL
prerank,synaptic vesicle transport (GO:0048489),-0.4179502948503389,-1.03385011768036,0.4166666666666667,0.7901337965647969,1.0,5/11,16.82%,RAB27A;SNAPIN;TOR1A;SYNJ1;DNM2
prerank,RNA export from nucleus (GO:0006405),-0.23891536430539653,-1.0337208927109667,0.35,0.7886527661504897,1.0,38/100,25.42%,YTHDC1;CDC40;SRSF5;WDR33;DDX19B;U2AF2;NUP133;UPF2;UPF1;SEH1L;POM121;HNRNPA1;SRSF7;SRSF9;RBM8A;NUP43;CHTOP;CPSF2;MAGOH;NUP210;NUP50;ZC3H11A;NUP98;HHEX;EIF4A3;SRSF3;POLDIP3;XPO5;NUP93;CPSF4;SARNP;MCM3AP;DDX39B;NUP88;NUP85;DDX39A;DDX25;THOC1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.44180678492371445,1.033305182568247,0.4510086455331412,0.7781485733447937,1.0,10/20,25.67%,CELF1;TNRC6B;MOV10;WTIP;HELZ;AGO2;AGO1;NRDE2;CNOT1;CNOT7
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2535063735211309,-1.0333048009781047,0.39285714285714285,0.7880129247439437,1.0,28/72,26.50%,ERCC5;COPS5;AQR;ISY1;ERCC6;ERCC3;UBC;COPS7B;EP300;UVSSA;POLD3;USP7;POLR2A;POLR2H;PCNA;POLR2G;POLR2F;PRPF19;GTF2H2;ERCC1;POLR2E;GTF2H4;RFC3;UBA52;GTF2H3;POLD2;RBX1;RPA2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4043538159670868,1.032574545078887,0.43686868686868685,0.7794562661977208,1.0,6/35,6.40%,PDE3A;PDE7B;APOE;ADCY2;CD36;AHR
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.32299558338209017,-1.0325160913394487,0.4048582995951417,0.7883934232504285,1.0,5/25,14.26%,RB1;IGF1;SIN3A;PER2;HEY2
prerank,keratinocyte differentiation (GO:0030216),0.4086467802507554,1.0321867371680813,0.42857142857142855,0.7798744086063705,1.0,9/29,21.50%,UGCG;JAG1;ANXA1;WNT5A;PIP5K1A;MED1;ADAM9;WNT16;EPHA2
prerank,regulation of lipid biosynthetic process (GO:0046890),0.40283620930940095,1.032123346476997,0.4401008827238335,0.7795315846563127,1.0,3/32,3.78%,C3;ADIPOQ;APOE
prerank,organelle assembly (GO:0070925),0.3353576108168287,1.0318667845219285,0.4152457372116349,0.7796941730503607,1.0,82/384,17.08%,TEKT4;NEK6;SH3PXD2B;VMP1;DYNLL1;FARP2;GORASP2;WIPI1;CEP19;SYNPO;ATXN2;ASAP1;STK36;CHMP4A;CHMP4B;DYNC1H1;PARVA;AMBRA1;INO80;IFT88;PCM1;VPS4A;HAUS3;ATG3;RAB8B;RAB7A;TMOD1;CEP41;EXOC4;EHD2;ACTR2;GBF1;GOLGA8B;FAM161A;EXOC1;EXOC7;WDPCP;ATP2A2;PCNT;RAB32;WDR35;DISC1;VPS37C;MAPRE2;PTPN23;ARF4;GALNT11;NPHP3;IFT172;IFT81;DBNL;ATG7;PDE6D;UBAP2L;SNX10;CFAP410;PACS2;CPLANE1;CHMP7;RAB1A;DYNC2H1;ATG16L1;DZIP1L;YTHDF3;KIF27;CDC14A;ATG16L2;TUBGCP4;PATL1;CHMP2B;TTC39C;EXOC5;WDR45;EXOC3;NUDCD3;POC1B;RCC1;PIK3C3;WDR90;DHX29;CSNK1D;PRRC2C
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4024759361224661,1.0315711889149435,0.4255050505050505,0.7799077806434648,1.0,6/34,6.39%,NRP1;DOCK1;MDK;LIMS1;CARMIL1;CDC42
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3325739232792924,1.0315457251409883,0.41323971915747243,0.7795012691163474,1.0,79/348,18.23%,RBMS3;ITGB8;SEC16B;ADAM19;YAP1;SFRP4;NOS1AP;CRP;TLR2;FGF7;MITF;TLE1;TREM2;STAT3;E2F1;UBR5;EPHX2;LGALS9;LIMS1;CD36;EGF;DTNBP1;ATM;VSTM2A;EMILIN1;TMEM119;PTPN1;PID1;FUBP1;ANGPT1;MAPK11;MSN;CELF1;TNRC6B;TGFBR1;MAP2K1;WNT5A;SETDB1;MOV10;NFE2L2;DNMT3B;SPRY2;SETDB2;TNF;GSK3B;FGF2;NTRK3;P2RX7;DDRGK1;CTCF;SMAD3;PSEN1;BMP7;FMR1;PPHLN1;RPL11;PDCD10;RESF1;DTX3L;CD63;SMAD1;SMO;ITCH;HIF1A;FGF18;MED26;PRKAB1;POU3F3;ATF7IP;LAMTOR5;OLFM1;MAPK1;AKT1;CALCOCO1;EIF2AK3;ATF4;ETS1;INHBA;RBPJ
prerank,regulation of viral genome replication (GO:0045069),0.38006571719302845,1.0307208496672693,0.44815256257449343,0.7810042246847955,1.0,11/56,12.29%,TNIP1;ILF3;TMEM39A;PPID;SHFL;CCL5;EIF2AK2;RAD23A;OASL;STAU1;TNF
prerank,amino acid import (GO:0043090),-0.33693583410487693,-1.0306628686685864,0.3726937269372694,0.7916971153650787,1.0,7/21,11.55%,SLC47A1;SLC6A6;SLC7A5;SLC1A1;SLC6A1;SLC22A4;SLC25A38
prerank,apoptotic mitochondrial changes (GO:0008637),0.4105789370534675,1.030558144556041,0.4508519003931848,0.7809011681873447,1.0,13/32,22.86%,BBC3;HK2;BCL2;ATG3;AIFM2;CCAR2;GGCT;TIMM50;HSPD1;VPS35;THEM4;CLU;FZD9
prerank,neural crest cell development (GO:0014032),-0.28235726454069826,-1.0301019830182931,0.40229885057471265,0.7914486375593723,1.0,20/44,26.72%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;ERBB4;TBX1;SEMA4D;SEMA5A;SEMA5B;CDH2;SEMA3G;RADIL;SEMA6C;SEMA4B;SOX8;SEMA3B;SEMA4A;KBTBD8;SEMA6B
prerank,neuron fate commitment (GO:0048663),0.4640160364568733,1.0298095473524491,0.4322289156626506,0.7822475350787506,1.0,2/14,9.03%,SHH;TGFBR1
prerank,bile acid biosynthetic process (GO:0006699),0.43171226465089924,1.0292428242690004,0.4501347708894879,0.7831009458987976,1.0,3/24,9.82%,CYP7B1;SLC27A2;OSBPL3
prerank,axonal transport (GO:0098930),0.39806005715252557,1.0287304269175324,0.4306748466257669,0.7838363197797615,1.0,7/36,12.26%,AP3B1;DYNC1H1;AP3S1;DTNBP1;RAB21;AP3D1;FBXW11
prerank,skeletal muscle organ development (GO:0060538),0.422616156459605,1.0286747863656809,0.4348993288590604,0.7834898526162685,1.0,2/26,3.22%,SVIL;CFLAR
prerank,nucleotide catabolic process (GO:0009166),-0.36753992759086285,-1.0283545365952675,0.4144927536231884,0.7943926609867723,1.0,6/16,18.00%,NT5E;NUDT3;SAMHD1;ITPA;DERA;NT5C
prerank,positive regulation of heart contraction (GO:0045823),0.44265769779482905,1.0282814202990873,0.4467496542185339,0.7839108241232271,1.0,5/19,14.55%,EDN3;ADM;ATP2A2;TGFB2;TRPM4
prerank,neural tube development (GO:0021915),0.4651411890840051,1.0279300665887974,0.44545454545454544,0.7842772401082958,1.0,3/15,13.84%,ALDH1A2;PKD2;DACT1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.4935312428094326,1.0279126419955784,0.4492753623188406,0.7838318062081779,1.0,6/11,17.60%,GHR;IRS1;GIGYF2;PIK3R1;AKT1;EIF2AK3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.32385331992879496,-1.0278885890626481,0.3941908713692946,0.7938834044087407,1.0,10/25,25.42%,LDB1;WDR43;ERCC6;EAF2;TSFM;SUPT4H1;CCNK;ZMYND11;DDX39B;THOC1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3560350609033925,1.0277783945746712,0.44271412680756395,0.7836890663471682,1.0,17/77,15.12%,TCF7L2;CFLAR;FXN;BCL2;ACVR1;SIAH2;BCL2L2;NOC2L;SH3RF1;TGFBR1;CSNK2A1;CSNK2A2;PELI3;TNF;SRC;CX3CL1;RIPK1
prerank,protein localization to nucleus (GO:0034504),0.3537169006294285,1.0274732634175352,0.4745945945945946,0.7838794725631283,1.0,26/102,19.56%,COL1A1;BCL3;STAT3;MORC3;PLK1;PRICKLE1;FAM53B;PINX1;SKP1;NUP153;TNPO1;CALR;E2F3;BMP7;RPL11;BANP;TOR1AIP2;NUP188;SEC13;AKT1;YWHAE;MDM2;TOR1AIP1;ZBTB7A;HEATR3;NUP214
prerank,regulation of intracellular pH (GO:0051453),-0.30008361192760247,-1.0273030532194574,0.4342105263157895,0.7937081861108476,1.0,11/34,10.98%,SLC4A10;SLC9A2;TMEM165;GPR89B;GPR89A;CA2;SLC4A8;CLN3;SLC9A6;SLC4A3;SLC9A7
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4000765594163687,1.0272042056085067,0.43914680050188204,0.7840132564951781,1.0,2/33,2.74%,CYP1B1;SNAI2
prerank,regulation of rRNA processing (GO:2000232),-0.36900270811909985,-1.0268329774229308,0.4084967320261438,0.793164621396159,1.0,7/16,27.82%,RIOK1;WDR43;DIMT1;SIRT7;UTP15;NUDT16;TRMT112
prerank,tetrahydrofolate metabolic process (GO:0046653),0.499590609828998,1.0267388469605452,0.4419713831478537,0.7846398486921525,1.0,3/10,11.59%,MTHFR;MTHFD1L;MTHFD2L
prerank,translational elongation (GO:0006414),-0.23002346371655077,-1.0265881028297308,0.3698630136986301,0.7920901191566709,1.0,48/101,31.25%,MRPS9;MRPS35;MRPS28;MRPS15;EEF1B2;MRPS24;MRPL13;MRPL10;MRPL21;MRPL39;GTPBP2;ERAL1;TSFM;RACK1;PTCD3;MRPL4;MRPS7;MRPS31;EEF1G;EEF1D;MRPL28;MRPL30;MRPS18C;MRPL22;MRPL40;GADD45GIP1;MRPL46;MRPS16;MRPS18B;MRPL58;MRPS22;MRPS6;MRPS25;MRPS12;MRPS34;MRPL44;EEF2;MRPL18;MRPL20;MRPL35;MRPL23;GFM1;MRPL42;MRPL43;MRPL54;MRPL34;MRPL2;MRPS10
prerank,ceramide metabolic process (GO:0006672),-0.2747812487179455,-1.0264700306753856,0.41935483870967744,0.7906150051958349,1.0,9/49,7.25%,ST6GALNAC3;ACER2;CERS4;SGMS1;PPP2R1A;SPTLC2;SPTLC1;SGMS2;DEGS2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.42271789424362427,1.0258371109723698,0.4351851851851852,0.7863005402776235,1.0,7/26,13.03%,SLC9A1;FHL2;EFHB;STIMATE;TNF;GSK3B;SPPL3
prerank,insulin secretion (GO:0030073),-0.34822870033607967,-1.0258255163185863,0.42160278745644597,0.7904319101788727,1.0,7/19,23.68%,SELENOT;RAB11B;PTPRN2;ADCYAP1;PTPRN;RIMS2;CYB5R4
prerank,iron ion homeostasis (GO:0055072),0.3703867317998028,1.0256258050861706,0.45308924485125857,0.7862971511243444,1.0,11/58,14.51%,HEPH;CP;SLC11A2;FXN;CUL1;ACO1;SKP1;SLC22A17;IREB2;SMAD4;FRRS1
prerank,cellular response to heat (GO:0034605),-0.3034103104876557,-1.0255525447234786,0.4351851851851852,0.7894065933348269,1.0,19/35,35.20%,HSP90AA1;FGF1;ATXN3;THBS1;TRPV4;HIKESHI;ANO1;DHX36;HTRA2;TCIM;HSP90AB1;IER5;HSPA1A;HSF1;HSBP1;HSPA1B;HMOX1;TPR;MAPT
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3465500909510749,1.025351481825155,0.4540763673890609,0.7864829308677709,1.0,35/144,18.91%,CEMIP;SEC16B;TCF7L2;TM9SF4;BBC3;E2F1;UBR5;BAG3;BCL2;PCM1;NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;PCNT;ZIC1;SEC16A;YWHAZ;CASP8;GSK3B;MICALL2;PIK3R1;SMAD3;PSEN1;PDCD10;ITGB1BP1;SH3GLB1;YWHAE;LEPROT;ICE1;USP36;BCAS3;ARIH2;PRNP
prerank,negative regulation of lipid metabolic process (GO:0045833),0.4309389826130102,1.0253224868540685,0.43441466854724964,0.7860729153387641,1.0,4/22,15.23%,APOD;PPP2R5A;TNF;CCDC3
prerank,positive regulation of vacuole organization (GO:0044090),0.49831010437421985,1.0251004164435111,0.46957878315132606,0.7861048638643883,1.0,7/10,26.81%,PIP4K2A;RAB3GAP2;RAB3GAP1;SH3GLB1;RALB;ANXA2;PIP4K2B
prerank,sphingolipid catabolic process (GO:0030149),-0.3845210233010287,-1.0250705901327153,0.4260355029585799,0.788901912047886,1.0,7/15,27.40%,ACER2;ENPP2;ASAH2;SMPD2;SMPDL3A;SPHK1;ASAH1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.33989666985565725,1.0250553894003,0.4514811031664964,0.7857541930666853,1.0,49/153,23.25%,NEK6;MAST4;LRRK2;PRKCA;MARK1;RICTOR;IKBKE;AKT3;CAMK2D;PRKD2;MORC3;ATM;PLK1;HIPK4;MAST2;ATR;TGFBR1;CSNK2A1;CSNK2A2;HIPK3;RPS6KB1;CSNK1G2;GSK3B;CSNK1A1;MKNK1;VRK3;RIPK1;PRKDC;STK4;CSNK1D;MAPK1;AKT1;LATS2;EIF2AK3;DCLK3;MAP3K12;PLK2;PRKCD;DYRK1A;VRK2;PKN1;RPS6KA4;MARK2;CDC7;LATS1;ROCK2;ROCK1;RPS6KA3;NLK
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3832553226711212,1.0250038102194434,0.4550970873786408,0.7853946951292361,1.0,18/50,25.82%,CDKN2B;CCNE2;CCND3;GTF2H1;CDC37;CCNB2;CDK7;CCNI;CDKN1B;CCNT1;SERTAD1;GADD45A;CCNH;MNAT1;CDC6;CDKN1A;CDC25A;BCCIP
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4415267105670543,1.0249512903045506,0.43776223776223777,0.7850504225568785,1.0,8/20,18.80%,STOML2;PMPCB;MICU2;SPG7;PMPCA;MCUR1;MAIP1;MICU3
prerank,negative regulation of leukocyte activation (GO:0002695),-0.3610611883965503,-1.024731778879662,0.4318936877076412,0.7880164952980073,1.0,6/15,18.69%,LRFN5;IL31RA;CD200;GRN;GPER1;HAVCR2
prerank,regulation of protein phosphorylation (GO:0001932),0.33268407495533014,1.0246119129462437,0.45125628140703516,0.7853687111154461,1.0,69/256,21.81%,C3;EPHA7;IL34;ADIPOQ;FBLN1;LRRK2;CD40;FGF7;EGFR;TREM2;PTPN13;PTEN;FAM20A;CCND3;LRP6;RAP2A;TMEM119;PID1;ANGPT1;GPNMB;EFNA5;NIBAN1;FBH1;PPP2R5A;FNIP1;WWTR1;IBTK;PTK2;BMPER;ZBED3;ACVR2A;TNF;VEGFC;FGF2;NTRK3;WDFY2;BMP7;FMR1;RAC1;RIPK1;FGF18;PRKDC;NSD1;STK4;PELI2;CSNK1D;AKT1;BRD4;EIF2AK3;ATF4;CLIP3;PLXNB2;XDH;AXIN2;PRNP;DVL2;IRGM;STAT2;CORO1C;PIN1;SPTBN4;NDUFS4;ZC3H12A;SIRPA;NPTN;PPP2R5C;AXIN1;VEGFB;PAK1
prerank,endochondral bone morphogenesis (GO:0060350),0.48778527316423737,1.0245533428691416,0.4695121951219512,0.7850291780339503,1.0,2/11,7.02%,COL13A1;TMEM119
prerank,regulation of lipid metabolic process (GO:0019216),0.3552958604698497,1.024233817970299,0.44396551724137934,0.7853126444745346,1.0,11/88,10.57%,RORA;NCOR2;MVK;CREBBP;PPARG;LACTB;CARM1;TBL1X;PANK2;NPC2;CHD9
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.43085614418567103,1.0242264693658794,0.4462809917355372,0.7848548899709079,1.0,5/22,14.55%,LACC1;WNT5A;TNF;SPHK2;TRPM4
prerank,monocarboxylic acid transport (GO:0015718),0.376440651249681,1.024127268422297,0.43735498839907194,0.7846262681975485,1.0,5/51,6.45%,NR1H4;ATP8B1;SLC10A6;CD36;SLC16A12
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.48714005231102364,1.0240656649530895,0.4561128526645768,0.7843015076599651,1.0,6/12,25.90%,MDK;MIA3;AKT1;FUT4;ASS1;PPARA
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.42990963351789424,1.023581972713509,0.46153846153846156,0.7849695389850314,1.0,1/24,0.40%,CEMIP
prerank,anterograde axonal transport (GO:0008089),0.39297080653285077,1.0230674419317876,0.4481012658227848,0.7856674364432693,1.0,8/37,9.93%,AP3B1;KIF1C;TRAK1;AP3S1;DTNBP1;RAB21;AP3D1;RAB27B
prerank,negative regulation of interleukin-8 production (GO:0032717),0.45638616644063335,1.0230445577306393,0.45545977011494254,0.7852506866986216,1.0,2/17,8.96%,BCL3;ANXA1
prerank,primary miRNA processing (GO:0031053),0.49784743034191914,1.022341472386033,0.46275752773375595,0.786384994034507,1.0,3/10,15.19%,SMAD2;SMAD3;SMAD1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4300590698870185,1.0219948080086139,0.4713541666666667,0.7867342501709669,1.0,9/26,17.68%,LUM;B4GALT5;ST3GAL3;PRELP;ST3GAL1;CHST1;SLC35D2;B4GALT2;B4GALT4
prerank,regulation of glucose import (GO:0046324),0.40710787825749745,1.021207109787129,0.44129032258064516,0.7881080083103971,1.0,3/30,2.62%,ENPP1;ADIPOQ;IRS1
prerank,myoblast fusion (GO:0007520),0.4799781216104465,1.0208194935539636,0.44296296296296295,0.7885450981702282,1.0,4/12,9.87%,ADAM12;ADAMTS15;ADAMTS5;PTGFRN
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.48864188363104366,1.02057358493908,0.4553846153846154,0.7886345258769714,1.0,4/11,26.68%,NRP1;RAC1;PAK1;BCAR1
prerank,positive regulation of protein kinase activity (GO:0045860),0.3438118879703474,1.0205187844444044,0.44559585492227977,0.7882755228065685,1.0,45/148,22.25%,IL34;IL23R;MAP4K4;TAOK1;JTB;LCP2;DDR2;CACUL1;CCL5;TOM1L1;DLG4;TAOK3;PTPN1;RASSF2;RPTOR;BORA;MAP2K1;TPX2;PTK2;SNX9;NRK;TGFB2;RHOA;TNF;NAB2;CALM2;SRC;PDCD10;IL6R;FCGR1A;ALS2;STK4;PTPRC;AGT;PRNP;IRGM;TELO2;HMGA2;PRKCD;MMD2;AXIN1;PAK1;MARK2;CLU;CSF1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.48123254911780944,1.0204829516345482,0.41287284144427,0.7878736080806165,1.0,3/11,11.44%,ZFPM2;JAG1;TGFB2
prerank,regulation of neuron death (GO:1901214),-0.24272114240440973,-1.0202272240284642,0.3793103448275862,0.7986495146190545,1.0,26/82,22.18%,DCC;GRID2;PRKN;MAP3K5;CD34;RILPL1;PPARGC1A;BTBD10;CD200;SORL1;GRIN2B;TRIM2;DDIT4;TSC1;DHCR24;EGLN2;EPHB1;EGLN3;INPP5A;AKT1S1;NAE1;HTRA2;CHGA;SARM1;MEF2C;IKBKG
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.38662833515954476,1.020158994334488,0.4559710494571773,0.7881847305223469,1.0,9/44,11.12%,ZFP36L1;ZFP36L2;PUM1;METTL16;GIGYF2;CELF1;TNRC6B;FTO;MOV10
prerank,telomere organization (GO:0032200),0.38390375209314564,1.0201130748130958,0.4614427860696517,0.7878174929008771,1.0,10/43,15.88%,PARP3;DNA2;ATM;TERT;ATR;SP100;LTO1;RIF1;CTC1;PRKDC
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.5022822238687229,1.0199432824145127,0.4742765273311897,0.7877431757708688,1.0,4/10,19.43%,DNMT3B;RIF1;ATRX;KDM1A
prerank,sphingolipid metabolic process (GO:0006665),-0.23720861493556403,-1.019740592366159,0.42857142857142855,0.7981921328930299,1.0,22/108,10.49%,ST6GALNAC3;CERT1;PPM1L;TECR;ACER2;CERS4;SGMS1;ESYT2;PPP2R1A;SPTLC2;ESYT1;SPTLC1;ELOVL7;SGMS2;ENPP2;ELOVL5;DEGS2;SPNS2;HACD1;HACD3;GAL3ST1;HACD4
prerank,regulation of neuron projection development (GO:0010975),0.3421460964289493,1.019411284158914,0.47785787847579814,0.7885014166634614,1.0,33/163,15.66%,ROR2;ROR1;PTN;MYLIP;LRRK2;DPYSL3;MARK1;TENM3;EPHB3;APOE;MDK;KIF13B;PTEN;FZD1;ABI2;WNT5A;DBN1;DISC1;GAK;PTPN9;DENND5A;FBXO7;CAMSAP2;GSK3B;NTRK3;RTN4RL1;PSEN1;ARHGAP35;PTK7;CX3CL1;FES;SETX;NDEL1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.4670073981498465,1.0191296888850696,0.4491899852724595,0.7886848325257461,1.0,1/15,0.28%,C3
prerank,mesenchymal cell development (GO:0014031),0.44010297327602904,1.0190431278450391,0.4514285714285714,0.788445295950605,1.0,4/18,14.87%,SNAI2;HEYL;TAPT1;NOLC1
prerank,embryonic hemopoiesis (GO:0035162),0.4762031821915878,1.018979076944856,0.4488888888888889,0.7881306661765792,1.0,1/12,0.42%,KMT2A
prerank,cellular response to alcohol (GO:0097306),0.3881528727912672,1.0187127918977903,0.45212121212121215,0.7882933193963848,1.0,11/42,15.47%,ADCY7;ADCY2;SFRP1;LRP6;AHR;GRAMD1A;GNAI1;GRAMD1C;SPHK2;SMO;CTNNA1
prerank,cellular protein localization (GO:0034613),0.3338713134085904,1.0183477506095582,0.4497991967871486,0.788665858851437,1.0,68/285,18.78%,CLTC;SH3PXD2B;SEC31A;LRRK2;WIPI1;COPA;FGF7;AP4M1;COPZ2;STX6;AP3B1;EGFR;ARCN1;TM9SF4;ITSN1;ARFGAP3;TBC1D16;COPZ1;ARMCX3;STX17;RAP2A;RAB21;SNX8;STXBP1;TBC1D2B;COPB2;RABGAP1L;MYO7A;ANGPT1;AP3D1;TBC1D8B;RRAGC;RABGAP1;WNT5A;RAB3GAP2;STXBP3;RAB32;WLS;ARF4;SEC23IP;SNX9;PACS2;TMED1;TBC1D1;ADPRH;RAB1A;ARF1;TBC1D10B;NIPBL;CD63;SNX15;STX11;SMURF1;RTP4;WDR45;COG7;TM9SF2;SEC13;CTSA;CTTN;STX1B;SCFD2;SCFD1;LAMTOR3;ARL5A;TMED5;EPB41L3;AXIN2
prerank,regulation of biomineral tissue development (GO:0070167),0.41390802588011,1.0181328351903216,0.458656330749354,0.7886926834133989,1.0,3/26,5.42%,ENPP1;DDR2;CYP27B1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.4262071569466609,-1.018020493348958,0.4547945205479452,0.8011066920451859,1.0,3/10,21.32%,VSIR;TLR4;NCKAP1L
prerank,triglyceride metabolic process (GO:0006641),0.3733209895752968,1.0177519016523808,0.4541176470588235,0.7890760661399457,1.0,7/48,13.16%,LIPC;APOE;APOH;LPL;GK;FABP5;GPAT3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3790585753735157,1.017488216249751,0.46079613992762364,0.7891941345488478,1.0,15/48,17.75%,RHOJ;CD40;PRKCA;AKT3;PRKD2;STAT5A;ANGPT1;ANXA1;FGFR1;FGF2;HIF1A;FGF18;AKT1;MAP3K3;ETS1
prerank,negative regulation of histone acetylation (GO:0035067),0.4948887812282858,1.0174212532308713,0.4712286158631415,0.7888910829814795,1.0,4/11,19.16%,TAF7;NOC2L;SPI1;THAP7
prerank,endothelial tube morphogenesis (GO:0061154),0.49615616780312305,1.0173278561867471,0.43333333333333335,0.7886416628444666,1.0,6/10,21.40%,PRKD2;CCM2;RHOA;ACVRL1;RBPJ;STARD13
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.37564830190261717,1.017104673875486,0.4744958481613286,0.7887107729777235,1.0,17/52,18.75%,LRP1;NKD2;EGFR;TREM2;GPSM2;ITGA3;PTPN9;GNAI1;TNF;KIF5B;PIK3R1;EPB41L2;STAC3;SQSTM1;AKT1;CLIP3;SPTBN1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4208905301977795,1.0170165431933638,0.42916093535075656,0.7884520802829078,1.0,4/22,12.52%,ALDH1A2;CYP27B1;CYP1A1;CYP2R1
prerank,positive regulation of RNA splicing (GO:0033120),-0.30875901632652825,-1.017007836940008,0.4393305439330544,0.8021082363109518,1.0,13/29,27.78%,NCL;U2AF2;CIRBP;POLR2A;DAZAP1;ERN1;HNRNPLL;NUP98;RBM3;SLC38A2;ZPR1;SF3B4;HSPA1A
prerank,glycerophospholipid metabolic process (GO:0006650),0.3589788049014814,1.0169732968545129,0.45374449339207046,0.7880831077874456,1.0,19/75,19.58%,PLA1A;PDXP;PDGFRB;PIGW;CPNE7;PIGN;DGKH;PLA2G7;PIGL;PIGC;PLCB3;PLA2G4A;PIGP;PLA2G4E;PIGH;PLEK;PIP5K1A;CPNE3;GDPD3
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.34626637675786737,1.016904680883915,0.4576271186440678,0.7877882517008761,1.0,32/113,22.34%,MMP3;ABCA1;ASAP1;FSCN1;CD36;ATM;GTF2H1;TIRAP;LCP1;ATR;BRK1;FNIP1;TNF;GSK3B;SRC;PLEK;SH3GLB1;DDB1;TPPP;ICE1;SLF2;PIEZO1;CAPG;PSMC6;ERCC2;EIF4G1;ISG15;TERF1;RHOC;RAP1B;CLU;RPA1
prerank,regulation of axon extension (GO:0030516),-0.2899090868296175,-1.0168047050418454,0.43005181347150256,0.8008411193347139,1.0,14/37,22.20%,MAP2;CDKL5;SEMA7A;DIP2B;SHTN1;TWF2;ZFYVE27;SIN3A;CDKL3;MAG;DNM2;SEMA3G;LIMK1;TRIM46
prerank,extracellular transport (GO:0006858),0.4764898379474639,1.0167510082437965,0.47112462006079026,0.787666367796182,1.0,2/12,6.77%,DNAAF4;SPEF2
prerank,RNA metabolic process (GO:0016070),0.34602839807372116,1.0165870584648093,0.4831223628691983,0.7875476439102962,1.0,45/127,23.26%,RBMS1;APOBEC1;ATXN1;SYNCRIP;ATXN2;SNRNP40;DDX17;WDR74;PABPC4;FTO;RNASEH1;GTF2F2;DICER1;SND1;DHX8;RNASEH2A;NCBP2;ALKBH1;HNRNPH2;PAPOLG;GTF2F1;RBM6;RNASE1;SETX;RBMX;HNRNPUL1;SIDT2;MTREX;RBFOX2;POLR2L;POLR2K;DDX20;RBM39;PARN;AGO2;LAGE3;DUSP11;RBMS2;DDX24;ZC3H12A;HNRNPC;RNASE3;RNASEH2B;POLR2D;PCBP1
prerank,regulation of pseudopodium assembly (GO:0031272),0.49134985429809025,1.0165242125982692,0.45806451612903226,0.7867683551090762,1.0,4/10,18.41%,CDC42;WASHC1;CDC42EP1;CDC42EP4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.49134985429809025,1.0165242125982692,0.45806451612903226,0.7867683551090762,1.0,4/10,18.41%,CDC42;WASHC1;CDC42EP1;CDC42EP4
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4017548592078924,1.0163737795525907,0.4674634794156706,0.7866431443962141,1.0,13/30,23.36%,TAF1D;POLR1E;GTF2H1;CDK7;POLR1B;TAF1A;POLR2L;POLR2K;POLR1G;ERCC2;POLR1A;CCNH;MNAT1
prerank,epithelial cell-cell adhesion (GO:0090136),0.4910591567431371,1.0162408821473412,0.4601226993865031,0.7864404486285219,1.0,2/11,1.76%,THBS4;ITGB5
prerank,sulfation (GO:0051923),-0.41085870053935836,-1.0159494113921799,0.42939481268011526,0.8013782998076472,1.0,2/11,6.17%,UST;SULT1A1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.41405679569875836,-1.015663211130297,0.4341317365269461,0.8003821489512868,1.0,4/10,6.69%,PDE4B;CACNB2;CALM1;NIPSNAP2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3939203527454395,1.0155161715155634,0.43954659949622166,0.7876321488289189,1.0,7/35,14.73%,C3;RAB21;CBL;VTN;ARF1;MKLN1;RAC1
prerank,positive regulation of peptidase activity (GO:0010952),-0.347709418268604,-1.0153182004662853,0.45255474452554745,0.7995404808534016,1.0,7/20,13.22%,APH1A;NDUFA13;VSIR;APH1B;PINK1;MAPK12;GRN
prerank,bile acid metabolic process (GO:0008206),0.4172923408116015,1.0150738523989566,0.46405228758169936,0.7881906966104844,1.0,3/27,9.82%,CYP7B1;SLC27A2;OSBPL3
prerank,regulation of mitotic nuclear division (GO:0007088),0.369533349018851,1.0150404145753689,0.4501187648456057,0.7878042224700413,1.0,20/55,24.43%,EDN3;PDXP;PDGFRB;EGF;TOM1L1;BORA;DRD3;BTC;BMP7;RCC1;OBSL1;FBXO5;LRP5;PIN1;CDK13;RGCC;IL1A;PRMT5;PHIP;CUL9
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4491909012455053,1.014789421350002,0.4465592972181552,0.7879249301581318,1.0,6/16,17.14%,NOS1AP;APOE;TERT;TNF;HIF1A;AKT1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.398145853657487,-1.0144006907175593,0.4526627218934911,0.8002698106397733,1.0,3/13,12.06%,MGLL;ABHD6;DGAT1
prerank,regulation of cytoplasmic transport (GO:1903649),0.4833976568046988,1.0142767148811545,0.43661971830985913,0.7885813279743559,1.0,5/11,17.06%,LRRK2;DNAJC13;MAP2K1;SRC;MAPK1
prerank,membrane depolarization (GO:0051899),-0.3057952748609347,-1.0141757392558886,0.41379310344827586,0.7991680366319964,1.0,8/32,10.05%,CACNB4;CAV1;SCN2A;CACNG2;SCN8A;CACNA1E;CACNA1B;SCN9A
prerank,positive regulation of lamellipodium organization (GO:1902745),0.39987305877374163,1.0141172457430423,0.4356687898089172,0.7884807543836514,1.0,10/32,14.73%,AUTS2;FSCN1;CARMIL1;CDC42;ABI2;ACTR2;BRK1;PIK3R1;SRC;RAC1
prerank,negative regulation of chemotaxis (GO:0050922),-0.3089855132533698,-1.0140680821129422,0.40476190476190477,0.7977075425438032,1.0,20/31,29.80%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;SEMA4D;SEMA5A;THBS1;SEMA5B;SLIT2;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;CORO1B;SEMA6B;NOTCH1;SEMA4G;SEMA3F
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.44362384815308004,1.0140517670336782,0.462707182320442,0.7872566537132514,1.0,4/20,6.21%,KLHL22;MAD2L1;ATM;PLK1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.44362384815308004,1.0140517670336782,0.462707182320442,0.7872566537132514,1.0,4/20,6.21%,KLHL22;MAD2L1;ATM;PLK1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.44362384815308004,1.0140517670336782,0.462707182320442,0.7872566537132514,1.0,4/20,6.21%,KLHL22;MAD2L1;ATM;PLK1
prerank,negative regulation of nuclear division (GO:0051784),-0.41043725830912836,-1.0136555609265392,0.4447592067988669,0.7970462066049725,1.0,2/11,1.76%,TOM1L2;BMP4
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4845930674793001,1.0126951614742599,0.46200607902735563,0.7898236214574877,1.0,7/12,24.10%,CTSS;CTSL;CTSB;MED1;KLF9;THRB;CTSH
prerank,axon guidance (GO:0007411),0.33128477870256157,1.0125605898135452,0.47619047619047616,0.7896508637106897,1.0,33/201,11.84%,EPHA7;LAMA2;PALLD;GLI2;CXCL12;LAMA1;ROBO2;SH3KBP1;GAB2;SLIT3;SLIT1;EFNA4;PRKCA;NRP1;PLXNC1;EPHB3;SHH;OPHN1;EPHA1;PLXND1;L1CAM;GRB2;PLXNA3;EFNA5;CXCR4;WNT5A;FRS2;SEMA3E;PTK2;DSCAM;DRAXIN;PTPRM;UNC5B
prerank,membrane protein proteolysis (GO:0033619),0.3887047551985788,1.0120983793795553,0.45925925925925926,0.790197196063465,1.0,12/37,21.39%,ADAM19;PRTN3;MYH9;SPPL3;PSEN1;PSENEN;RBMX;RHBDD1;NCSTN;ADAM9;PSEN2;HM13
prerank,ribosomal small subunit assembly (GO:0000028),0.455912548951645,1.0117416773815966,0.4568245125348189,0.7905673041363277,1.0,1/16,0.79%,RPSA
prerank,vitamin D metabolic process (GO:0042359),0.46148493406796753,1.0117227076475945,0.44976816074188564,0.7901449183357101,1.0,3/13,12.52%,CYP27B1;CYP1A1;CYP2R1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5005358100874543,1.011609350905142,0.4704968944099379,0.7890165672862498,1.0,2/10,5.88%,DNA2;XRCC3
prerank,t-circle formation (GO:0090656),0.5005358100874543,1.011609350905142,0.4704968944099379,0.7890165672862498,1.0,2/10,5.88%,DNA2;XRCC3
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5005358100874543,1.011609350905142,0.4704968944099379,0.7890165672862498,1.0,2/10,5.88%,DNA2;XRCC3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.37406769124210737,-1.0113030645418508,0.4303030303030303,0.8015284729751438,1.0,5/15,14.46%,CPEB3;PABPC1;TOB1;TNRC6C;POLR2G
prerank,cAMP-mediated signaling (GO:0019933),0.42004226198179645,1.0112976210958677,0.48064085447263016,0.7892600410914156,1.0,4/24,6.40%,PDE3A;PDE7B;ADCY2;AHR
prerank,regulation of phosphorylation (GO:0042325),0.3413248996311923,1.0112387522585928,0.4620253164556962,0.7889277278545549,1.0,34/120,20.96%,GLMN;DYNLL1;NRP1;CDKN2B;EGFR;NUP37;RAE1;CCL5;EGF;MCM7;OGT;FNIP1;NUP153;PTK2;DSCAM;GCK;PSEN1;BMP7;CDKN1B;NDC1;HIF1A;NUP35;NUP188;SEC13;ANKLE2;INHBA;PLXNB2;ZBTB7A;STAT2;NUP214;CORO1C;PIN1;NDUFS4;NUP107
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.29015338738883356,-1.0108755001043646,0.4,0.8009956134957229,1.0,6/35,2.94%,SEMA6A;SEMA3C;SEMA3D;PLXNA4;SEMA6D;SEMA7A
prerank,2-oxoglutarate metabolic process (GO:0006103),0.464422173828841,1.0107976712753663,0.4714946070878274,0.7894772902564142,1.0,3/13,16.99%,DLST;IDH2;L2HGDH
prerank,negative regulation of receptor internalization (GO:0002091),0.4804004943795107,1.010662169888315,0.4637462235649547,0.7893110890285001,1.0,5/12,22.30%,ATXN2;DLG4;ANKRD13B;MTMR2;SDCBP
prerank,folic acid-containing compound metabolic process (GO:0006760),0.43750346274734336,1.0106206575017218,0.45285714285714285,0.7889371442650367,1.0,10/19,27.33%,MTHFR;MTHFD1L;MTHFD2L;GGH;MTRR;SLC19A1;ALDH1L2;MTHFD1;FOLR2;SLC25A32
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.3591418359681094,-1.0104360600646043,0.4662576687116564,0.8004427994367111,1.0,3/15,4.13%,TJP1;FGF1;KLF4
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.32637242618824036,-1.009934908231713,0.4155405405405405,0.8000863303124387,1.0,6/22,8.92%,NCL;IPPK;WDR43;PHF8;PWP1;DHX33
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.37695623095315955,1.008940097714299,0.4681603773584906,0.7923055090401924,1.0,13/47,21.08%,CRP;PDGFRB;DHRS4;CD36;PID1;GRB2;RIPK1;AGT;XDH;GADD45A;DCXR;PRKCD;ZC3H12A
prerank,neuromuscular process (GO:0050905),0.44673091483796373,1.0087277299536044,0.45918367346938777,0.7923278477914841,1.0,4/16,11.46%,MYCBP2;HOXA1;UBA5;AGTPBP1
prerank,negative regulation of growth (GO:0045926),0.34344456742661256,1.008302587515381,0.47114375655823715,0.7928667251894724,1.0,20/121,14.44%,ENPP1;PPP1R9B;BCL6;SLIT3;SERTAD2;FRZB;CYP27B1;SFRP1;ENO1;CCAR2;BTG1;IP6K2;ACVR1B;RERG;PTPRJ;TGFB2;SPHK2;SMAD3;CDKN1B;SMAD4
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4116682959664785,1.007953200530229,0.47035040431266845,0.7932111558126578,1.0,8/25,21.74%,SULF1;SMAD2;ACVR2A;SMAD4;ACVRL1;RBPJ;BMPR1A;ZNF423
prerank,rRNA transcription (GO:0009303),0.43602633863796536,1.007786287919673,0.44871794871794873,0.7931316331949144,1.0,5/17,20.16%,POLR1E;GTF3A;BRF1;GTF3C4;POLR1G
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4601947429583325,1.0076457924666669,0.4653902798232695,0.792539741996819,1.0,3/15,8.35%,ZFP36L1;ZFP36L2;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4601947429583325,1.0076457924666669,0.4653902798232695,0.792539741996819,1.0,3/15,8.35%,ZFP36L1;ZFP36L2;TNRC6B
prerank,presynapse organization (GO:0099172),0.49904549808687115,1.0073316529495542,0.48868778280542985,0.7928043230321117,1.0,2/10,9.14%,FZD1;WNT5A
prerank,positive regulation of cytokinesis (GO:0032467),0.4013553062322752,1.0067037982391633,0.4513157894736842,0.7938333683394937,1.0,8/32,14.53%,SVIL;CDC42;DRD3;OPN1MW;CSPP1;RHOA;GIPC1;CDC14A
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3716584263793988,-1.0066566876593555,0.4,0.8071479162047779,1.0,5/15,11.77%,LEF1;JUN;CHD1;EP300;SP1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.43632559034803486,1.0065237081442744,0.45375722543352603,0.7937773427350295,1.0,3/18,11.11%,DNAAF4;SPEF2;NPHP3
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4527240692218448,1.006473485253339,0.45007451564828616,0.7934238556648369,1.0,3/15,7.85%,TREM2;CD53;EHD2
prerank,DNA strand elongation (GO:0022616),-0.35357249656784506,-1.0062871428461497,0.45,0.8064164259600665,1.0,12/18,30.44%,MRE11;POLD3;GINS3;DCLRE1B;MCMDC2;RFC3;GINS4;RAD50;POLD2;GINS1;RFC4;MCM3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4713803135270981,1.005305287376197,0.4785276073619632,0.7955794096682504,1.0,3/11,8.96%,BLK;LGALS9;ANXA1
prerank,cellular response to interleukin-12 (GO:0071349),0.3767058533713661,1.0045687083957202,0.47285886610373945,0.7968362103308417,1.0,14/48,21.93%,JAK1;JAK2;RALA;CDC42;MSN;LMNB1;LCP1;TALDO1;ARF1;TYK2;CAPZA1;HNRNPDL;SIRPA;RAP1B
prerank,regulation of multicellular organismal development (GO:2000026),0.4175061004395999,1.0042281178529906,0.4676354029062087,0.7971003446242114,1.0,7/25,17.21%,PTN;EHMT1;HPSE;BAG6;MYSM1;NIPBL;DUSP6
prerank,regulation of ERBB signaling pathway (GO:1901184),0.45296846120757894,1.003596875166493,0.47384155455904337,0.7980685810850268,1.0,3/15,6.99%,EGFR;EGF;PTPN18
prerank,DNA damage checkpoint signaling (GO:0000077),0.40664658369410395,1.0032869100947237,0.45918367346938777,0.7982934402677919,1.0,10/28,21.02%,BRIP1;E2F1;ATM;ATR;USP28;CLOCK;ATRIP;RAD9A;HINFP;MAP3K20
prerank,positive regulation of interferon-beta production (GO:0032728),0.3945972142730725,1.0025242956612554,0.4544303797468354,0.7995816699897832,1.0,9/33,20.62%,TLR2;IRF7;TLR7;IRF1;POLR3A;POLR3D;TRIM56;RNF135;ISG15
prerank,male meiosis I (GO:0007141),0.4422563691792789,1.0020264645342298,0.4622093023255814,0.8002175542707887,1.0,3/16,12.98%,MYBL1;ZSCAN21;FOXJ3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4577355907767302,1.0019821492814738,0.4907010014306152,0.7998531757531384,1.0,2/14,8.35%,ADIPOQ;PRKAR1B
prerank,negative regulation of heart contraction (GO:0045822),-0.3940796165529789,-1.0019337341255816,0.4514285714285714,0.8164086242257702,1.0,3/11,10.43%,ATP1A2;GRK2;PDE4D
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.37421212016586286,1.0019272757608095,0.4690909090909091,0.7995191671540859,1.0,9/48,14.73%,CEMIP;XCL1;CAMK2D;CXCL10;FKBP1B;SELENON;UBASH3B;CALM2;CX3CL1
prerank,glycerol metabolic process (GO:0006071),0.48753710532971634,1.00179710983509,0.5039123630672926,0.7993492982352565,1.0,2/10,11.60%,PDXP;GK
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3990499208189426,1.0017057311331465,0.4669312169312169,0.7990963268495941,1.0,6/27,12.48%,PDGFRA;IRS1;PDGFRB;AMBRA1;PTK2;FGF2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.41437042127693735,-1.0014815522805278,0.4732620320855615,0.815882686402461,1.0,6/10,19.93%,SHANK3;APP;CAMK2B;SYP;SYNGR1;DRD2
prerank,inositol lipid-mediated signaling (GO:0048017),0.3718787411642802,1.0014518268410748,0.47909199522102747,0.7992276496541266,1.0,13/50,13.29%,PDGFRA;GAB2;IRS1;PDGFRB;OGT;PLCL1;EXOC1;RPS6KB1;FGFR1;PLCB3;RHOA;PI4KA;PIK3R1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.33994549779634625,1.0011757261988665,0.477533960292581,0.799405110278845,1.0,23/124,12.49%,GPM6B;LAMB1;PPP1R9B;LRP12;ATXN10;APOE;BLK;IQCG;LIMA1;PKD2;OPHN1;CARMIL1;DTNBP1;VAPA;L1CAM;TTC17;FAM161A;WDPCP;SAMD14;TTC29;PTPRM;GSK3B;MICALL2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.31133929699434487,-1.0011170301383152,0.416,0.8151511513830506,1.0,12/26,20.84%,NRXN1;PRKCZ;SHANK3;SLC8A3;CUX2;SHANK1;APP;RIMS1;RELN;SLC8A2;NLGN1;RIMS2
prerank,response to progesterone (GO:0032570),0.43288502421714264,1.0008621047624495,0.4611032531824611,0.7996836752009445,1.0,5/18,14.47%,YAP1;TGFB3;TGFB2;SRC;CATSPER3
prerank,lymphocyte mediated immunity (GO:0002449),0.4734227614811784,0.9998922536243776,0.4539877300613497,0.8014039972288324,1.0,2/12,5.33%,JAG1;GNL1
prerank,cellular response to radiation (GO:0071478),0.3864369294281407,0.999776222770358,0.4700122399020808,0.801223104205168,1.0,14/40,24.47%,TNKS1BP1;INO80;GRB2;OPN1MW;OPN1MW3;TANK;CLOCK;GPR88;RAD9A;SWI5;GADD45A;RRH;RAD51;CDKN1A
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4238028852760546,0.9997627589824414,0.47406340057636887,0.8007951371902535,1.0,3/18,6.92%,ASPG;MTHFR;ASNS
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.46956426295434844,0.9997471120023287,0.4828101644245142,0.8003705808317608,1.0,2/13,5.88%,MAD2L1;XRCC3
prerank,striated muscle contraction (GO:0006941),-0.26738089937722775,-0.9996452042811177,0.43670886075949367,0.8172526903863961,1.0,4/53,3.33%,DMD;ATP1A2;ATP1B1;DTNA
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4826993103179461,0.9996418558012165,0.47318611987381703,0.8001497140016665,1.0,3/11,11.44%,ACVR1;TGFBR1;TGFB2
prerank,regulation of protein secretion (GO:0050708),0.34037943268629794,0.9994705574324582,0.4932221063607925,0.8000971724982561,1.0,23/119,13.20%,CACNA1A;DNAJC1;RAPGEF4;PRKCA;CACNA1C;TREM2;APOE;ABCG1;ITPR1;KCNA5;PPID;CCL5;TGFB3;FRMD4A;LLGL1;EXOC1;DRD3;EIPR1;TGFB2;GCK;DPH3;TNF;KCNS3
prerank,negative regulation of phosphorylation (GO:0042326),0.3441724070286652,0.9993478009316586,0.49242424242424243,0.7999251239268647,1.0,24/85,21.21%,FBLN1;DYNLL1;LRRK2;CDKN2B;PTPN13;PTEN;LRP6;NPRL2;PID1;NIBAN1;WWTR1;IBTK;ZBED3;NTRK3;BMP7;CDKN1B;PRKDC;ANKLE2;INHBA;XDH;PRNP;CORO1C;ZC3H12A;SIRPA
prerank,focal adhesion assembly (GO:0048041),0.4260537961113939,0.9992351963366761,0.465149359886202,0.7997258743509436,1.0,3/21,5.21%,DLC1;PEAK1;RHOD
prerank,membrane lipid metabolic process (GO:0006643),0.41784523549357055,0.9991108467744285,0.46258503401360546,0.7995291823248474,1.0,1/22,0.18%,CYP1B1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.31369960738014385,-0.9988450332524182,0.42857142857142855,0.8176735985938494,1.0,5/25,10.64%,CTNNA3;CXADR;CD200;VCAM1;ITGA4
prerank,regulation of peptide hormone secretion (GO:0090276),0.3623136249720689,0.9986326788296037,0.4781144781144781,0.8001699998310857,1.0,12/67,13.20%,CACNA1A;CHD7;RAPGEF4;PRKCA;CACNA1C;ITPR1;KCNA5;CCL5;EIPR1;GCK;TNF;KCNS3
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.38839822682760866,0.9984607832395973,0.4822085889570552,0.8000739519842331,1.0,8/38,12.43%,PRKCA;PUM1;CCL5;LY96;SASH1;OASL;ANKRD17;POLR3D
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3234285184497695,-0.9979848206629371,0.4645669291338583,0.818265477889511,1.0,9/24,20.11%,ABCG2;CPOX;FLVCR1;SLC25A38;UROS;COX10;ABCB10;RSAD1;ALAS1
prerank,nuclear membrane reassembly (GO:0031468),0.35935298090516593,0.997908999028829,0.4735605170387779,0.8008317935882611,1.0,18/54,20.96%,CHMP4A;CHMP4B;NUP37;VPS4A;LEMD2;PPP2R2A;CCNB2;CHMP7;NDC1;CHMP2B;NUP35;NUP188;RCC1;SEC13;ANKLE2;CC2D1B;UBXN2A;NUP107
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.41932610203217985,-0.997805254379325,0.48412698412698413,0.8170733882234046,1.0,3/10,7.06%,ATP1A2;OSR1;HECW1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.41792504032334654,-0.997669964922084,0.4598337950138504,0.815742011490325,1.0,2/10,4.50%,BICD1;APC
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.44131489749150077,0.9970738077266412,0.4847605224963715,0.8022595508304373,1.0,3/18,6.47%,IRS1;SFRP1;INHBB
prerank,retina homeostasis (GO:0001895),-0.32322417192157854,-0.9968857024370326,0.4730290456431535,0.8161467677143741,1.0,6/23,16.36%,ACTB;POTEF;HSPB1;WHRN;SOD1;BBS4
prerank,negative regulation of cation channel activity (GO:2001258),0.4030471816630035,0.9968265392109444,0.4650537634408602,0.8023663862905503,1.0,7/26,14.28%,PKD2;CBARP;FKBP1B;KCNAB1;DRD3;CALM2;FMR1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4060867027692532,0.9968232968683055,0.4773936170212766,0.8019180441338705,1.0,7/26,15.59%,ALPK1;TNFAIP3;NOD1;IRAK2;CASP8;TIFA;ITCH
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.38981192943975895,0.9963929197698852,0.4974937343358396,0.802428241944311,1.0,5/33,7.60%,ZFP36L1;IRS1;PTEN;NF1;PIK3R5
prerank,receptor metabolic process (GO:0043112),0.36771477843847256,0.9961949148475873,0.47740440324449596,0.8023973531084352,1.0,16/53,18.00%,CLTC;LRP1;ARFGEF2;ADM;CD36;GRB2;CALCRL;KIF16B;PIK3R4;SNX25;SMURF1;NEDD4;GRK4;SH3GLB1;PICALM;REP15
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.42548281625899853,0.9961315058381511,0.4793741109530583,0.8020720550190399,1.0,7/22,18.07%,DYNLL1;CDKN2B;BMP7;CDKN1B;PLEK;ANKLE2;INHBA
prerank,pulmonary valve development (GO:0003177),0.43196444785000027,0.9960908224515052,0.4835007173601148,0.8017088928608803,1.0,5/18,11.44%,ROBO2;JAG1;HEYL;TNFRSF1A;TGFB2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.3106228653169054,-0.9959001514958353,0.4652173913043478,0.8170597893979309,1.0,10/27,23.91%,SYT7;PPP3CB;RIMS1;VAMP7;SDF4;RIMS2;SYT12;SYT11;SYT13;SYT3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3711168019842515,0.9956547769487024,0.49707602339181284,0.8022666853841228,1.0,13/48,19.83%,PAPSS2;DCAKD;ADCY7;ADCY2;SLC25A16;NPR2;PANK2;SLC35B3;COASY;PANK1;AMPD2;IMPDH2;AMPD3
prerank,organic substance transport (GO:0071702),0.33383410140754216,0.9954088985487823,0.49216300940438873,0.8023667284027367,1.0,31/120,21.26%,ABCA1;TCN1;SLC6A2;ARRDC4;ABCA2;PLTP;MYH9;ABCG1;MIA3;LMAN2L;RAB7A;TCN2;ARRDC3;RCN3;PEX19;SLCO1B1;CALCRL;ABCA9;ABCG4;NDC1;CHMP2B;SNX4;RUFY1;HSP90B1;SLCO2B1;SLC50A1;TAP1;SLC18A2;TOM1;SLC19A1;MFSD12
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.43101291622863347,0.9951706912210116,0.4821917808219178,0.8024660798838025,1.0,7/21,18.53%,KLHL22;MAD2L1;ATM;PLK1;MAD1L1;TEX14;FBXO5
prerank,mRNA polyadenylation (GO:0006378),-0.31285701138927824,-0.9949359670465595,0.452755905511811,0.8163586804898285,1.0,8/26,23.17%,WDR33;PABPC1;LEO1;APP;TUT1;CPSF2;CLP1;PAPOLB
prerank,RNA polyadenylation (GO:0043631),-0.31285701138927824,-0.9949359670465595,0.452755905511811,0.8163586804898285,1.0,8/26,23.17%,WDR33;PABPC1;LEO1;APP;TUT1;CPSF2;CLP1;PAPOLB
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.4099855156876989,0.9949295367174291,0.48230668414154654,0.8025410440023147,1.0,4/23,12.65%,EPHX2;FADS1;CYP1A1;ELOVL6
prerank,determination of left/right symmetry (GO:0007368),0.381121231383382,0.9947827672314244,0.4935897435897436,0.8024264545459197,1.0,6/36,11.11%,DNAAF4;SHH;PKD2;DNAH11;GALNT11;NPHP3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.32637823885135103,0.9945043452539978,0.5242914979757085,0.8025613978855456,1.0,61/259,16.55%,TEKT4;PPP1R9B;DYNLL1;MAP4K4;EMP1;CEP19;NRP1;ASAP1;FSCN1;STK36;PARVA;PMP22;AIF1;RHOD;OPHN1;FGD4;CARMIL1;RAP2A;IFT88;PCM1;RAB8B;CEP41;EXOC4;EHD2;ACTR2;GBF1;S1PR2;MYLK;FAM161A;EXOC1;EXOC7;WDPCP;PCNT;WDR35;DISC1;PTPN23;ARF4;GALNT11;NPHP3;FGD6;IFT172;IFT81;PDE6D;SNX10;CFAP410;CPLANE1;P2RX7;RAB1A;AIF1L;DYNC2H1;DZIP1L;KIF27;CDC14A;RAC1;TTC39C;EMP3;EXOC5;EXOC3;NUDCD3;POC1B;WDR90
prerank,positive regulation of protein secretion (GO:0050714),0.3569717931133786,0.9944534495862368,0.4869169510807736,0.8022305526534144,1.0,14/69,11.60%,TCF7L2;TLR2;TREM2;BLK;ABCG1;ACSL4;PPID;TGFB3;FRMD4A;EXOC1;WLS;PTPN23;TGFB2;GCK
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3759232932598093,0.9944227925181286,0.46780072904009723,0.8018366470382878,1.0,11/37,23.22%,ATXN2;APOE;ABCA2;DLG4;TRAP1;ANKRD13B;MTMR2;SDCBP;NCOR1;ITGB3;AP1AR
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4069122208237126,0.9939122755620505,0.46553966189856955,0.8025244101717972,1.0,8/28,16.85%,PARP3;ACTR2;SHLD3;SETMAR;RIF1;DTX3L;PRKDC;PNKP
prerank,sensory perception of taste (GO:0050909),0.48882382849874545,0.9937315333256042,0.5048231511254019,0.8024568107417526,1.0,2/10,16.22%,CD36;PKD1L3
prerank,protein localization to chromosome (GO:0034502),0.3866950026600068,0.9935890092417197,0.4839124839124839,0.8023138712737994,1.0,12/34,18.97%,PARP3;PLK1;PINX1;LEMD2;ATR;MCM9;CHMP7;CTCF;ATRX;TNKS2;SLF2;WAPL
prerank,positive regulation of establishment of protein localization (GO:1904951),0.43522579776198966,0.9934064176976904,0.4933920704845815,0.802249343376305,1.0,5/18,14.46%,TREM2;CCT8;CEP120;TNF;CCT3
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.36443616447073435,0.9930074463782175,0.4809069212410501,0.8026690787641557,1.0,15/48,20.16%,ZMIZ1;TAF1D;SERTAD2;PADI2;PHF2;POLR1E;ARID1B;SPHK2;POLR1B;TAF1A;ASF1A;POLR2L;POLR2K;SERTAD1;POLR1G
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.43305547862654975,0.9929954717206811,0.46971935007385524,0.8022452206314953,1.0,4/15,12.29%,APOE;SNX33;SNX9;TNF
prerank,multivesicular body organization (GO:0036257),0.39227972382889525,0.9929035921456872,0.492772667542707,0.8019901387403635,1.0,6/31,15.31%,CHMP4A;CHMP4B;VPS4A;VPS37C;CHMP7;CHMP2B
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.40126332536625453,0.9926593961301599,0.46981627296587924,0.8020717538147439,1.0,11/27,23.02%,CUL1;CCM2;SKP1;MAPK11;FBXW11;MAPK1;KAT7;MAP3K20;TNIP2;RPS27A;MAP2K7
prerank,homotypic cell-cell adhesion (GO:0034109),0.377110719703033,0.9925955885399751,0.4880201765447667,0.8017740240122294,1.0,16/39,24.04%,PDGFRA;CSRP1;MYH9;STXBP1;STXBP3;UBASH3B;GNAS;PLEK;FERMT3;TYRO3;ACTN1;FIBP;P2RY12;MEGF10;ITGB3;METAP1
prerank,protein-containing complex subunit organization (GO:0043933),0.34294667235163895,0.9918468307077335,0.5126050420168067,0.8029813212724545,1.0,25/109,17.95%,KMT2A;YAP1;LAMC1;SKAP2;CD40;MITF;WIPF1;PPID;CREBBP;LLGL1;DLG4;KPNA3;ADD2;TEAD1;SNX9;TSPAN4;SPG7;TRAF2;RANBP9;NDC1;TUBGCP4;NUP35;MDM2;PICALM;CAPZA1
prerank,Ras protein signal transduction (GO:0007265),0.33403103270497286,0.9918378368126335,0.5052301255230126,0.8025493068162889,1.0,37/137,18.74%,COL1A2;FARP2;RASSF1;PLD1;TAX1BP3;AIF1;NF1;RHOD;RAB42;RALA;RAP2A;GPSM2;ARHGDIG;ABI2;MAPK11;GRB2;BRAP;RERG;BRK1;SETDB1;RALGDS;PDPN;RIT1;DBNL;RHOA;ARHGAP6;FGF2;RTKN;RAC1;CDC42EP1;USP28;ARHGDIA;GNA12;CDC42EP4;GNB1;SHC2;EPS8
prerank,regulation of cell growth (GO:0001558),0.3286383545370144,0.9917009859241737,0.5111788617886179,0.8024282299095004,1.0,31/204,11.44%,ENPP1;MMP14;PPP1R9B;EIF4G2;BCL6;SLIT3;KLHL22;EGFR;SERTAD2;FRZB;FXN;CAMK2D;BCL2;PABIR1;CYP27B1;INO80;SFRP1;ENO1;CDC42;RPTOR;CCAR2;BTG1;EXOSC4;TGFBR1;CSNK2A1;IP6K2;PAPPA2;ACVR1B;RERG;PTPRJ;TGFB2
prerank,intermediate filament organization (GO:0045109),-0.3504319730151483,-0.9911871494727257,0.46794871794871795,0.8245656256736263,1.0,8/17,30.30%,GFAP;BFSP2;KLHL24;BFSP1;DSP;TCHH;PKP2;NEFL
prerank,apical protein localization (GO:0045176),-0.41416273956085975,-0.9911695923390749,0.4558011049723757,0.8228799318066816,1.0,4/10,6.86%,MAL;ACTB;GOPC;SHROOM3
prerank,energy reserve metabolic process (GO:0006112),-0.3376265293915578,-0.9907640127311425,0.4574898785425101,0.82226123496815,1.0,3/19,5.04%,PRKAG2;GBE1;PYGM
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4209385515705373,-0.9901549896231189,0.4945054945054945,0.8222206515665708,1.0,2/10,3.17%,PODXL;DPP4
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3776293817151027,0.9900219584057656,0.4758364312267658,0.8055921275031307,1.0,9/34,15.39%,PDGFRA;IRS1;PDGFRB;AMBRA1;PTK2;FGF2;PIK3R1;WASHC1;PIK3R4
prerank,positive regulation of nervous system development (GO:0051962),-0.2708457516684145,-0.9897234745909231,0.5117647058823529,0.8215632193588231,1.0,14/42,19.82%,NRXN1;GRID2;IL1RAPL1;CLSTN3;SYNDIG1;CUX2;LRRC4B;CLSTN1;PTPRD;BDNF;EPHB1;TRIM32;GPER1;NLGN1
prerank,dendritic spine organization (GO:0097061),0.401878846010864,0.9893053541917382,0.47651006711409394,0.8066618441359658,1.0,10/26,19.20%,EPHB3;TREM2;PTEN;CDC42;DLG4;ITGA3;ARF1;DOCK10;PRNP;MTMR2
prerank,regulation of microtubule polymerization (GO:0031113),-0.26772200345719327,-0.9889928482948422,0.5126582278481012,0.8218940842071955,1.0,4/40,3.01%,MAP2;OCLN;EML2;CDH5
prerank,positive regulation of phospholipase activity (GO:0010518),0.4169512601083084,0.9882010015506523,0.4881450488145049,0.8086321399879158,1.0,7/22,12.55%,PDGFRA;PDGFRB;CCL5;FGFR1;ARF4;FGF2;NTRK3
prerank,positive regulation of autophagy (GO:0010508),0.34650475724746665,0.988106507664708,0.5093099671412924,0.8083976303842985,1.0,12/81,13.03%,DCN;TRIML2;LRRK2;TRIM21;NPRL2;TRIM13;TRIM8;FOXO3;FBXO7;PLEKHF1;GSK3B;ORMDL3
prerank,response to thyroid hormone (GO:0097066),0.4652505234624625,0.9878571717072873,0.481371087928465,0.8084946737651272,1.0,7/13,24.10%,CTSS;CTSL;CTSB;MED1;KLF9;THRB;CTSH
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.3568351526454261,-0.9877449147176642,0.4892966360856269,0.8233442851182227,1.0,3/16,4.33%,KCNC2;NOS3;NDNF
prerank,axon development (GO:0061564),-0.246009182593603,-0.9876645999392597,0.5,0.8218845271116627,1.0,24/78,17.87%,DCC;GRM7;CTNNA2;NTNG1;CNTN4;ACTB;KLF7;SHTN1;DSCAML1;FGFR2;SLITRK1;PARD3;ANK3;MAP1A;APP;ZDHHC17;S100B;PAK3;SEMA5A;PLP1;PLPPR4;DHFR;APBB1;TAOK2
prerank,negative regulation of viral transcription (GO:0032897),0.4648609662077001,0.9873573735934843,0.4873323397913562,0.8091807485814062,1.0,3/13,7.89%,UBP1;TRIM21;TRIM13
prerank,alpha-amino acid metabolic process (GO:1901605),0.36968826497258556,0.9871274556750371,0.4896719319562576,0.809245295362383,1.0,5/45,7.20%,ALDH18A1;ASPG;MTHFR;ASNS;KYAT1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.28425073864285905,-0.9871065890232198,0.45410628019323673,0.8216796538668169,1.0,15/36,24.77%,MECOM;PRKN;EZR;PER1;SH3RF2;DUSP10;PINK1;CYLD;QARS1;GPS2;HDAC3;PPIA;ZMYND11;DUSP19;MEN1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4394869963956903,0.9869762200143835,0.519774011299435,0.8091210223767485,1.0,6/17,14.97%,PRKCA;CD36;LY96;SASH1;CX3CL1;TRIB1
prerank,activation of protein kinase activity (GO:0032147),0.33848020810773444,0.9868566459319089,0.4983853606027987,0.8089039915739888,1.0,20/106,13.07%,MAP4K4;TAOK1;GHR;JAK2;ADCY7;RICTOR;ADCY2;TOM1L1;TAOK3;TIRAP;MAPKAP1;ANGPT1;BORA;PRKAR1B;WNT5A;TPX2;NRK;TGFB2;NTRK3;TRAF2
prerank,regulation of centrosome cycle (GO:0046605),0.4156087037579049,0.9868326454394117,0.48868175765645805,0.8085003742137212,1.0,4/21,15.31%,CHMP4B;XRCC3;NAT10;CHMP2B
prerank,response to gamma radiation (GO:0010332),0.4113376334263662,0.9867903557216083,0.5,0.8081484419273515,1.0,4/24,8.81%,YAP1;ATM;TRIM13;ATR
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.44922227700859574,0.9866217791239934,0.5007451564828614,0.808051797785515,1.0,10/16,27.70%,ATM;PINX1;SMG6;TNKS2;TERF1;SLX4;SMG5;TERF2;HNRNPA2B1;TINF2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.45920151473344417,0.9865991344704851,0.4703125,0.8076612700873984,1.0,2/11,5.62%,BCL3;NF2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.42474743743317894,0.9858436504394463,0.49712643678160917,0.8088823978133994,1.0,7/19,21.44%,SDSL;CRYM;DLST;ALDH7A1;HYKK;PIPOX;SLC25A21
prerank,chromatin remodeling (GO:0006338),0.3390079925798398,0.9854461294441719,0.5154091392136025,0.8092972892839081,1.0,30/100,22.80%,SATB2;BAZ1A;POLE3;MBD2;SMARCC1;BAZ2B;INO80;TADA2B;BAHD1;HDAC1;ARID1B;MTA2;GATAD2B;RSF1;RUVBL1;ATRX;MYSM1;BAZ2A;SRCAP;SMARCA4;HCFC2;HDAC5;ZBTB7A;MBD3;HMGA2;HNRNPC;PAK1;ACTL6B;CHD8;SMARCD3
prerank,regulation of vesicle-mediated transport (GO:0060627),0.34322365259792476,0.9853541152574856,0.5190839694656488,0.8090599996471104,1.0,24/91,17.88%,STON2;LRRK2;NRP1;PLD1;OPHN1;RALA;DNAJC13;ARFGAP1;RAB21;RAB8B;PTPN1;GAS1;MAP2K1;RINT1;RAB10;SRC;FES;PTPRC;MAPK1;RUFY1;RAB33B;PICALM;ZFYVE16;SCFD1
prerank,cellular response to glucose starvation (GO:0042149),-0.27241189196756865,-0.9852906509453911,0.49101796407185627,0.8247017373548191,1.0,11/41,14.59%,PRKAG2;PRKAA2;NIM1K;SIK1;SIK2;SESN2;SESN3;IMPACT;HNRNPA1;MYBBP1A;PRKAG3
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4081560521252085,0.9851118562614006,0.5040983606557377,0.8091702132835885,1.0,7/23,21.82%,TNFAIP3;PYDC1;NLRP2B;CX3CL1;CPTP;ZC3H12A;NLRP12
prerank,cellular response to hexose stimulus (GO:0071331),0.413263227119446,0.9850385404306982,0.4939759036144578,0.8088975320953067,1.0,1/23,0.13%,SLC39A14
prerank,spliceosomal complex assembly (GO:0000245),-0.27509475460842775,-0.9848384045590749,0.47305389221556887,0.8242274537040605,1.0,15/46,25.10%,CELF2;YTHDC1;PRPF6;SRSF5;RBM5;GCFC2;SNRPG;SRSF9;PRPF19;LUC7L3;DDX39B;CELF6;TXNL4A;SF3A1;SF3A3
prerank,response to zinc ion (GO:0010043),0.40092941665413706,0.9846217812563902,0.4897959183673469,0.8093579687051831,1.0,2/25,2.51%,HVCN1;PAM
prerank,microvillus organization (GO:0032528),-0.3752813857687688,-0.984294117102196,0.4818181818181818,0.8240821413829386,1.0,6/13,11.64%,MINK1;EZR;FXYD5;RAPGEF2;RAPGEF6;RAP1A
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.48750904418134633,0.9841423711930224,0.4891304347826087,0.8099680019012604,1.0,2/10,7.04%,CD40;BAG6
prerank,outer dynein arm assembly (GO:0036158),0.4375004844727852,0.9841364430600866,0.487369985141159,0.8095328532350807,1.0,3/14,13.37%,DNAAF4;ODAD1;DNAAF5
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.35072158425421673,0.9837793068854693,0.49206349206349204,0.809860904275214,1.0,15/63,15.12%,TCF7L2;CFLAR;ACVR1;TNFRSF12A;SIAH2;SH3RF1;SP100;TGFBR1;PELI3;FGFR1;CASP8;TNF;TRAF2;SRC;RIPK1
prerank,establishment of vesicle localization (GO:0051650),-0.3456454689881486,-0.9837732194286601,0.4934640522875817,0.8237904701389663,1.0,8/18,23.09%,RAB27A;SNAPIN;TOR1A;SYNJ1;DNM2;TESK1;IKBKG;SYT11
prerank,myelin maintenance (GO:0043217),0.48349050633092194,0.9837323484407945,0.5079617834394905,0.8095213007175492,1.0,4/10,22.12%,PTEN;CXCR4;EPB41L3;CLU
prerank,positive regulation of TOR signaling (GO:0032008),0.3777064983073946,0.9835133701940748,0.5018450184501845,0.8095545320498712,1.0,15/40,21.25%,KLHL22;TREM2;RICTOR;MIOS;RPTOR;RRAGC;FNIP1;SMCR8;LAMTOR5;SEC13;GPR137;SIK3;LAMTOR3;TELO2;CLEC16A
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3594667287723108,0.9834626020771808,0.4939613526570048,0.8087678283762055,1.0,15/51,17.78%,CHMP4A;CHMP4B;NUP37;VPS4A;LEMD2;PPP2R2A;CCNB2;CHMP7;NDC1;CHMP2B;NUP35;NUP188;RCC1;SEC13;ANKLE2
prerank,mitotic nuclear membrane organization (GO:0101024),0.3594667287723108,0.9834626020771808,0.4939613526570048,0.8087678283762055,1.0,15/51,17.78%,CHMP4A;CHMP4B;NUP37;VPS4A;LEMD2;PPP2R2A;CCNB2;CHMP7;NDC1;CHMP2B;NUP35;NUP188;RCC1;SEC13;ANKLE2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.34726449031355777,0.9831122193293519,0.5151187904967602,0.80908072557238,1.0,19/82,17.54%,DYNLL1;DYNC1H1;TUBG1;ALMS1;PLK1;PCM1;HAUS3;CEP41;CNTRL;DCTN3;TPX2;PCNT;CEP72;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5
prerank,glycogen catabolic process (GO:0005980),-0.3534061003316106,-0.9826357836422631,0.4521452145214521,0.8251150898135867,1.0,4/15,6.91%,CALM1;PGM2L1;PYGM;PYGB
prerank,response to acidic pH (GO:0010447),0.4561232448733805,0.9820388192467915,0.5234375,0.8110005088143212,1.0,2/13,5.02%,SLC9A1;CTSS
prerank,negative regulation of response to wounding (GO:1903035),-0.34232668102326064,-0.981982700892619,0.46853146853146854,0.8251665294718191,1.0,6/19,12.15%,EPHA4;INPP5F;CRK;AJAP1;GIT1;CD109
prerank,protein localization to chromatin (GO:0071168),0.424547190946302,0.9815800557534935,0.4985632183908046,0.8115051543740357,1.0,9/18,19.34%,PLK1;LEMD2;MCM9;CHMP7;LRWD1;PPHLN1;NIPBL;WAPL;TASOR
prerank,protein methylation (GO:0006479),0.38136318217684245,0.9815635408968527,0.4926289926289926,0.8110983565923194,1.0,20/40,27.81%,EHMT1;CARM1;CAMKMT;VCPKMT;NSD3;PCMT1;GSPT1;NSD1;ETFBKMT;PRMT3;SETD3;SNRPB;ETF1;N6AMT1;EEF2KMT;PRMT5;FAM98A;METTL21A;RAB6A;EEF1AKMT3
prerank,regulation of multicellular organism growth (GO:0040014),0.44500830850993417,0.9815020670068757,0.4985549132947977,0.8107888445708971,1.0,2/15,6.10%,GHR;STAT5A
prerank,positive regulation of interleukin-13 production (GO:0032736),0.4692762924995484,0.9814965219403262,0.5089722675367048,0.8103553170125629,1.0,3/10,13.14%,TSLP;LGALS9;SPHK2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.40607903445470506,0.9811124309476238,0.48484848484848486,0.8107360435255577,1.0,7/24,17.01%,XCL1;ITPR1;PKD2;IBTK;FGF2;ANXA6;PTPRC
prerank,microvillus assembly (GO:0030033),-0.36409528112603595,-0.981008324686218,0.49206349206349204,0.8260390907370729,1.0,6/14,11.64%,MINK1;EZR;FXYD5;RAPGEF2;RAPGEF6;RAP1A
prerank,positive regulation of secretion by cell (GO:1903532),0.3464667529660152,0.980865491514855,0.5005549389567148,0.8107897829187484,1.0,13/70,11.44%,EDN3;TREM2;RAB2B;ABCG1;PPID;DTNBP1;TGFB3;FRMD4A;UNC13D;RAB9A;EXOC1;RAB27B;TGFB2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.35255897328679653,-0.9807256535872751,0.49843260188087773,0.8250491954136318,1.0,6/16,19.56%,SFPQ;DDX5;SRSF9;RBM17;SCNM1;HNRNPM
prerank,regulation of amyloid-beta formation (GO:1902003),0.38095520021051527,0.9806127001255088,0.49232736572890023,0.8108417779132492,1.0,21/34,27.92%,SLC2A13;APOE;GSAP;ABCA2;ABCG1;TNF;PICALM;PRNP;PIN1;IFNGR1;CLU;RTN2;ROCK2;ROCK1;RELA;BIN1;CHRNA7;EFNA1;GGA3;GSK3A;TMED10
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.40788716943627934,0.9801474224636497,0.48435374149659866,0.8114422641284434,1.0,8/24,14.73%,AUTS2;FSCN1;CDC42;ABI2;ACTR2;BRK1;PIK3R1;RAC1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3723737948588663,0.9800843550473213,0.5,0.8111369499815152,1.0,6/43,7.31%,TAOK1;BABAM2;PABIR1;ATM;PLK1;TAOK3
prerank,peptidyl-proline modification (GO:0018208),-0.30330580255726536,-0.9798130441703681,0.5069767441860465,0.8259770183273254,1.0,8/25,15.45%,FKBP5;PPIG;P3H2;PPIH;PPIL2;PPIL3;FKBP1A;PPIB
prerank,cardiac muscle cell contraction (GO:0086003),0.42795303742206353,0.9793215252550291,0.49577464788732395,0.8123557886610673,1.0,3/19,4.56%,CACNA2D1;CACNA1C;CAMK2D
prerank,regulation of cell division (GO:0051302),0.34758504865837114,0.9790710032633606,0.5050847457627119,0.812437640133267,1.0,20/72,21.19%,POU5F1;PDXP;SHH;PLK1;KLHL13;ZFYVE26;SETD2;CSPP1;INSC;ENTR1;CALM2;PIK3R4;FSD1;PIK3C3;SH3GLB1;KIF20A;PIN1;PLK2;MYO19;BECN1
prerank,cardiocyte differentiation (GO:0035051),0.48226475286771153,0.9790521511402126,0.5141955835962145,0.8120336818327342,1.0,3/10,12.59%,GATA6;TGFB2;AKAP13
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4410502965228316,0.9788851604908144,0.5067873303167421,0.81194988267701,1.0,4/15,12.55%,CXCL12;IL16;VEGFC;NTRK3
prerank,smooth muscle tissue development (GO:0048745),0.4756287994220517,0.9786790392501592,0.4921383647798742,0.8119484390182319,1.0,4/10,15.46%,SHH;NF1;MYLK;SMO
prerank,cellular response to acid chemical (GO:0071229),-0.3010524640362672,-0.9782705919885658,0.4841628959276018,0.8285130329522141,1.0,12/27,20.44%,CPEB3;SLC38A9;KLF2;LAMTOR1;GLRA1;SESN2;RRAGB;SPAAR;RRAGD;GLRA2;LAMTOR2;RRAGA
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.47620613356523805,0.9779772860081095,0.5135135135135135,0.8130382122878556,1.0,2/10,17.01%,LGALS9;PTPRC
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.33301311663692634,-0.9778186995419438,0.49477351916376305,0.8280923553521122,1.0,7/20,23.26%,BICD1;YWHAB;GRK2;RNF157;MRAP2;RPGRIP1L;STMN1
prerank,glycolipid biosynthetic process (GO:0009247),-0.2747918653930642,-0.9775879702016484,0.49700598802395207,0.8269917626539769,1.0,19/38,27.34%,ST3GAL4;ST3GAL5;ST8SIA6;B4GALT6;PGAP2;PIGB;GBGT1;ST6GALNAC5;PIGG;PIGF;DPM3;SCCPDH;ST8SIA3;PIGZ;PIGM;PIGU;PGAP3;PIGO;PIGA
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3748881773009146,0.9775745231348841,0.48764629388816644,0.8134302732401061,1.0,10/33,15.69%,CREB3L1;JAK1;RHOJ;CEMIP2;ADAMTS9;BMPER;FGF2;ITGA5;SMAD1;FGF18
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4353042869983635,0.9775233856914363,0.5085714285714286,0.8131011835268691,1.0,2/17,2.85%,NOS1AP;CACNA2D1
prerank,amino acid transmembrane transport (GO:0003333),-0.26803377509826143,-0.9772981866663278,0.47770700636942676,0.8261635722049604,1.0,6/45,3.48%,SLC47A1;SLC6A6;LRRC8D;SLC38A9;SLC7A5;SLC38A11
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.33814431981078996,-0.9770141298376017,0.47651006711409394,0.8252489393613651,1.0,2/17,1.76%,ATP1A2;BMP4
prerank,protein O-linked mannosylation (GO:0035269),-0.3484479504540441,-0.976744860940276,0.5048543689320388,0.8243081095262288,1.0,1/18,0.12%,TMTC1
prerank,regulation of programmed cell death (GO:0043067),0.3248936868946702,0.9767234861023136,0.5552147239263804,0.8143700183806603,1.0,27/161,15.12%,BCL3;BCL6;STAT1;LRRK2;JAK2;BIRC3;CASP1;IFT57;NF2;STEAP3;CREBBP;ATM;OMA1;PTPN6;CXCL10;AIFM2;USP42;GAS1;CTSB;CALR;TNF;ANP32A;TRAF2;DAPK2;RTKN;RABGGTB;RIPK1
prerank,positive regulation of cell division (GO:0051781),0.3752686124684758,0.9764151345798442,0.5031605562579013,0.8146094674986464,1.0,9/38,14.53%,SVIL;SHH;CDC42;DRD3;OPN1MW;CSPP1;RHOA;GIPC1;CDC14A
prerank,nucleosome disassembly (GO:0006337),0.44696389056528774,0.9760243230052671,0.49850299401197606,0.8145490562761102,1.0,5/14,22.80%,SMARCC1;GRWD1;SMARCA4;ARID2;SMARCD3
prerank,chromatin disassembly (GO:0031498),0.44696389056528774,0.9760243230052671,0.49850299401197606,0.8145490562761102,1.0,5/14,22.80%,SMARCC1;GRWD1;SMARCA4;ARID2;SMARCD3
prerank,regulation of cilium assembly (GO:1902017),0.353726524916454,0.9759146015604062,0.5317919075144508,0.8143383750455947,1.0,17/62,17.41%,YAP1;TBC1D16;IFT88;TBC1D2B;ATG3;DYNC2LI1;CDK10;RABGAP1;ENTR1;CEP120;TAPT1;TBC1D1;ARHGAP35;TBC1D10B;TBC1D19;TBC1D20;CDKL1
prerank,endocytic recycling (GO:0032456),0.359402193901035,0.9758534181705939,0.5041716328963052,0.8140237883060533,1.0,14/50,16.56%,STX6;RAB7A;EHD2;VPS39;PTPN23;EIPR1;ENTR1;MICALL2;EPS15;CCDC93;ANKRD27;ACAP2;WASHC1;SNX4
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.39124146709310037,0.9748908308738171,0.4980392156862745,0.8156080013472156,1.0,4/28,8.40%,MMP14;EGFR;EGF;FBXW7
prerank,protein modification by small protein conjugation (GO:0032446),0.3156533846969059,0.9746796705793893,0.5771543086172345,0.8156290506863849,1.0,95/361,21.72%,TRIML2;DTX4;DCAF15;PDZRN3;MYLIP;PEX10;MYCBP2;SPSB1;ARRDC4;FBXL7;USP9X;CUL1;SMURF2;NUP37;TRIM21;RAE1;CNOT4;RNF144A;PLK1;ANAPC11;PIAS2;MIB1;CDC27;ATG3;RNF111;KLHL13;SKP1;TRIM13;DCUN1D1;CBL;FBXW7;AREL1;ARIH1;UBE2F;BRAP;DTX2;UBE2L3;FBH1;NUP153;TRIM44;UBE2R2;UBA5;EIPR1;FBXO7;NFE2L2;RNF213;KCTD10;ATG7;PJA2;FBXW11;RNF181;ZSWIM8;UBE2K;NSMCE2;DDRGK1;UBE2W;FBXO2;EGR2;VCPIP1;TRPM4;DTX3L;NDC1;SMURF1;ITCH;NEDD4;HIF1A;PRKDC;KLHL25;NUP35;NUP188;TRAIP;PCNP;KLHL7;TRIM33;DDB1;MDM2;TRPC4AP;ARIH2;PEX12;UBR1;FBXO32;NUP214;DCUN1D5;RNF135;UBE2E1;TRIM6;ISG15;NUP107;UBE2Z;VHL;TRIM27;TRIM62;RPS27A;RNF14;TNFAIP1
prerank,axonal fasciculation (GO:0007413),-0.382524371395631,-0.9745249934193617,0.484593837535014,0.8283928702355121,1.0,2/12,1.91%,EPHA4;CNTN4
prerank,positive regulation of ERAD pathway (GO:1904294),-0.3550767569984859,-0.9742901916827647,0.4878048780487805,0.8273640079272343,1.0,3/13,7.27%,CAV1;ATXN3;BCAP31
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3818513616028658,-0.9742594166372437,0.4984984984984985,0.8257882281572322,1.0,6/13,22.43%,HNRNPU;NELFB;LARP7;NELFA;SUPT4H1;NELFE
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3999486842734847,0.9742440195044523,0.5294943820224719,0.8161482203668707,1.0,3/25,7.63%,YAP1;ARHGAP24;CDK10
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4434198008458277,0.9741894104140719,0.48348348348348347,0.8158105516308176,1.0,5/14,18.69%,XCL1;SHLD3;RIF1;PAXIP1;HMCES
prerank,negative regulation of axonogenesis (GO:0050771),-0.2975782712823704,-0.974108798172631,0.47368421052631576,0.8245279287821703,1.0,10/27,22.20%,MAP2;DCC;DIP2B;ULK2;CDKL3;MAG;LINGO1;SEMA3G;EFNB3;TRIM46
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.35933501283607,0.9738092603315941,0.5266903914590747,0.8161852203383847,1.0,22/56,23.85%,JTB;CHMP4B;PLK1;VPS4A;DCTN3;SPIRE1;SNX18;SNX33;SNX9;RHOA;BIN3;RTKN;RASA1;TTC19;KIF20A;SPTBN1;SON;RHOC;ROCK2;ROCK1;PDCD6IP;RAB35
prerank,protein kinase A signaling (GO:0010737),-0.37918165561526285,-0.9731767176332958,0.498567335243553,0.8253570756245905,1.0,4/12,19.16%,EZR;RDX;MYOM1;RAB13
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3802294512356057,0.9725740716642627,0.5163398692810458,0.8183489873158893,1.0,14/32,24.58%,TAF1D;POLR1E;GTF2H1;CDK7;POLR1B;TAF1A;POLR2L;POLR2K;POLR1G;ERCC2;POLR1A;CCNH;MNAT1;RRN3
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.41207542394475344,0.9725685098719768,0.5168539325842697,0.8179124819217677,1.0,6/20,18.25%,CAMK2D;BCL2;ATP2A2;PACS2;PSEN1;THADA
prerank,substantia nigra development (GO:0021762),0.3686919789126615,0.9724818516499423,0.49120603015075376,0.8176627471424291,1.0,9/37,14.77%,DYNLL1;GNB4;PADI2;CDC42;MAPKAP1;SEC16A;RHOA;CALM2;HSPA5
prerank,glycine transport (GO:0015816),-0.4008512893601318,-0.9720166027981033,0.5217391304347826,0.8266661330104713,1.0,4/10,12.99%,SLC6A9;SLC38A5;SLC25A38;SLC6A17
prerank,error-free translesion synthesis (GO:0070987),-0.3233234790261301,-0.9717787117325343,0.5112781954887218,0.8256618934995081,1.0,14/22,35.18%,RCHY1;UBC;PCNA;UFD1;RFC3;NPLOC4;UBA52;POLH;RPA2;RFC4;RFC2;RPA3;SPRTN;RFC5
prerank,response to ketone (GO:1901654),0.405030997050864,0.9714889364995797,0.5074626865671642,0.8193799773767956,1.0,5/24,14.47%,YAP1;SLIT3;TGFB3;TGFB2;CATSPER3
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.29164749903165754,-0.9711532564258937,0.4541284403669725,0.8256793012245627,1.0,5/31,3.09%,SYNJ2BP;LRRC7;DLG2;LIN7A;EZR
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.23093937923515434,-0.9710883814682211,0.525,0.8242354510846207,1.0,36/96,25.42%,YTHDC1;CDC40;SRSF5;WDR33;DDX19B;U2AF2;NUP133;UPF2;UPF1;SEH1L;POM121;SRSF7;SRSF9;RBM8A;NUP43;CHTOP;CPSF2;MAGOH;NUP210;NUP50;ZC3H11A;NUP98;HHEX;EIF4A3;SRSF3;POLDIP3;NUP93;CPSF4;SARNP;MCM3AP;DDX39B;NUP88;NUP85;DDX39A;DDX25;THOC1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.33364118692904504,0.970614382315262,0.5252416756176155,0.8208034650054761,1.0,25/92,18.77%,SPARC;MAP4K4;FGF7;PRKCA;NRP1;DOCK1;PRKD2;EGF;SASH1;ANGPT1;WNT5A;MAPRE2;TGFB2;CALR;RIN2;FGF2;SRC;RAC1;HIF1A;ITGB1BP1;AKT1;ETS1;INSL3;AGT;BCAS3
prerank,double-strand break repair (GO:0006302),0.3208252181318889,0.9705220431144369,0.5455475946775844,0.8205946401084974,1.0,34/158,17.49%,RAD51B;PARP3;BRIP1;DNA2;RAD52;TNKS1BP1;BABAM2;INO80;XRCC3;ATM;MMS22L;ZFYVE26;DCLRE1C;SETMAR;FBH1;HMGB2;AP5Z1;MCM9;TDP2;KDM2A;MDC1;NSMCE2;RIF1;EME2;RMI1;XRCC1;DTX3L;PAXIP1;SETX;PRKDC;PSMD14;NUCKS1;DDX1;HELQ
prerank,organophosphate biosynthetic process (GO:0090407),-0.2846437582949748,-0.9702850442214318,0.46733668341708545,0.8246929054622829,1.0,9/37,12.84%,GPHN;TPK1;MBOAT1;IPPK;PCYT2;PPIP5K1;AGPAT3;MOCS2;TPI1
prerank,protein targeting to mitochondrion (GO:0006626),-0.25699711376020407,-0.970121370290847,0.5283018867924528,0.8235324035785979,1.0,23/52,27.20%,IMMP2L;HSP90AA1;DNAJC19;BCAP31;GRPEL2;NDUFA13;DNAJC15;TIMM17B;GDAP1;TOMM20;TIMM21;SAMM50;IMMP1L;TIMM22;TOMM70;TIMM8B;ROMO1;TOMM5;TOMM40;DNLZ;CHCHD4;MFF;TIMM9
prerank,protein autophosphorylation (GO:0046777),0.32013971441589845,0.9697832801274222,0.5482866043613707,0.8217193843520648,1.0,34/157,17.81%,PDGFRA;NEK6;TEC;TAOK1;PEAK1;LRRK2;PDGFRB;JAK2;EGFR;EPHB3;CAMK2D;PRKD2;DDR2;ATM;EIF2AK2;EPHA1;TAOK3;ATR;ACVR1B;FGFR1;PTK2;MYO3A;GSK3B;SRC;MKNK1;STK24;DAPK2;FES;RIPK1;STK4;AKT1;MAP3K3;EIF2AK3;MAP3K12
prerank,mitotic DNA replication (GO:1902969),0.4722535093116832,0.9696376447627038,0.5156739811912225,0.8215711148769363,1.0,2/10,7.29%,MCM2;LIG1
prerank,calcium ion transport (GO:0006816),0.3290495241025724,0.9695349311228535,0.5358649789029536,0.8213572397244284,1.0,11/113,5.67%,MCOLN2;CACNA1A;CACNA2D1;CACNA1C;CCR1;ITPR1;PKD2;TRPC6;CYP27B1;SLC24A5;CCL5
prerank,exit from mitosis (GO:0010458),0.45564739458353937,0.9692776126320374,0.5162790697674419,0.8214529158173624,1.0,6/12,27.10%,CHMP4B;CHMP7;EPS8;CLASP2;CTDP1;CLASP1
prerank,cellular response to light stimulus (GO:0071482),0.3533896622118622,0.9692284186969156,0.5411899313501144,0.8211145703278688,1.0,20/66,24.86%,INO80;CREBBP;NOC2L;ATR;TMEM161A;OPN1MW;OPN1MW3;FMR1;NEDD4;USP28;GPR88;ATF4;RHBDD1;GNB1;KDM1A;PRKCD;YY1;RRH;EIF2S1;CDC25A
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3762281701063719,0.9691318703807422,0.5187878787878788,0.8208775624297695,1.0,5/39,7.69%,TCF7L2;TNFSF11;BLK;ACSL4;AIMP1
prerank,establishment of mitotic spindle localization (GO:0040001),0.3920558693381465,0.9687228754862502,0.5213454075032341,0.8213102863392719,1.0,6/28,15.66%,MAD2L1;PLK1;GPSM2;INSC;FBXW11;NDEL1
prerank,neuron projection fasciculation (GO:0106030),-0.4044499871216997,-0.9686757830104655,0.49008498583569404,0.8255751039574253,1.0,2/10,1.91%,EPHA4;CNTN4
prerank,regulation of organelle assembly (GO:1902115),0.346096568402006,0.968609202575256,0.5308641975308642,0.821134607917832,1.0,20/72,17.44%,CEP295NL;ATXN2;TBC1D16;ALMS1;NPRL2;IFT88;TBC1D2B;ATG3;DYNC2LI1;MSN;RABGAP1;SENP6;TBC1D1;ADPRH;TBC1D10B;TBC1D19;TBC1D20;KIF9;CDKL1;MTMR3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3473233530777503,0.9685680224357095,0.5405105438401776,0.8207767814794853,1.0,14/68,22.05%,ENPP1;LRRK2;ACSF2;ACOT13;TPST1;SULT4A1;ENTPD7;ACOT9;AMPD2;AMPD3;PDE9A;HINT1;EPHA2;THEM4
prerank,RNA transport (GO:0050658),0.338946334195384,0.9683765383603536,0.5349611542730299,0.8207381215616306,1.0,24/71,26.81%,RFTN1;ZFP36L1;RBFOX1;ATXN2;RAE1;NCBP2;NUP153;FMR1;RTRAF;NUP188;SIDT2;CKAP5;SRSF2;NUP214;YBX1;SLU7;SRSF11;THOC5;RNPS1;THOC2;KIF5C;HNRNPA2B1;NUP155;SRSF1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3428085847152006,0.9682662537790844,0.536504424778761,0.8205239655324964,1.0,24/80,18.77%,AUTS2;DPYSL3;NRP1;FSCN1;RALA;TGFB3;CDC42;ABI2;ACTR2;BRK1;ENTR1;CEP120;TAPT1;P2RX7;PIK3R1;ARHGAP35;FMR1;WASHC1;RAC1;CDC42EP1;NDEL1;CDC42EP4;EPS8;BCAS3
prerank,mesonephric tubule development (GO:0072164),0.4287311607222195,0.9680351830202285,0.512937595129376,0.8205657802185624,1.0,4/15,14.04%,ROBO2;PKD2;SALL1;BMP7
prerank,protein import into mitochondrial matrix (GO:0030150),-0.341051859517705,-0.9676837816235401,0.46864686468646866,0.8265111257047034,1.0,10/18,26.74%,DNAJC19;GRPEL2;DNAJC15;TIMM17B;TOMM20;TIMM21;TOMM70;ROMO1;TOMM40;DNLZ
prerank,DNA double-strand break processing (GO:0000729),0.42993277135887276,0.9676084744239338,0.5283018867924528,0.8210126663343277,1.0,4/18,9.64%,DNA2;RAD52;ATM;SETMAR
prerank,negative regulation of type I interferon production (GO:0032480),0.3737540800813804,0.9674629757294575,0.5012165450121655,0.8208712272677056,1.0,12/40,22.02%,TNFAIP3;REL;IKBKE;ILRUN;ITCH;RELB;PIN1;RNF135;ISG15;YY1;SIRPA;UBE2L6
prerank,Rac protein signal transduction (GO:0016601),0.41963949895313113,0.9673331770967577,0.5214285714285715,0.8207162128963421,1.0,6/18,14.73%,FARP2;AIF1;ABI2;BRK1;DBNL;RAC1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.362306080170378,-0.9670372180545969,0.49079754601226994,0.826555722291182,1.0,7/15,20.10%,FGF1;TMSB4X;HSPB1;SEMA5A;THBS1;PRKD1;LGMN
prerank,positive regulation of superoxide anion generation (GO:0032930),0.4540235751989179,0.9668608216272653,0.5099846390168971,0.8213434013624671,1.0,1/13,2.18%,CRP
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3969449929461868,0.966439091981955,0.5406824146981627,0.8218805105537617,1.0,9/27,22.97%,TNFAIP3;IRAK3;PTPN6;TNF;CX3CL1;ZC3H12A;SIRPA;NLRP12;CD200R1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.42466439523493404,0.9661603427550439,0.5164051355206848,0.8220431651897989,1.0,6/17,18.77%,NRP1;BAIAP2;CDC42;NTRK3;FES;BCAS3
prerank,response to metal ion (GO:0010038),0.3401596531929293,0.9659033828364266,0.5345413363533409,0.8221377039814673,1.0,12/67,16.97%,SEC31A;HVCN1;PAM;SLC11A2;FXN;BCL2;PPP3CA;KHK;CALM2;NEDD4;HIF1A;TNNT2
prerank,modification-dependent protein catabolic process (GO:0019941),0.3217707983272264,0.9658551153513351,0.5768056968463886,0.8217984256030761,1.0,55/193,22.68%,RNF150;MYLIP;KCTD21;SPSB1;FBXL7;MAD2L1;SMURF2;UBR4;CNOT4;RNF144A;PLK1;ANAPC11;SIAH2;MIB1;CDC27;BAG6;RNF111;CBL;AREL1;ARIH1;NTAN1;UBE2L3;UBE2R2;FBXO7;RNF213;KCTD10;RNF19B;PSMF1;RNF149;UBE2K;RNF11;DTX3L;SMURF1;ITCH;NEDD4;SQSTM1;KLHL25;PSMD11;PSMD14;RC3H2;DDB1;MDM2;FBXW4;TRPC4AP;ARIH2;UBE2E1;COPS3;ISG15;FBXO22;RPS27A;RNF14;RBBP6;UBE2L6;FZR1;CHFR
prerank,regulation of developmental growth (GO:0048638),0.38464725683216605,0.9655837016224544,0.5247657295850067,0.8219816612952643,1.0,9/29,17.45%,GHR;APOE;STAT5A;GSK3B;NIPBL;STAT5B;OLFM1;LATS2;CTTN
prerank,negative regulation by host of viral process (GO:0044793),0.46925800926191286,0.9654045050009532,0.516380655226209,0.8219125178092259,1.0,2/10,7.36%,CRP;VAPA
prerank,recombinational repair (GO:0000725),0.33916469118142456,0.9649873474992358,0.515695067264574,0.822372694575371,1.0,17/77,18.69%,RAD51B;RAD52;INO80;XRCC3;MMS22L;ZFYVE26;FBH1;AP5Z1;MCM9;NSMCE2;RMI1;XRCC1;PSMD14;NUCKS1;HELQ;RBBP8;SWI5
prerank,cell-substrate junction assembly (GO:0007044),0.3822771426168385,0.9649069904555333,0.5287206266318538,0.8221116121103383,1.0,4/33,5.21%,DLC1;LAMC1;PEAK1;RHOD
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.383081369330756,-0.9644323511823918,0.49002849002849,0.831715310292673,1.0,2/12,3.58%,IGF1R;INSR
prerank,inositol phosphate catabolic process (GO:0071545),0.45396730664215934,0.9641720483493954,0.5014880952380952,0.8231768793044772,1.0,2/12,4.97%,INPP1;PTEN
prerank,plasma membrane tubulation (GO:0097320),0.45334131869351035,0.9640569157240042,0.5296875,0.8229816959517555,1.0,5/13,12.50%,CHMP4A;EHD2;SNX33;SNX9;BIN3
prerank,regulation of Ras protein signal transduction (GO:0046578),0.33211278389265925,0.9640123944093283,0.5483516483516484,0.8226339601910382,1.0,18/85,16.70%,DLC1;JAK2;OPHN1;ARFGAP1;DENND4C;MAPKAP1;GRB2;OGT;ERBIN;TGFB2;SPRY2;VAV1;AKAP13;ARHGEF18;PDCD10;SQSTM1;SYNGAP1;ARHGDIA
prerank,positive regulation of cation channel activity (GO:2001259),-0.26774976786603355,-0.9637628828086094,0.49693251533742333,0.8317713297832071,1.0,7/40,8.96%,ACTN2;AKAP6;ANK2;SHANK3;CALM1;TMSB4X;ANK3
prerank,skeletal muscle tissue development (GO:0007519),0.38155745535400254,0.9636808513101196,0.5201511335012594,0.8228913146705191,1.0,5/32,14.11%,SVIL;CFLAR;LEMD2;SELENON;EGR2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.39019125720985715,-0.963678619500435,0.4876543209876543,0.8303940117241064,1.0,3/12,15.14%,SNAP25;STX3;STX2
prerank,embryonic heart tube development (GO:0035050),0.4479295639165732,0.963637434677709,0.5286821705426357,0.8225418180615681,1.0,2/14,5.19%,TBX2;ACVR1
prerank,stress-activated MAPK cascade (GO:0051403),0.3496269262607187,0.9635149889516325,0.5375722543352601,0.8223495682045256,1.0,9/61,7.99%,ZFP36L1;MAP2K4;CUL1;LGALS9;NOD1;CCM2;IRAK2;SKP1;MAPK11
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4532869700184642,0.9633924013715769,0.5292307692307693,0.8221700446651984,1.0,2/13,12.95%,LRRK2;ENTPD7
prerank,peptidyl-serine modification (GO:0018209),0.317835205249242,0.9633739704863196,0.5714285714285714,0.8217741518205376,1.0,37/166,17.81%,NEK6;MAST4;LRRK2;PRKCA;MARK1;RICTOR;GALNT3;IKBKE;AKT3;CAMK2D;PRKD2;MORC3;ATM;PLK1;HIPK4;MAST2;ATR;TGFBR1;CSNK2A1;CSNK2A2;HIPK3;RPS6KB1;CSNK1G2;GSK3B;CSNK1A1;MKNK1;POGLUT3;VRK3;PRKDC;STK4;CSNK1D;MAPK1;AKT1;LATS2;EIF2AK3;DCLK3;MAP3K12
prerank,positive regulation of protein export from nucleus (GO:0046827),0.4350955523877529,0.963217173813805,0.516320474777448,0.8216331938587421,1.0,4/15,17.37%,TCF7L2;BAG3;GSK3B;YWHAE
prerank,negative regulation of cilium assembly (GO:1902018),0.4493643119062661,0.9630808256470177,0.5247208931419458,0.8214929293952096,1.0,2/12,7.63%,YAP1;CDK10
prerank,mitotic spindle assembly (GO:0090307),0.36974016552533284,0.9628566429500139,0.5264452644526445,0.8215380636904411,1.0,9/42,16.03%,KIFC1;SMC1A;KIF2A;STAG2;TPX2;STAG1;RHOA;TOGARAM1;CEP192
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.37243540810237363,-0.962753472983488,0.5308641975308642,0.8313098586855386,1.0,9/13,30.87%,GLRX3;NFU1;CIAO2A;YAE1;ISCA2;GLRX5;BOLA2;ISCA1;CIAO2B
prerank,glycoprotein metabolic process (GO:0009100),0.3517734283726687,0.9626643265113292,0.5403225806451613,0.8215033341133543,1.0,14/53,19.81%,TNIP1;B4GALT5;PRKCSH;HPSE;ADAMTS9;MAN2A1;MAN1C1;MGAT4A;FBXO2;B4GALT7;HIF1A;AGA;GANAB;MAN2A2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.36606313185633815,0.9626207646226651,0.530562347188264,0.8211598582049349,1.0,16/40,24.75%,DDX11;MMS22L;ATR;SETMAR;FBH1;MCM9;TIMELESS;EME2;ATRX;TRAIP;NUCKS1;CDK9;ZRANB3;RAD51;ETAA1;FAM111A
prerank,autophagy of nucleus (GO:0044804),0.41853669506579905,0.9625467798159855,0.513909224011713,0.8208899694309132,1.0,4/16,15.93%,WIPI1;ATG3;ATG7;WDR45
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4246685559382002,0.9620918950707699,0.5110456553755522,0.8214302662421006,1.0,3/17,5.33%,STAT3;JAG1;GNL1
prerank,T cell homeostasis (GO:0043029),-0.40589872449819825,-0.962016990206099,0.514367816091954,0.8315838906749348,1.0,7/10,37.46%,PPP2R3C;NCKAP1L;ZC3H8;JAK3;FAS;FADD;PMAIP1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.2941575698633555,-0.9618423914359491,0.5299539170506913,0.8303835785590401,1.0,16/31,31.49%,CTNNA2;HDAC9;FGFR2;MAPK12;IGF2;BNIP2;BOC;MYOCD;CDH2;MEF2C;MAPK14;SRF;CAMK1;PTBP1;ID2;CDON
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2822529550257993,-0.9616015330782622,0.49074074074074076,0.8293992273319325,1.0,9/32,16.23%,FHIT;DDX5;PPP1R13B;HIPK1;MSH2;EP300;DDIT4;MYBBP1A;DYRK2
prerank,regulation of inclusion body assembly (GO:0090083),-0.3809746956803074,-0.9615604831496122,0.4812680115273775,0.8279252728714541,1.0,2/11,2.49%,SNCAIP;SACS
prerank,"phagocytosis, engulfment (GO:0006911)",0.3693406780651978,0.9610353887405517,0.5194479297365119,0.8232183290730556,1.0,8/36,15.63%,DOCK1;MYH9;AIF1;CD36;CDC42;MSR1;RAC1;FCGR1A
prerank,negative regulation of telomere maintenance (GO:0032205),0.43946126493663396,0.9610051906903538,0.5388127853881278,0.8228524698129942,1.0,8/15,25.72%,ATM;PINX1;SMG6;TNKS2;TERF1;SLX4;TERF2IP;TERF2
prerank,peptide biosynthetic process (GO:0043043),-0.2140179921562372,-0.9608101061278123,0.5666666666666667,0.8282019046885848,1.0,53/153,22.52%,DMD;RPL34;RPL36;RPL8;RPS4X;COPS5;RPL18A;RPL19;RPL38;RPS21;MRPS15;RPL5;RPS10;RPLP0;RPL7;RPL13;MRPL13;RPS8;MRPL10;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL32;DHPS;EIF4EBP2;RPL10;RPL15;RPS27;RPL35;RPS16;RPL7A;RPS15;MRPS7;RPS29;RPL27;RPS13;RPS19;ABCF1;RPL41;SARS1;RPLP1;MRPL28;WARS1;MRPS18C;RPL28;GSPT2;RPS17;MRPS16;MRPS18B;RPS6KB2
prerank,autonomic nervous system development (GO:0048483),0.4158980881458398,0.9606597191081004,0.5128205128205128,0.8231922336219616,1.0,2/17,5.10%,NRP1;NF1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.40940571096616263,0.9606359414714963,0.5168067226890757,0.8228100059811974,1.0,8/21,22.53%,MITF;SUB1;MED13;PAXIP1;SETX;MED12;MED1;MED14
prerank,histone mRNA metabolic process (GO:0008334),0.38475035075076475,0.9604654178660391,0.5282522996057819,0.8227455543991214,1.0,6/27,11.16%,ATM;ERI1;EXOSC4;DCP2;NCBP2;XRN1
prerank,DNA metabolic process (GO:0006259),0.3133902526372632,0.9603581970527609,0.5887662988966901,0.8225412122582405,1.0,74/270,23.59%,RAD51B;PARP3;MPG;TCF7L2;POLE3;BACH1;SMC1A;DNA2;RAD52;MCM2;INO80;XRCC3;ATM;PDS5B;PWWP3A;GTF2H1;LIG1;TERT;PDS5A;MCM7;ATR;SP100;RNASEH1;SETMAR;DBF4;RNASEH2A;HMGB2;ALKBH1;USP3;TOP2B;TIMELESS;LTO1;POLI;POLA2;MGMT;RIF1;LRWD1;CTC1;XRCC1;ASF1A;MMS19;POLG;PRKDC;ATRIP;PNKP;DDB1;ZNF445;RAD9A;RBBP8;HINFP;AXIN2;EID3;GADD45A;MBD4;KPNA2;FANCC;NEIL1;PARP4;TOP3B;RFC1;RPS27A;TERF1;ZRANB3;CDC7;RPA1;SLX4;ENDOV;DMC1;RAD51;MNAT1;CDC6;MSH6;DDX21;DOT1L
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4549206055177265,0.9603149152592154,0.5502392344497608,0.822193420703377,1.0,2/12,4.21%,ZFP36L2;JAG1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3434589000111285,0.9601805998096187,0.5353418308227115,0.8220532837360783,1.0,18/67,17.41%,MYO10;ATP8B1;PLD1;FSCN1;TBC1D16;IFT88;CDC42;TBC1D2B;ATG3;DYNC2LI1;RABGAP1;TBC1D1;FMR1;TBC1D10B;RAC1;TBC1D19;TBC1D20;CDKL1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.36550774976894385,0.9597965094069831,0.5383647798742138,0.8224145136994515,1.0,15/38,19.96%,LRRK2;NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;LMAN1;MICALL2;BAG4;SREBF1;SH3GLB1;LEPROT;USP36;ARIH2;UBL5
prerank,mRNA modification (GO:0016556),0.40324189426626406,0.9597264328427707,0.5135869565217391,0.8221228813723892,1.0,4/22,9.72%,ZC3H13;METTL16;TRUB2;PUS3
prerank,cytosolic calcium ion transport (GO:0060401),0.3900031818162846,0.959618220375056,0.5304798962386511,0.821918867566382,1.0,8/28,18.80%,CACNA2D1;CACNA1C;ATP2A2;ATP2B1;MICU2;MCUR1;MAIP1;MICU3
prerank,fatty acid oxidation (GO:0019395),0.3439720226729903,0.9590079174923063,0.5473684210526316,0.8227283109094334,1.0,12/57,20.42%,ADIPOQ;EHHADH;SLC27A2;ACOX1;ALDH3A2;ECHS1;DECR1;PECR;HACL1;AUH;ADH5;ECHDC2
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4243196348740393,0.958449874450508,0.5239477503628447,0.8234577582431074,1.0,8/18,19.20%,DNAJC13;RAB21;MSN;MAP2K1;PTPN23;SRC;MAPK1;MTMR2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.4295167461681352,0.9583259242755311,0.53125,0.8232711212518907,1.0,5/16,18.25%,MDK;RHOA;TNF;ETS1;FUT4
prerank,regulation of astrocyte differentiation (GO:0048710),0.45441530973353006,0.9581459034824521,0.5095846645367412,0.8232024636245872,1.0,1/12,1.44%,SERPINE2
prerank,response to cAMP (GO:0051591),0.3732604024537204,0.9577743713094975,0.5314070351758794,0.823537032153502,1.0,5/37,6.40%,ZFP36L1;STAT1;IGFBP5;PKD2;AHR
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.40986781679102546,0.9573995380098931,0.5185714285714286,0.8238803822264322,1.0,3/18,8.70%,POLE3;LIG1;MCM7
prerank,dendrite morphogenesis (GO:0048813),0.3765986542182591,0.9571606375671364,0.5319693094629157,0.8239344796372075,1.0,7/35,8.32%,PTN;FARP1;EPHB3;PTEN;CDC42;DLG4;SDC2
prerank,positive regulation of immune system process (GO:0002684),0.4145361812748438,0.9571429350869317,0.4935251798561151,0.8235334057444393,1.0,4/16,11.44%,LGALS9;MIA3;ANXA1;TGFB2
prerank,regulation of protein kinase activity (GO:0045859),0.3283786652828573,0.9570388085853632,0.5508021390374331,0.823310841004848,1.0,26/106,17.14%,JTB;SPRED1;LCP2;DDR2;NF1;TAF7;CACUL1;DTNBP1;LRP6;EPHA1;RASSF2;GSKIP;PYDC1;WWTR1;PTK2;SNX9;TNF;UBASH3B;SMCR8;TRIB3;TRIB1;RTRAF;ALS2;ITGB1BP1;PTPRC;AKT1
prerank,lipid modification (GO:0030258),-0.27674403914429063,-0.9562804921712358,0.4607329842931937,0.8385014875288495,1.0,9/37,16.74%,DGKB;MBOAT1;DGKI;DGKA;DGKG;SGPP1;PORCN;PLPPR4;DGKQ
prerank,production of siRNA involved in RNA interference (GO:0030422),0.46123937958214745,0.9561664040512778,0.5160256410256411,0.8247038648019185,1.0,3/10,19.61%,TERT;DICER1;AGO2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3146658558012468,-0.9558233917260737,0.4982078853046595,0.8381383512058473,1.0,4/21,6.77%,ST3GAL6;FUT9;ST3GAL4;ST8SIA6
prerank,transferrin transport (GO:0033572),0.37538856333137227,0.9554854437205111,0.5233160621761658,0.8256763950482605,1.0,8/33,18.00%,CLTC;STEAP3;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1G1;ATP6V1D;REP15
prerank,neutral amino acid transport (GO:0015804),-0.2874444496955127,-0.9554336605022917,0.5394190871369294,0.8374714709869125,1.0,8/28,15.87%,SLC6A6;SLC6A9;SLC7A5;SLC1A1;SLC43A2;SLC38A5;SLC6A17;SLC6A7
prerank,regulation of mitochondrial translation (GO:0070129),0.4015377073036524,0.9553439565892639,0.52,0.8255355343284274,1.0,3/21,10.43%,RPUSD3;TRUB2;ALKBH1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.4190897297191015,0.9552755802681661,0.5176304654442877,0.8252411941266077,1.0,3/17,8.50%,STOML2;ATP5PO;DMAC2L
prerank,peptidyl-lysine methylation (GO:0018022),0.3973939076481409,0.9548588469220651,0.5383597883597884,0.8256619296959653,1.0,13/26,27.81%,ANTKMT;KMT5A;EHMT1;SETD2;VCPKMT;ETFBKMT;SETD3;N6AMT1;EEF2KMT;SETD7;SETD4;METTL21A;EEF1AKMT3
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.44352813590261925,0.9546558225220976,0.5464071856287425,0.8256560485531623,1.0,2/13,11.55%,LRRK2;NFE2L2
prerank,fatty acid transport (GO:0015908),0.41899846936325075,0.9546062728815645,0.5253731343283582,0.8253359192962572,1.0,4/17,12.66%,APOE;CD36;PPARG;FABP5
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3322015125698931,-0.9544277760959258,0.4931506849315068,0.8385175484012083,1.0,7/18,22.90%,NRXN1;SHANK3;CACNG2;CACNG7;RELN;NLGN1;CACNG8
prerank,regulation of superoxide anion generation (GO:0032928),0.4388581267878964,0.9542755652367285,0.5436746987951807,0.8255962297144626,1.0,1/14,2.18%,CRP
prerank,SNARE complex assembly (GO:0035493),-0.4076614229939698,-0.9539187776488913,0.518840579710145,0.8382306738520587,1.0,3/10,14.95%,STXBP6;VAMP4;VAMP8
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.32786528341798804,0.9536190487806102,0.5469083155650319,0.8264894587847922,1.0,23/101,18.36%,PRR16;BCL3;PLD1;PLK1;SAMD4A;MSN;NIBAN1;OGT;RPS6KB1;NAT10;CASP8;CLN6;ATG7;FBXW11;DACT1;YTHDF3;FMR1;PRKDC;AKT1;INHBA;PLXNB2;AGT;NFKBIA
prerank,protein homotetramerization (GO:0051289),-0.25171397533510276,-0.9534378452738901,0.5476190476190477,0.8379060797914645,1.0,20/49,28.76%,KCNJ2;SAMHD1;UPB1;ALDH9A1;GOLGA2;KCNJ12;GBP5;SSBP1;HCN1;SOD2;CBR4;GLS;USP16;APIP;CRYZ;PKD2L1;CTH;TRPA1;CBY1;HSD17B10
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.44145644936898415,0.9529739691167058,0.5182370820668692,0.827383889413921,1.0,5/12,21.83%,DPYSL3;CTPS1;DPYD;CTPS2;UMPS
prerank,acylglycerol catabolic process (GO:0046464),0.3782052058057544,0.952881584607947,0.5627425614489003,0.8271387262584863,1.0,5/30,16.48%,LIPC;LPL;ABHD16A;FABP5;LYPLA2
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2652328050394426,-0.952799346336487,0.5888888888888889,0.8379189840558902,1.0,10/41,15.59%,RNF152;WWP2;PRKN;UBE2E3;HECTD1;UBE2V2;UBE2B;UBE2N;BFAR;PRPF19
prerank,positive regulation of intracellular transport (GO:0032388),0.3671209198219723,0.9526314794774403,0.5507246376811594,0.8272371044114168,1.0,11/38,18.77%,DYNC1H1;PCM1;EHD2;PCNT;EIPR1;PDCD10;NEDD4;PLA2G4E;TBC1D20;ICE1;BCAS3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4586705382688104,0.9524791487705999,0.5538461538461539,0.8271307947085308,1.0,4/11,21.08%,ANXA1;SOCS5;RC3H2;ZC3H12A
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4435671730119076,0.9522277841974781,0.5467075038284839,0.8272189570302204,1.0,3/13,7.40%,TREM2;ENO1;PID1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.42153714186531777,0.9521117575949498,0.5127840909090909,0.8270318702042214,1.0,3/16,8.50%,STOML2;ATP5PO;DMAC2L
prerank,erythrocyte differentiation (GO:0030218),-0.2620873933909961,-0.9520962286822467,0.5517241379310345,0.8382622044975759,1.0,15/44,21.32%,KIT;TGFBR3;FLVCR1;CASP3;SLC25A38;CEBPG;DMTN;ABCB10;TAL1;HSPA9;IKZF1;RPS19;ZFPM1;ALAS1;NCKAP1L
prerank,rRNA catabolic process (GO:0016075),0.42316167611672756,0.9518238501372374,0.5252225519287834,0.8271577601247614,1.0,3/16,11.16%,ERN2;EXOSC4;XRN1
prerank,JNK cascade (GO:0007254),-0.26848075203712723,-0.9517651837146971,0.5138888888888888,0.8375464999831417,1.0,17/40,26.65%,MINK1;TAB3;MAP3K5;ARHGEF6;CRKL;UBC;UBE2N;MAPK9;GPS2;MAP3K7;MAPK10;IRAK1;IKBKG;UBA52;MAP3K11;NOD2;UBE2V1
prerank,calcium ion import into cytosol (GO:1902656),-0.3435678075202283,-0.9517178897137915,0.5345911949685535,0.8360877076023888,1.0,6/15,19.38%,SLC24A2;ATP2B4;SLC8A3;TRPV2;TRPV4;SLC8A2
prerank,cilium organization (GO:0044782),0.3153182952807979,0.9516662902041226,0.6036772216547498,0.8270681945780756,1.0,46/209,16.55%,TEKT4;DYNLL1;CEP19;ASAP1;STK36;PARVA;IQCG;PKD2;IFT88;PCM1;RAB8B;CEP41;EXOC4;TTC17;EHD2;ACTR2;GBF1;FAM161A;EXOC1;EXOC7;WDPCP;PCNT;WDR35;DISC1;TTC29;PTPN23;ARF4;GALNT11;NPHP3;IFT172;IFT81;PDE6D;SNX10;CFAP410;CPLANE1;RAB1A;DYNC2H1;DZIP1L;KIF27;CDC14A;TTC39C;EXOC5;EXOC3;NUDCD3;POC1B;WDR90
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.44440897158544473,0.9514063292916005,0.5098335854765507,0.8271710849567243,1.0,3/12,9.95%,CEP19;PCM1;NIN
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3621343958420891,0.9512501999763555,0.5356294536817102,0.8270545188408788,1.0,18/45,26.07%,ACVR1;TGFB3;INHBB;TGFBR1;BMP5;TGFB2;ACVR2A;BMP7;SMAD4;ACVRL1;INHBA;GDF9;GDF11;BMPR1A;SDCBP;BMPR2;GDF1;INHA
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3345307345120511,-0.9506696846481842,0.5032894736842105,0.8371680744420915,1.0,8/17,27.79%,HDAC4;CBFA2T3;GIT1;PDE12;MLXIPL;PPIF;PARP1;TIGAR
prerank,alanine transport (GO:0032328),0.4579468642464971,0.9505142378814562,0.5306799336650083,0.8281420116600804,1.0,2/10,8.93%,SLC38A3;SLC36A2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4624377291167959,0.9497040209159839,0.5416012558869702,0.829401868705308,1.0,1/10,2.70%,GATA6
prerank,regulation of protein targeting to membrane (GO:0090313),0.3875814365902714,0.949054014443091,0.5555555555555556,0.8302817940781761,1.0,1/28,0.40%,CEMIP
prerank,cytoplasmic translational initiation (GO:0002183),0.4143592787545886,0.9488893080281295,0.5064562410329986,0.8302078472582829,1.0,6/17,20.36%,EIF4A1;EIF5;EIF2B3;DHX29;MCTS1;EIF4G1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.45280319129565444,0.9488051701035536,0.5422427035330261,0.8299623426318092,1.0,9/11,33.21%,TRAP1;COA8;SLC18A2;MPV17L;PPARA;ABCD2;PARK7;ABCB7;FYN
prerank,positive regulation of mitochondrion organization (GO:0010822),0.34185657522350293,0.9484701132509201,0.5355064027939465,0.830232258511897,1.0,8/57,12.44%,DCN;TREM2;BBC3;RALA;ADCK1;SPIRE1;FBXO7;GSK3B
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.34774270127220464,-0.9481401025205255,0.5283018867924528,0.8420465263470153,1.0,7/16,24.87%,COX7A2;PINK1;UQCC2;PDE12;SLC25A33;MLXIPL;PPIF
prerank,apoptotic cell clearance (GO:0043277),0.37444013826826705,0.9476646971695162,0.5409836065573771,0.8314591947824824,1.0,4/30,8.96%,LRP1;TREM2;TXNDC5;ANXA1
prerank,negative regulation of cell cycle (GO:0045786),0.3389386252689365,0.9472419231215566,0.5805369127516778,0.831872978767181,1.0,13/73,14.24%,RUNX3;MAD2L1;NR2F2;PTPN3;PTEN;CDK6;PLK1;BTG1;GAS1;NLRP2B;SMAD3;BMP7;CDKN1B
prerank,protein-DNA complex disassembly (GO:0032986),0.42182663552643773,0.9469602117116732,0.5440115440115441,0.8320050982309055,1.0,5/16,22.80%,SMARCC1;GRWD1;SMARCA4;ARID2;SMARCD3
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.43585703036879214,0.9467332786655321,0.5369030390738061,0.8320361630650064,1.0,2/14,9.18%,EDN3;ENPEP
prerank,protein oxidation (GO:0018158),0.4440265219663671,0.9466433713939542,0.5192604006163328,0.831817407592681,1.0,2/11,10.24%,LOXL1;LOXL3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.33510086589971017,0.9466022079987744,0.5704622322435174,0.8314795906367913,1.0,9/72,8.93%,BCL3;BATF;TNKS1BP1;E2F1;CNOT4;ATM;E2F8;CARM1;SP100
prerank,cyclooxygenase pathway (GO:0019371),0.46215641756983733,0.9465084060562048,0.5366666666666666,0.8312439392825005,1.0,3/10,13.69%,PTGES;PTGES2;TBXAS1
prerank,aminoglycan biosynthetic process (GO:0006023),0.3501791825186889,0.9464972161080907,0.5483870967741935,0.8308419119151333,1.0,12/49,16.66%,HSPG2;GPC6;EXT1;EXT2;SDC1;HS2ST1;SDC2;GCNT2;UGDH;SLC35D2;B4GALT7;B3GNT9
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.4109048684082191,0.9460426843232962,0.536754507628294,0.831370461332136,1.0,6/18,25.90%,MIA3;GPNMB;AKT1;PAG1;ASS1;PPARA
prerank,regulation of wound healing (GO:0061041),0.3557748705770737,0.9460350602151509,0.5495049504950495,0.8309535079695042,1.0,8/42,12.48%,TNFAIP3;CASK;TNFRSF12A;ANXA1;MYLK;PTK2;VTN;FGF2
prerank,transcription by RNA polymerase I (GO:0006360),0.36710858455520157,0.9460073089568839,0.5533854166666666,0.8305775217316109,1.0,14/34,24.58%,TAF1D;POLR1E;GTF2H1;CDK7;POLR1B;TAF1A;POLR2L;POLR2K;POLR1G;ERCC2;POLR1A;CCNH;MNAT1;RRN3
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.39681714132267354,0.9458732512484547,0.5398110661268556,0.8304302891312771,1.0,3/22,5.01%,VMP1;SLC9A1;PKD2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.38057004779589015,-0.9455122776743028,0.5290519877675841,0.8472462042577724,1.0,4/12,12.90%,HNRNPU;NELFB;LARP7;NELFA
prerank,positive regulation of neuron differentiation (GO:0045666),0.3618869780775543,0.9450490765031833,0.5359712230215827,0.8317079229232605,1.0,5/40,11.96%,ZEB1;TCF4;HEYL;FGFR1;RHOA
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4609656306671451,0.9450024224650193,0.5492307692307692,0.8313762833169639,1.0,3/10,13.23%,EGF;FBXW7;BTC
prerank,regulation of actin filament polymerization (GO:0030833),0.3361667929702073,0.944918062894923,0.5779294653014789,0.8311190630697743,1.0,17/69,20.54%,CCL11;NCK1;BAIAP2;NCK2;CARMIL1;DBN1;SSH1;SNX9;DBNL;SSH2;CDC42EP1;RASA1;CTTN;CDC42EP4;PLEKHG2;WASHC5;PRKCD
prerank,acidic amino acid transport (GO:0015800),-0.33576676849563714,-0.9448514193142488,0.5258064516129032,0.8473683583982415,1.0,5/17,4.88%,SLC6A6;LRRC8D;SLC1A2;SLC1A1;SLC6A1
prerank,filopodium assembly (GO:0046847),0.41701744946913355,0.9435284580468412,0.5386949924127465,0.8334577176559607,1.0,4/16,11.23%,PPP1R9B;FGD4;S1PR2;FGD6
prerank,mRNA export from nucleus (GO:0006406),-0.21871329072428639,-0.9434961376879121,0.647887323943662,0.8493267378456375,1.0,37/102,25.42%,YTHDC1;CDC40;SRSF5;WDR33;DDX19B;U2AF2;NUP133;UPF2;UPF1;SEH1L;POM121;SRSF7;SRSF9;RBM8A;NUP43;CHTOP;CPSF2;MAGOH;NUP210;NUP50;ZC3H11A;NUP98;HHEX;EIF4A3;SRSF3;POLDIP3;NUP93;CPSF4;SARNP;MCM3AP;DDX39B;ENY2;NUP88;NUP85;DDX39A;DDX25;THOC1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4203436303309965,0.9427621067051694,0.5256024096385542,0.8345815926936426,1.0,4/17,9.04%,CACNA1C;GJD3;GJC1;FKBP1B
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.3270581582140012,-0.9421113898886041,0.488135593220339,0.8512449456077206,1.0,7/18,18.18%,RPS6KA5;ADCY1;EPHA5;CD200;LRP8;PRKD1;RELN
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.459887616366478,0.9421048320053873,0.5688524590163935,0.8354855684972559,1.0,2/10,5.04%,XCL1;LGALS9
prerank,ribosomal large subunit biogenesis (GO:0042273),0.34607064039784,0.9419028808772751,0.5687203791469194,0.8354616541704449,1.0,19/54,24.00%,MAK16;RPL3L;PES1;NOC2L;WDR74;NOP2;NIP7;GTF3A;LTO1;RPL14;RPL11;NOP16;RPF1;HEATR3;RPL6;PAK1IP1;RSL1D1;MDN1;PPAN
prerank,embryonic heart tube morphogenesis (GO:0003143),0.35282513724473374,0.9418706082961487,0.5555555555555556,0.8351008123193457,1.0,7/43,12.13%,TBX2;SHH;PKD2;ACVR1;TBX3;NPHP3;SETDB2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4386549296452226,0.941724708500032,0.5494505494505495,0.8349645107606635,1.0,5/13,21.15%,APOE;CYP27B1;BMP5;PLEK;DKK3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.39148292490591846,-0.9412075853136824,0.5516304347826086,0.8520190656996871,1.0,2/10,6.15%,CSGALNACT1;DSEL
prerank,cell projection assembly (GO:0030031),0.40472916035274786,0.9411587369109348,0.561662198391421,0.8357114836846014,1.0,3/22,6.39%,RHOJ;PARVA;CDC42
prerank,positive regulation of heart rate (GO:0010460),0.4175667661926295,0.9410277275750035,0.5455861070911722,0.8355676838567988,1.0,4/17,14.55%,EDN3;ADM;ATP2A2;TRPM4
prerank,establishment of protein localization to membrane (GO:0090150),0.337128592646141,0.9409879768004423,0.569284064665127,0.8352179855849853,1.0,13/66,16.83%,RFTN1;GORASP2;EGFR;ATG3;SEC63;RAB3GAP2;VPS37C;RAB10;RAB3GAP1;ZDHHC6;ZDHHC9;RTP4;ZDHHC3
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.35334552325162605,0.9409725704852046,0.5648584905660378,0.8348242163298821,1.0,4/47,4.25%,ADIPOQ;SNAI1;SNAI2;ABCA2
prerank,cellular response to retinoic acid (GO:0071300),0.3572145909721824,0.9409273026974273,0.5457788347205708,0.8344825696508162,1.0,7/42,15.71%,WNT2;WNT9A;ATM;WNT5A;PTK7;SETX;ADNP2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.2956703571903616,-0.9408632048108508,0.541501976284585,0.8513898475752849,1.0,9/26,21.38%,EPHA4;APH1A;VSIR;GRIN2B;APH1B;TTBK1;AIM2;USP50;PSME1
prerank,regulation of phagocytosis (GO:0050764),0.3399325079298313,0.9389729390202086,0.5828367103694875,0.8379514501184196,1.0,7/53,12.29%,ADIPOQ;TLR2;PRTN3;TREM2;MERTK;CALR;TNF
prerank,cell differentiation in spinal cord (GO:0021515),-0.3938449497402318,-0.938961516533847,0.5363881401617251,0.854564094021256,1.0,3/10,6.00%,MDGA2;SOX13;SOX6
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.32052640379175257,-0.9388364790050682,0.5306122448979592,0.8532829643607199,1.0,6/18,11.60%,ACSL1;TECR;ELOVL7;ELOVL5;HACD1;ACSL3
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.4033915614286919,0.9386589794550141,0.5492371705963939,0.8381294015743065,1.0,3/18,5.95%,NF1;MORC3;SFRP1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.34985195413664394,0.9385893670545769,0.5688836104513064,0.8378429262695662,1.0,20/51,24.17%,ATM;PINX1;SMG6;ATR;CCT8;DCP2;NAT10;XRN1;CTC1;SRC;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB;HNRNPC;TERF1;MAP2K7;SMG5
prerank,lipid translocation (GO:0034204),0.4025066055054865,0.9384671364442254,0.5730027548209367,0.8376636215856008,1.0,2/21,2.43%,ABCA1;ATP8B1
prerank,transport across blood-brain barrier (GO:0150104),0.3307832624482338,0.9384449205036559,0.5883002207505519,0.8372864849288961,1.0,9/83,6.45%,SLC7A2;SLC1A3;LRP1;SLC38A3;SLC2A13;SLC28A2;ABCA2;CD36;SLC16A12
prerank,protein O-linked glycosylation (GO:0006493),0.3225430555704933,0.9384141996911485,0.5771305285868392,0.8369227533657543,1.0,18/96,16.87%,PLOD2;B4GALT5;ST6GAL1;GALNT3;TRAK1;ST3GAL3;GXYLT2;OGT;SLC35C1;GALNTL6;ST3GAL1;GALNT11;TET2;POFUT2;POGLUT3;TMTC4;CRPPA;C1GALT1
prerank,ceramide transport (GO:0035627),0.4420887180570452,0.9382932685997025,0.5806451612903226,0.8367530410000418,1.0,2/12,4.28%,ABCA2;PLTP
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3987426984927476,0.9378210001297914,0.547887323943662,0.8368379596958837,1.0,8/20,26.03%,ACADSB;HIBCH;ECHS1;BCKDHB;AUH;HIBADH;BCAT1;SLC25A44
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3987426984927476,0.9378210001297914,0.547887323943662,0.8368379596958837,1.0,8/20,26.03%,ACADSB;HIBCH;ECHS1;BCKDHB;AUH;HIBADH;BCAT1;SLC25A44
prerank,regulation of neuron migration (GO:2001222),0.37912237422065176,0.9377734290979327,0.5516759776536313,0.8365282124939498,1.0,4/26,8.12%,COL3A1;TNN;MDK;IGSF10
prerank,response to muscle stretch (GO:0035994),-0.3432189814994189,-0.937772905693864,0.5446153846153846,0.854430115862678,1.0,2/15,3.22%,DMD;GSN
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3752028166107918,0.9377509206755985,0.5433911882510013,0.836153842461878,1.0,4/29,5.21%,PDGFRA;IRS1;PDGFRB;AMBRA1
prerank,sprouting angiogenesis (GO:0002040),0.3448744161404548,0.9376340493912878,0.5715962441314554,0.8359756056948175,1.0,12/51,12.48%,CCBE1;EGR3;NRP1;PARVA;E2F8;MIA3;ANGPT1;SEMA3E;BMPER;RNF213;VEGFC;FGF2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.32626383456933533,0.9372294260264961,0.5739130434782609,0.8363445491042822,1.0,27/78,24.12%,NKD2;LRRK2;PABIR1;RNF144A;PLK1;PRICKLE1;RAD23A;ARIH1;SOCS5;NFE2L2;RNF19B;GSK3B;CSNK1A1;DDRGK1;TRIB3;TRIB1;ZYG11B;CSNK1D;MDM2;ARIH2;FBXO22;RNF14;CLU;FZR1;RNF144B;RNF217;PIAS1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3391701138728382,-0.9371291469807335,0.5515151515151515,0.8545937650987036,1.0,6/16,25.95%,NCL;CIRBP;DAZAP1;NUP98;RBM3;SF3B4
prerank,cellular amide metabolic process (GO:0043603),0.31976706622402623,0.9368892722530157,0.5869098712446352,0.8366161189815932,1.0,26/102,22.76%,DNPEP;ST6GAL1;MTHFR;MTHFD1L;ABCA2;CPXM1;NLN;PANK2;ACSF2;NSMAF;ACOT13;ST3GAL1;MTHFD2L;ORMDL3;SMPD3;ACOT9;SGPL1;PLA2G4E;ATF4;MTRR;PCCA;SLC19A1;ALDH1L2;THEM4;AEBP1;GNE
prerank,phospholipid metabolic process (GO:0006644),0.33233359027432297,0.9362791359014121,0.5838020247469067,0.837428672900602,1.0,6/71,8.76%,LGALS13;PDXP;ABCA2;PIP4K2A;FADS1;LPL
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3630214999441812,0.9360842093752624,0.5732484076433121,0.8374024975913783,1.0,15/36,26.01%,E2F1;RNF2;YAF2;EHMT1;PHC3;MAX;RBBP8;MGA;SUZ12;CDC7;CBX5;RAD51;RYBP;TFDP1;RBBP7
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.37740312621563116,0.9359543862305892,0.5485175202156334,0.8372458323817117,1.0,7/26,17.14%,NOS1AP;PKD2;CD36;TMEM106A;TNF;SMAD3;AKT1
prerank,synapse organization (GO:0050808),0.3173535487588691,0.9356078673943902,0.6083769633507854,0.8374853357892131,1.0,25/125,14.73%,SLITRK6;PDZRN3;PCDHB6;PCDHB16;FARP1;LRRK2;GPC6;SDK2;ADGRL3;CACNB1;PPFIBP2;PTEN;C1QB;CDC42;PLXND1;L1CAM;PPFIBP1;SEMA3E;DSCAM;DBNL;SDK1;ELFN1;PSEN1;PPFIA4;CX3CL1
prerank,protein heterotetramerization (GO:0051290),0.43141885368293276,0.9356011846236525,0.5699088145896657,0.8370768145175774,1.0,2/13,8.54%,PKD2;HSD17B8
prerank,DNA biosynthetic process (GO:0071897),-0.3394283549185691,-0.9351285475532074,0.5579937304075235,0.8581352992170626,1.0,11/16,37.77%,POLD3;PPIA;RFC3;POLH;POLD2;POLE;CDKN2D;POLD4;WRN;POLL;SIRT1
prerank,negative regulation of apoptotic process (GO:0043066),0.3032751437158063,0.9347140552521102,0.7004008016032064,0.8384083523594807,1.0,88/444,17.37%,NR1H4;BCL3;YAP1;MAP4K4;EGR3;GATA6;SNAI2;BIRC3;PRKCA;FHL2;FSTL1;CFLAR;TSLP;EGFR;TLE1;TREM2;APOE;FXN;MAD2L1;MDK;SHH;BAG3;BABAM2;BCL2;NUGGC;ANGPTL4;APOH;TXNDC5;PTPRZ1;SFRP1;TGFB3;PLK1;SIAH2;ASNS;BCL2L2;ANGPT1;MERTK;CBL;AREL1;SH3RF1;ANXA1;WNT5A;HDAC1;CSNK2A1;CSNK2A2;IL7;HIPK3;RPS6KB1;TBX3;CCL2;FNIP1;DNAJB6;ARF4;PTK2;YWHAZ;PDPN;RNF213;UNC5B;SPRY2;TNF;GSK3B;MGMT;PIK3R1;DDRGK1;ITGA5;MAEA;PSEN1;SRC;CPEB4;PDCD10;CX3CL1;HSPA5;NAA15;RIPK1;SETX;ITCH;PRKDC;SQSTM1;POU3F3;RASA1;LAMTOR5;BAG4;ARHGDIA;MAPK1;HSPD1;AKT1;DNAJC3;YWHAE
prerank,purine nucleotide metabolic process (GO:0006163),-0.2933800402757061,-0.9346912578661981,0.5543859649122806,0.8576450779583675,1.0,5/24,9.41%,FHIT;PRPSAP2;NT5E;ITPA;PRPSAP1
prerank,protein insertion into membrane (GO:0051205),0.3684089020805255,0.9341771436171021,0.5596919127086007,0.8390635051260577,1.0,8/32,18.91%,EGFR;TRAM2;WDR83OS;VAPA;ALDH3A2;RTP4;MAIP1;PRNP
prerank,folic acid metabolic process (GO:0046655),0.4053240033108043,0.9341149922955992,0.5472496473906912,0.8387612278996178,1.0,9/18,27.33%,MTHFR;MTHFD1L;MTHFD2L;MTRR;SLC19A1;ALDH1L2;MTHFD1;FOLR2;SLC25A32
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.41372349769532374,0.9336947971369833,0.5581737849779087,0.8391537497354773,1.0,2/16,13.13%,ULBP1;KIF5B
prerank,B cell activation involved in immune response (GO:0002312),0.42327117287646854,0.9336872917654325,0.5369822485207101,0.8387412887193617,1.0,1/13,3.15%,BATF
prerank,chromosome condensation (GO:0030261),0.3650537399977173,0.9336781331413628,0.571608040201005,0.8383405923977731,1.0,11/36,21.09%,ERN2;KMT5A;PLK1;CSNK2A1;CSNK2A2;NCAPD2;NCAPG2;AIFM1;NCAPG;TENT4A;SMC4
prerank,vesicle transport along microtubule (GO:0047496),0.3809851795005038,0.9336540744153904,0.5434782608695652,0.8379676256501447,1.0,8/23,17.19%,DYNC1H1;KIF1C;TRAK1;FBXW11;KIF5B;RAB1A;NDEL1;KIF5A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.40347073253515275,0.9335325001002368,0.5515818431911967,0.8377944602474868,1.0,2/19,7.04%,BCL3;BAG6
prerank,mitochondrial translational elongation (GO:0070125),-0.21971836257550492,-0.9334914228028129,0.6666666666666666,0.8590551002394338,1.0,45/88,33.37%,MRPS9;MRPS35;MRPS28;MRPS15;MRPS24;MRPL13;MRPL10;MRPL21;MRPL39;ERAL1;TSFM;PTCD3;MRPL4;MRPS7;MRPS31;MRPL28;MRPL30;MRPS18C;MRPL22;MRPL40;GADD45GIP1;MRPL46;MRPS16;MRPS18B;MRPL58;MRPS22;MRPS6;MRPS25;MRPS12;MRPS34;MRPL44;MRPL18;MRPL20;MRPL35;MRPL23;GFM1;MRPL42;MRPL43;MRPL54;MRPL34;MRPL2;MRPS10;TUFM;MRPL16;MRPL11
prerank,neuron projection extension (GO:1990138),0.36905747523293153,0.9334193882610222,0.5636822194199244,0.8376034426283193,1.0,4/32,3.93%,TNN;AUTS2;NRP1;USP9X
prerank,regulation of activated T cell proliferation (GO:0046006),0.37317097596580495,0.9333465661280381,0.5539661898569571,0.8373214994030147,1.0,2/30,5.04%,IL23R;LGALS9
prerank,negative regulation of cell growth (GO:0030308),0.31783445338610694,0.933108112224391,0.6197916666666666,0.837357306432694,1.0,21/121,14.44%,ENPP1;PPP1R9B;BCL6;SLIT3;SERTAD2;FRZB;CYP27B1;SFRP1;ENO1;CCAR2;BTG1;IP6K2;ACVR1B;RERG;PTPRJ;TGFB2;FGF13;SPHK2;SMAD3;CDKN1B;SMAD4
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4345638417905521,0.9330043537116255,0.5636645962732919,0.8367205004524375,1.0,4/12,13.03%,SLC9A1;STIMATE;TNF;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4345638417905521,0.9330043537116255,0.5636645962732919,0.8367205004524375,1.0,4/12,13.03%,SLC9A1;STIMATE;TNF;SPPL3
prerank,DNA catabolic process (GO:0006308),0.4366058537219671,0.9329742385691446,0.5325914149443561,0.8363594221988131,1.0,2/11,10.03%,SETMAR;FBH1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.36390141255443376,-0.9327622006692589,0.56797583081571,0.8594351539887871,1.0,5/13,14.35%,RNF152;DEPDC5;SESN2;SESN3;SPAAR
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.44171780313905246,0.9325073415832471,0.5420711974110033,0.8368752477440174,1.0,2/11,8.15%,CREB3L1;ADAMTS9
prerank,response to estrogen (GO:0043627),0.373981030901747,0.9324530163739607,0.5696040868454662,0.8365693711558458,1.0,5/31,10.09%,RBBP5;ARID5A;CYP27B1;SFRP1;PELP1
prerank,amide transport (GO:0042886),0.3783247451624506,0.9322228582363674,0.5389696169088507,0.8366008310664371,1.0,2/26,4.28%,SLC14A2;PLTP
prerank,pulmonary valve morphogenesis (GO:0003184),0.40469831922931615,0.9319022458195478,0.5510791366906475,0.8368265821598072,1.0,4/17,11.44%,ROBO2;JAG1;HEYL;TGFB2
prerank,negative chemotaxis (GO:0050919),0.3693227652813671,0.9317543963599226,0.5622641509433962,0.8366985040348796,1.0,3/33,2.46%,EPHA7;SLIT3;SLIT1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.32203102166207986,0.9315525985486538,0.6237942122186495,0.8366801674486242,1.0,23/98,18.91%,CEMIP;LRP1;NKD2;EGFR;TREM2;BBC3;E2F1;BCL2;ITGA3;PTPN9;YWHAZ;CASP8;TNF;KIF5B;PIK3R1;STAC3;SQSTM1;ITGB1BP1;AKT1;YWHAE;CLIP3;SPTBN1;PRNP
prerank,regulation of membrane repolarization (GO:0060306),-0.3520390622864903,-0.9311870307969111,0.5608308605341247,0.8619157173753823,1.0,3/13,4.05%,CAV1;AKAP6;KCNJ2
prerank,response to interleukin-6 (GO:0070741),0.4449921772332299,0.9308489182655185,0.5527950310559007,0.8376611840561844,1.0,2/10,7.40%,SBNO2;PID1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.32329605099376224,0.9307594990331851,0.5856832971800434,0.8374070027130031,1.0,12/90,9.38%,ADIPOQ;PLAC8;CMKLR1;JAK2;DYNC1H1;CD36;ALMS1;OMA1;EHMT1;CXCR4;OGT;HCRT
prerank,positive regulation of cartilage development (GO:0061036),0.4128780343804664,0.930615757111256,0.5558739255014327,0.8372456467799061,1.0,3/17,5.17%,SOX5;MDK;BMP1
prerank,pyruvate metabolic process (GO:0006090),-0.2550671429561008,-0.9302557416047965,0.6287425149700598,0.8626769673370749,1.0,12/52,17.23%,BSG;ME3;ME1;SLC16A1;VDAC1;HAGH;LDHB;PFKM;TPI1;ALDOC;PGK1;LDHA
prerank,positive regulation of protein depolymerization (GO:1901881),0.452955115883947,0.9294835358213251,0.5683229813664596,0.8390305373783917,1.0,1/11,1.24%,PDXP
prerank,nucleosome assembly (GO:0006334),0.36482237716514154,0.9291493551022547,0.5607594936708861,0.8392118762661522,1.0,10/31,19.97%,GRWD1;HMGB2;RSF1;UBN1;SPTY2D1;NAP1L3;ATRX;ASF1A;KAT6B;NAP1L1
prerank,epiboly involved in wound healing (GO:0090505),0.4171173342813007,0.9291329326837525,0.5574018126888217,0.8388236312052634,1.0,6/16,14.53%,MRTFA;LCP1;PDPN;RHOA;ARHGAP35;PDCD10
prerank,catecholamine biosynthetic process (GO:0042423),-0.38089287518648385,-0.9290915473475156,0.5497237569060773,0.8639560623369693,1.0,2/11,12.12%,MOXD1;DDC
prerank,electron transport chain (GO:0022900),0.4226529770948644,0.9287124745422671,0.5739644970414202,0.8392294770785005,1.0,3/15,10.07%,ETFA;POR;SDHB
prerank,T cell migration (GO:0072678),-0.34627959252419466,-0.9283419118184737,0.5280898876404494,0.8643059240525086,1.0,2/13,4.04%,SLC12A2;S1PR1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.33364664585103,-0.9282592788433178,0.5703971119133574,0.8629501371678446,1.0,4/16,6.91%,CALM1;PGM2L1;PYGM;PYGB
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.389743660318312,0.9281151371403343,0.5539971949509116,0.8399859113420179,1.0,10/22,23.74%,EAPP;CCNT1;HMGN1;TCERG1;BRD4;KAT7;CDK13;CDK12;CDC73;THOC5
prerank,positive regulation of isotype switching (GO:0045830),0.42026188408225384,0.9279649733912309,0.5516739446870451,0.8398574057285062,1.0,5/15,18.69%,CD40;SHLD3;RIF1;PAXIP1;HMCES
prerank,methylguanosine-cap decapping (GO:0110156),0.45830576411184915,0.9278454862060556,0.5608974358974359,0.8396836688926059,1.0,4/10,15.07%,EDC4;DCP2;DCP1A;PATL1
prerank,excitatory postsynaptic potential (GO:0060079),0.4053248053810853,0.927544267608938,0.5593705293276109,0.839850895344719,1.0,8/19,23.06%,LRRK2;NPAS4;GSK3B;RAB3GAP1;AKT1;GRIN2A;NPFF;MAPK8IP2
prerank,regulation of embryonic development (GO:0045995),0.36229165361438237,0.9269020479937223,0.5435630689206762,0.8407455281969308,1.0,10/34,18.34%,B4GALT5;EHMT1;BAG6;WDPCP;NPHP3;ZBED3;PHLDB2;NIPBL;PHLDB1;NR2C2
prerank,development of primary male sexual characteristics (GO:0046546),0.3637676168298247,0.9268549976105425,0.5756035578144854,0.84041385123994,1.0,6/34,14.39%,LHFPL2;GATA6;WNT5A;TGFB2;ADAM21;TFAP2C
prerank,negative regulation of JUN kinase activity (GO:0043508),0.45908631018510726,0.9258142038437895,0.5879556259904913,0.8420478953008028,1.0,3/10,17.77%,AIDA;HIPK3;MAPK8IP1
prerank,neuronal action potential (GO:0019228),-0.30118693774811617,-0.9257512250923935,0.5688405797101449,0.8676092959224688,1.0,9/22,27.42%,SCN2A;SCN8A;ANK3;SCN9A;GPER1;MYH14;CACNA1I;SCN3A;KCNMB2
prerank,myotube cell development (GO:0014904),-0.3773439152478636,-0.9249442823363081,0.5601092896174863,0.8680245206714309,1.0,3/10,15.62%,CAV2;IGF1;SKI
prerank,ear morphogenesis (GO:0042471),0.38889786805700527,0.924930339280347,0.5680224403927069,0.8433620622694454,1.0,5/20,18.17%,CHD7;HOXA1;ZIC1;NIPBL;PAX8
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.38835204238724347,-0.9248777500453328,0.5702702702702702,0.8666358593415374,1.0,2/10,8.96%,CAV1;ANK3
prerank,positive regulation of hemostasis (GO:1900048),0.4506836521074583,0.9247792077568513,0.5700934579439252,0.8428228733493267,1.0,2/10,6.67%,APOH;HPSE
prerank,positive regulation of coagulation (GO:0050820),0.4506836521074583,0.9247792077568513,0.5700934579439252,0.8428228733493267,1.0,2/10,6.67%,APOH;HPSE
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.23038240569610313,-0.9242105483757757,0.5803571428571429,0.8667904965385037,1.0,25/69,30.55%,STT3B;ERLIN1;EDEM2;JKAMP;UBXN4;UBE4A;DNAJC18;DNAJB9;ERLIN2;DERL1;ANKZF1;WFS1;RNF185;UFD1;YOD1;SGTA;FBXO44;RNF5;NPLOC4;UBQLN2;DNAJB2;ECPAS;TMEM67;UBE2J2;TMEM129
prerank,myotube differentiation (GO:0014902),0.404111585770965,0.9238857569056659,0.5616045845272206,0.8441006855473566,1.0,3/17,5.90%,ADAM12;ADAMTS15;ADAMTS5
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3666031993023636,0.9238386793342355,0.5697823303457106,0.8437774636047534,1.0,6/31,15.08%,STXBP1;CBARP;SYT2;STXBP3;RAB3GAP1;DOC2B
prerank,"transcription, DNA-templated (GO:0006351)",0.30187750690242565,0.92379393489749,0.6459816887080366,0.8434418843041492,1.0,71/207,24.69%,PAX1;BCL3;DEAF1;SOX5;NFIX;E2F1;CEBPD;TAF7;MBD1;TTF2;GTF2H1;NFE2L3;SNAPC3;RRAGC;TRIP11;FOXO3;GTF2F2;CRCP;HIPK3;NCBP2;GTF3A;CBFB;POLR3A;RSF1;CDK7;NKX2-8;GLIS3;SMN1;GTF2F1;IRF9;DRAP1;BRF1;TAF1A;TAF4;MMS19;BAZ2A;SETX;CCNT1;GTF3C4;RBMX;MLLT1;POLRMT;ATF4;TAF2;POLR2L;POLR2K;PAX8;CDK9;IWS1;POLR3GL;PMF1;ERCC2;POLR3K;THRA;TWNK;NFIC;CCNH;THRB;TCEA1;FUBP3;POLR2D;MNAT1;DDX21;PRMT5;CDC73;TAF5;RNPS1;TAF3;TEFM;RNMT;XBP1
prerank,macrophage migration (GO:1905517),0.4246333616138208,0.9236738228236036,0.5699088145896657,0.8432445080288423,1.0,2/13,10.36%,CCL5;CCL2
prerank,regulation of autophagosome maturation (GO:1901096),0.42879867756184886,0.92360993177459,0.5622119815668203,0.8429490423907962,1.0,4/13,21.25%,TMEM39A;SMCR8;IRGM;CLEC16A
prerank,cellular response to oxidative stress (GO:0034599),0.3112004319370287,0.9235225137569739,0.6181434599156118,0.8427105833642606,1.0,29/118,21.45%,PDGFRA;LRRK2;RAD52;EGFR;AIF1;PKD2;PLA2R1;ETV5;ARNT;FOXO3;TMEM161A;NFE2L2;GPX8;TXNRD1;TXNRD2;SETX;CYCS;HIF1A;ADNP2;MAPK1;AKT1;ATF4;CYBB;TPM1;FANCC;PRKCD;ZC3H12A;WNT16;VRK2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3681056973769422,-0.923350388284693,0.5329949238578681,0.8674119224518916,1.0,7/11,33.01%,NDUFA13;TIMM22;TOMM70;TIMM8B;ROMO1;TIMM9;TIMM10
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3759120330344121,-0.9231643216840061,0.5555555555555556,0.8647264767453218,1.0,5/11,27.23%,NOTCH4;TNRC6C;ZFP36;AGO3;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3759120330344121,-0.9231643216840061,0.5555555555555556,0.8647264767453218,1.0,5/11,27.23%,NOTCH4;TNRC6C;ZFP36;AGO3;AGO4
prerank,vascular transport (GO:0010232),0.3260745724416579,0.9231277715754075,0.6077348066298343,0.8430002460530216,1.0,7/81,4.25%,SLC7A2;SLC1A3;LRP1;SLC38A3;SLC2A13;SLC28A2;ABCA2
prerank,inner mitochondrial membrane organization (GO:0007007),-0.24287722324892042,-0.9229612185408064,0.6167664670658682,0.8636764811408256,1.0,23/47,27.20%,ATP5MG;TMEM11;ATP5PD;ATP5PF;LETM1;NDUFA13;MTX3;IMMT;HSPA9;ATP5F1D;MICOS13;ATP5ME;SAMM50;APOO;TIMM22;APOOL;TOMM70;TIMM8B;ROMO1;MICOS10;UQCC3;ATP5MC2;TIMM9
prerank,glucan catabolic process (GO:0009251),-0.338165240044381,-0.9229412418399683,0.5694444444444444,0.8621943779300971,1.0,4/15,6.91%,CALM1;PGM2L1;PYGM;PYGB
prerank,negative regulation of programmed cell death (GO:0043069),0.30044387087340263,0.9228783883193692,0.6880641925777332,0.8430634973023885,1.0,66/355,17.28%,NR1H4;BCL3;MAP4K4;EGR3;GATA6;BIRC3;FHL2;FSTL1;CFLAR;TSLP;EGFR;TREM2;FXN;MAD2L1;SHH;BAG3;BABAM2;BCL2;NUGGC;ANGPTL4;TXNDC5;SFRP1;PLK1;SIAH2;ASNS;BCL2L2;RAB7A;AIFM2;ANGPT1;CBL;AREL1;SH3RF1;ANXA1;WNT5A;HDAC1;IL7;HIPK3;RPS6KB1;TBX3;ARF4;PTK2;YWHAZ;PDPN;SPRY2;GSK3B;MGMT;PIK3R1;DDRGK1;PSEN1;SRC;PDCD10;CX3CL1;HSPA5;NAA15;RIPK1;SETX;ITCH;PRKDC;SQSTM1;POU3F3;RASA1;BAG4;ARHGDIA;HSPD1;AKT1;DNAJC3
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3579594617965387,0.9228311044795905,0.5912031047865459,0.8427232000959863,1.0,4/33,6.70%,IAPP;FXN;OMA1;ADCK1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3916094247729087,0.9227780472175077,0.5677603423680456,0.8424231638185783,1.0,3/20,5.97%,EGFR;PKD2;CCND3
prerank,positive regulation of endothelial cell migration (GO:0010595),0.32073527550696806,0.9223749504128247,0.5926748057713651,0.8427876589490216,1.0,34/84,25.43%,SPARC;CD40;PRKCA;NRP1;AKT3;PRKD2;EGF;STAT5A;SASH1;ANGPT1;WNT5A;FGFR1;CALR;RIN2;FGF2;RAC1;HIF1A;FGF18;ITGB1BP1;AKT1;ETS1;AGT;BCAS3;ATP5F1A;FOXP1;ZC3H12A;ROCK2;ITGB3;GPI;BMPR2;VEGFA;AAMP;PLPP3;PDPK1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.30869857869248263,0.9220790689339683,0.6477857878475798,0.8429256112764661,1.0,22/159,11.84%,PALLD;CDH11;ROBO2;PCDHB6;JAML;PCDHB16;MILR1;GPC6;SDK2;ADGRL3;TENM3;DCHS1;ACVR1;CDH6;ICAM1;TENM4;L1CAM;DSCAM;TGFB2;CDH18;CDH24;PTPRM
prerank,nucleic acid-templated transcription (GO:0097659),0.344374682242075,0.9220668134882637,0.5783132530120482,0.8425305458654813,1.0,11/42,18.17%,BCL3;E2F1;TERT;RRAGC;POLR3A;NKX2-8;MMS19;BAZ2A;POLR2L;POLR2K;PAX8
prerank,regulation of response to stress (GO:0080134),-0.37801220211571157,-0.9220510519061591,0.5746478873239437,0.8628945444951392,1.0,8/10,44.05%,CORO2B;SLC38A2;MLC1;STOX1;OPRM1;DYRK3;ADCY8;CRHBP
prerank,regulation of T cell activation (GO:0050863),0.3516529634676224,0.9219299748490487,0.5789473684210527,0.8423895703451169,1.0,12/42,26.27%,TNFSF11;CCL5;GPNMB;CCL2;HSPD1;PAG1;SIRPA;CCDC88B;CYRIB;TNFRSF1B;THY1;PYCARD
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.32835946750299344,0.9218507687249795,0.6139380530973452,0.842133289361252,1.0,17/80,18.37%,EPHA7;CASP1;CTSD;NOD1;SIAH2;SH3RF1;CSNK2A1;FNIP1;DNAJB6;TNF;ACVR1C;SRC;CYCS;LAMTOR5;AKT1;YWHAE;SOX2
prerank,cellular response to copper ion (GO:0071280),-0.327188761553711,-0.9217830287040235,0.5723905723905723,0.8620631004633621,1.0,13/16,49.31%,MT2A;HSF1;AQP1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;SNCA;MT3
prerank,activation of adenylate cyclase activity (GO:0007190),0.3653087454035194,0.9216640965983254,0.5825977301387137,0.8420893929745761,1.0,4/35,4.40%,EDNRA;ADCY7;RXFP2;ADCY2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.45333640630553035,0.9208313456544038,0.5901898734177216,0.8432743916938028,1.0,6/10,30.06%,PIH1D2;RUVBL1;PIH1D1;RUVBL2;ZNHIT6;NUFIP1
prerank,regulation of neuron differentiation (GO:0045664),0.3213616815806631,0.9207877658765579,0.5960482985729967,0.842947077038683,1.0,16/76,19.61%,ZEB1;TCF4;LRRK2;NREP;HEYL;FGFR1;NEPRO;CALR;RHOA;BMP7;MOSMO;TCF3;ZFHX3;SOX2;VWC2;MED1
prerank,negative regulation of binding (GO:0051100),0.3224026807810201,0.9207138286049135,0.6058230683090705,0.8426880075035529,1.0,25/81,20.54%,LRRK2;JAK2;E2F1;ILRUN;DDX11;MDFI;EFHB;SP100;DISC1;RSF1;PEX19;GSK3B;GTF2F1;DACT1;SMO;ITGB1BP1;AKT1;NFKBIA;TLE5;WAPL;CTNNBIP1;KDM1A;PIN1;HMGA2;PRKCD
prerank,long-chain fatty acid transport (GO:0015909),-0.2752728410053843,-0.9206504077487574,0.594488188976378,0.8632308158096242,1.0,6/30,11.60%,PRKAG2;PRKAA2;ACSL1;ABCD3;SLC27A1;ACSL3
prerank,ganglioside metabolic process (GO:0001573),-0.3106879240709021,-0.9198589113438698,0.5625,0.863579887019203,1.0,6/20,12.49%,ST6GALNAC3;ST8SIA4;ST3GAL5;ST8SIA6;ST8SIA2;ST6GALNAC5
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.41588699025995063,0.9192903754991055,0.5776772247360482,0.8450165324605504,1.0,4/15,18.53%,MAD2L1;RPL11;DTX3L;FBXO5
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.34055273298994787,0.919027954406096,0.6036144578313253,0.8451175931494418,1.0,11/53,11.09%,SPRED1;EGFR;SPRED2;BABAM2;PLA2R1;ATM;EEF1E1;CCAR2;ATR;FBH1;TMEM161A
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.41808420241371536,0.9185119039218035,0.5760709010339734,0.8457058725524931,1.0,5/15,21.08%,POP1;RNASEH1;DICER1;ZC3H12B;ZC3H12A
prerank,entry into host (GO:0044409),0.4180089221728091,0.9184355132139046,0.5712143928035982,0.8454323987130627,1.0,4/13,14.06%,CBL;GRB2;CXCR4;SRC
prerank,pigment granule transport (GO:0051904),0.40353489857755315,0.918303018342459,0.569583931133429,0.8448601707597304,1.0,3/18,9.93%,MLPH;MYO5A;RAB27B
prerank,melanosome transport (GO:0032402),0.40353489857755315,0.918303018342459,0.569583931133429,0.8448601707597304,1.0,3/18,9.93%,MLPH;MYO5A;RAB27B
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.34451284269616045,-0.9180850017516886,0.5766871165644172,0.8663029101621247,1.0,6/14,18.65%,KLF4;MEOX2;CARD10;THBS1;TBXA2R;MAP2K5
prerank,sphingosine metabolic process (GO:0006670),-0.31880079256436017,-0.9171681635393526,0.5704697986577181,0.8669667242025807,1.0,6/17,16.84%,ACER2;SPTLC2;SPTLC1;SGPP1;ASAH2;NAAA
prerank,Golgi inheritance (GO:0048313),0.429176622234713,0.9171442492579613,0.5652866242038217,0.8466944129399969,1.0,4/11,14.53%,GBF1;YWHAZ;VCPIP1;PDCD10
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.37024202220198815,0.9168852526051244,0.5914552736982643,0.8467983626146015,1.0,5/28,11.58%,LACC1;TNFAIP3;NOD1;IRAK2;CASP8
prerank,blood vessel diameter maintenance (GO:0097746),0.35537613810345664,0.9164812157631361,0.5750636132315522,0.8471551710195229,1.0,3/34,2.89%,EDN3;CRP;EDNRA
prerank,protein K48-linked ubiquitination (GO:0070936),-0.23246967509101296,-0.9161571636595237,0.6299212598425197,0.8679359262120977,1.0,19/54,26.37%,RNF152;PRKN;KLHL3;UBE2E3;UBE2A;UBE3A;RFFL;HACE1;UBE2B;BFAR;SKP2;TRIM32;UBE2D1;KBTBD7;RNF5;NEDD4L;RNF126;RBX1;RNF115
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.33554691938478576,0.9154680997156713,0.6092636579572447,0.848685693282022,1.0,21/51,23.87%,SYNPO;NRP1;CARMIL1;NF2;SFRP1;TGFB3;CDC42;EPHA1;TGFBR1;RHOA;RAC1;CX3CL1;ITGB1BP1;PLEK;TPM1;PAK1;RHOC;RGCC;ROCK2;LPAR1;PXN
prerank,phagosome-lysosome fusion (GO:0090385),0.4454160212587013,0.9150824591633251,0.5609756097560976,0.8490272161579693,1.0,3/10,13.84%,RAB7A;RAB7B;RAB34
prerank,double-strand break repair via homologous recombination (GO:0000724),0.312501721332946,0.9150226586120348,0.6094929881337648,0.8487391825262833,1.0,20/95,18.69%,RAD51B;RAD52;MCM2;INO80;XRCC3;MMS22L;ZFYVE26;MCM7;FBH1;AP5Z1;MCM9;NSMCE2;RMI1;XRCC1;NIPBL;PSMD14;NUCKS1;HELQ;RBBP8;SWI5
prerank,mitotic recombination (GO:0006312),0.41737730530960004,0.9147356069993009,0.5798561151079137,0.8488828719604203,1.0,7/15,23.20%,RAD52;XRCC3;NSMCE2;TEP1;SMC5;DMC1;RAD51
prerank,histone acetylation (GO:0016573),-0.23223806475606834,-0.9140157828218893,0.6857142857142857,0.8717268157761763,1.0,23/69,17.75%,LEF1;JADE1;PER1;ACTL6A;PHF20L1;BRCA2;DR1;TADA1;JADE2;WDR5;EP300;TAF6;TAF6L;HAT1;NAA60;JADE3;MAP3K7;KAT6A;KAT5;TRIM16;EPC1;SUPT7L;APBB1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.36623104420709357,0.9139779568246493,0.5940337224383917,0.8499318545042757,1.0,8/31,18.69%,XCL1;SASH3;SHLD3;TNFRSF4;RIF1;PAXIP1;PTPRC;HMCES
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2991499938858957,-0.9138887440607535,0.536,0.8704545976286603,1.0,7/20,15.45%,FKBP5;PPIG;PPIH;PPIL2;PPIL3;FKBP1A;PPIB
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2560991841507512,-0.9131267873395864,0.6473988439306358,0.8707222490476065,1.0,11/48,16.74%,DGKB;DDHD1;GPD1L;DGKA;SLC27A1;AGPAT3;ACP6;DGKG;GPAT4;PLA2G6;DGKQ
prerank,cAMP metabolic process (GO:0046058),-0.3464156817784899,-0.9129737216814399,0.5821325648414986,0.8695878811149828,1.0,5/13,10.43%,ADCY5;ADCY9;ADCY1;ADCY4;PDE4D
prerank,fatty acid biosynthetic process (GO:0006633),0.3287946624519537,0.9129719434545474,0.608548931383577,0.8514378010744981,1.0,8/63,9.08%,LIPC;EPHX2;HACD2;SCD5;HSD17B8;FADS1;LPL;CYP1A1
prerank,polyol biosynthetic process (GO:0046173),0.4030046091524888,0.9119603417289903,0.574468085106383,0.8529233067048416,1.0,5/16,12.52%,CYP27B1;ITPKC;IP6K2;FGF2;CYP2R1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4058897216353169,0.9114796429497832,0.5963855421686747,0.8534094506985462,1.0,3/16,9.03%,ARHGAP24;AUTS2;OGT
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4097054418210704,0.9114540529838733,0.5718390804597702,0.8530522969580511,1.0,2/15,5.42%,SFRP4;CYP27B1
prerank,central nervous system neuron differentiation (GO:0021953),0.35773912486912013,0.9110167764048006,0.5949685534591195,0.853452665597219,1.0,6/33,11.46%,WNT2;MDGA1;OPHN1;LRP6;DRAXIN;AGTPBP1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3767323139167101,0.9104304305673581,0.5740740740740741,0.8541291590596106,1.0,6/25,14.77%,DNAJB1;HSPE1;GAK;DNAJC7;SDF2;HSPA5
prerank,positive regulation of protein metabolic process (GO:0051247),0.30907821939479774,0.9100693339098884,0.6427807486631016,0.8543797158168797,1.0,37/110,22.52%,IL23R;TNFAIP3;APOE;ABCA2;SMURF2;PAEP;OAZ3;RAB7A;AREL1;WNT5A;CSNK2A1;SLC25A37;ATG7;TNF;GSK3B;RAB1A;DACT1;PSEN1;CDKN1B;RANBP9;SMURF1;ITCH;NEDD4;AKT1;DDB1;INHBA;AGT;NFKBIA;TNFSF12;PLK2;EIF4G1;AXIN1;CLU;CSF1;FZR1;ROCK2;CD80
prerank,negative regulation of lymphocyte activation (GO:0051250),0.39411284696151583,0.909830859219443,0.5924895688456189,0.8544160001620992,1.0,3/21,11.70%,TNFAIP3;GPNMB;LST1
prerank,positive regulation of immune response (GO:0050778),0.32376436782718254,0.9095998761394157,0.6006787330316742,0.8544631941320193,1.0,7/64,13.14%,IL23R;LGALS9;CCL5;SASH3;TGFB2;POLR3D;SPHK2
prerank,stem cell differentiation (GO:0048863),0.3588677769543003,0.909456156683727,0.6022584692597239,0.8543188986615987,1.0,8/39,11.44%,BATF;SOX21;SHH;PUM1;SFRP1;LRP6;SETD2;TGFB2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3042952905542376,0.9094131645107119,0.6798336798336798,0.8539868722595884,1.0,35/148,18.96%,BRIP1;DNA2;NUAK1;RICTOR;KMT5A;PIP4K2A;TAF7;ATM;EHMT1;NOC2L;MAPKAP1;MAPK11;ATR;HDAC1;CSNK2A1;CSNK2A2;TPX2;PRDM1;MTA2;NOP2;BRPF1;RMI1;TAF4;RPL11;BANP;PRKAB1;ATRIP;AKT1;PHF20;ING5;MDM2;RAD9A;TAF2;RBBP8;MBD3
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.2969422055718335,0.9092736394599538,0.7221664994984955,0.8538523873230563,1.0,62/306,19.97%,RPSA;RRBP1;RBMS1;BCL3;ASMT;EIF4G2;TNIP1;B4GALT5;POLE3;BRIP1;DNA2;EXT1;RPL3L;APOE;E2F1;MCM2;EXT2;NT5M;ATM;PABPC4;TERT;RRAGC;MCM7;ATR;DBF4;GRWD1;RNASEH2A;MCM9;POLR3A;RPL12;MRPS18A;TIMELESS;EEFSEC;POLA2;NKX2-8;RPL22;RPL14;REV1;RMI1;MRPS14;RPL11;MMS19;BAZ2A;GSPT1;ATRIP;MRPL55;ING5;RPL36A;RAD9A;MRPL52;POLR2L;RPS9;INHBA;POLR2K;PAX8;RBBP8;RPL6;KAT7;RPLP2;AGO2;MRPS33;NAP1L1
prerank,regulation of DNA repair (GO:0006282),-0.24469046852144977,-0.9092411713769114,0.6464088397790055,0.8770732439193896,1.0,14/44,18.96%,EYA2;EYA1;EYA4;SMCHD1;ERCC6;UBE2V2;UBE2N;CEBPG;USP1;PCNA;SIRT7;FGF10;BABAM1;DEK
prerank,mitochondrial membrane organization (GO:0007006),-0.2648413951900357,-0.9092055647798905,0.600896860986547,0.8756515622045113,1.0,13/32,20.64%,SLC25A4;RCC1L;BCL2L1;TMEM11;MFN1;MTX3;IMMT;BNIP3;HSPA9;MICOS13;SAMM50;APOO;APOOL
prerank,membrane depolarization during action potential (GO:0086010),-0.29487904977696755,-0.9091977959651797,0.568,0.8741507368766384,1.0,5/26,10.05%,ATP1A2;SCN2A;KCNJ2;SCN8A;SCN9A
prerank,positive regulation of ATP metabolic process (GO:1903580),0.36203396914884955,0.9090981033983845,0.5871794871794872,0.853779602926052,1.0,9/32,15.67%,TREM2;ENO1;ARNT;PFKFB4;PID1;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,response to amino acid (GO:0043200),-0.26549772936263577,-0.9089815146744433,0.6303317535545023,0.8731990724711622,1.0,13/31,20.44%,CPEB3;SLC38A9;GLRA3;LAMTOR1;GLRA1;SESN2;RRAGB;SPAAR;RRAGD;GLRA2;LAMTOR2;TMBIM6;RRAGA
prerank,replication fork processing (GO:0031297),0.34857484807672456,0.9087578672740024,0.5821256038647343,0.8540051594303483,1.0,15/38,24.75%,DNA2;DDX11;MMS22L;ATR;SETMAR;FBH1;EME2;ATRX;TRAIP;NUCKS1;CDK9;ZRANB3;RAD51;ETAA1;FAM111A
prerank,regulation of gluconeogenesis (GO:0006111),0.3753126059675577,0.9087384590365222,0.5857519788918206,0.8536268053913777,1.0,6/27,17.41%,ADIPOQ;OGT;PTPN2;GCK;SDHAF3;DDB1
prerank,rRNA modification (GO:0000154),-0.2927902200679673,-0.9082517049125559,0.5972222222222222,0.8734736992303438,1.0,12/21,31.05%,ZCCHC4;TFB1M;DKC1;DIMT1;GAR1;NOP10;TSR3;THUMPD1;TRMT112;FBL;NHP2;TFB2M
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4151897670396602,0.908223493190954,0.5703245749613601,0.8542012661630048,1.0,6/13,20.69%,ZFPM2;TBX2;FGF2;GLI1;RBPJ;BMPR1A
prerank,regulation of lysosomal lumen pH (GO:0035751),0.43023551917118485,0.9080263428807565,0.578125,0.8541502587467965,1.0,3/12,11.74%,LRRK2;ATP6AP2;CLN6
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.4098707804449757,0.9076855497008398,0.5959595959595959,0.8543999646251481,1.0,3/16,9.71%,IGFBP4;IGFBP5;BMP5
prerank,linoleic acid metabolic process (GO:0043651),-0.313514891299318,-0.9075978780764212,0.5822368421052632,0.8735109211932374,1.0,2/17,7.04%,ACSL1;ELOVL5
prerank,response to leucine (GO:0043201),0.44413649235903274,0.9075527126967502,0.5901898734177216,0.8538282949446002,1.0,2/10,7.66%,KLHL22;RPTOR
prerank,cellular response to leucine (GO:0071233),0.44413649235903274,0.9075527126967502,0.5901898734177216,0.8538282949446002,1.0,2/10,7.66%,KLHL22;RPTOR
prerank,regulation of endocytosis (GO:0030100),0.32974424832816907,0.9074838591808603,0.6110458284371327,0.8535317464723271,1.0,6/61,7.37%,STON2;LRP1;APOE;OPHN1;ARFGAP1;PTPN1
prerank,non-motile cilium assembly (GO:1905515),0.3667172916107696,0.9063522812160257,0.6131479140328698,0.8553083743302345,1.0,6/30,17.00%,IFT57;IFT88;PCM1;DISC1;TOGARAM1;CSNK1D
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.34903570692267666,0.9062585932748106,0.5778894472361809,0.8550835399275266,1.0,9/35,16.70%,PDGFRA;NRP1;MDK;BAIAP2;CDC42;SEMA3E;NTRK3;FES;ARHGDIA
prerank,protein localization to organelle (GO:0033365),0.3066042331732969,0.905761356599591,0.6532343584305408,0.8556377892206282,1.0,37/133,21.74%,COL1A1;LRRK2;TRAM2;CD68;LAMP2;WDR83OS;VAPA;GBF1;WDR35;GAK;CALR;SNX10;DDRGK1;BMP7;RPL11;DCP1A;ALDH3A2;BANP;COG7;OBSL1;CSNK1D;YWHAE;ATP6V1D;DDX1;RAB33B;MDM2;TOR1AIP1;ZBTB7A;PRNP;TULP3;SYS1;LAMP5;ISG15;IFT20;VPS35;YBX1;ZNF423
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.40680825406438886,0.905300389055729,0.582701062215478,0.8560651279504349,1.0,6/15,17.00%,SFRP4;SFRP1;NPHP3;RNF213;DACT1;CSNK1D
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3398494534468893,-0.9037872044137047,0.6070381231671554,0.8812926533196261,1.0,5/14,19.13%,MALT1;CARD10;CARD14;MAP3K7;IRAK1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3669763271155285,-0.9032003509151686,0.5750708215297451,0.8812088878484114,1.0,2/10,6.00%,ZBTB16;SOX6
prerank,sulfur amino acid catabolic process (GO:0000098),-0.3681328827110138,-0.9031697916989246,0.5576923076923077,0.8797811969415811,1.0,5/10,33.30%,TXN2;CBS;CTH;ADO;MPST
prerank,positive regulation of viral genome replication (GO:0045070),0.36499311642517474,0.9029642513429138,0.5981675392670157,0.8600150313871462,1.0,6/29,11.48%,TMEM39A;PPID;CCL5;RAD23A;TOP2B;STAU1
prerank,metal ion transport (GO:0030001),0.3102339772569157,0.902748252064616,0.6540130151843818,0.8600009183598185,1.0,13/86,13.92%,CACNA1A;CACNA2D1;CACNA1C;CCR1;ITPR1;PKD2;CYP27B1;CCL5;NIPAL2;CALCRL;NIPAL4;TUSC3;PSEN1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.33836451970166803,-0.9026223915070234,0.5945205479452055,0.8796587761445739,1.0,5/13,24.29%,PRR5L;CNOT8;UPF1;RC3H1;ZC3HAV1
prerank,cellular response to zinc ion (GO:0071294),0.4036133690831962,0.902339480786339,0.5862573099415205,0.8603392697345222,1.0,1/15,1.99%,HVCN1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3425410013497885,-0.9020459412095637,0.5335120643431636,0.8795670752951655,1.0,2/13,2.73%,SOX13;HNRNPU
prerank,intestinal absorption (GO:0050892),0.42340841767148735,0.9020008666721749,0.5905631659056316,0.8605723496264194,1.0,2/13,5.55%,UGCG;CD36
prerank,cellular response to fluid shear stress (GO:0071498),-0.3523063566212576,-0.9015793023913566,0.563076923076923,0.8791620545982523,1.0,7/12,24.49%,KLF2;SREBF2;KLF4;HDAC3;MAP2K5;MEF2C;MAPK7
prerank,plasma membrane repair (GO:0001778),-0.342893768911911,-0.9015623163468004,0.5925925925925926,0.8776951539988725,1.0,3/13,8.42%,MYOF;DYSF;SYT7
prerank,regulation of phospholipase C activity (GO:1900274),0.4011860609659142,0.9011024757904441,0.5934718100890207,0.8618157390233421,1.0,5/15,12.55%,PDGFRA;PDGFRB;FGFR1;FGF2;NTRK3
prerank,regulation of protein transport (GO:0051223),0.36915875971839224,0.9010715303149213,0.5870712401055409,0.8614483521059887,1.0,8/27,18.88%,DNAJC1;LLGL1;PTPN1;LCP1;TNF;NDEL1;SCFD1;GAPVD1
prerank,regulation of neuron apoptotic process (GO:0043523),0.30708345523652314,0.9009887522475928,0.6712765957446809,0.8611954603652467,1.0,13/96,12.29%,EPHA7;TREM2;APOE;MDK;BCL2;NF1;PTPRZ1;TGFB3;FOXO3;CCL2;TGFB2;UNC5B;TNF
prerank,myeloid dendritic cell activation (GO:0001773),0.41360842276009646,0.9009338144190613,0.5912636505460218,0.8608808512623224,1.0,1/12,3.15%,BATF
prerank,embryonic appendage morphogenesis (GO:0035113),0.4298541721287852,0.9009057208511271,0.5927601809954751,0.8605213253838615,1.0,4/12,17.74%,SHH;LRP6;TGFB2;FBXW4
prerank,mitochondrion disassembly (GO:0061726),0.3455020273976512,0.9002936773309599,0.5997442455242967,0.8612650670875419,1.0,12/34,23.32%,WIPI1;AMBRA1;CTSK;ATG3;FBXO7;ATG7;WDR45;SQSTM1;FUNDC2;BECN1;MARK2;ATG2B
prerank,tRNA aminoacylation (GO:0043039),0.3494494460036645,0.9002376871850204,0.5925925925925926,0.8609503870378498,1.0,10/37,16.17%,PPA1;YARS1;AIMP1;EEF1E1;IARS2;TARS1;RARS2;RARS1;GARS1;LARS2
prerank,smooth muscle contraction (GO:0006939),0.40698227623460903,0.9000059992143983,0.5894736842105263,0.8609810468103153,1.0,6/14,22.93%,EDNRA;MYLK;TPCN2;SMTN;ROCK2;ROCK1
prerank,protein destabilization (GO:0031648),0.3499184565085225,0.8999952178004259,0.5992414664981036,0.8605897854995388,1.0,13/32,24.10%,SERF1A;TRIM21;CREBBP;PLK1;RAD23A;FBXW11;MDM2;PRNP;IRGM;SERF2;NR1D1;CDC73;CTSH
prerank,regulation of cellular pH (GO:0030641),0.3588025663528281,0.8999842043802692,0.5949535192563081,0.8601969383343384,1.0,5/29,10.22%,SLC9A1;LACC1;TM9SF4;SLC9A8;SLC4A7
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.260568556861439,-0.899895013170694,0.6367924528301887,0.8800792258318855,1.0,7/36,8.96%,KIF13A;RILPL1;GGA1;VAMP4;PREPL;NSF;ANK3
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.38054752387427637,0.8998090423199959,0.6033519553072626,0.8600916672502695,1.0,5/22,8.49%,TNKS1BP1;RAP2A;TOM1L1;RASSF2;GPNMB
prerank,organonitrogen compound catabolic process (GO:1901565),0.33024422463133096,0.8997116958359754,0.6369942196531792,0.8598650102895068,1.0,11/57,15.09%,LIPC;ANPEP;CPQ;NPEPPS;PLA2G7;ENPEP;CLN6;LVRN;AMDHD2;PLA2G4A;SGPL1
prerank,regulation of glycolytic process (GO:0006110),-0.22391251718130983,-0.8993636681324516,0.6581196581196581,0.8798480483653796,1.0,12/68,11.30%,PRKAG2;PRKAA2;HDAC4;INSR;NUP133;CBFA2T3;IGF1;SEH1L;POM121;APP;GIT1;EP300
prerank,regulation of protein dephosphorylation (GO:0035304),0.3468253455585454,0.8992088068090921,0.6344221105527639,0.8604268771516888,1.0,13/37,20.54%,DLC1;PPP2R5A;PPP1R2;SPPL3;PPP1R16A;CALM2;PTPA;ANKLE2;MFHAS1;HSP90B1;PIN1;PPP6R2;PRKCD
prerank,cilium assembly (GO:0060271),0.29552239235861105,0.8989372321816163,0.7376387487386479,0.8604953831088495,1.0,64/296,17.61%,TEKT4;DYNLL1;CEP19;ASAP1;STK36;DYNC1H1;PARVA;IFT57;TUBG1;ALMS1;IFT88;PLK1;PCM1;HAUS3;RAB8B;CEP41;EXOC4;DYNC2LI1;CNTRL;DCTN3;EHD2;ACTR2;GBF1;TRIP11;FAM161A;EXOC1;EXOC7;WDPCP;PCNT;WDR35;DISC1;PTPN23;ARF4;GALNT11;NPHP3;TNPO1;IFT172;IFT81;CEP72;PDE6D;SNX10;CFAP410;CPLANE1;ACTR1A;RAB1A;DYNC2H1;DZIP1L;AKAP9;KIF27;CDC14A;TTC39C;EXOC5;TOGARAM1;CEP192;EXOC3;NUDCD3;POC1B;WDR90;CSNK1D;SPATA6;YWHAE;ATP6V1D;CKAP5;CFAP74
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3735762633854427,0.8986100780508998,0.6097560975609756,0.8606836683319777,1.0,5/25,13.14%,LACC1;XCL1;WNT5A;TRAF2;SPHK2
prerank,macroautophagy (GO:0016236),0.30049980853078945,0.8983780416194164,0.6627534685165422,0.8607114047913639,1.0,29/118,18.27%,DYNLL1;WIPI1;CHMP4A;CHMP4B;AMBRA1;ILRUN;PIP4K2A;STX17;VPS4A;LAMP2;ATG3;VPS39;TOMM7;CSNK2A1;CSNK2A2;VPS37C;NBR1;ATG7;ATG16L1;SRC;CHMP2B;PIK3R4;PRKAB1;SQSTM1;RUBCNL;PIK3C3;MTMR3;LIX1L;TOMM22
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.37757920471457146,0.8980251839351188,0.6082191780821918,0.8609580499882395,1.0,1/23,0.48%,ADIPOQ
prerank,negative regulation of cell division (GO:0051782),0.43231949730671815,0.8979455643995069,0.5705229793977813,0.860683759757696,1.0,2/11,6.82%,VPS4A;E2F8
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3376705914984797,0.8977191028460343,0.6273809523809524,0.860711456417367,1.0,23/47,29.52%,ATXN2;APOE;FOXO3;SSH1;NOLC1;AKT1;INHBA;AGT;NFKBIA;RBM4B;EIF4G1;VPS35;CSF1;PCIF1;METAP1;EIF2A;NR1H3;PUM3;CYFIP1;WDR91;GEMIN5;NFKB1;EIF4E
prerank,sarcomere organization (GO:0045214),0.3683797825190982,0.8973366398267602,0.6034255599472991,0.8610221635243388,1.0,2/27,4.03%,CSRP1;FHOD3
prerank,cardiac muscle tissue development (GO:0048738),0.330842121180867,0.8968848069727801,0.6372093023255814,0.8614506123505832,1.0,11/50,15.19%,TBX18;GATA6;TBX2;ADAMTS9;SMAD5;BMP5;MAML1;AKAP13;BMP7;SMAD4;SMAD1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.4052523168833794,0.8965778539463598,0.5794947994056464,0.861606611162613,1.0,2/15,3.52%,TEC;EGFR
prerank,T cell mediated immunity (GO:0002456),0.41421925792866354,0.8955350789369367,0.5844961240310077,0.8632009605298872,1.0,2/13,5.33%,JAG1;GNL1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.34953448907750123,-0.8954396940233516,0.598314606741573,0.8875791772195222,1.0,2/11,8.04%,MAVS;CAMK4
prerank,protein acetylation (GO:0006473),0.3604478094718395,0.8953850237214678,0.6070528967254408,0.8630759143887621,1.0,8/30,18.30%,NAA50;CREBBP;NAT9;NAT10;NAA15;CLOCK;ING5;AANAT
prerank,cellular response to glucose stimulus (GO:0071333),0.35732558403554904,0.8953740189903258,0.6168582375478927,0.8626924794920483,1.0,1/30,0.13%,SLC39A14
prerank,negative regulation of insulin secretion (GO:0046676),0.39611283129439834,0.8952260728540605,0.5997109826589595,0.862570227578243,1.0,3/17,6.47%,IRS1;SFRP1;INHBB
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.37210382993570984,0.8952108827312336,0.606951871657754,0.8621883711100035,1.0,2/24,2.62%,ENPP1;IRS1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.40211102303394375,0.8949753557778155,0.6062767475035663,0.8622409986648486,1.0,4/16,18.30%,NAA50;CREBBP;NAA15;AANAT
prerank,regulation of JNK cascade (GO:0046328),0.3059216343570767,0.8948151760925861,0.6648590021691974,0.8621205935503773,1.0,29/101,23.06%,SH3RF3;MAP4K4;TAOK1;EGFR;UNC5CL;AIDA;RAP2A;TAOK3;RASSF2;TIRAP;SH3RF1;EDA2R;PJA2;TRAF2;DACT1;RIPK1;ITCH;TRAF5;MAPK8IP1;MFHAS1;GADD45A;DUSP15;WNT16;SIRPA;AXIN1;SDCBP;MAPK8IP3;NCOR1;MAPK8IP2
prerank,selective autophagy (GO:0061912),0.3294388076946698,0.8944363859280752,0.6438848920863309,0.862429639845851,1.0,11/56,13.32%,DYNLL1;DYNC1H1;AMBRA1;ATM;IFT88;RAB7A;PCNT;WDFY3;UBA5;NBR1;DDRGK1
prerank,positive regulation of chromatin organization (GO:1905269),-0.3522251761457042,-0.8943434645755608,0.5922865013774105,0.8886573226253528,1.0,4/12,16.59%,UBE2N;SIN3A;H3-3A;TAL1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.27267334652825825,-0.8941846248863888,0.6271929824561403,0.8875192775528203,1.0,6/30,7.73%,CAV1;INPP5F;PRKCZ;SRCIN1;PPP2R1A;PIBF1
prerank,long-term memory (GO:0007616),-0.30588423930559433,-0.8934863234673328,0.6029411764705882,0.8876263498584634,1.0,5/19,9.15%,CPEB3;LDLR;RASGRF1;CAMK4;SHANK1
prerank,regulation of lipid kinase activity (GO:0043550),-0.3583452782392955,-0.8934459506583181,0.5811965811965812,0.8862143202298205,1.0,2/11,3.11%,PIK3R3;RB1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2666943654561553,-0.8933925704894118,0.6329113924050633,0.8848509468252059,1.0,13/31,21.48%,ATXN3;STAMBP;USP8;USP7;CYLD;SPATA2;OTUD1;BABAM1;OTUD7A;YOD1;OTUD4;USP50;USP16
prerank,positive regulation of protein sumoylation (GO:0033235),-0.37415695990287906,-0.8930942150831603,0.6153846153846154,0.884079140082749,1.0,4/10,14.45%,HDAC4;PIAS3;UBA2;PIAS4
prerank,mitochondrial translational termination (GO:0070126),-0.2082173109025876,-0.8930704764645463,0.7411764705882353,0.8826473537348103,1.0,41/88,31.25%,MRPS9;MRPS35;MRPS28;MRPS15;MRPS24;MRPL13;MRPL10;MRPL21;MRPL39;ERAL1;MTRF1;PTCD3;MRPL4;MRPS7;MRPS31;MRPL28;MRPL30;MRPS18C;MRPL22;MRPL40;GADD45GIP1;MRPL46;MRPS16;MRPS18B;MRPL58;MRPS22;MRPS6;MRPS25;MRPS12;MRPS34;MRPL44;MRPL18;MRPL20;MRPL35;MRPL23;MRPL42;MRPL43;MRPL54;MRPL34;MRPL2;MRPS10
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.292416119439855,0.8925135273073229,0.7560240963855421,0.8655661071044305,1.0,67/314,20.35%,PSMA7;SPSB1;KLHL22;FBXL7;MAD2L1;CUL1;SMURF2;APPBP2;PLK1;ANAPC11;SIAH2;CDC27;BAG6;SKP1;SPOP;TRIM13;FBXL18;FBXW7;AREL1;PSMB8;RAD23A;PSMA6;TBL1X;RAD23B;DCAF11;UBE2J1;NFE2L2;KCTD10;FBXW11;DCAF12;ZSWIM8;PSMF1;UBE2K;MAEA;UBE2W;FBXO2;RHBDD2;HSPA5;PSMA8;SMURF1;ITCH;NEDD4;FBXL19;PSMD2;PSMD12;PSMD11;RBCK1;CLOCK;PCNP;PSMD14;KCTD2;FAM8A1;DDB1;MDM2;PSMB1;FBXW4;FBXO5;FBXO31;HSP90B1;LTN1;AMN1;UBR1;FBXO38;FBXL22;UBXN2A;PSMC6;UBE2E1
prerank,regulation of lamellipodium organization (GO:1902743),0.4065016129911516,0.8923914670396245,0.6002906976744186,0.8653768498789782,1.0,4/14,14.73%,CARMIL1;CDC42;PDPN;RAC1
prerank,blood vessel endothelial cell migration (GO:0043534),0.37394985395402064,0.8922036904696818,0.6089309878213802,0.8653187179184658,1.0,4/22,7.08%,EGR3;NRP1;MYH9;MIA3
prerank,prostaglandin biosynthetic process (GO:0001516),0.3928363455031978,0.8917705157885709,0.6124818577648766,0.8657449100629816,1.0,4/18,14.60%,PTGES;PTGES2;TBXAS1;PLA2G4A
prerank,regulation of exit from mitosis (GO:0007096),0.34327933379809716,0.8916688159057758,0.6219211822660099,0.8655267658389992,1.0,4/38,6.55%,PPP1R9B;MAD2L1;ANAPC11;CDC27
prerank,metal ion export (GO:0070839),0.3499782276408228,0.891615501007306,0.6237113402061856,0.8652192339555597,1.0,3/31,4.90%,KCNT2;SLC9A1;KCNA5
prerank,NAD biosynthetic process (GO:0009435),-0.2991488648738091,-0.8916068491920774,0.6073825503355704,0.8845541834282464,1.0,9/20,28.02%,NAMPT;NMNAT3;PARP16;NUDT12;NNMT;PARP10;NAXE;NAPRT;KYNU
prerank,actin filament capping (GO:0051693),0.39097414660550917,0.8914806026863146,0.5879828326180258,0.864643266872067,1.0,7/18,19.06%,SVIL;ADD2;VILL;ADD3;CAPZA1;EPS8;CAPG
prerank,barbed-end actin filament capping (GO:0051016),0.39097414660550917,0.8914806026863146,0.5879828326180258,0.864643266872067,1.0,7/18,19.06%,SVIL;ADD2;VILL;ADD3;CAPZA1;EPS8;CAPG
prerank,cellular response to starvation (GO:0009267),0.2967346745146003,0.8912100127868597,0.6983471074380165,0.8647321799661157,1.0,45/147,21.25%,DAP;LRRK2;WIPI1;NUAK1;MIOS;SFRP1;NPRL2;EIF2AK2;INHBB;LAMP2;ASNS;RPTOR;RRAGC;FADS1;FOXO3;KPTN;FNIP1;KLF10;ATP6V1F;ATG7;ATP6V1H;ATP6V1G2;STK24;CPEB4;HSPA5;PIK3R4;WDR45;PIK3C3;LAMTOR5;ATP6V1G1;SREBF1;SEC13;SH3GLB1;MAPK1;ATP6V1D;MTMR3;EIF2AK3;ATF4;LAMTOR3;TBL2;ZFYVE1;PDK4;ZC3H12A;BECN1;CLEC16A
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3403873571956064,0.8906922083562334,0.6196319018404908,0.8652816680488195,1.0,4/40,7.40%,LRRK2;STOML2;BCL2;PID1
prerank,positive regulation of cyclase activity (GO:0031281),0.412802214306387,0.8906787734438605,0.601526717557252,0.8649005740814191,1.0,2/14,5.10%,CACNA1C;NF1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.2647765066580477,-0.8906535062467122,0.6585365853658537,0.8853955780895811,1.0,11/32,13.78%,HDAC7;HDAC9;KLF4;KDR;MEOX2;CARD10;GATA2;JCAD;FGFBP1;FOXC2;THBS1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.37097089466272914,0.8905751114259689,0.6021505376344086,0.8647072136595414,1.0,7/23,15.67%,EGF;ARNT;PFKFB4;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.36905082958574953,-0.8905392131818506,0.6291208791208791,0.8842175389297864,1.0,3/10,7.73%,INPP5F;PPP2R1A;PIBF1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.35306498702086286,0.8904239489080421,0.6166666666666667,0.8645705109776959,1.0,3/31,9.03%,PDGFRA;HOXB3;TGFBR1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4128785592814409,0.8899634187862133,0.5899390243902439,0.8649714033610177,1.0,2/13,13.14%,GAB2;SPHK2
prerank,regulation of epithelial cell migration (GO:0010632),0.33168299395661927,0.8896050176360538,0.6390887290167866,0.8652084389253427,1.0,10/51,15.67%,PTN;RHOJ;DOCK1;SASH1;PTPN23;PTK2;BMPER;TGFB2;SRC;HIF1A
prerank,positive regulation of transport (GO:0051050),0.31014700671220996,0.8890855346643329,0.6662983425414365,0.8657561472026428,1.0,13/85,15.08%,KMT2A;LRP1;TREM2;APOE;DYNC1H1;MERTK;ANXA1;CALR;TNF;GSK3B;KCTD7;FMR1;DOC2B
prerank,release of cytochrome c from mitochondria (GO:0001836),0.38976348497218294,0.8888670393260939,0.6002886002886003,0.8657256817278968,1.0,6/17,22.86%,BBC3;BCL2;GGCT;TIMM50;CLU;FZD9
prerank,microtubule-based transport (GO:0099111),0.4123108937512629,0.888121392377694,0.5939849624060151,0.8667349233315492,1.0,2/12,6.77%,DNAAF4;SPEF2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3075654807724393,0.888023043547575,0.658454647256439,0.86650427411613,1.0,11/80,9.70%,LRRK2;MYCBP2;BIRC3;ARRDC4;PLK1;PRICKLE1;ARRDC3;ANGPT1;DCUN1D1;FBXW7;UBE2L3
prerank,phospholipid transport (GO:0015914),0.32606869153537316,0.8877653184257897,0.6376470588235295,0.8665673143511374,1.0,5/52,4.34%,ABCA1;ATP8B1;APOE;PLTP;ABCG1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.36201594060816056,-0.8877461523016524,0.5549295774647888,0.8891654859686843,1.0,7/11,28.08%,UQCRC2;UQCRB;UQCRH;UQCRFS1;UQCC3;UQCR10;UQCR11
prerank,modulation of chemical synaptic transmission (GO:0050804),0.30466590395101006,0.8874352911117962,0.6680805938494168,0.8667808093405686,1.0,12/107,9.38%,CEL;ADIPOQ;CACNA1A;LRRK2;NPAS4;PTEN;OPHN1;DLGAP3;DLG4;PXK;KCNMB4;HCRT
prerank,negative regulation of DNA replication (GO:0008156),0.40793982518827476,0.887327510834462,0.6255924170616114,0.8665922805165569,1.0,5/13,23.36%,PDS5A;ATR;WAPL;TERF1;CDC6
prerank,positive regulation of organelle organization (GO:0010638),0.34618399903941,0.8872797958635171,0.6007702182284981,0.8662698908047113,1.0,9/32,15.08%,TREM2;ANXA1;RAB3GAP2;LMAN1;GSK3B;P2RX7;SMCR8;RAB3GAP1;DOC2B
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3848765470588332,0.887270754412872,0.6111111111111112,0.8658829773945739,1.0,5/18,14.28%,LRRK2;DTNBP1;GSK3B;RAB3GAP1;FMR1
prerank,Rap protein signal transduction (GO:0032486),-0.3664417892503734,-0.8871015665707807,0.6168478260869565,0.8891349446833592,1.0,3/10,11.64%,RAPGEF3;RAPGEF2;RAP1A
prerank,histone H4 deacetylation (GO:0070933),-0.36853883417409034,-0.8867891751997167,0.6033057851239669,0.8884175971997551,1.0,3/10,5.95%,HDAC4;HDAC9;SMARCAD1
prerank,regulation of protein kinase C signaling (GO:0090036),0.4096517652666434,0.8866039380635871,0.6086956521739131,0.8666651597570395,1.0,4/14,13.14%,CD40;WNT5A;MC1R;SPHK2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.35305333536720473,-0.8865427470920074,0.5971014492753624,0.8875280978022628,1.0,4/12,15.94%,RAB27A;SLC5A3;TLR4;ZNF205
prerank,N-glycan processing (GO:0006491),0.37568169376044036,0.8861977278795031,0.6186556927297668,0.8669750165132901,1.0,7/18,19.81%,PRKCSH;MAN2A1;MAN1C1;MGAT4A;GNPTAB;GANAB;MAN2A2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.32947902649799254,0.8859145695627242,0.6486486486486487,0.8671196269850491,1.0,17/52,19.96%,BBC3;E2F1;BCL2;NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;YWHAZ;CASP8;MICALL2;SH3GLB1;YWHAE;LEPROT;USP36;ARIH2;UBL5
prerank,chemical homeostasis (GO:0048878),0.3199411957304671,0.8855799862744259,0.6411149825783972,0.8673115521844229,1.0,11/61,14.14%,TREM2;USF1;TLCD2;PPARG;ADCK1;ACOX1;FBXW7;SLC4A7;ZBTB20;ACOX3;ABHD8
prerank,leukotriene metabolic process (GO:0006691),0.3899887975286797,0.8855799005278735,0.6334269662921348,0.8669049363606139,1.0,3/19,14.60%,DPEP2;ABCC1;PLA2G4A
prerank,myoblast differentiation (GO:0045445),0.4122111695455962,0.8848173745277119,0.6136701337295691,0.867871078884478,1.0,4/14,8.05%,TCF7L2;JAG1;DDX17;SDC1
prerank,negative regulation of locomotion (GO:0040013),0.41502089270325543,0.8846342015918147,0.6188271604938271,0.867804883079902,1.0,1/12,1.00%,FBLN1
prerank,establishment of melanosome localization (GO:0032401),0.38660861484334325,0.8845668965392947,0.6357142857142857,0.8675162936024914,1.0,3/19,9.93%,MLPH;MYO5A;RAB27B
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.37077813319972985,0.8844024658014905,0.6288384512683578,0.8674264170007123,1.0,6/21,21.63%,FZD1;LRP6;GSK3B;CSNK1A1;DVL2;AXIN1
prerank,protein localization to cell surface (GO:0034394),-0.28555439945712635,-0.8843072941271898,0.6625,0.8912381459683251,1.0,12/26,26.61%,ANK2;FBLN5;GGA1;VCL;PTPRK;FGF10;WNT11;PIGU;UNC50;RIC3;PRRT1;PTPRU
prerank,transcription by RNA polymerase III (GO:0006383),0.36071783629300697,0.884161049579834,0.6016260162601627,0.8674470313252103,1.0,11/27,21.36%,SNAPC3;CRCP;GTF3A;BRF1;GTF3C4;ICE1;POLR2L;POLR2K;POLR3GL;POLR3K;SNAPC5
prerank,fibrinolysis (GO:0042730),0.40427647127930416,0.8835456782192197,0.6180451127819548,0.8681249805007168,1.0,1/13,6.23%,PLAT
prerank,gonad development (GO:0008406),0.3365167972010628,0.8833459345473549,0.6275,0.8680941560874343,1.0,10/41,21.01%,GATA6;NR2F2;WNT5A;SALL1;TGFB2;ADAM21;TFAP2C;INHBA;NUP107;CSDE1
prerank,modulation by host of symbiont process (GO:0051851),-0.2656825618709379,-0.8830508545746861,0.6761904761904762,0.8925482924785766,1.0,7/31,11.77%,LEF1;SAP30BP;JUN;INPP5K;CHD1;EP300;SP1
prerank,regulated exocytosis (GO:0045055),0.29399768730251147,0.882499234942114,0.7349027635619243,0.869241292500223,1.0,16/173,6.60%,KNG1;SERPING1;SPARC;LHFPL2;TIMP1;PROS1;STEAP2;BLK;MYH9;CD36;APOH;EGF;BRPF3;TGFB3;STXBP1;LAMP2
prerank,nuclear body organization (GO:0030575),0.4212293738409893,0.8824984849613757,0.6259541984732825,0.8688364383588226,1.0,4/12,22.31%,AFF2;USPL1;ETS1;HABP4
prerank,mitotic chromosome condensation (GO:0007076),0.36272764459756046,0.8823466521081595,0.6420079260237781,0.8686880233044068,1.0,9/26,21.09%,KMT5A;PLK1;CSNK2A1;CSNK2A2;NCAPD2;NCAPG2;NCAPG;TENT4A;SMC4
prerank,negative regulation of JNK cascade (GO:0046329),-0.2642419866474806,-0.8819731548642175,0.6781115879828327,0.8935759402412315,1.0,12/31,24.77%,MECOM;PRKN;PER1;SH3RF2;DUSP10;PINK1;CYLD;GPS2;HDAC3;ZMYND11;DUSP19;MEN1
prerank,sodium-independent organic anion transport (GO:0043252),-0.3726115690767472,-0.8815985621990597,0.6138888888888889,0.8930106199730696,1.0,3/10,8.27%,SLCO1C1;SLCO3A1;SLCO2A1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.280337093305598,-0.881285765831799,0.6254826254826255,0.892266404314445,1.0,5/24,11.39%,LPGAT1;SERAC1;ABCA3;SLC27A1;CDS2
prerank,cell junction maintenance (GO:0034331),0.39856927819886756,0.8807212190814241,0.6087591240875913,0.8711840021891644,1.0,1/14,2.72%,PRTN3
prerank,protein lipidation (GO:0006497),0.3218371888759023,0.8799479750461234,0.6485549132947976,0.8721570106010971,1.0,15/59,16.83%,WIPI1;UGCG;PIGW;PIGN;PIGL;PIGC;ATG7;HHAT;PIGP;ZDHHC6;ZDHHC9;WDR45;PIGH;PIK3C3;ZDHHC3
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.3428410418798627,-0.8794294035471796,0.6097560975609756,0.8950160399055338,1.0,4/11,22.05%,GPER1;DHX36;MYOCD;MEF2C
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3391610370166647,0.879279117488117,0.652744630071599,0.8729419773936133,1.0,14/42,22.61%,MBD2;SMARCC1;INO80;HDAC1;ARID1B;MTA2;GATAD2B;SPTY2D1;SRCAP;SMARCA4;MBD3;HNRNPC;ACTL6B;CHD8
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.32350211512156346,0.879202895721481,0.6600234466588512,0.8726624687112442,1.0,14/52,18.75%,LRP1;NKD2;EGFR;TREM2;ITGA3;PTPN9;TNF;KIF5B;PIK3R1;STAC3;SQSTM1;AKT1;CLIP3;SPTBN1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.23183209240492436,-0.8789623827159923,0.7183098591549296,0.894602292246018,1.0,8/57,6.50%,CHRM2;ADCY5;GRM7;ADCY9;GRM8;AKAP12;ADCY1;HTR1F
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.37421977521603383,0.8780159650125849,0.6327608982826949,0.8739582267543272,1.0,5/23,11.58%,BBC3;E2F1;BCL2;YWHAZ;CASP8
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.37421977521603383,0.8780159650125849,0.6327608982826949,0.8739582267543272,1.0,5/23,11.58%,BBC3;E2F1;BCL2;YWHAZ;CASP8
prerank,leukocyte tethering or rolling (GO:0050901),0.3772437486847293,0.8779289961751929,0.6228323699421965,0.8737009737625487,1.0,3/17,12.29%,SPN;ADD2;TNF
prerank,cellular response to interleukin-4 (GO:0071353),0.426048984236296,0.8777759452438327,0.6393700787401575,0.873585053716674,1.0,2/10,10.26%,XCL1;TCF7
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3546645639543663,0.877628508256656,0.6308900523560209,0.873029369958807,1.0,5/29,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,CENP-A containing chromatin organization (GO:0061641),0.3546645639543663,0.877628508256656,0.6308900523560209,0.873029369958807,1.0,5/29,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,protein localization to cilium (GO:0061512),-0.26065957247479693,-0.8770056480574924,0.6553398058252428,0.8974869615121673,1.0,12/32,25.15%,BBS9;INVS;TTC21B;ARL3;TCTN1;TCTN2;BBS4;TULP2;NPHP4;ARL6;IFT122;TULP1
prerank,regulation of neutrophil migration (GO:1902622),-0.3619242853319206,-0.8769333464042018,0.5978260869565217,0.8962107058109897,1.0,4/10,21.32%,RHOG;MPP1;RHOH;NCKAP1L
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3548781834058141,0.8768044142610565,0.6350461133069829,0.8740928108588505,1.0,9/27,17.14%,MARK1;TREM2;PTEN;DISC1;FBXO7;GSK3B;PSEN1;NDEL1;AKT1
prerank,positive regulation of neurogenesis (GO:0050769),0.3128748416833349,0.8767217449518196,0.6554809843400448,0.8738119090408676,1.0,22/68,22.89%,ROBO2;NUMBL;PLXNC1;PLXND1;SERPINF1;CAPRIN1;PLXNA3;DISC1;RHOA;NUMB;CX3CL1;ARHGDIA;OBSL1;PLXNB2;SPEN;KDM1A;NAP1L1;TIAM2;NPTN;SMARCD3;FZD3;PLXNB1
prerank,regulation of cell development (GO:0060284),0.34173972297175953,0.8761009412937097,0.6132315521628499,0.8745427014588733,1.0,7/36,17.14%,YAP1;BHLHE40;HEYL;HMGB2;CX3CL1;CLOCK;AKT1
prerank,skeletal muscle contraction (GO:0003009),0.37345039477014774,0.8754678615989678,0.6129032258064516,0.8752751849845356,1.0,3/19,14.95%,CCDC78;TNNC1;STAC3
prerank,clathrin-dependent endocytosis (GO:0072583),0.35734663492855034,0.8752368771029664,0.6248313090418354,0.8752635598729392,1.0,6/26,10.49%,CLTC;ITSN1;DNAJC6;CANX;GPR107;GAK
prerank,receptor internalization (GO:0031623),0.3366208623685675,0.8751889812610478,0.6626065773447016,0.8749428787822346,1.0,7/44,11.87%,CLTC;LRP1;ADM;CD36;GRB2;DRD3;CALCRL
prerank,protein mannosylation (GO:0035268),-0.28907283920143345,-0.8750044015188686,0.6458333333333334,0.8992200790706538,1.0,1/22,0.12%,TMTC1
prerank,protein autoubiquitination (GO:0051865),0.31544207724560186,0.8747462414320895,0.6770472895040369,0.8753193469210374,1.0,13/61,15.59%,SH3RF3;TRIM21;CNOT4;TRIM13;SH3RF1;RNF213;RNF19B;RNF181;TRAF2;RNF11;DTX3L;RNF141;ITCH
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3667947272033848,0.8747188959956615,0.6387362637362637,0.8749663091339995,1.0,14/24,30.92%,PHF1;DNMT3B;SPI1;PPHLN1;TASOR;TRIM27;SUZ12;PPM1D;MPHOSPH8;RBBP7;DNMT3A;EZH2;BMI1;JARID2
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.30946231203013774,-0.8743763720247891,0.6513761467889908,0.8991753257191828,1.0,5/17,10.72%,CLDN5;CDH5;ADD1;VCL;ZDHHC21
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.33309791251256265,-0.8739934197087877,0.6019417475728155,0.8985719092395871,1.0,2/12,1.54%,CAV1;CTNNA3
prerank,positive regulation of cell aging (GO:0090343),0.42052543906007583,0.8738550151985676,0.6290076335877862,0.8761293738882048,1.0,4/11,20.05%,EEF1E1;YPEL3;CGAS;HMGA2
prerank,activation of protein kinase B activity (GO:0032148),-0.2621665883492148,-0.8736744558941721,0.6767241379310345,0.8977300553185581,1.0,5/29,4.70%,IL18;GAS6;INSR;FGF1;CCDC88A
prerank,amyloid fibril formation (GO:1990000),0.3239307320044053,0.8734183863791248,0.6415094339622641,0.8764546940171081,1.0,6/51,6.45%,HSPG2;IAPP;USP9X;SERF1A;CD36;SIAH2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3768685662886782,0.873238226664852,0.6262341325811002,0.8763641693431871,1.0,1/19,2.62%,IRS1
prerank,protein localization to Golgi apparatus (GO:0034067),0.3528444496466901,0.8723604933143259,0.6335078534031413,0.8775127050278595,1.0,16/27,28.61%,VPS13C;GBF1;GAK;COG7;OBSL1;CSNK1D;RAB33B;ARL5A;SYS1;IFT20;ARL5C;ARFRP1;RAB6A;TMED10;OPTN;RIPOR1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.22725973512298997,-0.8721363793395138,0.7364341085271318,0.8998117697289105,1.0,20/62,22.43%,MLLT3;ELOC;CTR9;NELFB;ERCC3;LEO1;EAF2;POLR2A;POLR2H;NELFA;SSRP1;POLR2G;POLR2F;GTF2H2;SUPT4H1;POLR2E;ELOB;CCNK;GTF2H4;NELFE
prerank,striated muscle cell development (GO:0055002),-0.32016355882225633,-0.8720209322418089,0.637223974763407,0.8985848329857051,1.0,2/14,3.95%,PGM5;TMOD3
prerank,protein targeting (GO:0006605),0.2922260888825145,0.8716784536596495,0.7286166842661035,0.8782719108333827,1.0,26/118,19.53%,LTBP2;AP4M1;TRAK1;KIF13B;LAMP2;ATG3;TOMM7;SEC63;CDC37;VPS37C;FBXO7;PEX19;TIMM17A;GIPC1;SEC61A1;RPL11;ZDHHC6;ZDHHC9;RTP4;SRP14;ZDHHC3;PEX6;TOMM22;PEX12;HACL1;TIMM23
prerank,positive regulation of chromosome organization (GO:2001252),-0.32066116687310864,-0.8712770874877782,0.6226993865030674,0.8988574335057364,1.0,4/15,8.31%,RAD21;MRE11;PPP1R10;RTEL1
prerank,anion transmembrane transport (GO:0098656),0.30769888434742626,0.8710208409856794,0.664071190211346,0.8790294728303082,1.0,2/67,0.63%,SLC7A2;SLC1A3
prerank,GTP metabolic process (GO:0046039),0.39849614143821255,0.8702986318843077,0.6396396396396397,0.8799013424442617,1.0,4/15,23.82%,LRRK2;ENTPD7;IMPDH2;IMPDH1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.4161911531519633,0.8697817839668561,0.613251155624037,0.880414356385072,1.0,1/12,4.98%,BCL2
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2709344910211218,-0.8695996683271069,0.6696428571428571,0.901027902399611,1.0,10/27,20.24%,PRKN;UBE2E3;UBE2A;CDC23;UBE2B;ANAPC1;ANAPC4;ANAPC5;ANAPC13;CDC26
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3496319080063277,0.8695869937526924,0.6293333333333333,0.8803330880633687,1.0,10/29,25.79%,SMAD2;PUM1;DICER1;SMAD3;SMAD1;TUT7;AGO2;SNIP1;AGO1;HNRNPA2B1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.31382353448802486,0.8694066043641685,0.6579841449603624,0.8802396567548277,1.0,13/57,20.09%,TAOK1;BABAM2;ATM;PLK1;TAOK3;MDC1;RINT1;EME2;PRKDC;RAD9A;FBXO31;HMGA2;CDC14B
prerank,neurotransmitter uptake (GO:0001504),0.4077629246367925,0.8689531247408863,0.6394984326018809,0.8806200747550244,1.0,1/12,0.63%,SLC1A3
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.21803454305218822,-0.868829513768666,0.7983870967741935,0.9012716948118804,1.0,21/70,23.11%,CHPT1;MBOAT1;CHKA;ENPP2;LPCAT2;LPIN1;ABHD3;ABCA3;SLC27A1;GPLD1;PCYT1B;GPAT4;PLA2G6;MFSD2A;CHKB;DBI;PCTP;PCYT1A;PLA2G4C;PLAAT3;TMEM86B
prerank,photoreceptor cell development (GO:0042461),0.39205449689853655,0.8685518378579011,0.6194563662374821,0.8809023298999329,1.0,2/14,7.53%,CDHR1;MYO7A
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3686316512258713,0.8684164015859903,0.6356275303643725,0.8803276851211533,1.0,3/20,10.94%,MGST1;AKR1A1;GSTK1
prerank,glutathione derivative metabolic process (GO:1901685),0.3686316512258713,0.8684164015859903,0.6356275303643725,0.8803276851211533,1.0,3/20,10.94%,MGST1;AKR1A1;GSTK1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3591168681047566,-0.8683913424835398,0.6129032258064516,0.9006851749179384,1.0,3/10,12.54%,CCT4;CCT5;DKC1
prerank,protein deacetylation (GO:0006476),0.32998188427828246,0.8683555727408186,0.6706875753920386,0.8800250270837965,1.0,12/41,19.11%,RCOR1;MIER2;PRDM5;HDAC1;TBL1X;MTA2;SIRT3;BAZ2A;MTA3;RCOR2;HDAC5;BRMS1L
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.27411274380313766,-0.8678348693345633,0.6765799256505576,0.9004234450080739,1.0,14/25,37.46%,TNFSF10;PINK1;BNIP3;DNM1L;GPER1;BID;TP53;PPIF;MFF;BIK;PDCD5;BMF;HRK;PMAIP1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3715463719392841,0.8666930283734819,0.6311360448807855,0.8825418000720098,1.0,4/19,15.31%,CHMP4B;PLK1;EML3;CHMP2B
prerank,response to interleukin-4 (GO:0070670),0.42602669895179124,0.8659424979859133,0.6510903426791277,0.8833822494068324,1.0,2/10,10.26%,XCL1;TCF7
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.37249388674832973,0.865499216300657,0.6416666666666667,0.8837445274688035,1.0,3/18,13.29%,NCK1;BAG6;PIK3R1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3362810575968104,0.8653049595989213,0.6393034825870647,0.8836780416148444,1.0,9/36,14.52%,OPHN1;BAG6;EIF3H;CCAR2;OGT;PSMF1;GIPC1;DDRGK1;RPL11
prerank,heart looping (GO:0001947),0.3292367822667988,0.8651998032759165,0.6575342465753424,0.8834560652440091,1.0,7/39,15.46%,TBX2;SHH;PKD2;TBX3;NPHP3;SETDB2;SMO
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.39338024994767745,0.8651573480606775,0.6186046511627907,0.8831251752086202,1.0,1/15,1.62%,ASMT
prerank,anterior/posterior pattern specification (GO:0009952),0.3171429509274766,0.8650340749709488,0.6565420560747663,0.8829340819215304,1.0,7/53,9.97%,SMAD2;HOXB3;ATP6AP2;BHLHE40;HEYL;TGFBR1;WLS
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.28270975002908016,-0.8650329212565262,0.6534296028880866,0.9050342192823541,1.0,3/24,2.77%,DMD;AKAP6;CALM1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3332399074360117,0.8644823192430262,0.6471321695760599,0.8834421837979684,1.0,8/38,14.54%,CENPQ;CENPN;RSF1;CENPL;RUVBL1;UBN1;ATRX;ASF1A
prerank,ncRNA metabolic process (GO:0034660),0.3274304854410501,0.864200048680466,0.6455696202531646,0.8835223694344265,1.0,8/37,19.61%,DDX17;DICER1;DTD1;ZCCHC8;TUT7;PARN;BCDIN3D;AGO2
prerank,positive regulation of metabolic process (GO:0009893),0.2966706649433475,0.8640134935662308,0.7175080558539205,0.8834510256684112,1.0,28/103,21.99%,ADIPOQ;PLAC8;CMKLR1;JAK2;DYNC1H1;CD36;ALMS1;OMA1;EHMT1;CXCR4;OGT;HCRT;TNF;ELOVL6;FABP5;GNAS;PRKAB1;DECR1;ACACA;FASN;KDM1A;IL4R;LCN2;THRA;GRB10;DIO2;FABP4;CNOT3
prerank,V(D)J recombination (GO:0033151),0.42440499698579165,0.8638269793875719,0.6656101426307448,0.8833694677961801,1.0,4/11,16.54%,LIG1;HMGB2;PRKDC;TCF3
prerank,aggrephagy (GO:0035973),0.3461497702055964,0.8637767013808184,0.6261558784676354,0.8830554037229531,1.0,5/27,10.21%,DYNLL1;DYNC1H1;IFT88;PCNT;WDFY3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.338991688902734,-0.8634003471636801,0.6392045454545454,0.9071327368744365,1.0,4/12,12.96%,CCT4;CCT5;DKC1;GNL3L
prerank,mononuclear cell differentiation (GO:1903131),0.35162361983206575,0.8633319340174297,0.6432291666666666,0.8833970366372961,1.0,4/24,5.97%,TREM2;BLK;MYH9;PPARG
prerank,regulation of protein catabolic process (GO:0042176),0.29488905787924663,0.8632879402168987,0.7062634989200864,0.883065515873893,1.0,24/99,17.55%,TNFAIP3;EGFR;IRAK3;MAD2L1;SMURF2;OAZ3;RAB7A;AREL1;WNT5A;CSNK2A1;ATG7;TNF;GSK3B;DACT1;CENATAC;AZIN2;CDKN1B;BANP;SMURF1;ITCH;NEDD4;CTSA;DDB1;MDM2
prerank,cardiac ventricle development (GO:0003231),-0.28516359638049,-0.8631183911154366,0.6594982078853047,0.9062980945356298,1.0,5/20,14.26%,MATR3;HECTD1;MDM4;PDE2A;HEY2
prerank,pseudouridine synthesis (GO:0001522),0.3947992375103163,0.8629251407262433,0.6248062015503876,0.8833032937093389,1.0,3/13,9.72%,PUS7L;TRUB2;PUS3
prerank,activation of GTPase activity (GO:0090630),0.3005918342910436,0.8626055502003492,0.6983606557377049,0.8834550779568453,1.0,18/89,14.96%,SYDE1;ARHGAP24;ARHGAP42;SIPA1L3;TAX1BP3;TBC1D16;EPHA1;TBC1D2B;RABGAP1L;ARHGEF19;TBC1D8B;RABGAP1;NTRK3;TBC1D1;ADPRH;ARHGAP22;TBC1D10B;SIPA1L2
prerank,clathrin coat assembly (GO:0048268),0.38878912880877803,0.8624305465303055,0.6482861400894188,0.8833639561165014,1.0,1/15,0.64%,CLTC
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.36179145768862264,0.8619619042627412,0.6171428571428571,0.8837642861442229,1.0,3/20,9.55%,PUM1;TERT;DICER1
prerank,mRNA methylation (GO:0080009),0.38843446309102314,0.8619335520445143,0.6336206896551724,0.8834063519080695,1.0,5/15,23.58%,ZC3H13;METTL16;TRMT61B;TRMT61A;PCIF1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.23321164371354214,-0.861148219970474,0.717948717948718,0.9092628050008721,1.0,18/45,27.82%,BMP4;DDX5;RIOK1;U2AF2;WDR43;POLR2A;DIMT1;ERN1;HNRNPLL;SIRT7;ZC3H18;SUPV3L1;UTP15;TP53;SLC38A2;ZPR1;HSPA1A;TRMT112
prerank,DNA replication initiation (GO:0006270),0.33011799533313946,0.861143434461796,0.6564039408866995,0.8843214163898627,1.0,6/37,13.99%,POLE3;MCM2;MCM7;DBF4;POLA2;LRWD1
prerank,mitochondrion morphogenesis (GO:0070584),-0.3483842813294854,-0.8609740228066458,0.648936170212766,0.9082183205915138,1.0,7/11,27.02%,WASF1;DNM1L;SUPV3L1;SLIRP;MYH14;NUBPL;MFF
prerank,nucleus organization (GO:0006997),0.31868920276326057,0.8609600803928834,0.6761565836298933,0.8842230893773633,1.0,11/47,18.15%,CHMP4A;CHMP4B;VPS4A;LEMD2;CHMP7;NDC1;CHMP2B;SUN1;NUP35;PITPNB;USP36
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35111055895085713,0.860859805762179,0.6589446589446589,0.8840300112496347,1.0,6/28,13.92%,UBR5;BAG3;ZIC1;PIK3R1;SMAD3;PSEN1
prerank,nuclear export (GO:0051168),-0.21035342903717527,-0.8604725604248967,0.7956989247311828,0.907853828080219,1.0,28/80,25.42%,RANBP3L;MALT1;CDC40;SRSF5;U2AF2;DESI1;STRADB;POM121;HNRNPA1;SRSF7;SRSF9;RBM8A;CHTOP;MAGOH;ZC3H11A;EIF4A3;SRSF3;CSE1L;POLDIP3;XPO5;PHAX;SARNP;XPO6;NUTF2;DDX39B;DDX39A;XPO4;THOC1
prerank,homocysteine metabolic process (GO:0050667),0.4102519687278775,0.8603952084212554,0.624420401854714,0.8844258752787457,1.0,1/11,3.82%,MTHFR
prerank,negative regulation of stress fiber assembly (GO:0051497),0.35620903559824807,0.8596683392376101,0.6482758620689655,0.8852737850811125,1.0,6/24,14.32%,DLC1;CGNL1;ARHGAP6;PIK3R1;ARHGEF18;PHLDB2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4197176499930853,0.8583849155465313,0.6302652106084243,0.887055966511065,1.0,1/11,4.98%,BCL2
prerank,retrograde axonal transport (GO:0008090),0.3848380397183214,0.8582921325456278,0.6389684813753582,0.8868252918489877,1.0,6/16,20.40%,DYNC1H1;KIF1C;FBXW11;KIF5B;KIF5A;DST
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3777122605032433,0.8580272120850121,0.6376404494382022,0.8868494800712377,1.0,4/17,12.48%,EGR3;NRP1;MIA3;FGF2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3328647932223188,0.8573424824215471,0.6536523929471033,0.8876437510654676,1.0,9/37,14.52%,BAG6;EIF3H;CCAR2;OGT;CSNK2A1;CSNK2A2;GIPC1;DDRGK1;RPL11
prerank,cellular component maintenance (GO:0043954),-0.3297952974788071,-0.8572208232837962,0.638728323699422,0.9134599884533007,1.0,2/12,3.58%,IGF1R;INSR
prerank,glycolytic process (GO:0006096),0.3461380250876376,0.8571794094661478,0.6462585034013606,0.8875215660492131,1.0,4/28,11.60%,HK2;ENO1;GAPDH;GCK
prerank,negative regulation of endocytosis (GO:0045806),-0.27539747444197155,-0.8570110731177151,0.688212927756654,0.9124802376728434,1.0,14/24,39.35%,CAV1;MCTP1;ABCA7;PACSIN3;PRKD1;RUBCN;SYT11;LRSAM1;NR1H2;SCAMP5;ARF6;LILRB1;UNC119;EPHA3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.36081744823836603,0.8568796383935343,0.6756756756756757,0.8876167414545624,1.0,5/24,16.09%,PDE3A;PRKAR1B;GNAI1;RASD2;CGAS
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.341137749129837,0.8568556680245181,0.6831432192648923,0.8872603968595302,1.0,13/33,21.92%,APOE;PPARG;RHOA;TNF;FGF2;PDCD10;ITGB1BP1;ACVRL1;ANGPT2;HDAC5;GADD45A;STARD13;RGCC
prerank,RNA interference (GO:0016246),0.36774006711211793,0.8563016580231749,0.6200873362445415,0.8878322875968431,1.0,3/17,9.55%,CELF1;TERT;DICER1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2431738638675184,-0.8561228355081526,0.7471910112359551,0.9129197665083778,1.0,10/46,16.74%,DGKB;DDHD1;GPD1L;DGKA;SLC27A1;AGPAT3;ACP6;DGKG;GPAT4;DGKQ
prerank,protein import into nucleus (GO:0006606),0.3057858088141018,0.8560447839322776,0.6896551724137931,0.8878716823118357,1.0,16/66,20.96%,CBLB;STAT3;PRICKLE1;FAM53B;KPNA3;NUP153;TNPO1;E2F3;NUP35;NUP188;SEC13;AKT1;HEATR3;NUP214;KPNA2;NUP107
prerank,response to X-ray (GO:0010165),0.38704639843141175,0.8559953757232918,0.6438953488372093,0.8875522341407583,1.0,5/14,17.25%,ATM;ANXA1;IKBIP;NIPBL;NUCKS1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.32602247885288094,-0.8559373454921366,0.6706948640483383,0.9118939397390031,1.0,2/13,1.76%,BMP6;BMP4
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.38862566210229743,0.8558782698842708,0.6332842415316642,0.8873504664500771,1.0,4/15,13.84%,ACVR1;ACVR1B;ACVR2A;DACT1
prerank,determination of heart left/right asymmetry (GO:0061371),0.31989499727229587,0.8556404952466108,0.6621787025703795,0.8873627697768213,1.0,7/42,15.46%,TBX2;SHH;PKD2;TBX3;NPHP3;SETDB2;SMO
prerank,calcium import into the mitochondrion (GO:0036444),0.42315277954625774,0.8548730143167995,0.6415094339622641,0.8882750198331625,1.0,4/10,18.80%,MICU2;MCUR1;MAIP1;MICU3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3096076499485481,0.8547978070081264,0.7003444316877153,0.8880168905790324,1.0,5/59,3.46%,PALLD;ROBO2;PCDHB6;SDK2;TENM3
prerank,positive regulation of translational initiation (GO:0045948),0.371742309420904,0.8547967465912982,0.6450704225352113,0.8876164413556605,1.0,7/18,23.21%,KHDRBS1;CCL5;RPS6KB1;YTHDF3;HABP4;YTHDF2;POLR2D
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3606734685621684,0.8545819782103629,0.6532593619972261,0.8875608165563555,1.0,5/22,15.60%,VPS4A;TOM1L1;VPS37C;PTPN23;NEDD4
prerank,microtubule polymerization or depolymerization (GO:0031109),0.35333820538965155,0.8545188089152527,0.6559571619812584,0.8872554230111876,1.0,7/24,19.95%,NCKAP5;KIF2A;FGF13;NCKAP5L;TPPP;CKAP5;PIN1
prerank,gastrulation (GO:0007369),0.3815891463872093,0.8543661102446446,0.6676602086438153,0.887091743648098,1.0,5/15,19.34%,SMAD2;NPHP3;UGDH;LRP5;TASOR
prerank,neutrophil activation (GO:0042119),0.4004045771380663,0.8537787943648213,0.6405325443786982,0.8877133730007662,1.0,3/12,11.07%,CCL5;PREX1;KMT2E
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.34766626773725745,0.8525615501746839,0.6513513513513514,0.8893806989133808,1.0,5/26,12.48%,XCL1;ITPR1;PKD2;IBTK;FGF2
prerank,regulation of transport (GO:0051049),-0.24719765491327578,-0.8525435085191878,0.7448979591836735,0.9176787080201584,1.0,4/36,2.95%,ICA1;PRKN;EPB41;ACTB
prerank,"base-excision repair, AP site formation (GO:0006285)",0.37593950366671,0.8522952959666183,0.6515580736543909,0.8894440284936856,1.0,1/17,1.20%,MPG
prerank,positive regulation of mRNA processing (GO:0050685),-0.2858175562258153,-0.8518990215871293,0.675,0.9175814322737048,1.0,8/21,25.95%,NCL;CIRBP;LEO1;DAZAP1;DHX36;NUP98;RBM3;SF3B4
prerank,neuron apoptotic process (GO:0051402),0.3722899961227213,0.8518295434377618,0.6351351351351351,0.8898379572024498,1.0,3/19,10.28%,TNFRSF21;BCL2;GAPDH
prerank,response to chemokine (GO:1990868),0.39393731124883025,0.8517163146481077,0.6235119047619048,0.8896330327252434,1.0,4/13,21.08%,CXCL12;RHOA;LRCH1;ZC3H12A
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3027318738925434,0.8512340128267387,0.7104377104377104,0.8900320358351204,1.0,15/72,14.83%,IAPP;TAOK1;NAV3;TREM2;APOE;LIMA1;EMILIN1;TPX2;SSH1;CAMSAP2;FGF13;SSH2;PLEKHH2;SMAD4;PFDN1
prerank,hippo signaling (GO:0035329),0.3469399002315228,0.8511711987860904,0.6838624338624338,0.8897257111472389,1.0,12/26,22.19%,YAP1;AMOTL1;TEAD3;DCHS1;WWTR1;TEAD1;STK4;LATS2;YWHAE;DVL2;LATS1;SAV1
prerank,regulation of exosomal secretion (GO:1903541),0.36312072952053465,0.8509601224569386,0.6410998552821997,0.8896868328389456,1.0,9/19,25.84%,VPS4A;RAB7A;SDC1;SMPD3;SDC4;SDCBP;PDCD6IP;TSG101;CHMP3
prerank,positive regulation of integrin activation (GO:0033625),0.40719022222675433,0.8509370306869417,0.6506211180124224,0.8893212876513041,1.0,5/11,21.93%,SRC;PLEK;PIEZO1;P2RY12;RAP1B
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3877284940409047,0.8506554809209752,0.6526315789473685,0.8894032493668972,1.0,2/14,5.04%,XCL1;LGALS9
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.36960943190346474,0.8504581238726578,0.6708507670850767,0.8893700693207972,1.0,6/19,14.06%,PINX1;DCP2;NAT10;XRN1;CTC1;SRC
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.27732504783708173,-0.8498517609867678,0.6909722222222222,0.9203824769775577,1.0,8/23,22.66%,HSP90AA1;NDUFA13;COX18;SAMM50;TIMM22;TOMM70;TIMM8B;ROMO1
prerank,cellular glucose homeostasis (GO:0001678),0.32509764134340513,0.8498060739452107,0.6654320987654321,0.8900173958501996,1.0,8/41,17.25%,SLC39A14;HK2;FOXK2;GCK;ZBTB20;PIK3R1;HIF1A;NUCKS1
prerank,sphingoid biosynthetic process (GO:0046520),-0.3381410136926961,-0.8497893270459506,0.654891304347826,0.9176286467991357,1.0,3/11,5.15%,ACER2;SPTLC2;SPTLC1
prerank,sphingosine biosynthetic process (GO:0046512),-0.3381410136926961,-0.8497893270459506,0.654891304347826,0.9176286467991357,1.0,3/11,5.15%,ACER2;SPTLC2;SPTLC1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3777529384626199,0.8497507265350053,0.6566523605150214,0.8897178559129438,1.0,2/17,9.77%,NOS1AP;KCNAB1
prerank,positive regulation of ATPase activity (GO:0032781),0.31756677280607515,0.8497042638067065,0.6745341614906832,0.8894016449317337,1.0,3/41,3.17%,VMP1;DYNLL1;DNAJB1
prerank,TOR signaling (GO:0031929),0.3473818478569273,0.849409342036339,0.6714471968709257,0.889486590462738,1.0,6/26,11.23%,RICTOR;RPTOR;MAPKAP1;RPS6KB1;FNIP1;EIF4EBP1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3637724006411776,0.8472489403220531,0.6647646219686163,0.8927710644077551,1.0,9/21,25.67%,TNKS1BP1;CNOT4;SAMD4A;TUT7;PARN;CNOT2;CNOT3;CNOT1;CNOT7
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.37754570089263767,0.8472134531006978,0.649331352154532,0.8924315085696074,1.0,6/16,20.32%,SHH;PKD2;SALL1;FGF2;PAX8;GDNF
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.2408135889862713,-0.8468024660888112,0.8009259259259259,0.9223811883067957,1.0,17/36,26.62%,RB1;SGMS1;MADD;TPD52L1;NR4A2;CYLD;QARS1;BDNF;ASAH2;CRADD;BCL2L12;TMBIM6;PPIA;STYXL1;TRAF1;MAZ;TRIM39
prerank,peptide hormone secretion (GO:0030072),0.34556148164973866,0.84630405312323,0.6465968586387435,0.8935190227499735,1.0,3/26,13.45%,EDN3;ANXA1;RAB1A
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.3787780671831458,0.8462961248969093,0.653566229985444,0.8931314721725562,1.0,5/16,16.89%,DPYSL3;NT5M;TET2;DPYD;NT5C1A
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.221146221661155,-0.8457855990580259,0.8976377952755905,0.9231577395991242,1.0,17/57,21.02%,CYFIP2;MALT1;MAP3K5;TNFSF10;BCAP31;NDUFA13;GRIN2B;PERP;TTBK1;GRAMD4;GPER1;SOX7;SYK;AIM2;LGMN;HTRA2;USP50
prerank,regulation of water loss via skin (GO:0033561),0.37860306141730016,0.8457328358560132,0.6559297218155198,0.8932619777302967,1.0,1/15,2.95%,UGCG
prerank,establishment of skin barrier (GO:0061436),0.37860306141730016,0.8457328358560132,0.6559297218155198,0.8932619777302967,1.0,1/15,2.95%,UGCG
prerank,nuclear migration (GO:0007097),0.3930750530646805,0.8456445489456873,0.6553254437869822,0.8930406571398826,1.0,4/13,12.26%,DYNC1H1;PCM1;CEP120;FBXW11
prerank,DNA repair (GO:0006281),0.2760572539271479,0.845082182209245,0.8402010050251256,0.8935600525678032,1.0,65/284,20.79%,RAD51B;PARP3;MPG;BRIP1;BACH1;SMC1A;DNA2;RAD52;TNKS1BP1;ASCC3;BABAM2;INO80;XRCC3;ATM;PDS5B;PWWP3A;GTF2H1;LIG1;DCLRE1C;PDS5A;RAD23A;ATR;FTO;RAD23B;SETD2;RNASEH2A;FBH1;ALKBH5;ALKBH1;USP3;TIMELESS;TDP2;POLI;MC1R;MGMT;MDC1;EME2;XRCC1;VCPIP1;ASF1A;DTX3L;MMS19;SETX;PRKDC;SLC30A9;TRAIP;ATRIP;PNKP;NUCKS1;DDB1;DDX1;RAD9A;RBBP8;HINFP;EID3;GADD45A;MBD4;KPNA2;HMGA2;ERCC2;TENT4A;FANCC;NEIL1;PARP4;FANCE
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.38861816184783016,0.8447218500328787,0.6469719350073855,0.8937567475569508,1.0,4/14,21.92%,CD40;CCL2;ANO6;RGCC
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.38942149330630943,0.8446047162467331,0.6772793053545586,0.8935487141513081,1.0,7/15,25.49%,COL11A1;PIEZO2;TMEM120A;LHFPL5;ADGRV1;PDZD7;TMC1
prerank,proteoglycan biosynthetic process (GO:0030166),0.33635300222946096,0.8443114430241629,0.688212927756654,0.893645967202753,1.0,7/31,16.27%,CHST13;EXT1;EXT2;CHST11;UGDH;B4GALT7;FAM20B
prerank,negative regulation of cell projection organization (GO:0031345),0.31401046537936905,0.8440589123939144,0.7077100115074798,0.8936648440557693,1.0,9/48,13.48%,MYLIP;DPYSL3;APOE;PTEN;GAK;PTPN9;DENND5A;SPRY2;RTN4RL1
prerank,regulation of cytoplasmic translation (GO:2000765),0.3896800544992078,0.8440038432914239,0.6509863429438544,0.8933634057867242,1.0,4/14,14.51%,CPEB1;YBX3;FMR1;CPEB4
prerank,"DNA-templated transcription, termination (GO:0006353)",0.29860550105241934,0.8439026801856233,0.7208237986270023,0.8931427295292323,1.0,24/68,24.17%,TAF1D;POLR1E;CSTF1;TTF2;GTF2H1;NCBP2;CDK7;SMN1;POLR1B;TAF1A;SETX;POLR2L;POLR2K;SNRPB;POLR1G;ERCC2;POLR3K;PCF11;POLR1A;CCNH;MNAT1;PRMT5;FIP1L1;CPSF3
prerank,positive regulation of protein acetylation (GO:1901985),-0.3323311749019404,-0.8438724714872962,0.6477272727272727,0.9256652500145721,1.0,3/12,4.66%,PRKAA2;RAPGEF3;DIP2B
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.34636288124820297,0.8438507355035948,0.6967654986522911,0.8928304275906178,1.0,10/27,24.17%,POP1;RNASEH1;DICER1;XRN1;RNASE1;PARN;ZC3H12B;ZC3H12A;PCF11;CPSF3
prerank,microtubule depolymerization (GO:0007019),0.3775037058735423,0.8437526907678523,0.6768115942028986,0.8925979167794723,1.0,4/17,17.54%,NCKAP5;KIF2A;NCKAP5L;CKAP5
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3937213664050584,0.8433536537049506,0.6768759571209801,0.8928720014461462,1.0,4/13,17.75%,MDK;RHOA;TNF;ETS1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.36507940839005576,0.8433435968593908,0.6504992867332382,0.8924889644949524,1.0,6/18,12.48%,MDK;AKT3;PPARG;CCL2;FGFR1;FGF2
prerank,inorganic cation transmembrane transport (GO:0098662),0.2744758927647097,0.8424833146496349,0.8276209677419355,0.8935156370245124,1.0,16/268,5.83%,MCOLN2;SLC39A14;SLC1A3;CACNA1A;SLC6A2;HVCN1;SLC9A1;SLC11A2;CACNA1C;ATP5PO;KCNF1;KCNA5;PKD2;TRPC6;SLC24A5;SCN7A
prerank,positive regulation of glucose import (GO:0046326),0.35772230577023234,0.8424090720505831,0.6616022099447514,0.8932478575451949,1.0,2/21,2.62%,ADIPOQ;IRS1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3430836416098547,0.842167290494334,0.6720867208672087,0.8932749960275657,1.0,6/25,17.14%,NOS1AP;PKD2;CD36;TNF;SMAD3;AKT1
prerank,vitamin transport (GO:0051180),0.3338612419284709,0.842063857629669,0.6575875486381323,0.893039281495776,1.0,3/29,11.38%,TCN1;TCN2;PDPN
prerank,cytoplasmic microtubule organization (GO:0031122),0.3112116865807917,0.8413241184453583,0.7192982456140351,0.8938831617068858,1.0,18/54,23.08%,DYNC1H1;HOOK2;PCM1;RHOA;CAMSAP2;FIGN;FIGNL2;TUBGCP4;FSD1;TPPP;CLIP3;CAMSAP1;HOOK1;DST;DLG1;CCDC88B;CLIP4;KPNB1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3178526869353682,0.8412257411207824,0.6782178217821783,0.8936496503507433,1.0,14/41,20.96%,LACC1;NUP37;RAE1;OGT;NUP153;GCK;NDC1;HIF1A;NUP35;NUP188;SEC13;ZBTB7A;NUP214;NUP107
prerank,DNA duplex unwinding (GO:0032508),0.3091271877841595,0.8410713156337647,0.6793540945790081,0.8934978050568526,1.0,8/50,10.37%,ASCC3;MCM2;DDX11;GTF2H1;MCM7;ANXA1;RAD23B;MCM9
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.34952109363529593,0.8410166852448758,0.6903485254691689,0.8931918425227137,1.0,10/24,22.66%,PINX1;DCP2;NAT10;XRN1;CTC1;SRC;TNKS2;HNRNPC;TERF1;SLX4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3506966010058489,0.8404486088303399,0.65406162464986,0.8937276033925637,1.0,9/21,27.89%,CGNL1;MAPKAP1;TGFB2;SPRY2;SYNGAP1;SPRY4;CYRIB;ARHGAP12;SPRY1
prerank,UV protection (GO:0009650),-0.337435226455569,-0.8403918251842956,0.6701570680628273,0.9312926526278041,1.0,2/10,6.43%,ERCC5;CAT
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.2777845230927932,-0.8403222105217649,0.6851211072664359,0.9300007286892636,1.0,3/20,11.30%,RB1;IGF1;EP300
prerank,protein homooligomerization (GO:0051260),-0.1876821836529135,-0.8401818228591522,0.8392857142857143,0.9288473128118044,1.0,32/114,23.54%,KCNC2;GLRA3;EHD4;SLC1A2;KCNJ2;ATL3;SAMHD1;UPB1;DISP1;LETM1;AQP11;GSDMD;ALDH9A1;GOLGA2;EHD3;PRMT1;KCNJ12;GBP5;SSBP1;POLQ;HCN1;SOD2;NACC2;PRMT8;CBR4;GLS;USP16;APIP;VSTM5;G3BP2;MIF;CRYZ
prerank,regulation of protein localization to membrane (GO:1905475),0.3384012851946107,0.840079433810546,0.6821192052980133,0.893927090886127,1.0,3/28,6.56%,MMP14;GPC6;VPS4A
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3821882907079957,0.83998077481557,0.6936936936936937,0.8937053700462795,1.0,4/16,14.88%,NCBP2;SFSWAP;SRSF12;SNRNP200
prerank,regulation of protein export from nucleus (GO:0046825),0.3522003064293785,0.8399476320775682,0.6925170068027211,0.8933673448991516,1.0,4/23,12.44%,TCF7L2;BAG3;SP100;GSK3B
prerank,negative regulation of cyclase activity (GO:0031280),-0.3174764630848571,-0.8393669718673891,0.7110481586402266,0.9290244635091933,1.0,2/14,5.48%,PALM;GRM3
prerank,cellular response to osmotic stress (GO:0071470),0.3567097895349609,0.8393299517290285,0.6752021563342318,0.8939557925581221,1.0,4/21,13.71%,ZFP36L1;PKD2;MYLK;YBX3
prerank,regulation of presynapse assembly (GO:1905606),0.3696508856521554,0.8387788915604832,0.6614060258249641,0.8940452335437024,1.0,2/18,2.81%,MDGA1;GPC6
prerank,regulation of presynapse organization (GO:0099174),0.3696508856521554,0.8387788915604832,0.6614060258249641,0.8940452335437024,1.0,2/18,2.81%,MDGA1;GPC6
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3485154458200641,0.8387238017579219,0.6743243243243243,0.8937387569775191,1.0,6/25,18.70%,CHMP4A;CHMP4B;CHMP7;CHMP2B;LEPROT;LEPROTL1
prerank,protein heterooligomerization (GO:0051291),0.3668833473956819,0.8385915432253641,0.6791907514450867,0.8935672668907929,1.0,3/17,8.54%,TMEM120B;PKD2;HSD17B8
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.3924233596978188,0.838397688966811,0.6661466458658346,0.8934954569359518,1.0,2/12,12.29%,TREM2;TNF
prerank,regulation of receptor recycling (GO:0001919),-0.3003926731111147,-0.8383078494898885,0.7117437722419929,0.9298397454213821,1.0,4/16,14.26%,INPP5F;LAMTOR1;NSF;SCRIB
prerank,icosanoid secretion (GO:0032309),-0.3340608808153426,-0.837106290158123,0.6694444444444444,0.9308065321999428,1.0,4/12,19.93%,ABCC4;BDKRB2;ACE;DRD2
prerank,protein deneddylation (GO:0000338),-0.3451310017442013,-0.8364440681668953,0.6516516516516516,0.9307311924077175,1.0,3/10,16.01%,COPS5;COPS7B;TOR1A
prerank,regulation of lymphocyte proliferation (GO:0050670),0.37282919330379205,0.8364430400074002,0.6575539568345323,0.8963168818038562,1.0,2/16,11.70%,AHR;LST1
prerank,ureteric bud development (GO:0001657),0.36513908994265176,0.8360478933760873,0.6522388059701493,0.8965962435880958,1.0,4/17,14.04%,ROBO2;PKD2;SALL1;BMP7
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3227417028617888,-0.8360362686934392,0.6867816091954023,0.9301035903421772,1.0,2/12,3.11%,RAD21;RB1
prerank,apoptotic nuclear changes (GO:0030262),0.3481424600984738,0.8357881818052293,0.6902173913043478,0.896634736421159,1.0,4/24,12.75%,ERN2;DICER1;HMGB2;ACVR1C
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.32332358412645495,0.8357141726448712,0.7,0.8963589495832772,1.0,10/38,18.91%,IL34;NCK2;DLG4;PTPN1;MVP;SH3BP5L;FCGR1A;PTPRC;AGT;PRNP
prerank,cellular response to misfolded protein (GO:0071218),-0.27708656676416954,-0.8357103797091461,0.696113074204947,0.9293174409733574,1.0,9/20,24.84%,ATXN3;DNAJC18;DERL1;TOR1A;RNF185;UFD1;KLHL15;RNF5;RNF126
prerank,regulation of synapse organization (GO:0050807),0.3391075214238752,0.8352422654654035,0.6754270696452037,0.8967260002706321,1.0,8/26,15.60%,MDGA1;ABHD17C;WNT5A;YWHAZ;TNF;ARHGAP22;ABHD17B;NEDD4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.305372348932835,0.8345600756826596,0.7004716981132075,0.8974475722497467,1.0,17/52,23.21%,TNKS1BP1;EDC4;CNOT4;SAMD4A;EXOSC4;DCP2;DCP1A;PATL1;LSM7;RC3H2;TUT7;PARN;CNOT2;CNOT3;EXOSC5;PATL2;POLR2D
prerank,tRNA export from nucleus (GO:0006409),0.32697297774043477,0.8340805074720786,0.6842105263157895,0.8974105497868231,1.0,10/32,20.96%,NUP37;XPOT;RAE1;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.32697297774043477,0.8340805074720786,0.6842105263157895,0.8974105497868231,1.0,10/32,20.96%,NUP37;XPOT;RAE1;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107
prerank,mRNA splice site selection (GO:0006376),-0.25501614454392374,-0.8340144813582793,0.7327586206896551,0.9312390503588789,1.0,7/30,15.71%,CELF2;YTHDC1;SRSF5;ISY1;SNRPC;SRSF9;LUC7L3
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.29223666888369837,0.8338725931703627,0.7058165548098434,0.897365148250303,1.0,17/72,22.34%,ENPP1;DNA2;EDC4;GTF2H1;DICER1;SETMAR;FBH1;DCP1A;RNASE1;DXO;DDB1;DDX1;ERCC2;ZC3H12A;RFC1;RPS27A;RPA1
prerank,axonemal dynein complex assembly (GO:0070286),0.3316954635842287,0.8336736019781646,0.6826666666666666,0.8972695678600403,1.0,4/27,13.37%,DNAAF4;TTC12;ODAD1;DNAAF5
prerank,positive regulation of phosphatase activity (GO:0010922),0.3498053762901437,0.8330036504294832,0.6644204851752021,0.897975425316083,1.0,6/21,17.13%,PDGFRB;CALM2;MTMR9;ITGA1;PLEK;PTPA
prerank,regulation of cell projection organization (GO:0031344),0.3824640482332909,0.832501764992159,0.6851851851851852,0.8983437768342699,1.0,3/13,11.91%,TREM2;MOV10;SPRY2
prerank,regulation of leukocyte activation (GO:0002694),-0.30646718109047155,-0.8322799434361171,0.6857142857142857,0.933274754828259,1.0,5/14,22.86%,CD200;MYO18A;SHPK;GPER1;MIF
prerank,sphingoid metabolic process (GO:0046519),-0.33491882431006836,-0.8319593100115835,0.7023809523809523,0.9324887871308015,1.0,5/12,24.73%,DEGS2;SGPP1;ASAH2;NAAA;SPHK1
prerank,negative regulation of cell cycle process (GO:0010948),0.298919507702039,0.8310480163088084,0.7281213535589265,0.9002360886921522,1.0,23/61,26.01%,E2F1;RNF2;YAF2;EHMT1;VPS4A;TOM1L1;E2F8;BMP7;PHC3;MAX;RBBP8;FBXO5;WAPL;MGA;TERF1;SUZ12;CDC7;CBX5;RAD51;RYBP;TERF2;TFDP1;RBBP7
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.29396067184313496,-0.8309601099699018,0.7151702786377709,0.9329868942599701,1.0,6/16,15.61%,IGF1R;INSR;CLN3;UPF1;MTRF1;BNIP3
prerank,carbohydrate catabolic process (GO:0016052),0.32120959875932464,0.8307308709643307,0.6997455470737913,0.9003403886719897,1.0,13/38,25.93%,HK2;ENO1;GAPDH;GCK;NEU3;NEU1;MAN2C1;GPI;PFKFB1;MAN2B1;ENO3;PFKFB2;PGM1
prerank,Golgi to lysosome transport (GO:0090160),0.3940591085407106,0.830597132499012,0.6781789638932496,0.900156471943515,1.0,3/11,10.49%,AP4M1;ANKFY1;GAK
prerank,nucleotide-excision repair (GO:0006289),-0.18971820777274262,-0.830122547619928,0.9491525423728814,0.9332303813602171,1.0,42/101,29.31%,ERCC5;ATXN3;COPS5;AQR;ISY1;BRCA2;ERCC6;ERCC3;UBC;COPS7B;HUS1;EP300;UVSSA;POLD3;USP7;POLR2A;POLR2H;CHD1L;PCNA;POLR2G;DDB2;POLR2F;PRPF19;GTF2H2;ERCC1;POLR2E;OGG1;GTF2H4;RFC3;TP53;UBA52;GTF2H3;FAN1;POLD2;CETN2;RBX1;RPA2;PARP1;LIG4;XPC;POLE;RFC4
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.32240050435931533,-0.8300082188485317,0.7191977077363897,0.932032092591532,1.0,2/13,5.48%,PALM;GRM3
prerank,positive regulation of phospholipid transport (GO:2001140),0.39806333513490244,0.829471335455291,0.6833602584814217,0.9015334576488969,1.0,1/10,3.78%,APOE
prerank,cell cycle checkpoint signaling (GO:0000075),-0.32178892396962927,-0.8287639703478166,0.7118155619596542,0.9330687170372928,1.0,3/12,14.69%,ZWINT;NABP1;ZWILCH
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.28226037210737986,-0.8282914365797425,0.7152542372881356,0.932625905339397,1.0,6/18,23.85%,WDR43;PHF8;DHX33;SIRT7;UTP15;MAF1
prerank,negative regulation of protein secretion (GO:0050709),0.3227968280081402,0.8281501186841451,0.706700379266751,0.9032686332580679,1.0,6/38,12.15%,IRS1;APOE;SFRP1;INHBB;DRD3;DPH3
prerank,'de novo' posttranslational protein folding (GO:0051084),0.32690634807072366,0.8277299745794877,0.684010152284264,0.9035398732383397,1.0,10/30,24.86%,DNAJB1;HSPE1;GAK;DNAJC7;SDF2;HSPA5;HSPA13;DNAJB14;ST13;UGGT1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2716192217168475,-0.8274864757015514,0.7111913357400722,0.9328204109768656,1.0,18/23,49.63%,CADM1;PIK3R6;AP1G1;LAMP1;PVR;RAET1E;NECTIN2;RASGRP1;LILRB1;ARRB2;SLAMF6;CD226;IL12A;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,lysosome localization (GO:0032418),0.3212166232386302,0.8270715429560239,0.7092731829573935,0.9042257837661628,1.0,6/37,15.66%,BORCS6;MILR1;MYH9;KIF5B;RAB34;NDEL1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3369497545736675,0.8269126237740893,0.6856763925729443,0.9040941420423987,1.0,12/27,28.11%,NAA50;CREBBP;BAG6;RUVBL1;PHF20;KAT6B;KAT7;TRRAP;MORF4L2;MORF4L1;MRGBP;RUVBL2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4002251715005998,0.8255853217762615,0.6649659863945578,0.9058108892966528,1.0,5/10,24.21%,CBARP;DRD3;FMR1;GNB5;CALM3
prerank,endocardial cushion morphogenesis (GO:0003203),0.3608172717047792,0.8255435256252871,0.6776034236804565,0.9054770638503512,1.0,4/18,11.44%,TBX2;ACVR1;HEYL;TGFB2
prerank,protein acylation (GO:0043543),-0.24185729126162375,-0.8254084346587794,0.7635467980295566,0.9355289662069676,1.0,12/38,16.77%,GLUL;ZDHHC13;ZDHHC21;EP300;ZDHHC17;ZDHHC14;SELENOK;ZDHHC5;KAT6A;ZDHHC15;PORCN;ZDHHC2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.366974175770777,0.8253851250615275,0.6845151953690304,0.9053419276324401,1.0,5/17,17.13%,PDGFRB;CALM2;ITGA1;PTPRC;PTPA
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.22607499941907233,-0.824515600168019,0.7970297029702971,0.9359213871364974,1.0,5/41,5.90%,TGFBR3;BMP4;CPE;PROX1;FGFR2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.383992300781012,0.8242807760456883,0.6835066864784547,0.9067345755968683,1.0,3/12,12.29%,TIRAP;LPL;TNF
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2787274428467162,0.8241833353481979,0.7729166666666667,0.9065041283101246,1.0,35/119,19.98%,PIGW;PIP5K1B;PTPN13;PTEN;PIP4K2A;PI4K2B;PIGN;ITPKC;PIK3R5;TTC7A;IP6K2;PIGL;FIG4;PIGC;SOCS5;FGF2;PI4KA;PIK3R1;SACM1L;ARF1;PIGP;EFR3A;MTMR9;PIK3R4;PIGH;PIK3C3;MTMR3;RUFY1;PIP5K1A;PLEKHA2;MTMR2;MTMR6;MTMR1;MTM1;MPPE1
prerank,purine-containing compound salvage (GO:0043101),-0.3260666428190735,-0.8236239809397828,0.7210682492581603,0.9362310240584008,1.0,4/12,22.10%,ADK;GMPR;DCK;APRT
prerank,phosphatidylinositol metabolic process (GO:0046488),0.28134547595222764,0.8236179795999252,0.7571884984025559,0.9070263632298997,1.0,30/109,19.90%,PDGFRB;PIGW;PIP5K1B;PTPN13;PTEN;PIP4K2A;PI4K2B;PIK3R5;PLA2G12A;FIG4;PLCB3;FGF2;PI4KA;PIK3R1;SACM1L;ARF1;PLA2G4A;MTMR9;PIK3R4;PLA2G4E;PIK3C3;PLEK;MTMR3;RUFY1;PIP5K1A;PLEKHA2;MTMR2;MTMR6;MTMR1;MTM1
prerank,somite development (GO:0061053),0.3978916341172687,0.8235138056299487,0.6931464174454829,0.9067746266522354,1.0,3/11,15.46%,SHH;LOXL3;SMO
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3352179536465325,0.8234262572564273,0.6900662251655629,0.9065239989969813,1.0,1/27,0.65%,P2RY10
prerank,regulation of transposition (GO:0010528),0.3761574680390077,0.8229718083001473,0.6716867469879518,0.9068236511840408,1.0,1/13,4.62%,MYBL1
prerank,nucleotide metabolic process (GO:0009117),-0.2643750417044154,-0.8224488811429302,0.716,0.9370454361336129,1.0,3/23,7.23%,FHIT;ME1;NMNAT3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2846170584257006,0.8222467332202738,0.7693169092945129,0.9075946365661165,1.0,12/76,13.06%,TNIP1;LRRK2;MYCBP2;BIRC3;PRICKLE1;ANGPT1;DCUN1D1;FBXW7;UBE2L3;GNL3;RASD2;TANK
prerank,establishment of protein localization to organelle (GO:0072594),0.28891175767926014,0.8217814914797361,0.7376294591484465,0.9079211085046087,1.0,18/72,20.96%,STAT3;HK2;RALA;CD68;PRICKLE1;FAM53B;LAMP2;NUP153;TNPO1;PEX19;E2F3;NUP188;SEC13;AKT1;HEATR3;NUP214;LAMP5;NUP107
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2932177101958885,0.821753572235494,0.7290697674418605,0.9075709411741107,1.0,13/60,19.69%,PARM1;PDGFRB;PRKD2;ATM;ATR;CCT8;FGF2;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB
prerank,regulation of axon regeneration (GO:0048679),-0.32290513758314,-0.8213639800480743,0.6478494623655914,0.9376385845375975,1.0,2/12,1.20%,EPHA4;INPP5F
prerank,protein insertion into ER membrane (GO:0045048),0.3147156401569421,0.8213016090827913,0.7028714107365793,0.9078882617378458,1.0,5/37,7.66%,TRAM2;WDR83OS;BAG6;VAPA;EMC7
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.37468135187161417,0.8208114584597085,0.6845238095238095,0.9082629888427054,1.0,1/14,2.62%,IRS1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3343509855799964,0.8206821442219704,0.7042801556420234,0.9080656985696695,1.0,9/29,19.14%,ACSL4;HACD2;SCD5;HSD17B8;HSD17B12;ELOVL6;ACSL5;ACACA;FASN
prerank,cristae formation (GO:0042407),-0.2484183789278654,-0.8203842051709129,0.7613168724279835,0.9380478810497098,1.0,11/27,20.64%,ATP5MG;ATP5PD;ATP5PF;LETM1;IMMT;ATP5F1D;MICOS13;ATP5ME;SAMM50;APOO;APOOL
prerank,amide biosynthetic process (GO:0043604),0.30342770760525184,0.8198906982078574,0.7169811320754716,0.9089321127063635,1.0,3/47,2.51%,ASMT;CERS6;PAM
prerank,activation of phospholipase C activity (GO:0007202),0.3339586133636652,0.8196942844032449,0.704635761589404,0.9088512469128542,1.0,4/29,12.44%,EDNRA;EGFR;LPAR2;ARHGAP6
prerank,positive regulation of DNA metabolic process (GO:0051054),0.29525764181594216,0.8194256839041808,0.7359357060849598,0.90887542782226,1.0,6/61,5.00%,PARP3;PDGFRB;EGFR;USP9X;BABAM2;PRKD2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.36466712420146896,0.8193261075363579,0.6964028776978417,0.9086286264189645,1.0,3/17,4.34%,APOE;ABCA2;ABCG1
prerank,stress granule assembly (GO:0034063),0.35182341252445615,0.8192424764267461,0.6968449931412894,0.9083731876776872,1.0,8/20,24.23%,ATXN2;DYNC1H1;UBAP2L;YTHDF3;PRRC2C;CSDE1;YTHDF2;EIF2S1
prerank,positive regulation of histone modification (GO:0031058),-0.2397340694513701,-0.819191916231842,0.7641509433962265,0.9388950523510462,1.0,9/33,19.61%,RPS6KA5;PPARGC1A;SAP30BP;AKAP8;UBE2N;CHTOP;TET1;CTBP1;MAPK3
prerank,regulation of intracellular transport (GO:0032386),0.31476024437729155,0.8183673438155878,0.731457800511509,0.909317661228611,1.0,6/38,8.76%,LRRK2;ANTKMT;DYNC1H1;PTPN1;GAS1;LCP1
prerank,morphogenesis of an epithelium (GO:0002009),-0.25776940853903785,-0.8182627964404044,0.7326007326007326,0.9392607444457186,1.0,6/25,9.23%,ACTB;LAMA3;FGFR2;AHI1;LAMA5;VCL
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3169566707365216,0.8179774096563166,0.7082262210796915,0.9095339435289828,1.0,9/35,22.34%,MPG;LIG1;XRCC1;POLG;PNKP;MBD4;NEIL1;RFC1;RPA1
prerank,retinoic acid metabolic process (GO:0042573),0.3825509743836067,0.8177282832249702,0.6771300448430493,0.9095237442984424,1.0,3/14,18.23%,ALDH1A2;SCPEP1;ADH1A
prerank,peptidyl-amino acid modification (GO:0018193),0.3929562831201383,0.8174410645259332,0.6693290734824281,0.9095908671778294,1.0,5/10,27.13%,FKBP10;ATP7A;METAP1;TTLL4;METAP1D
prerank,isotype switching (GO:0045190),0.39850362292999353,0.817433624623244,0.6692789968652038,0.9092101503392427,1.0,4/10,25.95%,BATF;HSPD1;MSH6;RNF8
prerank,prostanoid biosynthetic process (GO:0046457),0.3720483348636948,0.8174050687589929,0.6893491124260355,0.9088584539699198,1.0,3/15,14.60%,PTGES;TBXAS1;PLA2G4A
prerank,double-strand break repair via break-induced replication (GO:0000727),0.37673061550780745,0.8172761573804594,0.7073552425665102,0.9086694295224125,1.0,2/12,8.70%,MCM2;MCM7
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.34472416335919753,0.8171260467399847,0.6912568306010929,0.9085101170831851,1.0,2/22,3.00%,DUSP2;DUSP5
prerank,glutathione metabolic process (GO:0006749),-0.23569552860683313,-0.8168459484896565,0.8088235294117647,0.9405051028045267,1.0,11/38,23.37%,GCLC;HAGH;GSTZ1;CHAC2;ETHE1;GSTA3;GSR;SOD1;CTNS;GSTM5;GCLM
prerank,positive regulation of stress fiber assembly (GO:0051496),0.30772369199392946,0.8166812744714933,0.750920245398773,0.908813380405334,1.0,18/44,23.87%,NRP1;CARMIL1;NF2;SFRP1;TGFB3;CDC42;EPHA1;TGFBR1;RHOA;RAC1;ITGB1BP1;TPM1;PAK1;RHOC;RGCC;ROCK2;LPAR1;PXN
prerank,ncRNA export from nucleus (GO:0097064),0.31561900907516793,0.8164777997806898,0.7166042446941323,0.9087079022450416,1.0,11/36,20.96%,NUP37;XPOT;RAE1;NCBP2;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107
prerank,melanosome localization (GO:0032400),0.34713492274357705,0.8159402725775381,0.7192737430167597,0.9091213736497666,1.0,3/21,9.93%,MLPH;MYO5A;RAB27B
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.33619976983390204,-0.8155254560031125,0.6968838526912181,0.9415828596582888,1.0,4/10,23.55%,ESR1;PSMC3;PSMC4;TP53
prerank,autophagosome maturation (GO:0097352),0.31929453071348146,0.8154566496768486,0.7088122605363985,0.9094909022871378,1.0,4/32,9.67%,VMP1;STX17;LAMP2;ATP2A2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3318341673038817,0.8151848079090186,0.7052341597796143,0.9095278538491248,1.0,11/26,24.21%,PKD2;CBARP;FKBP1B;DRD3;CALM2;FMR1;YWHAE;THADA;GSTM2;GNB5;CALM3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.30080087006777,0.8150094454104079,0.7514792899408284,0.9094130120909767,1.0,7/48,7.26%,NRP1;DOCK1;MDK;LIMS1;CARMIL1;CDC42;CAPRIN1
prerank,ion transport (GO:0006811),0.2753406528911295,0.8144119798205858,0.7843347639484979,0.9099463857019688,1.0,14/111,10.09%,SLC1A3;SLC15A3;SLC9A1;SLC12A4;PIEZO2;GLRB;SLC20A1;TRPC6;VDAC2;SLC24A5;SLC9A8;SLC36A2;LASP1;SLC15A1
prerank,negative regulation of transposition (GO:0010529),0.3609071145702337,0.8141014235131667,0.6937869822485208,0.9100208915399057,1.0,3/16,17.79%,MYBL1;MOV10;TUT7
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.29864471571786144,-0.8140004691493348,0.6991404011461319,0.9429395838037764,1.0,4/14,14.60%,PAICS;ATIC;ADK;RFK
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2978344273453266,0.8138987245720329,0.7402597402597403,0.9099604617456699,1.0,6/52,11.59%,ALDH18A1;MTHFR;MTHFD1L;DLST;IDH2;MTHFD2L
prerank,chromatin remodeling at centromere (GO:0031055),0.32505055316453,0.8136416260045362,0.711139896373057,0.9099791276993671,1.0,5/31,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.27820855914591436,-0.8135934709683769,0.7228070175438597,0.9422755005403675,1.0,6/19,18.65%,SLCO1C1;KLF2;KLF4;APP;WFS1;MAP2K5
prerank,positive regulation of embryonic development (GO:0040019),0.3489899125398712,0.8135129929554221,0.6949152542372882,0.9097818173426823,1.0,3/19,11.73%,B4GALT5;TENM4;ZBED3
prerank,atrial septum morphogenesis (GO:0060413),0.3923662982024271,0.8131689662595784,0.6792763157894737,0.9099396293630849,1.0,2/10,11.44%,ACVR1;TGFB2
prerank,telomere maintenance via recombination (GO:0000722),0.3961876317747244,0.8127701369952403,0.6904024767801857,0.9101793179274715,1.0,5/11,23.20%,XRCC3;NSMCE2;TEP1;SMC5;RAD51
prerank,histone exchange (GO:0043486),0.31629943990585,0.8126230345116969,0.722636815920398,0.9100045329428016,1.0,7/37,15.43%,CENPQ;CENPN;RSF1;CENPL;RUVBL1;SPTY2D1;SRCAP
prerank,cellular response to catecholamine stimulus (GO:0071870),0.33527346720512047,0.8116549924121206,0.7019230769230769,0.9111076620630931,1.0,2/23,2.43%,SLC9A1;LRRK2
prerank,regulation of secretion (GO:0051046),-0.31009936599522814,-0.8106044431519672,0.7314814814814815,0.9464433743852939,1.0,7/13,22.37%,GPLD1;ACSL3;KCNQ1;FGF10;OAS2;ERBB3;OPRK1
prerank,striated muscle cell differentiation (GO:0051146),-0.29656673256554855,-0.8100978282736354,0.7396825396825397,0.9459864073750401,1.0,8/16,28.39%,SORT1;SIK1;SKI;MYOCD;MEF2C;MTLN;KDM6B;CBY1
prerank,regulation of JUN kinase activity (GO:0043506),0.31979505707595923,0.8098731370537076,0.7350649350649351,0.9134655998781365,1.0,8/33,19.09%,AIDA;SASH1;TAOK3;HIPK3;TNF;TRAF2;MAPK8IP1;DVL2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.31921679043272927,-0.8098277092154469,0.7437325905292479,0.9451121043958598,1.0,5/12,31.91%,LFNG;MFNG;DOCK11;DLL1;PTK2B
prerank,positive regulation of protein import (GO:1904591),0.3262620275869264,0.8098044778865168,0.7170294494238156,0.9131863071478689,1.0,6/30,13.92%,UBR5;BAG3;ZIC1;PIK3R1;SMAD3;PSEN1
prerank,cAMP biosynthetic process (GO:0006171),0.4002169826879448,0.8097509101835,0.6753670473083198,0.9128748691865519,1.0,2/10,4.40%,ADCY7;ADCY2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3223736066535232,-0.8094812762484183,0.7111716621253406,0.9443507739030335,1.0,3/11,12.54%,CCT4;CCT5;DKC1
prerank,positive regulation of dendritic spine development (GO:0060999),0.3459465796877466,0.8092642124458742,0.6794326241134752,0.9132259826561846,1.0,7/20,14.28%,APOE;CAPRIN1;DBN1;DBNL;PSEN1;DLG5;FMR1
prerank,necroptotic process (GO:0070266),0.364166783914023,0.8090183181762735,0.727802037845706,0.9132339891073302,1.0,4/16,15.12%,LY96;CD14;MLKL;RIPK1
prerank,cell projection organization (GO:0030030),0.3298721947106297,0.8089694403963374,0.7133838383838383,0.9129198709091663,1.0,8/30,23.38%,RHOJ;PARVA;CDC42;RAC1;PLEK;CAPG;P2RY12;ITGB1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3126418499913768,0.808696375736366,0.72875,0.9129306226633073,1.0,8/37,17.10%,PABPC4;RNASEH1;SND1;RNASEH2A;ENTPD7;ENTPD6;SIDT2;MTREX
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.2939445478680176,-0.8086495127546354,0.7213622291021672,0.9445257991132203,1.0,3/15,7.43%,PRKCH;IL18;AGTR1
prerank,organelle transport along microtubule (GO:0072384),0.3155151505379333,0.8083791735561842,0.7246376811594203,0.9130317606072863,1.0,8/31,15.66%,TRAK1;MAP1S;CDC42;COPG1;FBXW11;KIF5B;RAB1A;NDEL1
prerank,rRNA 3'-end processing (GO:0031125),-0.3386975650763555,-0.808130849867101,0.7023498694516971,0.9440853701022962,1.0,5/10,22.00%,EXOSC7;RPS21;EXOSC8;EXOSC3;EXOSC10
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.2848272171472308,-0.8079823907623248,0.7365269461077845,0.9429703950009427,1.0,3/16,3.36%,DDX5;PPARGC1B;ESR1
prerank,tRNA wobble uridine modification (GO:0002098),-0.2991710348955175,-0.8077487803503013,0.7387096774193549,0.9419684357648812,1.0,2/14,4.38%,ALKBH8;TRMT9B
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.30034407250401907,-0.807721304942341,0.7129032258064516,0.9406311250832704,1.0,5/14,22.93%,CSTF2;TUT1;ERN1;CPSF2;CPSF4
prerank,cellular response to cAMP (GO:0071320),0.32746906577274354,0.8077023087453362,0.7281045751633987,0.913674079725494,1.0,4/30,6.40%,ZFP36L1;IGFBP5;PKD2;AHR
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.31923774781842007,0.8074706359741317,0.72870249017038,0.913646099534552,1.0,11/30,19.96%,NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;MICALL2;SH3GLB1;LEPROT;USP36;ARIH2;UBL5
prerank,covalent chromatin modification (GO:0016569),0.36626264684659915,0.8073923836523825,0.6918429003021148,0.9133800143320712,1.0,2/14,9.16%,MBD2;HDAC1
prerank,autophagy of mitochondrion (GO:0000422),0.3060870296814209,0.8068552040785925,0.719029374201788,0.9137946701258639,1.0,12/38,23.32%,WIPI1;AMBRA1;CTSK;ATG3;FBXO7;ATG7;WDR45;SQSTM1;FUNDC2;BECN1;MARK2;ATG2B
prerank,histone H4-K5 acetylation (GO:0043981),-0.3000315529832248,-0.8068332326436128,0.7574750830564784,0.9394526897904392,1.0,5/15,13.96%,JADE1;KANSL2;JADE2;WDR5;JADE3
prerank,histone H4-K8 acetylation (GO:0043982),-0.3000315529832248,-0.8068332326436128,0.7574750830564784,0.9394526897904392,1.0,5/15,13.96%,JADE1;KANSL2;JADE2;WDR5;JADE3
prerank,alpha-amino acid catabolic process (GO:1901606),-0.2399685480819215,-0.8065675667089052,0.8091286307053942,0.9385653835168503,1.0,5/29,13.47%,DDO;ALDH4A1;PRODH;GSTZ1;FAH
prerank,histone deacetylation (GO:0016575),0.3032902958051949,0.8063885653896458,0.7427884615384616,0.9141370716146308,1.0,12/43,19.11%,RCOR1;MIER2;PRDM5;HDAC1;TBL1X;MTA2;ELK4;BAZ2A;MTA3;RCOR2;HDAC5;BRMS1L
prerank,prostaglandin metabolic process (GO:0006693),0.33164127819716155,0.8057923548655184,0.7254641909814323,0.9146673499435798,1.0,4/26,14.60%,PTGES;ACOX1;TBXAS1;PLA2G4A
prerank,regulation of protein binding (GO:0043393),0.2735622755382717,0.8057398433491767,0.8042780748663102,0.9143616625922555,1.0,29/114,20.54%,LRP1;TCF7L2;LRRK2;TRIM21;PLK1;DDX11;EFHB;ADD2;NMD3;TERT;DISC1;VTN;GSK3B;SPPL3;GTF2F1;DACT1;PSEN1;TRIB3;RPL11;DTX3L;STK4;ITGB1BP1;AKT1;HDAC5;TLE5;CTNNBIP1;KDM1A;PIN1;PRKCD
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.33627122695177725,0.8051616977963053,0.7023643949930459,0.9148483083113859,1.0,3/22,5.93%,LRRK2;MDK;PTPRZ1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.2969193251310608,0.8049940770927408,0.7487864077669902,0.9146946260001321,1.0,6/46,10.88%,ADIPOQ;LAMA4;ADAMTS5;ARRDC3;PLCL1;ACOT13
prerank,cell part morphogenesis (GO:0032990),-0.31130710171062626,-0.8049364616680887,0.7464387464387464,0.9402405164791022,1.0,7/13,27.02%,WASF1;DNM1L;SUPV3L1;SLIRP;MYH14;NUBPL;MFF
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3636596720559335,0.8046986991657826,0.695067264573991,0.9147541433321394,1.0,4/15,19.00%,STAT3;TNF;HIF1A;IL17RA
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.28065078464133075,0.8044282301283541,0.7917109458023379,0.9147810113253823,1.0,26/94,22.62%,DYNLL1;DYNC1H1;TUBG1;ALMS1;PLK1;PCM1;HAUS3;CEP41;CNTRL;DCTN3;PCNT;CEP72;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;IQCB1;HAUS6;CEP162;HAUS5;RAB3IP;CC2D2A;NINL;C2CD3
prerank,regulation of axonogenesis (GO:0050770),0.3051524639962233,0.8042101629557705,0.7312206572769953,0.9147087985360007,1.0,10/51,14.08%,ROBO2;PLXNC1;EPHB3;KIF13B;PTEN;PLXND1;PLXNA3;RHOA;GSK3B;ARHGAP35
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.34688892943299676,0.8034321308838355,0.7154696132596685,0.9155017328608025,1.0,3/20,6.21%,NR2F2;PTEN;PLK1
prerank,response to UV (GO:0009411),0.28102677028171724,0.8033493019078043,0.8165038002171553,0.9152378391396904,1.0,22/95,21.00%,BCL3;EGFR;USF1;INO80;CREBBP;NOC2L;CCAR2;ATR;TMEM161A;MC1R;REV1;MFAP4;FMR1;NEDD4;USP28;AKT1;ATF4;RHBDD1;KDM1A;ERCC2;PRKCD;YY1
prerank,regulation of mitochondrial fusion (GO:0010635),0.38050784964033346,0.8030683386181031,0.7013996889580093,0.9152783412637819,1.0,4/11,14.63%,OMA1;ADCK1;PID1;ZDHHC6
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3200442564743419,0.8027256682626661,0.7139175257731959,0.9154029520436237,1.0,7/31,13.84%,CDKN2B;PTEN;PKD2;CDK6;GPNMB;CCL2;DACT1
prerank,regulation of histone modification (GO:0031056),-0.2979098665020814,-0.8024708780261771,0.7561643835616438,0.9433519682442083,1.0,5/13,18.42%,AKAP8;UBE2N;IGF2;NNMT;MYOCD
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.3867717951725991,0.8021867381818775,0.7093889716840537,0.9158352726044351,1.0,2/11,9.77%,ADM;DRD3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3518462020414158,0.8019960736138873,0.707492795389049,0.9157320279651497,1.0,3/16,11.00%,BCL3;NF2;PTPN2
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.2822533118349325,-0.8014729457098478,0.7260726072607261,0.9437634867705836,1.0,5/18,12.69%,EZR;HSP90AA1;VPS11;RDX;FAF1
prerank,melanosome organization (GO:0032438),0.3308642843898008,0.8013564630183106,0.7195767195767195,0.9162924955982851,1.0,4/26,9.89%,AP3B1;DTNBP1;AP3D1;RAB32
prerank,regulation of regulated secretory pathway (GO:1903305),0.313094881960077,0.8011994097595984,0.7381258023106547,0.9161228969599788,1.0,5/34,12.44%,LRRK2;DTNBP1;UNC13D;SYT2;GSK3B
prerank,positive regulation of macroautophagy (GO:0016239),0.2993748113310006,0.8008945059567087,0.7464622641509434,0.9161802336295369,1.0,7/48,13.50%,DCN;BAG3;PIP4K2A;TRIM13;RAB3GAP2;SMCR8;RAB3GAP1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.37375546305672835,0.80086573035545,0.7134146341463414,0.9158364781549475,1.0,4/13,14.77%,NCK1;PTPN1;DDRGK1;HSPA5
prerank,signal transduction by p53 class mediator (GO:0072331),0.3185883831543492,0.8007773135842978,0.717391304347826,0.9155829615967732,1.0,2/30,3.15%,BCL3;BATF
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.35046953055943486,0.8004187674646469,0.7130559540889526,0.9157359831920625,1.0,11/19,26.61%,FLOT2;APOE;PICALM;PRNP;PIN1;CLU;RTN2;ROCK1;BIN1;CHRNA7;GGA3
prerank,response to interferon-alpha (GO:0035455),-0.2896081895604218,-0.800390015839828,0.7261146496815286,0.9443378437892762,1.0,6/16,21.83%,GAS6;ADAR;IFNAR1;RO60;BST2;PDE12
prerank,meiosis I (GO:0007127),0.3325845428984572,0.8003710773304561,0.7250673854447439,0.915420936584082,1.0,3/23,12.98%,MYBL1;ZSCAN21;FOXJ3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3133224967868866,0.8002275449973896,0.7434620174346201,0.9152469536774414,1.0,10/35,20.45%,PDGFRB;NUAK1;FKBP1B;PPP1R2;GSK3B;CALM2;ITGA1;PTPA;HSP90B1;PPP6R2
prerank,carboxylic acid metabolic process (GO:0019752),-0.23424981663362537,-0.8000639800766864,0.8009708737864077,0.9435351687474525,1.0,7/33,15.75%,DDO;SLC2A1;GLUD1;CSGALNACT1;CARNMT1;CYB5A;LIAS
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.33471548658723166,0.7997285761372246,0.7122302158273381,0.9156140521231894,1.0,6/20,15.67%,ZMIZ1;DCUN1D1;TGFBR1;WASHC1;ITCH;HIF1A
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3833829490466593,0.7996581127541972,0.7264,0.9153313892866846,1.0,1/12,2.62%,IRS1
prerank,regulation of cellular protein localization (GO:1903827),0.30032574592277905,0.7995092585708241,0.7558139534883721,0.9151887214810814,1.0,11/45,15.66%,GPC6;ABCA2;SHH;EGF;PTPN1;GBF1;LCP1;SETD2;CEP72;VCPIP1;NDEL1
prerank,tRNA transport (GO:0051031),0.31115801253902226,0.7989906522340113,0.7372448979591837,0.9156144494069429,1.0,11/35,21.73%,NUP37;XPOT;RAE1;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107;YBX1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.33362731632064613,-0.7988719084458313,0.7387640449438202,0.9429491329893119,1.0,3/10,33.75%,CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.33362731632064613,-0.7988719084458313,0.7387640449438202,0.9429491329893119,1.0,3/10,33.75%,CACNA2D4;TULP1;CNGB1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3151718821844471,0.7984567105820181,0.7341115434500648,0.9160725729320157,1.0,9/31,20.69%,ZFPM2;TGFBR1;TNNC1;TGFB2;SMAD4;TNNT2;RBPJ;TPM1;BMPR1A
prerank,icosanoid biosynthetic process (GO:0046456),0.38686854708904295,0.7983275003847959,0.6984615384615385,0.9158875545616417,1.0,2/10,14.60%,FADS1;PLA2G4A
prerank,regulation of protein ubiquitination (GO:0031396),0.270126995378022,0.7981658788874255,0.8045112781954887,0.9157556583642159,1.0,14/108,9.70%,LRRK2;MYCBP2;TNFAIP3;BIRC3;PRICKLE1;NXN;PINX1;SASH1;ANGPT1;DCUN1D1;FBXW7;TGFBR1;OGT;UBE2L3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3443032743132979,0.7981253881736675,0.7336122733612274,0.9154271629258856,1.0,3/21,6.15%,ADCY7;ADCY2;NPR2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.3406974680662504,0.7977612036617995,0.7259475218658892,0.9155700757309839,1.0,3/18,12.29%,SPN;ADD2;TNF
prerank,peptidyl-lysine acetylation (GO:0018394),0.3974399971075197,0.7975468280747463,0.7294303797468354,0.915512882853256,1.0,2/10,7.04%,CREBBP;BAG6
prerank,protein localization to lysosome (GO:0061462),0.3205150936251868,0.797259211892998,0.7298335467349552,0.9155352687031931,1.0,7/28,17.84%,AP4M1;VPS4A;RAB7A;KPTN;NEDD4;LAMTOR5;ZFYVE16
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3793219363368748,0.7971332312178343,0.7120980091883614,0.914944703516343,1.0,5/11,24.21%,PKD2;FKBP1B;CALM2;GSTM2;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3793219363368748,0.7971332312178343,0.7120980091883614,0.914944703516343,1.0,5/11,24.21%,PKD2;FKBP1B;CALM2;GSTM2;CALM3
prerank,myelination in peripheral nervous system (GO:0022011),-0.30101498901958224,-0.7965847310931031,0.7288135593220338,0.9455538653721687,1.0,6/13,17.70%,ARHGEF10;PARD3;ADGRG6;SOD1;SKI;PRX
prerank,endocardial cushion development (GO:0003197),0.34288802556572995,0.7959133190073032,0.7283072546230441,0.9163682796376068,1.0,4/21,11.44%,TBX2;ACVR1;HEYL;TGFB2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.26338353391825187,-0.7958849560058816,0.7803921568627451,0.9454256660823265,1.0,12/22,28.70%,ERCC3;UBC;CHD1L;DDB2;GTF2H2;GTF2H4;UBA52;GTF2H3;CETN2;RBX1;PARP1;XPC
prerank,protein hydroxylation (GO:0018126),0.3620080682282841,0.795777898206891,0.7188405797101449,0.9161894156767922,1.0,1/15,1.48%,PLOD2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.27666184629620105,0.7956605122253005,0.801063829787234,0.9159780984440802,1.0,27/93,22.19%,TNKS1BP1;EGFR;NCK1;PTEN;PRKD2;NCK2;RASSF2;RPTOR;CNKSR3;FNIP1;SPRY2;TNF;NLRP2B;NTRK3;AKAP9;PDCD10;NSD1;STK4;AKT1;IRGM;EIF4G1;SPTBN4;TRIM6;AXIN1;PAK1;RAF1;LATS1
prerank,response to muramyl dipeptide (GO:0032495),0.3777234679594299,0.7955539599355258,0.7304747320061256,0.9157502348676266,1.0,2/12,11.01%,NOD1;ERBIN
prerank,response to purine-containing compound (GO:0014074),0.34879191401386705,0.7950891545757062,0.7178002894356006,0.9160750702473872,1.0,4/17,22.13%,STAT1;P2RX7;NDUFS4;TRPM2
prerank,cellular respiration (GO:0045333),-0.23116540494361174,-0.7950788995196993,0.8206521739130435,0.9454550773101437,1.0,20/41,29.96%,ME3;NDUFS1;PPARGC1A;UQCRC2;COX10;ETFRF1;ATP5F1D;UQCRB;ETFB;SDHAF4;UQCRH;UQCRFS1;LYRM7;MTFR1L;MTLN;NR4A3;UQCR10;MTFR2;SLC25A14;SDHA
prerank,positive regulation of wound healing (GO:0090303),0.3073302544038053,0.7950652691881225,0.7340966921119593,0.915731674736582,1.0,6/36,11.22%,APOH;HPSE;ANXA1;MYLK;PTK2;VTN
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3192062537243954,0.7947296853570995,0.7348951911220715,0.9158386826216842,1.0,6/31,12.44%,BBC3;E2F1;BCL2;YWHAZ;CASP8;GSK3B
prerank,mRNA metabolic process (GO:0016071),-0.19409208148646956,-0.7944317679904608,0.9438202247191011,0.9451998998468493,1.0,37/90,27.78%,SFPQ;DDX5;SRSF5;PPARGC1A;CNOT10;U2AF2;GEMIN2;RIDA;LSM6;PCBP3;SNRPG;SRSF7;SRSF9;NUDT12;ERN1;SRRM4;LSM5;HNRNPR;SNRPD3;RNASE4;SUPT4H1;HNRNPA0;PRPF8;ZFP36;LSM11;AGO3;TP53;TBRG4;SF3A1;SF3A3;LSM10;SF3B4;NUDT16;NUDT16L1;AGO4;U2AF1;HSPA1A
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.29901554477580616,0.7938000199521668,0.7386759581881533,0.9168005049275554,1.0,15/44,25.00%,SIAH2;SH3RF1;CSNK2A1;FNIP1;DNAJB6;TNF;SRC;LAMTOR5;AKT1;YWHAE;CAST;RAF1;RPS6KA3;PCID2;VEGFA
prerank,negative regulation of biosynthetic process (GO:0009890),0.3525021863040414,0.7930984161695203,0.7181303116147308,0.9174350226091127,1.0,4/16,20.52%,EMILIN1;TRAP1;COA8;SLC18A2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.29066206591457816,-0.7929842078745276,0.7337461300309598,0.9463176871040693,1.0,7/15,19.93%,SYN3;ADRA1A;CNTNAP4;CLN3;USP46;NLGN1;DRD2
prerank,response to steroid hormone (GO:0048545),0.3163092530807879,0.792862376613911,0.7426376440460948,0.9173936142735881,1.0,6/31,14.47%,YAP1;ABCA2;TGFB3;UBE2L3;TGFB2;CATSPER3
prerank,regulation of lamellipodium assembly (GO:0010591),0.3124513074000272,0.7928619692130217,0.752851711026616,0.917010622686704,1.0,8/34,14.73%,AUTS2;FSCN1;CDC42;ABI2;ACTR2;BRK1;PIK3R1;RAC1
prerank,mitochondrial transport (GO:0006839),-0.21210911373684047,-0.7926951579497463,0.8941176470588236,0.9454477957248426,1.0,22/53,27.20%,HSP90AA1;FLVCR1;DNAJC19;BCAP31;SLC25A4;BCL2L1;COX18;TIMM17B;GDAP1;ABCB10;BNIP3;TOMM20;STARD3;BCS1L;TIMM22;TOMM70;TIMM8B;TOMM5;TOMM40;PPIF;MFF;TIMM9
prerank,glycoprotein biosynthetic process (GO:0009101),0.28112211402846404,0.7925394662923754,0.7883771929824561,0.9170878101943594,1.0,16/79,18.25%,TNIP1;B4GALT5;CHST13;ST3GAL3;DDOST;ALG5;TMEM106A;CHST11;GCNT2;PMM2;B4GALT7;COG7;FAM20B;B3GNT9;ATP7A;FUT4
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.3145410420826322,-0.7922618445614238,0.773936170212766,0.9448436364765304,1.0,5/11,13.07%,ITM2A;BACE2;NECAB1;ITM2C;ABCA7
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.37930492308141067,0.7918903310340379,0.7091194968553459,0.9176703099777488,1.0,2/12,13.29%,PTPN1;PIK3R1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.24894902181385867,-0.7917637723913502,0.8076923076923077,0.9443893166579894,1.0,12/25,32.52%,PRPF6;PRPF4;GEMIN2;PRPF8;TXNL4A;SF3A3;SF3B4;LSM1;SRSF10;BCAS2;MPHOSPH10;WDR83
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.27616498029039743,-0.7915972798318596,0.7802547770700637,0.9433034066313646,1.0,8/17,24.49%,SFPQ;HSPB1;SOD1;SOD2;NME5;PPIA;HTRA2;MAPK7
prerank,positive regulation of cellular protein localization (GO:1903829),0.2802297161116982,0.7915567456964219,0.7697594501718213,0.9177527085711659,1.0,16/69,17.60%,YAP1;CENPQ;TM9SF4;PLK1;WWTR1;SNX33;ENTR1;TNF;GSK3B;GNL3;ORMDL3;DDRGK1;DTX3L;LAMTOR5;AKT1;EIF2AK3
prerank,atrial septum development (GO:0003283),-0.2957808049632854,-0.7915443196077967,0.7365439093484419,0.9420436431267808,1.0,4/13,18.68%,ANK2;MDM4;HEY2;ZFPM1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.3857043459144725,0.7912735724821635,0.702954898911353,0.9177846709186341,1.0,1/10,3.36%,ETFA
prerank,GPI anchor biosynthetic process (GO:0006506),0.31849619444553245,0.7908896618536391,0.7538461538461538,0.91798940558488,1.0,9/30,21.18%,PIGW;PIGN;PIGL;PIGC;PIGP;PIGH;PIGT;MPPE1;PIGK
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.364313607420605,0.7902589029876339,0.7031963470319634,0.9185287609801507,1.0,3/13,7.90%,CACNA1C;KCNA5;GJC1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.27975020842396486,-0.7900701102178393,0.7796610169491526,0.9431603513205403,1.0,6/19,15.74%,PRKN;SREBF2;CAMKK2;VDAC1;PINK1;DNM1L
prerank,positive regulation of dendrite development (GO:1900006),0.3869374533431786,0.7900533712540008,0.71658615136876,0.9184269250910435,1.0,3/10,14.04%,PTN;BMP5;BMP7
prerank,negative regulation of histone methylation (GO:0031061),0.3761321689550055,0.7897493420598105,0.7287581699346405,0.9184679278354746,1.0,3/10,19.43%,PHF1;DNMT3B;KDM1A
prerank,regulation of exocytosis (GO:0017157),0.2967630919688887,0.7896962973242038,0.7590799031476998,0.918160466991617,1.0,8/46,9.93%,RAB2B;RALA;RAB21;UNC13D;RAB8B;ANXA1;RAB9A;RAB27B
prerank,phagolysosome assembly (GO:0001845),0.37344754299699795,0.7894076672448075,0.7136498516320475,0.9182092105473797,1.0,3/12,13.84%,RAB7A;RAB7B;RAB34
prerank,C-terminal protein amino acid modification (GO:0018410),-0.31408459092069,-0.7886670276456046,0.7445054945054945,0.9442592842408555,1.0,3/11,10.52%,FOLH1;ATG12;GPLD1
prerank,ERAD pathway (GO:0036503),-0.19464991033369836,-0.7881590437222921,0.9230769230769231,0.9438037276658588,1.0,26/83,26.81%,PRKN;STT3B;ATXN3;ERLIN1;JKAMP;UBXN4;UBE4A;DNAJC18;DNAJB9;ERLIN2;DERL1;ANKZF1;TOR1A;WFS1;UBXN6;RNF185;UFD1;YOD1;SGTA;FBXO44;RNF5;NPLOC4;RNF139;UBQLN2;CCDC47;DNAJB2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.38380944533347483,0.7877236238001143,0.7387820512820513,0.9203012095230019,1.0,1/10,3.10%,NELL1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3281367553834218,0.7874207532004639,0.7424657534246575,0.9203422145264716,1.0,8/25,23.06%,LRRK2;NPAS4;GSK3B;RAB3GAP1;AKT1;GRIN2A;NPFF;MAPK8IP2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.35625692919876445,0.7873476020466291,0.6933333333333334,0.9200719069526889,1.0,4/14,17.47%,TSEN2;TRPT1;RTRAF;DDX1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3941572789501431,0.787309939323456,0.724960254372019,0.9197423148954232,1.0,2/10,5.95%,BATF;SFRP1
prerank,regulation of microtubule nucleation (GO:0010968),-0.332857826472777,-0.7864775036000916,0.7520891364902507,0.9454039867359504,1.0,2/10,11.09%,EML2;GIT1
prerank,positive regulation of axon extension (GO:0045773),0.33075938648551056,0.7863912057914905,0.728021978021978,0.9206893669372097,1.0,5/22,11.62%,NRP1;L1CAM;DBN1;DSCAM;DBNL
prerank,calcium ion transport into cytosol (GO:0060402),0.3347700509865774,0.7863487529490564,0.7156462585034014,0.9203716842011486,1.0,3/21,9.76%,CACNA2D1;CACNA1C;MS4A1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2851884909904615,0.7862370921529691,0.7658592848904268,0.9201336538693234,1.0,20/57,23.00%,PES1;NOC2L;WDR74;NOP14;NIP7;GTF3A;LTO1;DDX31;RPL14;RPL11;NOP16;BYSL;TGS1;HEATR3;PAK1IP1;RIOK2;XPO1;DHX37;NOM1;RRP36
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.3153732469528898,0.7860928974338188,0.7396694214876033,0.9199705087381937,1.0,9/26,20.32%,SNAI2;BCL2;TERT;FGFR1;UNC5B;TNF;AKT1;INHBA;GDNF
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.33394656583074883,0.7856389627045207,0.7537619699042407,0.9202333804371974,1.0,9/22,25.00%,SASH1;PJA2;SPI1;MFHAS1;XDH;GADD45A;ZC3H12A;RELL1;VEGFA
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.32460779026854947,0.7852994020718178,0.7383561643835617,0.9203387267818381,1.0,2/23,3.02%,SLC9A1;SLC12A4
prerank,indolalkylamine catabolic process (GO:0046218),0.39394112699684364,0.7849721368581593,0.7216828478964401,0.9204206749359954,1.0,1/10,7.20%,KYAT1
prerank,protein depolymerization (GO:0051261),-0.24413754262686638,-0.7840825670836729,0.8305785123966942,0.9479482276319656,1.0,11/27,25.67%,GSN;MICAL3;TWF2;STMN2;STMN3;MICAL1;CFL1;TWF1;KIF18A;STMN1;WDR1
prerank,negative regulation of neuron death (GO:1901215),0.2710240271397937,0.783263983813664,0.8191721132897604,0.9225089949397455,1.0,26/93,22.97%,LRRK2;APOE;CHMP4A;CHMP4B;MDK;BCL2;PTPRZ1;TGFB3;GPNMB;CCL2;FBXO7;UNC5B;GSK3B;TRAF2;CPEB4;RASA1;AKT1;ATF4;TYRO3;GDNF;EIF4G1;VPS35;CSF1;SNX6;FZD9;CD200R1
prerank,protein tetramerization (GO:0051262),-0.1897033032205286,-0.7830216530712814,0.9043478260869565,0.9483151943375222,1.0,23/67,28.76%,KCNJ2;SAMHD1;UPB1;GRIN2B;ALDH9A1;GOLGA2;KCNJ12;GBP5;SSBP1;KCNC1;HCN1;SOD2;CBR4;GLS;USP16;APIP;KCNC3;CRYZ;PKD2L1;CTH;TRPA1;CBY1;HSD17B10
prerank,protein alkylation (GO:0008213),0.3360021841223131,0.7828668911303123,0.7374830852503383,0.9227000809497705,1.0,11/22,27.43%,CAMKMT;VCPKMT;PCMT1;GSPT1;ETFBKMT;PRMT3;SNRPB;ETF1;EEF2KMT;FAM98A;METTL21A
prerank,histone H2A monoubiquitination (GO:0035518),-0.2719634073271803,-0.7825714943994457,0.7906137184115524,0.9476891782833936,1.0,2/17,1.99%,PCGF5;TRIM37
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.32774144010046896,0.7817643781012208,0.7552447552447552,0.9238735019923803,1.0,4/23,10.06%,DICER1;SETMAR;FBH1;HMGB2
prerank,glycosphingolipid metabolic process (GO:0006687),0.2950893669643854,0.7816946628087872,0.7824474660074165,0.9235916508001882,1.0,10/42,17.90%,UGCG;ABCA2;B4GALNT1;CLN6;SMPD3;NEU3;GALC;NEU1;CTSA;CPTP
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.37389559703848585,0.781433359159988,0.7641509433962265,0.9235752261106597,1.0,6/12,23.08%,ABCA2;H6PD;SREBF1;LPCAT3;SEC14L2;KPNB1
prerank,regulation of centriole replication (GO:0046599),0.33983794836490633,0.7810929280564202,0.7288135593220338,0.9236784619336222,1.0,2/17,5.80%,CEP295NL;ALMS1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.30596640790475876,0.7809770248668034,0.7569974554707379,0.9230905070651694,1.0,13/31,24.54%,GTF2H1;GTF2F2;NCBP2;RAMAC;CDK7;GTF2F1;POLR2L;POLR2K;ERCC2;CCNH;POLR2D;MNAT1;RNMT
prerank,7-methylguanosine RNA capping (GO:0009452),0.30596640790475876,0.7809770248668034,0.7569974554707379,0.9230905070651694,1.0,13/31,24.54%,GTF2H1;GTF2F2;NCBP2;RAMAC;CDK7;GTF2F1;POLR2L;POLR2K;ERCC2;CCNH;POLR2D;MNAT1;RNMT
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.3186143420394557,0.7807913991985589,0.7352150537634409,0.9229695969878481,1.0,3/23,4.89%,MYO10;KIF1C;HOOK2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.30243264793386465,0.7804902759017391,0.7635220125786164,0.9230319704346162,1.0,5/37,7.14%,JAML;TENM3;DCHS1;ICAM1;TENM4
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.31761725319580214,0.7802004725386265,0.746971736204576,0.9230550549456902,1.0,10/24,26.49%,DNAAF4;APOE;CTSC;PSMD14;TMF1;LATS1;USP14;ATP5IF1;RHBDF1;EFNA1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.30896138384648386,0.7797669032670684,0.768324607329843,0.9232860351276063,1.0,7/32,18.59%,BACH1;E2F1;CDK14;BRD4;CDK16;FBXO5;HINFP
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3362270689154113,0.7797558587578531,0.745125348189415,0.9229173667812246,1.0,2/20,5.12%,B4GALNT2;ST3GAL3
prerank,myelination (GO:0042552),0.2903683775822714,0.7796437976152257,0.7754854368932039,0.9226918523117009,1.0,4/46,5.10%,TNFRSF21;B4GALT5;PMP22;NF1
prerank,phospholipid biosynthetic process (GO:0008654),-0.22726339497206963,-0.7795943920040788,0.8,0.9512612574941505,1.0,10/36,20.25%,MBOAT1;SGMS1;PCYT2;SGMS2;CLN3;AGPAT3;HDHD5;IDI1;DHDDS;FDPS
prerank,GPI anchor metabolic process (GO:0006505),0.31830226579383253,0.7793314106855807,0.7528662420382166,0.9227268328997604,1.0,6/26,16.13%,PIGW;PIGN;PIGL;PIGC;PIGP;PIGH
prerank,insulin receptor signaling pathway (GO:0008286),0.27702286489006783,0.779270353127689,0.8128587830080367,0.9224337955511119,1.0,12/69,13.35%,SLC39A14;IRS1;BAIAP2;AP3S1;SH2B2;GRB2;PTPN2;ATP6V1F;GSK3B;ATP6V1H;PIK3R1;ATP6V1G2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3122222839080113,0.7790388254659228,0.7542483660130719,0.922384259694656,1.0,5/29,14.06%,JAK2;GRB2;ERBIN;VAV1;SRC
prerank,membrane organization (GO:0061024),0.2563971485043659,0.7790337171979116,0.8937246963562753,0.922012514571437,1.0,47/227,19.09%,CLTC;STON2;SH3KBP1;EGFR;ITSN1;CHMP4A;CHMP4B;RABIF;TLCD2;DNAJC6;EGF;VPS4A;VAPA;EPS15L1;LEMD2;ACTR2;AP3D1;CBL;SYT2;GRB2;WNT5A;GAK;SNX9;AGFG1;EPS15;CHMP7;BTC;TMCC1;AZIN2;AP2A2;STX11;CHMP2B;TIMM50;SUN1;RTP4;TOR1AIP2;REPS1;SH3GLB1;LPCAT3;CTTN;KIF20A;PICALM;CPTP;TOR1AIP1;SPTBN1;GAPVD1;DVL2
prerank,embryonic axis specification (GO:0000578),0.3524692659220643,0.7789878256838796,0.7411764705882353,0.9216965838997424,1.0,2/15,10.21%,SMAD2;TBX3
prerank,negative regulation of RNA splicing (GO:0033119),0.3353206716222176,0.778387274004694,0.7457386363636364,0.9221741058032666,1.0,5/19,15.89%,PTBP3;SAP18;SFSWAP;SRSF12;RBMX
prerank,purine-containing compound catabolic process (GO:0072523),0.36220416030444014,0.7779577343623931,0.7350157728706624,0.9223688787313302,1.0,4/13,18.52%,GDA;DPYD;NT5C1A;XDH
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3795689062208951,0.77754065477286,0.7467741935483871,0.9225697915551185,1.0,3/10,17.06%,MAP2K1;NBR1;MAPK1
prerank,negative regulation of ion transport (GO:0043271),0.32680577051123544,0.7773342396776188,0.7570469798657719,0.9224749805349911,1.0,5/24,18.32%,GPM6B;PXK;HRH3;NEDD4;HTR1B
prerank,regulation of myotube differentiation (GO:0010830),0.3249580158784403,0.7772539723603964,0.7520215633423181,0.9222111262768736,1.0,7/24,18.87%,MMP14;TMEM119;HDAC1;MAML1;HDAC5;PIEZO1;ATP11A
prerank,positive regulation of DNA binding (GO:0043388),0.3043668741483904,0.7770684868914809,0.7506329113924051,0.9220985025607186,1.0,4/31,10.06%,EGF;PPARG;PINX1;HMGB2
prerank,mitotic cytokinesis (GO:0000281),0.29551180929933,0.7767797747633575,0.7861557478368356,0.922129794932114,1.0,17/47,23.85%,JTB;CHMP4B;PLK1;SNX18;SNX33;SNX9;RTKN;RASA1;TTC19;KIF20A;SPTBN1;SON;RHOC;ROCK2;ROCK1;PDCD6IP;RAB35
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.34287247474067767,0.7767213522134431,0.7358757062146892,0.9218265887344559,1.0,5/16,23.20%,MCM2;MCM7;TWNK;RPA1;RAD51
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2925771700738268,0.7762699021358787,0.7811764705882352,0.9220900747171608,1.0,4/44,9.82%,CYP7B1;INSIG2;SLC27A2;OSBPL3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.33176678812499955,0.7755986566592847,0.7649456521739131,0.9226804239461235,1.0,6/21,12.46%,NCK1;PTEN;NCK2;RASSF2;CNKSR3;NLRP2B
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3115462400688519,0.7744263094138729,0.7647831800262812,0.9239534835986557,1.0,4/30,7.90%,CACNA2D1;CACNA1C;KCNA5;GJC1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.3169078229773135,0.7743358377516556,0.7642956764295676,0.923700241542422,1.0,7/23,20.32%,MDK;EGF;FGF2;SMO;PAX8;AGT;GDNF
prerank,carboxylic acid transmembrane transport (GO:1905039),0.29477284379711854,0.7742524370144871,0.7701711491442543,0.9234350766538569,1.0,10/40,21.44%,SLC38A3;SLC7A7;SLC38A4;SLC36A2;SLC7A8;ABCC1;SLC25A10;SLC19A1;SLC36A4;SLC25A21
prerank,protein stabilization (GO:0050821),0.2581061473961445,0.7740985372624045,0.8806584362139918,0.9232600224052219,1.0,35/168,17.09%,FLOT2;USP9X;PARVA;BAG3;PTEN;MORC3;RAB21;LAMP2;BAG6;RASSF2;FBXW7;CCT8;TBL1X;CDC37;OTUD3;SEC16A;GAPDH;TRIM44;PEX19;ZBED3;CALR;CDK7;PIK3R1;CCT3;COA8;RPL11;PDCD10;NAA15;MTMR9;COG7;STK4;ATF7IP;BAG4;PEX6;HSPD1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3064974726988652,-0.7740170099616137,0.7720797720797721,0.9590951121905426,1.0,3/12,11.90%,GCLC;HAGH;CHAC2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.335570477029074,0.773790087585937,0.7489177489177489,0.9233128880952799,1.0,5/18,13.84%,APOE;ABCA2;MSN;CTSC;DACT1
prerank,protein maturation (GO:0051604),0.2658522680848278,0.7735780330819485,0.8089033659066233,0.9232420511969383,1.0,20/95,21.31%,MMP14;ADAM19;NAA50;CTSS;CPXM1;MMP16;OGT;LMF2;PSEN1;XPNPEP3;MMS19;NAA15;PSENEN;TSPAN14;HSPD1;AANAT;PHEX;NCSTN;PITRM1;PSEN2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3041536352518798,0.7728923904981635,0.7544529262086515,0.9238365048358202,1.0,9/32,19.69%,ATM;ATR;CCT8;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB
prerank,spermatid development (GO:0007286),0.30239178019088986,0.7727721095403737,0.766624843161857,0.9236331876189305,1.0,3/32,8.47%,IQCG;ACRBP;ZMYND15
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.290030388412965,-0.7726349204691797,0.7784431137724551,0.9598968679558451,1.0,2/14,7.23%,ME1;NMNAT3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3724557817727774,0.7724425223493807,0.7147286821705426,0.9237246194287855,1.0,3/11,15.12%,EGFR;MAP2K1;RIPK1
prerank,response to copper ion (GO:0046688),-0.26244800533214513,-0.7719047044889953,0.7894736842105263,0.9597165538894722,1.0,14/20,45.67%,MT2A;ATP5F1D;HSF1;ATP7B;AQP1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;SNCA
prerank,response to organophosphorus (GO:0046683),0.3453925885281652,0.7711020072903029,0.7303703703703703,0.9252557576278223,1.0,2/16,12.90%,STAT1;P2RX7
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.2501814105095643,-0.7704048883050876,0.8122866894197952,0.9606760776654543,1.0,3/23,5.90%,TGFBR3;PROX1;FGFR2
prerank,organelle fusion (GO:0048284),-0.24916956672284063,-0.7693977318290453,0.8237410071942446,0.9609458286793388,1.0,5/22,14.58%,MIGA1;VPS11;MFN1;USP30;GDAP1
prerank,regulation of telomere maintenance (GO:0032204),-0.2366380462489442,-0.7692911096288627,0.8408163265306122,0.959755190804041,1.0,7/26,18.27%,MRE11;PPP1R10;RTEL1;UPF1;USP7;ERCC1;DHX36
prerank,regulation of response to oxidative stress (GO:1902882),-0.3063749697605988,-0.7683825142501456,0.775,0.9597792867893631,1.0,2/11,2.89%,PRKN;MCTP1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.22915068600518074,-0.7678895668696505,0.8595744680851064,0.9591737451810114,1.0,14/29,28.70%,ERCC5;ERCC3;UBC;CHD1L;DDB2;GTF2H2;GTF2H4;UBA52;GTF2H3;CETN2;RBX1;RPA2;PARP1;XPC
prerank,protein glycosylation (GO:0006486),0.2591532038605957,0.7678655685987793,0.851619644723093,0.9293605188737553,1.0,21/125,16.66%,MGAT5;PLOD2;B4GALT5;GFPT2;TRAK1;ST3GAL3;DDOST;ALG5;OGT;MAN1C1;MGAT4A;STT3A;ST3GAL1;GCNT2;TET2;TUSC3;PMM2;B4GALT7;RPN1;COG7;B3GNT9
prerank,negative regulation of defense response to virus (GO:0050687),0.37435376175029583,0.7670968998048057,0.7369281045751634,0.9300504505456623,1.0,2/10,15.59%,ILRUN;ITCH
prerank,tRNA processing (GO:0008033),-0.19334904780236406,-0.7669596134568961,0.9421487603305785,0.9592700271935367,1.0,19/61,21.28%,RTCB;TRMT9B;CSTF2;DTWD2;TYW5;ELP5;FAM98B;TRDMT1;QTRT1;NSUN6;TRMT10A;LCMT2;PTCD1;CDKAL1;POP5;SARS1;TRMT10B;ADAT1;CLP1
prerank,cellular response to amino acid starvation (GO:0034198),0.27280689780117756,0.7669233735765049,0.8260381593714927,0.9299108335523356,1.0,19/71,18.35%,DAP;MIOS;NPRL2;EIF2AK2;RPTOR;RRAGC;KPTN;ATP6V1F;ATP6V1H;ATP6V1G2;LAMTOR5;ATP6V1G1;SEC13;SH3GLB1;MAPK1;ATP6V1D;EIF2AK3;ATF4;LAMTOR3
prerank,negative regulation of metabolic process (GO:0009892),0.27690829208663004,0.7669029266430448,0.8037602820211516,0.9295606288100202,1.0,6/54,10.88%,ADIPOQ;LAMA4;ADAMTS5;ARRDC3;PLCL1;ACOT13
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.2852793557204846,-0.7668419446949485,0.7514792899408284,0.9581142992187536,1.0,3/15,9.42%,PRKN;BCL2L1;IGF1
prerank,chromatin assembly or disassembly (GO:0006333),0.36879994491890544,0.7667714058744148,0.7442922374429224,0.9293643006658637,1.0,2/11,9.89%,NOC2L;MTA2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.32394774447801095,0.7666044650330545,0.7476510067114094,0.9292014177664597,1.0,1/23,0.98%,MMP14
prerank,negative regulation of protein kinase activity (GO:0006469),0.2653637473222968,0.7665578684362249,0.8240437158469945,0.9288901919515187,1.0,25/88,19.84%,SPRED1;NF1;TAF7;DTNBP1;LRP6;EPHA1;PTPN1;GSKIP;PYDC1;MVP;WWTR1;DUSP26;UBASH3B;SMCR8;SH3BP5L;TRIB3;CDKN1B;TRIB1;RTRAF;ITGB1BP1;PTPRC;AKT1;LRP5;GADD45A;CORO1C
prerank,lung epithelium development (GO:0060428),0.37074372762415575,0.7664854741376197,0.7424,0.928609983285313,1.0,2/10,11.52%,ERRFI1;RCN3
prerank,positive regulation of telomerase activity (GO:0051973),-0.22687459295818185,-0.7664302526172195,0.8680851063829788,0.9573775894540554,1.0,10/33,22.45%,HSP90AA1;KLF4;CCT4;DKC1;PRKCQ;HMBOX1;MAPK3;NVL;HSP90AB1;TNKS
prerank,regulation of monooxygenase activity (GO:0032768),0.3255232891520933,0.7662507365613436,0.7827260458839406,0.9285722737121248,1.0,4/23,9.94%,NOS1AP;EGFR;POR;CYGB
prerank,pore complex assembly (GO:0046931),-0.25718554363694607,-0.7662177847330477,0.7901639344262295,0.9563674023873768,1.0,7/19,22.48%,PLEKHA7;ADAM10;TMEM170A;GSDMD;AFDN;NUP98;NUP93
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3501248942672796,0.7658424596574186,0.7784431137724551,0.9287580749255552,1.0,4/14,15.89%,SAP18;SFSWAP;SRSF12;RBMX
prerank,RNA processing (GO:0006396),0.25358490871408573,0.7656675746782725,0.9019407558733401,0.9286219282599121,1.0,38/176,21.08%,RBMS1;PPP1R9B;APOBEC1;TSEN2;ATXN1;SYNCRIP;SNRNP40;DDX17;CCAR2;PABPC4;CELF1;RRAGC;NONO;DICER1;DHX8;ALKBH5;NCBP2;PRPF18;SNRNP35;ZCCHC8;RNPC3;RBM6;SETX;HNRNPUL1;DHX15;TCERG1;TUT7;PRPF3;DDX20;RBM39;SRSF2;SON;SNRPB;DUSP11;TENT4A;RBMS2;SCAF11;CDK12
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.30277057120800466,-0.7655711764688286,0.7768361581920904,0.9560033062612546,1.0,2/12,10.22%,CENPC;SEH1L
prerank,protein export from nucleus (GO:0006611),-0.24036810106380807,-0.7653884165464183,0.8249027237354085,0.9549552524087241,1.0,9/27,25.07%,RANBP3L;DESI1;STRADB;CSE1L;XPO5;DUSP16;XPO6;NUTF2;XPO4
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.31922963372722024,0.7652807215474111,0.7587601078167115,0.9287863906600607,1.0,5/24,15.59%,TNFAIP3;NOD1;IRAK2;CASP8;ITCH
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.2730747115639451,-0.7652740155921909,0.7885196374622356,0.953800603184795,1.0,2/16,2.73%,SOX13;HNRNPU
prerank,steroid biosynthetic process (GO:0006694),0.2798417164712895,0.7651986618104175,0.8029445073612684,0.9285337604742818,1.0,5/56,9.82%,CYP7B1;INSIG2;SLC27A2;HSD11B1;OSBPL3
prerank,response to nutrient levels (GO:0031667),0.33703450449487615,0.7649743726136765,0.7571428571428571,0.9284895228969184,1.0,5/17,20.36%,CD68;RPTOR;RPS6KB1;ATF4;EIF4G1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.29182795813872225,0.764857613042781,0.7747183979974969,0.9282695528617836,1.0,10/39,16.47%,PIP4K2A;PI4K2B;ITPKC;TTC7A;IP6K2;SOCS5;PI4KA;PIK3R1;EFR3A;PIK3C3
prerank,positive regulation of nervous system process (GO:0031646),0.32849946542426767,0.7646593411547942,0.7655571635311144,0.9281773902352611,1.0,6/18,17.61%,TENM4;HCRT;DICER1;EGR2;TPPP;NCMAP
prerank,acyl-CoA metabolic process (GO:0006637),0.2957819043357728,0.764634203962407,0.76625,0.9278342899006798,1.0,8/35,18.58%,DLST;ACSF2;SUCLG2;ACOT13;ACOT9;SUCLA2;MCEE;ACACA
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3654590140193455,0.7645935994430345,0.7278481012658228,0.927515068118309,1.0,3/11,12.48%,ITPKC;IP6K2;FGF2
prerank,peroxisomal membrane transport (GO:0015919),0.3023801350292826,0.7641940287179629,0.7894039735099337,0.9276637852420503,1.0,6/27,19.39%,PEX10;RAB8B;PEX19;ALDH3A2;PEX6;PEX12
prerank,regulation of fibroblast migration (GO:0010762),0.31932240339726065,0.764181540348332,0.7513966480446927,0.9273031063772438,1.0,7/20,19.84%,DDR2;PTK2;FGF2;RAC1;ITGB1BP1;GNA12;CORO1C
prerank,ribosomal subunit export from nucleus (GO:0000054),0.35717424982063645,0.764152948354348,0.7571644042232277,0.9269687725503888,1.0,2/13,7.77%,ABCE1;NMD3
prerank,regulation of dendrite extension (GO:1903859),-0.26747439320174454,-0.7638700096344381,0.7737704918032787,0.9545928818513577,1.0,8/18,28.12%,ITSN2;RIMS1;RNF157;RIMS2;SYT3;NEDD4L;CPNE9;CPNE5
prerank,mitochondrial fusion (GO:0008053),0.333102540851842,0.7636684096600811,0.7568740955137482,0.9272336883116251,1.0,3/18,12.76%,STOML2;MIGA2;SPG7
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.23254358785040846,-0.763369752297291,0.8628318584070797,0.954044403354902,1.0,7/34,11.06%,GRID2;GABRA2;GABRG3;GABRA5;GLRA1;GRIN2D;GRIN2B
prerank,glutathione biosynthetic process (GO:0006750),-0.310955946224011,-0.7633255535626213,0.7520435967302452,0.9527982835600521,1.0,3/11,11.90%,GCLC;HAGH;CHAC2
prerank,glycerolipid metabolic process (GO:0046486),0.36213497618208773,0.7628258155281266,0.7307086614173228,0.9280070475932585,1.0,1/11,1.24%,PDXP
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.2713270380033346,-0.7626049766127269,0.7935483870967742,0.9526150480195791,1.0,5/17,13.07%,NTRK2;RTN1;SORL1;IGF1;ABCA7
prerank,positive regulation of dendrite extension (GO:1903861),-0.2730840554919555,-0.7625442595469296,0.7974683544303798,0.9513960635367762,1.0,8/17,28.12%,ITSN2;RIMS1;RNF157;RIMS2;SYT3;NEDD4L;CPNE9;CPNE5
prerank,peptide metabolic process (GO:0006518),0.26967879695141095,0.7622852032165389,0.8191964285714286,0.9283655026261924,1.0,11/75,13.92%,DNPEP;ANPEP;CPQ;CPXM1;NPEPPS;ENPEP;NLN;GSTK1;SPPL3;LVRN;PSEN1
prerank,regulation of secretion by cell (GO:1903530),0.2831103927751094,0.76192666586589,0.8091334894613583,0.9284903947226099,1.0,11/54,16.28%,DNAJC1;RALA;RAB21;LLGL1;RAB8B;KCNMB4;ANXA1;HCRT;RAB10;FMR1;MCTP2
prerank,nucleoside catabolic process (GO:0009164),-0.305600607323534,-0.7616835477412504,0.7606382978723404,0.9513736727366551,1.0,5/11,18.00%,NT5E;UPB1;NT5C3A;DERA;NT5C
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2784269290886745,0.7615476624512655,0.8057553956834532,0.9282551422563136,1.0,15/50,20.96%,NUP37;PUM1;RAE1;NUP153;FMR1;NDC1;NUP35;NUP188;SEC13;POLR2L;POLR2K;NUP214;AGO2;EIF4G1;NUP107
prerank,regulation of gene silencing by RNA (GO:0060966),0.2784269290886745,0.7615476624512655,0.8057553956834532,0.9282551422563136,1.0,15/50,20.96%,NUP37;PUM1;RAE1;NUP153;FMR1;NDC1;NUP35;NUP188;SEC13;POLR2L;POLR2K;NUP214;AGO2;EIF4G1;NUP107
prerank,regulation of dendrite development (GO:0050773),0.29049029262528786,0.7613667366509501,0.8017676767676768,0.9281283800306184,1.0,10/37,15.60%,PTN;MARK1;RAP2A;SDC2;BMP5;DBN1;CAMSAP2;GSK3B;BMP7;NEDD4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2780588468905202,0.7613450458813703,0.8145539906103286,0.9277824260233087,1.0,6/54,7.75%,TNKS1BP1;E2F1;CNOT4;ATM;E2F8;CARM1
prerank,phagosome maturation (GO:0090382),0.298631121679669,0.7613370295111074,0.7833333333333333,0.9274186212225966,1.0,8/35,17.43%,RAB7A;RAB32;ATP6V1F;ATP6V1H;ATP6V1G2;RAB34;ATP6V1G1;ATP6V1D
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.32302914994629023,-0.7610695653833806,0.7718309859154929,0.9509264955956426,1.0,6/10,31.06%,APC;RCC2;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,pharyngeal system development (GO:0060037),0.3374296098566305,0.7609361460315163,0.7380281690140845,0.9275897228875658,1.0,8/15,28.12%,TGFBR1;BMP5;TGFB2;BMP7;BMPR1A;BMPR2;HES1;PTCH1
prerank,positive regulation of axonogenesis (GO:0050772),0.29115670007129496,0.7606273025048145,0.8126520681265207,0.9276305867526233,1.0,8/43,11.96%,ROBO2;PLXNC1;PLXND1;L1CAM;PLXNA3;DBN1;DBNL;RHOA
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3637827476373556,0.7602761179599303,0.7653543307086614,0.927740556895731,1.0,2/11,16.22%,RTP4;PKD1L3
prerank,lipid droplet organization (GO:0034389),-0.2446290788546283,-0.7597174685546216,0.8264150943396227,0.9515991785153136,1.0,7/22,25.62%,RAB18;CDS2;BSCL2;SQLE;PPIA;PLA2G4C;FITM2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.29209519389244754,0.7597157345070038,0.78031212484994,0.9281215360298584,1.0,12/42,20.23%,ACTR2;SHLD3;SETD2;FBH1;PPP4R2;TIMELESS;RIF1;PPP4C;MMS19;CGAS;KDM1A;ARID2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2481888822395251,-0.7597007727500235,0.8432835820895522,0.9503208092990978,1.0,15/24,35.18%,UBC;POLD3;PCNA;RFC3;UBA52;POLD2;RPA2;LIG4;POLE;RFC4;POLD4;RFC2;RPA3;POLK;RFC5
prerank,tRNA wobble base modification (GO:0002097),-0.2877491130363796,-0.7594669399731949,0.7974683544303798,0.9493775540102841,1.0,2/14,4.38%,ALKBH8;TRMT9B
prerank,macromolecule catabolic process (GO:0009057),0.31602715419403193,0.7593543731770221,0.8058510638297872,0.9282452012948923,1.0,12/26,28.88%,CLN6;KIF16B;PIK3R4;SNX25;SMURF1;NEDD4;SH3GLB1;BECN1;CLN5;CLPX;PPT1;SIAH1
prerank,tryptophan metabolic process (GO:0006568),0.3741766971428249,0.7589183851938806,0.7559808612440191,0.9284739948933546,1.0,2/11,18.03%,KYAT1;ATP7A
prerank,negative regulation of lyase activity (GO:0051350),-0.27512295103392875,-0.7582019840868259,0.7861271676300579,0.9498668810888534,1.0,2/16,5.48%,PALM;GRM3
prerank,response to amino acid starvation (GO:1990928),0.26966923101223567,0.7580568802373936,0.8413948256467941,0.9292844118614073,1.0,19/72,18.35%,DAP;MIOS;NPRL2;EIF2AK2;RPTOR;RRAGC;KPTN;ATP6V1F;ATP6V1H;ATP6V1G2;LAMTOR5;ATP6V1G1;SEC13;SH3GLB1;MAPK1;ATP6V1D;EIF2AK3;ATF4;LAMTOR3
prerank,tRNA metabolic process (GO:0006399),0.3350595919560557,0.7579285899686974,0.7685714285714286,0.9290751915689048,1.0,3/17,10.05%,TRPT1;POP1;DTD1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3240465424262189,0.7575195848417691,0.7452574525745257,0.9288731180955332,1.0,6/20,15.67%,ARNT;PFKFB4;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,positive regulation of glycolytic process (GO:0045821),0.3240465424262189,0.7575195848417691,0.7452574525745257,0.9288731180955332,1.0,6/20,15.67%,ARNT;PFKFB4;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,histone modification (GO:0016570),0.25902027469531314,0.7573527556397285,0.8521276595744681,0.9287365138035342,1.0,25/109,19.11%,RCOR1;MIER2;PADI2;NAA50;PRDM5;CREBBP;EHMT1;CARM1;HDAC1;TBL1X;MTA2;USP3;RUVBL1;NSD3;USP22;BAZ2A;NSD1;MTA3;PHF20;RCOR2;MAP3K12;USP36;HDAC5;KAT6B;BRMS1L
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3222851066930651,0.7567012571669594,0.7574525745257452,0.9292241251463037,1.0,3/22,6.21%,NR2F2;PTEN;PLK1
prerank,protein modification process (GO:0036211),0.26689084596013435,0.7565512733709749,0.8327832783278328,0.9290551081778186,1.0,22/76,22.02%,PLOD2;PLAT;ATG3;UBE2L3;ST3GAL1;PPP4R2;PHKA2;MMP15;ADPRH;FBXO2;RABGGTB;B4GALT7;RPN1;PRKDC;PIGH;YES1;PHEX;UBL5;PARP4;USP25;FBXO22;UBE2L6
prerank,positive regulation of DNA recombination (GO:0045911),0.3110385190943301,0.756543535399146,0.7819843342036553,0.928691196377032,1.0,9/27,20.29%,ACTR2;SHLD3;TIMELESS;RIF1;MMS19;PAXIP1;HMCES;ARID2;ERCC2
prerank,vesicle organization (GO:0016050),0.2868044587044202,0.7555679073031818,0.7956730769230769,0.9295959942969124,1.0,15/46,20.02%,ARFGEF2;HOOK2;PI4K2B;DNAJC13;WASHC4;SNX33;PLEKHF1;SNX10;EPS15;CHMP2B;SQSTM1;ALS2;ZFYVE16;HOOK1;WASHC5
prerank,error-prone translesion synthesis (GO:0042276),-0.24683088693352132,-0.7553894258851024,0.8469750889679716,0.9526838796829159,1.0,13/21,35.18%,UBC;PCNA;RFC3;UBA52;POLH;RPA2;PRIMPOL;POLE2;RFC4;RFC2;RPA3;POLK;RFC5
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.36122327521241826,0.7553103719262003,0.776049766718507,0.9295662272712373,1.0,2/12,11.80%,ASXL1;CALR
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3472444161444976,0.7551597037954544,0.7527216174183515,0.9293752453375914,1.0,6/13,31.30%,SRD5A3;ALG11;ALG14;DPAGT1;ALG2;ALG8
prerank,long-chain fatty acid import into cell (GO:0044539),0.3744280771985671,0.7549524270207325,0.7402190923317684,0.9292797299902806,1.0,3/10,9.84%,CD36;SLC27A2;RPS6KB1
prerank,central nervous system neuron development (GO:0021954),0.34352874042180537,0.754176941085355,0.7697841726618705,0.929933819243191,1.0,6/15,18.03%,B4GALT5;PTEN;ARHGAP35;NPY;LHX6;ATP7A
prerank,protein localization to vacuole (GO:0072665),-0.29140251376838905,-0.7537935768557853,0.7879746835443038,0.953634324085765,1.0,3/13,11.55%,CD81;LMBRD1;RNF128
prerank,negative regulation of neuron projection development (GO:0010977),0.2795864507700072,0.7532762127734525,0.8163030998851895,0.930771728914875,1.0,9/56,13.48%,MYLIP;DPYSL3;APOE;PTEN;GAK;PTPN9;DENND5A;RHOA;RTN4RL1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3100842605167776,-0.7530418022816089,0.7922077922077922,0.9534018923495168,1.0,1/10,1.76%,BMP4
prerank,small GTPase mediated signal transduction (GO:0007264),0.25837921470329517,0.7530249750244524,0.8482905982905983,0.9307615717573382,1.0,22/103,16.29%,RASSF1;ARHGAP32;PLD1;NF1;NUCB2;RAB42;RALA;SIAH2;MAPK11;GRB2;RRAGC;BRAP;RERG;SETDB1;RALGDS;RIT1;RIN2;FGF2;ARHGEF18;RAC1;USP28;RGL1
prerank,N-terminal protein amino acid modification (GO:0031365),0.3440574003586163,0.7528620457316987,0.753731343283582,0.930598266122766,1.0,5/14,27.13%,NAA50;NAA15;AANAT;METAP1;METAP1D
prerank,positive regulation of TORC1 signaling (GO:1904263),0.33114956449969674,0.7521164529075409,0.7585714285714286,0.931223430258843,1.0,6/16,21.25%,KLHL22;LAMTOR5;GPR137;SIK3;TELO2;CLEC16A
prerank,sulfur amino acid metabolic process (GO:0000096),0.30782429374190357,0.7521042127101225,0.7804878048780488,0.9308670433900459,1.0,5/24,19.82%,MTHFR;AHCY;ADI1;MTRR;CDO1
prerank,superoxide metabolic process (GO:0006801),0.29857752851358066,0.752048692785493,0.7994858611825193,0.9305643796908638,1.0,5/29,19.23%,SH3PXD2B;PREX1;NRROS;ATP7A;CYBB
prerank,programmed necrotic cell death (GO:0097300),0.32863492450089204,0.7513425074932827,0.776183644189383,0.9311296829237214,1.0,4/18,15.12%,LY96;CD14;MLKL;RIPK1
prerank,regulation of protein modification process (GO:0031399),0.2739849444890261,0.7509185048693187,0.8190364277320799,0.9313187251778988,1.0,14/50,20.52%,SPRED1;ABCA2;SPRED2;CCAR2;FNIP1;PTK2;ATG7;PPP1R16A;PLXNB2;CDK9;STAT2;CORO1C;PIN1;NDUFS4
prerank,negative regulation of neuron differentiation (GO:0045665),0.31480849819332635,0.7505313413055965,0.7688243064729194,0.9314522047707096,1.0,6/22,19.61%,NEPRO;CALR;GSK3B;BMP7;SOX2;MED1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.29691085406655054,0.7500131736884676,0.7831168831168831,0.9317330126433684,1.0,6/33,10.36%,CDKN2B;PTEN;PKD2;CDK6;GPNMB;CCL2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.324567951956302,0.7499173652156657,0.7660818713450293,0.9314855674934418,1.0,1/19,3.78%,APOE
prerank,negative regulation of protein modification process (GO:0031400),0.2622413416692005,0.7494707715735349,0.8538713195201745,0.931701025820854,1.0,23/79,21.21%,FBLN1;LRRK2;PTPN13;PTEN;LRP6;PID1;NIBAN1;WWTR1;IBTK;ZBED3;GSK3B;NTRK3;XRCC1;PRKDC;PNKP;PTPA;TPPP;MFHAS1;XDH;PRNP;CORO1C;ZC3H12A;SIRPA
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.3123259392903004,0.7478492541876401,0.7833572453371592,0.9330711496315127,1.0,5/21,12.29%,SNAI2;BCL2;TERT;UNC5B;TNF
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.3123259392903004,0.7478492541876401,0.7833572453371592,0.9330711496315127,1.0,5/21,12.29%,SNAI2;BCL2;TERT;UNC5B;TNF
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3173082270923251,0.7477117310668722,0.7793296089385475,0.932879252045079,1.0,4/22,12.59%,APOE;MAP1S;CAMSAP2;AKAP13
prerank,negative regulation of protein binding (GO:0032091),0.2622559802598763,0.7474144823751984,0.8608017817371938,0.9329130071603878,1.0,16/71,20.54%,ADIPOQ;LRRK2;DDX11;EFHB;ATP2A2;DISC1;GSK3B;GTF2F1;DACT1;ITGB1BP1;AKT1;TLE5;CTNNBIP1;KDM1A;PIN1;PRKCD
prerank,T cell proliferation (GO:0042098),0.3389707452844988,0.7466263350869367,0.766566265060241,0.9335916936972022,1.0,3/13,11.94%,MSN;CTPS1;TNFRSF4
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2150944825703545,-0.7463553426455782,0.89,0.9614285456134194,1.0,16/40,31.73%,PRKN;TNFSF10;BCL2L1;IGF1;PINK1;BNIP3;DNM1L;GPER1;BID;TP53;PPIF;MFF;PSMD10;BIK;PDCD5;OPA1
prerank,pentose-phosphate shunt (GO:0006098),-0.300035425857819,-0.7461756383525415,0.783068783068783,0.9603859173984107,1.0,8/11,33.95%,RPIA;SHPK;DERA;RBKS;PGD;PGLS;PGM2;RPE
prerank,spliceosomal snRNP assembly (GO:0000387),-0.21235618558466315,-0.7456720892702617,0.9042553191489362,0.9597715064885055,1.0,10/38,23.03%,PRPF6;GEMIN2;SNRPC;SNRPG;PRPF19;SART1;SNRPD3;PRPF8;AAR2;SNUPN
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3656083700435198,0.744987694401008,0.7866666666666666,0.9353546292256797,1.0,2/10,11.25%,ERLEC1;UBE2J1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.32678558256312357,0.7449011779395008,0.764456981664316,0.9350829942495501,1.0,5/17,18.45%,CPEB1;ZC3H3;NCBP2;CCNT1;CDK9
prerank,regulation of neurotransmitter secretion (GO:0046928),0.295193422643739,0.7448790025846015,0.8188874514877102,0.9347426125216152,1.0,8/32,17.53%,LRRK2;DTNBP1;KCNMB4;HCRT;GSK3B;FMR1;MCTP2;STX1B
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.35765249432073526,0.7446688133033358,0.756838905775076,0.934651883635658,1.0,1/11,4.11%,PADI2
prerank,UV-damage excision repair (GO:0070914),0.35211393499887994,0.7445399846058103,0.7668621700879765,0.9344448942995693,1.0,3/12,17.41%,INO80;MC1R;DDB1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.28570739093397257,0.7440443872215063,0.8009708737864077,0.9347080764617389,1.0,10/41,18.91%,IL34;EGF;DLG4;PTPN1;FBXW7;BTC;SRC;FCGR1A;AGT;PRNP
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.33764963392571395,0.744010855770257,0.7891472868217054,0.9343797234882185,1.0,3/14,10.47%,NCK1;PPP3CA;PPP2R2A
prerank,diol biosynthetic process (GO:0034312),-0.26970539723516007,-0.7439490928921081,0.8369905956112853,0.9607901836206152,1.0,3/15,5.15%,ACER2;SPTLC2;SPTLC1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3676180664779393,0.7437719104688699,0.7705426356589147,0.9343317922209845,1.0,3/10,19.94%,IRS1;AKT1;PTH1R
prerank,intracellular protein transmembrane transport (GO:0065002),0.27963304081005624,0.7431579907222521,0.8101736972704715,0.9347521337537655,1.0,13/42,19.53%,PEX10;SEC63;TIMM17A;SEC61A1;HSPA5;SEC61A2;TIMM50;AIFM1;PEX6;HSPD1;PEX12;TIMM23;TOMM40L
prerank,mesoderm development (GO:0007498),0.32339440675291753,0.7430434888847204,0.7815602836879433,0.9345390418537806,1.0,3/18,10.21%,JAK2;MEST;TBX3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.3523710504607904,0.7429021967398336,0.7792998477929984,0.9336025830082375,1.0,3/12,13.21%,ANAPC11;CDC27;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.3523710504607904,0.7429021967398336,0.7792998477929984,0.9336025830082375,1.0,3/12,13.21%,ANAPC11;CDC27;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.3523710504607904,0.7429021967398336,0.7792998477929984,0.9336025830082375,1.0,3/12,13.21%,ANAPC11;CDC27;NSMCE2
prerank,positive regulation of protein catabolic process (GO:0045732),0.25460809813640467,0.7426949976407506,0.8456449834619625,0.9334956996417825,1.0,19/84,15.60%,TNFAIP3;APOE;SMURF2;OAZ3;RAB7A;MSN;AREL1;WNT5A;CSNK2A1;SNX33;SNX9;ATG7;TNF;GSK3B;DACT1;CDKN1B;SMURF1;ITCH;NEDD4
prerank,gas transport (GO:0015669),-0.30555562841369444,-0.7423852588218702,0.7762803234501348,0.9616768308665863,1.0,2/10,11.58%,CA2;IPCEF1
prerank,megakaryocyte differentiation (GO:0030219),0.3543007983038006,0.741580756304506,0.7735849056603774,0.9345524735736221,1.0,2/11,10.90%,CDKN2B;UBA5
prerank,negative regulation of cellular component movement (GO:0051271),0.3369299260207136,0.741035993493785,0.7800586510263929,0.9348605817750796,1.0,2/15,8.93%,FBLN1;SP100
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.3387166626674072,0.7405290946753158,0.7623318385650224,0.9351180193023606,1.0,3/13,12.29%,TM9SF4;SNX33;TNF
prerank,positive regulation of cell killing (GO:0031343),0.3391596011396958,0.7405209471093187,0.7885196374622356,0.934756652820945,1.0,3/13,19.09%,WNT5A;RAC1;DVL2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3224823682731607,0.7403327909031802,0.7907949790794979,0.9346205017498269,1.0,3/19,10.07%,EDN3;HRH1;PPP3CA
prerank,positive regulation of catabolic process (GO:0009896),0.2631717337588927,0.739998449279344,0.8494252873563218,0.9346806907878382,1.0,15/65,15.60%,TNFAIP3;SMURF2;OAZ3;RAB7A;AREL1;WNT5A;CSNK2A1;ATG7;TNF;GSK3B;DACT1;CDKN1B;SMURF1;ITCH;NEDD4
prerank,regulation of macrophage activation (GO:0043030),0.295012412400529,0.7390540988118272,0.7981888745148771,0.935487189523677,1.0,8/30,22.65%,LBP;WNT5A;PJA2;HSPD1;MFHAS1;ZC3H12A;TNIP2;IL33
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2560384209192369,-0.7387843141982958,0.8575949367088608,0.9652636295490532,1.0,5/19,20.48%,MAOB;CAT;SOD1;PRDX2;NOX1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.33032979735012713,0.7377957168697585,0.7638483965014577,0.9366654803209994,1.0,4/15,17.47%,TSEN2;TRPT1;RTRAF;DDX1
prerank,regulation of mRNA metabolic process (GO:1903311),0.3501757277733524,0.7376284270682427,0.7603686635944701,0.9364945823447649,1.0,4/11,23.14%,SAFB;SAFB2;IWS1;CDK11B
prerank,ganglion development (GO:0061548),0.3576304763903477,0.7375565555251763,0.8006230529595015,0.9362180120861867,1.0,1/11,3.11%,NRP1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.32202646868433116,0.7371120342710704,0.7790368271954674,0.9364149889799999,1.0,4/17,13.64%,SPRED1;SPRED2;SPRY2;CALM2
prerank,regulation of organelle organization (GO:0033043),0.25756449060524833,0.735881479426448,0.8660022148394242,0.9376284458248089,1.0,15/80,17.54%,ZEB2;TAOK1;SYDE1;MYO5A;CAPN2;MSN;LMAN1;PTK2;CAMSAP2;AKAP9;PDCD10;SQSTM1;ARMH3;MAPK1;RAB33B
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3033727603651861,0.7358366677974711,0.820615796519411,0.9373051433575409,1.0,5/25,14.52%,OPHN1;CSNK2A1;CSNK2A2;PSMF1;RPL11
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3030724358464616,0.7357024745082908,0.8220108695652174,0.9371134427337868,1.0,3/25,8.07%,EXT1;EXT2;HS2ST1
prerank,intracellular pH reduction (GO:0051452),-0.2213454167169327,-0.7356354456278987,0.9269406392694064,0.9680859439463299,1.0,10/33,21.98%,DMXL2;GPR89B;GPR89A;CLCN3;ATP6V1B2;ATP6V1E1;ATP6V0B;DMXL1;ATP6V0E2;ATP6V0D1
prerank,protein import into peroxisome matrix (GO:0016558),0.3457204996176678,0.7353981859419996,0.7923930269413629,0.9371270679549459,1.0,1/12,2.13%,PEX10
prerank,pre-miRNA processing (GO:0031054),-0.2730169150440681,-0.7353919866723725,0.8093841642228738,0.967091531750574,1.0,6/14,27.23%,ADAR;DROSHA;AGO3;TUT4;MRPL44;AGO4
prerank,nucleocytoplasmic transport (GO:0006913),0.28000510334139606,0.735130954351375,0.8193224592220828,0.9371009479009048,1.0,9/40,20.95%,ATXN1;NCBP2;ANP32A;SMN1;BACH2;DDX20;SNRPB;NEMF;XPO1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.2950254156043224,0.7348253226825643,0.8015267175572519,0.93711336372354,1.0,4/31,5.97%,TNN;SUFU;CDK6;PPARG
prerank,phagosome acidification (GO:0090383),0.2977137397519624,0.7340796155250968,0.7951807228915663,0.937697257891158,1.0,6/26,17.43%,RAB7A;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1G1;ATP6V1D
prerank,regulation of cell motility (GO:2000145),0.2479898419367318,0.7334932839337112,0.8771008403361344,0.938043368854372,1.0,21/121,18.10%,FBLN1;SERPINE2;FGF7;PLXNC1;AMOTL1;EGFR;KIF2A;EGF;CDK6;PLXND1;PLXNA3;MEMO1;RHOA;FGF2;BTC;RAC1;FES;FGF18;AKT1;DOCK10;PLXNB2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.3572592510586366,0.7334812841917487,0.7766990291262136,0.9376891335205271,1.0,4/10,26.50%,IFT88;ADGRV1;PDZD7;PLS1
prerank,negative regulation of transferase activity (GO:0051348),0.2929958767540742,0.7328989779115742,0.8035714285714286,0.9380249619992984,1.0,7/28,18.53%,NPRL2;PINX1;GSK3B;SRC;CDKN1B;DTX3L;FBXO5
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3258407619804917,0.7328635585813135,0.7922848664688428,0.9377050468247,1.0,6/15,25.67%,PTPN2;YTHDF3;STAT2;ISG15;YTHDF2;CNOT7
prerank,erythrocyte development (GO:0048821),-0.2949906049226174,-0.7323526384304541,0.8227146814404432,0.9697128156636642,1.0,4/10,21.32%,DMTN;ABCB10;ALAS1;NCKAP1L
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.347624509063192,0.7322105796743039,0.8076311605723371,0.9381630851889734,1.0,4/11,17.65%,NONO;FBXO7;HIF1A;ATF4
prerank,brain morphogenesis (GO:0048854),0.34702935023656767,0.7321537391318962,0.7779411764705882,0.9378645718664129,1.0,3/12,12.26%,PTEN;SPEF2;FBXW11
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2807780517523725,0.7309275395388558,0.8095823095823096,0.9390524897758198,1.0,12/38,22.05%,PTEN;SFRP5;OTUD3;DRD3;PTPRJ;TRIB3;PHLPP2;AKT1;XDH;EPHA2;PPP2R5C;THEM4
prerank,positive regulation of histone acetylation (GO:0035066),0.3034542360860773,0.730460267748106,0.8065843621399177,0.9392519992199563,1.0,10/23,28.11%,TADA2B;GLYR1;SPHK2;SMAD4;PAXIP1;KAT7;RPS6KA4;TADA2A;PIH1D1;RUVBL2
prerank,positive regulation of insulin secretion (GO:0032024),0.2834172573064399,0.7303840989681969,0.8193939393939393,0.9389809849282315,1.0,6/36,15.08%,TCF7L2;BLK;ACSL4;GCK;TRPM4;DOC2B
prerank,inorganic ion transmembrane transport (GO:0098660),0.3465880028362331,0.7295261970387454,0.7851622874806801,0.9396565422894215,1.0,2/12,14.55%,PKD2;TRPM4
prerank,transport along microtubule (GO:0010970),0.3385592531837536,0.7292319504210552,0.7854938271604939,0.9396583175322573,1.0,3/13,8.67%,BAG3;CDC42;COPG1
prerank,modulation by host of viral genome replication (GO:0044827),0.3348890488999778,0.7291007657084148,0.7879746835443038,0.939454920897369,1.0,6/13,21.37%,VAPA;FMR1;TBC1D20;NUCKS1;ZC3H12A;IFI27
prerank,protein targeting to peroxisome (GO:0006625),0.28675404492186607,0.7286528397732629,0.8394736842105263,0.9396359283052677,1.0,7/29,19.49%,PEX10;RAB8B;PEX19;ALDH3A2;PEX6;PEX12;HACL1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2696205492404834,-0.7282616702508378,0.8253968253968254,0.9735402024164721,1.0,3/15,11.23%,TIPIN;MRE11;HUS1
prerank,regulation of transferase activity (GO:0051338),0.324179462866948,0.7281546837447184,0.7944606413994169,0.9398798131500165,1.0,3/17,8.43%,ATM;PINX1;SMG6
prerank,centromere complex assembly (GO:0034508),0.2846700635226167,0.7281304986443033,0.8176100628930818,0.9395374228637415,1.0,5/36,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3035426673973114,-0.7269157967871255,0.8627450980392157,0.9739058902157247,1.0,3/10,14.38%,HOMER2;SLC8B1;STIM1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3577850248912142,0.7268892286129999,0.7917304747320061,0.9407041783685448,1.0,3/10,18.94%,IRAK3;PTPRC;TLE5
prerank,glycoprotein catabolic process (GO:0006516),0.3188869933130257,0.7256944974375595,0.8077474892395983,0.9418524951261111,1.0,4/17,13.80%,CTSL;ADAMTS12;ADAMTS9;FBXO2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.30471232062025405,-0.7255528564577011,0.8,0.9743116355598544,1.0,4/10,15.17%,GALNT13;POGLUT1;POGLUT2;GALNT1
prerank,regulation of histone deacetylation (GO:0031063),0.3320287446288401,0.724759798341931,0.7811550151975684,0.9426343407779255,1.0,3/13,14.64%,CAMK2D;SPHK2;NIPBL
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.25834162036853126,0.7246014861377429,0.8619909502262444,0.9424701470391132,1.0,15/63,21.99%,TNKS1BP1;E2F1;CNOT4;ATM;E2F8;CARM1;CDKN1B;PRKDC;MDM2;FBXO31;GADD45A;PLK2;CNOT2;RGCC;CNOT3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.30185938126822026,-0.7244002837590392,0.8169398907103825,0.9743623867603299,1.0,4/10,23.55%,KAT5;TFAP4;RPS6KA6;TP53
prerank,B cell homeostasis (GO:0001782),0.3525971566466753,0.7241373132471337,0.7863777089783281,0.9426900748226554,1.0,1/10,2.65%,TNFAIP3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.29512634022448075,0.7241030180457824,0.8142076502732241,0.9423636986949118,1.0,5/25,15.67%,OMA1;BAG6;UGGT2;UBE2W;ZYG11B
prerank,ribosomal small subunit biogenesis (GO:0042274),0.2835485043743956,0.7239731467438758,0.8298397040690506,0.9421596431979129,1.0,2/39,3.70%,RPSA;NOL11
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.33992420066638396,0.7239190060795015,0.7800312012480499,0.9418611517764277,1.0,2/12,8.61%,ACOX1;FADS1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.34175290848451906,0.7232577542261447,0.7970588235294118,0.9419308815364041,1.0,3/12,18.91%,FHL2;GSK3B;PRNP
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.34175290848451906,0.7232577542261447,0.7970588235294118,0.9419308815364041,1.0,3/12,18.91%,FHL2;GSK3B;PRNP
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.30863955571226576,0.7229174305190683,0.7997256515775034,0.9419980607370598,1.0,3/20,8.54%,ACSL4;SCD5;HSD17B8
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.22178531567664386,-0.7225773634085955,0.8872180451127819,0.9753034258476437,1.0,6/27,13.69%,PER1;SIK1;FBXL3;USP2;MTA1;PER2
prerank,innate immune response in mucosa (GO:0002227),-0.2945849946127891,-0.7224589873953463,0.8306878306878307,0.9741439526796065,1.0,1/10,6.75%,DEFA6
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2731785416758792,0.7223683337610729,0.8294478527607362,0.9422941639490304,1.0,6/41,12.48%,CACNA2D1;XCL1;ITPR1;PKD2;IBTK;FGF2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.25712243635565785,0.722060778224637,0.8747252747252747,0.9422881599082626,1.0,23/73,25.32%,TNKS1BP1;EGFR;PRKD2;RPTOR;FNIP1;SPRY2;TNF;NTRK3;AKAP9;PDCD10;STK4;AKT1;IRGM;EIF4G1;TRIM6;AXIN1;PAK1;RAF1;LATS1;TERF2IP;VEGFA;BRAF;PFN2
prerank,arachidonate transport (GO:1903963),0.3519053701859685,0.7216358179988588,0.7806873977086743,0.9420886793135304,1.0,2/10,9.77%,ANXA1;DRD3
prerank,arachidonic acid secretion (GO:0050482),0.3519053701859685,0.7216358179988588,0.7806873977086743,0.9420886793135304,1.0,2/10,9.77%,ANXA1;DRD3
prerank,cellular response to chemical stress (GO:0062197),0.24813586620321973,0.7212201323042081,0.8845315904139434,0.9422511569870436,1.0,16/96,15.71%,LRRK2;RAD52;AIF1;PKD2;ATM;ETV5;FOXO3;TMEM161A;NFE2L2;ATG7;GPX8;TXNRD1;TXNRD2;SETX;CYCS;ADNP2
prerank,in utero embryonic development (GO:0001701),0.2943624067759433,0.7211184499253672,0.8513157894736842,0.9420079329454085,1.0,3/25,9.03%,CHD7;TGFB3;TGFBR1
prerank,mRNA catabolic process (GO:0006402),0.2734273488259188,0.7206637615461543,0.8621103117505995,0.9421909036654758,1.0,10/44,17.79%,ZFP36L2;METTL16;EXOSC4;DCP2;RNH1;DHX34;XRN1;DXO;THRAP3;TUT7
prerank,regulation of mRNA processing (GO:0050684),0.2839521360543331,0.7203452891097946,0.8185328185328186,0.9422178019220676,1.0,8/32,19.24%,ZFP36L1;KHDRBS1;METTL16;SAFB;SAFB2;RBM39;IWS1;SON
prerank,negative regulation of inclusion body assembly (GO:0090084),0.34672235356605785,0.7201747239858883,0.7965299684542587,0.942051226027384,1.0,2/10,10.97%,DNAJB1;DNAJB6
prerank,mitochondrial gene expression (GO:0140053),0.27381918436229824,0.7201304503227194,0.8484848484848485,0.9417356917837495,1.0,10/42,16.99%,MRPL57;IARS2;FOXO3;MRPS18A;RARS2;MRPS14;MRPS2;NDUFA7;LARS2;POLRMT
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3037902542525515,0.7198934145254305,0.8172804532577904,0.9416556075403504,1.0,9/21,25.00%,MDK;DISC1;CX3CL1;KDM1A;NAP1L1;SMARCD3;FZD3;FZD9;VEGFA
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3183969503807188,0.7197185594875631,0.7991202346041055,0.9415123610536571,1.0,7/16,26.53%,GART;PPAT;AMPD2;IMPDH2;AMPD3;IMPDH1;ADSL
prerank,cellular response to increased oxygen levels (GO:0036295),-0.28782776863816245,-0.7195186155677988,0.8191780821917808,0.9763159215035744,1.0,6/11,34.86%,CAV1;TMEM199;ATP6V0D1;ATP6V1A;ATP6AP1;FAS
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3381246071727009,0.71948134314183,0.8104265402843602,0.9414272900722153,1.0,1/12,1.79%,COLEC12
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.28098898134887473,0.7183299228493353,0.8254364089775561,0.9423827033941244,1.0,8/33,18.20%,EGF;CBL;FBXW7;PDE6H;BTC;NEU3;AKT1;AGT
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.29014032423570324,-0.7175873795231809,0.8205128205128205,0.9772283917420427,1.0,4/11,23.55%,KAT5;TFAP4;RPS6KA6;TP53
prerank,regulation of protein sumoylation (GO:0033233),0.30795394749361943,0.7172810981944727,0.808972503617945,0.9432959358694811,1.0,3/17,12.80%,ZMIZ1;GNL3;RASD2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.26348251646263615,0.717059827542008,0.846987951807229,0.9431901532034076,1.0,15/48,20.96%,NUP37;RAE1;OGT;NUP153;GCK;KHK;NDC1;HIF1A;NUP35;RUBCNL;NUP188;SEC13;ZBTB7A;NUP214;NUP107
prerank,response to light stimulus (GO:0009416),-0.18967648107908933,-0.7169339455168651,0.946969696969697,0.9767346385194129,1.0,14/55,19.93%,ERCC5;UBE2A;CIRBP;ERCC6;ERCC3;UBE2B;UVSSA;USP1;DDB2;MAPK10;GTF2H2;TRIM32;CRY2;DRD2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3017139818471628,-0.7163491422484138,0.8128342245989305,0.9760746474773166,1.0,2/10,4.91%,DLGAP1;DLGAP2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.283926578934359,-0.7162662628045009,0.8258426966292135,0.9748750619296275,1.0,3/11,22.05%,SOX6;MYOCD;MEF2C
prerank,histone H2A acetylation (GO:0043968),0.31902328297944416,0.7160818683314858,0.8402877697841726,0.943952895844006,1.0,9/16,29.69%,RUVBL1;SPHK2;EP400;MEAF6;TRRAP;MORF4L2;MORF4L1;RUVBL2;ING3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3330594005832184,0.7154927397042173,0.8169838945827232,0.9443168711606565,1.0,7/13,29.93%,NOP14;BMS1;KRI1;TSR1;RCL1;RRS1;TBL3
prerank,intraciliary retrograde transport (GO:0035721),0.3326592186335183,0.714483558335612,0.8086124401913876,0.9451566196775367,1.0,3/12,13.72%,DYNC2LI1;WDR35;DYNC2H1
prerank,organelle disassembly (GO:1903008),0.28108305018898716,0.7143449769690052,0.8303571428571429,0.9449525875765766,1.0,7/33,17.80%,GBF1;UBA5;MTIF2;KIF5B;DDRGK1;KIF9;MCTS1
prerank,response to prostaglandin E (GO:0034695),-0.2929927094196174,-0.7142365628580991,0.8225352112676056,0.9758706262619735,1.0,1/10,1.66%,TGFBR3
prerank,regulation of TORC1 signaling (GO:1903432),0.2769509084031406,0.7140320989924239,0.8345959595959596,0.9449412714680765,1.0,11/33,21.82%,KLHL22;ATM;RRAGC;KPTN;SMCR8;LAMTOR5;GPR137;SIK3;TELO2;CLEC16A;SZT2
prerank,negative regulation of translational initiation (GO:0045947),0.3378582477392161,0.7139122758143948,0.8132045088566827,0.944721734351708,1.0,4/13,22.81%,EIF4EBP1;FMR1;AGO2;EIF3E
prerank,regulation of adenylate cyclase activity (GO:0045761),0.29524829118853835,0.712303589511808,0.825136612021858,0.9462297320953313,1.0,3/22,9.77%,CACNA1C;NF1;DRD3
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2852446853745396,0.7118050304546706,0.8547770700636943,0.9464378066707255,1.0,8/28,18.84%,CXCL12;DBN1;BRK1;DBNL;ARHGAP35;RASA1;CTTN;PLEKHG2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.2953730237210763,0.7115477875733537,0.8337912087912088,0.9463807214403156,1.0,3/22,9.67%,PES1;ERI1;NOP14
prerank,microtubule anchoring (GO:0034453),-0.2782093992678438,-0.711537056594029,0.8764705882352941,0.977608400045266,1.0,1/12,0.78%,BICD1
prerank,cardiac cell development (GO:0055006),0.3366242370526438,0.7112960913073529,0.8034055727554179,0.9463236801216213,1.0,1/11,4.21%,JAG1
prerank,sterol transport (GO:0015918),0.3088532875674444,0.7107669828074162,0.8302687411598303,0.9465888379367501,1.0,4/19,13.62%,CD36;NPC2;OSBPL5;MSR1
prerank,oligodendrocyte development (GO:0014003),0.3224738544408718,0.7106894847957149,0.8156342182890856,0.9463094802258643,1.0,1/15,2.07%,B4GALT5
prerank,protein import (GO:0017038),0.24459028914646572,0.7105778148206051,0.8953744493392071,0.9460735199043574,1.0,19/84,19.56%,APOE;STAT3;PRICKLE1;FAM53B;LAMP2;RAB8B;NUP153;SNX33;TNPO1;PEX19;E2F3;ALDH3A2;NUP188;SEC13;AKT1;TOMM22;HEATR3;PEX12;NUP214
prerank,ncRNA processing (GO:0034470),0.23693891344528376,0.7104190777958744,0.9553752535496958,0.9458867932702274,1.0,48/200,22.01%,C1D;SMAD2;NOL11;PES1;TRPT1;POP1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;DICER1;NOP14;PELP1;PIH1D2;UTP3;RPL12;INTS1;ZCCHC8;MRM2;POP4;RPL22;RPL14;SMAD3;TEX10;RPL11;INTS4;NOLC1;SMAD1;WDR36;BYSL;RPF1;MTREX;HELQ;RPL36A;TUT7;RPS9;RPL6;RPLP2;AGO2;FARS2;UTP11;INTS8;LYAR;DHX37;BMS1;DDX10;EXOSC5
prerank,cellular response to metal ion (GO:0071248),0.24263415113915604,0.7103689484596576,0.9064143007360673,0.9455817447507081,1.0,12/123,9.14%,HVCN1;LRRK2;ADCY7;EGFR;CAMK2D;PKD2;CPNE7;CPNE2;DLG4;SLC13A5;SYT2;WNT5A
prerank,organelle fission (GO:0048285),0.2958730492051302,0.7102130208107774,0.8050847457627118,0.9453945658935549,1.0,6/24,20.02%,SEC16B;PEX19;TMCC1;PEX11A;CORO1C;WASHC5
prerank,protein localization to centrosome (GO:0071539),0.31261875435461556,0.7101451325915409,0.8248914616497829,0.945112282387692,1.0,5/17,17.00%,PCM1;SNX10;CEP192;NUDCD3;CSNK1D
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.24990947764988208,-0.7092958712246258,0.8698630136986302,0.9788992105445673,1.0,5/18,22.24%,HIP1R;ZNF205;SLC35F6;BID;CHCHD10
prerank,negative regulation of myotube differentiation (GO:0010832),-0.2724981297449871,-0.7082842965497818,0.8724035608308606,0.9787400411543384,1.0,5/12,22.35%,HDAC4;CCN3;BDNF;HDAC3;BHLHE41
prerank,regulation of p38MAPK cascade (GO:1900744),0.2784933615178632,0.7082203610420151,0.8625954198473282,0.9469577859856931,1.0,10/35,21.08%,TREM2;LGALS9;SASH1;PJA2;SPI1;MFHAS1;XDH;GADD45A;DLG1;ZC3H12A
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.34162964110958205,0.7081136258457585,0.7940251572327044,0.9467119364633821,1.0,2/11,6.22%,NOL11;DDX11
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3269295877870344,0.7078083799382806,0.8009049773755657,0.9466996197924031,1.0,2/13,7.56%,ABCA2;SOAT1
prerank,negative regulation of mRNA processing (GO:0050686),0.31758384731689493,0.7066791988628909,0.8207407407407408,0.9476324653160575,1.0,4/15,15.89%,SAP18;SFSWAP;SRSF12;RBMX
prerank,histone H3-K36 demethylation (GO:0070544),-0.28420595332217413,-0.7066501891091302,0.8491048593350383,0.9792535221805179,1.0,2/10,10.15%,PHF8;RIOX2
prerank,iron-sulfur cluster assembly (GO:0016226),-0.2284881860258679,-0.7062568200302216,0.908745247148289,0.9783411712010623,1.0,14/24,30.96%,CIAPIN1;GLRX3;NFU1;CIAO2A;HSPA9;NFS1;ISCA2;GLRX5;BOLA2;ISCU;NUBPL;ISCA1;CIAO2B;CIAO3
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.3439842185113836,0.7059346610354054,0.8227060653188181,0.9481240853560091,1.0,4/11,11.08%,RAB21;MSN;PTPN23;EIPR1
prerank,sensory perception (GO:0007600),0.2652653579202575,0.7055342606395791,0.8537455410225921,0.9482238699917592,1.0,5/45,14.17%,PTGES;MYO7A;CCL2;P2RX7;GNAS
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.3465133736380912,0.7051528896351928,0.7922077922077922,0.9482868319475404,1.0,3/10,9.04%,SESTD1;CBARP;FKBP1B
prerank,cellular response to amino acid stimulus (GO:0071230),0.27679610454246467,0.7044189946734156,0.8463444857496902,0.9487346531668868,1.0,9/33,19.41%,KLHL22;CPEB1;CAPN2;RPTOR;RRAGC;CPEB4;LAMTOR5;LAMTOR3;UBR1
prerank,histone H3-K9 demethylation (GO:0033169),0.3288555351209405,0.7037270899842585,0.8125984251968504,0.9491743196237542,1.0,6/11,26.60%,KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,tRNA methylation (GO:0030488),-0.2070005813283163,-0.7031893882436313,0.9227053140096618,0.9803288704479886,1.0,14/34,29.44%,ALKBH8;TRMT1L;TRDMT1;NSUN6;TRMT10A;LCMT2;TRMT5;TRMT44;METTL6;TYW3;TRMT12;TRMT112;HSD17B10;TRMO
prerank,histone methylation (GO:0016571),0.28796194643313583,0.7030536766173094,0.841897233201581,0.9495714792787779,1.0,5/26,16.10%,CREBBP;EHMT1;CARM1;NSD3;NSD1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2347991949604215,0.7018475400821407,0.9282744282744283,0.9505971429238951,1.0,23/151,15.20%,TNIP1;CERS6;B4GALT5;PAM;MGST1;APOE;PRKD2;AKR1A1;HACD2;TYW1;VAPA;MOCS1;CSNK2A1;CSNK2A2;GSTK1;CSNK1G2;ELOVL6;SPHK2;CEPT1;SPTSSA;PLA2G4A;SGPL1;ALDH3A2
prerank,dicarboxylic acid transport (GO:0006835),0.28374921594611247,0.7017883066314565,0.8618857901726428,0.9502966085927468,1.0,5/28,15.94%,SLC1A3;SLC13A5;PDPN;GIPC1;SLC25A10
prerank,interstrand cross-link repair (GO:0036297),-0.1854682268822948,-0.700596603814801,0.9699248120300752,0.9818523951704353,1.0,22/53,29.19%,ERCC6L2;WDR48;UBC;RFWD3;DCLRE1A;FANCI;FAAP100;USP1;FANCM;ERCC1;DCLRE1B;MUS81;FAAP20;FANCB;FANCL;UBA52;FANCG;FAN1;NEIL3;RPA2;RAD51AP2;CENPX
prerank,positive regulation of microtubule polymerization (GO:0031116),0.28128503245413516,0.7003423684672739,0.8428390367553865,0.9515712173992343,1.0,6/28,17.54%,NAV3;AKAP9;RAC1;FES;TOGARAM1;CKAP5
prerank,protein catabolic process (GO:0030163),0.2520839005381519,0.7001813888164055,0.887115165336374,0.9513894524466914,1.0,10/59,15.41%,APOE;CTSD;SIAH2;LAMP2;BAG6;ADAMTS9;CLN6;FBXO2;RIPK1;PSMA8
prerank,DNA packaging (GO:0006323),-0.2553745675745648,-0.7001323362246568,0.8688524590163934,0.981027766410361,1.0,7/16,27.64%,HAT1;CDAN1;KAT6A;TP53;BANF1;H1-0;CHAF1A
prerank,histone H2B ubiquitination (GO:0033523),-0.2894277404912817,-0.6999259992219283,0.8481675392670157,0.9799551475786036,1.0,2/10,9.07%,CTR9;LEO1
prerank,mesenchyme development (GO:0060485),0.31756721890456363,0.6993625280502523,0.8254931714719271,0.9519366132169341,1.0,5/15,23.91%,PKD2;TGFBR1;BMP7;HMGA2;BMPR2
prerank,glycolipid metabolic process (GO:0006664),0.2607837355839935,0.6982614185918022,0.8616125150421179,0.9528121598820845,1.0,10/47,17.90%,UGCG;PIGW;ABCA2;B4GALNT1;SMPD3;NEU3;GALC;NEU1;CTSA;CPTP
prerank,snRNA metabolic process (GO:0016073),0.29937139871791435,0.6980368843266088,0.8404558404558404,0.9526749141161108,1.0,5/17,20.33%,INTS1;ZCCHC8;INTS4;MTREX;INTS8
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3342824750168789,0.697822884289041,0.8227272727272728,0.9525455585245134,1.0,1/10,3.16%,ATP5PO
prerank,translation (GO:0006412),0.23318728076832418,0.6977837940332335,0.9582059123343527,0.9522279615311658,1.0,45/208,21.55%,RPSA;RRBP1;ASMT;TNIP1;PPA1;RPL3L;MRPL57;YARS1;ABCE1;ZC3H15;AIMP1;EEF1E1;PABPC4;IARS2;TARS1;RPL12;MRPS18A;RARS2;EEFSEC;RWDD1;RARS1;RPL22;RPL14;MRPS14;MRPS2;RPL11;GARS1;GSPT1;NDUFA7;LARS2;MRPL55;RPL36A;MRPL52;RPS9;RPL6;RPLP2;AGO2;FARS2;MRPS33;ETF1;EIF4G1;N6AMT1;NARS1;TMA7;RPS27A
prerank,rRNA processing (GO:0006364),0.2343484988479252,0.6975550138070747,0.947261663286004,0.9521187127401366,1.0,43/172,22.01%,C1D;MAK16;NOL11;PES1;ERI1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;NOP14;NOP2;PELP1;PIH1D2;UTP3;NAT10;RPL12;MRM2;POP4;RPL22;RPL14;TEX10;RPL11;NOLC1;WDR36;BYSL;PRKDC;RPF1;MTREX;HELQ;RPL36A;RPS9;SRFBP1;RPL6;RPLP2;UTP11;RIOK2;LYAR;DHX37;BMS1;RSL1D1;DDX10;EXOSC5
prerank,gliogenesis (GO:0042063),0.3092965649469138,0.696289714257535,0.8282828282828283,0.9531103415942781,1.0,3/15,11.44%,CDK6;ANXA1;TGFB2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3329541929861285,0.6962085033126957,0.8095238095238095,0.9528305949267228,1.0,1/10,5.49%,SEC14L1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.2272956888343309,-0.6961417516020962,0.926829268292683,0.9827247062291314,1.0,8/21,26.43%,NT5E;NUDT3;PDE4D;PDE2A;NUDT11;MLYCD;FITM2;NUDT16
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2746095501377358,0.6959005367737316,0.8542199488491049,0.9528210964555498,1.0,13/33,25.72%,TNKS1BP1;ZBTB48;PINX1;TERT;CTC1;PPP6C;TELO2;RFC1;TERF1;RPA1;RAD51;TERF2IP;TERF2
prerank,myeloid cell development (GO:0061515),0.302582901657638,0.6958691447116011,0.8457300275482094,0.9524931233103007,1.0,6/18,20.99%,TLR2;SRC;NRROS;MED1;FOXP1;LYAR
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.27818229947809486,0.6956752406824589,0.8421052631578947,0.9523470980394839,1.0,7/30,14.52%,BAG6;EIF3H;CCAR2;OGT;GIPC1;DDRGK1;RPL11
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.29919262207853103,0.695465574257181,0.8275862068965517,0.952207005151005,1.0,4/21,13.26%,HK2;H6PD;GCK;TALDO1
prerank,regulation of ERAD pathway (GO:1904292),-0.2711154415262109,-0.6953559680258676,0.85,0.9823163616246938,1.0,3/11,17.63%,ATXN3;AQP11;RNF185
prerank,lipid biosynthetic process (GO:0008610),0.24593250555768975,0.6948146783819905,0.9068736141906873,0.9525694141361405,1.0,7/77,8.76%,LIPC;PAM;MVK;SCD5;HSD17B8;FADS1;LPL
prerank,cellular protein-containing complex assembly (GO:0034622),0.23115532461196367,0.6941630402142981,0.9364754098360656,0.9529129335057679,1.0,26/159,17.71%,CLTC;TCF4;SMAD2;CHMP4A;CHMP4B;NCK1;NCK2;OMA1;STXBP1;COG4;ANGPT1;COX7A2L;TTC12;NUP153;SNX9;EPS15;TRAF2;SMAD3;SRC;SMAD4;NDC1;SMAD1;PSMD11;AIFM1;HSPD1;PICALM
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3062072673416375,0.6938424113521392,0.809052333804809,0.952899161204297,1.0,3/17,15.97%,PLA2G12A;PLA2G4A;PLA2G4E
prerank,positive regulation of cellular component movement (GO:0051272),-0.22310024565071968,-0.6936008608437039,0.90625,0.9829432365532,1.0,9/24,32.40%,SPOCK2;CCDC25;TRIM32;RPS19;CFAP20;CSF1R;AKT2;NTN1;LYN
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.20055215219951372,-0.6933734265439494,0.9385245901639344,0.9819292649367788,1.0,8/31,19.44%,PRKN;ATXN3;HSPA14;DNAJC18;ERN1;HSPB8;HSPA9;TMBIM6
prerank,tRNA modification (GO:0006400),-0.18072118506060786,-0.6933641832881801,0.9824561403508771,0.9806718127456037,1.0,26/62,30.56%,ALKBH8;TRMT9B;DTWD2;TYW5;ELP5;TRDMT1;PUS10;QTRT1;NSUN6;TRMT10A;LCMT2;TRMT5;CDKAL1;TRMT44;METTL6;OSGEP;TRMT6;TYW3;THUMPD1;PUS1;TRMT12;TRMT112;AARS1;TRMO;MOCS3;PUS7
prerank,global genome nucleotide-excision repair (GO:0070911),-0.2148748392595572,-0.6927654485903619,0.8934426229508197,0.9799790733221618,1.0,13/26,28.70%,ERCC3;UBC;CHD1L;DDB2;GTF2H2;ERCC1;GTF2H4;UBA52;GTF2H3;CETN2;RBX1;PARP1;XPC
prerank,ribosome assembly (GO:0042255),0.26104534487262776,0.6925165890445012,0.8805790108564535,0.95399251210328,1.0,11/47,24.24%,RPSA;RPL3L;NOP2;MRPS2;RPL11;DHX29;RPL6;DHX37;MDN1;PPAN;EIF2A
prerank,RNA methylation (GO:0001510),0.25177331917913626,0.6918936731227119,0.8860465116279069,0.9543207689611345,1.0,13/60,19.17%,ZC3H13;METTL16;METTL1;MTERF4;THUMPD3;NOP2;MRM2;TGS1;TRMT61B;THADA;RBM15;BCDIN3D;THUMPD2
prerank,cognition (GO:0050890),0.25998483024498364,0.6918520175845498,0.8905660377358491,0.9540114208900574,1.0,9/42,16.60%,CHD7;NF1;HOXA1;TNF;HRH3;TUSC3;NIPBL;CHMP2B;SOBP
prerank,response to ethanol (GO:0045471),0.3119601683289136,0.6915378522549686,0.8088012139605463,0.9539995757729364,1.0,2/14,9.77%,ADCY7;DRD3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.22665795837866431,-0.69093035395344,0.9057971014492754,0.9804661465015843,1.0,9/22,25.80%,ESR1;PSMC3;MED4;MED24;PSMC4;DHX36;TP53;MED30;SRF
prerank,piRNA metabolic process (GO:0034587),0.29313918094642877,0.6908325125128867,0.8477011494252874,0.9543932338059162,1.0,1/19,4.62%,MYBL1
prerank,tRNA 5'-leader removal (GO:0001682),0.31967684519367867,0.6907735111697861,0.8138847858197932,0.9540985202652513,1.0,2/13,12.47%,POP1;POP4
prerank,protein deacylation (GO:0035601),0.28559209543051733,0.69041814978557,0.856951871657754,0.9541295714727305,1.0,7/23,18.30%,ABHD17C;HDAC1;LYPLAL1;ABHD17B;SIRT3;LYPLA2;HDAC5
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.26128890103815694,0.6903974127855736,0.8833746898263027,0.9537903485657346,1.0,13/41,20.96%,NUP37;RAE1;OGT;NUP153;GCK;NDC1;HIF1A;NUP35;NUP188;SEC13;ZBTB7A;NUP214;NUP107
prerank,negative regulation of DNA recombination (GO:0045910),0.2577313239181208,0.6902722747131304,0.8727490996398559,0.9535707602281881,1.0,14/43,25.72%,PARP3;SHLD3;FBH1;RIF1;ATRX;CGAS;POLR2L;POLR2K;TERF1;ZRANB3;POLR2D;MSH6;TERF2IP;TERF2
prerank,hemidesmosome assembly (GO:0031581),0.33183469686230105,0.6900267019095482,0.8225039619651348,0.9534641055766883,1.0,1/11,2.09%,LAMC1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2535995311367764,0.6900231520861766,0.8861985472154964,0.9531069883802038,1.0,13/46,21.26%,HK2;RALA;TOMM7;FBXO7;TIMM17A;TIMM50;AIFM1;HSPD1;AKT1;TOMM22;TIMM23;TOMM40L;PITRM1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.23959461849151342,-0.6899079874280468,0.8646864686468647,0.9802537523183815,1.0,7/19,25.89%,ADK;POLD3;GMPR;DCK;APRT;CDA;POLD2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.29176040841485823,0.6895490445736132,0.847887323943662,0.9532761213796468,1.0,3/20,12.44%,BCL2;BCL2L2;GSK3B
prerank,regulation of telomerase activity (GO:0051972),0.262337723907073,0.689278236682877,0.8787128712871287,0.9531889864122983,1.0,12/45,23.02%,PARM1;ATM;PINX1;SMG6;SRC;PNKP;MAPK1;PARN;PKIB;PARP4;TERF1;MAP2K7
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3259604363411313,0.6892404275730258,0.8457943925233645,0.9528697812797203,1.0,3/12,13.64%,CAMK2D;GJD3;CALM2
prerank,protein-containing complex disassembly (GO:0032984),0.25087471766196634,0.6888714019180534,0.8822170900692841,0.9528869401746173,1.0,10/54,19.09%,FZD1;STX17;LRP6;VPS4A;LAMP2;GSK3B;CSNK1A1;RUBCNL;LIX1L;DVL2
prerank,regulation of ATP metabolic process (GO:1903578),0.2507779699999025,0.6886271786503311,0.901307966706302,0.9528012064774568,1.0,16/54,20.96%,NUP37;RAE1;COX7A2L;OGT;NUP153;GCK;SPHK2;NDC1;HIF1A;NUP35;NUP188;SEC13;ATP7A;ZBTB7A;NUP214;NUP107
prerank,rRNA metabolic process (GO:0016072),0.2319591876062386,0.6884408016708754,0.9409368635437881,0.952647362001545,1.0,37/160,22.01%,C1D;ERN2;NOL11;PES1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;NOP14;PELP1;PIH1D2;UTP3;XRN1;RPL12;MRM2;POP4;RPL22;RPL14;TEX10;RPL11;NOLC1;WDR36;BYSL;RPF1;MTREX;HELQ;RPL36A;RPS9;RPL6;RPLP2;UTP11;LYAR;DHX37;BMS1;DDX10;EXOSC5
prerank,ether lipid biosynthetic process (GO:0008611),-0.2873499861164835,-0.6882623925608399,0.8609625668449198,0.9806456013326914,1.0,2/10,7.38%,CHPT1;LPCAT2
prerank,regulation of macroautophagy (GO:0016241),0.2374200088324306,0.6878338279616751,0.9214208826695371,0.9529240932885776,1.0,22/105,18.35%,DCN;LRRK2;EXOC4;RPTOR;TRIM13;RRAGC;EXOC1;EXOC7;GAPDH;ATP6V1H;SNX5;SMCR8;ATP6V1G2;NEDD4;PRKAB1;LAMTOR5;ATP6V1G1;SH3GLB1;AKT1;ATP6V1D;USP36;LAMTOR3
prerank,T-helper cell differentiation (GO:0042093),0.3082355067429929,0.6869075253528275,0.823088455772114,0.9535447003201765,1.0,1/14,3.15%,BATF
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2587904998986937,-0.6868647454893542,0.8650306748466258,0.9806528750737056,1.0,7/13,37.19%,CSTF2;TUT1;CPSF2;CPSF4;NUDT21;CPSF7;CPSF4L
prerank,ribosome biogenesis (GO:0042254),0.22942087675453093,0.6865984611059665,0.9553299492385787,0.9535200212327594,1.0,47/187,22.01%,C1D;NOL11;PES1;NOC2L;ABCE1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;NOP14;PELP1;NIP7;PIH1D2;GTF3A;UTP3;RPL12;LTO1;MRM2;DDX31;POP4;RPL22;RPL14;TEX10;RPL11;NOLC1;WDR36;NOP16;BYSL;RPF1;DHX29;MTREX;HELQ;RPL36A;RPS9;HEATR3;RPL6;RPLP2;UTP11;PAK1IP1;RIOK2;XPO1;LYAR;DHX37;BMS1;DDX10;EXOSC5
prerank,cellular amino acid catabolic process (GO:0009063),0.23836980816447156,0.6863924807984109,0.9120879120879121,0.9533788293612466,1.0,19/87,21.44%,SDSL;CRYM;ACADSB;HIBCH;AMT;GLDC;KYAT1;DLST;ALDH7A1;CARNS1;ECHS1;BCKDHB;MTRR;AUH;HYKK;QDPR;HIBADH;PIPOX;SLC25A21
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2883632535949855,0.6858560361284247,0.8577235772357723,0.9535895129694767,1.0,7/20,26.53%,GART;PPAT;AMPD2;IMPDH2;AMPD3;IMPDH1;ADSL
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2105289997087289,-0.6850171443895766,0.930327868852459,0.9811581258438159,1.0,5/28,12.41%,MAP2;MAP1A;STMN2;STMN3;PRUNE1
prerank,regulation of TOR signaling (GO:0032006),0.24691225120442822,0.6846548994517145,0.9101123595505618,0.9545259858606773,1.0,16/67,19.70%,TREM2;RICTOR;MIOS;NPRL2;RPTOR;RRAGC;TTI1;FNIP1;SMCR8;GPAT3;LAMTOR5;SEC13;GNA12;LAMTOR3;UBR1;TELO2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.2999929415994572,0.684331487084134,0.8364963503649635,0.9545290185288843,1.0,4/18,12.48%,RHOJ;AKT3;ANXA1;FGF2
prerank,quinone biosynthetic process (GO:1901663),-0.2566838308742389,-0.6841822918575391,0.8777777777777778,0.980733122793739,1.0,3/14,9.12%,PDSS1;COQ2;PDSS2
prerank,positive regulation of ion transport (GO:0043270),0.2541361974990644,0.6836176635883476,0.8846611177170036,0.9549560001896589,1.0,14/48,20.50%,CCR1;TRPC6;CCL5;MYLK;CNKSR3;ATP2B1;P2RX7;KIF5B;SNX4;ORAI1;ANO6;STIM2;GDNF;DLG1
prerank,regulation of myoblast differentiation (GO:0045661),0.2714539749176051,0.6834300265566836,0.8693982074263764,0.95480762442852,1.0,4/32,10.21%,ZFP36L1;FLOT2;BTG1;TBX3
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.27508960656197484,0.6833582755870573,0.8602015113350125,0.9545311958100345,1.0,8/29,21.73%,E2F1;TENT5A;DHX34;FMR1;THRAP3;AXIN2;GDNF;YBX1
prerank,histone deubiquitination (GO:0016578),-0.2321577636801817,-0.6823696855829268,0.8976109215017065,0.9811414523182203,1.0,7/18,24.16%,USP49;USP7;KAT2A;USP16;TAF10;ENY2;USP15
prerank,positive regulation of protein transport (GO:0051222),0.2462165859555449,0.6816168674995742,0.9029345372460497,0.9560275043017513,1.0,10/67,12.29%,TREM2;ABCG1;PPID;TGFB3;PCM1;FRMD4A;EXOC1;PCNT;TGFB2;TNF
prerank,cardiac atrium morphogenesis (GO:0003209),-0.24258811500618715,-0.6810573223209392,0.879154078549849,0.9810800810280434,1.0,11/16,45.95%,PROX1;HEY2;ZFPM1;NOTCH1;ENG;TBX20;NOG;MYH6;NOTCH2;GATA4;ISL1
prerank,protein targeting to membrane (GO:0006612),0.23881120431452416,0.6809314110240549,0.9288888888888889,0.9563969175004141,1.0,15/83,16.83%,CHMP4A;CHMP4B;ATG3;RAB8B;SSR2;SEC63;VPS37C;PEX19;SEC61A1;ZDHHC6;ZDHHC9;ALDH3A2;RTP4;SRP14;ZDHHC3
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.2686835135184385,0.6808955839235855,0.8746701846965699,0.9560730586918003,1.0,9/31,19.53%,PEX10;TIMM17A;TIMM50;AIFM1;PEX6;HSPD1;PEX12;TIMM23;TOMM40L
prerank,axonal transport of mitochondrion (GO:0019896),0.32666318825936924,0.6806264088610692,0.826645264847512,0.9560011722378834,1.0,2/11,15.67%,TRAK1;HIF1A
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3119832414214805,0.6804154036161304,0.8246376811594203,0.9558715057204562,1.0,4/14,17.41%,IRS1;PTPN2;AKT1;DDB1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.2929762615590793,0.6797587772828981,0.8589385474860335,0.9562140061989527,1.0,5/21,14.44%,JAK2;TGFB3;TGFBR1;WWTR1;SMAD4
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2629290616455489,0.6797000191630275,0.8767123287671232,0.9559106024872195,1.0,6/36,11.12%,TCF7L2;TNRC6B;WNT5A;PPP3CA;PLCB3;MOV10
prerank,maturation of LSU-rRNA (GO:0000470),0.27561226250353477,0.6793035987368251,0.8739946380697051,0.9559551876500558,1.0,3/26,10.05%,MAK16;PES1;NOP2
prerank,tryptophan catabolic process (GO:0006569),0.3335354790120784,0.6787614406338734,0.8438485804416404,0.9561355031337482,1.0,1/11,7.20%,KYAT1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.295664555581556,0.6786397325633202,0.8542274052478134,0.9559108387337656,1.0,6/16,20.69%,ZFPM2;TBX2;FGF2;GLI1;RBPJ;BMPR1A
prerank,actin nucleation (GO:0045010),0.2848860047956213,0.6785667516141456,0.853185595567867,0.9556343703915993,1.0,6/21,22.09%,ACTR2;SPIRE1;WASHC1;ARPC1B;TRIM27;ARPC2
prerank,response to histamine (GO:0034776),0.33673308416200376,0.6783508696143367,0.8615635179153095,0.9554941021934131,1.0,2/10,9.86%,DRD3;HRH1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.25346305384253576,0.6776788374581422,0.8886337543053962,0.9558079719024876,1.0,10/50,17.37%,SIAH2;SH3RF1;CSNK2A1;FNIP1;DNAJB6;TNF;SRC;LAMTOR5;AKT1;YWHAE
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.25965867138352666,-0.6776752990022555,0.8693333333333333,0.9828887081468402,1.0,4/12,21.94%,PRPSAP2;PRPSAP1;PRPS1;PRPS1L1
prerank,cellular macromolecule catabolic process (GO:0044265),0.24790107354020344,0.6775652100331394,0.9033412887828163,0.955567351646692,1.0,10/49,17.10%,SIAH2;PABPC4;ADAMTS9;RNASEH1;SND1;RNASEH2A;FBXO2;RIPK1;SIDT2;MTREX
prerank,Golgi ribbon formation (GO:0090161),0.31400930129146687,0.6771662677343051,0.8361669242658424,0.955603172192674,1.0,2/13,9.08%,STX6;TRIP11
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.27076760233742325,0.6757277157172309,0.8730366492146597,0.956703547378605,1.0,6/29,15.85%,EDC4;EXOSC4;DCP2;DCP1A;PATL1;LSM7
prerank,negative regulation of GTPase activity (GO:0034260),0.2811644691748887,0.6751245893880655,0.8518518518518519,0.9569692172128669,1.0,2/22,7.54%,LRRK2;RRP1B
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.25463674217375465,-0.675083440405275,0.884180790960452,0.9839552498540158,1.0,3/13,11.76%,EDEM2;BCAP31;SVIP
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.2918853499599234,0.6747217061832296,0.8611111111111112,0.9570113354714119,1.0,7/19,22.13%,STIMATE;FKBP1B;PTPRJ;PTPRC;PRNP;PTGFR;TRPM2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3031620451657242,0.6742749672384855,0.8517397881996974,0.9571044772616725,1.0,4/15,15.69%,PRKD2;FGFR1;FGF2;FGF18
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2985902148469423,0.6742617282728747,0.847124824684432,0.956759554864303,1.0,4/16,19.14%,SCD5;HSD17B8;ACACA;FASN
prerank,ceramide catabolic process (GO:0046514),-0.24480258563968943,-0.6741775355954156,0.8902077151335311,0.9834830597221204,1.0,7/14,35.81%,ACER2;ASAH2;GM2A;ASAH1;ACER3;HEXB;NEU2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.24854370045500013,-0.6737759289970194,0.8711656441717791,0.9825813984264528,1.0,1/14,1.83%,ENTPD1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.2908082331022591,0.6722691806046425,0.8797736916548797,0.9584079749358803,1.0,4/19,13.32%,EXT1;EXT2;HS2ST1;UGDH
prerank,peptidyl-lysine modification (GO:0018205),0.2299371876159738,0.6722454933140677,0.9487179487179487,0.9580730996852513,1.0,20/99,18.03%,PLOD2;NUP37;RAE1;PIAS2;LOXL1;USPL1;LOXL3;SENP6;NUP153;VCPKMT;NSMCE2;EGR2;TRPM4;SIRT3;NDC1;NUP35;NUP188;P3H3;ETFBKMT;ATP7A
prerank,regulation of T cell cytokine production (GO:0002724),0.30309144074743727,0.6715928365636155,0.8681481481481481,0.9583639165130343,1.0,3/15,14.55%,XCL1;TRAF2;TRPM4
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2620591564408243,0.6706565777698666,0.9012820512820513,0.9589560932175957,1.0,6/35,19.14%,PAM;SCD5;HSD17B8;GGT7;ACACA;FASN
prerank,purine nucleotide catabolic process (GO:0006195),0.30953942366335496,0.6706276907162341,0.832807570977918,0.9586282306165407,1.0,4/13,21.20%,GDA;NT5C1A;XDH;HINT1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3230670481446642,0.6698480142574137,0.8288431061806656,0.9590701426030781,1.0,3/11,14.54%,UBN1;ATRX;ASF1A
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.2744036580771493,0.6694452900451952,0.8720626631853786,0.9591265338886471,1.0,5/26,15.83%,NAV3;AKAP9;RAC1;FES;TOGARAM1
prerank,negative regulation by host of viral transcription (GO:0043922),0.32007236892782553,0.6684319172254578,0.8442367601246106,0.9597672919540237,1.0,2/12,9.16%,CCL5;HDAC1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.29975649455286274,0.6679694541832611,0.8423295454545454,0.9598693129669784,1.0,4/15,21.28%,AK8;ENTPD7;ENTPD6;NME2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.31836374439082815,0.6679640914803266,0.8589743589743589,0.9595200912968812,1.0,3/11,19.84%,PDPN;SRC;CORO1C
prerank,response to ionizing radiation (GO:0010212),0.24144201637594923,0.6677895443435022,0.9302325581395349,0.9593421976404369,1.0,15/70,19.28%,TNKS1BP1;BABAM2;INO80;ATM;TRIM13;GRB2;ANXA1;TANK;IKBIP;PAXIP1;USP28;CLOCK;RAD9A;SWI5;GADD45A
prerank,male gonad development (GO:0008584),0.26264680532456924,0.6672405822603085,0.8785529715762274,0.9595428467951169,1.0,6/34,18.07%,GATA6;WNT5A;TGFB2;ADAM21;TFAP2C;INHBA
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.2230499018099666,0.6660447359394156,0.9704081632653061,0.9603933809614199,1.0,47/168,24.18%,RPSA;ZFP36L1;CTIF;TNKS1BP1;SMG7;CNOT4;ATM;ERI1;SAMD4A;SMG6;EXOSC4;DCP2;DHX34;NCBP2;PPP2R2A;XRN1;RPL12;RPL22;RPL14;RPL11;DCP1A;DXO;PATL1;GSPT1;RC3H2;THRAP3;RPL36A;TUT7;RPS9;PARN;RPL6;RPLP2;ETF1;EIF4G1;CNOT2;CSDE1;ZC3H12A;NBDY;RPS27A;CNOT3;EXOSC5;EIF3E;PATL2;POLR2D;RNPS1;SMG5;AGO1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2597567698716642,0.6656235817083893,0.8709677419354839,0.9604305697415896,1.0,5/32,12.48%,TAOK1;NAV3;TPX2;CAMSAP2;FGF13
prerank,motor neuron axon guidance (GO:0008045),-0.24038860639239443,-0.6652257364718496,0.9,0.9887240159780776,1.0,6/15,20.76%,EPHA4;RHOG;TMEFF1;SLIT2;LAMC2;RHOH
prerank,positive regulation of cilium assembly (GO:0045724),0.29590740354928,0.6648086214790507,0.8585572842998586,0.9608688245782956,1.0,4/18,14.08%,ENTR1;CEP120;TAPT1;ARHGAP35
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.2166078191230486,-0.6647549776444466,0.9224489795918367,0.9878712403449214,1.0,11/24,31.49%,CTNNA2;MAPK12;BNIP2;BOC;MYOCD;CDH2;MEF2C;MAPK14;CAMK1;OLFM2;CDON
prerank,female gonad development (GO:0008585),0.28507786405929414,0.6647016063858449,0.8660968660968661,0.9606086030000905,1.0,8/19,26.91%,NR2F2;INHBB;INHBA;NUP107;VEGFA;EIF2B5;INHA;FSHR
prerank,positive regulation of JUN kinase activity (GO:0043507),0.2723079626383911,0.6646684906585302,0.8915989159891599,0.9602865055960592,1.0,4/23,13.07%,SASH1;TAOK3;TNF;TRAF2
prerank,cellular response to dsRNA (GO:0071359),0.2995878471049769,0.6646017843271412,0.8687782805429864,0.959992264554101,1.0,1/15,1.79%,COLEC12
prerank,mitochondrion organization (GO:0007005),0.22032696460254939,0.6637885449262673,0.9659442724458205,0.9604205781493501,1.0,32/165,18.27%,LRRK2;STOML2;PPRC1;AKT3;TRAK1;HK2;VPS13C;OMA1;ADCK1;PID1;AIFM2;MIGA2;COX7A2L;MTX2;TERT;TOMM7;ATPAF1;RAB32;FBXO7;AGTPBP1;TIMM17A;SPG7;GABPB1;MTX1;SIRT3;CYCS;TIMM50;AIFM1;POLRMT;HSPD1;ATP7A;TOMM22
prerank,photoperiodism (GO:0009648),-0.20347609933157024,-0.6630781798658726,0.9375,0.9879992534330687,1.0,6/28,13.69%,PER1;SIK1;FBXL3;USP2;MTA1;PER2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.323936862410762,0.6629989051283927,0.8516746411483254,0.9608156847458256,1.0,1/10,6.81%,DGKH
prerank,glial cell differentiation (GO:0010001),0.26931356132399703,0.6629752916361417,0.8855989232839838,0.9604849174632526,1.0,3/28,5.93%,STAT3;SHH;PTPRZ1
prerank,eye photoreceptor cell development (GO:0042462),-0.24572112776232582,-0.6622710006969447,0.8955696202531646,0.9874222340113075,1.0,5/15,25.15%,RORB;RP1;BBS4;RPGRIP1L;TULP1
prerank,negative regulation of leukocyte migration (GO:0002686),0.3213768384058755,0.6617841407998385,0.8454404945904173,0.961291852374522,1.0,2/10,9.71%,EMILIN1;BMP5
prerank,negative regulation of ATPase activity (GO:0032780),0.29742116796041324,0.6615968777208087,0.8690647482014389,0.9611178691286106,1.0,4/16,18.25%,PXK;VCPKMT;TNNT2;THADA
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2835935437675055,0.6615026774875945,0.8609179415855355,0.9608405826335205,1.0,5/18,18.90%,CCT8;DCP2;RUVBL1;CCT3;PARN
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.2837623560862926,0.6614501245757961,0.8748335552596538,0.9605367091574329,1.0,5/20,17.96%,ABCA2;FBXW7;BMP5;TRIB3;PRMT3
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.31514458658386607,0.6609043458818787,0.8584474885844748,0.9606759040970824,1.0,3/11,17.16%,ATL2;VCPIP1;LPCAT3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.25754744666410756,0.6605301778299801,0.9080604534005038,0.9606883006521796,1.0,9/35,19.69%,ATM;ATR;CCT8;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB
prerank,base-excision repair (GO:0006284),0.24648540904526803,0.6600585020197044,0.9105011933174224,0.9607956747547066,1.0,11/48,22.34%,MPG;DNA2;LIG1;XRCC1;POLG;PNKP;MBD4;HMGA2;NEIL1;RFC1;RPA1
prerank,lipoxygenase pathway (GO:0019372),-0.24741604611243778,-0.6596067190269927,0.9035087719298246,0.988322684789947,1.0,2/14,13.75%,PON2;HPGD
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.2887530516591494,0.6591362143445603,0.8610315186246418,0.9613170644480531,1.0,6/20,20.28%,PLOD2;GGCT;CNDP2;PTDSS2;GSS;PLSCR1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.2980145706446386,0.6590400924537607,0.8573596358118362,0.9610531239873161,1.0,3/14,14.77%,PTPN1;DDRGK1;HSPA5
prerank,metal ion homeostasis (GO:0055065),0.25528809030462574,0.6589084773381063,0.9002433090024331,0.9608296650990269,1.0,10/40,21.68%,SLC12A4;FAM20A;CYP27B1;SLC7A8;SELENON;SLC12A9;CNNM2;SLC12A8;LETM2;CNNM4
prerank,inorganic anion transport (GO:0015698),0.24145629468898158,0.6584004364367354,0.9279069767441861,0.9609579059951154,1.0,1/53,0.33%,ENPP1
prerank,regulation of phosphatase activity (GO:0010921),0.2783289076199028,0.658204798745118,0.8713286713286713,0.9607925872763965,1.0,8/24,23.98%,PPP1R36;PPP1R2;MTMR9;PTPA;HSP90B1;PPP6R2;GPATCH2;PPP1R35
prerank,superoxide anion generation (GO:0042554),-0.24862710401225122,-0.656710726798842,0.8953488372093024,0.9894245543602838,1.0,8/13,47.46%,NCF2;NOX1;TAFA4;CYBA;NCF1;NOX3;NCF4;DUOX1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3098599967547637,0.656585814414292,0.8660436137071651,0.9619501302092128,1.0,2/11,10.32%,BAG6;UGGT2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.29617190872731347,0.6564702565493454,0.8590308370044053,0.9617056163628496,1.0,8/15,29.74%,ACTR2;WASHC1;ARPC1B;TRIM27;ARPC2;JMY;WHAMM;ARPC3
prerank,B cell activation (GO:0042113),0.23334322982365735,0.6560085909090837,0.922384701912261,0.9618077905248638,1.0,15/68,18.94%,CD40;BCL2;LAT2;MS4A1;CTPS1;PTPRJ;PTPN2;CASP8;KLF6;TCF3;PTPRC;HSPD1;HDAC5;ZBTB7A;ADGRG3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.296517167696952,0.6556277104764396,0.8571428571428571,0.9617990627429961,1.0,5/15,16.21%,RAB3GAP2;RAB10;RAB3GAP1;SEC61A1;SRP14
prerank,ubiquinone metabolic process (GO:0006743),0.30251602390808074,0.6555261208756148,0.8670788253477589,0.9615364722444099,1.0,5/15,17.17%,AIFM2;COQ8B;COQ10B;COQ5;FDXR
prerank,neuron projection organization (GO:0106027),-0.23503346695682287,-0.6550103519247062,0.9203821656050956,0.9895793582667524,1.0,3/15,10.93%,INSR;MAP1A;APP
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.30502896530841717,0.6549680279802456,0.848714069591528,0.9617087972488768,1.0,1/13,5.25%,VDAC2
prerank,regulation of telomere capping (GO:1904353),0.2780967094149218,0.6543948111680169,0.8744769874476988,0.9618930043304355,1.0,7/23,23.02%,ATM;SMG6;TNKS2;PNKP;MAPK1;PKIB;MAP2K7
prerank,peptidyl-arginine modification (GO:0018195),0.2999981575624746,0.6543254279305312,0.8685446009389671,0.9616089108593497,1.0,1/15,4.11%,PADI2
prerank,negative regulation of cell death (GO:0060548),0.2253342870972342,0.6539096117374182,0.9463307776560789,0.9616370215648153,1.0,23/88,22.97%,LRRK2;CCN4;CHMP4A;CHMP4B;NCK1;GPNMB;GSK3B;FGF2;TRAF2;BMP7;CCN5;ADNP2;NPAS2;AKT1;CCN6;DUS2;EIF4G1;WNT16;BECN1;VPS35;CLU;CSF1;CD200R1
prerank,protein localization to microtubule organizing center (GO:1905508),0.2919014052064931,0.653171442590084,0.8588235294117647,0.9619466294262292,1.0,4/15,17.00%,PCM1;SNX10;CEP192;CSNK1D
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.30384482509806693,0.6528694376825412,0.867601246105919,0.9618670510988636,1.0,5/12,25.00%,SMO;PAX8;AGT;GDNF;VEGFA
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.26281466236678197,-0.6526641104771449,0.9147286821705426,0.9900908079702491,1.0,2/11,4.74%,TIPIN;SMARCAL1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.26795074480427183,0.6524560657988642,0.9025032938076416,0.9618815512979045,1.0,6/26,20.52%,CD36;TRAP1;SPHK2;COA8;CCN6;SLC18A2
prerank,snRNA transcription (GO:0009301),0.22813320452192595,0.6520115709952475,0.929608938547486,0.9619192564694042,1.0,17/70,18.50%,SNAPC3;POU2F1;GTF2F2;USPL1;NCBP2;ELL2;INTS1;CDK7;GTF2F1;INTS4;CCNT1;INTS14;ICE1;POLR2L;POLR2K;CDK9;RPAP2
prerank,ubiquinone biosynthetic process (GO:0006744),-0.2377803330435,-0.6520061369802471,0.9157303370786517,0.9893306297843163,1.0,3/15,9.12%,PDSS1;COQ2;PDSS2
prerank,regulation of microglial cell activation (GO:1903978),0.2942668214197781,0.6505465735021619,0.8682634730538922,0.9628769830553162,1.0,4/15,21.34%,TREM2;CX3CL1;PTPRC;NR1D1
prerank,gene expression (GO:0010467),0.2127729317045214,0.6504419060027093,0.990990990990991,0.9626228169659901,1.0,56/348,18.50%,RPSA;RRBP1;RBMS1;BCL3;APOBEC1;ASMT;TNIP1;ATXN1;SYNCRIP;RPL3L;NUP37;E2F1;SNRNP40;SMG7;RAE1;DDX17;PABPC4;SMG6;RRAGC;DHX8;ALKBH5;NCBP2;NUP153;POLR3A;RPL12;MRPS18A;AGFG1;NKX2-8;RPL22;RPL14;LMF2;RBM6;MRPS14;RPL11;MMS19;NDC1;BAZ2A;SETX;GSPT1;NUP35;NUP188;TSPAN14;HNRNPUL1;SEC13;MRPL55;HSPD1;ANGPT2;RPL36A;MRPL52;POLR2L;RPS9;POLR2K;PAX8;DDX20;RBM39;SRSF2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.21549173930780444,0.6497730234408389,0.9671457905544147,0.9628846297893896,1.0,40/172,20.28%,PLD1;PIP5K1B;PTPN13;PTEN;PIP4K2A;CPNE7;PI4K2B;DGKH;PIK3R5;CSNK2A1;CSNK2A2;PGS1;PLA2G12A;FIG4;FGF2;PI4KA;GPAT3;PIK3R1;CEPT1;SACM1L;ARF1;ABHD8;PLA2G4A;MTMR9;PIK3R4;DDHD2;PIK3C3;LPCAT3;MTMR3;RUFY1;PTDSS2;PIP5K1A;CPNE3;PLEKHA2;MTMR2;MTMR6;MTMR1;MTM1;ETNK1;PLSCR1
prerank,cGMP biosynthetic process (GO:0006182),0.31883626481427746,0.648044658258612,0.8724727838258165,0.9641150184392838,1.0,1/10,6.15%,NPR2
prerank,positive regulation of histone deacetylation (GO:0031065),-0.25080979204568027,-0.6480314943320779,0.8918128654970761,0.9910454145142569,1.0,4/12,18.65%,SAP30BP;AKAP8;PRKD1;CTBP1
prerank,peripheral nervous system development (GO:0007422),0.27042604686444816,0.647498028004656,0.8787465940054496,0.9642370550927684,1.0,4/23,15.20%,PMP22;NF1;EGR2;ALDH3A2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.23480793115541604,-0.6472105924265307,0.8967551622418879,0.9904146509081387,1.0,7/14,32.99%,RPL7;RPL35;RPF2;RPL7L1;WDR12;NOL9;URB1
prerank,protein polyglutamylation (GO:0018095),0.30578173641789547,0.6467744825893967,0.8474842767295597,0.9645491769671414,1.0,2/11,9.52%,CEP41;TPGS1
prerank,gene silencing by miRNA (GO:0035195),0.25730494801152914,0.6451211153762573,0.9155495978552279,0.9656681763880365,1.0,10/32,25.67%,PUM1;TNRC6B;DICER1;MOV10;WTIP;AGO2;SNIP1;AGO1;CNOT1;CNOT7
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.25552717413232395,-0.644059085569986,0.8844984802431611,0.9914845663460231,1.0,4/12,20.87%,TOPBP1;HUS1;NAE1;ORC1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2753942224003913,0.643349176961939,0.8953168044077136,0.9668658818205315,1.0,7/20,21.39%,PSEN1;PSENEN;RHBDD1;NCSTN;ADAM9;PSEN2;HM13
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2292931625127018,0.6418823968517167,0.9519450800915332,0.9677671266348334,1.0,12/69,16.40%,APOE;MDK;BCL2;PTPRZ1;TGFB3;NONO;CCL2;UNC5B;CPEB4;CX3CL1;HIF1A;RASA1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.22739646287848164,-0.6413934905539924,0.9085365853658537,0.992116471066499,1.0,8/15,35.63%,OGA;EXTL2;CHST3;RENBP;CHST7;NAGK;CHST2;CHST5
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.2663739963802451,-0.6409942910023617,0.8685015290519877,0.9911358771133815,1.0,1/10,1.13%,PRKCH
prerank,protein complex oligomerization (GO:0051259),0.22371980008763506,0.6407938994078426,0.9478935698447893,0.9684020817862824,1.0,13/85,16.68%,SLC9A1;STOML2;TMEM120B;PKD2;ATL2;MS4A1;RNF213;UGDH;TIFA;TMEM120A;RBMX;ALS2;TRMT61B
prerank,protein import into peroxisome membrane (GO:0045046),-0.2121093211472025,-0.6396065996273277,0.9448529411764706,0.990890006836489,1.0,9/22,27.01%,ABCD3;PEX3;GDAP1;ACBD5;PEX14;PEX26;PEX11B;SLC25A17;PEX13
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2660361445712006,-0.6396049893053375,0.9258241758241759,0.989654103391973,1.0,3/10,15.71%,DNAJC19;ABCA3;MFSD2A
prerank,regulation of cilium movement (GO:0003352),-0.26855333370806567,-0.6393862062104508,0.905,0.9885734098800695,1.0,8/10,41.61%,CCDC39;CFAP298;ODAD2;DRC1;CCDC65;CFAP43;CFAP206;CCDC40
prerank,mitochondrion transport along microtubule (GO:0047497),0.29517206473011004,0.6388518955293065,0.887905604719764,0.9697063771220289,1.0,2/13,15.67%,MAP1S;HIF1A
prerank,response to UV-B (GO:0010224),-0.24950383799633286,-0.6381809442893445,0.9244186046511628,0.9881808706950537,1.0,2/12,10.14%,MSH2;CRIP1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.23881197423310047,0.6375276783212178,0.9213349225268176,0.9704605777608668,1.0,12/50,20.67%,TNFAIP3;NXN;PINX1;OGT;SPRY2;DTX3L;SQSTM1;AKT1;PRMT3;FBXO5;ISG15;SVBP
prerank,response to unfolded protein (GO:0006986),0.23225572470901285,0.6372566854857836,0.920863309352518,0.9703514975181966,1.0,5/48,7.37%,DNAJB1;BAG3;SERPINH1;HSPE1;PTPN1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.25281376448030346,0.6371035736747624,0.9064935064935065,0.970124030991463,1.0,2/28,3.78%,PTN;APOE
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.2497419480922474,-0.6369983786711896,0.9192200557103064,0.9877742488697906,1.0,8/12,42.60%,RFWD3;PLK5;TP53;RPA2;PLK3;SDE2;CCND1;WAC
prerank,carbohydrate transport (GO:0008643),-0.258164440581043,-0.6369336899997466,0.9134078212290503,0.9865923213101837,1.0,6/11,48.32%,AQP11;SLC26A6;SLC2A2;AQP1;SLC2A5;AQP9
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.29829569586972254,0.6364288716940664,0.882262996941896,0.970347332144577,1.0,3/12,17.14%,MIA3;BMP5;AKT1
prerank,epithelial cell development (GO:0002064),0.2679644079340576,0.6358345931903421,0.8744710860366713,0.9704926677196742,1.0,2/20,10.22%,SIPA1L3;SLC4A7
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.25981060622020236,0.6356387107764027,0.9224598930481284,0.9702907029280019,1.0,5/26,17.65%,LRRK2;FBXO7;NFE2L2;AKT1;ATF4
prerank,protein sumoylation (GO:0016925),0.2336034011090286,0.6352446324781961,0.9536817102137767,0.9702819487989153,1.0,10/49,16.21%,NUP37;RAE1;PIAS2;NUP153;NSMCE2;EGR2;TRPM4;NDC1;NUP35;NUP188
prerank,glycerophospholipid catabolic process (GO:0046475),0.2607029665993966,0.6351879983017382,0.9026666666666666,0.9699812939319036,1.0,5/27,15.97%,LIPC;PLA2G7;ABHD16A;PLA2G4A;PLA2G4E
prerank,maturation of SSU-rRNA (GO:0030490),0.24977744930409382,0.6346043885459327,0.9144981412639405,0.9701261794652044,1.0,10/34,24.05%,NOL11;NOP14;UTP3;NAT10;SRFBP1;RIOK2;DHX37;BMS1;RRP36;TSR1
prerank,tRNA 5'-end processing (GO:0099116),0.28474148294431867,0.6338769141541469,0.8812589413447782,0.9703787194944751,1.0,2/15,12.47%,POP1;POP4
prerank,mitochondrial translation (GO:0032543),0.21670956445000034,0.6335531251179465,0.9626865671641791,0.9702874840495274,1.0,21/104,20.25%,MRPS26;MRPL57;MRPL48;DAP3;IARS2;MTIF2;MRPS18A;RARS2;MRPL19;MRPL15;MRPS14;MRPS2;EARS2;MTRF1L;NDUFA7;LARS2;MRPL55;MRPL52;MRPS27;MRPS33;MRPL49
prerank,histone H4 acetylation (GO:0043967),0.23755559360861775,0.6335359549160852,0.9226190476190477,0.969949389967969,1.0,16/47,25.60%,KMT2A;KANSL1;OGT;RUVBL1;PHF20;ING5;KAT7;TADA3;EP400;KANSL3;ACTL6B;MEAF6;TRRAP;MORF4L2;ATF2;MORF4L1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2464997014654989,-0.6328737137325892,0.9019607843137255,0.9879889769451227,1.0,6/12,37.12%,B3GALT2;B3GNT2;B3GNT3;B3GNT8;B4GAT1;B3GNT6
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.29823205539585906,0.6311359133312505,0.8900928792569659,0.9716055248951401,1.0,2/11,14.44%,MLIP;SMAD4
prerank,regulation of DNA recombination (GO:0000018),-0.1872814174750796,-0.6299213320545786,0.9684684684684685,0.9886608671857282,1.0,12/32,29.37%,SMARCAD1;MRE11;RTEL1;MSH2;MSH3;THOC1;RAD50;SHLD2;RPA2;H1-0;KPNA1;CHEK1
prerank,mitochondrial genome maintenance (GO:0000002),0.305226249128923,0.6299160283420929,0.8798751950078003,0.9722590038321797,1.0,1/11,4.37%,AKT3
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.24382648770889742,0.6280766741321724,0.9411764705882353,0.9733938222373462,1.0,4/37,10.03%,BBC3;NCK1;BCL2;FBH1
prerank,AMP metabolic process (GO:0046033),0.28702864456909094,0.6279468651546254,0.8775510204081632,0.9731503813729079,1.0,4/13,19.83%,AMPD2;NT5C1A;XDH;AMPD3
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2490369714033733,0.6264456814954029,0.9194805194805195,0.9740183027104911,1.0,6/31,15.85%,EDC4;EXOSC4;DCP2;DCP1A;PATL1;LSM7
prerank,receptor recycling (GO:0001881),-0.26985890547739877,-0.625565615062949,0.9281914893617021,0.990066490226587,1.0,5/10,21.45%,SORL1;RAB11B;EHD3;PHETA1;PLEKHJ1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.2632401938344868,0.6253275216369204,0.9139344262295082,0.9745721449733176,1.0,3/23,9.64%,PABIR1;VPS4A;SETMAR
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.2875060809190018,0.6235929876658627,0.8905775075987842,0.9755641081186578,1.0,1/12,5.11%,NUGGC
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.22289153242280904,0.6234821895011695,0.9434832756632064,0.9753009812815534,1.0,22/64,23.83%,POLR1E;GTF2H1;GTF2F2;SETD2;NCBP2;CDK7;GTF2F1;CCNT1;MLLT1;POLR2L;POLR2K;CDK9;IWS1;CDK13;ERCC2;CDK12;CCNH;TCEA1;POLR2D;MNAT1;CDC73;PCID2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.291469278911419,0.6230048466637745,0.8898550724637682,0.9753078518310386,1.0,4/14,20.23%,ACTR2;TIMELESS;MMS19;ARID2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.291067188814653,0.6217950730696429,0.913767019667171,0.9758733741120361,1.0,3/12,15.00%,FKBP1B;UBASH3B;ANXA6
prerank,negative regulation of double-strand break repair (GO:2000780),0.252329396905564,0.6200567244880059,0.9343629343629344,0.9768323638987862,1.0,6/30,16.09%,UBR5;SHLD3;RNF169;FBH1;RIF1;CGAS
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.26090819426337203,0.6199331033883756,0.9041278295605859,0.9765735954485456,1.0,4/24,15.30%,GFPT2;PID1;COQ10B;CYCS
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.30192178428256183,0.619326389298983,0.8852988691437803,0.9766949320434685,1.0,2/10,10.14%,CPEB1;NCBP2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.2981501010073148,0.6191794390481017,0.8793103448275862,0.9764504389654428,1.0,1/11,5.04%,LGALS9
prerank,mRNA transport (GO:0051028),0.21107670176791163,0.6190732886297902,0.9688841201716738,0.9761835951381325,1.0,33/101,26.96%,ZFP36L1;NUP37;SMG7;RAE1;SMG6;ALKBH5;NCBP2;NUP153;AGFG1;FMR1;NDC1;NUP35;NUP188;SEC13;SRSF2;NUP214;NUP107;FYTTD1;SLU7;SRSF11;THOC5;RNPS1;FIP1L1;CPSF3;SMG5;THOC2;GLE1;KIF5C;HNRNPA2B1;NUP42;NUP155;SRSF1;CPSF1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.22448750807588058,0.6179892467228053,0.9594438006952491,0.9766556520221807,1.0,14/58,20.00%,BABAM2;ATM;DCLRE1C;SETMAR;HMGB2;KDM2A;MDC1;NSMCE2;RIF1;PAXIP1;PRKDC;PSMD14;ZBTB7A;SMC5
prerank,telomere maintenance via telomerase (GO:0007004),0.2490311860657445,0.6178743764574003,0.9190600522193212,0.9763985217577685,1.0,10/28,25.72%,TNKS1BP1;PINX1;TERT;PPP6C;TELO2;RFC1;TERF1;RPA1;TERF2IP;TERF2
prerank,regulation of glycogen metabolic process (GO:0070873),0.2897683769430014,0.6178210580815023,0.9033742331288344,0.9760880862381349,1.0,3/12,17.14%,KHK;RUBCNL;AKT1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2134381523084214,-0.6177174414234149,0.9562289562289562,0.9934453059629809,1.0,2/17,9.45%,LPGAT1;SERAC1
prerank,positive regulation of DNA repair (GO:0045739),0.2330155974365108,0.6171527849181256,0.9364303178484108,0.9762539564482459,1.0,10/46,18.04%,EGFR;BABAM2;DDX11;SPIRE1;TMEM161A;TIMELESS;MGMT;XRCC1;NPAS2;SLF2
prerank,negative regulation of transmembrane transport (GO:0034763),0.30040401473211126,0.6169464730965787,0.9014084507042254,0.9760536507835237,1.0,3/10,17.14%,OAZ3;CTTNBP2NL;AKT1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2551881438448367,0.616699559041673,0.9243243243243243,0.9759002895595648,1.0,3/25,10.60%,FAM20A;CYP27B1;SELENON
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.22506622867682685,-0.6144572229403372,0.940983606557377,0.9941275183177907,1.0,4/15,30.55%,DERL1;UFD1;NPLOC4;TMEM129
prerank,cardiac muscle cell differentiation (GO:0055007),-0.20584508215909553,-0.6143464115594274,0.9657534246575342,0.9929568366594437,1.0,14/21,42.83%,CXADR;SIK1;MYOCD;MEF2C;KDM6B;CBY1;MYH11;TTN;NRG1;ALPK3;TCAP;IRX3;MYH6;ALPK2
prerank,histone monoubiquitination (GO:0010390),0.2559369102233772,0.6138764093771139,0.9026666666666666,0.9776264671159011,1.0,10/24,27.59%,RNF2;SKP1;DTX3L;DDB1;UBE2E1;CDC73;RYBP;PAF1;RNF40;ATXN7L3
prerank,regulation of dopamine secretion (GO:0014059),0.25148251915322306,0.6129646950428769,0.9195088676671214,0.9779642475452215,1.0,3/25,9.77%,DTNBP1;SYT2;DRD3
prerank,mucosal immune response (GO:0002385),-0.22149673530889002,-0.6128674522702853,0.954983922829582,0.992618305010492,1.0,15/15,77.88%,DEFA6;OTUD7B;IFNLR1;NOS2;RAB17;IL4;CAMP;BPIFB1;DEFB1;FFAR2;LTF;PIGR;PLA2G1B;RPL39;RNASE3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2270515974697037,0.6126618292808743,0.9566744730679156,0.9778269285487025,1.0,12/54,20.67%,TNFAIP3;TRIM21;NXN;PINX1;OGT;SPRY2;RPL11;SQSTM1;AKT1;PRMT3;ISG15;SVBP
prerank,steroid hormone biosynthetic process (GO:0120178),0.24537946095444654,0.6123634669695502,0.922879177377892,0.9776948600704898,1.0,5/29,19.96%,SRD5A3;HSD17B8;FDXR;MED1;SRD5A1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.25686365398974853,0.6121691926240943,0.9176788124156545,0.9774808582503991,1.0,6/21,18.80%,PDZD8;MICU2;MCUR1;ANXA6;MAIP1;MICU3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2541658241087895,0.6112382342279016,0.9114093959731544,0.977817837177862,1.0,9/23,22.55%,PTEN;SACM1L;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1;PIP4P2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.27826372222738915,0.6080159058420709,0.922962962962963,0.9797796264234652,1.0,3/15,19.43%,BCL2;MDM2;KDM1A
prerank,protein neddylation (GO:0045116),0.28397752961388434,0.6075045058961649,0.9142419601837672,0.9797697719282351,1.0,2/13,8.87%,DCUN1D1;UBE2F
prerank,ovarian follicle development (GO:0001541),-0.23443882985568776,-0.6075017503117677,0.9427710843373494,0.9943449218994167,1.0,8/13,35.33%,KIT;EIF2B2;SOD1;FOXL2;ANG;EIF2B4;LHCGR;CEBPB
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.1974572485531766,-0.6070137714808783,0.9676113360323887,0.9933727952335093,1.0,9/23,28.70%,COPS5;UBC;COPS7B;DDB2;UBA52;CETN2;RBX1;PARP1;XPC
prerank,negative regulation of phosphatase activity (GO:0010923),0.2507043589659364,0.6065586558865094,0.9212283044058746,0.9800791182788466,1.0,5/25,17.13%,PPP1R36;FKBP1B;TGFB2;GSK3B;PTPA
prerank,regulation of biosynthetic process (GO:0009889),0.2913547229270155,0.6061052669228023,0.9225806451612903,0.980032078111786,1.0,2/11,18.98%,SPHK2;CCN6
prerank,mitochondrial RNA metabolic process (GO:0000959),0.279311307651137,0.6054061992262132,0.8922155688622755,0.9801645580656183,1.0,6/14,26.99%,FOXO3;EARS2;POLRMT;TWNK;TEFM;MTERF2
prerank,regulation of blood circulation (GO:1903522),0.23598363582766427,0.6051429799265854,0.9421182266009852,0.9800111153870906,1.0,7/34,19.44%,TBX2;CAMK2D;KCNMB4;KCNIP2;TNNT2;AGT;TPM1
prerank,regulation of T cell mediated immunity (GO:0002709),0.2939182828092637,0.6048654812031776,0.9228346456692913,0.9798354090244025,1.0,10/10,70.63%,TRPM4;TNFRSF1B;FUT7;IL1B;RIPK3;WAS;HMGB1;CCR2;AGER;ZBTB1
prerank,ether lipid metabolic process (GO:0046485),0.2753265742739399,0.604690037256695,0.8862275449101796,0.9795949312405823,1.0,2/14,8.59%,DHRS7B;PLA2G7
prerank,RNA modification (GO:0009451),0.21801257215090045,0.6039784164249232,0.9583333333333334,0.9797284774818917,1.0,14/54,22.93%,PUS7L;METTL1;PUS3;NOP2;ALKBH1;NAT10;MRM2;ANKRD16;RBM15;PARN;BCDIN3D;DTWD1;FTSJ3;TRMT61A
prerank,RNA splicing (GO:0008380),0.20869378948094525,0.6038498116717571,0.9847991313789359,0.9794581665323012,1.0,11/95,12.26%,PPP1R9B;SYNCRIP;SNRNP40;CCAR2;RRAGC;NONO;DHX8;NCBP2;PRPF18;SNRNP35;RNPC3
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.22605270619858758,-0.6033591875651099,0.9553571428571429,0.9940566249967252,1.0,5/14,20.69%,NT5E;UPB1;NT5C3A;NT5C;DHODH
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.25928649969066264,0.6031114196226557,0.9230769230769231,0.9796143740791532,1.0,3/18,9.72%,TMEM119;HDAC1;FRS2
prerank,carboxylic acid catabolic process (GO:0046395),0.2832419815774561,0.6025571198324001,0.8939828080229226,0.9796335381440483,1.0,5/12,25.76%,AMDHD2;GNPDA2;NPL;PON3;GNPDA1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.22806547076902123,-0.6023222706566083,0.9327485380116959,0.9933269193894603,1.0,6/13,37.12%,B3GALT2;B3GNT2;B3GNT3;B3GNT8;B4GAT1;B3GNT6
prerank,respiratory electron transport chain (GO:0022904),0.27759032227331615,0.6022732240105951,0.90625,0.9794814023567426,1.0,2/14,10.07%,ETFA;SDHB
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2683319424108101,0.6022633600471515,0.9193083573487032,0.9791354670857713,1.0,6/16,27.36%,TOP2B;EME2;RMI1;SLX4;MSH4;SHOC1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.2731994480066229,0.6015115381962223,0.9104477611940298,0.9792999783791858,1.0,2/13,10.21%,PRICKLE1;TBX3
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.27879645392180635,0.6014348994118122,0.9180834621329211,0.9790026151731438,1.0,3/13,12.04%,SENP6;UBA5;ATG7
prerank,regulation of protein metabolic process (GO:0051246),0.2268883687674105,0.6012647697036977,0.9476813317479191,0.9787833102929255,1.0,5/44,9.92%,APOE;GSAP;SHH;SPOP;SSH1
prerank,negative regulation of catabolic process (GO:0009895),0.22250313741960936,0.6012112022925502,0.9500594530321046,0.9784717307701466,1.0,3/47,4.15%,EGFR;IRAK3;MAD2L1
prerank,regulation of neuron projection arborization (GO:0150011),0.2752096774562519,0.6011392583243099,0.9110105580693816,0.9781669477640335,1.0,3/15,11.12%,DLG4;WNT5A;MOV10
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.26123840211774135,0.6007091986021802,0.9171428571428571,0.9780993198961443,1.0,5/18,17.14%,NONO;NFE2L2;TRAP1;HIF1A;AKT1
prerank,response to calcium ion (GO:0051592),0.2059033089077871,0.5999048188798662,0.9818763326226013,0.9783021684983123,1.0,16/102,18.99%,SEC31A;CAMK2D;PKD2;CPNE7;CPNE2;KCNMB4;SYT2;WNT5A;PPP3CA;CALM2;KCNIP2;NEDD4;HPCA;TNNT2;CPNE3;ADGRV1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.23529044341217437,-0.5987235373577737,0.9283489096573209,0.9939418736292354,1.0,2/13,11.34%,CYFIP2;PERP
prerank,translational termination (GO:0006415),0.20713529826138155,0.5986494375764658,0.9793926247288504,0.9787857836576803,1.0,20/95,21.49%,MRPS26;MRPL57;MRPL48;DAP3;ABCE1;MRPS18A;MRPL19;MRPL15;MRPS14;MRPS2;MTRF1L;GSPT1;MRPL55;MRPL52;MRPS27;MRPS33;ETF1;MRPL49;N6AMT1;MRPL17
prerank,negative regulation of secretion by cell (GO:1903531),0.2308337530561097,0.5981323701603285,0.9591078066914498,0.9787672404639879,1.0,6/38,13.82%,APOE;ANXA1;DRD3;TNFRSF1A;DPH3;HRH3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2804184836133844,0.5978699226807446,0.9170506912442397,0.9785850232005731,1.0,3/13,20.43%,NT5M;MBD4;NEIL1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.2613030718939371,0.5967458205700771,0.9132290184921764,0.9789874811062842,1.0,5/17,25.46%,PTPRJ;PTPN2;PRNP;UBASH3A;THY1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.20905024769154723,0.5962913367036051,0.9720670391061452,0.9789269913667625,1.0,16/69,18.50%,SNAPC3;POU2F1;GTF2F2;NCBP2;ELL2;INTS1;CDK7;GTF2F1;INTS4;CCNT1;INTS14;ICE1;POLR2L;POLR2K;CDK9;RPAP2
prerank,mismatch repair (GO:0006298),0.23722836404805825,0.5959792135083385,0.9250334672021419,0.9787911615672801,1.0,4/27,10.37%,LIG1;SETD2;RNASEH2A;MCM9
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.24873907491114317,0.5958304398927651,0.9210884353741496,0.9785389356866812,1.0,3/22,10.32%,TRIM13;MAN1C1;UGGT2
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.27467307632451887,0.5950774469152945,0.9278195488721804,0.9786591699416543,1.0,6/14,24.51%,TREM2;CX3CL1;PTPRC;NR1D1;CD200R1;TNFRSF1B
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.2593965308474717,0.5944893229050108,0.9077340569877883,0.9786952851807191,1.0,5/19,22.61%,RPTOR;NAB2;ICE1;PRDX5;CHD8
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.22520625278098005,0.5931660388064589,0.9501822600243013,0.9791695748133495,1.0,5/45,11.65%,ATXN2;PUM1;METTL16;FOXO3;GCNT2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.2254125337548259,-0.5921733349573775,0.9512893982808023,0.995797500874577,1.0,5/13,33.21%,CPE;HEY2;RYR2;NOTCH1;NPY5R
prerank,negative regulation of secretion (GO:0051048),0.2998358387536025,0.5920628124386499,0.8911042944785276,0.9795101143582386,1.0,1/10,5.75%,EGF
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.18321718641580426,-0.5917658683613636,0.9785407725321889,0.9935163791788916,1.0,8/29,25.24%,ACBD6;GPAT4;ACLY;DBI;ACOT7;OXSM;ACSL6;MLYCD
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.18321718641580426,-0.5917658683613636,0.9785407725321889,0.9935163791788916,1.0,8/29,25.24%,ACBD6;GPAT4;ACLY;DBI;ACOT7;OXSM;ACSL6;MLYCD
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2687156426333962,0.5916054182664757,0.9264069264069265,0.9794575839831376,1.0,4/16,16.09%,SHLD3;FBH1;RIF1;CGAS
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.2908044738810921,0.5894286039165546,0.922077922077922,0.980491612706623,1.0,3/10,16.89%,NT5M;DPYD;NT5C1A
prerank,regulation of chromatin binding (GO:0035561),0.28528676453689467,0.5881010681483296,0.9322314049586777,0.9809587796459266,1.0,3/10,18.97%,DDX11;DTX3L;WAPL
prerank,proteasome assembly (GO:0043248),-0.23378668451251006,-0.5878078669924846,0.945054945054945,0.9940464292568566,1.0,5/11,35.24%,POMP;PSMD13;ADRM1;PSMD10;OTUD6B
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2041101224055651,-0.5868069364565172,0.9612403100775194,0.9932710761791811,1.0,14/20,57.57%,STARD3;STAR;HSD17B10;TSPOAP1;STARD3NL;FDX2;TSPO;HSD3B2;AKR1C1;DHRS9;AKR1D1;CYP11B1;CYP46A1;CYP11A1
prerank,antibacterial humoral response (GO:0019731),0.26090778379848645,0.5858816389165925,0.9355783308931186,0.9819563288839029,1.0,1/16,5.65%,RNASE7
prerank,histone H2A ubiquitination (GO:0033522),0.2612918702940892,0.5848671421177126,0.9200561009817672,0.9822332222461376,1.0,4/17,17.41%,RNF2;SKP1;DTX3L;DDB1
prerank,detection of calcium ion (GO:0005513),0.2675069622798711,0.5845062861209073,0.9057437407952872,0.9820858667358303,1.0,3/13,15.49%,KCNMB4;CALM2;KCNIP2
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.245241869943152,-0.584310616811432,0.9478021978021978,0.9931958352350165,1.0,5/10,26.50%,RFWD3;FEM1B;DDX39B;THOC1;RPA2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2336976691761717,0.5817988730807007,0.9517601043024772,0.983329260309439,1.0,10/29,25.72%,TNKS1BP1;PINX1;TERT;PPP6C;TELO2;RFC1;TERF1;RPA1;TERF2IP;TERF2
prerank,cell differentiation in hindbrain (GO:0021533),0.27781458269019277,0.5816358130984765,0.9205607476635514,0.9830761357949328,1.0,3/11,18.03%,OPHN1;AGTPBP1;ATP7A
prerank,DNA replication checkpoint signaling (GO:0000076),0.25272694413688335,0.5811741868083055,0.9103641456582633,0.98299132676447,1.0,3/16,17.64%,DNA2;TIMELESS;RAD9A
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.27499338896825415,0.5803985238431261,0.9118541033434651,0.9830978371689214,1.0,4/12,21.37%,KHDRBS1;NEDD4;NUP214;IFI27
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.23674935321398305,-0.5795427822941994,0.9555555555555556,0.9940012622542407,1.0,5/10,42.68%,SAG;PDE6A;CNGB1;PDE6G;PDE6B
prerank,cellular copper ion homeostasis (GO:0006878),0.2662934763019955,0.5795251918330637,0.9248554913294798,0.9832687268091711,1.0,5/14,22.96%,SLC31A1;ARF1;ATP7A;PRNP;SLC31A2
prerank,protein monoubiquitination (GO:0006513),0.22383623237582753,0.5792411639469524,0.9496221662468514,0.9830771564953367,1.0,13/36,27.59%,KLHL22;TRIM21;UBE2R2;UBE2W;DTX3L;PEX12;UBE2E1;UBE3D;CDC73;KLHL12;PAF1;RNF40;ATXN7L3
prerank,mitochondrial transcription (GO:0006390),0.2846563453102858,0.5773801839377577,0.9060509554140127,0.9838113309029419,1.0,5/10,26.99%,FOXO3;POLRMT;TWNK;TEFM;MTERF2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.28460957066331605,0.5772298975848844,0.9207606973058637,0.9835498920581865,1.0,1/10,5.04%,LGALS9
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.2663139361430518,0.5763442572232943,0.9313572542901716,0.9836842205892787,1.0,7/12,31.20%,GART;PPAT;IMPDH2;IMPDH1;ADSL;LHPP;ADSS2
prerank,ribosomal large subunit assembly (GO:0000027),0.23838452759678203,0.5761473394562413,0.9507323568575233,0.9834465068738734,1.0,4/24,14.52%,RPL3L;NOP2;DDX28;RPL11
prerank,serine family amino acid metabolic process (GO:0009069),-0.1963994940516789,-0.5746421505438034,0.9601226993865031,0.9947336156199813,1.0,5/16,28.21%,GCLC;SARS1;CBS;SEPHS2;CTH
prerank,cellular response to calcium ion (GO:0071277),0.20676164304250322,0.5745154597066635,0.9762979683972912,0.9839948690742415,1.0,6/67,9.14%,CAMK2D;PKD2;CPNE7;CPNE2;SYT2;WNT5A
prerank,regulation of histone methylation (GO:0031060),0.2643521782076557,0.5741038331130892,0.9213649851632048,0.9838688272461902,1.0,1/13,3.82%,MTHFR
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.22730279178903298,0.573655191740069,0.9616858237547893,0.9837750107523336,1.0,8/29,20.12%,TNFRSF12A;SFRP1;TNF;TRAF2;RIPK1;INHBA;AGT;TNFSF12
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.2633688691952736,0.5736096683579079,0.9416282642089093,0.9834480842441861,1.0,4/13,18.27%,SRSF12;PRPF31;PRPF3;DDX20
prerank,oligodendrocyte differentiation (GO:0048709),0.24499875837562574,0.5726685563968975,0.9380281690140845,0.9836200509185365,1.0,2/19,5.93%,SHH;PTPRZ1
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.17505054944056975,-0.572513544635561,0.9868995633187773,0.994340038667894,1.0,19/29,51.41%,RAD21;SIRT7;P3H4;PRDM9;MEI4;REC8;TRIP13;SYCE2;MEIOB;SYCP2;TEX12;ZCWPW1;IHO1;FANCD2;RAD21L1;RNF212B;ANKRD31;HORMAD1;TERB2
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.22800757916735545,-0.570823604966269,0.9475138121546961,0.993830291201749,1.0,4/11,22.00%,LARP7;DKC1;EXOSC3;EXOSC10
prerank,positive regulation of ruffle assembly (GO:1900029),0.2635264369965423,0.5665583789628977,0.9348484848484848,0.9865133715922788,1.0,6/13,27.03%,NDEL1;EPS8;DEF8;P2RY12;PLEKHM1;FAM98A
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.23396335414117395,-0.5665412933895271,0.9610027855153204,0.9941968819808903,1.0,1/10,2.62%,MALT1
prerank,regulation of immunoglobulin production (GO:0002637),0.23646613228632235,0.5654102069873366,0.9406896551724138,0.9867594948257872,1.0,5/23,24.69%,SASH3;TNFRSF4;PTPRC;GPI;XBP1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.20346496974468914,-0.5650299613232983,0.967930029154519,0.9935863021911245,1.0,1/15,1.76%,BMP4
prerank,snRNA 3'-end processing (GO:0034472),-0.19618989611059096,-0.5648165758265076,0.9584775086505191,0.9924610250292852,1.0,6/19,21.18%,INTS2;EXOSC7;TUT1;EXOSC8;EXOSC3;TOE1
prerank,import into nucleus (GO:0051170),0.19985713255403031,0.5641526383145108,0.9807037457434733,0.9870551858001608,1.0,16/73,20.96%,STAT3;PRICKLE1;FAM53B;NUP153;TNPO1;E2F3;SMN1;NUP188;SEC13;BACH2;AKT1;DDX20;HEATR3;NUP214;SNRPB;NUP107
prerank,cellular response to unfolded protein (GO:0034620),0.2264080712578031,0.5635219809407476,0.956989247311828,0.9870105284011701,1.0,6/26,19.22%,BAG3;PTPN1;HSPA5;HSPD1;RHBDD1;HSPA13
prerank,nuclear pore organization (GO:0006999),-0.21353540444391841,-0.5622144933563664,0.956268221574344,0.9922227321659521,1.0,9/14,36.35%,NUP133;SEH1L;TMEM170A;NUP98;NUP93;AHCTF1;TPR;NUP205;RTN4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.198758163246354,-0.5613225426827014,0.9843260188087775,0.9913200835393045,1.0,8/17,38.10%,DHDDS;ALG1;DOLK;ALG12;DOLPP1;MVD;ALG3;ALG9
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.21911742645682603,-0.5607135154807039,0.9615384615384616,0.9903480460043601,1.0,6/12,41.92%,STARD3;STAR;TSPOAP1;STARD3NL;FDX2;TSPO
prerank,histone lysine demethylation (GO:0070076),0.22768794859820574,0.5605626575823417,0.9538670284938942,0.9881516500301201,1.0,8/25,26.60%,PHF2;KDM2A;KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,cellular response to oxygen levels (GO:0071453),-0.23494083029276536,-0.5600078436236844,0.9552631578947368,0.9894218917289554,1.0,5/10,31.52%,TMEM199;NDUFS2;ATP6V0D1;ATP6V1A;ATP6AP1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.1920688376517224,-0.5588462032401964,0.9715189873417721,0.9886329175611266,1.0,7/17,32.11%,RAB27A;SLC4A8;NLGN1;CACNA1I;RAB3D;SCAMP5;KCNB1
prerank,phospholipid dephosphorylation (GO:0046839),0.21796361683523813,0.5583180286553843,0.9654320987654321,0.988859530969706,1.0,9/37,19.90%,EPHX2;PTEN;SACM1L;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.22764868233945312,0.5573936000104853,0.9490196078431372,0.9889596997047007,1.0,6/25,18.23%,CBL;PDE6H;NEU3;AKT1;AGT;RBPJ
prerank,peptidyl-methionine modification (GO:0018206),-0.22059852501465915,-0.5572499393900152,0.9691011235955056,0.9879672625993515,1.0,2/12,13.46%,METAP2;NAA60
prerank,carnitine metabolic process (GO:0009437),0.2598607842006857,0.5538497864894505,0.9591194968553459,0.9902327789692973,1.0,1/12,4.93%,TMLHE
prerank,sensory perception of chemical stimulus (GO:0007606),0.25110503281173474,0.552341558325954,0.9383070301291249,0.9905665477754034,1.0,2/15,14.17%,CD36;GNAS
prerank,regulation of leukocyte migration (GO:0002685),0.24362443074512513,0.5515801317546374,0.9587482219061166,0.990551671028103,1.0,3/16,14.73%,MIA3;ANXA1;RAC1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.2668179297388243,0.5508681296480826,0.9406099518459069,0.9905317727198284,1.0,2/10,13.39%,DCLRE1C;RIF1
prerank,regulation of catecholamine secretion (GO:0050433),0.22061308815528974,0.5488025746562366,0.9628205128205128,0.9910853377202166,1.0,4/29,13.82%,DTNBP1;SYT2;DRD3;HRH3
prerank,acetyl-CoA metabolic process (GO:0006084),0.24632398374414988,0.5457124287125277,0.9571639586410635,0.9920591107623785,1.0,3/15,18.58%,MVK;NUDT7;ACACA
prerank,synaptonemal complex organization (GO:0070193),-0.20174376858663612,-0.5442511292350054,0.975609756097561,0.9896914939448798,1.0,1/15,2.33%,RAD21
prerank,synaptonemal complex assembly (GO:0007130),-0.20174376858663612,-0.5442511292350054,0.975609756097561,0.9896914939448798,1.0,1/15,2.33%,RAD21
prerank,phosphate ion transmembrane transport (GO:0035435),0.2591563267555183,0.5436910080896096,0.9523809523809523,0.992575844930345,1.0,3/12,15.94%,SLC20A1;SLC37A1;SLC25A10
prerank,aminoglycan metabolic process (GO:0006022),0.2670047258783518,0.543167346171358,0.931637519872814,0.9924317932327454,1.0,6/10,32.00%,CLN6;B4GALT7;XYLT1;B3GAT3;GAL3ST3;XYLT2
prerank,phosphate ion transport (GO:0006817),0.2419429803409327,0.5422725807822284,0.9576642335766423,0.9924345916667481,1.0,3/16,15.94%,SLC20A1;SLC37A1;SLC25A10
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.20933362824748125,0.5421986813817311,0.969173859432799,0.9921181687185026,1.0,7/37,17.92%,TAOK1;EFNA5;MAPRE2;GSK3B;PHLDB2;TPPP;PHLDB1
prerank,signal peptide processing (GO:0006465),0.2609652470778585,0.5413840153696731,0.9293563579277865,0.992117131208201,1.0,6/11,26.64%,SPPL3;SEC11A;HM13;CLN5;PCSK5;FURIN
prerank,peptidyl-glutamic acid modification (GO:0018200),0.22134964378685423,0.5410241181601586,0.9685452162516383,0.9919060591977914,1.0,3/24,11.46%,CEP41;TPGS1;AGTPBP1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.2578070464273647,0.5389454202452333,0.9518459069020867,0.9923515338733806,1.0,6/12,31.42%,SOAT1;LPCAT3;P4HB;SOAT2;APOC1;MTTP
prerank,metallo-sulfur cluster assembly (GO:0031163),0.22587058278190464,0.537596302962104,0.9696969696969697,0.9925413206039693,1.0,4/22,14.71%,FXN;LYRM4;HSCB;MMS19
prerank,regulation of microtubule-based process (GO:0032886),0.21165954241227714,0.537391321102049,0.9759797724399494,0.9922651576191948,1.0,7/36,17.92%,TAOK1;EFNA5;MEMO1;GSK3B;PHLDB2;TPPP;PHLDB1
prerank,ncRNA 3'-end processing (GO:0043628),0.2445850143758952,0.5353054036195474,0.9588235294117647,0.9926921424303488,1.0,4/14,24.05%,ERI1;INTS14;INTS8;INTS6L
prerank,regulation of actin nucleation (GO:0051125),-0.2128066140231418,-0.5344402753304835,0.963076923076923,0.991302598620437,1.0,1/12,3.22%,GSN
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.23739235846800166,0.5326587009551393,0.9435600578871202,0.9933592660702463,1.0,3/15,14.46%,CCT8;RUVBL1;CCT3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.23550249662646297,0.532460375133537,0.9665697674418605,0.9930845374525454,1.0,5/17,21.68%,CCL5;TGFB2;PIEZO1;ADAM9;P2RY12
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.25908368131833254,0.530234959379754,0.9506933744221879,0.993590519683723,1.0,2/10,16.90%,OGT;SDHAF3
prerank,ribonucleoprotein complex assembly (GO:0022618),0.1775598799638403,0.5296384049110658,1.0,0.993458869949456,1.0,22/132,19.73%,RPSA;RPL3L;CELF1;EIF5;DICER1;NOP2;PRPF18;RAMAC;SMN1;RPL11;SNRNP200;SETX;PRKDC;TGS1;DHX29;DDX1;MCTS1;DDX20;RPL6;PUF60;CELF5;SNRPB
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.24225140450899701,0.5287739095396863,0.9690265486725663,0.9934302129469482,1.0,1/14,5.00%,PRKD2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.25991320313928234,0.5286021539312842,0.9548387096774194,0.9931383423466852,1.0,2/10,15.60%,CAMK2D;NEDD4
prerank,regulation of interleukin-1 production (GO:0032652),0.23696339303018943,0.526358218573181,0.9673105497771174,0.9935739749650658,1.0,4/15,21.82%,ANXA1;FOXP1;SIRPA;NLRP12
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.18403867888986564,-0.5241084655305123,0.9833333333333333,0.9926603991773566,1.0,17/17,81.62%,DERL1;UFD1;NPLOC4;TMEM129;SEL1L;VCP;HERPUD1;SELENOS;SYVN1;AUP1;FAF2;DERL2;SEC61B;OS9;HM13;HSP90B1;RHBDD1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2462835844416314,0.5230023058323117,0.9650793650793651,0.994349804561364,1.0,1/11,8.72%,PXDN
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.23197773865403604,0.522244394027137,0.9641791044776119,0.994263075716025,1.0,2/17,7.66%,BAG6;EMC7
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.1954801191301365,0.5216609552978482,0.98676293622142,0.9941089967012432,1.0,4/49,7.11%,BBC3;BCL2;BCL2L2;NOC2L
prerank,RNA stabilization (GO:0043489),0.206629156677002,0.5198964057550699,0.9899749373433584,0.9943493650745313,1.0,8/33,21.73%,E2F1;TENT5A;ZCCHC17;THRAP3;AXIN2;PARN;GDNF;YBX1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.17532174484829677,0.5190660805788235,0.9978969505783386,0.9942933793947687,1.0,10/117,10.01%,MTHFD1L;ACSL4;ACADSB;ALDH1A2;CD36;PPARG;LPL;CYP1A1;PANK2;ACSF2
prerank,water transport (GO:0006833),0.24624730515792184,0.5190282919737057,0.9839486356340289,0.9939616586048933,1.0,1/12,11.38%,PDPN
prerank,protein K48-linked deubiquitination (GO:0071108),0.2133392076374242,0.5160491274044866,0.9826897470039947,0.9945572878083118,1.0,3/23,14.40%,TNFAIP3;OTUD3;VCPIP1
prerank,nuclear envelope organization (GO:0006998),0.21984945952977686,0.5152962895913259,0.9765193370165746,0.9944432522059808,1.0,4/20,18.43%,VPS4A;LEMD2;SUN1;TOR1AIP1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.21169331772847078,0.515016755019957,0.9717741935483871,0.9941911971250057,1.0,4/23,18.76%,SEC16A;LMAN1;SEC13;HSP90B1
prerank,regulation of ruffle assembly (GO:1900027),0.21283880916307496,0.5144666581735058,0.9773030707610146,0.9940239982358865,1.0,8/23,27.03%,ARHGAP24;NDEL1;EPS8;DEF8;P2RY12;PFN2;PLEKHM1;FAM98A
prerank,cellular response to cadmium ion (GO:0071276),0.2113469753344279,0.5107690355491128,0.9800796812749004,0.994755000858691,1.0,3/24,17.14%,EGFR;MAPK1;AKT1
prerank,positive regulation of telomere maintenance (GO:0032206),0.20707217962263932,0.5092876002637405,0.986737400530504,0.9948433651277632,1.0,9/31,23.02%,ATM;GNL3;ATRX;TNKS2;PNKP;MAPK1;PKIB;SLX4;MAP2K7
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.21510526016337828,0.509161755420405,0.9758064516129032,0.9945332310674889,1.0,4/23,17.16%,PLA2G12A;PLA2G4A;PLA2G4E;LPCAT3
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.24970381327745528,0.5090407844701483,0.9691558441558441,0.9942275763527793,1.0,5/10,27.62%,TUT7;ISG15;RPS27A;CHFR;DIS3L2
prerank,aerobic respiration (GO:0009060),0.21934280637053366,0.5084863024154775,0.9760225669957687,0.994043251441941,1.0,5/20,18.51%,SDHB;UQCRC1;SIRT3;NDUFS7;NDUFS8
prerank,nuclear pore complex assembly (GO:0051292),0.24389076238601767,0.5058946680718354,0.9530744336569579,0.9944133022693519,1.0,3/10,20.96%,NUP153;NDC1;NUP107
prerank,apoptotic DNA fragmentation (GO:0006309),0.2268081485888764,0.5056552279469216,0.9737991266375546,0.9941328532335804,1.0,2/16,10.06%,DICER1;HMGB2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.25133760385958864,0.5053754163276051,0.9469320066334992,0.993863243337524,1.0,2/10,15.77%,EMC7;EMC1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.21275185385150605,0.5051509927848576,0.979253112033195,0.9935838892960682,1.0,6/22,26.46%,PTPRJ;PTPN2;PRNP;UBASH3A;THY1;CD300A
prerank,regulation of gastrulation (GO:0010470),0.23114935166403783,0.5045423418862305,0.9750390015600624,0.9934025894849117,1.0,3/14,17.92%,TENM4;PHLDB2;PHLDB1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.21455634667747678,0.5039284756314102,0.9801980198019802,0.9928841116315062,1.0,8/19,27.70%,ATRX;POLR2L;POLR2K;TERF1;POLR2D;TERF2IP;TERF2;TINF2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.21455634667747678,0.5039284756314102,0.9801980198019802,0.9928841116315062,1.0,8/19,27.70%,ATRX;POLR2L;POLR2K;TERF1;POLR2D;TERF2IP;TERF2;TINF2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.21700576257695153,0.5037921448976409,0.9802538787023978,0.9925775026659115,1.0,2/18,12.76%,BCL2;SPG7
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.18399589267181649,0.501963097041053,0.9988317757009346,0.9927321119930841,1.0,11/55,21.19%,BBC3;BCL2;TNFRSF12A;TGFBR1;TNF;TRAF2;RIPK1;ING5;AGT;TNFSF12;BECN1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.2191967106192429,0.5002716847765158,0.972027972027972,0.9928285660062484,1.0,2/18,10.32%,TRIM13;UGGT2
prerank,reticulophagy (GO:0061709),0.23262614940952417,0.5001040990742031,0.973293768545994,0.9925300790317715,1.0,2/12,13.32%,UBA5;DDRGK1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.23358443188951666,0.49985195581115943,0.9732540861812778,0.992249130359009,1.0,13/13,76.66%,DOC2B;SYT10;CACNA1H;CACNA1G;ZP3;SYT4;CLTRN;STX1A;SYT1;HYAL3;KCNB1;SCAMP5;CACNA1I
prerank,snRNA processing (GO:0016180),0.2204558075585108,0.4983029219265479,0.9602941176470589,0.9923007460665291,1.0,5/16,24.05%,INTS1;INTS4;INTS14;INTS8;INTS6L
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.18594170226878814,0.4970685494445209,0.9925373134328358,0.9922646673041887,1.0,10/40,24.29%,KMT5A;NEK4;FMR1;NPAS2;CDK9;FBXO5;HMGA2;PRKCD;ETAA1;FXR2
prerank,response to cadmium ion (GO:0046686),0.20170299082966664,0.49657240159175203,0.9830729166666666,0.9920374562663155,1.0,3/26,17.14%,EGFR;MAPK1;AKT1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.1582188110837208,-0.4959046690013684,0.9920634920634921,0.9971888622002429,1.0,13/23,44.39%,CALM1;METAP2;SAG;PDE6A;GUCA1B;CNGB1;PPEF1;PDE6G;NMT1;PDE6B;NMT2;GUCY2D;GUCY2F
prerank,cGMP metabolic process (GO:0046068),0.2357798619710963,0.4947883415628326,0.9772036474164134,0.9921480790883492,1.0,1/12,6.15%,NPR2
prerank,motile cilium assembly (GO:0044458),-0.18842705310411212,-0.48346403281632727,0.9885386819484241,0.9979026435859794,1.0,7/12,50.57%,CCDC39;DNAAF3;E2F4;CCDC40;RSPH6A;DNAAF1;BBS5
prerank,copper ion homeostasis (GO:0055070),0.21650259055735868,0.482939566798299,0.9798850574712644,0.9945057305734897,1.0,5/17,22.96%,SLC31A1;ARF1;ATP7A;PRNP;SLC31A2
prerank,telomere capping (GO:0016233),0.21056061616083696,0.4795538081386182,0.9742120343839542,0.9948752135117311,1.0,7/16,27.70%,DCLRE1C;CTC1;PRKDC;TERF1;TERF2IP;TERF2;TINF2
prerank,fluid transport (GO:0042044),0.22241107876796537,0.47469162067339177,0.9776714513556619,0.9954685026131826,1.0,1/12,11.38%,PDPN
prerank,vacuolar acidification (GO:0007035),0.20145481064207554,0.47371084059087765,0.9832869080779945,0.9953086548325638,1.0,3/21,12.91%,ATP6AP2;CLN6;ATP6V1H
prerank,cardiolipin metabolic process (GO:0032048),0.21839923151851998,0.47248117395296996,0.9764705882352941,0.9952042769769884,1.0,2/13,14.60%,PGS1;PLA2G4A
prerank,cellular response to alkaloid (GO:0071312),0.20569324234304215,0.47158891114951224,0.9741750358680057,0.9950248913266978,1.0,4/17,23.20%,CASP7;HTR1B;GSTM2;RAD51
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.18247107826991363,0.46590113184814674,0.9962358845671268,0.9956789744997285,1.0,10/33,27.82%,PRKD2;PTPRJ;PTPN2;PRNP;UBASH3A;RELA;THY1;CD300A;RPS3;RAB29
prerank,axoneme assembly (GO:0035082),-0.13793155834936346,-0.46135142855784966,1.0,0.999456590386813,1.0,12/30,36.64%,CCDC39;RP1;TTLL3;DNAAF3;LRGUK;SPAG1;GAS8;DRC1;JHY;FOXJ1;CCDC65;DNAAF2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2130736113041563,0.4564588574998008,0.9839650145772595,0.9968331459337292,1.0,4/14,25.18%,TIRAP;YBX3;HNRNPC;MYD88
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.1716886377903327,-0.4555743401773045,0.9970588235294118,0.998851733744227,1.0,13/13,82.85%,AQP11;WFS1;NR1H2;MBTPS2;ALOX5;MANF;USP19;FCGR2B;NUPR1;NR1H3;CLU;EIF2AK3;LPCAT3
prerank,regulation of DNA metabolic process (GO:0051052),0.17134479575812134,0.4549971190527543,0.9951515151515151,0.9966959913123974,1.0,12/44,25.72%,TOM1L1;SUB1;SMG6;NUCKS1;CDK9;KAT7;KPNA2;HDAC8;MPHOSPH8;SMG5;TERF2IP;TERF2
prerank,cellular response to purine-containing compound (GO:0071415),0.2214899893303208,0.4549148576945612,0.9742765273311897,0.9963667382779845,1.0,10/10,77.86%,GSTM2;TRPM2;SLC8A1;CACNA1S;RYR1;RYR3;P2RY1;RYR2;CASQ2;P2RY6
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.20749378895420517,0.45206627011021444,0.9908814589665653,0.9964265398928267,1.0,6/15,28.85%,DDRGK1;GLI1;CDC73;KLHL18;PAF1;EZH2
prerank,leukotriene biosynthetic process (GO:0019370),0.20628925889102662,0.4517121293359849,0.9855699855699855,0.9961352445397181,1.0,2/14,15.89%,PLA2G4A;GGT7
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.18282653570613355,-0.45065705286845964,0.9972375690607734,0.9980962069475167,1.0,3/12,24.86%,DCK;DHODH;CDA
prerank,aromatic amino acid family catabolic process (GO:0009074),0.20533252017316267,0.448162678799637,0.9836065573770492,0.9962696319709025,1.0,1/15,7.20%,KYAT1
prerank,DNA conformation change (GO:0071103),0.19582402077957978,0.44087817871203266,0.9913669064748202,0.9968296144025671,1.0,2/17,11.17%,HMGB2;TOP2B
prerank,termination of RNA polymerase II transcription (GO:0006369),0.1731001865332298,0.4376233122830541,0.9987261146496815,0.9968687935932071,1.0,8/33,24.17%,CSTF1;TTF2;NCBP2;SETX;SNRPB;PCF11;FIP1L1;CPSF3
prerank,nucleoside salvage (GO:0043174),-0.18094520805874598,-0.428207703330754,1.0,0.9984400475141492,1.0,10/10,81.92%,DCK;CDA;UPP1;UPP2;HPRT1;UCK1;TK2;TK1;UCK2;UCKL1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.17238901622774377,0.424830367105985,0.9973924380704041,0.997883789549952,1.0,13/29,30.71%,NOP14;UTP3;DHX37;BMS1;KRI1;RRP36;TSR1;RRS1;HELB;UTP6;TBL3;UTP4;HEATR1
prerank,nuclear transport (GO:0051169),0.18390155082564197,0.4175318439361567,0.9865067466266867,0.9981799761084313,1.0,16/16,81.63%,ANP32A;XPO1;RSRC1;AAAS;NXT2;NXT1;RBM15B;RGS14;CITED1;PSIP1;HMGA1;NUP205;NPM1;BANF1;NUTF2;NUP98
prerank,positive regulation of telomere capping (GO:1904355),0.18507469627986223,0.4173170223663343,0.9926470588235294,0.9978584898608597,1.0,5/17,23.02%,TNKS2;PNKP;MAPK1;PKIB;MAP2K7
prerank,regulation of chromosome organization (GO:0033044),0.17288986560738762,0.41122177530713677,0.9947019867549669,0.9979972723271561,1.0,7/22,25.72%,SMG6;SETMAR;WAPL;HDAC8;SMG5;TERF2IP;TERF2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.16883736637601338,0.39679254875588776,0.9945054945054945,0.998249303054828,1.0,4/22,17.93%,ZDHHC6;ZDHHC9;ZDHHC3;CLIP3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.16883736637601338,0.39679254875588776,0.9945054945054945,0.998249303054828,1.0,4/22,17.93%,ZDHHC6;ZDHHC9;ZDHHC3;CLIP3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.15354385554613942,0.38113438938873884,0.9987129987129987,0.9986535274880558,1.0,4/29,17.16%,PLA2G12A;PLA2G4A;PLA2G4E;LPCAT3
